CREATE OR REPLACE PROCEDURE SP0301_insert_ndc_codes(schema_name text, table_name text,logtbl_name text)
LANGUAGE plpgsql
AS $$
BEGIN
-- Log initiation message
        BEGIN
            CALL SP0019_log_initiation(schema_name,logtbl_name,'SP0301_insert_ndc_codes');   
        END;
BEGIN
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-0800_b02ed630-6947-431a-a8c8-227571403941','0002-0800','HUMAN OTC DRUG','Sterile Diluent','','diluent','INJECTION, SOLUTION','SUBCUTANEOUS','19870710','','BLA','BLA018781','Eli Lilly and Company','WATER','1','mL/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-1200_c731b9c5-eaa5-4310-9c0a-11df9268b9ae','0002-1200','HUMAN PRESCRIPTION DRUG','Amyvid','','Florbetapir F 18','INJECTION, SOLUTION','INTRAVENOUS','20120601','','NDA','NDA202008','Eli Lilly and Company','FLORBETAPIR F-18','51','mCi/mL','Positron Emitting Activity [MoA], Radioactive Diagnostic Agent [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-1210_d03b2693-0231-4df4-a037-63017a42e85a','0002-1210','HUMAN PRESCRIPTION DRUG','TAUVID','','Flortaucipir F-18','INJECTION, SOLUTION','INTRAVENOUS','20200528','','NDA','NDA212123','Eli Lilly and Company','FLORTAUCIPIR F-18','51','mCi/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-1220_d03b2693-0231-4df4-a037-63017a42e85a','0002-1220','HUMAN PRESCRIPTION DRUG','TAUVID','','Flortaucipir F-18','INJECTION, SOLUTION','INTRAVENOUS','20220701','','NDA','NDA212123','Eli Lilly and Company','FLORTAUCIPIR F-18','100','mCi/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-1433_547fdc66-8f4c-422d-ac7d-b78865738ce0','0002-1433','HUMAN PRESCRIPTION DRUG','Trulicity','','Dulaglutide','INJECTION, SOLUTION','SUBCUTANEOUS','20140918','','BLA','BLA125469','Eli Lilly and Company','DULAGLUTIDE','0.75','mg/.5mL','GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-1434_547fdc66-8f4c-422d-ac7d-b78865738ce0','0002-1434','HUMAN PRESCRIPTION DRUG','Trulicity','','Dulaglutide','INJECTION, SOLUTION','SUBCUTANEOUS','20140918','','BLA','BLA125469','Eli Lilly and Company','DULAGLUTIDE','1.5','mg/.5mL','GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-1436_bec46346-20b5-4dbe-bac3-b8564e906941','0002-1436','HUMAN PRESCRIPTION DRUG','EMGALITY','','galcanezumab-gnlm','INJECTION, SOLUTION','SUBCUTANEOUS','20180927','','BLA','BLA761063','Eli Lilly and Company','GALCANEZUMAB','120','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-1445_39e9a0c8-fced-467c-a773-4c07d7ba060c','0002-1445','HUMAN PRESCRIPTION DRUG','TALTZ','','ixekizumab','INJECTION, SOLUTION','SUBCUTANEOUS','20160322','','BLA','BLA125521','Eli Lilly and Company','IXEKIZUMAB','80','mg/mL','Interleukin-17A Antagonist [EPC], Interleukin-17A Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-1457_4cba6058-0d84-40ce-8edb-1505a27050e9','0002-1457','HUMAN PRESCRIPTION DRUG','MOUNJARO','','tirzepatide','INJECTION, SOLUTION','SUBCUTANEOUS','20220513','','NDA','NDA215866','Eli Lilly and Company','TIRZEPATIDE','15','mg/.5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-1460_4cba6058-0d84-40ce-8edb-1505a27050e9','0002-1460','HUMAN PRESCRIPTION DRUG','MOUNJARO','','tirzepatide','INJECTION, SOLUTION','SUBCUTANEOUS','20220513','','NDA','NDA215866','Eli Lilly and Company','TIRZEPATIDE','12.5','mg/.5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-1471_4cba6058-0d84-40ce-8edb-1505a27050e9','0002-1471','HUMAN PRESCRIPTION DRUG','MOUNJARO','','tirzepatide','INJECTION, SOLUTION','SUBCUTANEOUS','20220513','','NDA','NDA215866','Eli Lilly and Company','TIRZEPATIDE','10','mg/.5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-1484_4cba6058-0d84-40ce-8edb-1505a27050e9','0002-1484','HUMAN PRESCRIPTION DRUG','MOUNJARO','','tirzepatide','INJECTION, SOLUTION','SUBCUTANEOUS','20220513','','NDA','NDA215866','Eli Lilly and Company','TIRZEPATIDE','7.5','mg/.5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-1495_4cba6058-0d84-40ce-8edb-1505a27050e9','0002-1495','HUMAN PRESCRIPTION DRUG','MOUNJARO','','tirzepatide','INJECTION, SOLUTION','SUBCUTANEOUS','20220513','','NDA','NDA215866','Eli Lilly and Company','TIRZEPATIDE','5','mg/.5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-1506_4cba6058-0d84-40ce-8edb-1505a27050e9','0002-1506','HUMAN PRESCRIPTION DRUG','MOUNJARO','','tirzepatide','INJECTION, SOLUTION','SUBCUTANEOUS','20220513','','NDA','NDA215866','Eli Lilly and Company','TIRZEPATIDE','2.5','mg/.5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-2236_547fdc66-8f4c-422d-ac7d-b78865738ce0','0002-2236','HUMAN PRESCRIPTION DRUG','Trulicity','','Dulaglutide','INJECTION, SOLUTION','SUBCUTANEOUS','20200903','','BLA','BLA125469','Eli Lilly and Company','DULAGLUTIDE','3','mg/.5mL','GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-2377_bec46346-20b5-4dbe-bac3-b8564e906941','0002-2377','HUMAN PRESCRIPTION DRUG','EMGALITY','','galcanezumab-gnlm','INJECTION, SOLUTION','SUBCUTANEOUS','20180927','','BLA','BLA761063','Eli Lilly and Company','GALCANEZUMAB','120','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-2980_1ebfa429-955a-4e8b-a1bf-b77f5e790780','0002-2980','HUMAN PRESCRIPTION DRUG','RETEVMO','','selpercatinib','CAPSULE','ORAL','20200508','','NDA','NDA213246','Eli Lilly and Company','SELPERCATINIB','80','mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Rearranged during Transfection (RET) Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-3115_bec46346-20b5-4dbe-bac3-b8564e906941','0002-3115','HUMAN PRESCRIPTION DRUG','EMGALITY','','galcanezumab-gnlm','INJECTION, SOLUTION','SUBCUTANEOUS','20190604','','BLA','BLA761063','Eli Lilly and Company','GALCANEZUMAB','100','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-3182_547fdc66-8f4c-422d-ac7d-b78865738ce0','0002-3182','HUMAN PRESCRIPTION DRUG','Trulicity','','Dulaglutide','INJECTION, SOLUTION','SUBCUTANEOUS','20200903','','BLA','BLA125469','Eli Lilly and Company','DULAGLUTIDE','4.5','mg/.5mL','GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-3227_6963b20c-fce1-414e-90b6-5d0730f93191','0002-3227','HUMAN PRESCRIPTION DRUG','Strattera','','Atomoxetine hydrochloride','CAPSULE','ORAL','20021126','','NDA','NDA021411','Eli Lilly and Company','ATOMOXETINE HYDROCHLORIDE','10','mg/1','Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-3228_6963b20c-fce1-414e-90b6-5d0730f93191','0002-3228','HUMAN PRESCRIPTION DRUG','Strattera','','Atomoxetine hydrochloride','CAPSULE','ORAL','20021126','','NDA','NDA021411','Eli Lilly and Company','ATOMOXETINE HYDROCHLORIDE','25','mg/1','Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-3229_6963b20c-fce1-414e-90b6-5d0730f93191','0002-3229','HUMAN PRESCRIPTION DRUG','Strattera','','Atomoxetine hydrochloride','CAPSULE','ORAL','20021126','','NDA','NDA021411','Eli Lilly and Company','ATOMOXETINE HYDROCHLORIDE','40','mg/1','Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-3230_ddf34e1e-b997-44af-81af-fafed67b5ee2','0002-3230','HUMAN PRESCRIPTION DRUG','Symbyax','','Olanzapine and Fluoxetine hydrochloride','CAPSULE','ORAL','20070409','','NDA','NDA021520','Eli Lilly and Company','FLUOXETINE HYDROCHLORIDE; OLANZAPINE','25; 3','mg/1; mg/1','Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-3231_ddf34e1e-b997-44af-81af-fafed67b5ee2','0002-3231','HUMAN PRESCRIPTION DRUG','Symbyax','','Olanzapine and Fluoxetine hydrochloride','CAPSULE','ORAL','20031224','','NDA','NDA021520','Eli Lilly and Company','FLUOXETINE HYDROCHLORIDE; OLANZAPINE','25; 6','mg/1; mg/1','Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-3235_892f05de-dd11-4ae3-9a85-ce9cfcbeaacc','0002-3235','HUMAN PRESCRIPTION DRUG','Cymbalta','','Duloxetine hydrochloride','CAPSULE, DELAYED RELEASE','ORAL','20040824','','NDA','NDA021427','Eli Lilly and Company','DULOXETINE HYDROCHLORIDE','20','mg/1','Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-3238_6963b20c-fce1-414e-90b6-5d0730f93191','0002-3238','HUMAN PRESCRIPTION DRUG','Strattera','','Atomoxetine hydrochloride','CAPSULE','ORAL','20021126','','NDA','NDA021411','Eli Lilly and Company','ATOMOXETINE HYDROCHLORIDE','18','mg/1','Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-3239_6963b20c-fce1-414e-90b6-5d0730f93191','0002-3239','HUMAN PRESCRIPTION DRUG','Strattera','','Atomoxetine hydrochloride','CAPSULE','ORAL','20021126','','NDA','NDA021411','Eli Lilly and Company','ATOMOXETINE HYDROCHLORIDE','60','mg/1','Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-3240_892f05de-dd11-4ae3-9a85-ce9cfcbeaacc','0002-3240','HUMAN PRESCRIPTION DRUG','Cymbalta','','Duloxetine hydrochloride','CAPSULE, DELAYED RELEASE','ORAL','20040824','','NDA','NDA021427','Eli Lilly and Company','DULOXETINE HYDROCHLORIDE','30','mg/1','Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-3250_6963b20c-fce1-414e-90b6-5d0730f93191','0002-3250','HUMAN PRESCRIPTION DRUG','Strattera','','Atomoxetine hydrochloride','CAPSULE','ORAL','20050214','','NDA','NDA021411','Eli Lilly and Company','ATOMOXETINE HYDROCHLORIDE','80','mg/1','Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-3251_6963b20c-fce1-414e-90b6-5d0730f93191','0002-3251','HUMAN PRESCRIPTION DRUG','Strattera','','Atomoxetine hydrochloride','CAPSULE','ORAL','20050214','','NDA','NDA021411','Eli Lilly and Company','ATOMOXETINE HYDROCHLORIDE','100','mg/1','Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-3270_892f05de-dd11-4ae3-9a85-ce9cfcbeaacc','0002-3270','HUMAN PRESCRIPTION DRUG','Cymbalta','','Duloxetine hydrochloride','CAPSULE, DELAYED RELEASE','ORAL','20100115','','NDA','NDA021427','Eli Lilly and Company','DULOXETINE HYDROCHLORIDE','60','mg/1','Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-3977_1ebfa429-955a-4e8b-a1bf-b77f5e790780','0002-3977','HUMAN PRESCRIPTION DRUG','RETEVMO','','selpercatinib','CAPSULE','ORAL','20200508','','NDA','NDA213246','Eli Lilly and Company','SELPERCATINIB','40','mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Rearranged during Transfection (RET) Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4112_8008d181-4679-4320-a624-0072056c40c7','0002-4112','HUMAN PRESCRIPTION DRUG','Zyprexa','','Olanzapine','TABLET','ORAL','19970623','','NDA','NDA020592','Eli Lilly and Company','OLANZAPINE','2.5','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4115_8008d181-4679-4320-a624-0072056c40c7','0002-4115','HUMAN PRESCRIPTION DRUG','Zyprexa','','Olanzapine','TABLET','ORAL','19961001','','NDA','NDA020592','Eli Lilly and Company','OLANZAPINE','5','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4116_8008d181-4679-4320-a624-0072056c40c7','0002-4116','HUMAN PRESCRIPTION DRUG','Zyprexa','','Olanzapine','TABLET','ORAL','19961001','','NDA','NDA020592','Eli Lilly and Company','OLANZAPINE','7.5','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4117_8008d181-4679-4320-a624-0072056c40c7','0002-4117','HUMAN PRESCRIPTION DRUG','Zyprexa','','Olanzapine','TABLET','ORAL','19961001','','NDA','NDA020592','Eli Lilly and Company','OLANZAPINE','10','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4182_15ef688b-408f-4678-96b6-20068241d6db','0002-4182','HUMAN PRESCRIPTION DRUG','Olumiant','','baricitinib','TABLET, FILM COATED','ORAL','20180531','','NDA','NDA207924','Eli Lilly and Company','BARICITINIB','2','mg/1','Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4184_622b3137-725b-4beb-a9a1-1dc0a6c2f1d9','0002-4184','HUMAN PRESCRIPTION DRUG','Evista','','Raloxifene hydrochloride','TABLET','ORAL','19980106','','NDA','NDA020815','Eli Lilly and Company','RALOXIFENE HYDROCHLORIDE','60','mg/1','Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4312_5ef14cf2-d634-4a7b-9254-4cc480e8a48d','0002-4312','HUMAN PRESCRIPTION DRUG','Reyvow','','lasmiditan','TABLET','ORAL','20191011','','NDA','NDA211280','Eli Lilly and Company','LASMIDITAN','50','mg/1','','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4415_8008d181-4679-4320-a624-0072056c40c7','0002-4415','HUMAN PRESCRIPTION DRUG','Zyprexa','','Olanzapine','TABLET','ORAL','20000110','','NDA','NDA020592','Eli Lilly and Company','OLANZAPINE','15','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4420_8008d181-4679-4320-a624-0072056c40c7','0002-4420','HUMAN PRESCRIPTION DRUG','Zyprexa','','Olanzapine','TABLET','ORAL','20010301','','NDA','NDA020592','Eli Lilly and Company','OLANZAPINE','20','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4453_8008d181-4679-4320-a624-0072056c40c7','0002-4453','HUMAN PRESCRIPTION DRUG','ZYPREXA','Zydis','Olanzapine','TABLET, ORALLY DISINTEGRATING','ORAL','20000601','','NDA','NDA021086','Eli Lilly and Company','OLANZAPINE','5','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4454_8008d181-4679-4320-a624-0072056c40c7','0002-4454','HUMAN PRESCRIPTION DRUG','ZYPREXA','Zydis','Olanzapine','TABLET, ORALLY DISINTEGRATING','ORAL','20000601','','NDA','NDA021086','Eli Lilly and Company','OLANZAPINE','10','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4455_8008d181-4679-4320-a624-0072056c40c7','0002-4455','HUMAN PRESCRIPTION DRUG','ZYPREXA','Zydis','Olanzapine','TABLET, ORALLY DISINTEGRATING','ORAL','20010901','','NDA','NDA021086','Eli Lilly and Company','OLANZAPINE','15','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4456_8008d181-4679-4320-a624-0072056c40c7','0002-4456','HUMAN PRESCRIPTION DRUG','ZYPREXA','Zydis','Olanzapine','TABLET, ORALLY DISINTEGRATING','ORAL','20010901','','NDA','NDA021086','Eli Lilly and Company','OLANZAPINE','20','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4462_05dbd8b6-1b9d-436a-a67c-8a16713f753f','0002-4462','HUMAN PRESCRIPTION DRUG','Cialis','','Tadalafil','TABLET, FILM COATED','ORAL','20031126','','NDA','NDA021368','Eli Lilly and Company','TADALAFIL','5','mg/1','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4463_05dbd8b6-1b9d-436a-a67c-8a16713f753f','0002-4463','HUMAN PRESCRIPTION DRUG','Cialis','','Tadalafil','TABLET, FILM COATED','ORAL','20031126','','NDA','NDA021368','Eli Lilly and Company','TADALAFIL','10','mg/1','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4464_05dbd8b6-1b9d-436a-a67c-8a16713f753f','0002-4464','HUMAN PRESCRIPTION DRUG','Cialis','','Tadalafil','TABLET, FILM COATED','ORAL','20031126','','NDA','NDA021368','Eli Lilly and Company','TADALAFIL','20','mg/1','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4465_05dbd8b6-1b9d-436a-a67c-8a16713f753f','0002-4465','HUMAN PRESCRIPTION DRUG','Cialis','','Tadalafil','TABLET, FILM COATED','ORAL','20080107','','NDA','NDA021368','Eli Lilly and Company','TADALAFIL','2.5','mg/1','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4479_15ef688b-408f-4678-96b6-20068241d6db','0002-4479','HUMAN PRESCRIPTION DRUG','Olumiant','','baricitinib','TABLET, FILM COATED','ORAL','20220510','','NDA','NDA207924','Eli Lilly and Company','BARICITINIB','4','mg/1','Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4483_977140a1-3e11-4020-b744-4edad117cf97','0002-4483','HUMAN PRESCRIPTION DRUG','Verzenio','','abemaciclib','TABLET','ORAL','20170928','','NDA','NDA208716','Eli Lilly and Company','ABEMACICLIB','50','mg/1','Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4491_5ef14cf2-d634-4a7b-9254-4cc480e8a48d','0002-4491','HUMAN PRESCRIPTION DRUG','Reyvow','','lasmiditan','TABLET','ORAL','20191011','','NDA','NDA211280','Eli Lilly and Company','LASMIDITAN','100','mg/1','','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4732_15ef688b-408f-4678-96b6-20068241d6db','0002-4732','HUMAN PRESCRIPTION DRUG','Olumiant','','baricitinib','TABLET, FILM COATED','ORAL','20191008','','NDA','NDA207924','Eli Lilly and Company','BARICITINIB','1','mg/1','Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-4815_977140a1-3e11-4020-b744-4edad117cf97','0002-4815','HUMAN PRESCRIPTION DRUG','Verzenio','','abemaciclib','TABLET','ORAL','20170928','','NDA','NDA208716','Eli Lilly and Company','ABEMACICLIB','100','mg/1','Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-5337_977140a1-3e11-4020-b744-4edad117cf97','0002-5337','HUMAN PRESCRIPTION DRUG','Verzenio','','abemaciclib','TABLET','ORAL','20170928','','NDA','NDA208716','Eli Lilly and Company','ABEMACICLIB','150','mg/1','Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-6145_f88837b4-7c0d-4200-aba0-e92561310058','0002-6145','HUMAN PRESCRIPTION DRUG','Baqsimi','','glucagon','POWDER','NASAL','20190724','','NDA','NDA210134','Eli Lilly and Company','GLUCAGON','3','mg/1','Antihypoglycemic Agent [EPC], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-6216_977140a1-3e11-4020-b744-4edad117cf97','0002-6216','HUMAN PRESCRIPTION DRUG','Verzenio','','abemaciclib','TABLET','ORAL','20170928','','NDA','NDA208716','Eli Lilly and Company','ABEMACICLIB','200','mg/1','Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-6885_14a2ffe3-1d7e-4d1b-ac44-1698d5f92da4','0002-6885','HUMAN PRESCRIPTION DRUG','Baricitinib','','baricitinib','TABLET, FILM COATED','ORAL','20211220','','EMERGENCY USE AUTHORIZATION','','Eli Lilly and Company','BARICITINIB','4','mg/1','Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-6902_619c71c0-de59-4bcf-a98b-cf6b78280395','0002-6902','HUMAN PRESCRIPTION DRUG','JAYPIRCA','','pirtobrutinib','TABLET, COATED','ORAL','20230127','','NDA','NDA216059','Eli Lilly and Company','PIRTOBRUTINIB','50','mg/1','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7026_619c71c0-de59-4bcf-a98b-cf6b78280395','0002-7026','HUMAN PRESCRIPTION DRUG','JAYPIRCA','','pirtobrutinib','TABLET, COATED','ORAL','20230127','','NDA','NDA216059','Eli Lilly and Company','PIRTOBRUTINIB','100','mg/1','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7510_8fddc939-55b9-48ca-8d3b-171df8b0d937','0002-7510','HUMAN PRESCRIPTION DRUG','Humalog','','Insulin lispro','INJECTION, SOLUTION','INTRAVENOUS; SUBCUTANEOUS','19960614','','BLA','BLA020563','Eli Lilly and Company','INSULIN LISPRO','100','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7511_de1fc777-5d7c-4247-a6d9-6299404ef402','0002-7511','HUMAN PRESCRIPTION DRUG','Humalog','Mix75/25','Insulin lispro','INJECTION, SUSPENSION','SUBCUTANEOUS','19991222','','BLA','BLA021017','Eli Lilly and Company','INSULIN LISPRO','100','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7512_b2e34993-838d-4e33-bf5e-c9fa4920a536','0002-7512','HUMAN PRESCRIPTION DRUG','Humalog','Mix50/50','Insulin lispro','INJECTION, SUSPENSION','SUBCUTANEOUS','19991222','','BLA','BLA021018','Eli Lilly and Company','INSULIN LISPRO','100','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7516_8fddc939-55b9-48ca-8d3b-171df8b0d937','0002-7516','HUMAN PRESCRIPTION DRUG','Humalog','','Insulin lispro','INJECTION, SOLUTION','INTRAVENOUS; SUBCUTANEOUS','19980220','','BLA','BLA020563','Eli Lilly and Company','INSULIN LISPRO','100','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7589_7d1166d8-d772-4106-9aed-03b1ec583d7b','0002-7589','HUMAN PRESCRIPTION DRUG','Bebtelovimab','','Bebtelovimab','INJECTION, SOLUTION','INTRAVENOUS','20220211','','EMERGENCY USE AUTHORIZATION','','Eli Lilly and Company','BEBTELOVIMAB','87.5','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7597_8008d181-4679-4320-a624-0072056c40c7','0002-7597','HUMAN PRESCRIPTION DRUG','ZYPREXA','Intramuscular','Olanzapine','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR','20040401','','NDA','NDA021253','Eli Lilly and Company','OLANZAPINE','10','mg/2mL','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7623_69c9c01f-91a8-4af4-9405-ad5d0a61adc4','0002-7623','HUMAN PRESCRIPTION DRUG','Alimta','','Pemetrexed disodium','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20040204','','NDA','NDA021462','Eli Lilly and Company','PEMETREXED DISODIUM HEPTAHYDRATE','500','mg/20mL','Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7635_0a5b6cfe-5486-4622-a362-f1afd9bd8f56','0002-7635','HUMAN PRESCRIPTION DRUG','ZYPREXA','Relprevv','Olanzapine pamoate','KIT','INTRAMUSCULAR','20091211','','NDA','NDA022173','Eli Lilly and Company','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7636_0a5b6cfe-5486-4622-a362-f1afd9bd8f56','0002-7636','HUMAN PRESCRIPTION DRUG','ZYPREXA','Relprevv','Olanzapine pamoate','KIT','INTRAMUSCULAR','20091211','','NDA','NDA022173','Eli Lilly and Company','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7637_0a5b6cfe-5486-4622-a362-f1afd9bd8f56','0002-7637','HUMAN PRESCRIPTION DRUG','ZYPREXA','Relprevv','Olanzapine pamoate','KIT','INTRAMUSCULAR','20091211','','NDA','NDA022173','Eli Lilly and Company','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7640_69c9c01f-91a8-4af4-9405-ad5d0a61adc4','0002-7640','HUMAN PRESCRIPTION DRUG','Alimta','','Pemetrexed disodium','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20070907','','NDA','NDA021462','Eli Lilly and Company','PEMETREXED DISODIUM HEPTAHYDRATE','100','mg/4mL','Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7669_5bdad737-d958-4e6d-ba05-5b3cd39b16af','0002-7669','HUMAN PRESCRIPTION DRUG','CYRAMZA','','ramucirumab','SOLUTION','INTRAVENOUS','20140421','','BLA','BLA125477','Eli Lilly and Company','RAMUCIRUMAB','10','mg/mL','VEGFR2 Inhibitors [MoA], Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7678_5bdad737-d958-4e6d-ba05-5b3cd39b16af','0002-7678','HUMAN PRESCRIPTION DRUG','CYRAMZA','','ramucirumab','SOLUTION','INTRAVENOUS','20140421','','BLA','BLA125477','Eli Lilly and Company','RAMUCIRUMAB','10','mg/mL','VEGFR2 Inhibitors [MoA], Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7712_8fddc939-55b9-48ca-8d3b-171df8b0d937','0002-7712','HUMAN PRESCRIPTION DRUG','Humalog','KwikPen','Insulin lispro','INJECTION, SOLUTION','SUBCUTANEOUS','20150526','','BLA','BLA205747','Eli Lilly and Company','INSULIN LISPRO','200','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7714_8fddc939-55b9-48ca-8d3b-171df8b0d937','0002-7714','HUMAN PRESCRIPTION DRUG','Humalog','Junior KwikPen','Insulin lispro','INJECTION, SOLUTION','SUBCUTANEOUS','20170606','','BLA','BLA020563','Eli Lilly and Company','INSULIN LISPRO','100','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7715_e7bab364-76ef-46d9-b77b-b285a8e50bc0','0002-7715','HUMAN PRESCRIPTION DRUG','BASAGLAR','KwikPen','Insulin glargine','INJECTION, SOLUTION','SUBCUTANEOUS','20151216','','BLA','BLA205692','Eli Lilly and Company','INSULIN GLARGINE','100','[iU]/mL','Insulin Analog [EPC], Insulin [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7716_62de9272-71de-4b81-8ccf-ad7806f02081','0002-7716','HUMAN PRESCRIPTION DRUG','Portrazza','','necitumumab','SOLUTION','INTRAVENOUS','20151124','','BLA','BLA125547','Eli Lilly and Company','NECITUMUMAB','16','mg/mL','Epidermal Growth Factor Receptor Antagonist [EPC], HER1 Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7724_39e9a0c8-fced-467c-a773-4c07d7ba060c','0002-7724','HUMAN PRESCRIPTION DRUG','TALTZ','','ixekizumab','INJECTION, SOLUTION','SUBCUTANEOUS','20160322','','BLA','BLA125521','Eli Lilly and Company','IXEKIZUMAB','80','mg/mL','Interleukin-17A Antagonist [EPC], Interleukin-17A Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7726_fe78d073-9574-4288-9305-039ede953938','0002-7726','HUMAN PRESCRIPTION DRUG','LYUMJEV','','Insulin lispro-aabc','INJECTION, SOLUTION','SUBCUTANEOUS','20200615','','BLA','BLA761109','Eli Lilly and Company','INSULIN LISPRO','100','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7728_fe78d073-9574-4288-9305-039ede953938','0002-7728','HUMAN PRESCRIPTION DRUG','LYUMJEV','','Insulin lispro-aabc','INJECTION, SOLUTION','INTRAVENOUS; SUBCUTANEOUS','20200615','','BLA','BLA761109','Eli Lilly and Company','INSULIN LISPRO','100','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7737_610a4eaa-8927-479e-9050-391c83a0b453','0002-7737','HUMAN PRESCRIPTION DRUG','Insulin Lispro','','Insulin lispro','INJECTION, SOLUTION','INTRAVENOUS; SUBCUTANEOUS','20200212','','BLA','BLA020563','Eli Lilly and Company','INSULIN LISPRO','100','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7752_610a4eaa-8927-479e-9050-391c83a0b453','0002-7752','HUMAN PRESCRIPTION DRUG','Insulin Lispro','Junior KwikPen','Insulin lispro','INJECTION, SOLUTION','SUBCUTANEOUS','20200212','','BLA','BLA020563','Eli Lilly and Company','INSULIN LISPRO','100','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7910_8aa4f3ff-a512-4826-b910-85ab6e89f466','0002-7910','HUMAN PRESCRIPTION DRUG','Bamlanivimab','','Bamlanivimab','INJECTION, SOLUTION','INTRAVENOUS','20201109','','EMERGENCY USE AUTHORIZATION','','Eli Lilly and Company','BAMLANIVIMAB','35','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-7950_26bc28c0-e8ff-470f-96c7-db44b1e690ab','0002-7950','HUMAN PRESCRIPTION DRUG','Etesevimab','','Etesevimab','INJECTION, SOLUTION','INTRAVENOUS','20210209','','EMERGENCY USE AUTHORIZATION','','Eli Lilly and Company','ETESEVIMAB','35','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8031_dafe3502-49b5-4720-a496-2908ba12f830','0002-8031','HUMAN PRESCRIPTION DRUG','Glucagon','','glucagon','KIT','','19990301','','NDA','NDA020928','Eli Lilly and Company','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8147_9dbfe174-cb73-45d5-aee3-1c5f3cb3d017','0002-8147','HUMAN PRESCRIPTION DRUG','HUMATROPE','','Somatropin','KIT','INTRAMUSCULAR; SUBCUTANEOUS','20060127','','BLA','BLA019640','Eli Lilly and Company','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8148_9dbfe174-cb73-45d5-aee3-1c5f3cb3d017','0002-8148','HUMAN PRESCRIPTION DRUG','HUMATROPE','','Somatropin','KIT','INTRAMUSCULAR; SUBCUTANEOUS','20060127','','BLA','BLA019640','Eli Lilly and Company','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8149_9dbfe174-cb73-45d5-aee3-1c5f3cb3d017','0002-8149','HUMAN PRESCRIPTION DRUG','HUMATROPE','','Somatropin','KIT','INTRAMUSCULAR; SUBCUTANEOUS','20060127','','BLA','BLA019640','Eli Lilly and Company','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8207_fe78d073-9574-4288-9305-039ede953938','0002-8207','HUMAN PRESCRIPTION DRUG','LYUMJEV','KwikPen','Insulin lispro-aabc','INJECTION, SOLUTION','SUBCUTANEOUS','20200615','','BLA','BLA761109','Eli Lilly and Company','INSULIN LISPRO','100','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8213_8fddc939-55b9-48ca-8d3b-171df8b0d937','0002-8213','HUMAN PRESCRIPTION DRUG','Humalog','Tempo Pen','Insulin lispro','INJECTION, SOLUTION','SUBCUTANEOUS','20170606','','BLA','BLA020563','Eli Lilly and Company','INSULIN LISPRO','100','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8214_e7bab364-76ef-46d9-b77b-b285a8e50bc0','0002-8214','HUMAN PRESCRIPTION DRUG','BASAGLAR','Tempo Pen','Insulin glargine','INJECTION, SOLUTION','SUBCUTANEOUS','20151216','','BLA','BLA205692','Eli Lilly and Company','INSULIN GLARGINE','100','[iU]/mL','Insulin Analog [EPC], Insulin [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8215_2a7e20cb-858c-4ec1-854a-f0ff2fcdee8d','0002-8215','HUMAN OTC DRUG','Humulin','R','Insulin human','INJECTION, SOLUTION','PARENTERAL','19830627','','BLA','BLA018780','Eli Lilly and Company','INSULIN HUMAN','100','[iU]/mL','Insulin [CS], Insulin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8222_610a4eaa-8927-479e-9050-391c83a0b453','0002-8222','HUMAN PRESCRIPTION DRUG','Insulin Lispro','KwikPen','Insulin lispro','INJECTION, SOLUTION','INTRAVENOUS; SUBCUTANEOUS','20200212','','BLA','BLA020563','Eli Lilly and Company','INSULIN LISPRO','100','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8228_fe78d073-9574-4288-9305-039ede953938','0002-8228','HUMAN PRESCRIPTION DRUG','LYUMJEV','KwikPen','Insulin lispro-aabc','INJECTION, SOLUTION','SUBCUTANEOUS','20200615','','BLA','BLA761109','Eli Lilly and Company','INSULIN LISPRO','200','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8233_814c8fda-e511-4281-af46-03e475754eb6','0002-8233','HUMAN PRESCRIPTION DRUG','Insulin Lispro Protamine and Insulin Lispro Injectable Suspension','Mix75/25 KwikPen','Insulin lispro','INJECTION, SUSPENSION','SUBCUTANEOUS','20200212','','BLA','BLA021017','Eli Lilly and Company','INSULIN LISPRO','100','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8235_fe78d073-9574-4288-9305-039ede953938','0002-8235','HUMAN PRESCRIPTION DRUG','LYUMJEV','Tempo Pen','Insulin lispro-aabc','INJECTION, SOLUTION','SUBCUTANEOUS','20200615','','BLA','BLA761109','Eli Lilly and Company','INSULIN LISPRO','100','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8315_b02ed630-6947-431a-a8c8-227571403941','0002-8315','HUMAN OTC DRUG','Humulin','N','Insulin human','INJECTION, SUSPENSION','SUBCUTANEOUS','19830627','','BLA','BLA018781','Eli Lilly and Company','INSULIN HUMAN','100','[iU]/mL','Insulin [CS], Insulin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8351_fe78d073-9574-4288-9305-039ede953938','0002-8351','HUMAN PRESCRIPTION DRUG','LYUMJEV','Junior KwikPen','Insulin lispro-aabc','INJECTION, SOLUTION','SUBCUTANEOUS','20200615','','BLA','BLA761109','Eli Lilly and Company','INSULIN LISPRO','100','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8400_1eae52b9-257b-4ef7-9fe3-b4110d7cf980','0002-8400','HUMAN PRESCRIPTION DRUG','Forteo','','Teriparatide','INJECTION, SOLUTION','SUBCUTANEOUS','20021126','','NDA','NDA021318','Eli Lilly and Company','TERIPARATIDE','250','ug/mL','Parathyroid Hormone Analog [EPC], Parathyroid Hormone [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8501_4af9be56-8a3a-4dca-828f-fecca8cb1f3f','0002-8501','HUMAN PRESCRIPTION DRUG','Humulin','R U-500','Insulin human','INJECTION, SOLUTION','SUBCUTANEOUS','19940331','','BLA','BLA018780','Eli Lilly and Company','INSULIN HUMAN','500','[iU]/mL','Insulin [CS], Insulin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8715_7013253a-6424-404d-a0c7-626d0770f00e','0002-8715','HUMAN OTC DRUG','Humulin','70/30','Insulin human','INJECTION, SUSPENSION','SUBCUTANEOUS','19890626','','BLA','BLA019717','Eli Lilly and Company','INSULIN HUMAN','100','[iU]/mL','Insulin [CS], Insulin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8797_de1fc777-5d7c-4247-a6d9-6299404ef402','0002-8797','HUMAN PRESCRIPTION DRUG','Humalog','Mix75/25 KwikPen','Insulin lispro','INJECTION, SUSPENSION','SUBCUTANEOUS','20070906','','BLA','BLA021017','Eli Lilly and Company','INSULIN LISPRO','100','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8798_b2e34993-838d-4e33-bf5e-c9fa4920a536','0002-8798','HUMAN PRESCRIPTION DRUG','Humalog','Mix50/50 KwikPen','Insulin lispro','INJECTION, SUSPENSION','SUBCUTANEOUS','20070906','','BLA','BLA021018','Eli Lilly and Company','INSULIN LISPRO','100','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8799_8fddc939-55b9-48ca-8d3b-171df8b0d937','0002-8799','HUMAN PRESCRIPTION DRUG','Humalog','KwikPen','Insulin lispro','INJECTION, SOLUTION','INTRAVENOUS; SUBCUTANEOUS','20070906','','BLA','BLA020563','Eli Lilly and Company','INSULIN LISPRO','100','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8803_7013253a-6424-404d-a0c7-626d0770f00e','0002-8803','HUMAN OTC DRUG','Humulin','70/30 KwikPen','Insulin human','INJECTION, SUSPENSION','SUBCUTANEOUS','20131107','','BLA','BLA019717','Eli Lilly and Company','INSULIN HUMAN','100','[iU]/mL','Insulin [CS], Insulin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8805_b02ed630-6947-431a-a8c8-227571403941','0002-8805','HUMAN OTC DRUG','Humulin','N','Insulin human','INJECTION, SUSPENSION','SUBCUTANEOUS','20131107','','BLA','BLA018781','Eli Lilly and Company','INSULIN HUMAN','100','[iU]/mL','Insulin [CS], Insulin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8824_4af9be56-8a3a-4dca-828f-fecca8cb1f3f','0002-8824','HUMAN PRESCRIPTION DRUG','Humulin','R U-500 KwikPen','Insulin human','INJECTION, SOLUTION','SUBCUTANEOUS','20151229','','BLA','BLA018780','Eli Lilly and Company','INSULIN HUMAN','500','[iU]/mL','Insulin [CS], Insulin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0002-8980_446fd274-f4e5-4f9f-9be4-0c9d74f3b14e','0002-8980','HUMAN PRESCRIPTION DRUG','Rezvoglar','KwikPen','Insulin glargine-aglr','INJECTION, SOLUTION','SUBCUTANEOUS','20211217','','BLA','BLA761215','Eli Lilly and Company','INSULIN GLARGINE','100','[iU]/mL','Insulin Analog [EPC], Insulin [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-0249_7d355981-e4d6-4d06-a2b3-eb83edce221b','0003-0249','HUMAN PRESCRIPTION DRUG','HALOG','','Halcinonide','SOLUTION','TOPICAL','20090101','','NDA','NDA017823','E.R. Squibb & Sons, L.L.C.','HALCINONIDE','1','mg/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-0293_a835d88c-1fb9-4593-827a-89b929c6c614','0003-0293','HUMAN PRESCRIPTION DRUG','KENALOG-40','','TRIAMCINOLONE ACETONIDE','INJECTION, SUSPENSION','INTRA-ARTICULAR; INTRAMUSCULAR','20090601','','NDA','NDA014901','E.R. Squibb & Sons, L.L.C.','TRIAMCINOLONE ACETONIDE','40','mg/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-0315_a835d88c-1fb9-4593-827a-89b929c6c614','0003-0315','HUMAN PRESCRIPTION DRUG','KENALOG-80','','TRIAMCINOLONE ACETONIDE','INJECTION, SUSPENSION','INTRA-ARTICULAR; INTRAMUSCULAR','20190412','','NDA','NDA014901','E.R. Squibb & Sons, L.L.C.','TRIAMCINOLONE ACETONIDE','80','mg/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-0371_9057087d-7e59-4e5a-8e4a-96a532efb0ab','0003-0371','HUMAN PRESCRIPTION DRUG','NULOJIX','','BELATACEPT','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20110615','','BLA','BLA125288','E.R. Squibb & Sons, L.L.C.','BELATACEPT','250','mg/1','CD80-directed Antibody Interactions [MoA], CD86-directed Antibody Interactions [MoA], Selective T Cell Costimulation Blocker [EPC], T Lymphocyte Costimulation Activity Blockade [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-0494_92897e18-8dd6-477d-a994-f8bf1f7203c3','0003-0494','HUMAN PRESCRIPTION DRUG','KENALOG-10','','TRIAMCINOLONE ACETONIDE','INJECTION, SUSPENSION','INTRA-ARTICULAR; INTRALESIONAL','20090601','','NDA','NDA012041','E.R. Squibb & Sons, L.L.C.','TRIAMCINOLONE ACETONIDE','10','mg/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-0524_e69fc9e9-9b62-48ef-8c2d-7e07ba2fa5cf','0003-0524','HUMAN PRESCRIPTION DRUG','SPRYCEL','','dasatinib','TABLET','ORAL','20060627','','NDA','NDA021986','E.R. Squibb & Sons, L.L.C.','DASATINIB','70','mg/1','Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-0527_e69fc9e9-9b62-48ef-8c2d-7e07ba2fa5cf','0003-0527','HUMAN PRESCRIPTION DRUG','SPRYCEL','','dasatinib','TABLET','ORAL','20060627','','NDA','NDA021986','E.R. Squibb & Sons, L.L.C.','DASATINIB','20','mg/1','Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-0528_e69fc9e9-9b62-48ef-8c2d-7e07ba2fa5cf','0003-0528','HUMAN PRESCRIPTION DRUG','SPRYCEL','','dasatinib','TABLET','ORAL','20060627','','NDA','NDA021986','E.R. Squibb & Sons, L.L.C.','DASATINIB','50','mg/1','Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-0830_ff7bec97-40a2-46a7-b441-8264c98cc1bf','0003-0830','HUMAN PRESCRIPTION DRUG','HYDREA','','HYDROXYUREA','CAPSULE','ORAL','20090601','20250331','NDA','NDA016295','E.R. Squibb & Sons, L.L.C.','HYDROXYUREA','500','mg/1','Antimetabolite [EPC], Urea [CS]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-0852_e69fc9e9-9b62-48ef-8c2d-7e07ba2fa5cf','0003-0852','HUMAN PRESCRIPTION DRUG','SPRYCEL','','dasatinib','TABLET','ORAL','20080530','','NDA','NDA021986','E.R. Squibb & Sons, L.L.C.','DASATINIB','100','mg/1','Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-0855_e69fc9e9-9b62-48ef-8c2d-7e07ba2fa5cf','0003-0855','HUMAN PRESCRIPTION DRUG','SPRYCEL','','dasatinib','TABLET','ORAL','20101028','','NDA','NDA021986','E.R. Squibb & Sons, L.L.C.','DASATINIB','80','mg/1','Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-0857_e69fc9e9-9b62-48ef-8c2d-7e07ba2fa5cf','0003-0857','HUMAN PRESCRIPTION DRUG','SPRYCEL','','dasatinib','TABLET','ORAL','20101028','','NDA','NDA021986','E.R. Squibb & Sons, L.L.C.','DASATINIB','140','mg/1','Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-0893_a260aeff-75b6-4468-bc8a-c2f8d6ac66e3','0003-0893','HUMAN PRESCRIPTION DRUG','ELIQUIS','','apixaban','TABLET, FILM COATED','ORAL','20121228','','NDA','NDA202155','E.R. Squibb & Sons, L.L.C.','APIXABAN','2.5','mg/1','Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-0894_a260aeff-75b6-4468-bc8a-c2f8d6ac66e3','0003-0894','HUMAN PRESCRIPTION DRUG','ELIQUIS','','apixaban','TABLET, FILM COATED','ORAL','20121228','','NDA','NDA202155','E.R. Squibb & Sons, L.L.C.','APIXABAN','5','mg/1','Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-0895_ff4d7258-5068-4cdf-9692-8cae04c3198e','0003-0895','HUMAN PRESCRIPTION DRUG','SOTYKTU','','deucravacitinib','TABLET, FILM COATED','ORAL','20220909','','NDA','NDA214958','E.R. Squibb & Sons, L.L.C.','DEUCRAVACITINIB','6','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-1611_9994c6a8-37e8-4ddf-964b-4dc5ee199d4a','0003-1611','HUMAN PRESCRIPTION DRUG','BARACLUDE','','entecavir','TABLET, FILM COATED','ORAL','20050329','','NDA','NDA021797','E.R. Squibb & Sons, L.L.C.','ENTECAVIR','0.5','mg/1','Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-1612_9994c6a8-37e8-4ddf-964b-4dc5ee199d4a','0003-1612','HUMAN PRESCRIPTION DRUG','BARACLUDE','','entecavir','TABLET, FILM COATED','ORAL','20050329','','NDA','NDA021797','E.R. Squibb & Sons, L.L.C.','ENTECAVIR','1','mg/1','Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-1614_9994c6a8-37e8-4ddf-964b-4dc5ee199d4a','0003-1614','HUMAN PRESCRIPTION DRUG','BARACLUDE','','entecavir','SOLUTION','ORAL','20050329','','NDA','NDA021798','E.R. Squibb & Sons, L.L.C.','ENTECAVIR','0.05','mg/mL','Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-2187_e2d90872-c200-480d-b0ce-50f70bb43447','0003-2187','HUMAN PRESCRIPTION DRUG','ORENCIA','','abatacept','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20090101','','BLA','BLA125118','E.R. Squibb & Sons, L.L.C.','ABATACEPT','250','mg/15mL','Decreased Cytokine Activity [PE], Recombinant Fusion Proteins [CS], Selective T Cell Costimulation Modulator [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-2188_e2d90872-c200-480d-b0ce-50f70bb43447','0003-2188','HUMAN PRESCRIPTION DRUG','ORENCIA','','abatacept','INJECTION, SOLUTION','SUBCUTANEOUS','20110729','','BLA','BLA125118','E.R. Squibb & Sons, L.L.C.','ABATACEPT','125','mg/mL','Decreased Cytokine Activity [PE], Recombinant Fusion Proteins [CS], Selective T Cell Costimulation Modulator [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-2291_ef47282a-3cff-40ed-867f-36af14c8f99c','0003-2291','HUMAN PRESCRIPTION DRUG','EMPLICITI','','elotuzumab','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20151130','','BLA','BLA761035','E.R. Squibb & Sons, L.L.C.','ELOTUZUMAB','300','mg/1','Antibodies, Monoclonal [CS], SLAMF7-directed Antibody Interactions [MoA], SLAMF7-directed Immunostimulatory Antibody [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-2327_95abeb0e-7f43-491b-8938-7216b661ad5a','0003-2327','HUMAN PRESCRIPTION DRUG','YERVOY','','ipilimumab','INJECTION','INTRAVENOUS','20110325','','BLA','BLA125377','E.R. Squibb & Sons, L.L.C.','IPILIMUMAB','5','mg/mL','CTLA-4-directed Antibody Interactions [MoA], CTLA-4-directed Blocking Antibody [EPC], Increased T Lymphocyte Activation [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-2328_95abeb0e-7f43-491b-8938-7216b661ad5a','0003-2328','HUMAN PRESCRIPTION DRUG','YERVOY','','ipilimumab','INJECTION','INTRAVENOUS','20110325','','BLA','BLA125377','E.R. Squibb & Sons, L.L.C.','IPILIMUMAB','5','mg/mL','CTLA-4-directed Antibody Interactions [MoA], CTLA-4-directed Blocking Antibody [EPC], Increased T Lymphocyte Activation [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-2560_9df12e77-7962-45e7-82a2-549ea4e331fa','0003-2560','HUMAN PRESCRIPTION DRUG','AZACTAM','','AZTREONAM','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','20100401','','NDA','NDA050580','E.R. Squibb & Sons, L.L.C.','AZTREONAM','1','g/1','Monobactam Antibacterial [EPC], Monobactams [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-2570_9df12e77-7962-45e7-82a2-549ea4e331fa','0003-2570','HUMAN PRESCRIPTION DRUG','AZACTAM','','AZTREONAM','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','20100401','','NDA','NDA050580','E.R. Squibb & Sons, L.L.C.','AZTREONAM','2','g/1','Monobactam Antibacterial [EPC], Monobactams [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-2814_e2d90872-c200-480d-b0ce-50f70bb43447','0003-2814','HUMAN PRESCRIPTION DRUG','ORENCIA','','abatacept','INJECTION, SOLUTION','SUBCUTANEOUS','20110729','','BLA','BLA125118','E.R. Squibb & Sons, L.L.C.','ABATACEPT','50','mg/.4mL','Decreased Cytokine Activity [PE], Recombinant Fusion Proteins [CS], Selective T Cell Costimulation Modulator [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-2818_e2d90872-c200-480d-b0ce-50f70bb43447','0003-2818','HUMAN PRESCRIPTION DRUG','ORENCIA','','abatacept','INJECTION, SOLUTION','SUBCUTANEOUS','20110729','','BLA','BLA125118','E.R. Squibb & Sons, L.L.C.','ABATACEPT','87.5','mg/.7mL','Decreased Cytokine Activity [PE], Recombinant Fusion Proteins [CS], Selective T Cell Costimulation Modulator [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-3622_1cab2232-648a-4961-a179-30087315de3b','0003-3622','HUMAN PRESCRIPTION DRUG','REYATAZ','','ATAZANAVIR','CAPSULE, GELATIN COATED','ORAL','20030624','','NDA','NDA021567','E.R. Squibb & Sons, L.L.C.','ATAZANAVIR SULFATE','300','mg/1','Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-3624_1cab2232-648a-4961-a179-30087315de3b','0003-3624','HUMAN PRESCRIPTION DRUG','REYATAZ','','ATAZANAVIR','CAPSULE, GELATIN COATED','ORAL','20030624','20230430','NDA','NDA021567','E.R. Squibb & Sons, L.L.C.','ATAZANAVIR SULFATE','150','mg/1','Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-3631_1cab2232-648a-4961-a179-30087315de3b','0003-3631','HUMAN PRESCRIPTION DRUG','REYATAZ','','ATAZANAVIR','CAPSULE, GELATIN COATED','ORAL','20030624','','NDA','NDA021567','E.R. Squibb & Sons, L.L.C.','ATAZANAVIR SULFATE','200','mg/1','Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-3638_1cab2232-648a-4961-a179-30087315de3b','0003-3638','HUMAN PRESCRIPTION DRUG','REYATAZ','','ATAZANAVIR','POWDER','ORAL','20141219','','NDA','NDA206352','E.R. Squibb & Sons, L.L.C.','ATAZANAVIR SULFATE','50','mg/1','Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-3641_2803041c-c3ba-4b03-a293-032ec79e6b66','0003-3641','HUMAN PRESCRIPTION DRUG','EVOTAZ','','atazanavir and cobicistat','TABLET','ORAL','20150129','','NDA','NDA206353','E.R. Squibb & Sons, L.L.C.','ATAZANAVIR SULFATE; COBICISTAT','300; 150','mg/1; mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-3734_b3e159bf-ae20-4857-aa05-dd7579f2272d','0003-3734','HUMAN PRESCRIPTION DRUG','OPDIVO','','nivolumab','INJECTION','INTRAVENOUS','20171208','','BLA','BLA125554','E.R. Squibb & Sons, L.L.C.','NIVOLUMAB','10','mg/mL','Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-3756_b3e159bf-ae20-4857-aa05-dd7579f2272d','0003-3756','HUMAN PRESCRIPTION DRUG','OPDIVO','','nivolumab','INJECTION','INTRAVENOUS','20210830','','BLA','BLA125554','E.R. Squibb & Sons, L.L.C.','NIVOLUMAB','10','mg/mL','Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-3764_a260aeff-75b6-4468-bc8a-c2f8d6ac66e3','0003-3764','HUMAN PRESCRIPTION DRUG','ELIQUIS','30-Day Starter Pack','apixaban','KIT','','20171129','','NDA','NDA202155','E.R. Squibb & Sons, L.L.C.','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-3772_b3e159bf-ae20-4857-aa05-dd7579f2272d','0003-3772','HUMAN PRESCRIPTION DRUG','OPDIVO','','nivolumab','INJECTION','INTRAVENOUS','20141222','','BLA','BLA125554','E.R. Squibb & Sons, L.L.C.','NIVOLUMAB','10','mg/mL','Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-3774_b3e159bf-ae20-4857-aa05-dd7579f2272d','0003-3774','HUMAN PRESCRIPTION DRUG','OPDIVO','','nivolumab','INJECTION','INTRAVENOUS','20141222','','BLA','BLA125554','E.R. Squibb & Sons, L.L.C.','NIVOLUMAB','10','mg/mL','Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-4522_ef47282a-3cff-40ed-867f-36af14c8f99c','0003-4522','HUMAN PRESCRIPTION DRUG','EMPLICITI','','elotuzumab','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20151130','','BLA','BLA761035','E.R. Squibb & Sons, L.L.C.','ELOTUZUMAB','400','mg/1','Antibodies, Monoclonal [CS], SLAMF7-directed Antibody Interactions [MoA], SLAMF7-directed Immunostimulatory Antibody [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-6335_4e5c3df1-3e9c-4eb1-959e-1ab30dbb84f2','0003-6335','HUMAN PRESCRIPTION DRUG','DROXIA','','HYDROXYUREA','CAPSULE','ORAL','20090601','20250331','NDA','NDA016295','E.R. Squibb & Sons, L.L.C.','HYDROXYUREA','200','mg/1','Antimetabolite [EPC], Urea [CS]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-6336_4e5c3df1-3e9c-4eb1-959e-1ab30dbb84f2','0003-6336','HUMAN PRESCRIPTION DRUG','DROXIA','','HYDROXYUREA','CAPSULE','ORAL','20090601','20250531','NDA','NDA016295','E.R. Squibb & Sons, L.L.C.','HYDROXYUREA','300','mg/1','Antimetabolite [EPC], Urea [CS]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-6337_4e5c3df1-3e9c-4eb1-959e-1ab30dbb84f2','0003-6337','HUMAN PRESCRIPTION DRUG','DROXIA','','HYDROXYUREA','CAPSULE','ORAL','20090601','20250531','NDA','NDA016295','E.R. Squibb & Sons, L.L.C.','HYDROXYUREA','400','mg/1','Antimetabolite [EPC], Urea [CS]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0003-7125_b22c9d83-3256-4e17-85f7-f331a504adc6','0003-7125','HUMAN PRESCRIPTION DRUG','OPDUALAG','','nivolumab and relatlimab-rmbw','INJECTION','INTRAVENOUS','20220318','','BLA','BLA761234','E.R. Squibb & Sons, L.L.C.','NIVOLUMAB; RELATLIMAB','12; 4','mg/mL; mg/mL','Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0004-0038_80c62d56-ae54-45a5-8121-16ef65a9bc48','0004-0038','HUMAN PRESCRIPTION DRUG','Valcyte','','valganciclovir','TABLET, FILM COATED','ORAL','20010329','','NDA','NDA021304','Genentech, Inc.','VALGANCICLOVIR HYDROCHLORIDE','450','mg/1','Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0004-0039_80c62d56-ae54-45a5-8121-16ef65a9bc48','0004-0039','HUMAN PRESCRIPTION DRUG','Valcyte','','valganciclovir hydrochloride','POWDER, FOR SOLUTION','ORAL','20090828','','NDA','NDA022257','Genentech, Inc.','VALGANCICLOVIR HYDROCHLORIDE','50','mg/mL','Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0004-0058_78069474-118f-4b14-ba38-42dcb1e0d51b','0004-0058','HUMAN PRESCRIPTION DRUG','Klonopin','','Clonazepam','TABLET','ORAL','19750602','20240228','NDA','NDA017533','Genentech, Inc.','CLONAZEPAM','1','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0004-0068_78069474-118f-4b14-ba38-42dcb1e0d51b','0004-0068','HUMAN PRESCRIPTION DRUG','Klonopin','','Clonazepam','TABLET','ORAL','19750602','20240131','NDA','NDA017533','Genentech, Inc.','CLONAZEPAM','0.5','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0004-0098_78069474-118f-4b14-ba38-42dcb1e0d51b','0004-0098','HUMAN PRESCRIPTION DRUG','Klonopin','','Clonazepam','TABLET','ORAL','19750602','20230630','NDA','NDA017533','Genentech, Inc.','CLONAZEPAM','2','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0004-0186_ea7ba1c4-117f-4670-8575-0cde1c39a61a','0004-0186','HUMAN PRESCRIPTION DRUG','Boniva','','ibandronate sodium','TABLET, FILM COATED','ORAL','20050324','20230731','NDA','NDA021455','Genentech, Inc.','IBANDRONATE SODIUM','150','mg/1','Bisphosphonate [EPC], Diphosphonates [CS]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0004-0244_a9982b9f-49dc-474b-8179-da91897a7237','0004-0244','HUMAN PRESCRIPTION DRUG','Invirase','','saquinavir mesylate','TABLET, FILM COATED','ORAL','20041217','20240430','NDA','NDA021785','Genentech, Inc.','SAQUINAVIR MESYLATE','500','mg/1','Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0004-0259_0ab859a2-aff9-4df4-bd01-3d687d27239a','0004-0259','HUMAN PRESCRIPTION DRUG','CellCept','','Mycophenolate Mofetil','CAPSULE','ORAL','19950503','','NDA','NDA050722','Genentech, Inc.','MYCOPHENOLATE MOFETIL','250','mg/1','Antimetabolite Immunosuppressant [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0004-0260_0ab859a2-aff9-4df4-bd01-3d687d27239a','0004-0260','HUMAN PRESCRIPTION DRUG','CellCept','','Mycophenolate Mofetil','TABLET, FILM COATED','ORAL','19970619','','NDA','NDA050723','Genentech, Inc.','MYCOPHENOLATE MOFETIL','500','mg/1','Antimetabolite Immunosuppressant [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0004-0261_0ab859a2-aff9-4df4-bd01-3d687d27239a','0004-0261','HUMAN PRESCRIPTION DRUG','CellCept','','Mycophenolate Mofetil','POWDER, FOR SUSPENSION','ORAL','19981001','','NDA','NDA050759','Genentech, Inc.','MYCOPHENOLATE MOFETIL','200','mg/mL','Antimetabolite Immunosuppressant [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0004-0298_0ab859a2-aff9-4df4-bd01-3d687d27239a','0004-0298','HUMAN PRESCRIPTION DRUG','CellCept','','Mycophenolate Mofetil hydrochloride','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','19980812','','NDA','NDA050758','Genentech, Inc.','MYCOPHENOLATE MOFETIL HYDROCHLORIDE','500','mg/20mL','Antimetabolite Immunosuppressant [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0004-0350_cc1e24aa-6242-4429-bfeb-c92907641f3e','0004-0350','HUMAN PRESCRIPTION DRUG','Pegasys','','peginterferon alfa-2a','INJECTION, SOLUTION','SUBCUTANEOUS','20021016','20250630','BLA','BLA103964','Genentech, Inc.','PEGINTERFERON ALFA-2A','180','ug/mL','Interferon alpha [EPC], Interferon-alpha [CS]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0004-0357_cc1e24aa-6242-4429-bfeb-c92907641f3e','0004-0357','HUMAN PRESCRIPTION DRUG','Pegasys','','peginterferon alfa-2a','INJECTION, SOLUTION','SUBCUTANEOUS','20110329','20240630','BLA','BLA103964','Genentech, Inc.','PEGINTERFERON ALFA-2A','180','ug/.5mL','Interferon alpha [EPC], Interferon-alpha [CS]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0004-0381_c73e3929-f256-4abf-b2a5-5bec18dadf71','0004-0381','HUMAN PRESCRIPTION DRUG','FUZEON','','Enfuvirtide','KIT','','20120410','','NDA','NDA021481','Genentech, Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0004-0800_ce6467c3-e42d-4c77-8918-1bbcec3f6e41','0004-0800','HUMAN PRESCRIPTION DRUG','Tamiflu','','oseltamivir phosphate','CAPSULE','ORAL','19991027','','NDA','NDA021087','Genentech, Inc.','OSELTAMIVIR PHOSPHATE','75','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0004-0801_ce6467c3-e42d-4c77-8918-1bbcec3f6e41','0004-0801','HUMAN PRESCRIPTION DRUG','Tamiflu','','oseltamivir phosphate','CAPSULE','ORAL','19991027','','NDA','NDA021087','Genentech, Inc.','OSELTAMIVIR PHOSPHATE','45','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0004-0802_ce6467c3-e42d-4c77-8918-1bbcec3f6e41','0004-0802','HUMAN PRESCRIPTION DRUG','Tamiflu','','oseltamivir phosphate','CAPSULE','ORAL','19991027','','NDA','NDA021087','Genentech, Inc.','OSELTAMIVIR PHOSPHATE','30','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0004-0822_ce6467c3-e42d-4c77-8918-1bbcec3f6e41','0004-0822','HUMAN PRESCRIPTION DRUG','Tamiflu','','Oseltamivir Phosphate','POWDER, FOR SUSPENSION','ORAL','20110321','','NDA','NDA021246','Genentech, Inc.','OSELTAMIVIR PHOSPHATE','6','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0004-1100_7905031f-2a24-4618-bd70-cf4343ad0a0e','0004-1100','HUMAN PRESCRIPTION DRUG','Xeloda','','capecitabine','TABLET, FILM COATED','ORAL','19980430','','NDA','NDA020896','Genentech, Inc.','CAPECITABINE','150','mg/1','Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0004-1101_7905031f-2a24-4618-bd70-cf4343ad0a0e','0004-1101','HUMAN PRESCRIPTION DRUG','Xeloda','','capecitabine','TABLET, FILM COATED','ORAL','19980430','','NDA','NDA020896','Genentech, Inc.','CAPECITABINE','500','mg/1','Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0005-0100_f073f2a0-1d30-47e6-b18c-c3f52fb45ea3','0005-0100','VACCINE','Trumenba','','meningococcal group B vaccine','INJECTION, SUSPENSION','INTRAMUSCULAR','20141105','','BLA','BLA125549','Wyeth Pharmaceutical Division of Wyeth Holdings LLC','NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN; NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 B01 PROTEIN VARIANT ANTIGEN','60; 60','ug/.5mL; ug/.5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0005-1971_43760dbc-2686-49c4-96f3-38f4cd120a07','0005-1971','VACCINE','PREVNAR 13','','pneumococcal 13-valent conjugate vaccine','INJECTION, SUSPENSION','INTRAMUSCULAR','20100312','','BLA','BLA125324','Wyeth Pharmaceutical Division of Wyeth Holdings LLC','STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9V CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN','2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 4.4; 2.2; 2.2','ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL','Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Vaccines, Conjugate [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0005-2000_d6a91837-4a26-4e15-9f32-47ee9d29504e','0005-2000','VACCINE','Prevnar 20','','Pneumococcal 20-valent Conjugate Vaccine','INJECTION, SUSPENSION','INTRAMUSCULAR','20210810','','BLA','BLA125731','Wyeth Pharmaceutical Division of Wyeth Holdings LLC','STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 15B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 22F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 33F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 8 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9V CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN','2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 4.4; 2.2; 2.2; 2.2','ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL','Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Vaccines, Conjugate [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-0005_18f09198-23e9-48c9-8426-e39828d75ad8','0006-0005','HUMAN PRESCRIPTION DRUG','BELSOMRA','','suvorexant','TABLET, FILM COATED','ORAL','20140829','','NDA','NDA204569','Merck Sharp & Dohme LLC','SUVOREXANT','5','mg/1','Cytochrome P450 3A Inhibitors [MoA], Orexin Receptor Antagonist [EPC], Orexin Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-0032_17e428ae-b3d6-42aa-9e14-70747e607fc0','0006-0032','HUMAN PRESCRIPTION DRUG','STROMECTOL','','ivermectin','TABLET','ORAL','19961122','','NDA','NDA050742','Merck Sharp & Dohme LLC','IVERMECTIN','3','mg/1','Antiparasitic [EPC], Pediculicide [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-0033_18f09198-23e9-48c9-8426-e39828d75ad8','0006-0033','HUMAN PRESCRIPTION DRUG','BELSOMRA','','suvorexant','TABLET, FILM COATED','ORAL','20140829','','NDA','NDA204569','Merck Sharp & Dohme LLC','SUVOREXANT','10','mg/1','Cytochrome P450 3A Inhibitors [MoA], Orexin Receptor Antagonist [EPC], Orexin Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-0078_3919504c-edce-4cc6-a41a-9b9094e685b8','0006-0078','HUMAN PRESCRIPTION DRUG','JANUMET','XR','sitagliptin and metformin hydrochloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20120202','','NDA','NDA202270','Merck Sharp & Dohme LLC','METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE','500; 50','mg/1; mg/1','Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-0080_3919504c-edce-4cc6-a41a-9b9094e685b8','0006-0080','HUMAN PRESCRIPTION DRUG','JANUMET','XR','sitagliptin and metformin hydrochloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20120202','','NDA','NDA202270','Merck Sharp & Dohme LLC','METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE','1000; 50','mg/1; mg/1','Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-0081_3919504c-edce-4cc6-a41a-9b9094e685b8','0006-0081','HUMAN PRESCRIPTION DRUG','JANUMET','XR','sitagliptin and metformin hydrochloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20120202','','NDA','NDA202270','Merck Sharp & Dohme LLC','METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE','1000; 100','mg/1; mg/1','Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-0112_68b2efd6-5450-4645-8b8c-e05f278e1130','0006-0112','HUMAN PRESCRIPTION DRUG','JANUVIA','','sitagliptin','TABLET, FILM COATED','ORAL','20061016','','NDA','NDA021995','Merck Sharp & Dohme LLC','SITAGLIPTIN PHOSPHATE','50','mg/1','Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-0221_68b2efd6-5450-4645-8b8c-e05f278e1130','0006-0221','HUMAN PRESCRIPTION DRUG','JANUVIA','','sitagliptin','TABLET, FILM COATED','ORAL','20061016','','NDA','NDA021995','Merck Sharp & Dohme LLC','SITAGLIPTIN PHOSPHATE','25','mg/1','Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-0227_67c2113b-07f8-40d6-9cc6-3611116abf50','0006-0227','HUMAN PRESCRIPTION DRUG','ISENTRESS','','RALTEGRAVIR','TABLET, FILM COATED','ORAL','20071012','','NDA','NDA022145','Merck Sharp & Dohme LLC','RALTEGRAVIR POTASSIUM','400','mg/1','HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-0277_68b2efd6-5450-4645-8b8c-e05f278e1130','0006-0277','HUMAN PRESCRIPTION DRUG','JANUVIA','','sitagliptin','TABLET, FILM COATED','ORAL','20061016','','NDA','NDA021995','Merck Sharp & Dohme LLC','SITAGLIPTIN PHOSPHATE','100','mg/1','Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-0325_18f09198-23e9-48c9-8426-e39828d75ad8','0006-0325','HUMAN PRESCRIPTION DRUG','BELSOMRA','','suvorexant','TABLET, FILM COATED','ORAL','20140829','','NDA','NDA204569','Merck Sharp & Dohme LLC','SUVOREXANT','15','mg/1','Cytochrome P450 3A Inhibitors [MoA], Orexin Receptor Antagonist [EPC], Orexin Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-0335_18f09198-23e9-48c9-8426-e39828d75ad8','0006-0335','HUMAN PRESCRIPTION DRUG','BELSOMRA','','suvorexant','TABLET, FILM COATED','ORAL','20140829','','NDA','NDA204569','Merck Sharp & Dohme LLC','SUVOREXANT','20','mg/1','Cytochrome P450 3A Inhibitors [MoA], Orexin Receptor Antagonist [EPC], Orexin Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-0461_396b7a7b-c5bf-40b0-a474-9fcf92cba20c','0006-0461','HUMAN PRESCRIPTION DRUG','EMEND','','aprepitant','CAPSULE','ORAL','20030326','','NDA','NDA021549','Merck Sharp & Dohme LLC','APREPITANT','80','mg/1','Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-0462_396b7a7b-c5bf-40b0-a474-9fcf92cba20c','0006-0462','HUMAN PRESCRIPTION DRUG','EMEND','','aprepitant','CAPSULE','ORAL','20030326','','NDA','NDA021549','Merck Sharp & Dohme LLC','APREPITANT','125','mg/1','Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-0464_396b7a7b-c5bf-40b0-a474-9fcf92cba20c','0006-0464','HUMAN PRESCRIPTION DRUG','EMEND','','aprepitant','CAPSULE','ORAL','20030326','','NDA','NDA021549','Merck Sharp & Dohme LLC','APREPITANT','40','mg/1','Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-0473_67c2113b-07f8-40d6-9cc6-3611116abf50','0006-0473','HUMAN PRESCRIPTION DRUG','ISENTRESS','','RALTEGRAVIR','TABLET, CHEWABLE','ORAL','20111221','','NDA','NDA203045','Merck Sharp & Dohme LLC','RALTEGRAVIR POTASSIUM','25','mg/1','HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-0477_67c2113b-07f8-40d6-9cc6-3611116abf50','0006-0477','HUMAN PRESCRIPTION DRUG','ISENTRESS','','RALTEGRAVIR','TABLET, CHEWABLE','ORAL','20111221','','NDA','NDA203045','Merck Sharp & Dohme LLC','RALTEGRAVIR POTASSIUM','100','mg/1','HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-0568_24afbb2d-d7e5-425d-aaca-f28a06c937c9','0006-0568','HUMAN PRESCRIPTION DRUG','ZOLINZA','','vorinostat','CAPSULE','ORAL','20061006','','NDA','NDA021991','Merck Sharp & Dohme LLC','VORINOSTAT','100','mg/1','Histone Deacetylase Inhibitor [EPC], Histone Deacetylase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-0575_563eaa59-b53b-4658-954b-73d94a9a91db','0006-0575','HUMAN PRESCRIPTION DRUG','JANUMET','','SITAGLIPTIN and METFORMIN HYDROCHLORIDE','TABLET, FILM COATED','ORAL','20070330','','NDA','NDA022044','Merck Sharp & Dohme LLC','METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE','500; 50','mg/1; mg/1','Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-0577_563eaa59-b53b-4658-954b-73d94a9a91db','0006-0577','HUMAN PRESCRIPTION DRUG','JANUMET','','SITAGLIPTIN and METFORMIN HYDROCHLORIDE','TABLET, FILM COATED','ORAL','20070330','','NDA','NDA022044','Merck Sharp & Dohme LLC','METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE','1000; 50','mg/1; mg/1','Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-3025_7d665327-8fd3-4d81-aba4-0aa5af25c148','0006-3025','HUMAN PRESCRIPTION DRUG','ZINPLAVA','','bezlotoxumab','INJECTION, SOLUTION','INTRAVENOUS','20161021','','BLA','BLA761046','Merck Sharp & Dohme LLC','BEZLOTOXUMAB','25','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-3026_157262d6-15e0-4b0a-968f-b99bab4aef50','0006-3026','HUMAN PRESCRIPTION DRUG','KEYTRUDA','','pembrolizumab','INJECTION, SOLUTION','INTRAVENOUS','20150115','','BLA','BLA125514','Merck Sharp & Dohme LLC','PEMBROLIZUMAB','25','mg/mL','Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-3061_1767ea30-408d-403c-b1b1-dd2013353d26','0006-3061','HUMAN PRESCRIPTION DRUG','EMEND','','FOSAPREPITANT DIMEGLUMINE','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20170203','','NDA','NDA022023','Merck Sharp & Dohme LLC','FOSAPREPITANT DIMEGLUMINE','150','mg/5mL','Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-3066_396b7a7b-c5bf-40b0-a474-9fcf92cba20c','0006-3066','HUMAN PRESCRIPTION DRUG','EMEND','','aprepitant','POWDER, FOR SUSPENSION','ORAL','20151217','','NDA','NDA207865','Merck Sharp & Dohme LLC','APREPITANT','125','mg/1','Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-3069_14a717ce-d963-4ead-958a-dcef32807567','0006-3069','HUMAN PRESCRIPTION DRUG','PIFELTRO','','doravirine','TABLET, FILM COATED','ORAL','20180720','','NDA','NDA210806','Merck Sharp & Dohme LLC','DORAVIRINE','100','mg/1','Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-3074_18d430c5-69f2-4824-ae66-80a37c51ae83','0006-3074','HUMAN PRESCRIPTION DRUG','ZEPATIER','','elbasvir and grazoprevir','TABLET, FILM COATED','ORAL','20160128','','NDA','NDA208261','Merck Sharp & Dohme LLC','ELBASVIR; GRAZOPREVIR ANHYDROUS','50; 100','mg/1; mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HCV NS3/4A Protease Inhibitors [MoA], Hepatitis C Virus NS3/4A Protease Inhibitor [EPC], Hepatitis C Virus NS5A Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-3075_179a9105-1fd2-4d0b-83d9-81aba13d9d44','0006-3075','HUMAN PRESCRIPTION DRUG','PREVYMIS','','LETERMOVIR','TABLET, FILM COATED','ORAL','20171108','','NDA','NDA209939','Merck Sharp & Dohme LLC','LETERMOVIR','240','mg/1','Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytomegalovirus DNA Terminase Complex Inhibitor [EPC], DNA Terminase Complex Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-3076_179a9105-1fd2-4d0b-83d9-81aba13d9d44','0006-3076','HUMAN PRESCRIPTION DRUG','PREVYMIS','','LETERMOVIR','TABLET, FILM COATED','ORAL','20171108','','NDA','NDA209939','Merck Sharp & Dohme LLC','LETERMOVIR','480','mg/1','Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytomegalovirus DNA Terminase Complex Inhibitor [EPC], DNA Terminase Complex Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-3080_67c2113b-07f8-40d6-9cc6-3611116abf50','0006-3080','HUMAN PRESCRIPTION DRUG','ISENTRESS','','RALTEGRAVIR','TABLET, FILM COATED','ORAL','20170526','','NDA','NDA022145','Merck Sharp & Dohme LLC','RALTEGRAVIR POTASSIUM','600','mg/1','HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-3516_314c9ca7-26c9-4aae-bd43-805fc724887e','0006-3516','HUMAN PRESCRIPTION DRUG','PRIMAXIN','IV','imipenem and cilastatin sodium','INJECTION, POWDER, FOR SOLUTION','INTRAVENOUS','19851126','','NDA','NDA050587','Merck Sharp & Dohme LLC','CILASTATIN SODIUM; IMIPENEM','500; 500','mg/100mL; mg/100mL','Carbapenems [CS], Dipeptidase Inhibitors [MoA], Penem Antibacterial [EPC], Renal Dehydropeptidase Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-3519_1482d00e-8ed4-496b-be57-9a22b09139bd','0006-3519','HUMAN PRESCRIPTION DRUG','TRUSOPT','','dorzolamide hydrochloride','SOLUTION','OPHTHALMIC','19941209','','NDA','NDA020408','Merck Sharp & Dohme LLC','DORZOLAMIDE HYDROCHLORIDE','20','mg/mL','Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-3603_67c2113b-07f8-40d6-9cc6-3611116abf50','0006-3603','HUMAN PRESCRIPTION DRUG','ISENTRESS','','RALTEGRAVIR','GRANULE, FOR SUSPENSION','ORAL','20131220','','NDA','NDA205786','Merck Sharp & Dohme LLC','RALTEGRAVIR POTASSIUM','100','mg/1','HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-3822_38feba4f-a86c-4d3f-9a01-0cef84c46680','0006-3822','HUMAN PRESCRIPTION DRUG','CANCIDAS','','CASPOFUNGIN ACETATE','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20010126','','NDA','NDA021227','Merck Sharp & Dohme LLC','CASPOFUNGIN ACETATE','5','mg/mL','Echinocandin Antifungal [EPC], Lipopeptides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-3823_38feba4f-a86c-4d3f-9a01-0cef84c46680','0006-3823','HUMAN PRESCRIPTION DRUG','CANCIDAS','','CASPOFUNGIN ACETATE','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20010126','','NDA','NDA021227','Merck Sharp & Dohme LLC','CASPOFUNGIN ACETATE','7','mg/mL','Echinocandin Antifungal [EPC], Lipopeptides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-3843_3683e9d0-d313-462a-bc29-23a2b9c73fae','0006-3843','HUMAN PRESCRIPTION DRUG','INVANZ','','ertapenem sodium','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','20011121','','NDA','NDA021337','Merck Sharp & Dohme LLC','ERTAPENEM SODIUM','1','g/1','Carbapenems [CS], Penem Antibacterial [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-3856_77133ed0-fcc5-45d3-9a34-034277caa9fa','0006-3856','HUMAN PRESCRIPTION DRUG','RECARBRIO','','imipenem anhydrous, cilastatin, and relebactam anhydrous','INJECTION, POWDER, FOR SOLUTION','INTRAVENOUS','20200106','','NDA','NDA212819','Merck Sharp & Dohme LLC','CILASTATIN; IMIPENEM ANHYDROUS; RELEBACTAM ANHYDROUS','500; 500; 250','mg/100mL; mg/100mL; mg/100mL','Carbapenems [CS], Dipeptidase Inhibitors [MoA], Penem Antibacterial [EPC], Renal Dehydropeptidase Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-3862_396b7a7b-c5bf-40b0-a474-9fcf92cba20c','0006-3862','HUMAN PRESCRIPTION DRUG','EMEND','','aprepitant','KIT','','20030326','','NDA','NDA021549','Merck Sharp & Dohme LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4045_289dcbba-52c0-487d-a6e5-bb7f53f52eca','0006-4045','VACCINE','GARDASIL','','Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant','INJECTION, SUSPENSION','INTRAMUSCULAR','20060608','','BLA','BLA125126','Merck Sharp & Dohme LLC','HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN','40; 40; 20; 20','ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL','Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4047_401b9855-686d-456c-8e71-091b7aa07bc8','0006-4047','VACCINE','RotaTeq','','Rotavirus Vaccine, Live, Oral, Pentavalent','SOLUTION','ORAL','20060203','','BLA','BLA125122','Merck Sharp & Dohme LLC','HUMAN ROTAVIRUS A TYPE G1P7(5) STRAIN WI79 LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G2P7(5) STRAIN SC2 LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G3P7(5) STRAIN WI78 LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G4P7(5) STRAIN BRB LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G6P1A(8) STRAIN WI79 LIVE ANTIGEN','2200000; 2800000; 2200000; 2000000; 2300000','[iU]/2mL; [iU]/2mL; [iU]/2mL; [iU]/2mL; [iU]/2mL','Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Live Rotavirus Vaccine [EPC], Live Rotavirus Vaccine [EPC], Live Rotavirus Vaccine [EPC], Live Rotavirus Vaccine [EPC], Live Rotavirus Vaccine [EPC], Rotavirus Vaccines [CS], Rotavirus Vaccines [CS], Rotavirus Vaccines [CS], Rotavirus Vaccines [CS], Rotavirus Vaccines [CS], Vaccines, Live, Unattenuated [CS], Vaccines, Live, Unattenuated [CS], Vaccines, Live, Unattenuated [CS], Vaccines, Live, Unattenuated [CS], Vaccines, Live, Unattenuated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4093_283756c3-db2a-48f8-b5e6-0102b97e8d73','0006-4093','VACCINE','RECOMBIVAX HB','','Hepatitis B Vaccine (Recombinant)','INJECTION, SUSPENSION','INTRAMUSCULAR; SUBCUTANEOUS','19860723','','BLA','BLA101066','Merck Sharp & Dohme LLC','HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN','5','ug/.5mL','Actively Acquired Immunity [PE], Hepatitis B Vaccines [CS], Inactivated Hepatitis B Virus Vaccine [EPC], Vaccines, Inactivated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4094_283756c3-db2a-48f8-b5e6-0102b97e8d73','0006-4094','VACCINE','RECOMBIVAX HB','','Hepatitis B Vaccine (Recombinant)','INJECTION, SUSPENSION','INTRAMUSCULAR; SUBCUTANEOUS','19860723','','BLA','BLA101066','Merck Sharp & Dohme LLC','HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN','10','ug/mL','Actively Acquired Immunity [PE], Hepatitis B Vaccines [CS], Inactivated Hepatitis B Virus Vaccine [EPC], Vaccines, Inactivated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4095_2567bef1-a2e7-43a3-8cc0-19b05f5ada47','0006-4095','VACCINE','VAQTA','','hepatitis A vaccine, inactivated','INJECTION, SUSPENSION','INTRAMUSCULAR','19960329','','BLA','BLA103606','Merck Sharp & Dohme LLC','HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED)','25','[iU]/.5mL','Actively Acquired Immunity [PE], Hepatitis A Vaccines [CS], Inactivated Hepatitis A Virus Vaccine [EPC], Vaccines, Inactivated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4096_2567bef1-a2e7-43a3-8cc0-19b05f5ada47','0006-4096','VACCINE','VAQTA','','hepatitis A vaccine, inactivated','INJECTION, SUSPENSION','INTRAMUSCULAR','19960329','','BLA','BLA103606','Merck Sharp & Dohme LLC','HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED)','50','[iU]/mL','Actively Acquired Immunity [PE], Hepatitis A Vaccines [CS], Inactivated Hepatitis A Virus Vaccine [EPC], Vaccines, Inactivated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4109_289dcbba-52c0-487d-a6e5-bb7f53f52eca','0006-4109','VACCINE','GARDASIL','','Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant','INJECTION, SUSPENSION','INTRAMUSCULAR','20060608','','BLA','BLA125126','Merck Sharp & Dohme LLC','HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN','40; 40; 20; 20','ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL','Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4119_2093af33-84be-4f13-ae72-cc9b19172fa0','0006-4119','VACCINE','GARDASIL 9','','Human Papillomavirus 9-valent Vaccine, Recombinant','INJECTION, SUSPENSION','INTRAMUSCULAR','20141210','','BLA','BLA125508','Merck Sharp & Dohme LLC','HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 31 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 33 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 45 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 52 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 58 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN','40; 60; 40; 20; 20; 20; 20; 20; 30','ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL','Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4121_2093af33-84be-4f13-ae72-cc9b19172fa0','0006-4121','VACCINE','GARDASIL 9','','Human Papillomavirus 9-valent Vaccine, Recombinant','INJECTION, SUSPENSION','INTRAMUSCULAR','20141210','','BLA','BLA125508','Merck Sharp & Dohme LLC','HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 31 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 33 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 45 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 52 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 58 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN','40; 60; 40; 20; 20; 20; 20; 20; 30','ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL','Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4171_23c30c01-38a4-42bf-9103-9c8cb5ea9992','0006-4171','VACCINE','ProQuad','','Measles, Mumps, Rubella and Varicella Virus Vaccine Live','INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION','SUBCUTANEOUS','20150701','','BLA','BLA125108','Merck Sharp & Dohme LLC','MEASLES VIRUS STRAIN ENDERS'''' ATTENUATED EDMONSTON LIVE ANTIGEN; MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN; RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN; VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN','1000; 20000; 1000; 9772','[TCID_50]/.5mL; [TCID_50]/.5mL; [TCID_50]/.5mL; [PFU]/.5mL','Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Chickenpox Vaccine [CS], Herpes Zoster Vaccine [CS], Live Attenuated Herpes Zoster Virus Vaccine [EPC], Live Attenuated Measles Virus Vaccine [EPC], Live Attenuated Mumps Virus Vaccine [EPC], Live Attenuated Rubella Virus Vaccine [EPC], Live Attenuated Varicella Zoster Virus Vaccine [EPC], Measles Vaccine [CS], Mumps Vaccine [CS], Rubella Vaccine [CS], Vaccines, Attenuated [CS], Vaccines, Attenuated [CS], Vaccines, Attenuated [CS], Vaccines, Attenuated [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4293_11e8268d-630c-4f98-a22e-8f258481f1ea','0006-4293','VACCINE','ERVEBO','','ZAIRE EBOLAVIRUS (STRAIN KIKWIT-95) ENVELOPE GLYCOPROTEIN','INJECTION, SOLUTION','INTRAMUSCULAR','20191219','','BLA','BLA125690','Merck Sharp & Dohme LLC','ZAIRE EBOLAVIRUS (STRAIN KIKWIT-95) ENVELOPE GLYCOPROTEIN','72000000','[PFU]/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4305_fc8da8a3-76dd-4c0d-a987-236eec11b184','0006-4305','HUMAN PRESCRIPTION DRUG','Renflexis','','infliximab','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20170701','','BLA','BLA761054','Merck Sharp & Dohme LLC','INFLIXIMAB','100','mg/1','Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4329_848cc0e7-3441-4afb-88d9-2af7519dbb55','0006-4329','VACCINE','VAXNEUVANCE','','Pneumococcal 15-valent Conjugate Vaccine CRM197 Protein adsorbed','INJECTION, SUSPENSION','INTRAMUSCULAR','20210716','','BLA','BLA125741','Merck Sharp & Dohme LLC','CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN; STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 22F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 33F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9V CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN','30; 2; 2; 2; 2; 2; 2; 2; 2; 2; 2; 2; 2; 4; 2; 2','ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL','Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Vaccines, Conjugate [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4681_32acdee2-0847-4e37-84dc-afc43e0a68a3','0006-4681','VACCINE','M-M-R II','','measles, mumps, and rubella virus vaccine live','INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION','SUBCUTANEOUS','19710421','','BLA','BLA101069','Merck Sharp & Dohme LLC','MEASLES VIRUS STRAIN ENDERS'''' ATTENUATED EDMONSTON LIVE ANTIGEN; MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN; RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN','1000; 12500; 1000','[TCID_50]/.5mL; [TCID_50]/.5mL; [TCID_50]/.5mL','Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Live Attenuated Measles Virus Vaccine [EPC], Live Attenuated Mumps Virus Vaccine [EPC], Live Attenuated Rubella Virus Vaccine [EPC], Measles Vaccine [CS], Mumps Vaccine [CS], Rubella Vaccine [CS], Vaccines, Attenuated [CS], Vaccines, Attenuated [CS], Vaccines, Attenuated [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4826_39b40257-19bf-414c-815d-c5eb2e7b0686','0006-4826','VACCINE','VARIVAX','','Varicella Virus Vaccine Live','INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION','SUBCUTANEOUS','19950317','','BLA','BLA103552','Merck Sharp & Dohme LLC','VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN','1350','[PFU]/.5mL','Actively Acquired Immunity [PE], Chickenpox Vaccine [CS], Herpes Zoster Vaccine [CS], Live Attenuated Herpes Zoster Virus Vaccine [EPC], Live Attenuated Varicella Zoster Virus Vaccine [EPC], Vaccines, Attenuated [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4827_39b40257-19bf-414c-815d-c5eb2e7b0686','0006-4827','VACCINE','VARIVAX','','Varicella Virus Vaccine Live','INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION','SUBCUTANEOUS','19950317','','BLA','BLA103552','Merck Sharp & Dohme LLC','VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN','1350','[PFU]/.5mL','Actively Acquired Immunity [PE], Chickenpox Vaccine [CS], Herpes Zoster Vaccine [CS], Live Attenuated Herpes Zoster Virus Vaccine [EPC], Live Attenuated Varicella Zoster Virus Vaccine [EPC], Vaccines, Attenuated [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4831_2567bef1-a2e7-43a3-8cc0-19b05f5ada47','0006-4831','VACCINE','VAQTA','','hepatitis A vaccine, inactivated','INJECTION, SUSPENSION','INTRAMUSCULAR','19960329','','BLA','BLA103606','Merck Sharp & Dohme LLC','HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED)','25','[iU]/.5mL','Actively Acquired Immunity [PE], Hepatitis A Vaccines [CS], Inactivated Hepatitis A Virus Vaccine [EPC], Vaccines, Inactivated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4837_317a2dc7-b213-4058-8f85-5ad7cb86cd97','0006-4837','VACCINE','PNEUMOVAX 23','','pneumococcal vaccine polyvalent','INJECTION, SOLUTION','INTRAMUSCULAR; SUBCUTANEOUS','20140721','','BLA','BLA101094','Merck Sharp & Dohme LLC','STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 15B CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 17F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 2 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 20 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 22F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 33F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6B CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 8 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9N CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9V CAPSULAR POLYSACCHARIDE ANTIGEN','25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25','ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL','Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4841_2567bef1-a2e7-43a3-8cc0-19b05f5ada47','0006-4841','VACCINE','VAQTA','','hepatitis A vaccine, inactivated','INJECTION, SUSPENSION','INTRAMUSCULAR','19960329','','BLA','BLA103606','Merck Sharp & Dohme LLC','HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED)','50','[iU]/mL','Actively Acquired Immunity [PE], Hepatitis A Vaccines [CS], Inactivated Hepatitis A Virus Vaccine [EPC], Vaccines, Inactivated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4897_1682000d-37ad-4cfa-9778-5dd23967d30b','0006-4897','VACCINE','PedvaxHIB','','Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)','INJECTION, SUSPENSION','INTRAMUSCULAR','19891220','','BLA','BLA103237','Merck Sharp & Dohme LLC','HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN','7.5','ug/.5mL','Actively Acquired Immunity [PE], Haemophilus Vaccines [CS], Inactivated Haemophilus Influenzae B Vaccine [EPC], Vaccines, Inactivated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4943_317a2dc7-b213-4058-8f85-5ad7cb86cd97','0006-4943','VACCINE','PNEUMOVAX 23','','pneumococcal vaccine polyvalent','INJECTION, SOLUTION','INTRAMUSCULAR; SUBCUTANEOUS','19830707','','BLA','BLA101094','Merck Sharp & Dohme LLC','STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 15B CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 17F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 2 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 20 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 22F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 33F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6B CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 8 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9N CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9V CAPSULAR POLYSACCHARIDE ANTIGEN','25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25','ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL','Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4981_283756c3-db2a-48f8-b5e6-0102b97e8d73','0006-4981','VACCINE','RECOMBIVAX HB','','Hepatitis B Vaccine (Recombinant)','INJECTION, SUSPENSION','INTRAMUSCULAR; SUBCUTANEOUS','19860723','','BLA','BLA101066','Merck Sharp & Dohme LLC','HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN','5','ug/.5mL','Actively Acquired Immunity [PE], Hepatitis B Vaccines [CS], Inactivated Hepatitis B Virus Vaccine [EPC], Vaccines, Inactivated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4992_283756c3-db2a-48f8-b5e6-0102b97e8d73','0006-4992','VACCINE','RECOMBIVAX HB','','Hepatitis B Vaccine (Recombinant)','INJECTION, SUSPENSION','INTRAMUSCULAR; SUBCUTANEOUS','19860723','','BLA','BLA101066','Merck Sharp & Dohme LLC','HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN','40','ug/mL','Actively Acquired Immunity [PE], Hepatitis B Vaccines [CS], Inactivated Hepatitis B Virus Vaccine [EPC], Vaccines, Inactivated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-4995_283756c3-db2a-48f8-b5e6-0102b97e8d73','0006-4995','VACCINE','RECOMBIVAX HB','','Hepatitis B Vaccine (Recombinant)','INJECTION, SUSPENSION','INTRAMUSCULAR; SUBCUTANEOUS','19860723','','BLA','BLA101066','Merck Sharp & Dohme LLC','HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN','10','ug/mL','Actively Acquired Immunity [PE], Hepatitis B Vaccines [CS], Inactivated Hepatitis B Virus Vaccine [EPC], Vaccines, Inactivated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-5003_179a9105-1fd2-4d0b-83d9-81aba13d9d44','0006-5003','HUMAN PRESCRIPTION DRUG','PREVYMIS','','LETERMOVIR','INJECTION, SOLUTION','INTRAVENOUS','20171108','','NDA','NDA209940','Merck Sharp & Dohme LLC','LETERMOVIR','20','mg/mL','Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytomegalovirus DNA Terminase Complex Inhibitor [EPC], DNA Terminase Complex Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-5004_179a9105-1fd2-4d0b-83d9-81aba13d9d44','0006-5004','HUMAN PRESCRIPTION DRUG','PREVYMIS','','LETERMOVIR','INJECTION, SOLUTION','INTRAVENOUS','20171108','','NDA','NDA209940','Merck Sharp & Dohme LLC','LETERMOVIR','20','mg/mL','Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytomegalovirus DNA Terminase Complex Inhibitor [EPC], DNA Terminase Complex Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-5007_14d7aa46-2338-4249-a088-aab661c9d572','0006-5007','HUMAN PRESCRIPTION DRUG','DELSTRIGO','','doravirine, lamivudine, and tenofovir disoproxil fumarate','TABLET, FILM COATED','ORAL','20180720','','NDA','NDA210807','Merck Sharp & Dohme LLC','DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE','100; 300; 300','mg/1; mg/1; mg/1','Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-5028_78117dab-b91a-46e0-b833-858d9110e98f','0006-5028','HUMAN PRESCRIPTION DRUG','VERQUVO','','vericiguat','TABLET, FILM COATED','ORAL','20210201','','NDA','NDA214377','Merck Sharp & Dohme LLC','VERICIGUAT','2.5','mg/1','Guanylate Cyclase Stimulators [MoA], Soluble Guanylate Cyclase Stimulator [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-5029_78117dab-b91a-46e0-b833-858d9110e98f','0006-5029','HUMAN PRESCRIPTION DRUG','VERQUVO','','vericiguat','TABLET, FILM COATED','ORAL','20210201','','NDA','NDA214377','Merck Sharp & Dohme LLC','VERICIGUAT','5','mg/1','Guanylate Cyclase Stimulators [MoA], Soluble Guanylate Cyclase Stimulator [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-5030_78117dab-b91a-46e0-b833-858d9110e98f','0006-5030','HUMAN PRESCRIPTION DRUG','VERQUVO','','vericiguat','TABLET, FILM COATED','ORAL','20210201','','NDA','NDA214377','Merck Sharp & Dohme LLC','VERICIGUAT','10','mg/1','Guanylate Cyclase Stimulators [MoA], Soluble Guanylate Cyclase Stimulator [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-5033_419c4f97-e6d6-4bed-9014-a69a39d2149f','0006-5033','HUMAN PRESCRIPTION DRUG','Ontruzant','','trastuzumab','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20200415','20230930','BLA','BLA761100','Merck Sharp & Dohme Corp.','TRASTUZUMAB','150','mg/1','HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-5034_419c4f97-e6d6-4bed-9014-a69a39d2149f','0006-5034','HUMAN PRESCRIPTION DRUG','Ontruzant','','Ontruzant','KIT','INTRAVENOUS','20200415','20230930','BLA','BLA761100','Merck Sharp & Dohme Corp.','','','','','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-5055_16225f34-8c88-49c7-b8b7-7975daf0f52d','0006-5055','HUMAN PRESCRIPTION DRUG','LAGEVRIO','','molnupiravir','CAPSULE','ORAL','20211223','','EMERGENCY USE AUTHORIZATION','','Merck Sharp & Dohme LLC','MOLNUPIRAVIR','200','mg/1','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-5331_3e4d6cc7-abe4-4d8f-beae-16a0e6ac0610','0006-5331','HUMAN PRESCRIPTION DRUG','WELIREG','','belzutifan','TABLET, FILM COATED','ORAL','20210813','','NDA','NDA215383','Merck Sharp & Dohme LLC','BELZUTIFAN','40','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-5363_12558857-2657-4382-8f3b-bc9109e96bc1','0006-5363','HUMAN PRESCRIPTION DRUG','STEGLATRO','','ertugliflozin','TABLET, FILM COATED','ORAL','20171219','','NDA','NDA209803','Merck Sharp & Dohme LLC','ERTUGLIFLOZIN PIDOLATE','5','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-5364_12558857-2657-4382-8f3b-bc9109e96bc1','0006-5364','HUMAN PRESCRIPTION DRUG','STEGLATRO','','ertugliflozin','TABLET, FILM COATED','ORAL','20171219','','NDA','NDA209803','Merck Sharp & Dohme LLC','ERTUGLIFLOZIN PIDOLATE','15','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-5367_16acf8c3-3e36-469f-91a6-1cb03f3c909b','0006-5367','HUMAN PRESCRIPTION DRUG','STEGLUJAN','','ertugliflozin and sitagliptin','TABLET, FILM COATED','ORAL','20171219','','NDA','NDA209805','Merck Sharp & Dohme LLC','ERTUGLIFLOZIN PIDOLATE; SITAGLIPTIN PHOSPHATE','5; 100','mg/1; mg/1','Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-5368_16acf8c3-3e36-469f-91a6-1cb03f3c909b','0006-5368','HUMAN PRESCRIPTION DRUG','STEGLUJAN','','ertugliflozin and sitagliptin','TABLET, FILM COATED','ORAL','20171219','','NDA','NDA209805','Merck Sharp & Dohme LLC','ERTUGLIFLOZIN PIDOLATE; SITAGLIPTIN PHOSPHATE','15; 100','mg/1; mg/1','Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-5369_140ab008-48fc-438f-b0a3-b54506e3a996','0006-5369','HUMAN PRESCRIPTION DRUG','SEGLUROMET','','ertugliflozin and metformin hydrochloride','TABLET, FILM COATED','ORAL','20171219','','NDA','NDA209806','Merck Sharp & Dohme LLC','ERTUGLIFLOZIN PIDOLATE; METFORMIN HYDROCHLORIDE','2.5; 500','mg/1; mg/1','Biguanide [EPC], Biguanides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-5370_140ab008-48fc-438f-b0a3-b54506e3a996','0006-5370','HUMAN PRESCRIPTION DRUG','SEGLUROMET','','ertugliflozin and metformin hydrochloride','TABLET, FILM COATED','ORAL','20171219','','NDA','NDA209806','Merck Sharp & Dohme LLC','ERTUGLIFLOZIN PIDOLATE; METFORMIN HYDROCHLORIDE','7.5; 500','mg/1; mg/1','Biguanide [EPC], Biguanides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-5373_140ab008-48fc-438f-b0a3-b54506e3a996','0006-5373','HUMAN PRESCRIPTION DRUG','SEGLUROMET','','ertugliflozin and metformin hydrochloride','TABLET, FILM COATED','ORAL','20171219','','NDA','NDA209806','Merck Sharp & Dohme LLC','ERTUGLIFLOZIN PIDOLATE; METFORMIN HYDROCHLORIDE','2.5; 1000','mg/1; mg/1','Biguanide [EPC], Biguanides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-5374_140ab008-48fc-438f-b0a3-b54506e3a996','0006-5374','HUMAN PRESCRIPTION DRUG','SEGLUROMET','','ertugliflozin and metformin hydrochloride','TABLET, FILM COATED','ORAL','20171219','','NDA','NDA209806','Merck Sharp & Dohme LLC','ERTUGLIFLOZIN PIDOLATE; METFORMIN HYDROCHLORIDE','7.5; 1000','mg/1; mg/1','Biguanide [EPC], Biguanides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-5423_2098382c-064f-4f2c-a670-801eda929bf7','0006-5423','HUMAN PRESCRIPTION DRUG','BRIDION','','sugammadex','INJECTION, SOLUTION','INTRAVENOUS','20151215','','NDA','NDA022225','Merck Sharp & Dohme LLC','SUGAMMADEX SODIUM','100','mg/mL','gamma-Cyclodextrins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-5424_23a76b07-ee50-424c-94a5-088278773874','0006-5424','PLASMA DERIVATIVE','ANTIVENIN','','Latrodectus mactans','KIT','','20141201','','BLA','BLA101062','Merck Sharp & Dohme LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0006-5425_2098382c-064f-4f2c-a670-801eda929bf7','0006-5425','HUMAN PRESCRIPTION DRUG','BRIDION','','sugammadex','INJECTION, SOLUTION','INTRAVENOUS','20151215','','NDA','NDA022225','Merck Sharp & Dohme LLC','SUGAMMADEX SODIUM','100','mg/mL','gamma-Cyclodextrins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0007-3370_d03bd95a-f9f1-4f4a-9ea5-bc972ad55761','0007-3370','HUMAN PRESCRIPTION DRUG','COREG','CR','carvedilol phosphate','CAPSULE, EXTENDED RELEASE','ORAL','20070209','20230430','NDA','NDA022012','GlaxoSmithKline LLC','CARVEDILOL PHOSPHATE','10','mg/1','Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0007-3371_d03bd95a-f9f1-4f4a-9ea5-bc972ad55761','0007-3371','HUMAN PRESCRIPTION DRUG','COREG','CR','carvedilol phosphate','CAPSULE, EXTENDED RELEASE','ORAL','20070206','20230930','NDA','NDA022012','GlaxoSmithKline LLC','CARVEDILOL PHOSPHATE','20','mg/1','Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0007-3372_d03bd95a-f9f1-4f4a-9ea5-bc972ad55761','0007-3372','HUMAN PRESCRIPTION DRUG','COREG','CR','carvedilol phosphate','CAPSULE, EXTENDED RELEASE','ORAL','20070214','20230531','NDA','NDA022012','GlaxoSmithKline LLC','CARVEDILOL PHOSPHATE','40','mg/1','Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0007-3373_d03bd95a-f9f1-4f4a-9ea5-bc972ad55761','0007-3373','HUMAN PRESCRIPTION DRUG','COREG','CR','carvedilol phosphate','CAPSULE, EXTENDED RELEASE','ORAL','20070220','20230930','NDA','NDA022012','GlaxoSmithKline LLC','CARVEDILOL PHOSPHATE','80','mg/1','Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0007-3383_d03bd95a-f9f1-4f4a-9ea5-bc972ad55761','0007-3383','HUMAN PRESCRIPTION DRUG','COREG','CR','carvedilol phosphate','CAPSULE, EXTENDED RELEASE','ORAL','20191101','20240731','NDA','NDA022012','GlaxoSmithKline LLC','CARVEDILOL PHOSPHATE','10','mg/1','Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0007-3385_d03bd95a-f9f1-4f4a-9ea5-bc972ad55761','0007-3385','HUMAN PRESCRIPTION DRUG','COREG','CR','carvedilol phosphate','CAPSULE, EXTENDED RELEASE','ORAL','20191101','20250131','NDA','NDA022012','GlaxoSmithKline LLC','CARVEDILOL PHOSPHATE','20','mg/1','Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0007-3387_d03bd95a-f9f1-4f4a-9ea5-bc972ad55761','0007-3387','HUMAN PRESCRIPTION DRUG','COREG','CR','carvedilol phosphate','CAPSULE, EXTENDED RELEASE','ORAL','20191101','20250131','NDA','NDA022012','GlaxoSmithKline LLC','CARVEDILOL PHOSPHATE','40','mg/1','Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0007-4139_5ff6a50b-2be3-44f9-bc0d-3e064b204e76','0007-4139','HUMAN PRESCRIPTION DRUG','COREG','','carvedilol','TABLET, FILM COATED','ORAL','19970603','20230630','NDA','NDA020297','GlaxoSmithKline LLC','CARVEDILOL','3.125','mg/1','Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0007-4140_5ff6a50b-2be3-44f9-bc0d-3e064b204e76','0007-4140','HUMAN PRESCRIPTION DRUG','COREG','','carvedilol','TABLET, FILM COATED','ORAL','19970603','20230630','NDA','NDA020297','GlaxoSmithKline LLC','CARVEDILOL','6.25','mg/1','Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0007-4141_5ff6a50b-2be3-44f9-bc0d-3e064b204e76','0007-4141','HUMAN PRESCRIPTION DRUG','COREG','','carvedilol','TABLET, FILM COATED','ORAL','19970603','20230630','NDA','NDA020297','GlaxoSmithKline LLC','CARVEDILOL','12.5','mg/1','Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0007-4142_5ff6a50b-2be3-44f9-bc0d-3e064b204e76','0007-4142','HUMAN PRESCRIPTION DRUG','COREG','','carvedilol','TABLET, FILM COATED','ORAL','19970603','20231031','NDA','NDA020297','GlaxoSmithKline LLC','CARVEDILOL','25','mg/1','Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-0100_46f22997-83ff-4ff3-bc6b-263767c792dc','0008-0100','HUMAN PRESCRIPTION DRUG','Besponsa','','inotuzumab ozogamicin','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20170818','','BLA','BLA761040','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','INOTUZUMAB OZOGAMICIN','0.25','mg/mL','CD22-directed Antibody Interactions [MoA], CD22-directed Immunoconjugate [EPC], Decreased DNA Integrity [PE], Immunoconjugates [CS], Increased Cellular Death [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-0423_7a16fb9b-c963-48d9-90f9-b428857ab5de','0008-0423','HUMAN PRESCRIPTION DRUG','North American Coral Snake Antivenin (Equine)','','Coral Snake (Micrurus Fulvius) Immune Globulin Antivenin (Equine)','INJECTION, POWDER, FOR SOLUTION','INTRAVENOUS','20161012','','BLA','BLA101099','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','CORAL SNAKE (MICRURUS FULVIUS) IMMUNE GLOBULIN ANTIVENIN (EQUINE)','250','[arb''''U]/10mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-0833_46df92d7-cc7b-4b8c-8f40-921dc6b4a5d2','0008-0833','HUMAN PRESCRIPTION DRUG','Effexor','XR','VENLAFAXINE HYDROCHLORIDE','CAPSULE, EXTENDED RELEASE','ORAL','19971101','','NDA','NDA020699','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','VENLAFAXINE HYDROCHLORIDE','75','mg/1','Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-0836_46df92d7-cc7b-4b8c-8f40-921dc6b4a5d2','0008-0836','HUMAN PRESCRIPTION DRUG','Effexor','XR','VENLAFAXINE HYDROCHLORIDE','CAPSULE, EXTENDED RELEASE','ORAL','19971101','','NDA','NDA020699','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','VENLAFAXINE HYDROCHLORIDE','150','mg/1','Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-0837_46df92d7-cc7b-4b8c-8f40-921dc6b4a5d2','0008-0837','HUMAN PRESCRIPTION DRUG','Effexor','XR','VENLAFAXINE HYDROCHLORIDE','CAPSULE, EXTENDED RELEASE','ORAL','19971101','','NDA','NDA020699','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','VENLAFAXINE HYDROCHLORIDE','37.5','mg/1','Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-0841_c4a0d749-2697-4c3d-a8cd-87eafcfd8171','0008-0841','HUMAN PRESCRIPTION DRUG','Protonix','Delayed-Release','PANTOPRAZOLE SODIUM','TABLET, DELAYED RELEASE','ORAL','20000501','','NDA','NDA020987','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','PANTOPRAZOLE SODIUM','40','mg/1','Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-0843_c4a0d749-2697-4c3d-a8cd-87eafcfd8171','0008-0843','HUMAN PRESCRIPTION DRUG','Protonix','Delayed-Release','PANTOPRAZOLE SODIUM','TABLET, DELAYED RELEASE','ORAL','20000501','','NDA','NDA020987','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','PANTOPRAZOLE SODIUM','20','mg/1','Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-0844_c4a0d749-2697-4c3d-a8cd-87eafcfd8171','0008-0844','HUMAN PRESCRIPTION DRUG','Protonix','Delayed-Release','PANTOPRAZOLE SODIUM','GRANULE, DELAYED RELEASE','ORAL','20080229','','NDA','NDA022020','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','PANTOPRAZOLE SODIUM','40','mg/1','Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-0923_a0bb7c85-0a97-482c-9466-4b55644531e4','0008-0923','HUMAN PRESCRIPTION DRUG','Protonix','I.V.','PANTOPRAZOLE SODIUM','INJECTION, POWDER, FOR SOLUTION','INTRAVENOUS','20010501','','NDA','NDA020988','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','PANTOPRAZOLE SODIUM','40','mg/10mL','Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-1030_c589f3b2-cdc6-4ac3-8e5a-52aab770e7ab','0008-1030','HUMAN PRESCRIPTION DRUG','Rapamune','','SIROLIMUS','SOLUTION','ORAL','19990901','','NDA','NDA021083','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','SIROLIMUS','1','mg/mL','Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-1040_c589f3b2-cdc6-4ac3-8e5a-52aab770e7ab','0008-1040','HUMAN PRESCRIPTION DRUG','Rapamune','','SIROLIMUS','TABLET, SUGAR COATED','ORAL','20100301','','NDA','NDA021110','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','SIROLIMUS','0.5','mg/1','Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-1041_c589f3b2-cdc6-4ac3-8e5a-52aab770e7ab','0008-1041','HUMAN PRESCRIPTION DRUG','Rapamune','','SIROLIMUS','TABLET, SUGAR COATED','ORAL','20010701','','NDA','NDA021110','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','SIROLIMUS','1','mg/1','Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-1042_c589f3b2-cdc6-4ac3-8e5a-52aab770e7ab','0008-1042','HUMAN PRESCRIPTION DRUG','Rapamune','','SIROLIMUS','TABLET, SUGAR COATED','ORAL','20010701','','NDA','NDA021110','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','SIROLIMUS','2','mg/1','Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-1123_4ad64636-3859-49ab-a346-b26d2420fee2','0008-1123','HUMAN PRESCRIPTION DRUG','Duavee','','conjugated estrogens/bazedoxifene','TABLET, FILM COATED','ORAL','20131003','','NDA','NDA022247','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED','20; .45','mg/1; mg/1','Estrogen Agonist/Antagonist [EPC], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS], Selective Estrogen Receptor Modulators [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-1179_93ad7624-ea57-4fb4-b99f-5def9a34995a','0008-1179','HUMAN PRESCRIPTION DRUG','Torisel','','temsirolimus','KIT','','20070701','','NDA','NDA022088','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-1210_0c40d9ea-730a-42d8-abd1-5a1da444dfb6','0008-1210','HUMAN PRESCRIPTION DRUG','Pristiq','Extended-Release','desvenlafaxine succinate','TABLET, EXTENDED RELEASE','ORAL','20150401','','NDA','NDA021992','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','DESVENLAFAXINE SUCCINATE','25','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-1211_0c40d9ea-730a-42d8-abd1-5a1da444dfb6','0008-1211','HUMAN PRESCRIPTION DRUG','Pristiq','Extended-Release','desvenlafaxine succinate','TABLET, EXTENDED RELEASE','ORAL','20080501','','NDA','NDA021992','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','DESVENLAFAXINE SUCCINATE','50','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-1222_0c40d9ea-730a-42d8-abd1-5a1da444dfb6','0008-1222','HUMAN PRESCRIPTION DRUG','Pristiq','Extended-Release','desvenlafaxine succinate','TABLET, EXTENDED RELEASE','ORAL','20080501','','NDA','NDA021992','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','DESVENLAFAXINE SUCCINATE','100','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-2001_ffc4c349-c863-49bf-b179-caa42b759898','0008-2001','HUMAN PRESCRIPTION DRUG','Protonix','I.V.','PANTOPRAZOLE SODIUM','INJECTION, POWDER, FOR SOLUTION','INTRAVENOUS','20140317','','NDA','NDA020988','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','PANTOPRAZOLE SODIUM','40','mg/10mL','Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-4001_9dd8d3c4-b06c-4c4d-8000-161cdd10d030','0008-4001','HUMAN PRESCRIPTION DRUG','Protonix','I.V.','PANTOPRAZOLE SODIUM','INJECTION, POWDER, FOR SOLUTION','INTRAVENOUS','20130501','','NDA','NDA020988','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','PANTOPRAZOLE SODIUM','40','mg/10mL','Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-4117_ef2f733d-0771-4184-8a90-d9df4114c0d9','0008-4117','HUMAN PRESCRIPTION DRUG','Trecator','','ethionamide','TABLET, FILM COATED','ORAL','20041108','','NDA','NDA013026','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','ETHIONAMIDE','250','mg/1','Antimycobacterial [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-4510_8323fbb8-fc24-472f-b6a7-c9bd0af1acee','0008-4510','HUMAN PRESCRIPTION DRUG','Mylotarg','','gemtuzumab ozogamicin','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20170907','','BLA','BLA761060','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','GEMTUZUMAB OZOGAMICIN','5','mg/5mL','CD33-directed Antibody Interactions [MoA], CD33-directed Immunoconjugate [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-4990_7e88761a-2780-431b-83b9-f5de38a73de6','0008-4990','HUMAN PRESCRIPTION DRUG','Tygacil','','TIGECYCLINE','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20080615','','NDA','NDA021821','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','TIGECYCLINE','50','mg/5mL','Tetracycline-class Antibacterial [EPC], Tetracyclines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0008-4994_6f8f7843-f620-4077-b0be-929d04d22884','0008-4994','HUMAN PRESCRIPTION DRUG','Tygacil','','TIGECYCLINE','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20170208','','NDA','NDA021821','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','TIGECYCLINE','50','mg/5mL','Tetracycline-class Antibacterial [EPC], Tetracyclines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0003_289fe43b-bdde-422c-ac63-65795a6af311','0009-0003','HUMAN PRESCRIPTION DRUG','SOLU-MEDROL','','methylprednisolone sodium succinate','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19590402','','NDA','NDA011856','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE SODIUM SUCCINATE','500','mg/4mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0005_939cad4d-f7a3-4e4a-858c-ee9e36dd89b2','0009-0005','HUMAN PRESCRIPTION DRUG','Solu-Cortef','','hydrocortisone sodium succinate','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19550427','','NDA','NDA009866','Pharmacia & Upjohn Company LLC','HYDROCORTISONE SODIUM SUCCINATE','1000','mg/8mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0011_939cad4d-f7a3-4e4a-858c-ee9e36dd89b2','0009-0011','HUMAN PRESCRIPTION DRUG','Solu-Cortef','','hydrocortisone sodium succinate','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19550427','','NDA','NDA009866','Pharmacia & Upjohn Company LLC','HYDROCORTISONE SODIUM SUCCINATE','100','mg/2mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0012_2f02bfd1-10bc-4b78-b6b5-770176e0433b','0009-0012','HUMAN PRESCRIPTION DRUG','CORTEF','','hydrocortisone','TABLET','ORAL','19521215','','NDA','NDA008697','Pharmacia & Upjohn Company LLC','HYDROCORTISONE','5','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0013_939cad4d-f7a3-4e4a-858c-ee9e36dd89b2','0009-0013','HUMAN PRESCRIPTION DRUG','Solu-Cortef','','hydrocortisone sodium succinate','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19550427','','NDA','NDA009866','Pharmacia & Upjohn Company LLC','HYDROCORTISONE SODIUM SUCCINATE','250','mg/2mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0016_939cad4d-f7a3-4e4a-858c-ee9e36dd89b2','0009-0016','HUMAN PRESCRIPTION DRUG','Solu-Cortef','','hydrocortisone sodium succinate','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19550427','','NDA','NDA009866','Pharmacia & Upjohn Company LLC','HYDROCORTISONE SODIUM SUCCINATE','500','mg/4mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0017_3d52d1b7-1aa3-48f2-b75c-dd1a913a4bd6','0009-0017','HUMAN PRESCRIPTION DRUG','Halcion','','triazolam','TABLET','ORAL','19821115','','NDA','NDA017892','Pharmacia & Upjohn Company LLC','TRIAZOLAM','0.25','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0018_289fe43b-bdde-422c-ac63-65795a6af311','0009-0018','HUMAN PRESCRIPTION DRUG','SOLU-MEDROL','','methylprednisolone sodium succinate','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19590402','','NDA','NDA011856','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE SODIUM SUCCINATE','1','g/8mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0020_7f26cb97-bd8b-4a8e-9fb5-8037f808f28e','0009-0020','HUMAN PRESCRIPTION DRUG','Medrol','','methylprednisolone','TABLET','ORAL','20130920','','NDA','NDA011153','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE','2','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0022_7f26cb97-bd8b-4a8e-9fb5-8037f808f28e','0009-0022','HUMAN PRESCRIPTION DRUG','Medrol','','methylprednisolone','TABLET','ORAL','19571024','','NDA','NDA011153','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE','8','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0029_b75669ce-39ef-4fbb-8228-c6c1c0c7dcc9','0009-0029','HUMAN PRESCRIPTION DRUG','Xanax','','alprazolam','TABLET','ORAL','19811016','','NDA','NDA018276','PHARMACIA & UPJOHN COMPANY LLC','ALPRAZOLAM','0.25','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0031_2f02bfd1-10bc-4b78-b6b5-770176e0433b','0009-0031','HUMAN PRESCRIPTION DRUG','CORTEF','','hydrocortisone','TABLET','ORAL','19521215','','NDA','NDA008697','Pharmacia & Upjohn Company LLC','HYDROCORTISONE','10','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0039_289fe43b-bdde-422c-ac63-65795a6af311','0009-0039','HUMAN PRESCRIPTION DRUG','SOLU-MEDROL','','methylprednisolone sodium succinate','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19590402','','NDA','NDA011856','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE SODIUM SUCCINATE','40','mg/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0039_411c816c-a44b-4366-bfb1-b89fd9c6cbdd','0009-0039','HUMAN PRESCRIPTION DRUG','SOLU-MEDROL','','methylprednisolone sodium succinate','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19590402','','NDA','NDA011856','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE SODIUM SUCCINATE','40','mg/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0044_2f02bfd1-10bc-4b78-b6b5-770176e0433b','0009-0044','HUMAN PRESCRIPTION DRUG','CORTEF','','hydrocortisone','TABLET','ORAL','19521215','','NDA','NDA008697','Pharmacia & Upjohn Company LLC','HYDROCORTISONE','20','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0047_289fe43b-bdde-422c-ac63-65795a6af311','0009-0047','HUMAN PRESCRIPTION DRUG','SOLU-MEDROL','','methylprednisolone sodium succinate','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19590402','','NDA','NDA011856','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE SODIUM SUCCINATE','125','mg/2mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0047_411c816c-a44b-4366-bfb1-b89fd9c6cbdd','0009-0047','HUMAN PRESCRIPTION DRUG','SOLU-MEDROL','','methylprednisolone sodium succinate','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19590402','','NDA','NDA011856','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE SODIUM SUCCINATE','125','mg/2mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0051_c2de256d-0907-4f1d-8d42-2af51c241b71','0009-0051','HUMAN PRESCRIPTION DRUG','Provera','','medroxyprogesterone acetate','TABLET','ORAL','20200720','','NDA','NDA011839','Pharmacia and Upjohn Company','MEDROXYPROGESTERONE ACETATE','10','mg/1','Progesterone Congeners [CS], Progestin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0055_b75669ce-39ef-4fbb-8228-c6c1c0c7dcc9','0009-0055','HUMAN PRESCRIPTION DRUG','Xanax','','alprazolam','TABLET','ORAL','19811016','','NDA','NDA018276','PHARMACIA & UPJOHN COMPANY LLC','ALPRAZOLAM','0.5','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0056_7f26cb97-bd8b-4a8e-9fb5-8037f808f28e','0009-0056','HUMAN PRESCRIPTION DRUG','Medrol','','methylprednisolone','TABLET','ORAL','19571024','','NDA','NDA011153','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE','4','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0057_517892a9-e740-42f8-becd-71d975c96949','0009-0057','HUMAN PRESCRIPTION DRUG','Xanax','XR','alprazolam','TABLET, EXTENDED RELEASE','ORAL','20030117','','NDA','NDA021434','PHARMACIA & UPJOHN COMPANY LLC','ALPRAZOLAM','0.5','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0059_517892a9-e740-42f8-becd-71d975c96949','0009-0059','HUMAN PRESCRIPTION DRUG','Xanax','XR','alprazolam','TABLET, EXTENDED RELEASE','ORAL','20030117','','NDA','NDA021434','PHARMACIA & UPJOHN COMPANY LLC','ALPRAZOLAM','1','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0065_c2de256d-0907-4f1d-8d42-2af51c241b71','0009-0065','HUMAN PRESCRIPTION DRUG','Provera','','medroxyprogesterone acetate','TABLET','ORAL','20190903','','NDA','NDA011839','Pharmacia and Upjohn Company','MEDROXYPROGESTERONE ACETATE','2.5','mg/1','Progesterone Congeners [CS], Progestin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0066_517892a9-e740-42f8-becd-71d975c96949','0009-0066','HUMAN PRESCRIPTION DRUG','Xanax','XR','alprazolam','TABLET, EXTENDED RELEASE','ORAL','20030117','','NDA','NDA021434','PHARMACIA & UPJOHN COMPANY LLC','ALPRAZOLAM','2','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0068_517892a9-e740-42f8-becd-71d975c96949','0009-0068','HUMAN PRESCRIPTION DRUG','Xanax','XR','alprazolam','TABLET, EXTENDED RELEASE','ORAL','20030117','','NDA','NDA021434','PHARMACIA & UPJOHN COMPANY LLC','ALPRAZOLAM','3','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0073_7f26cb97-bd8b-4a8e-9fb5-8037f808f28e','0009-0073','HUMAN PRESCRIPTION DRUG','Medrol','','methylprednisolone','TABLET','ORAL','19571024','','NDA','NDA011153','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE','16','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0085_304a4928-e4fe-44ab-8219-81967dfe77e8','0009-0085','HUMAN PRESCRIPTION DRUG','Depo-Testosterone','','testosterone cypionate','INJECTION, SOLUTION','INTRAMUSCULAR','20140701','','ANDA','ANDA085635','Pharmacia and Upjohn Company LLC','TESTOSTERONE CYPIONATE','100','mg/mL','Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]','CIII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0086_304a4928-e4fe-44ab-8219-81967dfe77e8','0009-0086','HUMAN PRESCRIPTION DRUG','Depo-Testosterone','','testosterone cypionate','INJECTION, SOLUTION','INTRAMUSCULAR','20140701','','ANDA','ANDA085635','Pharmacia and Upjohn Company LLC','TESTOSTERONE CYPIONATE','200','mg/mL','Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]','CIII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0090_b75669ce-39ef-4fbb-8228-c6c1c0c7dcc9','0009-0090','HUMAN PRESCRIPTION DRUG','Xanax','','alprazolam','TABLET','ORAL','19811016','','NDA','NDA018276','PHARMACIA & UPJOHN COMPANY LLC','ALPRAZOLAM','1','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0094_b75669ce-39ef-4fbb-8228-c6c1c0c7dcc9','0009-0094','HUMAN PRESCRIPTION DRUG','Xanax','','alprazolam','TABLET','ORAL','19811016','','NDA','NDA018276','PHARMACIA & UPJOHN COMPANY LLC','ALPRAZOLAM','2','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0176_7f26cb97-bd8b-4a8e-9fb5-8037f808f28e','0009-0176','HUMAN PRESCRIPTION DRUG','Medrol','','methylprednisolone','TABLET','ORAL','19571024','','NDA','NDA011153','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE','32','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0215_68b1c5b9-b121-4cbc-8232-80f6f8b41e24','0009-0215','HUMAN PRESCRIPTION DRUG','PROSTIN','VR PEDIATRIC','alprostadil','INJECTION, SOLUTION','INTRAVASCULAR; INTRAVENOUS','20221003','','NDA','NDA018484','Pharmacia & Upjohn Company LLC','ALPROSTADIL','500','ug/mL','Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0225_fe7c5eb1-3812-4765-8d6a-ec48ef3cd6b8','0009-0225','HUMAN PRESCRIPTION DRUG','Cleocin Hydrochloride','','clindamycin hydrochloride','CAPSULE','ORAL','19700522','','NDA','NDA050162','Pharmacia & Upjohn Company LLC','CLINDAMYCIN HYDROCHLORIDE','150','mg/1','Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0260_a479b637-19d2-4d15-85e2-0162a04ed101','0009-0260','HUMAN PRESCRIPTION DRUG','Colestid','','Colestipol Hydrochloride','GRANULE, FOR SUSPENSION','ORAL','19770404','','NDA','NDA017563','Pharmacia & Upjohn Company LLC','COLESTIPOL HYDROCHLORIDE','5','g/5g','Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0271_5d5c29d1-9e18-4447-b158-dbc85490d29e','0009-0271','HUMAN PRESCRIPTION DRUG','Depo-Estradiol','','estradiol cypionate','INJECTION','INTRAMUSCULAR','19790815','','ANDA','ANDA085470','Pharmacia & Upjohn Company LLC','ESTRADIOL CYPIONATE','5','mg/mL','Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0274_a5e769c3-2f35-4c4c-b032-ca745ad3092a','0009-0274','HUMAN PRESCRIPTION DRUG','Depo-Medrol','','methylprednisolone acetate','INJECTION, SUSPENSION','INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE','19590528','','NDA','NDA011757','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE ACETATE','20','mg/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0280_a5e769c3-2f35-4c4c-b032-ca745ad3092a','0009-0280','HUMAN PRESCRIPTION DRUG','Depo-Medrol','','methylprednisolone acetate','INJECTION, SUSPENSION','INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE','19590528','','NDA','NDA011757','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE ACETATE','40','mg/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0286_c2de256d-0907-4f1d-8d42-2af51c241b71','0009-0286','HUMAN PRESCRIPTION DRUG','Provera','','medroxyprogesterone acetate','TABLET','ORAL','19591201','','NDA','NDA011839','Pharmacia and Upjohn Company','MEDROXYPROGESTERONE ACETATE','5','mg/1','Progesterone Congeners [CS], Progestin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0287_c2de256d-0907-4f1d-8d42-2af51c241b71','0009-0287','HUMAN PRESCRIPTION DRUG','Provera','','medroxyprogesterone acetate','TABLET','ORAL','20181111','','NDA','NDA011839','Pharmacia and Upjohn Company','MEDROXYPROGESTERONE ACETATE','5','mg/1','Progesterone Congeners [CS], Progestin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0302_31cb49dc-52fb-4c17-85ed-d82b71c18021','0009-0302','HUMAN PRESCRIPTION DRUG','Cleocin Phosphate','','clindamycin phosphate','INJECTION, SOLUTION','INTRAMUSCULAR; INTRAVENOUS','20140410','','NDA','NDA050441','Pharmacia & Upjohn Company LLC','CLINDAMYCIN PHOSPHATE','150','mg/mL','Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0306_a5e769c3-2f35-4c4c-b032-ca745ad3092a','0009-0306','HUMAN PRESCRIPTION DRUG','Depo-Medrol','','methylprednisolone acetate','INJECTION, SUSPENSION','INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE','19590528','','NDA','NDA011757','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE ACETATE','80','mg/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0331_fe7c5eb1-3812-4765-8d6a-ec48ef3cd6b8','0009-0331','HUMAN PRESCRIPTION DRUG','Cleocin Hydrochloride','','clindamycin hydrochloride','CAPSULE','ORAL','19700522','','NDA','NDA050162','Pharmacia & Upjohn Company LLC','CLINDAMYCIN HYDROCHLORIDE','75','mg/1','Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0341_03bce5d4-2e0d-41c5-8048-ceb4749b0b5a','0009-0341','HUMAN PRESCRIPTION DRUG','Glynase','','glyburide','TABLET','ORAL','19920304','','NDA','NDA020051','Pharmacia and Upjohn Company LLC','GLYBURIDE','1.5','mg/1','Sulfonylurea Compounds [CS], Sulfonylurea [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0347_94d37908-39b9-4eac-9320-f8c2263275f0','0009-0347','HUMAN PRESCRIPTION DRUG','Depo-Testosterone','','testosterone cypionate','INJECTION, SOLUTION','INTRAMUSCULAR','19790725','','ANDA','ANDA085635','Pharmacia and Upjohn Company LLC','TESTOSTERONE CYPIONATE','100','mg/mL','Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]','CIII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0352_03bce5d4-2e0d-41c5-8048-ceb4749b0b5a','0009-0352','HUMAN PRESCRIPTION DRUG','Glynase','','glyburide','TABLET','ORAL','19920304','','NDA','NDA020051','Pharmacia and Upjohn Company LLC','GLYBURIDE','3','mg/1','Sulfonylurea Compounds [CS], Sulfonylurea [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0370_a479b637-19d2-4d15-85e2-0162a04ed101','0009-0370','HUMAN PRESCRIPTION DRUG','Flavored Colestid','','Colestipol Hydrochloride','GRANULE, FOR SUSPENSION','ORAL','19770404','','NDA','NDA017563','Pharmacia & Upjohn Company LLC','COLESTIPOL HYDROCHLORIDE','5','g/7.5g','Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0395_fe7c5eb1-3812-4765-8d6a-ec48ef3cd6b8','0009-0395','HUMAN PRESCRIPTION DRUG','Cleocin Hydrochloride','','clindamycin hydrochloride','CAPSULE','ORAL','19700522','','NDA','NDA050162','Pharmacia & Upjohn Company LLC','CLINDAMYCIN HYDROCHLORIDE','300','mg/1','Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0417_94d37908-39b9-4eac-9320-f8c2263275f0','0009-0417','HUMAN PRESCRIPTION DRUG','Depo-Testosterone','','testosterone cypionate','INJECTION, SOLUTION','INTRAMUSCULAR','19790725','','ANDA','ANDA085635','Pharmacia and Upjohn Company LLC','TESTOSTERONE CYPIONATE','200','mg/mL','Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]','CIII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0436_88378534-2d5b-4736-a94d-3c104231dcf5','0009-0436','HUMAN PRESCRIPTION DRUG','R-Gene','','Arginine Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19760615','','NDA','NDA016931','Pharmacia & Upjohn Company LLC','ARGININE HYDROCHLORIDE','10','g/100mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0450_8f3a7262-6f88-4d2e-b122-a51f791e9437','0009-0450','HUMAN PRESCRIPTION DRUG','Colestid','','Colestipol Hydrochloride','TABLET','ORAL','19940719','','NDA','NDA020222','Pharmacia & Upjohn Company LLC','COLESTIPOL HYDROCHLORIDE','1','g/1','Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0555_c8d5c5c0-c7a0-4706-8518-f0739ff44ce0','0009-0555','HUMAN PRESCRIPTION DRUG','Lincocin','','lincomycin hydrochloride','INJECTION, SOLUTION','INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL','19641229','','NDA','NDA050317','Pharmacia & Upjohn Company LLC','LINCOMYCIN HYDROCHLORIDE','300','mg/mL','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0698_289fe43b-bdde-422c-ac63-65795a6af311','0009-0698','HUMAN PRESCRIPTION DRUG','SOLU-MEDROL','','methylprednisolone sodium succinate','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19590402','','NDA','NDA011856','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE SODIUM SUCCINATE','1','g/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0698_411c816c-a44b-4366-bfb1-b89fd9c6cbdd','0009-0698','HUMAN PRESCRIPTION DRUG','SOLU-MEDROL','','methylprednisolone sodium succinate','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19590402','','NDA','NDA011856','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE SODIUM SUCCINATE','1','g/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0728_e1cef283-1e43-40ae-b892-093b539c3bf4','0009-0728','HUMAN PRESCRIPTION DRUG','Cleocin Phosphate','','clindamycin phosphate','INJECTION, SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19721002','','NDA','NDA050441','Pharmacia & Upjohn Company LLC','CLINDAMYCIN PHOSPHATE','150','mg/mL','Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0746_8088c906-ead8-4afb-965a-599ff3ae1919','0009-0746','HUMAN PRESCRIPTION DRUG','Depo-Provera','','medroxyprogesterone acetate','INJECTION, SUSPENSION','INTRAMUSCULAR','19921029','','NDA','NDA020246','Pharmacia & Upjohn Company LLC','MEDROXYPROGESTERONE ACETATE','150','mg/mL','Progesterone Congeners [CS], Progestin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0758_289fe43b-bdde-422c-ac63-65795a6af311','0009-0758','HUMAN PRESCRIPTION DRUG','SOLU-MEDROL','','methylprednisolone sodium succinate','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19590402','','NDA','NDA011856','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE SODIUM SUCCINATE','500','mg/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0760_90c67ed0-3459-45ad-97b2-fddd7d96ac3f','0009-0760','HUMAN PRESCRIPTION DRUG','Cleocin Pediatric','','clindamycin palmitate hydrochloride','GRANULE, FOR SOLUTION','ORAL','19860417','','ANDA','ANDA062644','Pharmacia & Upjohn Company LLC','CLINDAMYCIN PALMITATE HYDROCHLORIDE','75','mg/5mL','Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0775_e1cef283-1e43-40ae-b892-093b539c3bf4','0009-0775','HUMAN PRESCRIPTION DRUG','Cleocin Phosphate','','clindamycin phosphate','INJECTION, SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19721002','','NDA','NDA050441','Pharmacia & Upjohn Company LLC','CLINDAMYCIN PHOSPHATE','150','mg/mL','Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0825_939cad4d-f7a3-4e4a-858c-ee9e36dd89b2','0009-0825','HUMAN PRESCRIPTION DRUG','Solu-Cortef','','hydrocortisone sodium succinate','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19550427','','NDA','NDA009866','Pharmacia & Upjohn Company LLC','HYDROCORTISONE SODIUM SUCCINATE','100','mg/2mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0850_289fe43b-bdde-422c-ac63-65795a6af311','0009-0850','HUMAN PRESCRIPTION DRUG','SOLU-MEDROL','','methylprednisolone sodium succinate','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19590402','','NDA','NDA011856','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE SODIUM SUCCINATE','2','g/30.6mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0856_244be587-b9ec-4072-8a6c-e1ed1165acc7','0009-0856','HUMAN PRESCRIPTION DRUG','Hemabate','','carboprost tromethamine','INJECTION, SOLUTION','INTRAMUSCULAR','19790109','','NDA','NDA017989','Pharmacia & Upjohn Company LLC','CARBOPROST TROMETHAMINE','250','ug/mL','Prostaglandin Analog [EPC], Prostaglandins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0870_e1cef283-1e43-40ae-b892-093b539c3bf4','0009-0870','HUMAN PRESCRIPTION DRUG','Cleocin Phosphate','','clindamycin phosphate','INJECTION, SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19721002','','NDA','NDA050441','Pharmacia & Upjohn Company LLC','CLINDAMYCIN PHOSPHATE','150','mg/mL','Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0901_31cb49dc-52fb-4c17-85ed-d82b71c18021','0009-0901','HUMAN PRESCRIPTION DRUG','Cleocin Phosphate','','clindamycin phosphate','INJECTION, SOLUTION','INTRAMUSCULAR; INTRAVENOUS','20140410','','NDA','NDA050441','Pharmacia & Upjohn Company LLC','CLINDAMYCIN PHOSPHATE','150','mg/mL','Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-0902_e1cef283-1e43-40ae-b892-093b539c3bf4','0009-0902','HUMAN PRESCRIPTION DRUG','Cleocin Phosphate','','clindamycin phosphate','INJECTION, SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19721002','','NDA','NDA050441','Pharmacia & Upjohn Company LLC','CLINDAMYCIN PHOSPHATE','150','mg/mL','Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-3051_92e62bb5-3fa1-4d85-a8dc-882c0d115f6d','0009-3051','HUMAN PRESCRIPTION DRUG','Cleocin Phosphate','','clindamycin phosphate','INJECTION, SOLUTION','INTRAMUSCULAR; INTRAVENOUS','20191118','','NDA','NDA050441','Pharmacia & Upjohn Company LLC','CLINDAMYCIN PHOSPHATE','150','mg/mL','Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-3073_05019624-5f4d-4839-a5c5-09f85b9f2d64','0009-3073','HUMAN PRESCRIPTION DRUG','Depo-Medrol','','methylprednisolone acetate','INJECTION, SUSPENSION','INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE','19590528','','NDA','NDA011757','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE ACETATE','40','mg/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-3073_b2eabec8-4fae-4441-b4dd-9a01b0f91c4a','0009-3073','HUMAN PRESCRIPTION DRUG','Depo-Medrol','','methylprednisolone acetate','INJECTION, SUSPENSION','INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE','19590528','','NDA','NDA011757','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE ACETATE','40','mg/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-3169_b352eb18-5983-473a-a627-0271ef2ba4cf','0009-3169','HUMAN PRESCRIPTION DRUG','PROSTIN','VR PEDIATRIC','alprostadil','INJECTION, SOLUTION','INTRAVASCULAR; INTRAVENOUS','19811016','','NDA','NDA018484','Pharmacia and Upjohn Company LLC','ALPROSTADIL','500','ug/mL','Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-3329_ace3af2a-85d9-410f-8d4e-19f190b1e2ec','0009-3329','HUMAN PRESCRIPTION DRUG','Cleocin T','','clindamycin phosphate','LOTION','TOPICAL','19890531','','NDA','NDA050600','Pharmacia & Upjohn Company LLC','CLINDAMYCIN PHOSPHATE','10','mg/mL','Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-3359_b3ab31df-3b44-45f1-ae08-73542f13cd68','0009-3359','HUMAN PRESCRIPTION DRUG','Prepidil','','dinoprostone','GEL','VAGINAL','19921209','','NDA','NDA019617','Pharmacia and Upjohn Company LLC','DINOPROSTONE','0.5','mg/3g','Prostaglandin Analog [EPC], Prostaglandins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-3448_4d9b3edd-e1d8-4007-ab69-c1411f489432','0009-3448','HUMAN PRESCRIPTION DRUG','Cleocin','','clindamycin phosphate','CREAM','VAGINAL','19920811','','NDA','NDA050680','Pharmacia & Upjohn Company LLC','CLINDAMYCIN PHOSPHATE','20','mg/g','Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-3449_03bce5d4-2e0d-41c5-8048-ceb4749b0b5a','0009-3449','HUMAN PRESCRIPTION DRUG','Glynase','','glyburide','TABLET','ORAL','19920304','','NDA','NDA020051','Pharmacia and Upjohn Company LLC','GLYBURIDE','6','mg/1','Sulfonylurea Compounds [CS], Sulfonylurea [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-3475_05019624-5f4d-4839-a5c5-09f85b9f2d64','0009-3475','HUMAN PRESCRIPTION DRUG','Depo-Medrol','','methylprednisolone acetate','INJECTION, SUSPENSION','INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE','19590528','','NDA','NDA011757','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE ACETATE','80','mg/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-3475_b2eabec8-4fae-4441-b4dd-9a01b0f91c4a','0009-3475','HUMAN PRESCRIPTION DRUG','Depo-Medrol','','methylprednisolone acetate','INJECTION, SUSPENSION','INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE','19590528','','NDA','NDA011757','Pharmacia & Upjohn Company LLC','METHYLPREDNISOLONE ACETATE','80','mg/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-3701_dfeca358-37c1-4337-b549-5d53160ffe84','0009-3701','HUMAN PRESCRIPTION DRUG','Caverject','','Alprostadil','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRACAVERNOUS','19950706','','NDA','NDA020379','Pharmacia & Upjohn Company LLC','ALPROSTADIL','20.5','ug/mL','Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-3794_13e6540f-3b41-4480-a729-c6cc78b59ca6','0009-3794','HUMAN PRESCRIPTION DRUG','Corvert','','ibutilide fumarate','INJECTION, SOLUTION','INTRAVENOUS','19951228','','NDA','NDA020491','Pharmacia & Upjohn Company LLC','IBUTILIDE FUMARATE','0.1','mg/mL','Antiarrhythmic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-3794_387c1cc9-4afc-4a1a-82e4-cd0fb535a82c','0009-3794','HUMAN PRESCRIPTION DRUG','Corvert','','ibutilide fumarate','INJECTION, SOLUTION','INTRAVENOUS','19951228','','NDA','NDA020491','Pharmacia and Upjohn Company LLC','IBUTILIDE FUMARATE','0.1','mg/mL','Antiarrhythmic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-4073_92e62bb5-3fa1-4d85-a8dc-882c0d115f6d','0009-4073','HUMAN PRESCRIPTION DRUG','Cleocin Phosphate','','clindamycin phosphate','INJECTION, SOLUTION','INTRAMUSCULAR; INTRAVENOUS','20191118','','NDA','NDA050441','Pharmacia & Upjohn Company LLC','CLINDAMYCIN PHOSPHATE','150','mg/mL','Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-4541_75d531d1-9683-4809-ab23-7f7872928085','0009-4541','HUMAN PRESCRIPTION DRUG','Detrol','','tolterodine tartrate','TABLET, FILM COATED','ORAL','19980325','','NDA','NDA020771','Pharmacia & Upjohn Company LLC','TOLTERODINE TARTRATE','1','mg/1','Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-4544_75d531d1-9683-4809-ab23-7f7872928085','0009-4544','HUMAN PRESCRIPTION DRUG','Detrol','','tolterodine tartrate','TABLET, FILM COATED','ORAL','19980325','','NDA','NDA020771','Pharmacia & Upjohn Company LLC','TOLTERODINE TARTRATE','2','mg/1','Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-4709_537374db-8865-4583-88b6-84d22b05736d','0009-4709','HUMAN PRESCRIPTION DRUG','Depo-SubQ Provera','','medroxyprogesterone acetate','INJECTION, SUSPENSION','SUBCUTANEOUS','20050502','','NDA','NDA021583','Pharmacia & Upjohn Company LLC','MEDROXYPROGESTERONE ACETATE','104','mg/.65mL','Progesterone Congeners [CS], Progestin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-4992_dadada4c-83d4-4526-8341-9df1fd642f63','0009-4992','HUMAN PRESCRIPTION DRUG','Zyvox','','linezolid','INJECTION, SOLUTION','INTRAVENOUS','20150706','','NDA','NDA021131','Pharmacia & Upjohn Company LLC','LINEZOLID','600','mg/300mL','Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-5091_00ba8044-31f3-4c9f-9fd7-172e2ac036f9','0009-5091','HUMAN PRESCRIPTION DRUG','Ellence','','epirubicin hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19990915','','NDA','NDA050778','Pharmacia & Upjohn Company LLC','EPIRUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-5093_00ba8044-31f3-4c9f-9fd7-172e2ac036f9','0009-5093','HUMAN PRESCRIPTION DRUG','Ellence','','epirubicin hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19990915','','NDA','NDA050778','Pharmacia & Upjohn Company LLC','EPIRUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-5095_92e62bb5-3fa1-4d85-a8dc-882c0d115f6d','0009-5095','HUMAN PRESCRIPTION DRUG','Cleocin Phosphate','','clindamycin phosphate','INJECTION, SOLUTION','INTRAMUSCULAR; INTRAVENOUS','20191118','','NDA','NDA050441','Pharmacia & Upjohn Company LLC','CLINDAMYCIN PHOSPHATE','150','mg/mL','Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-5136_d7d02cf2-72a9-414b-91f1-e6a21b3191d4','0009-5136','HUMAN PRESCRIPTION DRUG','Zyvox','','linezolid','GRANULE, FOR SUSPENSION','ORAL','20000418','','NDA','NDA021132','Pharmacia & Upjohn Company LLC','LINEZOLID','100','mg/5mL','Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-5137_d7d02cf2-72a9-414b-91f1-e6a21b3191d4','0009-5137','HUMAN PRESCRIPTION DRUG','Zyvox','','linezolid','INJECTION, SOLUTION','INTRAVENOUS','20000418','','NDA','NDA021131','Pharmacia & Upjohn Company LLC','LINEZOLID','200','mg/100mL','Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-5138_d7d02cf2-72a9-414b-91f1-e6a21b3191d4','0009-5138','HUMAN PRESCRIPTION DRUG','Zyvox','','linezolid','TABLET, FILM COATED','ORAL','20151012','','NDA','NDA021130','Pharmacia & Upjohn Company LLC','LINEZOLID','600','mg/1','Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-5140_d7d02cf2-72a9-414b-91f1-e6a21b3191d4','0009-5140','HUMAN PRESCRIPTION DRUG','Zyvox','','linezolid','INJECTION, SOLUTION','INTRAVENOUS','20000418','','NDA','NDA021131','Pharmacia & Upjohn Company LLC','LINEZOLID','600','mg/300mL','Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-5181_e8453e6e-3089-4f34-9834-9683179276cb','0009-5181','HUMAN PRESCRIPTION DRUG','Caverject Impulse','','Alprostadil','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRACAVERNOUS','20020611','','NDA','NDA021212','Pharmacia & Upjohn Company LLC','ALPROSTADIL','10','ug/.5mL','Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-5182_e8453e6e-3089-4f34-9834-9683179276cb','0009-5182','HUMAN PRESCRIPTION DRUG','Caverject Impulse','','Alprostadil','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRACAVERNOUS','20020611','','NDA','NDA021212','Pharmacia & Upjohn Company LLC','ALPROSTADIL','20','ug/.5mL','Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-5190_54731895-ffd4-4d24-acb1-97fdde96382f','0009-5190','HUMAN PRESCRIPTION DRUG','Detrol LA','','tolterodine tartrate','CAPSULE, EXTENDED RELEASE','ORAL','20000222','','NDA','NDA021228','Pharmacia and Upjohn Company LLC','TOLTERODINE TARTRATE','2','mg/1','Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-5191_54731895-ffd4-4d24-acb1-97fdde96382f','0009-5191','HUMAN PRESCRIPTION DRUG','Detrol LA','','tolterodine tartrate','CAPSULE, EXTENDED RELEASE','ORAL','20000222','','NDA','NDA021228','Pharmacia and Upjohn Company LLC','TOLTERODINE TARTRATE','4','mg/1','Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-5400_00c25938-fb91-4e66-ac58-11b6e10d6d3a','0009-5400','HUMAN PRESCRIPTION DRUG','Nicotrol','','nicotine','INHALANT','RESPIRATORY (INHALATION)','19970502','','NDA','NDA020714','Pharmacia & Upjohn Company LLC','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-5401_81c50c19-8c24-4258-9a63-7b01f42e7ff6','0009-5401','HUMAN PRESCRIPTION DRUG','Nicotrol','','nicotine','SPRAY, METERED','NASAL','19960522','','NDA','NDA020385','Pharmacia & Upjohn Company LLC','NICOTINE','10','mg/mL','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-7166_dc1f532e-7b5a-4359-b6d5-9659e3305223','0009-7166','HUMAN PRESCRIPTION DRUG','SOMAVERT','','pegvisomant','KIT','','20161001','','BLA','BLA021106','Pharmacia & Upjohn Company LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-7168_dc1f532e-7b5a-4359-b6d5-9659e3305223','0009-7168','HUMAN PRESCRIPTION DRUG','SOMAVERT','','pegvisomant','KIT','','20161001','','BLA','BLA021106','Pharmacia & Upjohn Company LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-7188_dc1f532e-7b5a-4359-b6d5-9659e3305223','0009-7188','HUMAN PRESCRIPTION DRUG','SOMAVERT','','pegvisomant','KIT','','20161001','','BLA','BLA021106','Pharmacia & Upjohn Company LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-7199_dc1f532e-7b5a-4359-b6d5-9659e3305223','0009-7199','HUMAN PRESCRIPTION DRUG','SOMAVERT','','pegvisomant','KIT','','20161001','','BLA','BLA021106','Pharmacia & Upjohn Company LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-7200_dc1f532e-7b5a-4359-b6d5-9659e3305223','0009-7200','HUMAN PRESCRIPTION DRUG','SOMAVERT','','pegvisomant','KIT','','20161001','','BLA','BLA021106','Pharmacia & Upjohn Company LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-7224_0d478b52-6fdd-4d6e-bdb2-535b4b40d0eb','0009-7224','PLASMA DERIVATIVE','Atgam','','EQUINE THYMOCYTE IMMUNE GLOBULIN','INJECTION, SOLUTION','INTRAVENOUS','19811117','','BLA','BLA103676','Pharmacia & Upjohn Company LLC','EQUINE THYMOCYTE IMMUNE GLOBULIN','50','mg/mL','Antibody-Surface Protein Interactions [MoA], Immunoglobulin G [EPC], Immunoglobulins [CS], Increased T Lymphocyte Destruction [PE], Lymphocyte Function Alteration [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-7376_8088c906-ead8-4afb-965a-599ff3ae1919','0009-7376','HUMAN PRESCRIPTION DRUG','Depo-Provera','','medroxyprogesterone acetate','INJECTION, SUSPENSION','INTRAMUSCULAR','19921029','','NDA','NDA020246','Pharmacia & Upjohn Company LLC','MEDROXYPROGESTERONE ACETATE','150','mg/mL','Progesterone Congeners [CS], Progestin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-7529_4613bc2e-a8b3-4424-98c7-8d83e074d871','0009-7529','HUMAN PRESCRIPTION DRUG','Camptosar','','irinotecan hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19960614','','NDA','NDA020571','Pharmacia & Upjohn Company LLC','IRINOTECAN HYDROCHLORIDE','20','mg/mL','Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-7663_cc3365b3-e1c4-4cc6-ae6c-cdc1837ac730','0009-7663','HUMAN PRESCRIPTION DRUG','Aromasin','','exemestane','TABLET','ORAL','19991021','','NDA','NDA020753','Pharmacia & Upjohn Company LLC','EXEMESTANE','25','mg/1','Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-7667_2f2c2547-3d8d-4904-b155-23eff23b7ce9','0009-7667','HUMAN PRESCRIPTION DRUG','Cleocin','','clindamycin phosphate','SUPPOSITORY','VAGINAL','19990813','','NDA','NDA050767','Pharmacia & Upjohn Company LLC','CLINDAMYCIN PHOSPHATE','100','mg/1','Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-7686_dfeca358-37c1-4337-b549-5d53160ffe84','0009-7686','HUMAN PRESCRIPTION DRUG','Caverject','','Alprostadil','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRACAVERNOUS','19950706','','NDA','NDA020379','Pharmacia & Upjohn Company LLC','ALPROSTADIL','41.1','ug/mL','Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0009-7807_a813de3d-c737-4511-91b4-7464a82179eb','0009-7807','HUMAN PRESCRIPTION DRUG','Zyvox','','linezolid','INJECTION, SOLUTION','INTRAVENOUS','20150218','','NDA','NDA021131','Pharmacia & Upjohn Company LLC','LINEZOLID','600','mg/300mL','Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-0101_66df1e05-ac72-4c81-9ec8-281ca9fae8c5','0013-0101','HUMAN PRESCRIPTION DRUG','Azulfidine','','Sulfasalazine','TABLET','ORAL','19500620','','NDA','NDA007073','Pfizer Laboratories Div Pfizer Inc','SULFASALAZINE','500','mg/1','Aminosalicylate [EPC], Aminosalicylic Acids [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-0102_8da70297-7d35-4c91-85b2-cf938a8bb98f','0013-0102','HUMAN PRESCRIPTION DRUG','Azulfidine','EN-tabs','Sulfasalazine','TABLET, DELAYED RELEASE','ORAL','19500620','','NDA','NDA007073','Pfizer Laboratories Div Pfizer Inc','SULFASALAZINE','500','mg/1','Aminosalicylate [EPC], Aminosalicylic Acids [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-0132_33a0b2e3-316f-42e5-979e-aad10c550611','0013-0132','HUMAN PRESCRIPTION DRUG','Emcyt','','estramustine phosphate sodium','CAPSULE','ORAL','19920101','','NDA','NDA018045','Pharmacia and Upjohn Company LLC','ESTRAMUSTINE PHOSPHATE SODIUM','140','mg/1','Alkylating Activity [MoA], Alkylating Drug [EPC], Estradiol [CS], Nitrogen Mustard Compounds [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-1114_ab00f36a-2210-472f-8a3c-0a06358a745b','0013-1114','HUMAN PRESCRIPTION DRUG','Cyklokapron','','tranexamic acid','INJECTION, SOLUTION','INTRAVENOUS','19861230','','NDA','NDA019281','Pfizer Laboratories Div Pfizer Inc','TRANEXAMIC ACID','100','mg/mL','Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-2150_12580cdd-51cd-4833-835b-060faf1251bc','0013-2150','HUMAN PRESCRIPTION DRUG','Estring','','estradiol','RING','VAGINAL','19960426','','NDA','NDA020472','Pfizer Laboratories Div Pfizer Inc','ESTRADIOL','2','mg/1','Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-2576_96b759b6-7a1e-4c5e-97f3-64ab477e1628','0013-2576','HUMAN PRESCRIPTION DRUG','Idamycin PFS','','idarubicin hydrochloride','SOLUTION','INTRAVENOUS','19970217','','NDA','NDA050734','Pfizer Laboratories Div Pfizer Inc','IDARUBICIN HYDROCHLORIDE','1','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-2586_96b759b6-7a1e-4c5e-97f3-64ab477e1628','0013-2586','HUMAN PRESCRIPTION DRUG','Idamycin PFS','','idarubicin hydrochloride','SOLUTION','INTRAVENOUS','19970217','','NDA','NDA050734','Pfizer Laboratories Div Pfizer Inc','IDARUBICIN HYDROCHLORIDE','1','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-2596_96b759b6-7a1e-4c5e-97f3-64ab477e1628','0013-2596','HUMAN PRESCRIPTION DRUG','Idamycin PFS','','idarubicin hydrochloride','SOLUTION','INTRAVENOUS','19970217','','NDA','NDA050734','Pfizer Laboratories Div Pfizer Inc','IDARUBICIN HYDROCHLORIDE','1','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-2626_8733c88d-6a13-4119-8c3b-e6b388a64b47','0013-2626','HUMAN PRESCRIPTION DRUG','GENOTROPIN','','somatropin','KIT','','19951220','','BLA','BLA020280','Pfizer Laboratories Div Pfizer Inc','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-2646_8733c88d-6a13-4119-8c3b-e6b388a64b47','0013-2646','HUMAN PRESCRIPTION DRUG','GENOTROPIN','','somatropin','KIT','','19951220','','BLA','BLA020280','Pfizer Laboratories Div Pfizer Inc','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-2649_8733c88d-6a13-4119-8c3b-e6b388a64b47','0013-2649','HUMAN PRESCRIPTION DRUG','GENOTROPIN','','somatropin','KIT','','19951220','','BLA','BLA020280','Pfizer Laboratories Div Pfizer Inc','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-2650_8733c88d-6a13-4119-8c3b-e6b388a64b47','0013-2650','HUMAN PRESCRIPTION DRUG','GENOTROPIN','','somatropin','KIT','','19951220','','BLA','BLA020280','Pfizer Laboratories Div Pfizer Inc','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-2651_8733c88d-6a13-4119-8c3b-e6b388a64b47','0013-2651','HUMAN PRESCRIPTION DRUG','GENOTROPIN','','somatropin','KIT','','19951220','','BLA','BLA020280','Pfizer Laboratories Div Pfizer Inc','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-2652_8733c88d-6a13-4119-8c3b-e6b388a64b47','0013-2652','HUMAN PRESCRIPTION DRUG','GENOTROPIN','','somatropin','KIT','','19951220','','BLA','BLA020280','Pfizer Laboratories Div Pfizer Inc','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-2653_8733c88d-6a13-4119-8c3b-e6b388a64b47','0013-2653','HUMAN PRESCRIPTION DRUG','GENOTROPIN','','somatropin','KIT','','19951220','','BLA','BLA020280','Pfizer Laboratories Div Pfizer Inc','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-2654_8733c88d-6a13-4119-8c3b-e6b388a64b47','0013-2654','HUMAN PRESCRIPTION DRUG','GENOTROPIN','','somatropin','KIT','','19951220','','BLA','BLA020280','Pfizer Laboratories Div Pfizer Inc','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-2655_8733c88d-6a13-4119-8c3b-e6b388a64b47','0013-2655','HUMAN PRESCRIPTION DRUG','GENOTROPIN','','somatropin','KIT','','19951220','','BLA','BLA020280','Pfizer Laboratories Div Pfizer Inc','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-2656_8733c88d-6a13-4119-8c3b-e6b388a64b47','0013-2656','HUMAN PRESCRIPTION DRUG','GENOTROPIN','','somatropin','KIT','','19951220','','BLA','BLA020280','Pfizer Laboratories Div Pfizer Inc','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-2657_8733c88d-6a13-4119-8c3b-e6b388a64b47','0013-2657','HUMAN PRESCRIPTION DRUG','GENOTROPIN','','somatropin','KIT','','19951220','','BLA','BLA020280','Pfizer Laboratories Div Pfizer Inc','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-2658_8733c88d-6a13-4119-8c3b-e6b388a64b47','0013-2658','HUMAN PRESCRIPTION DRUG','GENOTROPIN','','somatropin','KIT','','19951220','','BLA','BLA020280','Pfizer Laboratories Div Pfizer Inc','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-5301_47f0a676-c541-4d24-8710-bef6180556e3','0013-5301','HUMAN PRESCRIPTION DRUG','Mycobutin','','rifabutin','CAPSULE','ORAL','19921223','','NDA','NDA050689','Pfizer Laboratories Div Pfizer Inc','RIFABUTIN','150','mg/1','Rifamycin Antimycobacterial [EPC], Rifamycins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0013-8303_bd6c67b9-3ea0-4ffb-acff-a3692f09f71f','0013-8303','HUMAN PRESCRIPTION DRUG','Xalatan','','latanoprost','SOLUTION','OPHTHALMIC','19950320','','NDA','NDA020597','PFIZER LABORATORIES DIV PFIZER INC','LATANOPROST','50','ug/mL','Prostaglandin Analog [EPC], Prostaglandins [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0019-0862_ff628e06-2cb5-4714-a741-1dec04bd5602','0019-0862','HUMAN PRESCRIPTION DRUG','Cysto-Conray II','','Iothalamate meglumine','INJECTION','URETERAL','20101008','','NDA','NDA017057','Liebel-Flarsheim Company LLC','IOTHALAMATE MEGLUMINE','172','mg/mL','Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0019-0953_013b8c94-c1ab-4d63-a1c9-786f200d2e8f','0019-0953','HUMAN PRESCRIPTION DRUG','Conray','','iothalamate meglumine','INJECTION','INTRAVASCULAR','20031014','','NDA','NDA013295','Liebel-Flarsheim Company LLC','IOTHALAMATE MEGLUMINE','600','mg/mL','Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0019-1188_cdff7813-7b00-4f61-a017-18ab8910d49d','0019-1188','HUMAN PRESCRIPTION DRUG','SODIUM CHLORIDE','','sodium chloride','INJECTION','INTRAVASCULAR','20120901','','NDA','NDA021569','Liebel-Flarsheim Company LLC','SODIUM CHLORIDE','0.9','mg/mL','Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0019-1323_345cefe8-b318-49df-b334-87a344c689fd','0019-1323','HUMAN PRESCRIPTION DRUG','Optiray','320','Ioversol','INJECTION','INTRA-ARTERIAL; INTRAVENOUS','20111017','','NDA','NDA020923','Liebel-Flarsheim Company LLC','IOVERSOL','678','mg/mL','Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0019-1323_5e006996-af60-4f62-b1cd-584cf6842db7','0019-1323','HUMAN PRESCRIPTION DRUG','Optiray','320','Ioversol','INJECTION','INTRA-ARTERIAL; INTRAVENOUS','20120304','','NDA','NDA019710','Liebel-Flarsheim Company LLC','IOVERSOL','678','mg/mL','Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0019-1323_e6627d0b-5735-4aee-b94f-02ff39233e8a','0019-1323','HUMAN PRESCRIPTION DRUG','Optiray','320','Ioversol','INJECTION','INTRA-ARTERIAL; INTRAVENOUS','20201118','','NDA','NDA020923','Liebel-Flarsheim Company LLC','IOVERSOL','678','mg/mL','Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0019-1332_345cefe8-b318-49df-b334-87a344c689fd','0019-1332','HUMAN PRESCRIPTION DRUG','Optiray','300','Ioversol','INJECTION','INTRA-ARTERIAL; INTRAVENOUS','20111017','','NDA','NDA020923','Liebel-Flarsheim Company LLC','IOVERSOL','636','mg/mL','Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0019-1332_5e006996-af60-4f62-b1cd-584cf6842db7','0019-1332','HUMAN PRESCRIPTION DRUG','Optiray','300','Ioversol','INJECTION','INTRA-ARTERIAL; INTRAVENOUS','20120304','','NDA','NDA019710','Liebel-Flarsheim Company LLC','IOVERSOL','636','mg/mL','Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0019-1332_e6627d0b-5735-4aee-b94f-02ff39233e8a','0019-1332','HUMAN PRESCRIPTION DRUG','Optiray','300','Ioversol','INJECTION','INTRA-ARTERIAL; INTRAVENOUS','20201118','','NDA','NDA020923','Liebel-Flarsheim Company LLC','IOVERSOL','636','mg/mL','Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0019-1333_345cefe8-b318-49df-b334-87a344c689fd','0019-1333','HUMAN PRESCRIPTION DRUG','Optiray','350','Ioversol','INJECTION','INTRA-ARTERIAL; INTRAVENOUS','20111017','','NDA','NDA020923','Liebel-Flarsheim Company LLC','IOVERSOL','741','mg/mL','Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0019-1333_5e006996-af60-4f62-b1cd-584cf6842db7','0019-1333','HUMAN PRESCRIPTION DRUG','Optiray','350','Ioversol','INJECTION','INTRA-ARTERIAL; INTRAVENOUS','20120304','','NDA','NDA019710','Liebel-Flarsheim Company LLC','IOVERSOL','741','mg/mL','Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0019-1333_e6627d0b-5735-4aee-b94f-02ff39233e8a','0019-1333','HUMAN PRESCRIPTION DRUG','Optiray','350','Ioversol','INJECTION','INTRA-ARTERIAL; INTRAVENOUS','20201118','','NDA','NDA020923','Liebel-Flarsheim Company LLC','IOVERSOL','741','mg/mL','Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0019-4816_79425e73-456a-458a-986d-baf4291584a2','0019-4816','HUMAN PRESCRIPTION DRUG','MD GASTROVIEW','','diatrizoate meglumine and diatrizoate sodium','SOLUTION','ORAL; RECTAL','20090831','','ANDA','ANDA087388','Liebel-Flarsheim Company LLC','DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM','600; 100','mg/mL; mg/mL','Radiographic Contrast Agent [EPC], Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA], X-Ray Contrast Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-0042_1160972d-e679-415b-83dd-5ca6b66b42d7','0023-0042','HUMAN PRESCRIPTION DRUG','TAZORAC','','tazarotene','GEL','CUTANEOUS','19970801','','NDA','NDA020600','Allergan, Inc.','TAZAROTENE','1','mg/g','Retinoid [EPC], Retinoids [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-0240_599e3ac1-fd3e-4c0f-99d1-5161accb79cb','0023-0240','HUMAN OTC DRUG','REFRESH P.M.','','mineral oil, petrolatum','OINTMENT','OPHTHALMIC','19900423','','OTC MONOGRAPH FINAL','part349','Allergan, Inc.','MINERAL OIL; PETROLATUM','425; 573','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-0312_cb825aaf-6eef-4f24-a2d2-ab62be69de0d','0023-0312','HUMAN OTC DRUG','REFRESH LACRI-LUBE','','mineral oil, petrolatum','OINTMENT','OPHTHALMIC','19771215','','OTC MONOGRAPH FINAL','part349','Allergan, Inc.','MINERAL OIL; PETROLATUM','425; 568','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-0403_505c79f4-7339-4d4a-9987-186e33f06e1b','0023-0403','HUMAN OTC DRUG','REFRESH PLUS','','carboxymethylcellulose sodium','SOLUTION/ DROPS','OPHTHALMIC','19961009','','OTC MONOGRAPH FINAL','part349','Allergan, Inc.','CARBOXYMETHYLCELLULOSE SODIUM','5','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-0506_c401b586-2650-4ebb-93fd-7681877fca46','0023-0506','HUMAN OTC DRUG','REFRESH Classic','','Polyvinyl Alcohol, Povidone','SOLUTION/ DROPS','OPHTHALMIC','19850912','','OTC MONOGRAPH FINAL','part349','Allergan, Inc.','POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE','14; 6','mg/mL; mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-0667_599e3ac1-fd3e-4c0f-99d1-5161accb79cb','0023-0667','HUMAN OTC DRUG','REFRESH P.M.','','mineral oil, petrolatum','OINTMENT','OPHTHALMIC','20160826','','OTC MONOGRAPH FINAL','part349','Allergan, Inc.','MINERAL OIL; PETROLATUM','425; 573','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-0798_59ec8513-21db-40cf-b13e-16125371a1f9','0023-0798','HUMAN OTC DRUG','REFRESH TEARS','','carboxymethylcellulose sodium','SOLUTION/ DROPS','OPHTHALMIC','19970516','','OTC MONOGRAPH FINAL','part349','Allergan, Inc.','CARBOXYMETHYLCELLULOSE SODIUM','5','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-1145_d5b66063-85df-4f29-ad93-b6c3aa1349a6','0023-1145','HUMAN PRESCRIPTION DRUG','BOTOX','','onabotulinumtoxinA','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRADERMAL; INTRAMUSCULAR','19891215','','BLA','BLA103000','Allergan, Inc.','BOTULINUM TOXIN TYPE A','100','[USP''''U]/1','Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-2181_bd032819-57d9-4871-9afd-78fe8f2d1a53','0023-2181','HUMAN PRESCRIPTION DRUG','Acular','','Ketorolac Tromethamine','SOLUTION/ DROPS','OPHTHALMIC','19921201','','NDA','NDA019700','Allergan, Inc.','KETOROLAC TROMETHAMINE','5','mg/mL','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-3205_157ec58b-058b-4a9f-988e-38d19ff72cab','0023-3205','HUMAN PRESCRIPTION DRUG','LUMIGAN','','bimatoprost','SOLUTION/ DROPS','OPHTHALMIC','20100910','','NDA','NDA022184','Allergan, Inc.','BIMATOPROST','0.1','mg/mL','Prostaglandin Analog [EPC], Prostaglandins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-3240_e03532da-dd6f-4cdd-b85f-75b1c92e1353','0023-3240','HUMAN OTC DRUG','REFRESH OPTIVE','','carboxymethylcellulose sodium and glycerin','SOLUTION/ DROPS','OPHTHALMIC','20060906','','OTC MONOGRAPH FINAL','part349','Allergan, Inc.','CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN','5; 9','mg/mL; mg/mL','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-3348_cd7bbbc5-4640-4bbe-ad61-c18349110ec8','0023-3348','HUMAN PRESCRIPTION DRUG','OZURDEX','','dexamethasone','IMPLANT','INTRAVITREAL','20090901','','NDA','NDA022315','Allergan, Inc.','DEXAMETHASONE','0.7','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-3416_67effe73-14b2-4d22-a24e-66156f9d9743','0023-3416','HUMAN OTC DRUG','Refresh Optive','','Carboxymethylcellulose Sodium, Glycerin','SOLUTION/ DROPS','OPHTHALMIC','20080822','','OTC MONOGRAPH FINAL','part349','Allergan, Inc.','CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN','5; 9','mg/mL; mg/mL','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-3507_812e6690-e71e-4319-8d60-8b4dda88b5a8','0023-3507','HUMAN PRESCRIPTION DRUG','ACUVAIL','','ketorolac tromethamine','SOLUTION/ DROPS','OPHTHALMIC','20090801','','NDA','NDA022427','Allergan, Inc.','KETOROLAC TROMETHAMINE','4.5','mg/mL','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-3615_9637ee2e-46de-4f8f-ae4f-b19139d57657','0023-3615','HUMAN PRESCRIPTION DRUG','ZYMAXID','','gatifloxacin','SOLUTION/ DROPS','OPHTHALMIC','20100519','','NDA','NDA022548','Allergan, Inc.','GATIFLOXACIN','5','mg/mL','Quinolone Antimicrobial [EPC], Quinolones [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-3616_8fe604a8-ced5-4a73-9a68-6604a53cb766','0023-3616','HUMAN PRESCRIPTION DRUG','LATISSE','','bimatoprost','SOLUTION/ DROPS','OPHTHALMIC','20090126','','NDA','NDA022369','Allergan, Inc.','BIMATOPROST','0.3','mg/mL','Prostaglandin Analog [EPC], Prostaglandins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-3670_dfe068d3-6b3f-428a-9471-21287cada2a8','0023-3670','HUMAN PRESCRIPTION DRUG','ACZONE','','dapsone','GEL','TOPICAL','20090624','','NDA','NDA021794','Allergan, Inc.','DAPSONE','50','mg/g','Sulfone [EPC], Sulfones [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-3919_11b267bd-fc21-4d19-b507-11c7557640de','0023-3919','HUMAN PRESCRIPTION DRUG','BOTOX Cosmetic','','onabotulinumtoxinA','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAMUSCULAR','20080715','','BLA','BLA103000','Allergan, Inc.','BOTULINUM TOXIN TYPE A','50','[USP''''U]/1','Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-3921_d5b66063-85df-4f29-ad93-b6c3aa1349a6','0023-3921','HUMAN PRESCRIPTION DRUG','BOTOX','','onabotulinumtoxinA','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRADERMAL; INTRAMUSCULAR','20100111','','BLA','BLA103000','Allergan, Inc.','BOTULINUM TOXIN TYPE A','200','[USP''''U]/1','Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-4290_849f0849-528f-43b9-a43b-d13ceefe977d','0023-4290','HUMAN PRESCRIPTION DRUG','LASTACAFT','','alcaftadine','SOLUTION/ DROPS','OPHTHALMIC','20101101','','NDA','NDA022134','Allergan, Inc.','ALCAFTADINE','2.5','mg/mL','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-4291_3110f1f0-8f7d-425b-8ed5-99673f085be6','0023-4291','HUMAN OTC DRUG','LASTACAFT','','alcaftadine','SOLUTION/ DROPS','OPHTHALMIC','20211201','','NDA','NDA022134','Allergan, Inc.','ALCAFTADINE','2.5','mg/mL','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-4307_26dbb2cb-bf55-4f66-bee4-ee40546108de','0023-4307','HUMAN OTC DRUG','REFRESH OPTIVE Advanced','','carboxymethylcellulose sodium, glycerin, and polysorbate 80','SOLUTION/ DROPS','OPHTHALMIC','20111130','','OTC MONOGRAPH FINAL','part349','Allergan, Inc.','CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN; POLYSORBATE 80','5; 10; 5','mg/mL; mg/mL; mg/mL','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-4491_0e3007df-4345-462c-943f-599183b2bb5a','0023-4491','HUMAN OTC DRUG','REFRESH OPTIVE Advanced','','carboxymethylcellulose sodium, glycerin, polysorbate 80','SOLUTION/ DROPS','OPHTHALMIC','20130115','','OTC MONOGRAPH FINAL','part349','Allergan, Inc.','CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN; POLYSORBATE 80','5; 10; 5','mg/mL; mg/mL; mg/mL','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-4515_59ee97f0-932b-4211-9786-c7342666e468','0023-4515','HUMAN OTC DRUG','Refresh RELIEVA PF','','Carboxymethylcellulose sodium and Glycerin','SOLUTION/ DROPS','OPHTHALMIC','20200925','','OTC MONOGRAPH FINAL','part349','Allergan, Inc.','CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN','5; 10','mg/mL; mg/mL','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-4554_e82ef3a8-b7dc-4b3c-8eb2-033367cdbaad','0023-4554','HUMAN OTC DRUG','REFRESH CELLUVISC','','carboxymethylcellulose sodium','GEL','OPHTHALMIC','19891004','','OTC MONOGRAPH FINAL','part349','Allergan, Inc.','CARBOXYMETHYLCELLULOSE SODIUM','10','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-4857_a17381ee-e2b7-4b8e-8bb9-704edf68ed22','0023-4857','HUMAN PRESCRIPTION DRUG','VANIQA','','eflornithine hydrochloride','CREAM','TOPICAL','20130601','20231031','NDA','NDA021145','Allergan, Inc.','EFLORNITHINE HYDROCHLORIDE','139','mg/g','Antiprotozoal [EPC], Decarboxylase Inhibitor [EPC], Decarboxylase Inhibitors [MoA]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-4948_72b4b58c-8964-4cce-9509-1720e9614475','0023-4948','HUMAN OTC DRUG','SKIN MEDICA Purifying Foaming Wash','','salicylic acid','LIQUID','TOPICAL','20130101','','OTC MONOGRAPH FINAL','part333D','Allergan, Inc.','SALICYLIC ACID','20','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-5206_a355f6ab-62c2-4ec3-828f-177b660e6684','0023-5206','HUMAN PRESCRIPTION DRUG','ACZONE','7.5','dapsone','GEL','TOPICAL','20160226','','NDA','NDA207154','Allergan, Inc.','DAPSONE','75','mg/g','Sulfone [EPC], Sulfones [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-5300_1acd8f72-9d36-4756-a3b0-3e354f12d7b2','0023-5300','HUMAN PRESCRIPTION DRUG','RHOFADE','','Oxymetazoline Hydrochloride','CREAM','TOPICAL','20170118','','NDA','NDA208552','Allergan, Inc.','OXYMETAZOLINE HYDROCHLORIDE','10','mg/g','Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-5301_884a1d8c-14e0-464c-a6b6-bfdd7009d514','0023-5301','HUMAN PRESCRIPTION DRUG','Restasis MultiDose','','cyclosporine','EMULSION','OPHTHALMIC','20161110','','NDA','NDA050790','Allergan, Inc.','CYCLOSPORINE','0.5','mg/mL','Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-5459_9bef723b-4c5b-4358-928b-8235813878ed','0023-5459','HUMAN OTC DRUG','REFRESH OPTIVE Drops','','carboxymethylcellulose sodium and glycerin','SOLUTION/ DROPS','OPHTHALMIC','20150930','','OTC MONOGRAPH FINAL','part349','Allergan, Inc.','CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN','10; 9','mg/mL; mg/mL','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-5494_40305204-1e1b-4a6b-9b62-be0147554caa','0023-5494','HUMAN OTC DRUG','TOTAL DEFENSE REPAIR BROAD SPECTRUM SPF 34 Sunscreen','','Octinoxate, Octisalate and Zinc Oxide','LOTION','TOPICAL','20150615','','OTC MONOGRAPH NOT FINAL','part352','Allergan, Inc.','OCTINOXATE; OCTISALATE; ZINC OXIDE','75; 30; 80','mg/g; mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-5497_69d29aec-0838-4a4e-9b3b-79331bf40be6','0023-5497','HUMAN OTC DRUG','TOTAL DEFENSE REPAIR BROAD SPECTRUM SPF 34 Sunscreen (Tinted)','','Octinoxate, Octisalate, Titanium dioxide and Zinc Oxide','LOTION','TOPICAL','20150615','','OTC MONOGRAPH NOT FINAL','part352','Allergan, Inc.','OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE','75; 30; 35; 80','mg/g; mg/g; mg/g; mg/g','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-5675_2136e5f1-64fe-4c81-b235-cd39df3b94f3','0023-5675','HUMAN OTC DRUG','Essential Defense Mineral Shield Broad Spectrum SPF 32 TINTED Sunscreen','','Titanium Dioxide and Zinc Oxide','LOTION','TOPICAL','20160316','','OTC MONOGRAPH NOT FINAL','part352','Allergan, Inc.','TITANIUM DIOXIDE; ZINC OXIDE','50; 60','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-5703_dca40d43-971d-45a0-b952-940f7d7c2e08','0023-5703','HUMAN OTC DRUG','Essential Defense Mineral Shield Broad Spectrum SPF 35 Sunscreen','','Titanium Dioxide and Zinc oxide','LOTION','TOPICAL','20160316','','OTC MONOGRAPH NOT FINAL','part352','Allergan, Inc.','TITANIUM DIOXIDE; ZINC OXIDE','50; 60','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-5738_69edf72f-0eb4-4cfe-b1ab-a706f6cdfd4b','0023-5738','HUMAN OTC DRUG','Essential Defense Everyday Clear Broad Spectrum SPF 47 Sunscreen','','Zinc Oxide and Octinoxate','LOTION','TOPICAL','20160316','','OTC MONOGRAPH NOT FINAL','part352','Allergan, Inc.','OCTINOXATE; ZINC OXIDE','75; 120','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-5773_0776c9e3-a64d-40b2-b22d-aa66a5d4fa76','0023-5773','HUMAN OTC DRUG','REFRESH Optive Mega-3','','Carboxymethylcellulose sodium, Glycerin and Polysorbate 80','SOLUTION/ DROPS','OPHTHALMIC','20170530','','OTC MONOGRAPH FINAL','part349','Allergan, Inc.','CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN; POLYSORBATE 80','5; 10; 5','mg/mL; mg/mL; mg/mL','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-5853_bc74e71b-a05d-406b-b6fe-afb816500c1b','0023-5853','HUMAN PRESCRIPTION DRUG','Delzicol','','mesalamine','CAPSULE, DELAYED RELEASE','ORAL','20160516','','NDA','NDA204412','Allergan, Inc.','MESALAMINE','400','mg/1','Aminosalicylate [EPC], Aminosalicylic Acids [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-5858_6fbf6e04-6c81-4865-9c6b-3a422806d792','0023-5858','HUMAN PRESCRIPTION DRUG','LILETTA','','Levonorgestrel','INTRAUTERINE DEVICE','INTRAUTERINE','20160531','','NDA','NDA206229','Allergan, Inc.','LEVONORGESTREL','52','mg/1','Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-5861_d533364d-0f54-41a9-b996-c8fd98403bec','0023-5861','HUMAN PRESCRIPTION DRUG','GELNIQUE','','oxybutynin chloride','GEL','TRANSDERMAL','20170401','','NDA','NDA022204','Allergan, Inc.','OXYBUTYNIN CHLORIDE','100','mg/g','Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-5862_248a208c-8f3a-4656-98b3-aad66ca4f17b','0023-5862','HUMAN PRESCRIPTION DRUG','Taytulla','','norethindrone acetate and ethinyl estradiol, and ferrous fumarate','KIT','','20160501','','NDA','NDA204426','Allergan, Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-5901_226dd324-f8a6-4b37-88a0-d99d15806921','0023-5901','HUMAN PRESCRIPTION DRUG','Asacol HD','','mesalamine','TABLET, DELAYED RELEASE','ORAL','20080528','','NDA','NDA021830','Allergan, Inc.','MESALAMINE','800','mg/1','Aminosalicylate [EPC], Aminosalicylic Acids [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-5990_cd69eaab-a8ad-412a-a56e-2feaa59c5639','0023-5990','HUMAN PRESCRIPTION DRUG','Androderm','','Testosterone','PATCH','TRANSDERMAL','19950929','20240930','NDA','NDA020489','Allergan, Inc.','TESTOSTERONE','2','mg/d','Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]','CIII','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-5992_cd69eaab-a8ad-412a-a56e-2feaa59c5639','0023-5992','HUMAN PRESCRIPTION DRUG','Androderm','','Testosterone','PATCH','TRANSDERMAL','19950929','20240930','NDA','NDA020489','Allergan, Inc.','TESTOSTERONE','4','mg/d','Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]','CIII','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-6011_4e3fa51f-456d-4863-af4b-1e1ae5e59b72','0023-6011','HUMAN PRESCRIPTION DRUG','Kadian','','morphine sulfate','CAPSULE, EXTENDED RELEASE','ORAL','20090407','20230630','NDA','NDA020616','Allergan, Inc.','MORPHINE SULFATE','10','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-6019_4e3fa51f-456d-4863-af4b-1e1ae5e59b72','0023-6019','HUMAN PRESCRIPTION DRUG','Kadian','','morphine sulfate','CAPSULE, EXTENDED RELEASE','ORAL','20090407','20230331','NDA','NDA020616','Allergan, Inc.','MORPHINE SULFATE','200','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-6030_af66e4f1-67a2-4051-a724-452c0a20f434','0023-6030','HUMAN PRESCRIPTION DRUG','GENERESS Fe','','norethindrone and ethinyl estradiol and ferrous fumarate','KIT','ORAL','20111223','20230930','NDA','NDA022573','Allergan, Inc.','','','','','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-6082_083529e1-6505-4d0b-9992-62ed512e0704','0023-6082','HUMAN PRESCRIPTION DRUG','INFeD','','Iron Dextran','INJECTION','INTRAMUSCULAR; INTRAVENOUS','19740429','','NDA','NDA017441','Allergan, Inc.','IRON DEXTRAN','50','mg/mL','Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-6118_80db0ad5-b20d-4c50-8d96-bb586488c832','0023-6118','HUMAN PRESCRIPTION DRUG','Condylox','','podofilox','GEL','TOPICAL','19970313','','NDA','NDA020529','Allergan, Inc.','PODOFILOX','5','mg/g','Decreased Mitosis [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-6142_6cba0207-6e74-431e-9298-710b5fc592d4','0023-6142','HUMAN PRESCRIPTION DRUG','RAPAFLO','','silodosin','CAPSULE','ORAL','20090323','','NDA','NDA022206','Allergan, Inc.','SILODOSIN','8','mg/1','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-6147_6cba0207-6e74-431e-9298-710b5fc592d4','0023-6147','HUMAN PRESCRIPTION DRUG','RAPAFLO','','silodosin','CAPSULE','ORAL','20090323','','NDA','NDA022206','Allergan, Inc.','SILODOSIN','4','mg/1','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-6150_da3178d8-d328-4d13-8e3f-18acc75e54d4','0023-6150','HUMAN PRESCRIPTION DRUG','Crinone','','progesterone','GEL','VAGINAL','19970513','','NDA','NDA020701','Allergan, Inc.','PROGESTERONE','45','mg/1.125g','Progesterone [CS], Progesterone [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-6151_da3178d8-d328-4d13-8e3f-18acc75e54d4','0023-6151','HUMAN PRESCRIPTION DRUG','Crinone','','progesterone','GEL','VAGINAL','19970513','','NDA','NDA020701','Allergan, Inc.','PROGESTERONE','90','mg/1.125g','Progesterone [CS], Progesterone [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-6153_fa52d43f-dafe-4170-b615-baa3d39889ed','0023-6153','HUMAN PRESCRIPTION DRUG','OXYTROL','','Oxybutynin','PATCH','TRANSDERMAL','20030226','','NDA','NDA021351','Allergan, Inc.','OXYBUTYNIN','3.9','mg/d','Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-6498_c36b0e56-3be2-41cd-b84f-5ebd0330e212','0023-6498','HUMAN PRESCRIPTION DRUG','UBRELVY','','ubrogepant','TABLET','ORAL','20191223','','NDA','NDA211765','Allergan, Inc.','UBROGEPANT','50','mg/1','Calcitonin Gene-related Peptide Receptor Antagonist [EPC], Calcitonin Gene-related Peptide Receptor Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-6501_c36b0e56-3be2-41cd-b84f-5ebd0330e212','0023-6501','HUMAN PRESCRIPTION DRUG','UBRELVY','','ubrogepant','TABLET','ORAL','20191223','','NDA','NDA211765','Allergan, Inc.','UBROGEPANT','100','mg/1','Calcitonin Gene-related Peptide Receptor Antagonist [EPC], Calcitonin Gene-related Peptide Receptor Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-6630_8e0f8349-7be7-4055-970f-3af4ff2ae82c','0023-6630','HUMAN OTC DRUG','Refresh Relieva','','Carboxymethylcellulose sodium, Glycerin','SOLUTION/ DROPS','OPHTHALMIC','20190722','','OTC MONOGRAPH FINAL','part349','Allergan, Inc.','CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN','5; 9','mg/mL; mg/mL','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-6634_31b36b67-6a09-4fd7-9d8b-be30627efe6a','0023-6634','HUMAN OTC DRUG','Refresh Relieva Preservative Free','','Carboxymethylcellulose sodium and Glycerin','SOLUTION/ DROPS','OPHTHALMIC','20190726','','OTC MONOGRAPH FINAL','part349','Allergan, Inc.','CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN','5; 9','mg/mL; mg/mL','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-6934_c610570f-3cee-4b6e-88eb-255e53d51e45','0023-6934','HUMAN OTC DRUG','OcuMend','Healing Gels','Arnica Montana and Ledum Palustre Twig','PATCH','TOPICAL','20200901','','UNAPPROVED HOMEOPATHIC','','Allergan, Inc.','ARNICA MONTANA; LEDUM PALUSTRE TWIG','50; 50','[hp_X]/1; [hp_X]/1','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-6952_dd173188-3b98-4e7c-b210-94ba9552306d','0023-6952','HUMAN OTC DRUG','Refresh Digital','','Carboxymethylcellulose sodium, Glycerin, Polysorbate 80','SOLUTION/ DROPS','OPHTHALMIC','20200801','','OTC MONOGRAPH FINAL','part349','Allergan, Inc.','CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN; POLYSORBATE 80','5; 10; 5','mg/mL; mg/mL; mg/mL','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-6954_2833c9c8-363d-4e72-a4b4-9c909473f01a','0023-6954','HUMAN OTC DRUG','Refresh Digital PF','','Carboxymethylcellulose sodium, Glycerin and Polysorbate 80','SOLUTION/ DROPS','OPHTHALMIC','20200801','','OTC MONOGRAPH FINAL','part349','Allergan, Inc.','CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN; POLYSORBATE 80','5; 10; 5','mg/mL; mg/mL; mg/mL','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-7151_0776c9e3-a64d-40b2-b22d-aa66a5d4fa76','0023-7151','HUMAN OTC DRUG','REFRESH Optive Mega-3','','Carboxymethylcellulose sodium, Glycerin and Polysorbate 80','SOLUTION/ DROPS','OPHTHALMIC','20210615','','OTC MONOGRAPH FINAL','part349','Allergan, Inc.','CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN; POLYSORBATE 80','5; 10; 5','mg/mL; mg/mL; mg/mL','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-7824_49251a09-17e6-4bb4-8491-4956e24cc173','0023-7824','HUMAN PRESCRIPTION DRUG','Polytrim','','polymyxin b sulfate and trimethoprim sulfate','SOLUTION/ DROPS','OPHTHALMIC','19900123','20230930','NDA','NDA050567','Allergan, Inc.','POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE','100000; 1','[USP''''U]/mL; mg/mL','Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-8335_1160972d-e679-415b-83dd-5ca6b66b42d7','0023-8335','HUMAN PRESCRIPTION DRUG','TAZORAC','','tazarotene','GEL','CUTANEOUS','19970801','','NDA','NDA020600','Allergan, Inc.','TAZAROTENE','0.5','mg/g','Retinoid [EPC], Retinoids [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-8842_0aeb87da-f1d5-4a28-ad87-80fb3c31b3ea','0023-8842','HUMAN PRESCRIPTION DRUG','ALOCRIL','','nedocromil sodium','SOLUTION/ DROPS','OPHTHALMIC','20000203','','NDA','NDA021009','Allergan, Inc.','NEDOCROMIL SODIUM','20','mg/mL','Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-9163_456f37fc-9b84-488a-b7f6-5f8bdf0bfcf3','0023-9163','HUMAN PRESCRIPTION DRUG','RESTASIS','','cyclosporine','EMULSION','OPHTHALMIC','20030401','','NDA','NDA050790','Allergan, Inc.','CYCLOSPORINE','0.5','mg/mL','Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-9177_0fdf3a78-f862-4b7c-810a-3ef3b1907b08','0023-9177','HUMAN PRESCRIPTION DRUG','ALPHAGAN P','','brimonidine tartrate','SOLUTION/ DROPS','OPHTHALMIC','20010710','','NDA','NDA021262','Allergan, Inc.','BRIMONIDINE TARTRATE','1.5','mg/mL','Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-9205_7a6e5495-f68b-4007-917f-8a40c8404422','0023-9205','HUMAN OTC DRUG','REFRESH LIQUIGEL','','Carboxymethylcellulose sodium','GEL','OPHTHALMIC','20011004','','OTC MONOGRAPH FINAL','part349','Allergan, Inc.','CARBOXYMETHYLCELLULOSE SODIUM','10','mg/mL','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-9211_c2946063-4406-44a4-9907-ca33438607b6','0023-9211','HUMAN PRESCRIPTION DRUG','COMBIGAN','','brimonidine tartrate, timolol maleate','SOLUTION/ DROPS','OPHTHALMIC','20071114','','NDA','NDA021398','Allergan, Inc.','BRIMONIDINE TARTRATE; TIMOLOL MALEATE','2; 5','mg/mL; mg/mL','Adrenergic alpha-Agonists [MoA], Adrenergic beta-Antagonists [MoA], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-9232_11b267bd-fc21-4d19-b507-11c7557640de','0023-9232','HUMAN PRESCRIPTION DRUG','BOTOX Cosmetic','','onabotulinumtoxinA','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAMUSCULAR','20080520','','BLA','BLA103000','Allergan, Inc.','BOTULINUM TOXIN TYPE A','100','[USP''''U]/1','Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-9277_f709e651-1e4a-4c41-9e6d-ba300bab56bc','0023-9277','HUMAN PRESCRIPTION DRUG','ACULAR LS','','Ketorolac Tromethamine','SOLUTION/ DROPS','OPHTHALMIC','20030819','','NDA','NDA021528','Allergan, Inc.','KETOROLAC TROMETHAMINE','4','mg/mL','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-9321_0fdf3a78-f862-4b7c-810a-3ef3b1907b08','0023-9321','HUMAN PRESCRIPTION DRUG','ALPHAGAN P','','brimonidine tartrate','SOLUTION/ DROPS','OPHTHALMIC','20060125','','NDA','NDA021770','Allergan, Inc.','BRIMONIDINE TARTRATE','1','mg/mL','Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-9537_59ee97f0-932b-4211-9786-c7342666e468','0023-9537','HUMAN OTC DRUG','Refresh RELIEVA PF','','Carboxymethylcellulose sodium and Glycerin','SOLUTION/ DROPS','OPHTHALMIC','20200925','','OTC MONOGRAPH FINAL','part349','Allergan, Inc.','CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN','5; 10','mg/mL; mg/mL','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-9637_60f892e8-3c6b-4dd1-bb27-77e3e387bf6f','0023-9637','HUMAN OTC DRUG','Oxytrol for Women','','Oxybutynin','PATCH','TRANSDERMAL','20160101','','NDA','NDA202211','Allergan, Inc.','OXYBUTYNIN','3.9','mg/d','Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0023-9652_6225f055-4a8b-4519-8eca-837c4c347983','0023-9652','HUMAN PRESCRIPTION DRUG','DURYSTA','','bimatoprost','IMPLANT','INTRACAMERAL','20200304','','NDA','NDA211911','Allergan, Inc.','BIMATOPROST','10','ug/1','Prostaglandin Analog [EPC], Prostaglandins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-0654_1954b45c-23b6-4de5-a540-f9be3a347da4','0024-0654','HUMAN PRESCRIPTION DRUG','Sarclisa','','isatuximab','INJECTION, SOLUTION, CONCENTRATE','INTRAVENOUS','20200302','','BLA','BLA761113','sanof-aventis U.S. LLC','ISATUXIMAB','100','mg/5mL','Antibodies, Monoclonal [CS], CD38-directed Antibody Interactions [MoA], CD38-directed Cytolytic Antibody [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-0656_1954b45c-23b6-4de5-a540-f9be3a347da4','0024-0656','HUMAN PRESCRIPTION DRUG','Sarclisa','','isatuximab','INJECTION, SOLUTION, CONCENTRATE','INTRAVENOUS','20200302','','BLA','BLA761113','sanof-aventis U.S. LLC','ISATUXIMAB','500','mg/25mL','Antibodies, Monoclonal [CS], CD38-directed Antibody Interactions [MoA], CD38-directed Cytolytic Antibody [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-1171_9720bfe8-9e1a-4ffd-b76b-cf96f280150f','0024-1171','HUMAN PRESCRIPTION DRUG','Plavix','','clopidogrel','TABLET, FILM COATED','ORAL','19971117','','NDA','NDA020839','sanofi-aventis U.S. LLC','CLOPIDOGREL BISULFATE','75','mg/1','Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-1332_9720bfe8-9e1a-4ffd-b76b-cf96f280150f','0024-1332','HUMAN PRESCRIPTION DRUG','Plavix','','clopidogrel','TABLET, FILM COATED','ORAL','20090509','','NDA','NDA020839','sanofi-aventis U.S. LLC','CLOPIDOGREL BISULFATE','300','mg/1','Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-1596_015ee43c-fbf1-4435-bb3d-ca97d6589037','0024-1596','HUMAN PRESCRIPTION DRUG','Primaquine Phosphate','','Primaquine Phosphate','TABLET, FILM COATED','ORAL','20110415','','NDA','NDA008316','Sanofi-Aventis U.S. LLC','PRIMAQUINE PHOSPHATE','15','mg/1','Antimalarial [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-2792_c13b28ee-c828-4b06-b2f4-3817c5cf38a1','0024-2792','HUMAN PRESCRIPTION DRUG','Ferrlecit','','sodium ferric gluconate complex','INJECTION','INTRAVENOUS','20110301','','NDA','NDA020955','sanofi-aventis U.S. LLC','SODIUM FERRIC GLUCONATE COMPLEX','12.5','mg/mL','Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-2794_07ce6987-8136-40fd-8cab-84f8ac73a0d0','0024-2794','HUMAN PRESCRIPTION DRUG','Ferrlecit','','sodium ferric gluconate complex','INJECTION','INTRAVENOUS','20140707','','NDA','NDA020955','sanofi-aventis U.S. LLC','SODIUM FERRIC GLUCONATE COMPLEX','12.5','mg/mL','Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-4142_5987bb71-d249-45fb-b6fb-c21799332de2','0024-4142','HUMAN PRESCRIPTION DRUG','Multaq','','Dronedarone','TABLET, FILM COATED','ORAL','20090701','','NDA','NDA022425','sanofi-aventis U.S. LLC','DRONEDARONE','400','mg/1','Antiarrhythmic [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-4512_f17ba6ea-25d5-23c3-e053-2a95a90ab2a6','0024-4512','HUMAN PRESCRIPTION DRUG','Fexinidazole','','Fexinidazole','TABLET','ORAL','20210716','','NDA','NDA214429','Sanofi-Aventis U.S. LLC','FEXINIDAZOLE','600','mg/1','Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA], Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5150_87ffb3b6-2e99-467e-bfdf-5ab8023f6219','0024-5150','HUMAN PRESCRIPTION DRUG','Elitek','','rasburicase','KIT','','20020712','','BLA','BLA103946','Sanofi-Aventis U.S. LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5151_87ffb3b6-2e99-467e-bfdf-5ab8023f6219','0024-5151','HUMAN PRESCRIPTION DRUG','Elitek','','rasburicase','KIT','','20060601','','BLA','BLA103946','Sanofi-Aventis U.S. LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5401_c8f05d12-bc35-43cb-8b65-588bec02c73d','0024-5401','HUMAN PRESCRIPTION DRUG','Ambien','','zolpidem tartrate','TABLET, FILM COATED','ORAL','19930401','','NDA','NDA019908','sanofi-aventis U.S. LLC','ZOLPIDEM TARTRATE','5','mg/1','Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5421_c8f05d12-bc35-43cb-8b65-588bec02c73d','0024-5421','HUMAN PRESCRIPTION DRUG','Ambien','','zolpidem tartrate','TABLET, FILM COATED','ORAL','19930401','','NDA','NDA019908','sanofi-aventis U.S. LLC','ZOLPIDEM TARTRATE','10','mg/1','Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5501_8138a0a9-168c-46d2-b13e-e7e84f27eaee','0024-5501','HUMAN PRESCRIPTION DRUG','Ambien','CR','zolpidem tartrate','TABLET, COATED','ORAL','20050919','','NDA','NDA021774','sanofi-aventis U.S. LLC','ZOLPIDEM TARTRATE','6.25','mg/1','Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5521_8138a0a9-168c-46d2-b13e-e7e84f27eaee','0024-5521','HUMAN PRESCRIPTION DRUG','Ambien','CR','zolpidem tartrate','TABLET, COATED','ORAL','20050919','','NDA','NDA021774','sanofi-aventis U.S. LLC','ZOLPIDEM TARTRATE','12.5','mg/1','Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5745_7ea21219-5fcf-4575-acfd-7ff02629e07b','0024-5745','HUMAN PRESCRIPTION DRUG','ADLYXIN','','Lixisenatide','KIT','','20160727','','BLA','BLA208471','sanofi-aventis U.S. LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5747_7ea21219-5fcf-4575-acfd-7ff02629e07b','0024-5747','HUMAN PRESCRIPTION DRUG','ADLYXIN','','Lixisenatide','INJECTION, SOLUTION','SUBCUTANEOUS','20160727','','BLA','BLA208471','sanofi-aventis U.S. LLC','LIXISENATIDE','100','ug/mL','GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5761_f21575d4-db01-40b2-910a-7629d65452d4','0024-5761','HUMAN PRESCRIPTION DRUG','Soliqua 100/33','','insulin glargine and lixisenatide','INJECTION, SOLUTION','SUBCUTANEOUS','20161121','','BLA','BLA208673','sanofi-aventis U.S. LLC','INSULIN GLARGINE; LIXISENATIDE','100; 33','U/mL; ug/mL','GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Insulin Analog [EPC], Insulin [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5824_3435cdcd-58f1-4c27-98f6-a2509d2a7fd7','0024-5824','HUMAN PRESCRIPTION DRUG','Jevtana','','cabazitaxel','KIT','','20100617','','NDA','NDA201023','Sanofi-Aventis U.S. LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5837_f17b7d67-baa2-9958-e053-2a95a90a0662','0024-5837','HUMAN PRESCRIPTION DRUG','FLOMAX','','tamsulosin hydrochloride','CAPSULE','ORAL','20190416','','NDA','NDA020579','sanofi-aventis U.S. LLC','TAMSULOSIN HYDROCHLORIDE','0.4','mg/1','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5840_51ce31b3-7c70-426f-9f78-b6f7b2e733ec','0024-5840','HUMAN PRESCRIPTION DRUG','ZALTRAP','','ziv-aflibercept','SOLUTION, CONCENTRATE','INTRAVENOUS','20120803','','BLA','BLA125418','sanofi-aventis U.S. LLC','AFLIBERCEPT','100','mg/4mL','Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5841_51ce31b3-7c70-426f-9f78-b6f7b2e733ec','0024-5841','HUMAN PRESCRIPTION DRUG','ZALTRAP','','ziv-aflibercept','SOLUTION, CONCENTRATE','INTRAVENOUS','20120803','','BLA','BLA125418','sanofi-aventis U.S. LLC','AFLIBERCEPT','200','mg/8mL','Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5850_cf3ca8df-5a3f-413d-a895-65685cc17313','0024-5850','HUMAN PRESCRIPTION DRUG','Avapro','','irbesartan','TABLET, FILM COATED','ORAL','20130101','','NDA','NDA020757','Sanofi-Aventis U.S. LLC','IRBESARTAN','75','mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5851_cf3ca8df-5a3f-413d-a895-65685cc17313','0024-5851','HUMAN PRESCRIPTION DRUG','Avapro','','irbesartan','TABLET, FILM COATED','ORAL','20130101','','NDA','NDA020757','Sanofi-Aventis U.S. LLC','IRBESARTAN','150','mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5852_cf3ca8df-5a3f-413d-a895-65685cc17313','0024-5852','HUMAN PRESCRIPTION DRUG','Avapro','','irbesartan','TABLET, FILM COATED','ORAL','20130101','','NDA','NDA020757','Sanofi-Aventis U.S. LLC','IRBESARTAN','300','mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5855_18162dad-7813-4074-b159-d94ce6bb5fca','0024-5855','HUMAN PRESCRIPTION DRUG','Avalide','','irbesartan and hydrochlorothiazide','TABLET, FILM COATED','ORAL','20130101','','NDA','NDA020758','sanofi-aventis U.S. LLC','HYDROCHLOROTHIAZIDE; IRBESARTAN','12.5; 150','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5856_18162dad-7813-4074-b159-d94ce6bb5fca','0024-5856','HUMAN PRESCRIPTION DRUG','Avalide','','irbesartan and hydrochlorothiazide','TABLET, FILM COATED','ORAL','20130101','','NDA','NDA020758','sanofi-aventis U.S. LLC','HYDROCHLOROTHIAZIDE; IRBESARTAN','12.5; 300','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5860_6da3b3b5-9695-4d88-b19c-b4ee259da417','0024-5860','HUMAN PRESCRIPTION DRUG','Clolar','','clofarabine','INJECTION','INTRAVENOUS','20130401','','NDA','NDA021673','Sanofi-Aventis U.S. LLC','CLOFARABINE','1','mg/mL','Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5862_cb439e6f-6dd2-4ee0-afca-b65936b81efb','0024-5862','HUMAN PRESCRIPTION DRUG','Mozobil','','PLERIXAFOR','INJECTION, SOLUTION','SUBCUTANEOUS','20130901','','NDA','NDA022311','sanofi-aventis U.S. LLC','PLERIXAFOR','24','mg/1.2mL','Hematopoietic Stem Cell Mobilizer [EPC], Increased Hematopoietic Stem Cell Mobilization [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5869_5a4a1c66-9279-4a19-a9da-8d6f0e28f4e4','0024-5869','HUMAN PRESCRIPTION DRUG','TOUJEO','','insulin glargine','INJECTION, SOLUTION','SUBCUTANEOUS','20150215','','BLA','BLA206538','Sanofi-Aventis U.S. LLC','INSULIN GLARGINE','300','U/mL','Insulin Analog [EPC], Insulin [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5871_5a4a1c66-9279-4a19-a9da-8d6f0e28f4e4','0024-5871','HUMAN PRESCRIPTION DRUG','TOUJEO Max','','insulin glargine','INJECTION, SOLUTION','SUBCUTANEOUS','20150215','','BLA','BLA206538','Sanofi-Aventis U.S. LLC','INSULIN GLARGINE','300','U/mL','Insulin Analog [EPC], Insulin [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5901_d6e3eeb8-c775-4382-85c3-3f3e8999c280','0024-5901','HUMAN PRESCRIPTION DRUG','Praluent','','alirocumab','INJECTION, SOLUTION','SUBCUTANEOUS','20150724','','BLA','BLA125559','Sanofi-Aventis U.S. LLC','ALIROCUMAB','75','mg/mL','Antibodies, Monoclonal [CS], PCSK9 Inhibitor [EPC], PCSK9 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5902_d6e3eeb8-c775-4382-85c3-3f3e8999c280','0024-5902','HUMAN PRESCRIPTION DRUG','Praluent','','alirocumab','INJECTION, SOLUTION','SUBCUTANEOUS','20150724','','BLA','BLA125559','Sanofi-Aventis U.S. LLC','ALIROCUMAB','150','mg/mL','Antibodies, Monoclonal [CS], PCSK9 Inhibitor [EPC], PCSK9 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5903_d6e3eeb8-c775-4382-85c3-3f3e8999c280','0024-5903','HUMAN PRESCRIPTION DRUG','Praluent','','alirocumab','INJECTION, SOLUTION','SUBCUTANEOUS','20150724','','BLA','BLA125559','Sanofi-Aventis U.S. LLC','ALIROCUMAB','75','mg/mL','Antibodies, Monoclonal [CS], PCSK9 Inhibitor [EPC], PCSK9 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5904_d6e3eeb8-c775-4382-85c3-3f3e8999c280','0024-5904','HUMAN PRESCRIPTION DRUG','Praluent','','alirocumab','INJECTION, SOLUTION','SUBCUTANEOUS','20150724','','BLA','BLA125559','Sanofi-Aventis U.S. LLC','ALIROCUMAB','150','mg/mL','Antibodies, Monoclonal [CS], PCSK9 Inhibitor [EPC], PCSK9 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5908_c30777b0-0e4c-4f20-b42c-2b29c984220b','0024-5908','HUMAN PRESCRIPTION DRUG','KEVZARA','','sarilumab','INJECTION, SOLUTION','SUBCUTANEOUS','20170522','','BLA','BLA761037','sanofi-aventis U.S. LLC','SARILUMAB','150','mg/1.14mL','Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5910_c30777b0-0e4c-4f20-b42c-2b29c984220b','0024-5910','HUMAN PRESCRIPTION DRUG','KEVZARA','','sarilumab','INJECTION, SOLUTION','SUBCUTANEOUS','20170522','','BLA','BLA761037','sanofi-aventis U.S. LLC','SARILUMAB','200','mg/1.14mL','Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5911_250b4a7d-0ccc-4341-af0b-c48cc06af4b6','0024-5911','HUMAN PRESCRIPTION DRUG','Dupixent','','Dupilumab','INJECTION, SOLUTION','SUBCUTANEOUS','20211020','','BLA','BLA761055','sanofi-aventis U.S. LLC','DUPILUMAB','100','mg/.67mL','Antibodies, Monoclonal [CS], Interleukin 4 Receptor alpha Antagonists [MoA], Interleukin-4 Receptor alpha Antagonist [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5914_250b4a7d-0ccc-4341-af0b-c48cc06af4b6','0024-5914','HUMAN PRESCRIPTION DRUG','Dupixent','','Dupilumab','INJECTION, SOLUTION','SUBCUTANEOUS','20170328','','BLA','BLA761055','sanofi-aventis U.S. LLC','DUPILUMAB','300','mg/2mL','Antibodies, Monoclonal [CS], Interleukin 4 Receptor alpha Antagonists [MoA], Interleukin-4 Receptor alpha Antagonist [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5915_250b4a7d-0ccc-4341-af0b-c48cc06af4b6','0024-5915','HUMAN PRESCRIPTION DRUG','Dupixent','','Dupilumab','INJECTION, SOLUTION','SUBCUTANEOUS','20200619','','BLA','BLA761055','sanofi-aventis U.S. LLC','DUPILUMAB','300','mg/2mL','Antibodies, Monoclonal [CS], Interleukin 4 Receptor alpha Antagonists [MoA], Interleukin-4 Receptor alpha Antagonist [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5918_250b4a7d-0ccc-4341-af0b-c48cc06af4b6','0024-5918','HUMAN PRESCRIPTION DRUG','Dupixent','','Dupilumab','INJECTION, SOLUTION','SUBCUTANEOUS','20181019','','BLA','BLA761055','sanofi-aventis U.S. LLC','DUPILUMAB','200','mg/1.14mL','Antibodies, Monoclonal [CS], Interleukin 4 Receptor alpha Antagonists [MoA], Interleukin-4 Receptor alpha Antagonist [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5919_250b4a7d-0ccc-4341-af0b-c48cc06af4b6','0024-5919','HUMAN PRESCRIPTION DRUG','Dupixent','','Dupilumab','INJECTION, SOLUTION','SUBCUTANEOUS','20210614','','BLA','BLA761055','sanofi-aventis U.S. LLC','DUPILUMAB','200','mg/1.14mL','Antibodies, Monoclonal [CS], Interleukin 4 Receptor alpha Antagonists [MoA], Interleukin-4 Receptor alpha Antagonist [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5920_c30777b0-0e4c-4f20-b42c-2b29c984220b','0024-5920','HUMAN PRESCRIPTION DRUG','KEVZARA','','sarilumab','INJECTION, SOLUTION','SUBCUTANEOUS','20170522','','BLA','BLA761037','sanofi-aventis U.S. LLC','SARILUMAB','150','mg/1.14mL','Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5922_c30777b0-0e4c-4f20-b42c-2b29c984220b','0024-5922','HUMAN PRESCRIPTION DRUG','KEVZARA','','sarilumab','INJECTION, SOLUTION','SUBCUTANEOUS','20170522','','BLA','BLA761037','sanofi-aventis U.S. LLC','SARILUMAB','200','mg/1.14mL','Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5924_a9ff7a53-ba49-484d-9b03-7654ef04dabf','0024-5924','HUMAN PRESCRIPTION DRUG','ADMELOG','','insulin lispro','INJECTION, SOLUTION','INTRAVENOUS; SUBCUTANEOUS','20171211','','BLA','BLA209196','Sanofi-Aventis U.S. LLC','INSULIN LISPRO','100','U/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5925_a9ff7a53-ba49-484d-9b03-7654ef04dabf','0024-5925','HUMAN PRESCRIPTION DRUG','ADMELOG','','insulin lispro','INJECTION, SOLUTION','SUBCUTANEOUS','20171211','','BLA','BLA209196','Sanofi-Aventis U.S. LLC','INSULIN LISPRO','100','U/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0024-5926_a9ff7a53-ba49-484d-9b03-7654ef04dabf','0024-5926','HUMAN PRESCRIPTION DRUG','ADMELOG','','insulin lispro','INJECTION, SOLUTION','INTRAVENOUS; SUBCUTANEOUS','20181019','','BLA','BLA209196','Sanofi-Aventis U.S. LLC','INSULIN LISPRO','100','U/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-0061_8ba80b03-ae98-4942-a04e-e16421dc8e50','0025-0061','HUMAN PRESCRIPTION DRUG','Lomotil','','diphenoxylate hydrochloride and atropine sulfate','TABLET','ORAL','19600915','','NDA','NDA012462','Pfizer Laboratories Div Pfizer Inc','ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE','.025; 2.5','mg/1; mg/1','Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-0166_bbb3315f-c436-4ae0-8374-300bf31826ed','0025-0166','HUMAN PRESCRIPTION DRUG','Synarel','','nafarelin acetate','SPRAY, METERED','NASAL','19900213','','NDA','NDA019886','Pfizer Laboratories Div Pfizer Inc','NAFARELIN ACETATE','2','mg/mL','Gonadotropin Releasing Hormone Receptor Agonist [EPC], Gonadotropin Releasing Hormone Receptor Agonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-1001_0010e0e6-5d51-4147-a75e-bae453d3cf44','0025-1001','HUMAN PRESCRIPTION DRUG','Aldactone','','spironolactone','TABLET, FILM COATED','ORAL','19600121','','NDA','NDA012151','Pfizer Laboratories Div Pfizer Inc','SPIRONOLACTONE','25','mg/1','Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-1011_f6b71298-6d0c-4af3-98d8-51be7510a7b3','0025-1011','HUMAN PRESCRIPTION DRUG','ALDACTAZIDE','','spironolactone and hydrochlorothiazide','TABLET, FILM COATED','ORAL','19780101','','NDA','NDA012616','Pfizer Laboratories Div Pfizer Inc','HYDROCHLOROTHIAZIDE; SPIRONOLACTONE','25; 25','mg/1; mg/1','Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-1021_f6b71298-6d0c-4af3-98d8-51be7510a7b3','0025-1021','HUMAN PRESCRIPTION DRUG','ALDACTAZIDE','','spironolactone and hydrochlorothiazide','TABLET, FILM COATED','ORAL','19780101','','NDA','NDA012616','Pfizer Laboratories Div Pfizer Inc','HYDROCHLOROTHIAZIDE; SPIRONOLACTONE','50; 50','mg/1; mg/1','Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-1031_0010e0e6-5d51-4147-a75e-bae453d3cf44','0025-1031','HUMAN PRESCRIPTION DRUG','Aldactone','','spironolactone','TABLET, FILM COATED','ORAL','19600121','','NDA','NDA012151','Pfizer Laboratories Div Pfizer Inc','SPIRONOLACTONE','100','mg/1','Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-1041_0010e0e6-5d51-4147-a75e-bae453d3cf44','0025-1041','HUMAN PRESCRIPTION DRUG','Aldactone','','spironolactone','TABLET, FILM COATED','ORAL','19600121','','NDA','NDA012151','Pfizer Laboratories Div Pfizer Inc','SPIRONOLACTONE','50','mg/1','Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-1381_b2dd3c39-1c89-470f-b43b-0c85ed1a2fe1','0025-1381','HUMAN PRESCRIPTION DRUG','Daypro','','oxaprozin','TABLET, FILM COATED','ORAL','19921029','','NDA','NDA018841','Pfizer Laboratories Div Pfizer Inc','OXAPROZIN','600','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-1411_e33f3361-03b3-4829-83ca-2fff4f5901e6','0025-1411','HUMAN PRESCRIPTION DRUG','ARTHROTEC','','diclofenac sodium and misoprostol','TABLET, FILM COATED','ORAL','19971224','','NDA','NDA020607','Pfizer Laboratories Div Pfizer Inc','DICLOFENAC SODIUM; MISOPROSTOL','50; 200','mg/1; ug/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-1421_e33f3361-03b3-4829-83ca-2fff4f5901e6','0025-1421','HUMAN PRESCRIPTION DRUG','ARTHROTEC','','diclofenac sodium and misoprostol','TABLET, FILM COATED','ORAL','19971224','','NDA','NDA020607','Pfizer Laboratories Div Pfizer Inc','DICLOFENAC SODIUM; MISOPROSTOL','75; 200','mg/1; ug/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-1451_a84b3f70-cd54-4d4b-904e-c76719e8da24','0025-1451','HUMAN PRESCRIPTION DRUG','Cytotec','','misoprostol','TABLET','ORAL','19861227','','NDA','NDA019268','Pfizer Laboratories Div Pfizer Inc','MISOPROSTOL','100','ug/1','Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-1461_a84b3f70-cd54-4d4b-904e-c76719e8da24','0025-1461','HUMAN PRESCRIPTION DRUG','Cytotec','','misoprostol','TABLET','ORAL','19861227','','NDA','NDA019268','Pfizer Laboratories Div Pfizer Inc','MISOPROSTOL','200','ug/1','Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-1515_aa50b33d-5037-4cd8-968a-b0f64f8fb490','0025-1515','HUMAN PRESCRIPTION DRUG','CELEBREX','','Celecoxib','CAPSULE','ORAL','19981002','','NDA','NDA020998','Pfizer Laboratories Div Pfizer Inc','CELECOXIB','50','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-1520_aa50b33d-5037-4cd8-968a-b0f64f8fb490','0025-1520','HUMAN PRESCRIPTION DRUG','CELEBREX','','Celecoxib','CAPSULE','ORAL','19981002','','NDA','NDA020998','Pfizer Laboratories Div Pfizer Inc','CELECOXIB','100','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-1525_aa50b33d-5037-4cd8-968a-b0f64f8fb490','0025-1525','HUMAN PRESCRIPTION DRUG','CELEBREX','','Celecoxib','CAPSULE','ORAL','19981002','','NDA','NDA020998','Pfizer Laboratories Div Pfizer Inc','CELECOXIB','200','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-1530_aa50b33d-5037-4cd8-968a-b0f64f8fb490','0025-1530','HUMAN PRESCRIPTION DRUG','CELEBREX','','Celecoxib','CAPSULE','ORAL','19981002','','NDA','NDA020998','Pfizer Laboratories Div Pfizer Inc','CELECOXIB','400','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-1710_9007c574-2827-4d8a-901f-4d2b92ee80dc','0025-1710','HUMAN PRESCRIPTION DRUG','Inspra','','eplerenone','TABLET, FILM COATED','ORAL','20020927','','NDA','NDA021437','Pfizer Laboratories Div Pfizer Inc','EPLERENONE','25','mg/1','Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-1720_9007c574-2827-4d8a-901f-4d2b92ee80dc','0025-1720','HUMAN PRESCRIPTION DRUG','Inspra','','eplerenone','TABLET, FILM COATED','ORAL','20020927','','NDA','NDA021437','Pfizer Laboratories Div Pfizer Inc','EPLERENONE','50','mg/1','Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-1942_a1b35265-932c-42e4-b9fe-a013d7233fc4','0025-1942','HUMAN PRESCRIPTION DRUG','Flagyl','','metronidazole','CAPSULE','ORAL','19950503','','NDA','NDA020334','Pfizer Laboratories Div Pfizer Inc','METRONIDAZOLE','375','mg/1','Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-2712_7ed8d0e7-7bab-4a38-af2b-65aa9e6edfec','0025-2712','HUMAN PRESCRIPTION DRUG','CALAN SR','','verapamil hydrochloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20211025','','NDA','NDA019152','Pfizer Laboratories Div Pfizer Inc','VERAPAMIL HYDROCHLORIDE','120','mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-2732_7f19cb56-80b1-40b1-b195-54503481bf48','0025-2732','HUMAN PRESCRIPTION DRUG','Norpace CR','','disopyramide phosphate','CAPSULE, EXTENDED RELEASE','ORAL','19820720','','NDA','NDA018655','Pfizer Laboratories Div Pfizer Inc','DISOPYRAMIDE PHOSPHATE','100','mg/1','Antiarrhythmic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-2742_7f19cb56-80b1-40b1-b195-54503481bf48','0025-2742','HUMAN PRESCRIPTION DRUG','Norpace CR','','disopyramide phosphate','CAPSULE, EXTENDED RELEASE','ORAL','19820720','','NDA','NDA018655','Pfizer Laboratories Div Pfizer Inc','DISOPYRAMIDE PHOSPHATE','150','mg/1','Antiarrhythmic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-2752_7f19cb56-80b1-40b1-b195-54503481bf48','0025-2752','HUMAN PRESCRIPTION DRUG','Norpace','','disopyramide phosphate','CAPSULE, GELATIN COATED','ORAL','19770901','','NDA','NDA017447','Pfizer Laboratories Div Pfizer Inc','DISOPYRAMIDE PHOSPHATE','100','mg/1','Antiarrhythmic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-2762_7f19cb56-80b1-40b1-b195-54503481bf48','0025-2762','HUMAN PRESCRIPTION DRUG','Norpace','','disopyramide phosphate','CAPSULE, GELATIN COATED','ORAL','19770901','','NDA','NDA017447','Pfizer Laboratories Div Pfizer Inc','DISOPYRAMIDE PHOSPHATE','150','mg/1','Antiarrhythmic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-2818_7ed8d0e7-7bab-4a38-af2b-65aa9e6edfec','0025-2818','HUMAN PRESCRIPTION DRUG','CALAN SR','','verapamil hydrochloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20201216','','NDA','NDA019152','Pfizer Laboratories Div Pfizer Inc','VERAPAMIL HYDROCHLORIDE','180','mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0025-2924_7ed8d0e7-7bab-4a38-af2b-65aa9e6edfec','0025-2924','HUMAN PRESCRIPTION DRUG','CALAN SR','','verapamil hydrochloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20210601','','NDA','NDA019152','Pfizer Laboratories Div Pfizer Inc','VERAPAMIL HYDROCHLORIDE','240','mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0026-3782_95810928-b700-4a13-8d83-f19f1539e822','0026-3782','PLASMA DERIVATIVE','Kogenate FS','','Antihemophilic Factor (Recombinant)','KIT','','20130626','','BLA','BLA103332','Bayer HealthCare LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0026-3783_95810928-b700-4a13-8d83-f19f1539e822','0026-3783','PLASMA DERIVATIVE','Kogenate FS','','Antihemophilic Factor (Recombinant)','KIT','','20130626','','BLA','BLA103332','Bayer HealthCare LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0026-3785_95810928-b700-4a13-8d83-f19f1539e822','0026-3785','PLASMA DERIVATIVE','Kogenate FS','','Antihemophilic Factor (Recombinant)','KIT','','20130626','','BLA','BLA103332','Bayer HealthCare LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0026-3786_95810928-b700-4a13-8d83-f19f1539e822','0026-3786','PLASMA DERIVATIVE','Kogenate FS','','Antihemophilic Factor (Recombinant)','KIT','','20130626','','BLA','BLA103332','Bayer HealthCare LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0026-3787_95810928-b700-4a13-8d83-f19f1539e822','0026-3787','PLASMA DERIVATIVE','Kogenate FS','','Antihemophilic Factor (Recombinant)','KIT','','20130626','','BLA','BLA103332','Bayer HealthCare LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0026-3821_ad5cbc7e-870e-4a96-a770-d8d6680f0a11','0026-3821','PLASMA DERIVATIVE','Kovaltry','','Antihemophilic Factor (Recombinant)','KIT','','20160317','','BLA','BLA125574','Bayer HealthCare LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0026-3822_ad5cbc7e-870e-4a96-a770-d8d6680f0a11','0026-3822','PLASMA DERIVATIVE','Kovaltry','','Antihemophilic Factor (Recombinant)','KIT','','20160317','','BLA','BLA125574','Bayer HealthCare LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0026-3824_ad5cbc7e-870e-4a96-a770-d8d6680f0a11','0026-3824','PLASMA DERIVATIVE','Kovaltry','','Antihemophilic Factor (Recombinant)','KIT','','20160317','','BLA','BLA125574','Bayer HealthCare LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0026-3826_ad5cbc7e-870e-4a96-a770-d8d6680f0a11','0026-3826','PLASMA DERIVATIVE','Kovaltry','','Antihemophilic Factor (Recombinant)','KIT','','20160317','','BLA','BLA125574','Bayer HealthCare LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0026-3828_ad5cbc7e-870e-4a96-a770-d8d6680f0a11','0026-3828','PLASMA DERIVATIVE','Kovaltry','','Antihemophilic Factor (Recombinant)','KIT','','20160317','','BLA','BLA125574','Bayer HealthCare LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0026-3942_f1d11754-9630-44ec-b7f5-99c2c0ce9ba8','0026-3942','PLASMA DERIVATIVE','Jivi','','Antihemophilic Factor (Recombinant) Pegylated-aucl','KIT','','20180830','','BLA','BLA125661','Bayer HealthCare LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0026-3944_f1d11754-9630-44ec-b7f5-99c2c0ce9ba8','0026-3944','PLASMA DERIVATIVE','Jivi','','Antihemophilic Factor (Recombinant) Pegylated-aucl','KIT','','20180830','','BLA','BLA125661','Bayer HealthCare LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0026-3946_f1d11754-9630-44ec-b7f5-99c2c0ce9ba8','0026-3946','PLASMA DERIVATIVE','Jivi','','Antihemophilic Factor (Recombinant) Pegylated-aucl','KIT','','20180830','','BLA','BLA125661','Bayer HealthCare LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0026-3948_f1d11754-9630-44ec-b7f5-99c2c0ce9ba8','0026-3948','PLASMA DERIVATIVE','Jivi','','Antihemophilic Factor (Recombinant) Pegylated-aucl','KIT','','20180830','','BLA','BLA125661','Bayer HealthCare LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-2097_d13efbcd-1277-45d0-8389-1ba0337f7a24','0031-2097','HUMAN OTC DRUG','Robitussin Elderberry Maximum Strength Cough plus Chest Congestion DM','','dextromethorphan HBr, guaifenesin','SOLUTION','ORAL','20210614','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN','20; 400','mg/20mL; mg/20mL','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-2098_fe903448-b422-42e0-b05b-aeb3e5481e3c','0031-2098','HUMAN OTC DRUG','Childrens Robitussin Elderberry Cough and Chest Congestion DM','','dextromethorphan HBr, guaifenesin','SOLUTION','ORAL','20210614','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN','20; 400','mg/20mL; mg/20mL','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8655_76e2e2e1-5df8-45fc-b9d2-3e2155ecac5a','0031-8655','HUMAN OTC DRUG','Robitussin 12 Hour Cough Relief','','dextromethorphan polistirex','SUSPENSION, EXTENDED RELEASE','ORAL','20150701','','ANDA','ANDA091135','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE','30','mg/5mL','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8692_f44ae4e4-f676-4935-9bf6-6c3f76da5607','0031-8692','HUMAN OTC DRUG','Childrens Robitussin Nighttime Cough Long-Acting DM','','chlorpheniramine maleate, dextromethorphan hydrobromide','SOLUTION','ORAL','20140701','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE','2; 15','mg/10mL; mg/10mL','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8693_6f0fba24-5f21-40bf-868b-6e3c24854391','0031-8693','HUMAN OTC DRUG','CHILDRENS ROBITUSSIN COUGH AND COLD LONG-ACTING','','chlorpheniramine maleate, dextrometrorphan HBr','LIQUID','ORAL','20040101','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE','2; 15','mg/10mL; mg/10mL','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8694_367f1720-27d8-45b1-876a-50d47e904c4f','0031-8694','HUMAN OTC DRUG','Childrens Robitussin Cough Long-Acting','','dextromethorphan hydrobromide','LIQUID','ORAL','20040101','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE','7.5','mg/5mL','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8702_6dbc0a50-8ae8-4587-8e75-9e72bf47e00c','0031-8702','HUMAN OTC DRUG','Childrens Robitussin Cough and Chest Congestion DM','','dextromethorphan hydrobromide and guaifenesin','LIQUID','ORAL','20200512','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN','20; 200','mg/20mL; mg/20mL','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8715_b01f57f4-e836-4523-900f-a8796f1fd98a','0031-8715','HUMAN OTC DRUG','Childrens Robitussin Cough and Chest Congestion DM','','dextromethorphan hydrobromide, guaifenesin','LIQUID','ORAL','20140701','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN','5; 100','mg/5mL; mg/5mL','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8716_0477b6c8-f487-43ab-8a42-3bcc82369caf','0031-8716','HUMAN OTC DRUG','Childrens Robitussin Cough and Cold CF','','dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride','LIQUID','ORAL','20090901','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE','5; 50; 2.5','mg/5mL; mg/5mL; mg/5mL','Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8718_f73b00e8-032c-4bc3-bffe-9d35cb0f2395','0031-8718','HUMAN OTC DRUG','Robitussin Maximum Strength Nighttime Cough DM','','dextromethorphan hydrobromide, doxylamine succinate','SOLUTION','ORAL','20160601','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE','30; 12.5','mg/20mL; mg/20mL','Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8719_07a996c0-1cb6-477f-ac53-06bf70ac6f86','0031-8719','HUMAN OTC DRUG','Robitussin Maximum Strength Cough Plus Chest Congestion DM','','dextromethorphan hydrobromide and guaifenesin','CAPSULE, LIQUID FILLED','ORAL','20130523','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN','10; 200','mg/1; mg/1','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8725_27f2c7ef-df41-4a3f-aaf0-18c88af40256','0031-8725','HUMAN OTC DRUG','Childrens Robitussin 12 Hour Cough Relief','','dextromethorphan polistirex','SUSPENSION, EXTENDED RELEASE','ORAL','20160705','','ANDA','ANDA091135','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE','30','mg/5mL','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8726_27f2c7ef-df41-4a3f-aaf0-18c88af40256','0031-8726','HUMAN OTC DRUG','Childrens Robitussin 12 Hour Cough Relief','','dextromethorphan polistirex','SUSPENSION, EXTENDED RELEASE','ORAL','20160705','','ANDA','ANDA091135','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE','30','mg/5mL','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8739_011d653e-0754-40bd-b4c8-2280bdd1953c','0031-8739','HUMAN OTC DRUG','ROBITUSSIN MAXIMUM STRENGTH COUGH PLUS CHEST CONGESTION DM','','dextromethorphan hydrobromide, guaifenesin','SOLUTION','ORAL','20160601','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN','20; 400','mg/20mL; mg/20mL','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8742_0326bb79-e66a-4186-add1-af99a1896988','0031-8742','HUMAN OTC DRUG','Robitussin Peak Cold Multi-Symptom Cold','','dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride','LIQUID','ORAL','20110612','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE','10; 100; 5','mg/5mL; mg/5mL; mg/5mL','Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8743_e8b94761-b393-410b-8f1d-3f95401eea70','0031-8743','HUMAN OTC DRUG','ROBITUSSIN LONG-ACTING COUGHGELS','','dextromethorphan hydrobromide','CAPSULE, LIQUID FILLED','ORAL','20190104','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE','15','mg/1','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8744_c1631d7e-c920-4f6b-b6fa-e63e081f997c','0031-8744','HUMAN OTC DRUG','Robitussin Maximum Strength Severe Multi-Symptom 7 in 1 Relief Nighttime','','acetaminophen, dextromethorphan hydrobromide, and doxylamine succinate','CAPSULE, LIQUID FILLED','ORAL','20150701','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE','325; 15; 6.25','mg/1; mg/1; mg/1','Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8750_90199483-457d-4f7b-915d-72250ec14390','0031-8750','HUMAN OTC DRUG','Robitussin Maximum Strength Severe Cough Plus Sore Throat','','acetaminophen, dextromethorphan hydrobromide','LIQUID','ORAL','20170410','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE','650; 20','mg/20mL; mg/20mL','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8751_62ce8cd8-57d2-48a6-aaf1-d9b0cdb5753c','0031-8751','HUMAN OTC DRUG','Robitussin Severe Multi-Symptom Cough Cold Flu','','acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride','LIQUID','ORAL','20150501','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE','650; 20; 400; 10','mg/20mL; mg/20mL; mg/20mL; mg/20mL','Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8752_1d94c4de-0064-4f64-bbbb-b3123e6ba05d','0031-8752','HUMAN OTC DRUG','Robitussin Severe Multi-Symptom Cough Cold Flu Nighttime','','acetaminophen, diphenhydramine hydrochloride, phenylephrine hydrochloride','SOLUTION','ORAL','20150701','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE','650; 25; 10','mg/20mL; mg/20mL; mg/20mL','Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8753_76e2e2e1-5df8-45fc-b9d2-3e2155ecac5a','0031-8753','HUMAN OTC DRUG','Robitussin 12 Hour Cough Relief','','dextromethorphan polistirex','SUSPENSION, EXTENDED RELEASE','ORAL','20150701','','ANDA','ANDA091135','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE','30','mg/5mL','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8754_76e2e2e1-5df8-45fc-b9d2-3e2155ecac5a','0031-8754','HUMAN OTC DRUG','Robitussin 12 Hour Cough Relief','','dextromethorphan polistirex','SUSPENSION, EXTENDED RELEASE','ORAL','20160705','','ANDA','ANDA091135','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE','30','mg/5mL','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8755_76e2e2e1-5df8-45fc-b9d2-3e2155ecac5a','0031-8755','HUMAN OTC DRUG','Robitussin 12 Hour Cough Relief','','dextromethorphan polistirex','SUSPENSION, EXTENDED RELEASE','ORAL','20160705','','ANDA','ANDA091135','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE','30','mg/5mL','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8756_e8322a96-9e8e-4e9d-9d55-d5893f312f92','0031-8756','HUMAN OTC DRUG','Robitussin Honey Maximum Strength Cough and Chest Congestion DM','','dextromethorphan HBr, guaifenesin','SOLUTION','ORAL','20180625','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN','20; 400','mg/20mL; mg/20mL','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8757_76a458d5-fa29-48d4-b99d-97117b1d24c1','0031-8757','HUMAN OTC DRUG','ROBITUSSIN COUGH PLUS CHEST CONGESTION DM','','dextromethorphan hydrobromide and guaifenesin','SOLUTION','ORAL','20180601','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN','20; 200','mg/20mL; mg/20mL','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8758_3caaba28-7abf-4a16-8f3b-a0490ae0bc23','0031-8758','HUMAN OTC DRUG','Robitussin Honey Maximum Strength Nighttime Cough DM','','dextromethorphan HBr, doxylamine succinate','SOLUTION','ORAL','20180625','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE','30; 12.5','mg/20mL; mg/20mL','Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8759_8e630a92-84b8-40e7-bcb9-7e3f608b17b1','0031-8759','HUMAN OTC DRUG','Robitussin Sugar-Free Dye-Free Cough Plus Chest Congestion DM','','dextromethorphan hydrobromide, guaifenesin','SOLUTION','ORAL','20180216','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN','20; 200','mg/20mL; mg/20mL','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8760_f5952d8d-f142-460b-b6d3-96a21720396d','0031-8760','HUMAN OTC DRUG','Childrens Robitussin Honey Cough and Chest Congestion DM','','dextromethorphan HBr, guaifenesin','SOLUTION','ORAL','20180625','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN','10; 100','mg/10mL; mg/10mL','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8762_21d923b0-56ca-49f3-9fb1-a50a770f9539','0031-8762','HUMAN OTC DRUG','Childrens Robitussin Honey Nighttime Cough DM','','dextromethorphan hbr, doxylamine succinate','SOLUTION','ORAL','20190527','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE','15; 6.25','mg/10mL; mg/10mL','Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8765_0b1a4da5-cba1-4bd3-93c9-3e3113cb1ef0','0031-8765','HUMAN OTC DRUG','Robitussin Maximum Strength 12 Hour Cough and Mucus Relief','','Dextromethorphan Hydrobromide, Guaifenesin','TABLET, EXTENDED RELEASE','ORAL','20190614','','ANDA','ANDA207602','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN','60; 1200','mg/1; mg/1','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8770_0f6f1624-42d6-48d7-9a6b-9e4fbc48ee71','0031-8770','HUMAN OTC DRUG','Robitussin Honey Severe Cough, Flu Plus Sore Throat Nighttime','','acetaminophen and diphenhydramine hydrochloride','SOLUTION','ORAL','20200615','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE','650; 25','mg/20mL; mg/20mL','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-8771_d511de1c-8caa-49de-8742-a6922d31099c','0031-8771','HUMAN OTC DRUG','Robitussin Honey Severe Cough, Flu Plus Sore Throat','','acetaminophen, dextromethorphan hbr','SOLUTION','ORAL','20200615','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE','650; 20','mg/20mL; mg/20mL','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-9301_347be09c-9731-4265-b1c5-71cb97014aff','0031-9301','HUMAN OTC DRUG','Robitussin Direct Sore Throat Pain','','acetaminophen','TABLET, COATED','ORAL','20220715','','OTC MONOGRAPH NOT FINAL','part343','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN','500','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-9302_70c9556b-063a-4fb3-96f6-1d4ffa495ed4','0031-9302','HUMAN OTC DRUG','Robitussin Direct Cough','','dextromethorphan hydrobromide','CAPSULE, LIQUID FILLED','ORAL','20220715','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE','15','mg/1','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-9303_31fb6502-50db-4216-a202-f5604b1469d4','0031-9303','HUMAN OTC DRUG','Robitussin Direct Chest Congestion','','guaifenesin','TABLET, COATED','ORAL','20220715','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','GUAIFENESIN','400','mg/1','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-9304_7a049de2-8f24-4cb3-8b30-331db00a455e','0031-9304','HUMAN OTC DRUG','Robitussin Direct Runny Nose','','diphenhydramine','TABLET, COATED','ORAL','20220715','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DIPHENHYDRAMINE HYDROCHLORIDE','25','mg/1','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0031-9305_7ac1ce3a-efe2-4773-9ed9-dcc49c6e651e','0031-9305','HUMAN OTC DRUG','Robitussin Direct Stuffy Nose','','Phenylephrine hcl','TABLET, COATED','ORAL','20220715','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','PHENYLEPHRINE HYDROCHLORIDE','10','mg/1','Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0032-1203_073421ec-2bf3-4a89-a442-c381ac401b43','0032-1203','HUMAN PRESCRIPTION DRUG','Creon','','Pancrelipase','CAPSULE, DELAYED RELEASE','ORAL','20090430','','BLA','BLA020725','AbbVie Inc.','PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE','15000; 3000; 9500','[USP''''U]/1; [USP''''U]/1; [USP''''U]/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0032-1206_073421ec-2bf3-4a89-a442-c381ac401b43','0032-1206','HUMAN PRESCRIPTION DRUG','Creon','','Pancrelipase','CAPSULE, DELAYED RELEASE PELLETS','ORAL','20090430','','BLA','BLA020725','AbbVie Inc.','PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE','30000; 6000; 19000','[USP''''U]/1; [USP''''U]/1; [USP''''U]/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0032-1212_073421ec-2bf3-4a89-a442-c381ac401b43','0032-1212','HUMAN PRESCRIPTION DRUG','Creon','','Pancrelipase','CAPSULE, DELAYED RELEASE PELLETS','ORAL','20090430','','BLA','BLA020725','AbbVie Inc.','PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE','60000; 12000; 38000','[USP''''U]/1; [USP''''U]/1; [USP''''U]/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0032-1224_073421ec-2bf3-4a89-a442-c381ac401b43','0032-1224','HUMAN PRESCRIPTION DRUG','Creon','','Pancrelipase','CAPSULE, DELAYED RELEASE PELLETS','ORAL','20090430','','BLA','BLA020725','AbbVie Inc.','PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE','120000; 24000; 76000','[USP''''U]/1; [USP''''U]/1; [USP''''U]/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0032-3016_073421ec-2bf3-4a89-a442-c381ac401b43','0032-3016','HUMAN PRESCRIPTION DRUG','Creon','','Pancrelipase','CAPSULE, DELAYED RELEASE PELLETS','ORAL','20130314','','BLA','BLA020725','AbbVie Inc.','PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE','180000; 36000; 114000','[USP''''U]/1; [USP''''U]/1; [USP''''U]/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-0022_b2a66521-48b9-4ae4-9fe6-ccf52b4c0d27','0037-0022','HUMAN PRESCRIPTION DRUG','sfRowasa','Sulfite-Free Formulation','mesalamine','SUSPENSION','RECTAL','20160324','','NDA','NDA019618','Meda Pharmaceuticals Inc.','MESALAMINE','4','g/60mL','Aminosalicylate [EPC], Aminosalicylic Acids [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-0066_abd60218-40b4-4350-94c7-221789e3fe30','0037-0066','HUMAN PRESCRIPTION DRUG','Rowasa','','mesalamine','SUSPENSION','RECTAL','20160324','','NDA','NDA019618','Meda Pharmaceuticals Inc.','MESALAMINE','4','g/60mL','Aminosalicylate [EPC], Aminosalicylic Acids [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-0245_4b104121-a698-414e-b0c1-8af6fb7f2a41','0037-0245','HUMAN PRESCRIPTION DRUG','DYMISTA','','Azelastine Hydrochloride and Fluticasone Propionate','SPRAY, METERED','NASAL','20120501','','NDA','NDA202236','Meda Pharmaceuticals Inc.','AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE','137; 50','ug/1; ug/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-0430_1814c148-d0bf-405a-9e20-f3d1aa8c1d9e','0037-0430','HUMAN PRESCRIPTION DRUG','Felbatol','','felbamate','TABLET','ORAL','19930729','','NDA','NDA020189','Meda Pharmaceuticals Inc.','FELBAMATE','400','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-0431_1814c148-d0bf-405a-9e20-f3d1aa8c1d9e','0037-0431','HUMAN PRESCRIPTION DRUG','Felbatol','','felbamate','TABLET','ORAL','19930729','','NDA','NDA020189','Meda Pharmaceuticals Inc.','FELBAMATE','600','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-0442_1814c148-d0bf-405a-9e20-f3d1aa8c1d9e','0037-0442','HUMAN PRESCRIPTION DRUG','Felbatol','','felbamate','SUSPENSION','ORAL','19930729','','NDA','NDA020189','Meda Pharmaceuticals Inc.','FELBAMATE','600','mg/5mL','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-0678_6c00dfda-8bd6-4f4e-a2fc-8b544c8b38d4','0037-0678','HUMAN PRESCRIPTION DRUG','Gastrocrom','','cromolyn sodium','LIQUID','ORAL','20150501','','NDA','NDA020479','Meda Pharmaceuticals','CROMOLYN SODIUM','20','mg/mL','Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-2001_f1040579-1917-4488-9df8-ca3424ebd03b','0037-2001','HUMAN PRESCRIPTION DRUG','Soma','','Carisoprodol','TABLET','ORAL','19590701','','NDA','NDA011792','Meda Pharmaceuticals','CARISOPRODOL','350','mg/1','Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-2250_f1040579-1917-4488-9df8-ca3424ebd03b','0037-2250','HUMAN PRESCRIPTION DRUG','Soma','','Carisoprodol','TABLET','ORAL','20070901','','NDA','NDA011792','Meda Pharmaceuticals','CARISOPRODOL','250','mg/1','Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-4401_7e6bc201-d33d-45f0-9a6e-fdb5fc0995be','0037-4401','HUMAN PRESCRIPTION DRUG','Depen','','Penicillamine','TABLET','ORAL','19781130','','NDA','NDA019854','Meda Pharmaceuticals','PENICILLAMINE','250','mg/1','Antirheumatic Agent [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-4801_02a70900-90dd-43e0-b5f6-e618ccb07859','0037-4801','HUMAN PRESCRIPTION DRUG','ELESTRIN','','ESTRADIOL','GEL, METERED','TOPICAL','20140602','','NDA','NDA021813','Meda Pharmaceuticals','ESTRADIOL','0.52','mg/.87g','Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-6010_79fd5fd0-e6cf-49af-a632-8cc578fde3d8','0037-6010','HUMAN PRESCRIPTION DRUG','Edluar','','Zolpidem Tartrate','TABLET','ORAL','20090724','','NDA','NDA021997','Meda Pharmaceuticals Inc.','ZOLPIDEM TARTRATE','10','mg/1','Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-6050_79fd5fd0-e6cf-49af-a632-8cc578fde3d8','0037-6050','HUMAN PRESCRIPTION DRUG','Edluar','','Zolpidem Tartrate','TABLET','ORAL','20090724','','NDA','NDA021997','Meda Pharmaceuticals Inc.','ZOLPIDEM TARTRATE','5','mg/1','Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-6321_3c4ac6f5-f382-4cf7-aa0d-87959fa0c705','0037-6321','HUMAN PRESCRIPTION DRUG','URELLE','','hyoscyamine sulfate, methenamine, methylene blue, phenyl salicylate, and sodium phosphate, monobasic, monohydrate','TABLET','ORAL','20150112','','UNAPPROVED DRUG OTHER','','Meda Pharmaceuticals','HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE','.12; 81; 10.8; 32.4; 40.8','mg/1; mg/1; mg/1; mg/1; mg/1','Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-6822_ed540cbc-cfaa-4eee-ba7a-0f324c779df4','0037-6822','HUMAN PRESCRIPTION DRUG','PROCTOFOAM','HC','pramoxine hydrochloride hydrocortisone acetate','AEROSOL, FOAM','TOPICAL','20140815','','ANDA','ANDA086195','Meda Pharmaceuticals Inc.','HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE','100; 100','mg/10g; mg/10g','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-6823_67f367b7-f7e8-466d-bd32-3e799d522aaf','0037-6823','HUMAN OTC DRUG','PROCTOFOAM','NS','pramoxine hydrochloride','AEROSOL, FOAM','RECTAL','20140818','','OTC MONOGRAPH FINAL','part346','Meda Pharmaceuticals','PRAMOXINE HYDROCHLORIDE','150','mg/15g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-6824_74d3a7b5-1602-4861-a662-50fe63a9cdfe','0037-6824','HUMAN PRESCRIPTION DRUG','EPIFOAM','','pramoxine hydrochloride and hydrocortisone acetate','AEROSOL, FOAM','TOPICAL','20140825','','ANDA','ANDA086457','Meda Pharmaceuticals','HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE','100; 100','mg/10g; mg/10g','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-6830_96e601d3-53ec-46d6-9f54-822ef75f5071','0037-6830','HUMAN PRESCRIPTION DRUG','Cortifoam','','hydrocortisone acetate','AEROSOL, FOAM','TOPICAL','20150615','','NDA','NDA017351','Meda Pharmaceuticals Inc.','HYDROCORTISONE ACETATE','1500','mg/15g','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-6860_ee7ce9b7-3e92-47b6-a662-c335bf7e3f44','0037-6860','HUMAN PRESCRIPTION DRUG','Dipentum','','olsalazine sodium','CAPSULE, GELATIN COATED','ORAL','20150515','','NDA','NDA019715','Meda Pharmaceuticals Inc.','OLSALAZINE SODIUM','250','mg/1','Aminosalicylate [EPC], Aminosalicylic Acids [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-8120_0209b68d-e74a-43a9-ad21-c9bca0293f0f','0037-8120','HUMAN PRESCRIPTION DRUG','MUSE','','Alprostadil','SUPPOSITORY','URETHRAL','20110722','','NDA','NDA020700','Meda Pharmaceuticals Inc.','ALPROSTADIL','250','ug/1','Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-8130_0209b68d-e74a-43a9-ad21-c9bca0293f0f','0037-8130','HUMAN PRESCRIPTION DRUG','MUSE','','Alprostadil','SUPPOSITORY','URETHRAL','20110722','','NDA','NDA020700','Meda Pharmaceuticals Inc.','ALPROSTADIL','500','ug/1','Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0037-8140_0209b68d-e74a-43a9-ad21-c9bca0293f0f','0037-8140','HUMAN PRESCRIPTION DRUG','MUSE','','Alprostadil','SUPPOSITORY','URETHRAL','20110722','','NDA','NDA020700','Meda Pharmaceuticals Inc.','ALPROSTADIL','1000','ug/1','Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0039-0221_f54571bb-4a69-4326-aad3-96b1b7198b6d','0039-0221','HUMAN PRESCRIPTION DRUG','AMARYL','','glimepiride','TABLET','ORAL','20090618','','NDA','NDA020496','Sanofi-Aventis U.S. LLC','GLIMEPIRIDE','1','mg/1','Sulfonylurea Compounds [CS], Sulfonylurea [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0039-0222_f54571bb-4a69-4326-aad3-96b1b7198b6d','0039-0222','HUMAN PRESCRIPTION DRUG','AMARYL','','glimepiride','TABLET','ORAL','20090618','','NDA','NDA020496','Sanofi-Aventis U.S. LLC','GLIMEPIRIDE','2','mg/1','Sulfonylurea Compounds [CS], Sulfonylurea [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0039-0223_f54571bb-4a69-4326-aad3-96b1b7198b6d','0039-0223','HUMAN PRESCRIPTION DRUG','AMARYL','','glimepiride','TABLET','ORAL','20090618','','NDA','NDA020496','Sanofi-Aventis U.S. LLC','GLIMEPIRIDE','4','mg/1','Sulfonylurea Compounds [CS], Sulfonylurea [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0046-0749_f2e60564-2b7d-4a5f-bc81-226c2c8c43a9','0046-0749','HUMAN PRESCRIPTION DRUG','Premarin','','CONJUGATED ESTROGENS','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19561201','','NDA','NDA010402','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','ESTROGENS, CONJUGATED','25','mg/5mL','Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0046-0872_04173235-a8c8-4c09-a5f9-875fe81e3cc2','0046-0872','HUMAN PRESCRIPTION DRUG','Premarin','Vaginal','conjugated estrogens','CREAM','VAGINAL','19781101','','NDA','NDA020216','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','ESTROGENS, CONJUGATED','0.625','mg/g','Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0046-1100_9cd6d169-2f92-4251-bca1-b02e499545c0','0046-1100','HUMAN PRESCRIPTION DRUG','Premarin','','estrogens, conjugated','TABLET, FILM COATED','ORAL','20060101','','NDA','NDA004782','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','ESTROGENS, CONJUGATED','0.3','mg/1','Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0046-1101_9cd6d169-2f92-4251-bca1-b02e499545c0','0046-1101','HUMAN PRESCRIPTION DRUG','Premarin','','estrogens, conjugated','TABLET, FILM COATED','ORAL','20060101','','NDA','NDA004782','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','ESTROGENS, CONJUGATED','0.45','mg/1','Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0046-1102_9cd6d169-2f92-4251-bca1-b02e499545c0','0046-1102','HUMAN PRESCRIPTION DRUG','Premarin','','estrogens, conjugated','TABLET, FILM COATED','ORAL','20060101','','NDA','NDA004782','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','ESTROGENS, CONJUGATED','0.625','mg/1','Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0046-1103_9cd6d169-2f92-4251-bca1-b02e499545c0','0046-1103','HUMAN PRESCRIPTION DRUG','Premarin','','estrogens, conjugated','TABLET, FILM COATED','ORAL','20060101','','NDA','NDA004782','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','ESTROGENS, CONJUGATED','0.9','mg/1','Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0046-1104_9cd6d169-2f92-4251-bca1-b02e499545c0','0046-1104','HUMAN PRESCRIPTION DRUG','Premarin','','estrogens, conjugated','TABLET, FILM COATED','ORAL','20040901','','NDA','NDA004782','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','ESTROGENS, CONJUGATED','1.25','mg/1','Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0046-1105_8e3308f2-3aa5-46f1-bd14-ab4ef89db72c','0046-1105','HUMAN PRESCRIPTION DRUG','Prempro','','conjugated estrogens and medroxyprogesterone acetate','TABLET, SUGAR COATED','ORAL','20090921','','NDA','NDA020527','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE','.3; 1.5','mg/1; mg/1','Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS], Progesterone Congeners [CS], Progestin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0046-1106_8e3308f2-3aa5-46f1-bd14-ab4ef89db72c','0046-1106','HUMAN PRESCRIPTION DRUG','Prempro','','conjugated estrogens and medroxyprogesterone acetate','TABLET, SUGAR COATED','ORAL','20090921','','NDA','NDA020527','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE','.45; 1.5','mg/1; mg/1','Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS], Progesterone Congeners [CS], Progestin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0046-1107_8e3308f2-3aa5-46f1-bd14-ab4ef89db72c','0046-1107','HUMAN PRESCRIPTION DRUG','Prempro','','conjugated estrogens and medroxyprogesterone acetate','TABLET, SUGAR COATED','ORAL','20090921','','NDA','NDA020527','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE','.625; 2.5','mg/1; mg/1','Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS], Progesterone Congeners [CS], Progestin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0046-1108_8e3308f2-3aa5-46f1-bd14-ab4ef89db72c','0046-1108','HUMAN PRESCRIPTION DRUG','Prempro','','conjugated estrogens and medroxyprogesterone acetate','TABLET, SUGAR COATED','ORAL','20121203','','NDA','NDA020527','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE','.625; 5','mg/1; mg/1','Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS], Progesterone Congeners [CS], Progestin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0046-2575_8e3308f2-3aa5-46f1-bd14-ab4ef89db72c','0046-2575','HUMAN PRESCRIPTION DRUG','Premphase','','conjugated estrogens and medroxyprogesterone acetate','KIT','','20120301','','NDA','NDA020527','Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0013_1d9ff1e7-9cb0-45d9-92af-ad3c6b94da1c','0049-0013','HUMAN PRESCRIPTION DRUG','UNASYN','','ampicillin sodium and sulbactam sodium','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19911122','','NDA','NDA050608','Roerig','AMPICILLIN SODIUM; SULBACTAM SODIUM','1; .5','g/1; g/1','Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0014_1d9ff1e7-9cb0-45d9-92af-ad3c6b94da1c','0049-0014','HUMAN PRESCRIPTION DRUG','UNASYN','','ampicillin sodium and sulbactam sodium','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19911122','','NDA','NDA050608','Roerig','AMPICILLIN SODIUM; SULBACTAM SODIUM','2; 1','g/1; g/1','Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0024_7f7f02c4-0f71-45a1-a890-22a9582a2292','0049-0024','HUMAN PRESCRIPTION DRUG','UNASYN','','ampicillin sodium and sulbactam sodium','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19911122','','NDA','NDA050608','Roerig','AMPICILLIN SODIUM; SULBACTAM SODIUM','100; 50','mg/mL; mg/mL','Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0050_8783c1aa-e993-47d3-86cf-0bc1c01d69d0','0049-0050','HUMAN PRESCRIPTION DRUG','Zoloft','','sertraline hydrochloride','SOLUTION, CONCENTRATE','ORAL','20170106','','NDA','NDA020990','ROERIG','SERTRALINE HYDROCHLORIDE','20','mg/mL','Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0052_234488e0-550f-4c40-bd70-d98d051371b9','0049-0052','HUMAN PRESCRIPTION DRUG','Geodon','','ziprasidone hydrochloride','CAPSULE','ORAL','20190801','','NDA','NDA020825','Roerig','ZIPRASIDONE HYDROCHLORIDE','20','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0054_234488e0-550f-4c40-bd70-d98d051371b9','0049-0054','HUMAN PRESCRIPTION DRUG','Geodon','','ziprasidone hydrochloride','CAPSULE','ORAL','20190319','','NDA','NDA020825','Roerig','ZIPRASIDONE HYDROCHLORIDE','40','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0056_234488e0-550f-4c40-bd70-d98d051371b9','0049-0056','HUMAN PRESCRIPTION DRUG','Geodon','','ziprasidone hydrochloride','CAPSULE','ORAL','20190801','','NDA','NDA020825','Roerig','ZIPRASIDONE HYDROCHLORIDE','60','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0058_234488e0-550f-4c40-bd70-d98d051371b9','0049-0058','HUMAN PRESCRIPTION DRUG','Geodon','','ziprasidone hydrochloride','CAPSULE','ORAL','20190801','','NDA','NDA020825','Roerig','ZIPRASIDONE HYDROCHLORIDE','80','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0114_3ac66b17-3e99-4e85-bdf3-ee219c10c18d','0049-0114','HUMAN PRESCRIPTION DRUG','ERAXIS','','anidulafungin','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20060217','','NDA','NDA021632','Roerig','ANIDULAFUNGIN','50','mg/15mL','Echinocandin Antifungal [EPC], Lipopeptides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0116_3ac66b17-3e99-4e85-bdf3-ee219c10c18d','0049-0116','HUMAN PRESCRIPTION DRUG','ERAXIS','','anidulafungin','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20060217','','NDA','NDA021632','Roerig','ANIDULAFUNGIN','100','mg/30mL','Echinocandin Antifungal [EPC], Lipopeptides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0170_65586351-ffe1-429c-956f-6d45c635a422','0049-0170','HUMAN PRESCRIPTION DRUG','Glucotrol','XL','glipizide','TABLET, EXTENDED RELEASE','ORAL','20130715','','NDA','NDA020329','Roerig','GLIPIZIDE','2.5','mg/1','Sulfonylurea Compounds [CS], Sulfonylurea [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0174_65586351-ffe1-429c-956f-6d45c635a422','0049-0174','HUMAN PRESCRIPTION DRUG','Glucotrol','XL','glipizide','TABLET, EXTENDED RELEASE','ORAL','20130509','','NDA','NDA020329','Roerig','GLIPIZIDE','5','mg/1','Sulfonylurea Compounds [CS], Sulfonylurea [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0178_65586351-ffe1-429c-956f-6d45c635a422','0049-0178','HUMAN PRESCRIPTION DRUG','Glucotrol','XL','glipizide','TABLET, EXTENDED RELEASE','ORAL','20130509','','NDA','NDA020329','Roerig','GLIPIZIDE','10','mg/1','Sulfonylurea Compounds [CS], Sulfonylurea [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0352_234488e0-550f-4c40-bd70-d98d051371b9','0049-0352','HUMAN PRESCRIPTION DRUG','Geodon','','ziprasidone','CAPSULE','ORAL','20211108','','NDA','NDA020825','Roerig','ZIPRASIDONE','20','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0356_234488e0-550f-4c40-bd70-d98d051371b9','0049-0356','HUMAN PRESCRIPTION DRUG','Geodon','','ziprasidone','CAPSULE','ORAL','20211108','','NDA','NDA020825','Roerig','ZIPRASIDONE','60','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0358_234488e0-550f-4c40-bd70-d98d051371b9','0049-0358','HUMAN PRESCRIPTION DRUG','Geodon','','ziprasidone','CAPSULE','ORAL','20211108','','NDA','NDA020825','Roerig','ZIPRASIDONE','80','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0420_97f36a31-5188-431e-91f0-558c90a65154','0049-0420','HUMAN PRESCRIPTION DRUG','Pfizerpen','','penicillin G potassium','POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAPLEURAL; INTRATHECAL; INTRAVENOUS','20100601','','ANDA','ANDA060657','Roerig','PENICILLIN G POTASSIUM','5000000','[iU]/1','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0430_97f36a31-5188-431e-91f0-558c90a65154','0049-0430','HUMAN PRESCRIPTION DRUG','Pfizerpen','','penicillin G potassium','POWDER, FOR SOLUTION','INTRAVENOUS','20100601','','ANDA','ANDA060657','Roerig','PENICILLIN G POTASSIUM','20000000','[iU]/1','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0520_a8c2b40f-2586-434e-837e-df07882fa110','0049-0520','HUMAN PRESCRIPTION DRUG','Pfizerpen','','penicillin G potassium','POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAPLEURAL; INTRATHECAL; INTRAVENOUS','20100601','','ANDA','ANDA060657','Roerig','PENICILLIN G POTASSIUM','5000000','[iU]/1','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0520_e1397703-b0c7-4ff2-865d-fa2d6bfa7693','0049-0520','HUMAN PRESCRIPTION DRUG','Pfizerpen','','penicillin G potassium','POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAPLEURAL; INTRATHECAL; INTRAVENOUS','20100601','','ANDA','ANDA060657','Roerig','PENICILLIN G POTASSIUM','5000000','[iU]/1','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0530_a8c2b40f-2586-434e-837e-df07882fa110','0049-0530','HUMAN PRESCRIPTION DRUG','Pfizerpen','','penicillin G potassium','POWDER, FOR SOLUTION','INTRAVENOUS','20100601','','ANDA','ANDA060657','Roerig','PENICILLIN G POTASSIUM','20000000','[iU]/1','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-0530_e1397703-b0c7-4ff2-865d-fa2d6bfa7693','0049-0530','HUMAN PRESCRIPTION DRUG','Pfizerpen','','penicillin G potassium','POWDER, FOR SOLUTION','INTRAVENOUS','20100601','','ANDA','ANDA060657','Roerig','PENICILLIN G POTASSIUM','20000000','[iU]/1','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-1203_6f13378f-ffe4-440e-aca4-73b0ffa9e552','0049-1203','HUMAN PRESCRIPTION DRUG','Geodon','','ziprasidone mesylate','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAMUSCULAR','20170724','','NDA','NDA020919','Roerig','ZIPRASIDONE MESYLATE','20','mg/mL','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-2040_ce91fee4-e6c0-4192-bc1e-6510c5a02430','0049-2040','HUMAN PRESCRIPTION DRUG','Cardura','XL','doxazosin','TABLET, MULTILAYER, EXTENDED RELEASE','ORAL','20210121','','NDA','NDA021269','Roerig','DOXAZOSIN MESYLATE','4','mg/1','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-2080_ce91fee4-e6c0-4192-bc1e-6510c5a02430','0049-2080','HUMAN PRESCRIPTION DRUG','Cardura','XL','doxazosin','TABLET, MULTILAYER, EXTENDED RELEASE','ORAL','20220426','','NDA','NDA021269','Roerig','DOXAZOSIN MESYLATE','8','mg/1','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-2330_60fa2e8b-4d0d-4546-a087-3f0efb3e7560','0049-2330','HUMAN PRESCRIPTION DRUG','Relpax','','eletriptan hydrobromide','TABLET, FILM COATED','ORAL','20021226','','NDA','NDA021016','Roerig','ELETRIPTAN HYDROBROMIDE','20','mg/1','Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-2340_60fa2e8b-4d0d-4546-a087-3f0efb3e7560','0049-2340','HUMAN PRESCRIPTION DRUG','Relpax','','eletriptan hydrobromide','TABLET, FILM COATED','ORAL','20021226','','NDA','NDA021016','Roerig','ELETRIPTAN HYDROBROMIDE','40','mg/1','Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-2410_6b4a9119-c0d5-4ed6-b7cc-4e2d9b8a40b3','0049-2410','HUMAN PRESCRIPTION DRUG','Cardura','','doxazosin','TABLET','ORAL','20211019','','NDA','NDA019668','ROERIG','DOXAZOSIN MESYLATE','1','mg/1','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-2512_6b4a9119-c0d5-4ed6-b7cc-4e2d9b8a40b3','0049-2512','HUMAN PRESCRIPTION DRUG','Cardura','','doxazosin','TABLET','ORAL','20211019','','NDA','NDA019668','ROERIG','DOXAZOSIN MESYLATE','2','mg/1','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-2614_6b4a9119-c0d5-4ed6-b7cc-4e2d9b8a40b3','0049-2614','HUMAN PRESCRIPTION DRUG','Cardura','','doxazosin','TABLET','ORAL','20211019','','NDA','NDA019668','ROERIG','DOXAZOSIN MESYLATE','4','mg/1','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-2716_6b4a9119-c0d5-4ed6-b7cc-4e2d9b8a40b3','0049-2716','HUMAN PRESCRIPTION DRUG','Cardura','','doxazosin','TABLET','ORAL','20230215','','NDA','NDA019668','ROERIG','DOXAZOSIN MESYLATE','8','mg/1','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-2780_6b4a9119-c0d5-4ed6-b7cc-4e2d9b8a40b3','0049-2780','HUMAN PRESCRIPTION DRUG','Cardura','','doxazosin mesylate','TABLET','ORAL','19910101','20230930','NDA','NDA019668','ROERIG','DOXAZOSIN MESYLATE','8','mg/1','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-3160_d2d9cc9b-9859-4f59-8d06-05d2de5eb192','0049-3160','HUMAN PRESCRIPTION DRUG','VFEND','','voriconazole','POWDER, FOR SUSPENSION','ORAL','20030328','','NDA','NDA021630','Roerig','VORICONAZOLE','40','mg/mL','Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-3170_d2d9cc9b-9859-4f59-8d06-05d2de5eb192','0049-3170','HUMAN PRESCRIPTION DRUG','VFEND','','voriconazole','TABLET, FILM COATED','ORAL','20030328','','NDA','NDA021266','Roerig','VORICONAZOLE','50','mg/1','Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-3180_d2d9cc9b-9859-4f59-8d06-05d2de5eb192','0049-3180','HUMAN PRESCRIPTION DRUG','VFEND','','voriconazole','TABLET, FILM COATED','ORAL','20030328','','NDA','NDA021266','Roerig','VORICONAZOLE','200','mg/1','Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-3190_91925285-3037-4bf6-8f10-654c72bb0a57','0049-3190','HUMAN PRESCRIPTION DRUG','VFEND','','voriconazole','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20121024','','NDA','NDA021267','Roerig','VORICONAZOLE','10','mg/mL','Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-3190_d2d9cc9b-9859-4f59-8d06-05d2de5eb192','0049-3190','HUMAN PRESCRIPTION DRUG','VFEND','','voriconazole','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20030328','','NDA','NDA021267','Roerig','VORICONAZOLE','10','mg/mL','Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-3190_f098cc33-f6ee-4a49-9329-cbc1d1c31bd2','0049-3190','HUMAN PRESCRIPTION DRUG','VFEND','','Voriconazole','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20020524','','NDA','NDA021267','Roerig','VORICONAZOLE','10','mg/mL','Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-3410_47c97c06-7171-48b1-b7a6-0000cec3f397','0049-3410','HUMAN PRESCRIPTION DRUG','Diflucan','','fluconazole','TABLET','ORAL','19900129','','NDA','NDA019949','Roerig','FLUCONAZOLE','50','mg/1','Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-3420_47c97c06-7171-48b1-b7a6-0000cec3f397','0049-3420','HUMAN PRESCRIPTION DRUG','Diflucan','','fluconazole','TABLET','ORAL','19900129','','NDA','NDA019949','Roerig','FLUCONAZOLE','100','mg/1','Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-3430_47c97c06-7171-48b1-b7a6-0000cec3f397','0049-3430','HUMAN PRESCRIPTION DRUG','Diflucan','','fluconazole','TABLET','ORAL','19900129','','NDA','NDA019949','Roerig','FLUCONAZOLE','200','mg/1','Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-3440_47c97c06-7171-48b1-b7a6-0000cec3f397','0049-3440','HUMAN PRESCRIPTION DRUG','Diflucan','','fluconazole','POWDER, FOR SUSPENSION','ORAL','19931223','','NDA','NDA020090','Roerig','FLUCONAZOLE','350','mg/35mL','Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-3450_47c97c06-7171-48b1-b7a6-0000cec3f397','0049-3450','HUMAN PRESCRIPTION DRUG','Diflucan','','fluconazole','POWDER, FOR SUSPENSION','ORAL','19931223','','NDA','NDA020090','Roerig','FLUCONAZOLE','1400','mg/35mL','Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-3500_47c97c06-7171-48b1-b7a6-0000cec3f397','0049-3500','HUMAN PRESCRIPTION DRUG','Diflucan','','fluconazole','TABLET','ORAL','19940630','','NDA','NDA019949','Roerig','FLUCONAZOLE','150','mg/1','Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-3920_234488e0-550f-4c40-bd70-d98d051371b9','0049-3920','HUMAN PRESCRIPTION DRUG','Geodon','','ziprasidone mesylate','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAMUSCULAR','20031223','','NDA','NDA020919','Roerig','ZIPRASIDONE MESYLATE','20','mg/mL','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-4190_d827ff6f-9a87-4641-b400-497661924dde','0049-4190','HUMAN PRESCRIPTION DRUG','VFEND','','VORICONAZOLE','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20121024','','NDA','NDA021267','Roerig','VORICONAZOLE','10','mg/mL','Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-4900_8783c1aa-e993-47d3-86cf-0bc1c01d69d0','0049-4900','HUMAN PRESCRIPTION DRUG','Zoloft','','sertraline hydrochloride','TABLET, FILM COATED','ORAL','19920211','','NDA','NDA019839','ROERIG','SERTRALINE HYDROCHLORIDE','50','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-4910_8783c1aa-e993-47d3-86cf-0bc1c01d69d0','0049-4910','HUMAN PRESCRIPTION DRUG','Zoloft','','sertraline hydrochloride','TABLET, FILM COATED','ORAL','19920211','','NDA','NDA019839','ROERIG','SERTRALINE HYDROCHLORIDE','100','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0049-4960_8783c1aa-e993-47d3-86cf-0bc1c01d69d0','0049-4960','HUMAN PRESCRIPTION DRUG','Zoloft','','sertraline hydrochloride','TABLET, FILM COATED','ORAL','19920211','','NDA','NDA019839','ROERIG','SERTRALINE HYDROCHLORIDE','25','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0051-8450_256a0dc6-682d-4f6a-ad85-8ce48271b4dd','0051-8450','HUMAN PRESCRIPTION DRUG','Androgel','','Testosterone','GEL','TRANSDERMAL','20110314','20230331','NDA','NDA021015','AbbVie Inc.','TESTOSTERONE','10','mg/g','Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]','CIII','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0051-8462_20e9e091-ab9f-4e48-a13d-fcbc93d94637','0051-8462','HUMAN PRESCRIPTION DRUG','Androgel','','Testosterone','GEL','TRANSDERMAL','20110429','20250501','NDA','NDA022309','AbbVie Inc.','TESTOSTERONE','16.2','mg/g','Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]','CIII','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0052-0313_19e6b8fb-87e6-4dca-96c4-3cf8385533c1','0052-0313','HUMAN PRESCRIPTION DRUG','Follistim AQ','','follitropin','INJECTION, SOLUTION','SUBCUTANEOUS','20040324','','BLA','BLA021211','Merck Sharp & Dohme LLC','FOLLITROPIN','350','[iU]/.42mL','Gonadotropin [EPC], Gonadotropins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0052-0315_169aacc4-4598-4680-8bc4-37c09935677e','0052-0315','HUMAN PRESCRIPTION DRUG','Pregnyl','','CHORIOGONADOTROPIN ALFA','KIT','','19761020','','BLA','BLA017692','Merck Sharp & Dohme LLC','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0052-0316_19e6b8fb-87e6-4dca-96c4-3cf8385533c1','0052-0316','HUMAN PRESCRIPTION DRUG','Follistim AQ','','follitropin','INJECTION, SOLUTION','SUBCUTANEOUS','20040324','','BLA','BLA021211','Merck Sharp & Dohme LLC','FOLLITROPIN','650','[iU]/.78mL','Gonadotropin [EPC], Gonadotropins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0052-0326_19e6b8fb-87e6-4dca-96c4-3cf8385533c1','0052-0326','HUMAN PRESCRIPTION DRUG','Follistim AQ','','follitropin','INJECTION, SOLUTION','SUBCUTANEOUS','20040324','','BLA','BLA021211','Merck Sharp & Dohme LLC','FOLLITROPIN','975','[iU]/1.17mL','Gonadotropin [EPC], Gonadotropins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0052-0602_1864239e-c460-4379-bbc2-f0d7486a8647','0052-0602','HUMAN PRESCRIPTION DRUG','TICE BCG','','BACILLUS CALMETTE-GUERIN','POWDER, FOR SUSPENSION','INTRAVESICAL','19900824','','BLA','BLA102821','Merck Sharp & Dohme LLC','BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN','50','mg/50mL','Actively Acquired Immunity [PE], BCG Vaccine [CS], Increased Immunologically Active Molecule Activity [PE], Increased Macrophage Proliferation [PE], Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC], Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC], Vaccines, Attenuated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0052-0603_17c0b3eb-3c34-435b-a7b4-6ac0ebd1f8eb','0052-0603','VACCINE','BCG VACCINE','','BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','PERCUTANEOUS','19890621','','BLA','BLA103050','Merck Sharp & Dohme LLC','BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN','50','mg/1','Actively Acquired Immunity [PE], BCG Vaccine [CS], Increased Immunologically Active Molecule Activity [PE], Increased Macrophage Proliferation [PE], Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC], Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC], Vaccines, Attenuated [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0100_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0100','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0110_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0110','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0120_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0120','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0130_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0130','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0140_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0140','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0150_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0150','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0160_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0160','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0170_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0170','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0180_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0180','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0190_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0190','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0200_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0200','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0210_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0210','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0220_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0220','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0230_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0230','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0240_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0240','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0250_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0250','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0260_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0260','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0270_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0270','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0280_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0280','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0290_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0290','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0300_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0300','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0310_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0310','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0320_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0320','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0330_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0330','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0340_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0340','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0350_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0350','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0360_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0360','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0370_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0370','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0380_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0380','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0390_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0390','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0400_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0400','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0410_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0410','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0420_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0420','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0430_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0430','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0440_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0440','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0450_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0450','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0460_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0460','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0470_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0470','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-0480_a63335a6-f333-4105-a03d-1478f94fc7e3','0053-0480','HUMAN PRESCRIPTION DRUG','HEMGENIX','','etranacogene dezaparvovec','KIT','','20221122','','BLA','BLA125772','CSL Behring','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-7201_c2b6f34e-ac6e-42e8-86f2-63b8bf151b48','0053-7201','PLASMA DERIVATIVE','Zemaira','','alpha-1-proteinase inhibitor human','KIT','','20030708','','BLA','BLA125078','CSL Behring LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-7202_c2b6f34e-ac6e-42e8-86f2-63b8bf151b48','0053-7202','PLASMA DERIVATIVE','ZEMAIRA','','.ALPHA.1-PROTEINASE INHIBITOR HUMAN','KIT','','20190424','','BLA','BLA125078','CSL Behring LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0053-7203_c2b6f34e-ac6e-42e8-86f2-63b8bf151b48','0053-7203','PLASMA DERIVATIVE','ZEMAIRA','','.ALPHA.1-PROTEINASE INHIBITOR HUMAN','KIT','','20190424','','BLA','BLA125078','CSL Behring LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0007_f53104e2-9ac9-4e26-bd97-bee39d3397ff','0054-0007','HUMAN PRESCRIPTION DRUG','Calcitriol','','Calcitriol','CAPSULE','ORAL','20060327','','ANDA','ANDA076917','Hikma Pharmaceuticals USA Inc.','CALCITRIOL','0.25','ug/1','Cholecalciferol [CS], Vitamin D3 Analog [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0010_fb4e03f5-aaef-472e-8109-7726f6362c22','0054-0010','HUMAN PRESCRIPTION DRUG','Flecainide Acetate','','flecainide acetate','TABLET','ORAL','20030114','','ANDA','ANDA076278','West-Ward Pharmaceuticals Corp.','FLECAINIDE ACETATE','50','mg/1','Antiarrhythmic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0011_fb4e03f5-aaef-472e-8109-7726f6362c22','0054-0011','HUMAN PRESCRIPTION DRUG','Flecainide Acetate','','flecainide acetate','TABLET','ORAL','20030114','','ANDA','ANDA076278','West-Ward Pharmaceuticals Corp.','FLECAINIDE ACETATE','100','mg/1','Antiarrhythmic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0012_fb4e03f5-aaef-472e-8109-7726f6362c22','0054-0012','HUMAN PRESCRIPTION DRUG','Flecainide Acetate','','flecainide acetate','TABLET','ORAL','20030114','','ANDA','ANDA076278','West-Ward Pharmaceuticals Corp.','FLECAINIDE ACETATE','150','mg/1','Antiarrhythmic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0017_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae','0054-0017','HUMAN PRESCRIPTION DRUG','PredniSONE','','PredniSONE','TABLET','ORAL','20030213','','ANDA','ANDA084122','Hikma Pharmaceuticals USA Inc.','PREDNISONE','10','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0018_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae','0054-0018','HUMAN PRESCRIPTION DRUG','PredniSONE','','PredniSONE','TABLET','ORAL','20030213','','ANDA','ANDA087342','Hikma Pharmaceuticals USA Inc.','PREDNISONE','20','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0019_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae','0054-0019','HUMAN PRESCRIPTION DRUG','PredniSONE','','PredniSONE','TABLET','ORAL','20030314','','ANDA','ANDA084283','Hikma Pharmaceuticals USA Inc.','PREDNISONE','50','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0020_593206b4-429f-475f-9494-02b43ff2dd03','0054-0020','HUMAN PRESCRIPTION DRUG','Lithium Carbonate','','Lithium Carbonate','TABLET, EXTENDED RELEASE','ORAL','20040113','','ANDA','ANDA076691','Hikma Pharmaceuticals USA Inc.','LITHIUM CARBONATE','450','mg/1','Mood Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0021_08a343a4-7d8d-4de9-9bdb-df27ed006392','0054-0021','HUMAN PRESCRIPTION DRUG','Lithium Carbonate','','Lithium Carbonate','TABLET, EXTENDED RELEASE','ORAL','20041028','','ANDA','ANDA076832','Hikma Pharmaceuticals USA Inc.','LITHIUM CARBONATE','300','mg/1','Mood Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0025_e6ca0066-8671-4719-8707-90b4121cba11','0054-0025','HUMAN PRESCRIPTION DRUG','Mefloquine Hydrochloride','','mefloquine hydrochloride','TABLET','ORAL','20041001','','ANDA','ANDA076523','Hikma Pharmaceuticals USA Inc.','MEFLOQUINE HYDROCHLORIDE','250','mg/1','Antimalarial [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0028_d872300b-ff60-4709-a667-aab53462bfac','0054-0028','HUMAN PRESCRIPTION DRUG','Cilostazol','','Cilostazol','TABLET','ORAL','20050517','','ANDA','ANDA077024','West-Ward Pharmaceuticals Corp.','CILOSTAZOL','50','mg/1','Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0044_d872300b-ff60-4709-a667-aab53462bfac','0054-0044','HUMAN PRESCRIPTION DRUG','Cilostazol','','Cilostazol','TABLET','ORAL','20050517','','ANDA','ANDA077024','West-Ward Pharmaceuticals Corp.','CILOSTAZOL','100','mg/1','Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0045_b5392074-d029-4f71-adff-f2484b47671f','0054-0045','HUMAN PRESCRIPTION DRUG','Ipratropium Bromide','','Ipratropium Bromide','SPRAY','NASAL','20031105','','ANDA','ANDA076664','West-Ward Pharmaceuticals Corp.','IPRATROPIUM BROMIDE','21','ug/1','Anticholinergic [EPC], Cholinergic Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0046_5523ec2e-969f-431d-8eb2-258fe8fe4160','0054-0046','HUMAN PRESCRIPTION DRUG','Ipratropium Bromide','','Ipratropium Bromide','SPRAY','NASAL','20031105','','ANDA','ANDA076598','West-Ward Pharmaceuticals Corp.','IPRATROPIUM BROMIDE','42','ug/1','Anticholinergic [EPC], Cholinergic Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0057_7a1520a8-09f2-424a-a825-01156b57db5f','0054-0057','HUMAN PRESCRIPTION DRUG','Digoxin','','Digoxin','SOLUTION','ORAL','20040826','','NDA','NDA021648','West-Ward Pharmaceuticals Corp.','DIGOXIN','0.05','mg/mL','Cardiac Glycoside [EPC], Cardiac Glycosides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0062_f9dc1d03-96f8-4ddf-85d2-3f1c66256b89','0054-0062','HUMAN PRESCRIPTION DRUG','Citalopram','','Citalopram','SOLUTION','ORAL','20040525','','ANDA','ANDA077043','Hikma Pharmaceuticals USA Inc.','CITALOPRAM HYDROBROMIDE','10','mg/5mL','Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0063_151ddfd0-d116-4f92-80d4-567624ccb0da','0054-0063','HUMAN PRESCRIPTION DRUG','Risperidone','','Risperidone','SOLUTION','ORAL','20090729','','ANDA','ANDA076904','Hikma Pharmaceuticals USA Inc.','RISPERIDONE','1','mg/mL','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0064_5888823c-c0e3-4b3b-ba2d-2054951af97a','0054-0064','HUMAN PRESCRIPTION DRUG','Ondansetron Hydrochloride','','Ondansetron Hydrochloride','SOLUTION','ORAL','20061226','','ANDA','ANDA076960','Hikma Pharmaceuticals USA Inc.','ONDANSETRON HYDROCHLORIDE','4','mg/5mL','Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0077_9952a81e-773e-4186-a6df-c53952693dbc','0054-0077','HUMAN PRESCRIPTION DRUG','Torsemide','','Torsemide','TABLET','ORAL','20050303','','ANDA','ANDA076943','West-Ward Pharmaceuticals Corp.','TORSEMIDE','20','mg/1','Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0079_56901335-7272-4aed-9d7f-3d5894b2c8f3','0054-0079','HUMAN PRESCRIPTION DRUG','Balsalazide Disodium','','Balsalazide Disodium','CAPSULE','ORAL','20071228','','ANDA','ANDA077806','Hikma Pharmaceuticals USA Inc.','BALSALAZIDE DISODIUM','750','mg/1','Aminosalicylate [EPC], Aminosalicylic Acids [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0080_76ca55bd-c459-4de7-8f26-33349ceb2462','0054-0080','HUMAN PRESCRIPTION DRUG','Exemestane','','Exemestane','TABLET, FILM COATED','ORAL','20110401','','ANDA','ANDA077431','Hikma Pharmaceuticals USA Inc','EXEMESTANE','25','mg/1','Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0084_9c96d731-3818-475f-9181-d5fd621ce68d','0054-0084','HUMAN PRESCRIPTION DRUG','Zaleplon','','Zaleplon','CAPSULE','ORAL','20080606','','ANDA','ANDA077237','West-Ward Pharmaceuticals Corp.','ZALEPLON','5','mg/1','Central Nervous System Depression [PE], GABA A Agonists [MoA], gamma-Aminobutyric Acid A Receptor Agonist [EPC]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0085_9c96d731-3818-475f-9181-d5fd621ce68d','0054-0085','HUMAN PRESCRIPTION DRUG','Zaleplon','','Zaleplon','CAPSULE','ORAL','20080606','','ANDA','ANDA077237','West-Ward Pharmaceuticals Corp.','ZALEPLON','10','mg/1','Central Nervous System Depression [PE], GABA A Agonists [MoA], gamma-Aminobutyric Acid A Receptor Agonist [EPC]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0088_454bd52f-2207-47c9-95c0-d59fd38b87c7','0054-0088','HUMAN PRESCRIPTION DRUG','Calcium Acetate','','Calcium Acetate','CAPSULE','ORAL','20080226','','ANDA','ANDA077728','Hikma Pharmaceuticals USA Inc.','CALCIUM ACETATE','667','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0106_4019e596-dfb9-43a4-b027-a2bdf6d0f5b4','0054-0106','HUMAN PRESCRIPTION DRUG','Ramipril','','Ramipril','CAPSULE','ORAL','20080618','','ANDA','ANDA077900','Hikma Pharmaceuticals USA Inc.','RAMIPRIL','1.25','mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0107_4019e596-dfb9-43a4-b027-a2bdf6d0f5b4','0054-0107','HUMAN PRESCRIPTION DRUG','Ramipril','','Ramipril','CAPSULE','ORAL','20080618','','ANDA','ANDA077900','Hikma Pharmaceuticals USA Inc.','RAMIPRIL','2.5','mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0108_4019e596-dfb9-43a4-b027-a2bdf6d0f5b4','0054-0108','HUMAN PRESCRIPTION DRUG','Ramipril','','Ramipril','CAPSULE','ORAL','20080618','','ANDA','ANDA077900','Hikma Pharmaceuticals USA Inc.','RAMIPRIL','5','mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0109_4019e596-dfb9-43a4-b027-a2bdf6d0f5b4','0054-0109','HUMAN PRESCRIPTION DRUG','Ramipril','','Ramipril','CAPSULE','ORAL','20080618','','ANDA','ANDA077900','Hikma Pharmaceuticals USA Inc.','RAMIPRIL','10','mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0110_69e52900-b152-447e-8b5a-6964a0b6f03e','0054-0110','HUMAN PRESCRIPTION DRUG','Perindopril Erbumine','','Perindopril Erbumine','TABLET','ORAL','20091110','','ANDA','ANDA090072','West-Ward Pharmaceuticals Corp.','PERINDOPRIL ERBUMINE','2','mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0111_69e52900-b152-447e-8b5a-6964a0b6f03e','0054-0111','HUMAN PRESCRIPTION DRUG','Perindopril Erbumine','','Perindopril Erbumine','TABLET','ORAL','20091110','','ANDA','ANDA090072','West-Ward Pharmaceuticals Corp.','PERINDOPRIL ERBUMINE','4','mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0112_69e52900-b152-447e-8b5a-6964a0b6f03e','0054-0112','HUMAN PRESCRIPTION DRUG','Perindopril Erbumine','','Perindopril Erbumine','TABLET','ORAL','20091110','','ANDA','ANDA090072','West-Ward Pharmaceuticals Corp.','PERINDOPRIL ERBUMINE','8','mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0123_856bc6e8-6f23-48cd-a2b7-d222c3f99913','0054-0123','HUMAN PRESCRIPTION DRUG','Losartan Potassium','','Losartan Potassium','TABLET','ORAL','20200713','','ANDA','ANDA077459','Hikma Pharmaceuticals USA Inc.','LOSARTAN POTASSIUM','25','mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0124_856bc6e8-6f23-48cd-a2b7-d222c3f99913','0054-0124','HUMAN PRESCRIPTION DRUG','Losartan Potassium','','Losartan Potassium','TABLET','ORAL','20200713','','ANDA','ANDA077459','Hikma Pharmaceuticals USA Inc.','LOSARTAN POTASSIUM','50','mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0125_856bc6e8-6f23-48cd-a2b7-d222c3f99913','0054-0125','HUMAN PRESCRIPTION DRUG','Losartan Potassium','','Losartan Potassium','TABLET','ORAL','20200713','','ANDA','ANDA077459','Hikma Pharmaceuticals USA Inc.','LOSARTAN POTASSIUM','100','mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0137_5a722d4a-2132-4d7c-a2c3-43b739dcb0cf','0054-0137','HUMAN PRESCRIPTION DRUG','Galantamine Hydrobromide','','Galantamine Hydrobromide','SOLUTION','ORAL','20090814','','ANDA','ANDA078185','Hikma Pharmaceuticals USA Inc.','GALANTAMINE HYDROBROMIDE','4','mg/mL','Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0140_f327486e-33db-4b3f-957f-6df9fbc2a33c','0054-0140','HUMAN PRESCRIPTION DRUG','Acarbose','','Acarbose','TABLET','ORAL','20080507','','ANDA','ANDA078470','West-Ward Pharmaceuticals Inc.','ACARBOSE','25','mg/1','alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0141_f327486e-33db-4b3f-957f-6df9fbc2a33c','0054-0141','HUMAN PRESCRIPTION DRUG','Acarbose','','Acarbose','TABLET','ORAL','20080507','','ANDA','ANDA078470','West-Ward Pharmaceuticals Inc.','ACARBOSE','50','mg/1','alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0142_f327486e-33db-4b3f-957f-6df9fbc2a33c','0054-0142','HUMAN PRESCRIPTION DRUG','Acarbose','','Acarbose','TABLET','ORAL','20080507','','ANDA','ANDA078470','West-Ward Pharmaceuticals Inc.','ACARBOSE','100','mg/1','alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0163_26b454ba-2535-4aba-9199-782ebc1fefc8','0054-0163','HUMAN PRESCRIPTION DRUG','Mycophenolate Mofetil','','Mycophenolate Mofetil','CAPSULE','ORAL','20080729','','ANDA','ANDA065410','Hikma Pharmaceuticals USA Inc.','MYCOPHENOLATE MOFETIL','250','mg/1','Antimetabolite Immunosuppressant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0166_26b454ba-2535-4aba-9199-782ebc1fefc8','0054-0166','HUMAN PRESCRIPTION DRUG','Mycophenolate Mofetil','','Mycophenolate Mofetil','TABLET','ORAL','20080729','','ANDA','ANDA065413','Hikma Pharmaceuticals USA Inc.','MYCOPHENOLATE MOFETIL','500','mg/1','Antimetabolite Immunosuppressant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0176_31e383be-2fec-4827-81a3-8c32ad246c44','0054-0176','HUMAN PRESCRIPTION DRUG','Buprenorphine HCl','','Buprenorphine HCl','TABLET','SUBLINGUAL','20091008','','ANDA','ANDA078633','Hikma Pharmaceuticals USA Inc.','BUPRENORPHINE HYDROCHLORIDE','2','mg/1','Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]','CIII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0177_31e383be-2fec-4827-81a3-8c32ad246c44','0054-0177','HUMAN PRESCRIPTION DRUG','Buprenorphine HCl','','Buprenorphine HCl','TABLET','SUBLINGUAL','20091008','','ANDA','ANDA078633','Hikma Pharmaceuticals USA Inc.','BUPRENORPHINE HYDROCHLORIDE','8','mg/1','Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]','CIII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0188_0fa8266a-4a18-465a-9671-afc968decb1b','0054-0188','HUMAN PRESCRIPTION DRUG','buprenorphine hydrochloride and naloxone hydrochloride dihydrate','','buprenorphine hydrochloride and naloxone hydrochloride dihydrate','TABLET','SUBLINGUAL','20140627','','ANDA','ANDA203326','Hikma Pharmaceuticals USA Inc.','BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE','2; .5','mg/1; mg/1','Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]','CIII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0189_0fa8266a-4a18-465a-9671-afc968decb1b','0054-0189','HUMAN PRESCRIPTION DRUG','buprenorphine hydrochloride and naloxone hydrochloride dihydrate','','buprenorphine hydrochloride and naloxone hydrochloride dihydrate','TABLET','SUBLINGUAL','20140627','','ANDA','ANDA203326','Hikma Pharmaceuticals USA Inc.','BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE','8; 2','mg/1; mg/1','Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]','CIII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0199_5656afa9-bc76-4583-aa0b-95af5cb0b15a','0054-0199','HUMAN PRESCRIPTION DRUG','Oxcarbazepine','','Oxcarbazepine','SUSPENSION','ORAL','20121003','','ANDA','ANDA201193','West-Ward Pharmaceuticals Corp.','OXCARBAZEPINE','300','mg/5mL','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0210_5e20e02b-8764-41bf-acd3-aecd03c2dfc8','0054-0210','HUMAN PRESCRIPTION DRUG','Protriptyline Hydrochloride','','Protriptyline Hydrochloride','TABLET','ORAL','20080916','','ANDA','ANDA078913','West-Ward Pharmaceuticals Corp.','PROTRIPTYLINE HYDROCHLORIDE','5','mg/1','Tricyclic Antidepressant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0211_5e20e02b-8764-41bf-acd3-aecd03c2dfc8','0054-0211','HUMAN PRESCRIPTION DRUG','Protriptyline Hydrochloride','','Protriptyline Hydrochloride','TABLET','ORAL','20080916','','ANDA','ANDA078913','West-Ward Pharmaceuticals Corp.','PROTRIPTYLINE HYDROCHLORIDE','10','mg/1','Tricyclic Antidepressant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0220_dba92d73-0329-4152-9add-7a53f2fe250b','0054-0220','HUMAN PRESCRIPTION DRUG','Quetiapine Fumarate','','Quetiapine Fumarate','TABLET','ORAL','20120327','','ANDA','ANDA090120','West-Ward Pharmaceuticals Corp','QUETIAPINE FUMARATE','25','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0221_dba92d73-0329-4152-9add-7a53f2fe250b','0054-0221','HUMAN PRESCRIPTION DRUG','Quetiapine Fumarate','','Quetiapine Fumarate','TABLET','ORAL','20120327','','ANDA','ANDA090749','West-Ward Pharmaceuticals Corp','QUETIAPINE FUMARATE','100','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0222_dba92d73-0329-4152-9add-7a53f2fe250b','0054-0222','HUMAN PRESCRIPTION DRUG','Quetiapine Fumarate','','Quetiapine Fumarate','TABLET','ORAL','20120327','','ANDA','ANDA090749','West-Ward Pharmaceuticals Corp','QUETIAPINE FUMARATE','200','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0223_dba92d73-0329-4152-9add-7a53f2fe250b','0054-0223','HUMAN PRESCRIPTION DRUG','Quetiapine Fumarate','','Quetiapine Fumarate','TABLET','ORAL','20120327','','ANDA','ANDA090749','West-Ward Pharmaceuticals Corp','QUETIAPINE FUMARATE','300','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0229_dba92d73-0329-4152-9add-7a53f2fe250b','0054-0229','HUMAN PRESCRIPTION DRUG','Quetiapine Fumarate','','Quetiapine Fumarate','TABLET','ORAL','20120327','','ANDA','ANDA090749','West-Ward Pharmaceuticals Corp','QUETIAPINE FUMARATE','50','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0230_dba92d73-0329-4152-9add-7a53f2fe250b','0054-0230','HUMAN PRESCRIPTION DRUG','Quetiapine Fumarate','','Quetiapine Fumarate','TABLET','ORAL','20120327','','ANDA','ANDA090749','West-Ward Pharmaceuticals Corp','QUETIAPINE FUMARATE','400','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0235_34042697-232a-44f7-b2b1-377e0d5f5bb6','0054-0235','HUMAN PRESCRIPTION DRUG','Morphine Sulfate','','Morphine Sulfate','TABLET','ORAL','20080317','','NDA','NDA022207','Hikma Pharmaceuticals USA Inc.','MORPHINE SULFATE','15','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0236_34042697-232a-44f7-b2b1-377e0d5f5bb6','0054-0236','HUMAN PRESCRIPTION DRUG','Morphine Sulfate','','Morphine Sulfate','TABLET','ORAL','20080317','','NDA','NDA022207','Hikma Pharmaceuticals USA Inc.','MORPHINE SULFATE','30','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0237_1682ab5e-e4be-45eb-9b18-d96ab65a176d','0054-0237','HUMAN PRESCRIPTION DRUG','Morphine Sulfate','','Morphine Sulfate','SOLUTION','ORAL','20080317','','NDA','NDA022195','Hikma Pharmaceuticals USA Inc.','MORPHINE SULFATE','10','mg/5mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0238_1682ab5e-e4be-45eb-9b18-d96ab65a176d','0054-0238','HUMAN PRESCRIPTION DRUG','Morphine Sulfate','','Morphine Sulfate','SOLUTION','ORAL','20080317','','NDA','NDA022195','Hikma Pharmaceuticals USA Inc.','MORPHINE SULFATE','20','mg/5mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0243_bf96e069-9d09-4c83-a843-f189e89ddd56','0054-0243','HUMAN PRESCRIPTION DRUG','Codeine sulfate','','codeine sulfate','TABLET','ORAL','20090716','','NDA','NDA022402','West-Ward Pharmaceuticals Corp.','CODEINE SULFATE','15','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0244_bf96e069-9d09-4c83-a843-f189e89ddd56','0054-0244','HUMAN PRESCRIPTION DRUG','Codeine sulfate','','codeine sulfate','TABLET','ORAL','20090716','','NDA','NDA022402','West-Ward Pharmaceuticals Corp.','CODEINE SULFATE','30','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0245_bf96e069-9d09-4c83-a843-f189e89ddd56','0054-0245','HUMAN PRESCRIPTION DRUG','Codeine sulfate','','codeine sulfate','TABLET','ORAL','20090716','','NDA','NDA022402','West-Ward Pharmaceuticals Corp.','CODEINE SULFATE','60','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0248_6bee6fa5-7883-4e39-b381-e2ed52f566e1','0054-0248','HUMAN PRESCRIPTION DRUG','Imatinib Mesylate','','Imatinib Mesylate','TABLET, FILM COATED','ORAL','20180928','','ANDA','ANDA207586','Hikma Pharmaceuticals USA Inc.','IMATINIB MESYLATE','100','mg/1','Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0249_6bee6fa5-7883-4e39-b381-e2ed52f566e1','0054-0249','HUMAN PRESCRIPTION DRUG','Imatinib Mesylate','','Imatinib Mesylate','TABLET, FILM COATED','ORAL','20180928','','ANDA','ANDA207586','Hikma Pharmaceuticals USA Inc.','IMATINIB MESYLATE','400','mg/1','Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0254_1786e07d-ad22-4e8b-b999-3442da68882e','0054-0254','HUMAN PRESCRIPTION DRUG','Irbesartan and Hydrochlorothiazide','','Irbesartan and Hydrochlorothiazide','TABLET','ORAL','20121015','','ANDA','ANDA090351','Hikma Pharmaceuticals USA Inc.','HYDROCHLOROTHIAZIDE; IRBESARTAN','12.5; 150','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0255_1786e07d-ad22-4e8b-b999-3442da68882e','0054-0255','HUMAN PRESCRIPTION DRUG','Irbesartan and Hydrochlorothiazide','','Irbesartan and Hydrochlorothiazide','TABLET','ORAL','20121015','','ANDA','ANDA090351','Hikma Pharmaceuticals USA Inc.','HYDROCHLOROTHIAZIDE; IRBESARTAN','12.5; 300','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0264_6d31049c-2cef-4f8e-9e8b-2fd65c1e0b33','0054-0264','HUMAN PRESCRIPTION DRUG','Hydromorphone Hydrochloride','','hydromorphone hydrochloride','TABLET','ORAL','20090729','','ANDA','ANDA074597','Hikma Pharmaceuticals USA Inc.','HYDROMORPHONE HYDROCHLORIDE','4','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0265_6d31049c-2cef-4f8e-9e8b-2fd65c1e0b33','0054-0265','HUMAN PRESCRIPTION DRUG','Hydromorphone Hydrochloride','','hydromorphone hydrochloride','TABLET','ORAL','20090729','','ANDA','ANDA074597','Hikma Pharmaceuticals USA Inc.','HYDROMORPHONE HYDROCHLORIDE','8','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0271_877b6a5d-d461-4787-abda-777931722842','0054-0271','HUMAN PRESCRIPTION DRUG','Capecitabine','','Capecitabine','TABLET, FILM COATED','ORAL','20160715','','ANDA','ANDA200483','Hikma Pharmaceuticals USA Inc.','CAPECITABINE','150','mg/1','Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0272_877b6a5d-d461-4787-abda-777931722842','0054-0272','HUMAN PRESCRIPTION DRUG','Capecitabine','','Capecitabine','TABLET, FILM COATED','ORAL','20160715','','ANDA','ANDA200483','Hikma Pharmaceuticals USA Inc.','CAPECITABINE','500','mg/1','Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0273_4f0700ec-c11f-4f9a-a99b-8f6c7c1186d1','0054-0273','HUMAN PRESCRIPTION DRUG','Imipramine Pamoate','','Imipramine Pamoate','CAPSULE','ORAL','20100419','','ANDA','ANDA091099','Hikma Pharmaceuticals USA Inc','IMIPRAMINE PAMOATE','75','mg/1','Tricyclic Antidepressant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0274_4f0700ec-c11f-4f9a-a99b-8f6c7c1186d1','0054-0274','HUMAN PRESCRIPTION DRUG','Imipramine Pamoate','','Imipramine Pamoate','CAPSULE','ORAL','20100419','','ANDA','ANDA091099','Hikma Pharmaceuticals USA Inc','IMIPRAMINE PAMOATE','100','mg/1','Tricyclic Antidepressant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0275_4f0700ec-c11f-4f9a-a99b-8f6c7c1186d1','0054-0275','HUMAN PRESCRIPTION DRUG','Imipramine Pamoate','','Imipramine Pamoate','CAPSULE','ORAL','20100419','','ANDA','ANDA091099','Hikma Pharmaceuticals USA Inc','IMIPRAMINE PAMOATE','125','mg/1','Tricyclic Antidepressant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0276_4f0700ec-c11f-4f9a-a99b-8f6c7c1186d1','0054-0276','HUMAN PRESCRIPTION DRUG','Imipramine Pamoate','','Imipramine Pamoate','CAPSULE','ORAL','20100419','','ANDA','ANDA091099','Hikma Pharmaceuticals USA Inc','IMIPRAMINE PAMOATE','150','mg/1','Tricyclic Antidepressant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0278_3fa2553a-28c7-47ba-999f-3448f20dedc4','0054-0278','HUMAN PRESCRIPTION DRUG','Naratriptan','','Naratriptan','TABLET','ORAL','20100707','','ANDA','ANDA090381','Hikma Pharmaceuticals USA Inc.','NARATRIPTAN HYDROCHLORIDE','1','mg/1','Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0279_3fa2553a-28c7-47ba-999f-3448f20dedc4','0054-0279','HUMAN PRESCRIPTION DRUG','Naratriptan','','Naratriptan','TABLET','ORAL','20100707','','ANDA','ANDA090381','Hikma Pharmaceuticals USA Inc.','NARATRIPTAN HYDROCHLORIDE','2.5','mg/1','Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0282_850e217b-2c59-48c1-a7fc-92f991060186','0054-0282','HUMAN PRESCRIPTION DRUG','Alendronate Sodium','','Alendronate Sodium','SOLUTION','ORAL','20201030','','ANDA','ANDA090520','Hikma Pharmaceuticals USA Inc.','ALENDRONATE SODIUM','70','mg/75mL','Bisphosphonate [EPC], Diphosphonates [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0283_fa3949ae-3244-4993-bb03-e9fd784a69cb','0054-0283','HUMAN PRESCRIPTION DRUG','Oxymorphone Hydrochloride','','oxymorphone hydrochloride','TABLET','ORAL','20100927','','ANDA','ANDA090964','West-Ward Pharmaceuticals Corp.','OXYMORPHONE HYDROCHLORIDE','5','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0284_fa3949ae-3244-4993-bb03-e9fd784a69cb','0054-0284','HUMAN PRESCRIPTION DRUG','Oxymorphone Hydrochloride','','oxymorphone hydrochloride','TABLET','ORAL','20100927','','ANDA','ANDA090964','West-Ward Pharmaceuticals Corp.','OXYMORPHONE HYDROCHLORIDE','10','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0293_420d7fc2-1aed-4a14-a6ce-db173115f1f2','0054-0293','HUMAN PRESCRIPTION DRUG','Azelastine Hydrochloride','','Azelastine Hydrochloride','SPRAY, METERED','NASAL','20141027','','ANDA','ANDA091444','West-Ward Pharmaceuticals Corp.','AZELASTINE HYDROCHLORIDE','137','ug/1','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0295_ca09da58-08c8-4520-b2a7-f33d3feaa15f','0054-0295','HUMAN PRESCRIPTION DRUG','Alosetron Hydrochloride','','alosetron hydrochloride','TABLET','ORAL','20130715','','ANDA','ANDA200652','West-Ward Pharmaceuticals Corp.','ALOSETRON HYDROCHLORIDE','0.5','mg/1','Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0296_ca09da58-08c8-4520-b2a7-f33d3feaa15f','0054-0296','HUMAN PRESCRIPTION DRUG','Alosetron Hydrochloride','','alosetron hydrochloride','TABLET','ORAL','20130715','','ANDA','ANDA200652','West-Ward Pharmaceuticals Corp.','ALOSETRON HYDROCHLORIDE','1','mg/1','Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0319_7fac7605-d411-4cbd-bc84-95949660b4f3','0054-0319','HUMAN PRESCRIPTION DRUG','Linezolid','','linezolid','POWDER, FOR SUSPENSION','ORAL','20150603','','ANDA','ANDA200068','Hikma Pharmaceuticals USA Inc.','LINEZOLID','100','mg/5mL','Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0326_abc1327e-ede8-4263-8d6e-44d4d23449d5','0054-0326','HUMAN PRESCRIPTION DRUG','fluticasone propionate and salmeterol','','fluticasone propionate and salmeterol','POWDER','RESPIRATORY (INHALATION)','20201217','','ANDA','ANDA203433','Hikma Pharmaceuticals USA Inc.','FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE','100; 50','ug/1; ug/1','Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0327_abc1327e-ede8-4263-8d6e-44d4d23449d5','0054-0327','HUMAN PRESCRIPTION DRUG','fluticasone propionate and salmeterol','','fluticasone propionate and salmeterol','POWDER','RESPIRATORY (INHALATION)','20201217','','ANDA','ANDA203433','Hikma Pharmaceuticals USA Inc.','FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE','250; 50','ug/1; ug/1','Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0334_f6904d40-78ae-4f7a-ad6b-65d63902651c','0054-0334','HUMAN PRESCRIPTION DRUG','Cevimeline Hydrochloride','','Cevimeline Hydrochloride','CAPSULE','ORAL','20130708','','ANDA','ANDA091591','Hikma Pharmaceuticals USA Inc.','CEVIMELINE HYDROCHLORIDE','30','mg/1','Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0349_ccfdacba-c4d3-4977-8a7e-c265d0fe277a','0054-0349','HUMAN PRESCRIPTION DRUG','Phenoxybenzamine Hydrochloride','','Phenoxybenzamine Hydrochloride','CAPSULE','ORAL','20150810','','ANDA','ANDA201050','Hikma Pharmaceuticals USA Inc.','PHENOXYBENZAMINE HYDROCHLORIDE','10','mg/1','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0356_dc93082a-969b-474f-baeb-3dd5e340e089','0054-0356','HUMAN PRESCRIPTION DRUG','Disulfiram','','Disulfiram','TABLET','ORAL','20141104','','ANDA','ANDA202652','West-Ward Pharmaceuticals Corp.','DISULFIRAM','250','mg/1','Acetyl Aldehyde Dehydrogenase Inhibitors [MoA], Aldehyde Dehydrogenase Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0357_dc93082a-969b-474f-baeb-3dd5e340e089','0054-0357','HUMAN PRESCRIPTION DRUG','Disulfiram','','Disulfiram','TABLET','ORAL','20141104','','ANDA','ANDA202652','West-Ward Pharmaceuticals Corp.','DISULFIRAM','500','mg/1','Acetyl Aldehyde Dehydrogenase Inhibitors [MoA], Aldehyde Dehydrogenase Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0382_80bba81a-806d-4feb-b53f-24013b28f187','0054-0382','HUMAN PRESCRIPTION DRUG','Cyclophosphamide','','Cyclophosphamide','CAPSULE','ORAL','20130916','','NDA','NDA203856','West-Ward Pharmaceuticals Corp.','CYCLOPHOSPHAMIDE','25','mg/1','Alkylating Activity [MoA], Alkylating Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0383_80bba81a-806d-4feb-b53f-24013b28f187','0054-0383','HUMAN PRESCRIPTION DRUG','Cyclophosphamide','','Cyclophosphamide','CAPSULE','ORAL','20130916','','NDA','NDA203856','West-Ward Pharmaceuticals Corp.','CYCLOPHOSPHAMIDE','50','mg/1','Alkylating Activity [MoA], Alkylating Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0386_6d31049c-2cef-4f8e-9e8b-2fd65c1e0b33','0054-0386','HUMAN PRESCRIPTION DRUG','Hydromorphone Hydrochloride','','hydromorphone hydrochloride','SOLUTION','ORAL','20120301','','ANDA','ANDA074653','Hikma Pharmaceuticals USA Inc.','HYDROMORPHONE HYDROCHLORIDE','1','mg/mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0389_c3e51e2e-f967-479e-862b-013a816d8ccd','0054-0389','HUMAN PRESCRIPTION DRUG','Methamphetamine Hydrochloride','','Methamphetamine Hydrochloride','TABLET','ORAL','20161206','','ANDA','ANDA203846','Hikma Pharmaceuticals USA Inc.','METHAMPHETAMINE HYDROCHLORIDE','5','mg/1','Amphetamine Anorectic [EPC], Amphetamines [CS], Appetite Suppression [PE], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0390_0cb44981-167f-45c3-b2da-4a83f2c2b7d5','0054-0390','HUMAN PRESCRIPTION DRUG','oxycodone hydrochloride','','oxycodone hydrochloride','SOLUTION','ORAL','20140904','','ANDA','ANDA204037','Hikma Pharmceuticals USA Inc.','OXYCODONE HYDROCHLORIDE','5','mg/5mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0391_b9a70827-03b9-47c6-adc6-a785a407ae3b','0054-0391','HUMAN PRESCRIPTION DRUG','Methadone Hydrochloride','','Methadone Hydrochloride','CONCENTRATE','ORAL','20100623','','ANDA','ANDA089897','Hikma Pharmaceuticals USA','METHADONE HYDROCHLORIDE','10','mg/mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0392_b9a70827-03b9-47c6-adc6-a785a407ae3b','0054-0392','HUMAN PRESCRIPTION DRUG','Methadone Hydrochloride','','Methadone Hydrochloride','CONCENTRATE','ORAL','20100316','','ANDA','ANDA040180','Hikma Pharmaceuticals USA','METHADONE HYDROCHLORIDE','10','mg/mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0399_2be86673-4c9c-4543-a545-9871a8f72e12','0054-0399','HUMAN PRESCRIPTION DRUG','Bexarotene','','bexarotene','CAPSULE, LIQUID FILLED','ORAL','20201111','','ANDA','ANDA203663','Hikma Pharmaceuticals USA Inc.','BEXAROTENE','75','mg/1','Retinoid [EPC], Retinoids [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0400_2a8e1805-b94a-4ad5-bb8d-bf25c139606d','0054-0400','HUMAN PRESCRIPTION DRUG','Desvenlafaxine','','Desvenlafaxine','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20170301','','ANDA','ANDA204082','Hikma Pharmaceuticals USA Inc.','DESVENLAFAXINE SUCCINATE','50','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0401_2a8e1805-b94a-4ad5-bb8d-bf25c139606d','0054-0401','HUMAN PRESCRIPTION DRUG','Desvenlafaxine','','Desvenlafaxine','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20170301','','ANDA','ANDA204083','Hikma Pharmaceuticals USA Inc.','DESVENLAFAXINE SUCCINATE','100','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0404_ca359246-4674-4b32-b8b2-673d32b7112f','0054-0404','HUMAN PRESCRIPTION DRUG','Morphine Sulfate','','Morphine Sulfate','SOLUTION','ORAL','20080317','','NDA','NDA022195','Hikma Pharmaceuticals USA Inc.','MORPHINE SULFATE','100','mg/5mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0407_ec8d993c-1d1e-4c8d-83d9-87f6048b1902','0054-0407','HUMAN PRESCRIPTION DRUG','Ritonavir','','Ritonavir','TABLET, FILM COATED','ORAL','20180320','','ANDA','ANDA202573','West-Ward Pharmaceuticals Corp.','RITONAVIR','100','mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0413_e52b9d07-e55f-477b-873a-8a35c1ff4b3b','0054-0413','HUMAN PRESCRIPTION DRUG','Febuxostat','','Febuxostat','TABLET','ORAL','20191111','','ANDA','ANDA205414','Hikma Pharmaceuticals USA Inc','FEBUXOSTAT','40','mg/1','Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0414_e52b9d07-e55f-477b-873a-8a35c1ff4b3b','0054-0414','HUMAN PRESCRIPTION DRUG','Febuxostat','','Febuxostat','TABLET','ORAL','20191111','','ANDA','ANDA205414','Hikma Pharmaceuticals USA Inc','FEBUXOSTAT','80','mg/1','Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0415_d214319c-d8e9-491f-b7f5-29674983fcc6','0054-0415','HUMAN PRESCRIPTION DRUG','Ethacrynic Acid','','Ethacrynic Acid','TABLET','ORAL','20170224','','ANDA','ANDA207262','West-Ward Pharmaceuticals Corp.','ETHACRYNIC ACID','25','mg/1','Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0425_72348f03-413e-4d00-be89-00c719af669b','0054-0425','HUMAN PRESCRIPTION DRUG','Rufinamide','','Rufinamide','TABLET, FILM COATED','ORAL','20210530','','ANDA','ANDA204988','Hikma Pharmaceuticals USA Inc.','RUFINAMIDE','200','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0426_72348f03-413e-4d00-be89-00c719af669b','0054-0426','HUMAN PRESCRIPTION DRUG','Rufinamide','','Rufinamide','TABLET, FILM COATED','ORAL','20210530','','ANDA','ANDA204988','Hikma Pharmaceuticals USA Inc.','RUFINAMIDE','400','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0427_106c5c0b-dd29-4371-96f3-ce216cae9f99','0054-0427','HUMAN PRESCRIPTION DRUG','flucytosine','','flucytosine','CAPSULE','ORAL','20171017','','ANDA','ANDA206550','West-Ward Pharmaceuticals Corp','FLUCYTOSINE','250','mg/1','Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0428_106c5c0b-dd29-4371-96f3-ce216cae9f99','0054-0428','HUMAN PRESCRIPTION DRUG','flucytosine','','flucytosine','CAPSULE','ORAL','20171017','','ANDA','ANDA206550','West-Ward Pharmaceuticals Corp','FLUCYTOSINE','500','mg/1','Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0438_f8d8feb2-eb74-43af-8c6e-e7ce2c96e6f8','0054-0438','HUMAN PRESCRIPTION DRUG','LEVORPHANOL TARTRATE','','LEVORPHANOL TARTRATE','TABLET','ORAL','20000331','','ANDA','ANDA074278','Hikma Pharmaceuticals USA Inc.','LEVORPHANOL TARTRATE','2','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0470_0158d8f9-ca9e-46ec-9a66-8cfa40c6c4b0','0054-0470','HUMAN PRESCRIPTION DRUG','Everolimus','','Everolimus','TABLET','ORAL','20200310','','ANDA','ANDA206133','Hikma Pharmaceuticals USA Inc.','EVEROLIMUS','0.25','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0471_0158d8f9-ca9e-46ec-9a66-8cfa40c6c4b0','0054-0471','HUMAN PRESCRIPTION DRUG','Everolimus','','Everolimus','TABLET','ORAL','20200310','','ANDA','ANDA206133','Hikma Pharmaceuticals USA Inc.','EVEROLIMUS','0.5','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0472_0158d8f9-ca9e-46ec-9a66-8cfa40c6c4b0','0054-0472','HUMAN PRESCRIPTION DRUG','Everolimus','','Everolimus','TABLET','ORAL','20200310','','ANDA','ANDA206133','Hikma Pharmaceuticals USA Inc.','EVEROLIMUS','0.75','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0479_a0bb43bc-276d-4e32-bac3-7b19e78e5a4d','0054-0479','HUMAN PRESCRIPTION DRUG','Dalfampridine','','Dalfampridine','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20200713','','ANDA','ANDA206646','Hikma Pharmaceuticals USA Inc.','DALFAMPRIDINE','10','mg/1','Potassium Channel Antagonists [MoA], Potassium Channel Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0480_f2747ee4-4f32-4503-aa9a-b94001799a36','0054-0480','HUMAN PRESCRIPTION DRUG','Everolimus','','Everolimus','TABLET','ORAL','20200608','','ANDA','ANDA207486','Hikma Pharmaceuticals USA Inc.','EVEROLIMUS','2.5','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0481_f2747ee4-4f32-4503-aa9a-b94001799a36','0054-0481','HUMAN PRESCRIPTION DRUG','Everolimus','','Everolimus','TABLET','ORAL','20200608','','ANDA','ANDA207486','Hikma Pharmaceuticals USA Inc.','EVEROLIMUS','5','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0482_f2747ee4-4f32-4503-aa9a-b94001799a36','0054-0482','HUMAN PRESCRIPTION DRUG','Everolimus','','Everolimus','TABLET','ORAL','20200608','','ANDA','ANDA207486','Hikma Pharmaceuticals USA Inc.','EVEROLIMUS','10','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0497_f2747ee4-4f32-4503-aa9a-b94001799a36','0054-0497','HUMAN PRESCRIPTION DRUG','Everolimus','','Everolimus','TABLET','ORAL','20200608','','ANDA','ANDA207486','Hikma Pharmaceuticals USA Inc.','EVEROLIMUS','7.5','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0508_2417e4be-d579-4c3d-8ec0-a42dc51aabf5','0054-0508','HUMAN PRESCRIPTION DRUG','Icosapent Ethyl','','Icosapent Ethyl','CAPSULE','ORAL','20201104','','ANDA','ANDA209457','Hikma Pharmaceuticals USA Inc.','ICOSAPENT ETHYL','1','g/1','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0517_ca359246-4674-4b32-b8b2-673d32b7112f','0054-0517','HUMAN PRESCRIPTION DRUG','Morphine Sulfate','','Morphine Sulfate','SOLUTION','ORAL','20080317','','NDA','NDA022195','Hikma Pharmaceuticals USA Inc.','MORPHINE SULFATE','100','mg/5mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0520_03c560f4-2afd-4b15-9466-cff8a3627610','0054-0520','HUMAN PRESCRIPTION DRUG','Bosentan','','Bosentan','TABLET','ORAL','20190604','','ANDA','ANDA208695','West-Ward Pharmaceuticals Corp.','BOSENTAN','62.5','mg/1','Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0521_03c560f4-2afd-4b15-9466-cff8a3627610','0054-0521','HUMAN PRESCRIPTION DRUG','Bosentan','','Bosentan','TABLET','ORAL','20190604','','ANDA','ANDA208695','West-Ward Pharmaceuticals Corp.','BOSENTAN','125','mg/1','Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0528_eb1cdda2-10c1-4acc-ab6a-c6aba2c7db80','0054-0528','HUMAN PRESCRIPTION DRUG','Rufinamide','','Rufinamide','SUSPENSION','ORAL','20201101','','ANDA','ANDA207363','Hikma Pharmaceuticals USA Inc.','RUFINAMIDE','40','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0532_32e24bbf-d284-4365-9aab-947496046910','0054-0532','HUMAN PRESCRIPTION DRUG','Droxidopa','','Droxidopa','CAPSULE','ORAL','20210218','','ANDA','ANDA212835','Hikma Pharmaceuticals USA Inc.','DROXIDOPA','100','mg/1','Catecholamines [CS], Increased Blood Pressure [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0533_32e24bbf-d284-4365-9aab-947496046910','0054-0533','HUMAN PRESCRIPTION DRUG','Droxidopa','','Droxidopa','CAPSULE','ORAL','20210218','','ANDA','ANDA212835','Hikma Pharmaceuticals USA Inc.','DROXIDOPA','200','mg/1','Catecholamines [CS], Increased Blood Pressure [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0534_32e24bbf-d284-4365-9aab-947496046910','0054-0534','HUMAN PRESCRIPTION DRUG','Droxidopa','','Droxidopa','CAPSULE','ORAL','20210218','','ANDA','ANDA212835','Hikma Pharmaceuticals USA Inc.','DROXIDOPA','300','mg/1','Catecholamines [CS], Increased Blood Pressure [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0576_51ef0b6b-7dbb-4675-a21b-439f381d264a','0054-0576','HUMAN PRESCRIPTION DRUG','Deferiprone','','Deferiprone','TABLET, COATED','ORAL','20210603','','ANDA','ANDA213239','Hikma Pharmaceuticals USA Inc.','DEFERIPRONE','500','mg/1','Iron Chelating Activity [MoA], Iron Chelator [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0603_2a8e1805-b94a-4ad5-bb8d-bf25c139606d','0054-0603','HUMAN PRESCRIPTION DRUG','Desvenlafaxine','','Desvenlafaxine','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20170829','','ANDA','ANDA204082','Hikma Pharmaceuticals USA Inc.','DESVENLAFAXINE SUCCINATE','25','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0604_0158d8f9-ca9e-46ec-9a66-8cfa40c6c4b0','0054-0604','HUMAN PRESCRIPTION DRUG','Everolimus','','Everolimus','TABLET','ORAL','20211118','','ANDA','ANDA206133','Hikma Pharmaceuticals USA Inc.','EVEROLIMUS','1','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0621_2417e4be-d579-4c3d-8ec0-a42dc51aabf5','0054-0621','HUMAN PRESCRIPTION DRUG','Icosapent Ethyl','','Icosapent Ethyl','CAPSULE','ORAL','20201104','','ANDA','ANDA209457','Hikma Pharmaceuticals USA Inc.','ICOSAPENT ETHYL','0.5','g/1','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0622_4bf3b046-52c5-4943-9c05-f517f5506f05','0054-0622','HUMAN PRESCRIPTION DRUG','Dicyclomine Hydrochloride','','Dicyclomine Hydrochloride','SOLUTION','ORAL','20200522','','ANDA','ANDA212286','Hikma Pharmaceuticals USA Inc.','DICYCLOMINE HYDROCHLORIDE','10','mg/5mL','Anticholinergic [EPC], Cholinergic Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0639_f4e0883a-f280-7586-e053-2995a90abccd','0054-0639','HUMAN PRESCRIPTION DRUG','Methylergonovine Maleate','','Methylergonovine Maleate','TABLET','ORAL','20180703','','ANDA','ANDA210424','West-Ward Pharmaceuticals Corp','METHYLERGONOVINE MALEATE','0.2','mg/1','Ergolines [CS], Ergot Derivative [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0650_604e214c-d5fb-4061-9a88-b582d3a45f28','0054-0650','HUMAN PRESCRIPTION DRUG','Butalbital, Acetaminophen, Caffeine and Codeine Phosphate','','Butalbital, Acetaminophen, Caffeine and Codeine Phosphate','CAPSULE','ORAL','20220509','','ANDA','ANDA215138','Hikma Pharmaceuticals USA Inc.','ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE','300; 50; 40; 30','mg/1; mg/1; mg/1; mg/1','Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Full Opioid Agonists [MoA], Methylxanthine [EPC], Opioid Agonist [EPC], Xanthines [CS]','CIII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0652_5ed8d293-b7d8-4c66-9c31-8075e6f99092','0054-0652','HUMAN PRESCRIPTION DRUG','Vigabatrin','','Vigabatrin','TABLET','ORAL','20220909','','ANDA','ANDA213104','Hikma Pharmaceuticals USA Inc','VIGABATRIN','500','mg/1','Anti-epileptic Agent [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0702_f4cea32f-ca86-ce64-e053-2995a90a3cd1','0054-0702','HUMAN PRESCRIPTION DRUG','Vigabatrin for oral solution USP, 500 mg','','Vigabatrin','FOR SOLUTION','ORAL','20200710','','ANDA','ANDA213469','Hikma Pharmaceuticals USA Inc.','VIGABATRIN','50','mg/mL','Anti-epileptic Agent [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0709_66729506-8c98-4822-8402-1b21bb6cf450','0054-0709','HUMAN PRESCRIPTION DRUG','METHADONE HYDROCHLORIDE','','METHADONE HYDROCHLORIDE','TABLET','ORAL','19830308','','ANDA','ANDA088108','Hikma Pharmaceuticals USA Inc.','METHADONE HYDROCHLORIDE','5','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0710_66729506-8c98-4822-8402-1b21bb6cf450','0054-0710','HUMAN PRESCRIPTION DRUG','METHADONE HYDROCHLORIDE','','METHADONE HYDROCHLORIDE','TABLET','ORAL','19830308','','ANDA','ANDA088109','Hikma Pharmaceuticals USA Inc.','METHADONE HYDROCHLORIDE','10','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0711_c4f9e9be-39e7-4940-9cb0-f17772d7e524','0054-0711','HUMAN PRESCRIPTION DRUG','Deferiprone','','Deferiprone','TABLET, COATED','ORAL','20220208','','ANDA','ANDA213239','Hikma Pharmaceuticals USA Inc.','DEFERIPRONE','1000','mg/1','Iron Chelating Activity [MoA], Iron Chelator [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-0742_07a1b9ad-58cb-4c21-b8df-6854da990f85','0054-0742','HUMAN PRESCRIPTION DRUG','Albuterol Sulfate','','Albuterol Sulfate','AEROSOL, METERED','RESPIRATORY (INHALATION)','20211130','','ANDA','ANDA207085','Hikma Pharmaceuticals USA Inc.','ALBUTEROL SULFATE','90','ug/1','Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-2526_82f2a1ee-741f-42a6-a609-735d54f1a8cd','0054-2526','HUMAN PRESCRIPTION DRUG','Lithium Carbonate','','Lithium Carbonate','CAPSULE, GELATIN COATED','ORAL','19870128','','NDA','NDA017812','Hikma Pharmaceuticals USA Inc.','LITHIUM CARBONATE','150','mg/1','Mood Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-2527_82f2a1ee-741f-42a6-a609-735d54f1a8cd','0054-2527','HUMAN PRESCRIPTION DRUG','Lithium Carbonate','','Lithium Carbonate','CAPSULE, GELATIN COATED','ORAL','19801126','','NDA','NDA017812','Hikma Pharmaceuticals USA Inc.','LITHIUM CARBONATE','300','mg/1','Mood Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-2531_82f2a1ee-741f-42a6-a609-735d54f1a8cd','0054-2531','HUMAN PRESCRIPTION DRUG','Lithium Carbonate','','Lithium Carbonate','CAPSULE, GELATIN COATED','ORAL','19870128','','NDA','NDA017812','Hikma Pharmaceuticals USA Inc.','LITHIUM CARBONATE','600','mg/1','Mood Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3000_604e214c-d5fb-4061-9a88-b582d3a45f28','0054-3000','HUMAN PRESCRIPTION DRUG','Butalbital, Acetaminophen, Caffeine and Codeine Phosphate','','Butalbital, Acetaminophen, Caffeine and Codeine Phosphate','CAPSULE','ORAL','20220509','','ANDA','ANDA215138','Hikma Pharmaceuticals USA Inc.','ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE','325; 50; 40; 30','mg/1; mg/1; mg/1; mg/1','Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Full Opioid Agonists [MoA], Methylxanthine [EPC], Opioid Agonist [EPC], Xanthines [CS]','CIII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3068_f61b0308-0616-49ae-99f9-07b9fd62bc3d','0054-3068','HUMAN PRESCRIPTION DRUG','Alprazolam','','Alprazolam','SOLUTION, CONCENTRATE','ORAL','19931031','','ANDA','ANDA074312','Hikma Pharmaceuticals USA Inc.','ALPRAZOLAM','1','mg/mL','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3090_ea512825-f928-4a7a-93f3-56dc1c0686b1','0054-3090','HUMAN PRESCRIPTION DRUG','Butorphanol Tartrate','','Butorphanol Tartrate','SPRAY, METERED','NASAL','20020312','','ANDA','ANDA075824','Hikma Pharmaceuticals USA Inc.','BUTORPHANOL TARTRATE','10','mg/mL','Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3117_8c0aefee-0ab5-4a1b-9a5f-0107ab3e0681','0054-3117','HUMAN OTC DRUG','Calcium Carbonate','','Calcium Carbonate','SUSPENSION','ORAL','20041118','20240531','OTC MONOGRAPH FINAL','part331','Hikma Pharmaceuticals USA Inc.','CALCIUM CARBONATE','1250','mg/5mL','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3120_6596f0ea-7fe9-4de5-8370-88c980461c7c','0054-3120','HUMAN PRESCRIPTION DRUG','Calcitriol','','Calcitriol','SOLUTION','ORAL','20030718','','ANDA','ANDA076242','Hikma Pharmaceuticals USA Inc.','CALCITRIOL','1','ug/mL','Cholecalciferol [CS], Vitamin D3 Analog [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3176_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13','0054-3176','HUMAN PRESCRIPTION DRUG','Dexamethasone Intensol','','Dexamethasone Intensol','SOLUTION, CONCENTRATE','ORAL','19830901','','ANDA','ANDA088252','Hikma Pharmaceuticals USA, Inc.','DEXAMETHASONE','1','mg/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3177_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13','0054-3177','HUMAN PRESCRIPTION DRUG','Dexamethasone','','Dexamethasone','SOLUTION','ORAL','19830901','','ANDA','ANDA088248','Hikma Pharmaceuticals USA, Inc.','DEXAMETHASONE','0.5','mg/5mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3185_eca7ecf2-1608-438a-8ff4-358df026ed10','0054-3185','HUMAN PRESCRIPTION DRUG','Diazepam Intensol','','Diazepam Intensol','SOLUTION, CONCENTRATE','ORAL','19870403','','ANDA','ANDA071415','West-Ward Pharmaceuticals Corp.','DIAZEPAM','5','mg/mL','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3188_c08016d8-3957-4ef4-9584-2a6bf1fc5cae','0054-3188','HUMAN PRESCRIPTION DRUG','Diazepam','','Diazepam','SOLUTION','ORAL','19870403','','ANDA','ANDA070928','Hikma Pharmaceuticals USA Inc.','DIAZEPAM','5','mg/5mL','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3194_dd4c9d02-850c-413b-9e3a-2a251a3993d9','0054-3194','HUMAN PRESCRIPTION DRUG','Diphenoxylate Hydrochloride and Atropine Sulfate','','Diphenoxylate Hydrochloride and Atropine Sulfate','SOLUTION','ORAL','19820503','','ANDA','ANDA087708','West-Ward Pharmaceuticals Corp.','ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE','.025; 2.5','mg/5mL; mg/5mL','Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3270_5adfc3e5-7fef-4872-b899-85f570a4988d','0054-3270','HUMAN PRESCRIPTION DRUG','Fluticasone Propionate','','Fluticasone Propionate','SPRAY, METERED','NASAL','20060222','','ANDA','ANDA076504','West-Ward Pharmaceuticals Corp.','FLUTICASONE PROPIONATE','50','ug/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3294_27097d45-7ebd-480d-9d3a-68b539b4fd9b','0054-3294','HUMAN PRESCRIPTION DRUG','Furosemide','','Furosemide','SOLUTION','ORAL','19880712','','ANDA','ANDA070434','West-Ward Pharmaceuticals Corp.','FUROSEMIDE','10','mg/mL','Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3298_27097d45-7ebd-480d-9d3a-68b539b4fd9b','0054-3298','HUMAN PRESCRIPTION DRUG','Furosemide','','Furosemide','SOLUTION','ORAL','19870422','','ANDA','ANDA070433','West-Ward Pharmaceuticals Corp.','FUROSEMIDE','40','mg/5mL','Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3500_88b367cd-aabd-4ff5-a7bb-bc53ba412651','0054-3500','HUMAN PRESCRIPTION DRUG','Lidocaine Viscous','','Lidocaine Hydrochloride','SOLUTION','ORAL; TOPICAL','19850426','','ANDA','ANDA088802','West-Ward Pharmaceuticals Corp.','LIDOCAINE HYDROCHLORIDE','20','mg/mL','Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3505_6a9202c0-b928-4b63-a37d-11d07158711a','0054-3505','HUMAN PRESCRIPTION DRUG','Lidocaine Hydrochloride','','Lidocaine Hydrochloride','SOLUTION','TOPICAL','19850403','','ANDA','ANDA088803','West-Ward Pharmaceuticals Corp','LIDOCAINE HYDROCHLORIDE','40','mg/mL','Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3532_49bc93b6-9f7b-463c-bbf4-d1f02a0dd533','0054-3532','HUMAN PRESCRIPTION DRUG','Lorazepam','','Lorazepam','SOLUTION, CONCENTRATE','ORAL','19910628','','ANDA','ANDA072755','West-Ward Pharmaceuticals Corp.','LORAZEPAM','2','mg/mL','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3545_8d3293b9-a59f-4adc-89ae-4b881c957d4d','0054-3545','HUMAN PRESCRIPTION DRUG','Meperidine Hydrochloride','','Meperidine Hydrochloride','SOLUTION','ORAL','19850130','','ANDA','ANDA088744','West-Ward Pharmaceuticals Corp.','MEPERIDINE HYDROCHLORIDE','50','mg/5mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3553_92f6e14b-cfa0-4c55-bc9e-3dadbd80f598','0054-3553','HUMAN PRESCRIPTION DRUG','Methadone Hydrochloride','','Methadone Hydrochloride','CONCENTRATE','ORAL','19880906','','ANDA','ANDA089897','Hikma Pharmaceuticals USA Inc.','METHADONE HYDROCHLORIDE','10','mg/mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3555_7505e1a8-3931-4d3c-ba74-303247d29265','0054-3555','HUMAN PRESCRIPTION DRUG','Methadone Hydrochloride','','Methadone Hydrochloride','SOLUTION','ORAL','19810522','','ANDA','ANDA087393','Hikma Pharmaceuticals USA Inc.','METHADONE HYDROCHLORIDE','5','mg/5mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3556_7505e1a8-3931-4d3c-ba74-303247d29265','0054-3556','HUMAN PRESCRIPTION DRUG','Methadone Hydrochloride','','Methadone Hydrochloride','SOLUTION','ORAL','19820830','','ANDA','ANDA087997','Hikma Pharmaceuticals USA Inc.','METHADONE HYDROCHLORIDE','10','mg/5mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3566_83e0ae08-f443-4c83-a995-5f2efd5b43ff','0054-3566','HUMAN PRESCRIPTION DRUG','Midazolam Hydrochloride','','Midazolam Hydrochloride','SYRUP','ORAL','20020430','','ANDA','ANDA075873','Hikma Pharmaceuticals USA Inc.','MIDAZOLAM HYDROCHLORIDE','2','mg/mL','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3630_4f3ddcb9-fcec-404a-b2aa-90c5a281b794','0054-3630','HUMAN PRESCRIPTION DRUG','Naproxen','','Naproxen','SUSPENSION','ORAL','20210224','','ANDA','ANDA074190','Hikma Pharmaceuticals USA Inc.','NAPROXEN','125','mg/5mL','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3721_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae','0054-3721','HUMAN PRESCRIPTION DRUG','PredniSONE Intensol','','PredniSONE Intensol','SOLUTION, CONCENTRATE','ORAL','19850220','','ANDA','ANDA088810','Hikma Pharmaceuticals USA Inc.','PREDNISONE','5','mg/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3722_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae','0054-3722','HUMAN PRESCRIPTION DRUG','PredniSONE','','PredniSONE','SOLUTION','ORAL','19841108','','ANDA','ANDA088703','Hikma Pharmaceuticals USA Inc.','PREDNISONE','5','mg/5mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3727_3d701a3e-d5c9-4754-9bc1-9e520741813d','0054-3727','HUMAN PRESCRIPTION DRUG','Propranolol Hydrochloride','','Propranolol Hydrochloride','SOLUTION','ORAL','19870515','','ANDA','ANDA070979','West Ward Pharmaceuticals Corp.','PROPRANOLOL HYDROCHLORIDE','20','mg/5mL','Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-3730_3d701a3e-d5c9-4754-9bc1-9e520741813d','0054-3730','HUMAN PRESCRIPTION DRUG','Propranolol Hydrochloride','','Propranolol Hydrochloride','SOLUTION','ORAL','19870515','','ANDA','ANDA070690','West Ward Pharmaceuticals Corp.','PROPRANOLOL HYDROCHLORIDE','40','mg/5mL','Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4146_4badcce8-f27a-44dd-87f1-2fd1375d39a0','0054-4146','HUMAN PRESCRIPTION DRUG','Clotrimazole','','Clotrimazole','LOZENGE','ORAL; TOPICAL','20040729','','ANDA','ANDA076387','Hikma Pharmacuticals USA USA Inc.','CLOTRIMAZOLE','10','mg/1','Azole Antifungal [EPC], Azoles [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4179_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13','0054-4179','HUMAN PRESCRIPTION DRUG','Dexamethasone','','Dexamethasone','TABLET','ORAL','19750725','','ANDA','ANDA084611','Hikma Pharmaceuticals USA, Inc.','DEXAMETHASONE','0.5','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4180_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13','0054-4180','HUMAN PRESCRIPTION DRUG','Dexamethasone','','Dexamethasone','TABLET','ORAL','19750603','','ANDA','ANDA084613','Hikma Pharmaceuticals USA, Inc.','DEXAMETHASONE','0.75','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4181_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13','0054-4181','HUMAN PRESCRIPTION DRUG','Dexamethasone','','Dexamethasone','TABLET','ORAL','19830915','','ANDA','ANDA088306','Hikma Pharmaceuticals USA, Inc.','DEXAMETHASONE','1','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4182_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13','0054-4182','HUMAN PRESCRIPTION DRUG','Dexamethasone','','Dexamethasone','TABLET','ORAL','19750519','','ANDA','ANDA084610','Hikma Pharmaceuticals USA, Inc.','DEXAMETHASONE','1.5','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4183_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13','0054-4183','HUMAN PRESCRIPTION DRUG','Dexamethasone','','Dexamethasone','TABLET','ORAL','19820826','','ANDA','ANDA087916','Hikma Pharmaceuticals USA, Inc.','DEXAMETHASONE','2','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4184_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13','0054-4184','HUMAN PRESCRIPTION DRUG','Dexamethasone','','Dexamethasone','TABLET','ORAL','19780719','','ANDA','ANDA084612','Hikma Pharmaceuticals USA, Inc.','DEXAMETHASONE','4','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4186_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13','0054-4186','HUMAN PRESCRIPTION DRUG','Dexamethasone','','Dexamethasone','TABLET','ORAL','19830915','','ANDA','ANDA088316','Hikma Pharmaceuticals USA, Inc.','DEXAMETHASONE','6','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4297_27097d45-7ebd-480d-9d3a-68b539b4fd9b','0054-4297','HUMAN PRESCRIPTION DRUG','Furosemide','','Furosemide','TABLET','ORAL','19831110','','NDA','NDA018823','West-Ward Pharmaceuticals Corp.','FUROSEMIDE','20','mg/1','Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4299_27097d45-7ebd-480d-9d3a-68b539b4fd9b','0054-4299','HUMAN PRESCRIPTION DRUG','Furosemide','','Furosemide','TABLET','ORAL','19831110','','NDA','NDA018823','West-Ward Pharmaceuticals Corp.','FUROSEMIDE','40','mg/1','Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4301_27097d45-7ebd-480d-9d3a-68b539b4fd9b','0054-4301','HUMAN PRESCRIPTION DRUG','Furosemide','','Furosemide','TABLET','ORAL','19910313','','ANDA','ANDA070086','West-Ward Pharmaceuticals Corp.','FUROSEMIDE','80','mg/1','Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4496_2bead056-06b2-4a6c-9df2-e437147df79b','0054-4496','HUMAN PRESCRIPTION DRUG','Leucovorin Calcium','','Leucovorin Calcium','TABLET','ORAL','19930222','','ANDA','ANDA072733','West-Ward Pharmaceuticals Corp.','LEUCOVORIN CALCIUM','5','mg/1','Folate Analog [EPC], Folic Acid [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4497_2bead056-06b2-4a6c-9df2-e437147df79b','0054-4497','HUMAN PRESCRIPTION DRUG','Leucovorin Calcium','','Leucovorin Calcium','TABLET','ORAL','19930222','','ANDA','ANDA072734','West-Ward Pharmaceuticals Corp.','LEUCOVORIN CALCIUM','10','mg/1','Folate Analog [EPC], Folic Acid [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4498_2bead056-06b2-4a6c-9df2-e437147df79b','0054-4498','HUMAN PRESCRIPTION DRUG','Leucovorin Calcium','','Leucovorin Calcium','TABLET','ORAL','19930222','','ANDA','ANDA072735','West-Ward Pharmaceuticals Corp.','LEUCOVORIN CALCIUM','15','mg/1','Folate Analog [EPC], Folic Acid [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4499_2bead056-06b2-4a6c-9df2-e437147df79b','0054-4499','HUMAN PRESCRIPTION DRUG','Leucovorin Calcium','','Leucovorin Calcium','TABLET','ORAL','19930222','','ANDA','ANDA072736','West-Ward Pharmaceuticals Corp.','LEUCOVORIN CALCIUM','25','mg/1','Folate Analog [EPC], Folic Acid [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4527_82f2a1ee-741f-42a6-a609-735d54f1a8cd','0054-4527','HUMAN PRESCRIPTION DRUG','Lithium Carbonate','','Lithium Carbonate','TABLET','ORAL','19820129','','NDA','NDA018558','Hikma Pharmaceuticals USA Inc.','LITHIUM CARBONATE','300','mg/1','Mood Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4538_821a6427-0ce6-4049-86d8-0ee9099c29f6','0054-4538','HUMAN PRESCRIPTION DRUG','DISKETS','','Methadone Hydrochloride','TABLET','ORAL','19730314','','NDA','NDA017058','Hikma Pharmaceuticals USA Inc.','METHADONE HYDROCHLORIDE','40','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4550_d72fc36a-3aee-493b-9fa1-5ce69d35b39d','0054-4550','HUMAN PRESCRIPTION DRUG','Methotrexate Sodium','','Methotrexate Sodium','TABLET','ORAL','19940801','','ANDA','ANDA040054','West-Ward Pharmaceuticals Corp.','METHOTREXATE SODIUM','2.5','mg/1','Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4570_b2d1a6bb-c12c-428c-b21f-0d918d247570','0054-4570','HUMAN PRESCRIPTION DRUG','METHADONE HYDROCHLORIDE','','METHADONE HYDROCHLORIDE','TABLET','ORAL','20011011','20230831','NDA','NDA006134','Hikma Pharmaceuticals USA Inc.','METHADONE HYDROCHLORIDE','5','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4571_b2d1a6bb-c12c-428c-b21f-0d918d247570','0054-4571','HUMAN PRESCRIPTION DRUG','METHADONE HYDROCHLORIDE','','METHADONE HYDROCHLORIDE','TABLET','ORAL','20011011','20230831','NDA','NDA006134','Hikma Pharmaceuticals USA Inc.','METHADONE HYDROCHLORIDE','10','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4581_0af63ac3-f9e8-4cba-8bb0-b42cec662c80','0054-4581','HUMAN PRESCRIPTION DRUG','Mercaptopurine','','Mercaptopurine','TABLET','ORAL','20040213','','ANDA','ANDA040528','Hikma Pharmaceuticals USA Inc.','MERCAPTOPURINE','50','mg/1','Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4728_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae','0054-4728','HUMAN PRESCRIPTION DRUG','PredniSONE','','PredniSONE','TABLET','ORAL','19720421','','ANDA','ANDA080352','Hikma Pharmaceuticals USA Inc.','PREDNISONE','5','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4741_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae','0054-4741','HUMAN PRESCRIPTION DRUG','PredniSONE','','PredniSONE','TABLET','ORAL','19820422','','ANDA','ANDA087800','Hikma Pharmaceuticals USA Inc.','PREDNISONE','1','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4742_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae','0054-4742','HUMAN PRESCRIPTION DRUG','PredniSONE','','PredniSONE','TABLET','ORAL','19820422','','ANDA','ANDA087801','Hikma Pharmaceuticals USA Inc.','PREDNISONE','2.5','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4858_5f2e46af-164a-4ca1-a126-823e4a4fe3e7','0054-4858','HUMAN PRESCRIPTION DRUG','Triazolam','','Triazolam','TABLET','ORAL','20181029','','ANDA','ANDA074224','Hikma Pharmaceuticals USA Inc.','TRIAZOLAM','0.125','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-4859_5f2e46af-164a-4ca1-a126-823e4a4fe3e7','0054-4859','HUMAN PRESCRIPTION DRUG','Triazolam','','Triazolam','TABLET','ORAL','20181029','','ANDA','ANDA074224','Hikma Pharmaceuticals USA Inc.','TRIAZOLAM','0.25','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8146_4badcce8-f27a-44dd-87f1-2fd1375d39a0','0054-8146','HUMAN PRESCRIPTION DRUG','Clotrimazole','','Clotrimazole','LOZENGE','ORAL; TOPICAL','20040729','','ANDA','ANDA076387','Hikma Pharmacuticals USA USA Inc.','CLOTRIMAZOLE','10','mg/1','Azole Antifungal [EPC], Azoles [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8174_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13','0054-8174','HUMAN PRESCRIPTION DRUG','Dexamethasone','','Dexamethasone','TABLET','ORAL','19830915','','ANDA','ANDA088306','Hikma Pharmaceuticals USA, Inc.','DEXAMETHASONE','1','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8175_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13','0054-8175','HUMAN PRESCRIPTION DRUG','Dexamethasone','','Dexamethasone','TABLET','ORAL','19780719','','ANDA','ANDA084612','Hikma Pharmaceuticals USA, Inc.','DEXAMETHASONE','4','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8176_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13','0054-8176','HUMAN PRESCRIPTION DRUG','Dexamethasone','','Dexamethasone','TABLET','ORAL','19820826','','ANDA','ANDA087916','Hikma Pharmaceuticals USA, Inc.','DEXAMETHASONE','2','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8179_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13','0054-8179','HUMAN PRESCRIPTION DRUG','Dexamethasone','','Dexamethasone','TABLET','ORAL','19750725','','ANDA','ANDA084611','Hikma Pharmaceuticals USA, Inc.','DEXAMETHASONE','0.5','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8180_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13','0054-8180','HUMAN PRESCRIPTION DRUG','Dexamethasone','','Dexamethasone','TABLET','ORAL','19750603','','ANDA','ANDA084613','Hikma Pharmaceuticals USA, Inc.','DEXAMETHASONE','0.75','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8181_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13','0054-8181','HUMAN PRESCRIPTION DRUG','Dexamethasone','','Dexamethasone','TABLET','ORAL','19750519','','ANDA','ANDA084610','Hikma Pharmaceuticals USA, Inc.','DEXAMETHASONE','1.5','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8183_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13','0054-8183','HUMAN PRESCRIPTION DRUG','Dexamethasone','','Dexamethasone','TABLET','ORAL','19830915','','ANDA','ANDA088316','Hikma Pharmaceuticals USA, Inc.','DEXAMETHASONE','6','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8297_27097d45-7ebd-480d-9d3a-68b539b4fd9b','0054-8297','HUMAN PRESCRIPTION DRUG','Furosemide','','Furosemide','TABLET','ORAL','19831110','','NDA','NDA018823','West-Ward Pharmaceuticals Corp.','FUROSEMIDE','20','mg/1','Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8299_27097d45-7ebd-480d-9d3a-68b539b4fd9b','0054-8299','HUMAN PRESCRIPTION DRUG','Furosemide','','Furosemide','TABLET','ORAL','19831110','','NDA','NDA018823','West-Ward Pharmaceuticals Corp.','FUROSEMIDE','40','mg/1','Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8301_27097d45-7ebd-480d-9d3a-68b539b4fd9b','0054-8301','HUMAN PRESCRIPTION DRUG','Furosemide','','Furosemide','TABLET','ORAL','19910313','','ANDA','ANDA070086','West-Ward Pharmaceuticals Corp.','FUROSEMIDE','80','mg/1','Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8496_2bead056-06b2-4a6c-9df2-e437147df79b','0054-8496','HUMAN PRESCRIPTION DRUG','Leucovorin Calcium','','Leucovorin Calcium','TABLET','ORAL','19930222','','ANDA','ANDA072733','West-Ward Pharmaceuticals Corp.','LEUCOVORIN CALCIUM','5','mg/1','Folate Analog [EPC], Folic Acid [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8526_82f2a1ee-741f-42a6-a609-735d54f1a8cd','0054-8526','HUMAN PRESCRIPTION DRUG','Lithium Carbonate','','Lithium Carbonate','CAPSULE, GELATIN COATED','ORAL','19870128','','NDA','NDA017812','Hikma Pharmaceuticals USA Inc.','LITHIUM CARBONATE','150','mg/1','Mood Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8527_82f2a1ee-741f-42a6-a609-735d54f1a8cd','0054-8527','HUMAN PRESCRIPTION DRUG','Lithium Carbonate','','Lithium Carbonate','CAPSULE, GELATIN COATED','ORAL','19801126','','NDA','NDA017812','Hikma Pharmaceuticals USA Inc.','LITHIUM CARBONATE','300','mg/1','Mood Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8528_82f2a1ee-741f-42a6-a609-735d54f1a8cd','0054-8528','HUMAN PRESCRIPTION DRUG','Lithium Carbonate','','Lithium Carbonate','TABLET','ORAL','19820614','','NDA','NDA018558','Hikma Pharmaceuticals USA Inc.','LITHIUM CARBONATE','300','mg/1','Mood Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8531_82f2a1ee-741f-42a6-a609-735d54f1a8cd','0054-8531','HUMAN PRESCRIPTION DRUG','Lithium Carbonate','','Lithium Carbonate','CAPSULE, GELATIN COATED','ORAL','19870128','','NDA','NDA017812','Hikma Pharmaceuticals USA Inc.','LITHIUM CARBONATE','600','mg/1','Mood Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8550_d72fc36a-3aee-493b-9fa1-5ce69d35b39d','0054-8550','HUMAN PRESCRIPTION DRUG','Methotrexate Sodium','','Methotrexate Sodium','TABLET','ORAL','19940801','','ANDA','ANDA040054','West-Ward Pharmaceuticals Corp.','METHOTREXATE SODIUM','2.5','mg/1','Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8553_b2d1a6bb-c12c-428c-b21f-0d918d247570','0054-8553','HUMAN PRESCRIPTION DRUG','METHADONE HYDROCHLORIDE','','METHADONE HYDROCHLORIDE','TABLET','ORAL','20011011','20230831','NDA','NDA006134','Hikma Pharmaceuticals USA Inc.','METHADONE HYDROCHLORIDE','5','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8554_b2d1a6bb-c12c-428c-b21f-0d918d247570','0054-8554','HUMAN PRESCRIPTION DRUG','METHADONE HYDROCHLORIDE','','METHADONE HYDROCHLORIDE','TABLET','ORAL','20011011','20230831','NDA','NDA006134','Hikma Pharmaceuticals USA Inc.','METHADONE HYDROCHLORIDE','10','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8724_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae','0054-8724','HUMAN PRESCRIPTION DRUG','PredniSONE','','PredniSONE','TABLET','ORAL','19720421','','ANDA','ANDA080352','Hikma Pharmaceuticals USA Inc.','PREDNISONE','5','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8739_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae','0054-8739','HUMAN PRESCRIPTION DRUG','PredniSONE','','PredniSONE','TABLET','ORAL','19820422','','ANDA','ANDA087800','Hikma Pharmaceuticals USA Inc.','PREDNISONE','1','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-8740_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae','0054-8740','HUMAN PRESCRIPTION DRUG','PredniSONE','','PredniSONE','TABLET','ORAL','19820422','','ANDA','ANDA087801','Hikma Pharmaceuticals USA Inc.','PREDNISONE','2.5','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-9628_fda967e8-1066-4084-be92-3ae5495cf85f','0054-9628','HUMAN PRESCRIPTION DRUG','sodium oxybate','','sodium oxybate','SOLUTION','ORAL','20230103','','NDA AUTHORIZED GENERIC','NDA021196','Hikma Pharmaceuticals USA Inc.','SODIUM OXYBATE','0.5','g/mL','Central Nervous System Depressant [EPC], Central Nervous System Depression [PE], Decreased Central Nervous System Organized Electrical Activity [PE]','CIII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-9817_62ebfd2e-967b-42b9-b442-e33fdffa02a1','0054-9817','HUMAN PRESCRIPTION DRUG','PredniSONE','','PredniSONE','TABLET','ORAL','20200323','','ANDA','ANDA084122','Hikma Pharmaceuticals USA Inc.','PREDNISONE','10','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-9818_62ebfd2e-967b-42b9-b442-e33fdffa02a1','0054-9818','HUMAN PRESCRIPTION DRUG','PredniSONE','','PredniSONE','TABLET','ORAL','20200323','','ANDA','ANDA087342','Hikma Pharmaceuticals USA Inc.','PREDNISONE','20','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0054-9828_62ebfd2e-967b-42b9-b442-e33fdffa02a1','0054-9828','HUMAN PRESCRIPTION DRUG','PredniSONE','','PredniSONE','TABLET','ORAL','20200323','','ANDA','ANDA080352','Hikma Pharmaceuticals USA Inc.','PREDNISONE','5','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0056-0470_41a64d5a-31b4-47ba-b508-83ad0aa316f0','0056-0470','HUMAN PRESCRIPTION DRUG','SUSTIVA','','Efavirenz','CAPSULE, GELATIN COATED','ORAL','19980917','','NDA','NDA020972','Bristol-Myers Squibb Pharma Company','EFAVIRENZ','50','mg/1','Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0056-0474_41a64d5a-31b4-47ba-b508-83ad0aa316f0','0056-0474','HUMAN PRESCRIPTION DRUG','SUSTIVA','','efavirenz','CAPSULE, GELATIN COATED','ORAL','19980917','','NDA','NDA020972','Bristol-Myers Squibb Pharma Company','EFAVIRENZ','200','mg/1','Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0056-0510_41a64d5a-31b4-47ba-b508-83ad0aa316f0','0056-0510','HUMAN PRESCRIPTION DRUG','SUSTIVA','','efavirenz','TABLET, FILM COATED','ORAL','20020201','20230331','NDA','NDA021360','Bristol-Myers Squibb Pharma Company','EFAVIRENZ','600','mg/1','Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0002_1ef6712d-31dc-4ad8-8b8a-f8ac518af6d4','0065-0002','HUMAN PRESCRIPTION DRUG','NEVANAC','','nepafenac','SUSPENSION/ DROPS','OPHTHALMIC','20050906','20230430','NDA','NDA021862','Alcon Laboratories, Inc.','NEPAFENAC','1','mg/mL','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0023_a76a34d0-2e07-408d-a8c8-d00f2715cad7','0065-0023','HUMAN PRESCRIPTION DRUG','MIOSTAT','','carbachol','SOLUTION','OPHTHALMIC','19740415','','NDA','NDA016968','Alcon Laboratories, Inc.','CARBACHOL','0.1','mg/mL','Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0085_e3740797-4cde-46a9-9f83-77a898a2015a','0065-0085','HUMAN OTC DRUG','Naphcon A','','naphazoline hydrochloride and pheniramine maleate','SOLUTION/ DROPS','OPHTHALMIC','19940608','','NDA','NDA020226','Alcon Laboratories, Inc.','NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE','.25; 3','mg/mL; mg/mL','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0092_da24f096-d906-49a0-b617-b6efd92b5137','0065-0092','HUMAN PRESCRIPTION DRUG','FLUORESCITE','','fluorescein sodium','INJECTION, SOLUTION','OPHTHALMIC','19720915','','NDA','NDA021980','Alcon, Inc.','FLUORESCEIN SODIUM','100','mg/mL','Diagnostic Dye [EPC], Dyes [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0246_35ea44d6-4fbe-4388-bd89-56db723454ec','0065-0246','HUMAN PRESCRIPTION DRUG','Betoptic S','','betaxolol hydrochloride','SUSPENSION/ DROPS','OPHTHALMIC','19960115','20240831','NDA','NDA019845','Alcon Laboratories, Inc.','BETAXOLOL HYDROCHLORIDE','2.8','mg/mL','Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0303_b3493429-e973-4c38-8e7b-23376075bd20','0065-0303','HUMAN PRESCRIPTION DRUG','Isopto Atropine','','atropine sulfate','SOLUTION','OPHTHALMIC','20180801','','NDA','NDA208151','Alcon Laboratories, Inc.','ATROPINE SULFATE','10','mg/mL','Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0345_03d9a61d-ef23-486d-a798-2e604f84d2f3','0065-0345','HUMAN PRESCRIPTION DRUG','ALOMIDE','','lodoxamide tromethamine','SOLUTION/ DROPS','OPHTHALMIC','19930930','','NDA','NDA020191','Alcon Laboratories, Inc.','LODOXAMIDE TROMETHAMINE','1','mg/mL','Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0355_3dd122a9-260c-4d25-9f18-38373ce1b07d','0065-0355','HUMAN PRESCRIPTION DRUG','Mydriacyl','','tropicamide','SOLUTION/ DROPS','OPHTHALMIC','19590401','','ANDA','ANDA084306','Alcon Laboratories, Inc.','TROPICAMIDE','10','mg/mL','Anticholinergic [EPC], Cholinergic Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0359_75764abf-89a0-42c8-8140-490ec64af364','0065-0359','HUMAN PRESCRIPTION DRUG','Cyclomydril','','cyclopentolate hydrochloride and phenylephrine hydrochloride','SOLUTION/ DROPS','OPHTHALMIC','19580630','','ANDA','ANDA084300','Alcon Laboratories, Inc.','CYCLOPENTOLATE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE','2; 10','mg/mL; mg/mL','Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0395_cfb4f056-5116-4202-9867-c0d6822c1ca4','0065-0395','HUMAN PRESCRIPTION DRUG','Cyclogyl','','cyclopentolate hydrochloride','SOLUTION/ DROPS','OPHTHALMIC','19751015','','ANDA','ANDA084109','Alcon Laboratories, Inc.','CYCLOPENTOLATE HYDROCHLORIDE','5','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0396_cfb4f056-5116-4202-9867-c0d6822c1ca4','0065-0396','HUMAN PRESCRIPTION DRUG','Cyclogyl','','cyclopentolate hydrochloride','SOLUTION/ DROPS','OPHTHALMIC','19751015','','ANDA','ANDA084110','Alcon Laboratories, Inc.','CYCLOPENTOLATE HYDROCHLORIDE','10','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0397_cfb4f056-5116-4202-9867-c0d6822c1ca4','0065-0397','HUMAN PRESCRIPTION DRUG','Cyclogyl','','cyclopentolate hydrochloride','SOLUTION/ DROPS','OPHTHALMIC','19751015','','ANDA','ANDA084108','Alcon Laboratories, Inc.','CYCLOPENTOLATE HYDROCHLORIDE','20','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0408_e68a7561-ccb1-4543-8cb8-5d9c0bf97054','0065-0408','HUMAN OTC DRUG','Alcon Tears Lubricant Eye Drops','','hypromellose 2910','SOLUTION/ DROPS','OPHTHALMIC','20220301','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','HYPROMELLOSE 2910 (4000 MPA.S)','5','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0411_45bf2066-cfd2-48ef-acf9-b590c69b83d8','0065-0411','HUMAN PRESCRIPTION DRUG','Betadine','','povidone-iodine','SOLUTION','OPHTHALMIC','20000401','','NDA','NDA018634','Alcon Laboratories, Inc.','POVIDONE-IODINE','5','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0419_65b7dae5-23bd-4b9f-9b71-44302929d888','0065-0419','HUMAN OTC DRUG','BION TEARS','','Dextran, Hypromellose','SOLUTION/ DROPS','OPHTHALMIC','19921019','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','DEXTRAN 70; HYPROMELLOSE 2910 (4000 MPA.S)','1; 3','mg/mL; mg/mL','Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0426_3a0ab361-3294-46f0-8a06-b9e3116a196c','0065-0426','HUMAN OTC DRUG','GenTeal Tears (Moderate)','','Dextran 70, Glycerin, Hypromellose','SOLUTION/ DROPS','OPHTHALMIC','20160301','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','DEXTRAN 70; GLYCERIN; HYPROMELLOSES','1; 2; 3','mg/mL; mg/mL; mg/mL','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Intravascular Volume [PE], Non-Standardized Chemical Allergen [EPC], Osmotic Activity [MoA], Plasma Volume Expander [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0429_da3602aa-464a-48f0-b271-bb8a92510976','0065-0429','HUMAN OTC DRUG','Systane Lubricant','','polyethylene glycol 400 and Propylene Glycol','SOLUTION/ DROPS','OPHTHALMIC','20030225','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL','4; 3','mg/mL; mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0431_b85c2dbe-8d3d-4710-be36-b29f6da96996','0065-0431','HUMAN OTC DRUG','Systane','','polyethylene glycol and propylene glycol','SOLUTION/ DROPS','OPHTHALMIC','20151030','','OTC MONOGRAPH FINAL','part349','Alcon Research Ltd','POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL','4; 3','mg/mL; mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0454_512ea6a9-e2fc-4abf-b017-27592c0104c4','0065-0454','HUMAN OTC DRUG','Systane','','polyethylene glycol 400 and propylene glycol','GEL','OPHTHALMIC','20110209','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL','4; 3','mg/mL; mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0474_ee82919f-c30d-4080-90fc-3a19399fa8c3','0065-0474','HUMAN OTC DRUG','Systane','','hypromellose','GEL','OPHTHALMIC','20121215','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','HYPROMELLOSE 2910 (4000 MPA.S)','3','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0481_bb5079f7-97b5-4717-a9c3-38a5ec6f53b9','0065-0481','HUMAN OTC DRUG','Systane COMPLETE','','propylene glycol','SOLUTION/ DROPS','OPHTHALMIC','20180118','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','PROPYLENE GLYCOL','0.06','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0509_9a55faee-28be-47c0-afb8-9ebb908588f9','0065-0509','HUMAN OTC DRUG','Systane Nighttime','','mineral oil and white petrolatum','OINTMENT','OPHTHALMIC','20080626','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','MINERAL OIL; PETROLATUM','30; 940','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0518_c369d5b6-f62d-4c99-8fc7-de156cb6c344','0065-0518','HUMAN OTC DRUG','GenTeal','Tears NIGHT-TIME','mineral oil, white petrolatum','OINTMENT','OPHTHALMIC','20190905','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','MINERAL OIL; PETROLATUM','.03; .94','g/g; g/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0530_b61b61a6-aea9-463b-90ca-c683fea1104c','0065-0530','HUMAN OTC DRUG','Eye Stream','','purified water','SOLUTION','OPHTHALMIC','19900930','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','WATER','986','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0543_327d9281-7dab-4282-87c3-3fcc73005a26','0065-0543','HUMAN PRESCRIPTION DRUG','TRIESENCE','','triamcinolone acetonide','INJECTION, SUSPENSION','OPHTHALMIC','20071115','','NDA','NDA022048','Alcon Laboratories, Inc.','TRIAMCINOLONE ACETONIDE','40','mg/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0631_7cafb7c6-1bf0-42d8-aa07-bc544149b50d','0065-0631','HUMAN PRESCRIPTION DRUG','MAXITROL','','neomycin sulfate, polymyxin b sulfate and dexamethasone','OINTMENT','OPHTHALMIC','19720117','20240531','NDA','NDA050065','Alcon Laboratories, Inc.','DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE','1; 3.5; 10000','mg/g; mg/g; [USP''''U]/g','Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0643_a87d9282-fb88-4622-a142-db8da80df7a1','0065-0643','HUMAN PRESCRIPTION DRUG','Tobrex','','tobramycin','SOLUTION/ DROPS','OPHTHALMIC','19810315','20230331','NDA','NDA050541','Alcon Laboratories, Inc.','TOBRAMYCIN','3','mg/mL','Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0644_0b5a5e18-a461-4803-bda1-06c69bc4e7f3','0065-0644','HUMAN PRESCRIPTION DRUG','TOBREX','','tobramycin','OINTMENT','OPHTHALMIC','19810628','20230731','NDA','NDA050555','Alcon Laboratories, Inc.','TOBRAMYCIN','3','mg/g','Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0647_17119e04-12c0-47aa-87a6-8b6f385c5e87','0065-0647','HUMAN PRESCRIPTION DRUG','TobraDex','','tobramycin and dexamethasone','SUSPENSION/ DROPS','OPHTHALMIC','19880915','20230831','NDA','NDA050592','Alcon Laboratories, Inc.','DEXAMETHASONE; TOBRAMYCIN','1; 3','mg/mL; mg/mL','Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0656_0b3a3acd-dc13-403e-a8b1-761de56a476a','0065-0656','HUMAN PRESCRIPTION DRUG','Ciloxan','','ciprofloxacin hydrochloride','SOLUTION/ DROPS','OPHTHALMIC','19910115','20230430','NDA','NDA019992','Alcon Laboratories, Inc.','CIPROFLOXACIN HYDROCHLORIDE','3','mg/mL','Quinolone Antimicrobial [EPC], Quinolones [CS]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0741_02b341d7-93f6-4fde-a883-cdf4df6155b7','0065-0741','HUMAN PRESCRIPTION DRUG','Tetracaine Hydrochloride','','tetracaine hydrochloride','SOLUTION','OPHTHALMIC','20161026','','NDA','NDA208135','Alcon Laboratories, Inc.','TETRACAINE HYDROCHLORIDE','5','mg/mL','Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0795_19d9e9e4-f86c-4139-8c67-e5f88c828ecf','0065-0795','HUMAN PRESCRIPTION DRUG','BSS','','balanced salt solution','SOLUTION','OPHTHALMIC','19690328','','NDA','NDA020742','Alcon Laboratories, Inc.','CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE','.48; .3; .75; 3.9; 6.4; 1.7','mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL','Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0800_8b79ed6c-9cc6-490a-b054-f77f9d1043d8','0065-0800','HUMAN PRESCRIPTION DRUG','BSS PLUS','','balanced salt solution enriched with bicarbonate, dextrose, and glutathione','KIT','','19820628','','NDA','NDA018469','Alcon Laboratories, Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0800_b114037a-b679-4ede-9b62-10039fa28948','0065-0800','HUMAN PRESCRIPTION DRUG','BSS PLUS','','balanced salt solution enriched with bicarbonate, dextrose, and glutathione','KIT','','20130620','','NDA','NDA018469','Alcon Laboratories, Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0816_c6eef41b-de2a-4461-9880-bc220176e886','0065-0816','HUMAN OTC DRUG','PATADAY ONCE DAILY RELIEF','','OLOPATADINE HYDROCHLORIDE','SOLUTION','OPHTHALMIC','20200901','','NDA','NDA206276','Alcon Laboratories, Inc.','OLOPATADINE HYDROCHLORIDE','7','mg/mL','Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-0817_4da0512b-9d9f-4a23-a0da-4d4c80248e5d','0065-0817','HUMAN PRESCRIPTION DRUG','atropine sulfate','','atropine sulfate','SOLUTION','OPHTHALMIC','20221101','','NDA','NDA208151','Alcon Laboratories, Inc.','ATROPINE SULFATE','10','mg/mL','Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-1431_c8c80056-650c-4e2f-aa09-b53de5509a19','0065-1431','HUMAN OTC DRUG','Systane Ultra','','Polyethylene Glycol 400 and Propylene Glycol','SOLUTION/ DROPS','OPHTHALMIC','20141001','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL','4; 3','mg/mL; mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-1432_0652d5f3-8712-4c77-8378-c70ae2dd8057','0065-1432','HUMAN OTC DRUG','Systane','ULTRA','polyethylene glycol 400 and propylene glycol','SOLUTION/ DROPS','OPHTHALMIC','20090727','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL','4; 3','mg/mL; mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-1433_bd53f321-290c-43ed-99f5-ceb1fda201b8','0065-1433','HUMAN OTC DRUG','Systane Balance','','propylene glycol','EMULSION','OPHTHALMIC','20100727','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','PROPYLENE GLYCOL','0.06','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-1437_8e15cbf5-54ae-4824-a500-52a2f68f7735','0065-1437','HUMAN OTC DRUG','SYSTANE HYDRATION PF PRESERVATIVE FREE','','Polyethylene Glycol 400 and Propylene Glycol','SOLUTION/ DROPS','OPHTHALMIC','20200201','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL','4; 3','mg/mL; mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-1502_76d6a71f-7fb8-479f-864f-c4e669cb2335','0065-1502','HUMAN OTC DRUG','Systane Day and Night Value Pack','','Polyethylene Glycol 400, Propylene Glycol 0.3%','KIT','','20171024','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-1507_1750df8b-79ac-4629-a431-8fa938f75a75','0065-1507','HUMAN OTC DRUG','Systane Ultra Preservative Free','','Polyethylene Glycol 400 and Propylene Glycol','SOLUTION/ DROPS','OPHTHALMIC','20220215','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL','4; 3','mg/mL; mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-1509_2b02d7cd-aaa7-4c77-8242-da03ad6fa3f3','0065-1509','HUMAN OTC DRUG','Systane COMPLETE PF','','propylene glycol','SOLUTION/ DROPS','OPHTHALMIC','20220118','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','PROPYLENE GLYCOL','0.06','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-1510_61d6e239-9631-42a6-827f-e85aa1b5483c','0065-1510','HUMAN OTC DRUG','SYSTANE HYDRATION PF PRESERVATIVE FREE','','Polyethylene Glycol 400 and Propylene Glycol','SOLUTION/ DROPS','OPHTHALMIC','20210201','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL','4; 3','mg/mL; mg/mL','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-1530_de8a86a8-51e9-4885-8208-1eab14ad027e','0065-1530','HUMAN OTC DRUG','Systane COMPLETE PF','','propylene glycol','SOLUTION/ DROPS','OPHTHALMIC','20220201','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','PROPYLENE GLYCOL','0.06','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-1795_aab0e1e5-e73f-487e-8577-b957220cf461','0065-1795','HUMAN PRESCRIPTION DRUG','BSS','','balanced salt solution','SOLUTION','OPHTHALMIC','19690328','','NDA','NDA020742','Alcon Laboratories, Inc.','CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE','.48; .3; .75; 3.9; 6.4; 1.7','mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL','Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-4011_6e40b121-083f-4f1f-8ed4-e685ec6c4c20','0065-4011','HUMAN OTC DRUG','Zaditor','','ketotifen fumarate','SOLUTION','OPHTHALMIC','20121221','','ANDA','ANDA077200','Alcon Laboratories, Inc.','KETOTIFEN FUMARATE','0.25','mg/mL','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-4147_fabf46ca-fe61-46db-a256-9f7fc346f700','0065-4147','HUMAN PRESCRIPTION DRUG','SIMBRINZA','','brinzolamide/brimonidine tartrate','SUSPENSION/ DROPS','OPHTHALMIC','20130506','','NDA','NDA204251','Alcon Laboratories, Inc.','BRIMONIDINE TARTRATE; BRINZOLAMIDE','2; 10','mg/mL; mg/mL','Adrenergic alpha-Agonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], alpha-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-4274_74a99914-4b5d-4428-9184-043f0dbe4c9e','0065-4274','HUMAN OTC DRUG','PATADAY TWICE A DAY RELIEF','','OLOPATADINE HYDROCHLORIDE','SOLUTION','OPHTHALMIC','20200228','','NDA','NDA020688','Alcon Laboratories, Inc.','OLOPATADINE HYDROCHLORIDE','1','mg/mL','Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-8063_0bdcea3f-656b-44b8-82e6-f17af8f79659','0065-8063','HUMAN OTC DRUG','GenTeal Tears Moderate Preservative Free','','dextran 70, hypromellose 2910','SOLUTION/ DROPS','OPHTHALMIC','20171222','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','DEXTRAN 70; HYPROMELLOSE 2910 (4000 MPA.S)','1; 3','mg/mL; mg/mL','Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-8064_c964fdd3-2f59-4404-90e1-80f30e7e2743','0065-8064','HUMAN OTC DRUG','GenTeal Tears','Severe','Hypromellose','GEL','OPHTHALMIC','20191214','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','HYPROMELLOSE 2910 (4000 MPA.S)','0.003','g/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-8067_1ad1f206-b037-4e6d-97dc-01171a64fae8','0065-8067','HUMAN OTC DRUG','GenTeal Tears Gel Drops','','polyethylene glycol 400 and propylene glycol','GEL','OPHTHALMIC','20210201','','OTC MONOGRAPH FINAL','part349','Alcon Laboratories, Inc.','POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL','4; 3','mg/mL; mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-8150_37f1bf3b-3e04-42b3-aa80-a22afd9b3e55','0065-8150','HUMAN OTC DRUG','PATADAY ONCE DAILY RELIEF','','OLOPATADINE HYDROCHLORIDE','SOLUTION','OPHTHALMIC','20200228','','NDA','NDA021545','Alcon Laboratories, Inc.','OLOPATADINE HYDROCHLORIDE','2','mg/mL','Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-8531_9fccedfd-5a06-45e3-85a8-5c89687bb0e2','0065-8531','HUMAN PRESCRIPTION DRUG','CIPRO','HC','ciprofloxacin hydrochloride and hydrocortisone','SUSPENSION','AURICULAR (OTIC)','19990315','20230531','NDA','NDA020805','Alcon Laboratories, Inc.','CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE','2; 10','mg/mL; mg/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Quinolone Antimicrobial [EPC], Quinolones [CS]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0065-9240_ff961dd4-e9a3-4a20-9a36-62319724d973','0065-9240','HUMAN PRESCRIPTION DRUG','DUREZOL','','DUREZOL','EMULSION','OPHTHALMIC','20110125','','NDA','NDA022212','Alcon Laboratories, Inc.','DIFLUPREDNATE','0.5','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-0117_93452d1f-a643-4402-b67e-364d1903996c','0067-0117','HUMAN OTC DRUG','Gas-X','Extra Strength','Simethicone','TABLET, CHEWABLE','ORAL','20120101','','OTC MONOGRAPH FINAL','part332','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DIMETHICONE','125','mg/1','Skin Barrier Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-0118_edb0f11a-bdb7-484d-9257-09ff47b0fca4','0067-0118','HUMAN OTC DRUG','Gas-X','Total Relief Maximum Strength','Calcium carbonate, Simethicone','TABLET, CHEWABLE','ORAL','20220203','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE; DIMETHICONE','750; 250','mg/1; mg/1','Skin Barrier Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-0119_62fc0a91-c44f-4546-a472-c183a2d95486','0067-0119','HUMAN OTC DRUG','Gas-X','Total Relief Maximum Strength','Calcium carbonate, Simethicone','TABLET, CHEWABLE','ORAL','20220203','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE; DIMETHICONE','750; 250','mg/1; mg/1','Skin Barrier Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-0129_a2b9dd33-249e-4128-9d57-5b0ff0f99414','0067-0129','HUMAN OTC DRUG','Gas-X','Extra Strength','Simethicone','TABLET, CHEWABLE','ORAL','20120101','','OTC MONOGRAPH FINAL','part332','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DIMETHICONE','125','mg/1','Skin Barrier Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-2001_a94552c2-4521-4e49-a759-ff664cdb5966','0067-2001','HUMAN OTC DRUG','Excedrin','Extra Strength Pain Reliever','Acetaminophen, Aspirin (NSAID), and Caffeine','TABLET, FILM COATED','ORAL','20190315','','OTC MONOGRAPH NOT FINAL','part343','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; ASPIRIN; CAFFEINE','250; 250; 65','mg/1; mg/1; mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-2021_7cb14fb8-1195-4da3-b9d7-7375d26fa029','0067-2021','HUMAN OTC DRUG','Excedrin','Extra Strength Geltabs','Acetaminophen, Asprin, Caffeine','TABLET, COATED','ORAL','20110913','','OTC MONOGRAPH NOT FINAL','part343','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; ASPIRIN; CAFFEINE','250; 250; 65','mg/1; mg/1; mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-2035_edbb64b9-f8ba-48db-8a36-d5837114f822','0067-2035','HUMAN OTC DRUG','Excedrin','Migraine Geltabs','Acetaminophen, Asprin, Caffeine','TABLET, COATED','ORAL','20110913','','NDA','NDA020802','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; ASPIRIN; CAFFEINE','250; 250; 65','mg/1; mg/1; mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-2040_f0e1a3a4-1ddd-4d82-8595-efc9d55df0df','0067-2040','HUMAN OTC DRUG','Excedrin','Migraine','Acetaminophen, Aspirin, and Caffeine','TABLET, FILM COATED','ORAL','20200930','','NDA','NDA020802','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; ASPIRIN; CAFFEINE','250; 250; 65','mg/1; mg/1; mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-2056_c6dee30c-40a2-423b-878c-7c1fa335626f','0067-2056','HUMAN OTC DRUG','Excedrin PM Triple Action Caplets','','Acetaminophen, Aspirin (NSAID) and Diphenhydramine Citrate','TABLET, COATED','ORAL','20140924','','OTC MONOGRAPH NOT FINAL','part343','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; ASPIRIN; DIPHENHYDRAMINE CITRATE','250; 250; 38','mg/1; mg/1; mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-2086_87d7b11c-4227-4073-95e2-1404bfe6d2f2','0067-2086','HUMAN OTC DRUG','4 Way','Fast Acting','Phenylephrine hydrochloride','SPRAY','NASAL','20100101','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','PHENYLEPHRINE HYDROCHLORIDE','10','mg/mL','Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-3998_f4438d90-0dcc-40ee-92a7-bdceb17ef010','0067-3998','HUMAN OTC DRUG','Lamisil','AT','TERBINAFINE HYDROCHLORIDE','CREAM','TOPICAL','20050810','','NDA','NDA020980','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','TERBINAFINE HYDROCHLORIDE','10','mg/g','Allylamine Antifungal [EPC], Allylamine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-3999_331b6cb8-35ae-483d-be2e-350d6c565175','0067-3999','HUMAN OTC DRUG','Lamisil','AT Jock Itch','TERBINAFINE HYDROCHLORIDE','CREAM','TOPICAL','20061208','','NDA','NDA020980','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','TERBINAFINE HYDROCHLORIDE','10','mg/g','Allylamine Antifungal [EPC], Allylamine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-6089_b7b2ee07-9848-415d-a071-f0b6458f83ca','0067-6089','HUMAN OTC DRUG','Theraflu','Cough Relief','Dextromethorphan HBr, Guaifenesin','POWDER, FOR SOLUTION','ORAL','20190701','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN','20; 400','mg/1; mg/1','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-6094_76f40bbc-261d-4a92-af8f-a7930bf3f167','0067-6094','HUMAN OTC DRUG','Theraflu','PowerPods Daytime Severe Cold','ACETAMINOPHEN, DEXTROMETHORPHAN, PHENYLEPHRINE','POWDER, FOR SOLUTION','ORAL','20180728','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE','650; 20; 10','mg/1; mg/1; mg/1','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-6095_6fa9cf74-c86e-437d-8a4e-32ff375b159f','0067-6095','HUMAN OTC DRUG','THERAFLU','POWERPODS NIGHTTIME SEVERE COLD','ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL','POWDER, FOR SOLUTION','ORAL','20180728','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE','650; 25; 10','mg/1; mg/1; mg/1','Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-6274_a0c9b428-1d79-44ea-a82b-eb9328e32f92','0067-6274','HUMAN OTC DRUG','Gas-X','Ultra Strength AntiGas Softgels','Simethicone','CAPSULE, LIQUID FILLED','ORAL','20070901','','OTC MONOGRAPH FINAL','part332','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DIMETHICONE','180','mg/1','Skin Barrier Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-6275_ce31eabe-0a51-4523-afe7-f5bf95e46591','0067-6275','HUMAN OTC DRUG','Gas-X','Extra Strength Softgels','Simethicone','CAPSULE, LIQUID FILLED','ORAL','20110912','','OTC MONOGRAPH FINAL','part332','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DIMETHICONE','125','mg/1','Skin Barrier Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-6283_bfbaaf31-a38c-48bf-9672-5df6d3006c5a','0067-6283','HUMAN OTC DRUG','Gas-X','Maximum Strength Softgels','Simethicone','CAPSULE, LIQUID FILLED','ORAL','20190310','','OTC MONOGRAPH FINAL','part332','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DIMETHICONE','250','mg/1','Skin Barrier Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-6296_54dd4021-d70c-426b-9506-1d1f1819782f','0067-6296','HUMAN OTC DRUG','LAMISIL','AT','TERBINAFINE HYDROCHLORIDE','AEROSOL, SPRAY','TOPICAL','20180307','','NDA','NDA021124','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','TERBINAFINE HYDROCHLORIDE','0.84','g/125mL','Allylamine Antifungal [EPC], Allylamine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-6297_1d96797c-7a93-40e9-8332-4aa2ccdcd129','0067-6297','HUMAN OTC DRUG','LAMISIL','AT','TERBINAFINE HYDROCHLORIDE','AEROSOL, SPRAY','TOPICAL','20180307','','NDA','NDA021124','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','TERBINAFINE HYDROCHLORIDE','0.84','g/125mL','Allylamine Antifungal [EPC], Allylamine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-6426_f0bd643f-a6ac-4478-b5fe-0ec307def4c5','0067-6426','HUMAN OTC DRUG','THERAFLU','MULTI-SYMPTOM SEVERE COLD','ACETAMINOPHEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl','POWDER, FOR SOLUTION','ORAL','20140701','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE','500; 20; 10','mg/237mL; mg/237mL; mg/237mL','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-6804_e5ef7b85-feee-44a7-bd0e-ed91352c7434','0067-6804','HUMAN OTC DRUG','Theraflu Severe Cold Relief Daytime and Theraflu Severe Cold Relief Nighttime','','Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, Diphenhydramine HCl','KIT','','20230120','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-7916_d8ddbe3f-aaa9-46a9-a96f-11670daec9ac','0067-7916','HUMAN OTC DRUG','Theraflu','Flu and Sore Throat','Acetaminophen, Pheniramine Maleate, Phenylephrine HCl','POWDER, FOR SOLUTION','ORAL','20050513','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; PHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE','650; 20; 10','mg/1; mg/1; mg/1','Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-7917_c7ca2bea-2ccc-4f67-aff6-4aa21d05f4ed','0067-7917','HUMAN OTC DRUG','Theraflu','Daytime Severe Cold and Cough','ACETAMINOPHEN, DEXTROMETHORPHAN, PHENYLEPHRINE','POWDER, FOR SOLUTION','ORAL','20120924','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE','650; 20; 10','mg/1; mg/1; mg/1','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-7918_8ac4a635-5408-41f8-874a-b3991083eddb','0067-7918','HUMAN OTC DRUG','THERAFLU','NIGHTTIME SEVERE COLD AND COUGH','ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL','POWDER, FOR SOLUTION','ORAL','20140701','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE','650; 25; 10','mg/237mL; mg/237mL; mg/237mL','Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-7919_1f6e6d6b-2793-45b1-95e7-31b709f87fb2','0067-7919','HUMAN OTC DRUG','Theraflu Multi-Symptom Severe Cold and Theraflu Nighttime Severe Cold and Cough','','Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, Diphenhydramine HCl','KIT','','20160101','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-7920_69e0a4f3-21ba-4901-9184-9af5b0fea0d0','0067-7920','HUMAN OTC DRUG','THERAFLU','SINUS AND PAIN','ACETAMINOPHEN, PHENIRAMINE MALEATE, PHENYLEPHRINE HCL','POWDER, FOR SOLUTION','ORAL','20200101','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; PHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE','650; 20; 10','mg/1; mg/1; mg/1','Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-7923_812a093f-cf83-4f7a-927a-1b5695be7f90','0067-7923','HUMAN OTC DRUG','Theraflu Flu Relief Max Strength','Daytime Nighttime Combo Pack','Acetaminophen, Dextromethorphan HBr, and Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr','KIT','','20220615','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8100_3831085f-f03b-4da1-823c-9574561dd92f','0067-8100','HUMAN OTC DRUG','Lamisil AT','','Terbinafine Hydrochloride','CREAM','TOPICAL','20070702','','ANDA','ANDA077511','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','TERBINAFINE HYDROCHLORIDE','1','g/100g','Allylamine Antifungal [EPC], Allylamine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8105_a7817767-c6af-459c-b807-8a7aac951dea','0067-8105','HUMAN OTC DRUG','Triaminic','Day Time Cold and Cough','Dextromethorphan HBr, Phenylephrine HCl','SYRUP','ORAL','20121015','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE','5; 2.5','mg/5mL; mg/5mL','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8106_893f86bf-9058-4b2f-a703-e25174cda029','0067-8106','HUMAN OTC DRUG','TRIAMINIC','Night Time Cold and Cough','Diphenhydramine HCl, Phenylephrine HCl','SYRUP','ORAL','20121015','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE','6.25; 2.5','mg/5mL; mg/5mL','Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8114_e076139d-60e6-4e93-81b0-aacebf68cbfb','0067-8114','HUMAN OTC DRUG','Lamisil AT','for Jock Itch','Terbinafine Hydrochloride','CREAM','TOPICAL','20070702','','ANDA','ANDA077511','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','TERBINAFINE HYDROCHLORIDE','1','g/100g','Allylamine Antifungal [EPC], Allylamine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8116_e26aeeb9-84ec-4809-837b-fdadd8649585','0067-8116','HUMAN OTC DRUG','Triaminic','Multi-Symptom Fever and Cold','Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan HBr, Phenylephrine HCl','SUSPENSION','ORAL','20130930','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE','160; 1; 5; 2.5','mg/5mL; mg/5mL; mg/5mL; mg/5mL','Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8124_16be0a08-f1de-4da9-a689-c1e71bde4926','0067-8124','HUMAN OTC DRUG','Theraflu Nighttime Multi-Symptom Severe Cold Powder','','Acetaminophen, Diphenhydramine Hydrochloride, Phenylephrine Hydrochloride','POWDER','ORAL','20150715','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE','500; 25; 10','mg/1; mg/1; mg/1','Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8125_5752247a-a951-49c8-b52a-2b7f387e4fbe','0067-8125','HUMAN OTC DRUG','Theraflu ExpressMax','Daytime Nighttime Value Pack','Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl and Acetaminophen, Diphenhydramine HCl, Phenylephrine HCl','KIT','','20150715','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8127_83aacea7-68a1-494d-b36c-6d72a1e61584','0067-8127','HUMAN OTC DRUG','Theraflu ExpressMax','Daytime Severe Cold and Cough','Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl','SYRUP','ORAL','20150715','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE','650; 20; 10','mg/30mL; mg/30mL; mg/30mL','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8129_515a0df6-7148-4edc-bfb8-aa1a036d436b','0067-8129','HUMAN OTC DRUG','Theraflu ExpressMax','Nighttime Severe Cold and Cough','Acetaminophen, Diphenhydramine HCl, Phenylephrine HCl','SYRUP','ORAL','20150715','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE','650; 25; 10','mg/30mL; mg/30mL; mg/30mL','Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8132_777d2ac7-e3cc-4513-8b6f-b90b2ff2c672','0067-8132','HUMAN OTC DRUG','Theraflu ExpressMax Severe Cold and Flu Syrup','','Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl','SYRUP','ORAL','20170707','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC.','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE','650; 20; 400; 10','mg/1; mg/1; mg/1; mg/1','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8136_0b77b02d-9a4a-4208-a291-c829d9655bba','0067-8136','HUMAN OTC DRUG','Theraflu ExpressMax','Daytime Severe Cold and Cough','acetaminophen, dextromethorphan HBr, phenylephrine HCl','TABLET, FILM COATED','ORAL','20160705','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE','325; 10; 5','mg/1; mg/1; mg/1','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8137_5201084d-a412-4c4f-b101-0432e97abd9f','0067-8137','HUMAN OTC DRUG','Theraflu ExpressMax','Nighttime Severe Cold and Cough','acetaminophen, diphenhydramine HCl, phenylephrine HCl','TABLET, FILM COATED','ORAL','20160705','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE','325; 12.5; 5','mg/1; mg/1; mg/1','Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8138_bf2f5e57-ca6d-4cd9-b851-b12ae84ef476','0067-8138','HUMAN OTC DRUG','Theraflu Expressmax Daytime Severe Cold and Cough and Theraflu Expressmax Nighttime Severe Cold and Cough','','acetaminophen, dextromethorphan HBr, phenylephrine HCl, diphenhydramine HCl','KIT','','20160705','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8139_e96aaf28-7d91-4bfc-8114-5523ea77c81c','0067-8139','HUMAN OTC DRUG','Excedrin','Tension Headache','Acetaminophen, Caffeine','TABLET, FILM COATED','ORAL','20161215','','OTC MONOGRAPH NOT FINAL','part343','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; CAFFEINE','500; 65','mg/1; mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8140_61fe32dd-8c1a-49ee-83ee-f854879925d5','0067-8140','HUMAN OTC DRUG','EX-LAX','REGULAR STRENGTH CHOCOLATED STIMULANT LAXATIVE','SENNOSIDES','TABLET, CHEWABLE','ORAL','20170801','','OTC MONOGRAPH NOT FINAL','part334','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','SENNOSIDES','15','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8141_7a0ee04e-9da2-40c8-81c6-29dd56c0ccf2','0067-8141','HUMAN OTC DRUG','EX-LAX','REGULAR STRENGTH STIMULANT LAXATIVE','SENNOSIDES','TABLET','ORAL','20170701','','OTC MONOGRAPH NOT FINAL','part334','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','SENNOSIDES','15','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8142_c2602e10-2671-4a6d-912f-18503a75461a','0067-8142','HUMAN OTC DRUG','EX-LAX','MAXIMUM STRENGTH STIMULANT LAXATIVE','SENNOSIDES','PILL','ORAL','20170701','','OTC MONOGRAPH NOT FINAL','part334','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','SENNOSIDES','25','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8143_0279e79c-0820-4702-9533-fcce3a23e1ad','0067-8143','HUMAN OTC DRUG','Perdiem','','Sennosides, stimulant laxative','TABLET','ORAL','20170701','','OTC MONOGRAPH NOT FINAL','part334','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','SENNOSIDES','15','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8145_8e22f6bc-33ce-4bb0-99be-7947aa21f60e','0067-8145','HUMAN OTC DRUG','Theraflu ExpressMax Severe Cold and Flu Caplets','','Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl','TABLET, COATED','ORAL','20170717','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC.','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE','325; 10; 200; 5','mg/1; mg/1; mg/1; mg/1','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8147_8bf52f8d-cf39-4015-bbc0-8af8a90bfde7','0067-8147','HUMAN OTC DRUG','Excedrin PM Triple Action Caplets and Excedrin Tension Headache','','Acetaminophen, Aspirin (NSAID), Caffeine, and Diphenhydramine Citrate','KIT','','20170601','','OTC MONOGRAPH NOT FINAL','part343','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8152_2b066c97-9554-41eb-92ed-f038062128d4','0067-8152','HUMAN OTC DRUG','Voltaren','Arthritis Pain','diclofenac sodium','GEL','TOPICAL','20200513','','NDA','NDA022122','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DICLOFENAC SODIUM','10','mg/g','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8153_2b066c97-9554-41eb-92ed-f038062128d4','0067-8153','HUMAN OTC DRUG','Voltaren','Arthritis Pain','diclofenac sodium','KIT','','20200513','','NDA','NDA022122','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8161_68d3e88a-d1be-410b-92a1-863903b3aa61','0067-8161','HUMAN OTC DRUG','Theraflu Flu Relief Maximum Strength','Daytime Nighttime Combo Pack','Acetaminophen, Dextromethorphan HBr and Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr','KIT','','20220627','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8200_1f6e6d6b-2793-45b1-95e7-31b709f87fb2','0067-8200','HUMAN OTC DRUG','Theraflu Multi-Symptom Severe Cold and Theraflu Nighttime Severe Cold and Cough','','Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, Diphenhydramine HCl','KIT','','20160101','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8201_029a0be5-dfe8-49a7-afc6-44235d5f9944','0067-8201','HUMAN OTC DRUG','EXCEDRIN','MIGRAINE','Acetaminophen, Aspirin (NSAID) and Caffeine','TABLET, FILM COATED','ORAL','20100215','','NDA','NDA020802','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; ASPIRIN; CAFFEINE','250; 250; 65','mg/1; mg/1; mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8202_60acc110-03ee-44f1-9c51-f4bf0c92f688','0067-8202','HUMAN OTC DRUG','Excedrin','Extra Strength Pain Reliever','Acetaminophen, Aspirin (NSAID), and Caffeine','TABLET, FILM COATED','ORAL','20200309','','OTC MONOGRAPH NOT FINAL','part343','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; ASPIRIN; CAFFEINE','250; 250; 65','mg/1; mg/1; mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8203_a6c98766-63c5-4376-9823-6a26a43646dc','0067-8203','HUMAN OTC DRUG','Excedrin','Extra Strength Pain Reliever','Acetaminophen, Aspirin (NSAID), and Caffeine','TABLET, FILM COATED','ORAL','20210115','','OTC MONOGRAPH NOT FINAL','part343','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; ASPIRIN; CAFFEINE','250; 250; 65','mg/1; mg/1; mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8204_0324195f-506d-4747-990e-ad44e2a117d9','0067-8204','HUMAN OTC DRUG','Theraflu Flu Relief Max Strength','Daytime','Acetaminophen, Dextromethorphan HBr','SYRUP','ORAL','20220627','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE','1000; 30','mg/30mL; mg/30mL','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8205_61898c20-fbf7-4d08-bb32-9bc248da25d5','0067-8205','HUMAN OTC DRUG','Theraflu Flu Relief Max Strength','Nighttime','Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr','SYRUP','ORAL','20220627','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE','1000; 4; 30','mg/30mL; mg/30mL; mg/30mL','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0067-8206_3618ccf0-1f30-42e0-bb50-bfa45cf2b583','0067-8206','HUMAN OTC DRUG','Theraflu Flu Relief Max Strength','Daytime Nighttime Value Pack','Acetaminophen, Dextromethorphan HBr, and Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr','KIT','','20220627','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0068-0597_0db28d98-b7ae-4691-a449-44abbb57648a','0068-0597','HUMAN PRESCRIPTION DRUG','Rifadin IV','','rifampin','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','19890525','','NDA','NDA050627','Sanofi-Aventis U.S. LLC','RIFAMPIN','600','mg/10mL','Rifamycin Antibacterial [EPC], Rifamycins [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0068-0599_f1d1e8af-f114-472e-b376-4e15fa9f7680','0068-0599','HUMAN PRESCRIPTION DRUG','Rifadin IV NOVAPLUS','','rifampin','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20170201','','NDA','NDA050627','Sanofi-Aventis U.S. LLC','RIFAMPIN','600','mg/10mL','Rifamycin Antibacterial [EPC], Rifamycins [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0043_402dbe94-888a-4e23-ba4b-b910f15c31e1','0069-0043','HUMAN PRESCRIPTION DRUG','Heparin Sodium','','Heparin Sodium','INJECTION','INTRAVENOUS; SUBCUTANEOUS','20110721','','NDA','NDA201370','Pfizer Laboratories Div Pfizer Inc','HEPARIN SODIUM','1000','[USP''''U]/mL','Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0058_402dbe94-888a-4e23-ba4b-b910f15c31e1','0069-0058','HUMAN PRESCRIPTION DRUG','Heparin Sodium','','Heparin Sodium','INJECTION','INTRAVENOUS; SUBCUTANEOUS','20110721','','NDA','NDA201370','Pfizer Laboratories Div Pfizer Inc','HEPARIN SODIUM','1000','[USP''''U]/mL','Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0059_402dbe94-888a-4e23-ba4b-b910f15c31e1','0069-0059','HUMAN PRESCRIPTION DRUG','Heparin Sodium','','Heparin Sodium','INJECTION','INTRAVENOUS; SUBCUTANEOUS','20110721','','NDA','NDA201370','Pfizer Laboratories Div Pfizer Inc','HEPARIN SODIUM','5000','[USP''''U]/mL','Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0106_6ea80913-7294-4abd-8280-c3ac61da48db','0069-0106','HUMAN PRESCRIPTION DRUG','ELELYSO','','Taliglucerase alfa','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20120501','','BLA','BLA022458','Pfizer Laboratories Div Pfizer Inc','TALIGLUCERASE ALFA','200','U/5mL','Glucosylceramidase [CS], Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0135_82e13ea7-3676-4f21-bb63-d35d9acad57e','0069-0135','HUMAN PRESCRIPTION DRUG','BOSULIF','','Bosutinib monohydrate','TABLET, FILM COATED','ORAL','20120904','','NDA','NDA203341','Pfizer Laboratories Div Pfizer Inc','BOSUTINIB MONOHYDRATE','100','mg/1','Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0136_82e13ea7-3676-4f21-bb63-d35d9acad57e','0069-0136','HUMAN PRESCRIPTION DRUG','BOSULIF','','Bosutinib monohydrate','TABLET, FILM COATED','ORAL','20120904','','NDA','NDA203341','Pfizer Laboratories Div Pfizer Inc','BOSUTINIB MONOHYDRATE','500','mg/1','Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0137_402dbe94-888a-4e23-ba4b-b910f15c31e1','0069-0137','HUMAN PRESCRIPTION DRUG','Heparin Sodium','','Heparin Sodium','INJECTION','INTRAVENOUS; SUBCUTANEOUS','20130311','','NDA','NDA201370','Pfizer Laboratories Div Pfizer Inc','HEPARIN SODIUM','1000','[USP''''U]/mL','Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0145_821c42cd-0e83-4558-beff-1d3baff1d9f4','0069-0145','HUMAN PRESCRIPTION DRUG','INLYTA','','axitinib','TABLET, FILM COATED','ORAL','20120127','','NDA','NDA202324','Pfizer Laboratories Div Pfizer Inc','AXITINIB','1','mg/1','Kinase Inhibitor [EPC], Receptor Tyrosine Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0151_821c42cd-0e83-4558-beff-1d3baff1d9f4','0069-0151','HUMAN PRESCRIPTION DRUG','INLYTA','','axitinib','TABLET, FILM COATED','ORAL','20120127','','NDA','NDA202324','Pfizer Laboratories Div Pfizer Inc','AXITINIB','5','mg/1','Kinase Inhibitor [EPC], Receptor Tyrosine Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0187_f507cc8d-e50e-4f91-a630-826483118efb','0069-0187','HUMAN PRESCRIPTION DRUG','Ibrance','','palbociclib','CAPSULE','ORAL','20150203','','NDA','NDA207103','Pfizer Laboratories Div Pfizer Inc','PALBOCICLIB','75','mg/1','Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0188_f507cc8d-e50e-4f91-a630-826483118efb','0069-0188','HUMAN PRESCRIPTION DRUG','Ibrance','','palbociclib','CAPSULE','ORAL','20150203','','NDA','NDA207103','Pfizer Laboratories Div Pfizer Inc','PALBOCICLIB','100','mg/1','Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0189_f507cc8d-e50e-4f91-a630-826483118efb','0069-0189','HUMAN PRESCRIPTION DRUG','Ibrance','','palbociclib','CAPSULE','ORAL','20150203','','NDA','NDA207103','Pfizer Laboratories Div Pfizer Inc','PALBOCICLIB','125','mg/1','Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0193_82e13ea7-3676-4f21-bb63-d35d9acad57e','0069-0193','HUMAN PRESCRIPTION DRUG','BOSULIF','','Bosutinib monohydrate','TABLET, FILM COATED','ORAL','20171218','','NDA','NDA203341','Pfizer Laboratories Div Pfizer Inc','BOSUTINIB MONOHYDRATE','400','mg/1','Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0195_ac17f7ce-f87e-4ad9-8dff-743e82ea16ca','0069-0195','HUMAN PRESCRIPTION DRUG','Fragmin','','Dalteparin Sodium','INJECTION','SUBCUTANEOUS','20150401','','NDA','NDA020287','Pfizer Laboratories Div Pfizer Inc','DALTEPARIN SODIUM','2500','[iU]/.2mL','Anti-coagulant [EPC], Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0196_ac17f7ce-f87e-4ad9-8dff-743e82ea16ca','0069-0196','HUMAN PRESCRIPTION DRUG','Fragmin','','Dalteparin Sodium','INJECTION','SUBCUTANEOUS','20150401','','NDA','NDA020287','Pfizer Laboratories Div Pfizer Inc','DALTEPARIN SODIUM','5000','[iU]/.2mL','Anti-coagulant [EPC], Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0197_470f74a3-f9ef-4a24-9bcd-aa54a3538ea9','0069-0197','HUMAN PRESCRIPTION DRUG','Vizimpro','','dacomitinib','TABLET, FILM COATED','ORAL','20181004','','NDA','NDA211288','Pfizer Laboratories Div Pfizer Inc','DACOMITINIB','15','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0206_ac17f7ce-f87e-4ad9-8dff-743e82ea16ca','0069-0206','HUMAN PRESCRIPTION DRUG','Fragmin','','Dalteparin Sodium','INJECTION','SUBCUTANEOUS','20150401','','NDA','NDA020287','Pfizer Laboratories Div Pfizer Inc','DALTEPARIN SODIUM','7500','[iU]/.3mL','Anti-coagulant [EPC], Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0209_9adaecc3-28c7-42f4-aa8f-02c81a98eb9b','0069-0209','HUMAN PRESCRIPTION DRUG','Propofol','','Propofol','INJECTION, EMULSION','INTRAVENOUS','20201005','','ANDA','ANDA205576','Pfizer Laboratories Div Pfizer Inc','PROPOFOL','10','mg/mL','General Anesthesia [PE], General Anesthetic [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0217_ac17f7ce-f87e-4ad9-8dff-743e82ea16ca','0069-0217','HUMAN PRESCRIPTION DRUG','Fragmin','','Dalteparin Sodium','INJECTION','SUBCUTANEOUS','20150401','','NDA','NDA020287','Pfizer Laboratories Div Pfizer Inc','DALTEPARIN SODIUM','10000','[iU]/mL','Anti-coagulant [EPC], Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0220_ac17f7ce-f87e-4ad9-8dff-743e82ea16ca','0069-0220','HUMAN PRESCRIPTION DRUG','Fragmin','','Dalteparin Sodium','INJECTION','SUBCUTANEOUS','20150401','','NDA','NDA020287','Pfizer Laboratories Div Pfizer Inc','DALTEPARIN SODIUM','12500','[iU]/.5mL','Anti-coagulant [EPC], Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0223_ac17f7ce-f87e-4ad9-8dff-743e82ea16ca','0069-0223','HUMAN PRESCRIPTION DRUG','Fragmin','','Dalteparin Sodium','INJECTION','SUBCUTANEOUS','20150401','','NDA','NDA020287','Pfizer Laboratories Div Pfizer Inc','DALTEPARIN SODIUM','15000','[iU]/.6mL','Anti-coagulant [EPC], Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0227_6eabc444-932f-496c-b7b4-574634008418','0069-0227','HUMAN PRESCRIPTION DRUG','Lorbrena','','lorlatinib','TABLET, FILM COATED','ORAL','20181119','','NDA','NDA210868','Pfizer Laboratories Div Pfizer Inc','LORLATINIB','25','mg/1','Cytochrome P450 3A4 Inducers [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0228_ac17f7ce-f87e-4ad9-8dff-743e82ea16ca','0069-0228','HUMAN PRESCRIPTION DRUG','Fragmin','','Dalteparin Sodium','INJECTION','SUBCUTANEOUS','20150401','','NDA','NDA020287','Pfizer Laboratories Div Pfizer Inc','DALTEPARIN SODIUM','18000','[iU]/.72mL','Anti-coagulant [EPC], Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0231_6eabc444-932f-496c-b7b4-574634008418','0069-0231','HUMAN PRESCRIPTION DRUG','Lorbrena','','lorlatinib','TABLET, FILM COATED','ORAL','20181119','','NDA','NDA210868','Pfizer Laboratories Div Pfizer Inc','LORLATINIB','100','mg/1','Cytochrome P450 3A4 Inducers [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0232_ac17f7ce-f87e-4ad9-8dff-743e82ea16ca','0069-0232','HUMAN PRESCRIPTION DRUG','Fragmin','','Dalteparin Sodium','INJECTION','SUBCUTANEOUS','20150401','','NDA','NDA020287','Pfizer Laboratories Div Pfizer Inc','DALTEPARIN SODIUM','25000','[iU]/mL','Anti-coagulant [EPC], Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0234_9adaecc3-28c7-42f4-aa8f-02c81a98eb9b','0069-0234','HUMAN PRESCRIPTION DRUG','Propofol','','Propofol','INJECTION, EMULSION','INTRAVENOUS','20201005','','ANDA','ANDA205576','Pfizer Laboratories Div Pfizer Inc','PROPOFOL','10','mg/mL','General Anesthesia [PE], General Anesthetic [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0235_c609c75c-0008-4c78-8cc9-b0e78a92a0de','0069-0235','HUMAN PRESCRIPTION DRUG','Cibinqo','','abrocitinib','TABLET, FILM COATED','ORAL','20220224','','NDA','NDA213871','Pfizer Laboratories Div Pfizer Inc','ABROCITINIB','50','mg/1','Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0238_51df4093-b8e1-4708-b3d0-627ee7086f18','0069-0238','HUMAN PRESCRIPTION DRUG','Ruxience','','rituximab-pvvr','INJECTION, SOLUTION','INTRAVENOUS','20200123','','BLA','BLA761103','Pfizer Laboratories Div Pfizer Inc','RITUXIMAB','100','mg/10mL','CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0242_55939ee5-708b-40f9-9a8c-9f47a1aa5c40','0069-0242','HUMAN PRESCRIPTION DRUG','Toviaz','','fesoterodine fumarate','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20081031','','NDA','NDA022030','Pfizer Laboratories Div Pfizer Inc','FESOTERODINE FUMARATE','4','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0244_55939ee5-708b-40f9-9a8c-9f47a1aa5c40','0069-0244','HUMAN PRESCRIPTION DRUG','Toviaz','','fesoterodine fumarate','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20081031','','NDA','NDA022030','Pfizer Laboratories Div Pfizer Inc','FESOTERODINE FUMARATE','8','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0248_9adaecc3-28c7-42f4-aa8f-02c81a98eb9b','0069-0248','HUMAN PRESCRIPTION DRUG','Propofol','','Propofol','INJECTION, EMULSION','INTRAVENOUS','20201005','','ANDA','ANDA205576','Pfizer Laboratories Div Pfizer Inc','PROPOFOL','10','mg/mL','General Anesthesia [PE], General Anesthetic [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0249_51df4093-b8e1-4708-b3d0-627ee7086f18','0069-0249','HUMAN PRESCRIPTION DRUG','Ruxience','','rituximab-pvvr','INJECTION, SOLUTION','INTRAVENOUS','20200123','','BLA','BLA761103','Pfizer Laboratories Div Pfizer Inc','RITUXIMAB','500','mg/50mL','CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0253_ac17f7ce-f87e-4ad9-8dff-743e82ea16ca','0069-0253','HUMAN PRESCRIPTION DRUG','Fragmin','','Dalteparin Sodium','INJECTION','SUBCUTANEOUS','20221017','','NDA','NDA020287','Pfizer Laboratories Div Pfizer Inc','DALTEPARIN SODIUM','2500','[iU]/mL','Anti-coagulant [EPC], Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0284_42b1133b-b05f-49ef-8710-a29937753b54','0069-0284','HUMAN PRESCRIPTION DRUG','Ibrance','','palbociclib','TABLET, FILM COATED','ORAL','20200330','','NDA','NDA212436','Pfizer Laboratories Div Pfizer Inc','PALBOCICLIB','75','mg/1','Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0291_3a976868-6b9c-44b2-987a-3ec9cda3e7a1','0069-0291','HUMAN PRESCRIPTION DRUG','Nivestym','','filgrastim-aafi','INJECTION, SOLUTION','SUBCUTANEOUS','20180924','','BLA','BLA761080','Pfizer Laboratories Div Pfizer Inc','FILGRASTIM','300','ug/.5mL','Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0292_3a976868-6b9c-44b2-987a-3ec9cda3e7a1','0069-0292','HUMAN PRESCRIPTION DRUG','Nivestym','','filgrastim-aafi','INJECTION, SOLUTION','SUBCUTANEOUS','20180924','','BLA','BLA761080','Pfizer Laboratories Div Pfizer Inc','FILGRASTIM','480','ug/.8mL','Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0293_3a976868-6b9c-44b2-987a-3ec9cda3e7a1','0069-0293','HUMAN PRESCRIPTION DRUG','Nivestym','','filgrastim-aafi','INJECTION, SOLUTION','INTRAVENOUS; SUBCUTANEOUS','20190311','','BLA','BLA761080','Pfizer Laboratories Div Pfizer Inc','FILGRASTIM','300','ug/mL','Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0294_3a976868-6b9c-44b2-987a-3ec9cda3e7a1','0069-0294','HUMAN PRESCRIPTION DRUG','Nivestym','','filgrastim-aafi','INJECTION, SOLUTION','INTRAVENOUS; SUBCUTANEOUS','20190311','','BLA','BLA761080','Pfizer Laboratories Div Pfizer Inc','FILGRASTIM','480','ug/1.6mL','Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0296_b09c6407-5885-4f14-82cb-447b36ad8824','0069-0296','HUMAN PRESCRIPTION DRUG','Talzenna','','talazoparib','CAPSULE','ORAL','20181026','','NDA','NDA211651','Pfizer Laboratories Div Pfizer Inc','TALAZOPARIB TOSYLATE','0.25','mg/1','Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0297_989db61e-58f4-4685-9110-3e5c17a7fd57','0069-0297','VACCINE','TicoVac','','Tick-Borne Encephalitis Vaccine','INJECTION','INTRAMUSCULAR','20220627','','BLA','BLA125740','Pfizer Laboratories Div Pfizer Inc','TICK-BORNE ENCEPHALITIS PURIFIED ANTIGEN (FORMALDEHYDE INACTIVATED)','1.2','ug/.25mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0298_6a167fd2-e69a-41b0-971d-a7b46ac6e90c','0069-0298','HUMAN PRESCRIPTION DRUG','Daurismo','','glasdegib','TABLET, FILM COATED','ORAL','20181210','','NDA','NDA210656','Pfizer Laboratories Div Pfizer Inc','GLASDEGIB','25','mg/1','Hedgehog Pathway Inhibitor [EPC], Smoothened Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0305_24399684-3818-4410-aecb-32b822817a4b','0069-0305','HUMAN PRESCRIPTION DRUG','Trazimera','','trastuzumab-qyyp','KIT','','20200224','','BLA','BLA761081','Pfizer Laboratories Div Pfizer Inc','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0308_24399684-3818-4410-aecb-32b822817a4b','0069-0308','HUMAN PRESCRIPTION DRUG','Trazimera','','trastuzumab-qyyp','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20210310','','BLA','BLA761081','Pfizer Laboratories Div Pfizer Inc','TRASTUZUMAB','150','mg/7.15mL','HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0314_581f5471-6975-4e7d-a18d-c052ebe0ddae','0069-0314','HUMAN PRESCRIPTION DRUG','MERREM','IV','Meropenem','INJECTION','INTRAVENOUS','20180716','20230331','NDA','NDA050706','Pfizer Laboratories Div Pfizer Inc','MEROPENEM','1','g/30mL','Carbapenems [CS], Penem Antibacterial [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0315_c88a8a06-a393-4ed8-ad58-660d8fe190ad','0069-0315','HUMAN PRESCRIPTION DRUG','Zirabev','','bevacizumab-bvzr','INJECTION, SOLUTION','INTRAVENOUS','20200113','','BLA','BLA761099','Pfizer Laboratories Div Pfizer Inc','BEVACIZUMAB','100','mg/4mL','Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0324_62b9180d-a0e5-40f6-92ec-dcb874dca33d','0069-0324','HUMAN PRESCRIPTION DRUG','NYVEPRIA','','pegfilgrastim-apgf','INJECTION, SOLUTION','SUBCUTANEOUS','20201215','','BLA','BLA761111','Pfizer Laboratories Div Pfizer Inc','PEGFILGRASTIM','6','mg/.6mL','Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0335_c609c75c-0008-4c78-8cc9-b0e78a92a0de','0069-0335','HUMAN PRESCRIPTION DRUG','Cibinqo','','abrocitinib','TABLET, FILM COATED','ORAL','20220224','','NDA','NDA213871','Pfizer Laboratories Div Pfizer Inc','ABROCITINIB','100','mg/1','Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0336_0a7a0411-dfcf-43be-999b-558344c7bbe3','0069-0336','HUMAN PRESCRIPTION DRUG','Revatio','','sildenafil citrate','POWDER, FOR SUSPENSION','ORAL','20140602','','NDA','NDA203109','PFIZER LABORATORIES DIV PFIZER INC','SILDENAFIL CITRATE','10','mg/mL','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0338_0a7a0411-dfcf-43be-999b-558344c7bbe3','0069-0338','HUMAN PRESCRIPTION DRUG','Revatio','','sildenafil citrate','INJECTION, SOLUTION','INTRAVENOUS','20091118','','NDA','NDA022473','PFIZER LABORATORIES DIV PFIZER INC','SILDENAFIL CITRATE','0.8','mg/mL','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0342_c88a8a06-a393-4ed8-ad58-660d8fe190ad','0069-0342','HUMAN PRESCRIPTION DRUG','Zirabev','','bevacizumab-bvzr','INJECTION, SOLUTION','INTRAVENOUS','20200113','','BLA','BLA761099','Pfizer Laboratories Div Pfizer Inc','BEVACIZUMAB','400','mg/16mL','Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0345_3514662e-b2c8-4481-9ce3-ed84e0e7ed10','0069-0345','HUMAN PRESCRIPTION DRUG','Paxlovid','','nirmatrelvir and ritonavir','KIT','','20220418','','EMERGENCY USE AUTHORIZATION','','Pfizer Laboratories Div Pfizer Inc','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0400_9ed58343-d62a-4979-a3c3-07f784f3161b','0069-0400','HUMAN PRESCRIPTION DRUG','Zithromax','','azithromycin dihydrate','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20140307','','NDA','NDA050733','Pfizer Laboratories Div Pfizer Inc','AZITHROMYCIN DIHYDRATE','500','mg/5mL','Macrolide Antimicrobial [EPC], Macrolides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0411_989db61e-58f4-4685-9110-3e5c17a7fd57','0069-0411','VACCINE','TicoVac','','Tick-Borne Encephalitis Vaccine','INJECTION','INTRAMUSCULAR','20211025','','BLA','BLA125740','Pfizer Laboratories Div Pfizer Inc','TICK-BORNE ENCEPHALITIS PURIFIED ANTIGEN (FORMALDEHYDE INACTIVATED)','2.4','ug/.5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0435_c609c75c-0008-4c78-8cc9-b0e78a92a0de','0069-0435','HUMAN PRESCRIPTION DRUG','Cibinqo','','abrocitinib','TABLET, FILM COATED','ORAL','20220224','','NDA','NDA213871','Pfizer Laboratories Div Pfizer Inc','ABROCITINIB','200','mg/1','Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0468_b98d3e2a-7091-4a12-9139-e0f94683292b','0069-0468','HUMAN PRESCRIPTION DRUG','CHANTIX','','varenicline tartrate','TABLET, FILM COATED','ORAL','20060510','','NDA','NDA021928','Pfizer Labs, Division of Pfizer Inc.','VARENICLINE TARTRATE','0.5','mg/1','Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0469_b98d3e2a-7091-4a12-9139-e0f94683292b','0069-0469','HUMAN PRESCRIPTION DRUG','CHANTIX','','varenicline tartrate','TABLET, FILM COATED','ORAL','20060510','','NDA','NDA021928','Pfizer Labs, Division of Pfizer Inc.','VARENICLINE TARTRATE','1','mg/1','Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0471_b98d3e2a-7091-4a12-9139-e0f94683292b','0069-0471','HUMAN PRESCRIPTION DRUG','CHANTIX','','varenicline tartrate','KIT','','20060510','','NDA','NDA021928','Pfizer Labs, Division of Pfizer Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0486_42b1133b-b05f-49ef-8710-a29937753b54','0069-0486','HUMAN PRESCRIPTION DRUG','Ibrance','','palbociclib','TABLET, FILM COATED','ORAL','20200330','','NDA','NDA212436','Pfizer Laboratories Div Pfizer Inc','PALBOCICLIB','100','mg/1','Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0501_73cac6bb-6522-4cc3-b832-3d710080c23f','0069-0501','HUMAN PRESCRIPTION DRUG','XELJANZ','XR','tofacitinib','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20160307','','NDA','NDA208246','Pfizer Laboratories Div Pfizer Inc','TOFACITINIB CITRATE','11','mg/1','Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0502_73cac6bb-6522-4cc3-b832-3d710080c23f','0069-0502','HUMAN PRESCRIPTION DRUG','XELJANZ','XR','tofacitinib','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20200121','','NDA','NDA208246','Pfizer Laboratories Div Pfizer Inc','TOFACITINIB CITRATE','22','mg/1','Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0550_98991164-3067-460c-8c8b-4ca0976ad736','0069-0550','HUMAN PRESCRIPTION DRUG','SUTENT','','Sunitinib malate','CAPSULE','ORAL','20060126','','NDA','NDA021938','Pfizer Laboratories Div Pfizer Inc','SUNITINIB MALATE','12.5','mg/1','Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0688_42b1133b-b05f-49ef-8710-a29937753b54','0069-0688','HUMAN PRESCRIPTION DRUG','Ibrance','','palbociclib','TABLET, FILM COATED','ORAL','20200330','','NDA','NDA212436','Pfizer Laboratories Div Pfizer Inc','PALBOCICLIB','125','mg/1','Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0770_98991164-3067-460c-8c8b-4ca0976ad736','0069-0770','HUMAN PRESCRIPTION DRUG','SUTENT','','Sunitinib malate','CAPSULE','ORAL','20060126','','NDA','NDA021938','Pfizer Laboratories Div Pfizer Inc','SUNITINIB MALATE','25','mg/1','Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0809_11db24ec-e95d-4127-a1e8-fb3aa917317d','0069-0809','HUMAN PRESCRIPTION DRUG','INFLECTRA','','infliximab-dyyb','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20161121','','BLA','BLA125544','Pfizer Laboratories Div Pfizer Inc','INFLIXIMAB','100','mg/10mL','Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0830_98991164-3067-460c-8c8b-4ca0976ad736','0069-0830','HUMAN PRESCRIPTION DRUG','SUTENT','','Sunitinib malate','CAPSULE','ORAL','20140712','','NDA','NDA021938','Pfizer Laboratories Div Pfizer Inc','SUNITINIB MALATE','37.5','mg/1','Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0950_5414f42d-cfc3-465c-9aaf-d34adcb2626e','0069-0950','HUMAN PRESCRIPTION DRUG','Vibramycin Hyclate','','doxycycline hyclate','CAPSULE','ORAL','19671205','','NDA','NDA050007','Pfizer Laboratories Div Pfizer Inc','DOXYCYCLINE HYCLATE','100','mg/1','Tetracycline-class Drug [EPC], Tetracyclines [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0970_5414f42d-cfc3-465c-9aaf-d34adcb2626e','0069-0970','HUMAN PRESCRIPTION DRUG','Vibramycin Monohydrate','','doxycycline','POWDER, FOR SUSPENSION','ORAL','19671206','','NDA','NDA050006','Pfizer Laboratories Div Pfizer Inc','DOXYCYCLINE','25','mg/5mL','Tetracycline-class Drug [EPC], Tetracyclines [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0971_5414f42d-cfc3-465c-9aaf-d34adcb2626e','0069-0971','HUMAN PRESCRIPTION DRUG','Vibramycin Calcium','','doxycycline calcium','SYRUP','ORAL','19740923','','NDA','NDA050480','Pfizer Laboratories Div Pfizer Inc','DOXYCYCLINE CALCIUM','50','mg/5mL','Tetracycline-class Drug [EPC], Tetracyclines [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-0980_98991164-3067-460c-8c8b-4ca0976ad736','0069-0980','HUMAN PRESCRIPTION DRUG','SUTENT','','Sunitinib malate','CAPSULE','ORAL','20060126','','NDA','NDA021938','Pfizer Laboratories Div Pfizer Inc','SUNITINIB MALATE','50','mg/1','Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1001_73cac6bb-6522-4cc3-b832-3d710080c23f','0069-1001','HUMAN PRESCRIPTION DRUG','XELJANZ','','tofacitinib','TABLET, FILM COATED','ORAL','20121109','','NDA','NDA203214','Pfizer Laboratories Div Pfizer Inc','TOFACITINIB CITRATE','5','mg/1','Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1002_73cac6bb-6522-4cc3-b832-3d710080c23f','0069-1002','HUMAN PRESCRIPTION DRUG','XELJANZ','','tofacitinib','TABLET, FILM COATED','ORAL','20180702','','NDA','NDA203214','Pfizer Laboratories Div Pfizer Inc','TOFACITINIB CITRATE','10','mg/1','Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1011_070501cc-8328-4bc3-91c8-8688fba3f982','0069-1011','PLASMA DERIVATIVE','Panzyga','','immune globulin intravenous (human)','SOLUTION','INTRAVENOUS','20190809','','BLA','BLA125587','Pfizer Laboratories Div Pfizer Inc','HUMAN IMMUNOGLOBULIN G','100','mg/mL','Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1029_73cac6bb-6522-4cc3-b832-3d710080c23f','0069-1029','HUMAN PRESCRIPTION DRUG','XELJANZ','','tofacitinib','SOLUTION','ORAL','20210208','','NDA','NDA213082','Pfizer Laboratories Div Pfizer Inc','TOFACITINIB CITRATE','1','mg/mL','Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1061_40f980d3-2ca6-b207-d6ed-c04c24f70c66','0069-1061','PLASMA DERIVATIVE','Cutaquig','','immunoglobulin G','SOLUTION','SUBCUTANEOUS','20190913','','BLA','BLA125668','Pfizer Laboratories Div Pfizer Inc','HUMAN IMMUNOGLOBULIN G','165','mg/mL','Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1085_3514662e-b2c8-4481-9ce3-ed84e0e7ed10','0069-1085','HUMAN PRESCRIPTION DRUG','Paxlovid','','nirmatrelvir and ritonavir','KIT','','20211222','','EMERGENCY USE AUTHORIZATION','','Pfizer Laboratories Div Pfizer Inc','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1101_3514662e-b2c8-4481-9ce3-ed84e0e7ed10','0069-1101','HUMAN PRESCRIPTION DRUG','Paxlovid','','nirmatrelvir and ritonavir','KIT','','20220317','','EMERGENCY USE AUTHORIZATION','','Pfizer Laboratories Div Pfizer Inc','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1109_070501cc-8328-4bc3-91c8-8688fba3f982','0069-1109','PLASMA DERIVATIVE','Panzyga','','immune globulin intravenous (human)','SOLUTION','INTRAVENOUS','20190809','','BLA','BLA125587','Pfizer Laboratories Div Pfizer Inc','HUMAN IMMUNOGLOBULIN G','100','mg/mL','Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1195_b09c6407-5885-4f14-82cb-447b36ad8824','0069-1195','HUMAN PRESCRIPTION DRUG','Talzenna','','talazoparib','CAPSULE','ORAL','20181026','','NDA','NDA211651','Pfizer Laboratories Div Pfizer Inc','TALAZOPARIB TOSYLATE','1','mg/1','Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1198_470f74a3-f9ef-4a24-9bcd-aa54a3538ea9','0069-1198','HUMAN PRESCRIPTION DRUG','Vizimpro','','dacomitinib','TABLET, FILM COATED','ORAL','20181004','','NDA','NDA211288','Pfizer Laboratories Div Pfizer Inc','DACOMITINIB','30','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1224_070501cc-8328-4bc3-91c8-8688fba3f982','0069-1224','PLASMA DERIVATIVE','Panzyga','','immune globulin intravenous (human)','SOLUTION','INTRAVENOUS','20190809','','BLA','BLA125587','Pfizer Laboratories Div Pfizer Inc','HUMAN IMMUNOGLOBULIN G','100','mg/mL','Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1305_1b2796dd-509d-4a99-b464-48b8f3d2a217','0069-1305','HUMAN PRESCRIPTION DRUG','RETACRIT','','epoetin alfa-epbx','INJECTION, SOLUTION','INTRAVENOUS; SUBCUTANEOUS','20180618','','BLA','BLA125545','Pfizer Laboratories Div Pfizer Inc','EPOETIN','2000','[iU]/mL','Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1306_1b2796dd-509d-4a99-b464-48b8f3d2a217','0069-1306','HUMAN PRESCRIPTION DRUG','RETACRIT','','epoetin alfa-epbx','INJECTION, SOLUTION','INTRAVENOUS; SUBCUTANEOUS','20180618','','BLA','BLA125545','Pfizer Laboratories Div Pfizer Inc','EPOETIN','3000','[iU]/mL','Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1307_1b2796dd-509d-4a99-b464-48b8f3d2a217','0069-1307','HUMAN PRESCRIPTION DRUG','RETACRIT','','epoetin alfa-epbx','INJECTION, SOLUTION','INTRAVENOUS; SUBCUTANEOUS','20180618','','BLA','BLA125545','Pfizer Laboratories Div Pfizer Inc','EPOETIN','4000','[iU]/mL','Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1308_1b2796dd-509d-4a99-b464-48b8f3d2a217','0069-1308','HUMAN PRESCRIPTION DRUG','RETACRIT','','epoetin alfa-epbx','INJECTION, SOLUTION','INTRAVENOUS; SUBCUTANEOUS','20180618','','BLA','BLA125545','Pfizer Laboratories Div Pfizer Inc','EPOETIN','10000','[iU]/mL','Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1309_1b2796dd-509d-4a99-b464-48b8f3d2a217','0069-1309','HUMAN PRESCRIPTION DRUG','RETACRIT','','epoetin alfa-epbx','INJECTION, SOLUTION','INTRAVENOUS; SUBCUTANEOUS','20180618','','BLA','BLA125545','Pfizer Laboratories Div Pfizer Inc','EPOETIN','40000','[iU]/mL','Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1311_1b2796dd-509d-4a99-b464-48b8f3d2a217','0069-1311','HUMAN PRESCRIPTION DRUG','RETACRIT','','epoetin alfa-epbx','INJECTION, SOLUTION','INTRAVENOUS; SUBCUTANEOUS','20201109','','BLA','BLA125545','Pfizer Laboratories Div Pfizer Inc','EPOETIN','20000','[iU]/mL','Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1312_070501cc-8328-4bc3-91c8-8688fba3f982','0069-1312','PLASMA DERIVATIVE','Panzyga','','immune globulin intravenous (human)','SOLUTION','INTRAVENOUS','20190809','','BLA','BLA125587','Pfizer Laboratories Div Pfizer Inc','HUMAN IMMUNOGLOBULIN G','100','mg/mL','Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1318_1b2796dd-509d-4a99-b464-48b8f3d2a217','0069-1318','HUMAN PRESCRIPTION DRUG','RETACRIT','','epoetin alfa-epbx','INJECTION, SOLUTION','INTRAVENOUS; SUBCUTANEOUS','20201109','','BLA','BLA125545','Pfizer Laboratories Div Pfizer Inc','EPOETIN','10000','[iU]/mL','Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1415_070501cc-8328-4bc3-91c8-8688fba3f982','0069-1415','PLASMA DERIVATIVE','Panzyga','','immune globulin intravenous (human)','SOLUTION','INTRAVENOUS','20190809','','BLA','BLA125587','Pfizer Laboratories Div Pfizer Inc','HUMAN IMMUNOGLOBULIN G','100','mg/mL','Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1476_40f980d3-2ca6-b207-d6ed-c04c24f70c66','0069-1476','PLASMA DERIVATIVE','Cutaquig','','immunoglobulin G','SOLUTION','SUBCUTANEOUS','20190913','','BLA','BLA125668','Pfizer Laboratories Div Pfizer Inc','HUMAN IMMUNOGLOBULIN G','165','mg/mL','Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1501_b09c6407-5885-4f14-82cb-447b36ad8824','0069-1501','HUMAN PRESCRIPTION DRUG','Talzenna','','talazoparib','CAPSULE','ORAL','20220131','','NDA','NDA211651','Pfizer Laboratories Div Pfizer Inc','TALAZOPARIB TOSYLATE','0.5','mg/1','Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1509_40f980d3-2ca6-b207-d6ed-c04c24f70c66','0069-1509','PLASMA DERIVATIVE','Cutaquig','','immunoglobulin G','SOLUTION','SUBCUTANEOUS','20190913','','BLA','BLA125668','Pfizer Laboratories Div Pfizer Inc','HUMAN IMMUNOGLOBULIN G','165','mg/mL','Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1520_80f34426-dbf5-41e4-9aaa-75526d0f3cf0','0069-1520','HUMAN PRESCRIPTION DRUG','Norvasc','','amlodipine besylate','TABLET','ORAL','19920731','','NDA','NDA019787','Pfizer Laboratories Div Pfizer Inc','AMLODIPINE BESYLATE','2.5','mg/1','Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1530_80f34426-dbf5-41e4-9aaa-75526d0f3cf0','0069-1530','HUMAN PRESCRIPTION DRUG','Norvasc','','amlodipine besylate','TABLET','ORAL','19920731','','NDA','NDA019787','Pfizer Laboratories Div Pfizer Inc','AMLODIPINE BESYLATE','5','mg/1','Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1531_6a167fd2-e69a-41b0-971d-a7b46ac6e90c','0069-1531','HUMAN PRESCRIPTION DRUG','Daurismo','','glasdegib','TABLET, FILM COATED','ORAL','20181210','','NDA','NDA210656','Pfizer Laboratories Div Pfizer Inc','GLASDEGIB','100','mg/1','Hedgehog Pathway Inhibitor [EPC], Smoothened Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1540_80f34426-dbf5-41e4-9aaa-75526d0f3cf0','0069-1540','HUMAN PRESCRIPTION DRUG','Norvasc','','amlodipine besylate','TABLET','ORAL','19920731','','NDA','NDA019787','Pfizer Laboratories Div Pfizer Inc','AMLODIPINE BESYLATE','10','mg/1','Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1558_070501cc-8328-4bc3-91c8-8688fba3f982','0069-1558','PLASMA DERIVATIVE','Panzyga','','immune globulin intravenous (human)','SOLUTION','INTRAVENOUS','20190809','','BLA','BLA125587','Pfizer Laboratories Div Pfizer Inc','HUMAN IMMUNOGLOBULIN G','100','mg/mL','Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1751_b09c6407-5885-4f14-82cb-447b36ad8824','0069-1751','HUMAN PRESCRIPTION DRUG','Talzenna','','talazoparib','CAPSULE','ORAL','20220131','','NDA','NDA211651','Pfizer Laboratories Div Pfizer Inc','TALAZOPARIB TOSYLATE','0.75','mg/1','Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1802_40f980d3-2ca6-b207-d6ed-c04c24f70c66','0069-1802','PLASMA DERIVATIVE','Cutaquig','','immunoglobulin G','SOLUTION','SUBCUTANEOUS','20190913','','BLA','BLA125668','Pfizer Laboratories Div Pfizer Inc','HUMAN IMMUNOGLOBULIN G','165','mg/mL','Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1960_40f980d3-2ca6-b207-d6ed-c04c24f70c66','0069-1960','PLASMA DERIVATIVE','Cutaquig','','immunoglobulin G','SOLUTION','SUBCUTANEOUS','20190913','','BLA','BLA125668','Pfizer Laboratories Div Pfizer Inc','HUMAN IMMUNOGLOBULIN G','165','mg/mL','Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1965_40f980d3-2ca6-b207-d6ed-c04c24f70c66','0069-1965','PLASMA DERIVATIVE','Cutaquig','','immunoglobulin G','SOLUTION','SUBCUTANEOUS','20190913','','BLA','BLA125668','Pfizer Laboratories Div Pfizer Inc','HUMAN IMMUNOGLOBULIN G','165','mg/mL','Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-1975_6d777993-e6a4-4882-822d-5351be3f501a','0069-1975','HUMAN PRESCRIPTION DRUG','Vyndaqel','','tafamidis meglumine','CAPSULE, LIQUID FILLED','ORAL','20190516','','NDA','NDA211996','Pfizer Laboratories Div Pfizer Inc','TAFAMIDIS MEGLUMINE','20','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-2025_082353dd-2add-43a0-ad60-aba8a6818372','0069-2025','VACCINE','Comirnaty','','COVID-19 Vaccine, mRNA','INJECTION, SUSPENSION','INTRAMUSCULAR','20220518','','BLA','BLA125742','Pfizer Laboratories Div Pfizer Inc','TOZINAMERAN','0.225','mg/2.25mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-2150_f6d65460-2cca-4fe6-a965-1d9b6c884665','0069-2150','HUMAN PRESCRIPTION DRUG','Caduet','','amlodipine besylate and atorvastatin calcium','TABLET, FILM COATED','ORAL','20040130','','NDA','NDA021540','Pfizer Laboratories Div Pfizer Inc','AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE','5; 10','mg/1; mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-2160_f6d65460-2cca-4fe6-a965-1d9b6c884665','0069-2160','HUMAN PRESCRIPTION DRUG','Caduet','','amlodipine besylate and atorvastatin calcium','TABLET, FILM COATED','ORAL','20040130','','NDA','NDA021540','Pfizer Laboratories Div Pfizer Inc','AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE','10; 10','mg/1; mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-2170_f6d65460-2cca-4fe6-a965-1d9b6c884665','0069-2170','HUMAN PRESCRIPTION DRUG','Caduet','','amlodipine besylate and atorvastatin calcium','TABLET, FILM COATED','ORAL','20040130','','NDA','NDA021540','Pfizer Laboratories Div Pfizer Inc','AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE','5; 20','mg/1; mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-2180_f6d65460-2cca-4fe6-a965-1d9b6c884665','0069-2180','HUMAN PRESCRIPTION DRUG','Caduet','','amlodipine besylate and atorvastatin calcium','TABLET, FILM COATED','ORAL','20040130','','NDA','NDA021540','Pfizer Laboratories Div Pfizer Inc','AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE','10; 20','mg/1; mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-2190_f6d65460-2cca-4fe6-a965-1d9b6c884665','0069-2190','HUMAN PRESCRIPTION DRUG','Caduet','','amlodipine besylate and atorvastatin calcium','TABLET, FILM COATED','ORAL','20040130','','NDA','NDA021540','Pfizer Laboratories Div Pfizer Inc','AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE','5; 40','mg/1; mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-2250_f6d65460-2cca-4fe6-a965-1d9b6c884665','0069-2250','HUMAN PRESCRIPTION DRUG','Caduet','','amlodipine besylate and atorvastatin calcium','TABLET, FILM COATED','ORAL','20040130','','NDA','NDA021540','Pfizer Laboratories Div Pfizer Inc','AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE','10; 40','mg/1; mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-2260_f6d65460-2cca-4fe6-a965-1d9b6c884665','0069-2260','HUMAN PRESCRIPTION DRUG','Caduet','','amlodipine besylate and atorvastatin calcium','TABLET, FILM COATED','ORAL','20040130','','NDA','NDA021540','Pfizer Laboratories Div Pfizer Inc','AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE','5; 80','mg/1; mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-2270_f6d65460-2cca-4fe6-a965-1d9b6c884665','0069-2270','HUMAN PRESCRIPTION DRUG','Caduet','','amlodipine besylate and atorvastatin calcium','TABLET, FILM COATED','ORAL','20040130','','NDA','NDA021540','Pfizer Laboratories Div Pfizer Inc','AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE','10; 80','mg/1; mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-2299_470f74a3-f9ef-4a24-9bcd-aa54a3538ea9','0069-2299','HUMAN PRESCRIPTION DRUG','Vizimpro','','dacomitinib','TABLET, FILM COATED','ORAL','20181004','','NDA','NDA211288','Pfizer Laboratories Div Pfizer Inc','DACOMITINIB','45','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-2650_19b5d6c8-4916-44f9-b2a5-0c2e303f405f','0069-2650','HUMAN PRESCRIPTION DRUG','Procardia','XL','nifedipine','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','19890906','','NDA','NDA019684','Pfizer Laboratories Div Pfizer Inc','NIFEDIPINE','30','mg/1','Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-2660_19b5d6c8-4916-44f9-b2a5-0c2e303f405f','0069-2660','HUMAN PRESCRIPTION DRUG','Procardia','XL','nifedipine','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','19890906','','NDA','NDA019684','Pfizer Laboratories Div Pfizer Inc','NIFEDIPINE','60','mg/1','Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-2670_19b5d6c8-4916-44f9-b2a5-0c2e303f405f','0069-2670','HUMAN PRESCRIPTION DRUG','Procardia','XL','nifedipine','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','19890906','','NDA','NDA019684','Pfizer Laboratories Div Pfizer Inc','NIFEDIPINE','90','mg/1','Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-3030_347b56fa-d8d4-4fa8-aa2c-364b3a0c1799','0069-3030','HUMAN PRESCRIPTION DRUG','Doxorubicin Hydrochloride','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19871223','','NDA','NDA050629','Pfizer Laboratories Div Pfizer Inc','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-3031_347b56fa-d8d4-4fa8-aa2c-364b3a0c1799','0069-3031','HUMAN PRESCRIPTION DRUG','Doxorubicin Hydrochloride','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19871223','','NDA','NDA050629','Pfizer Laboratories Div Pfizer Inc','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-3032_347b56fa-d8d4-4fa8-aa2c-364b3a0c1799','0069-3032','HUMAN PRESCRIPTION DRUG','Doxorubicin Hydrochloride','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19871223','','NDA','NDA050629','Pfizer Laboratories Div Pfizer Inc','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-3033_347b56fa-d8d4-4fa8-aa2c-364b3a0c1799','0069-3033','HUMAN PRESCRIPTION DRUG','Doxorubicin Hydrochloride','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19871223','','NDA','NDA050629','Pfizer Laboratories Div Pfizer Inc','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-3034_347b56fa-d8d4-4fa8-aa2c-364b3a0c1799','0069-3034','HUMAN PRESCRIPTION DRUG','Doxorubicin Hydrochloride','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19871223','','NDA','NDA050629','Pfizer Laboratories Div Pfizer Inc','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-3051_04ff75a3-1031-4a4e-849a-30cf77a53a7b','0069-3051','HUMAN PRESCRIPTION DRUG','ZITHROMAX','','AZITHROMYCIN DIHYDRATE','POWDER, FOR SUSPENSION','ORAL','19940928','','NDA','NDA050693','Pfizer Laboratories Div Pfizer Inc','AZITHROMYCIN DIHYDRATE','1','g/1','Macrolide Antimicrobial [EPC], Macrolides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-3060_5b33b535-1d78-43b3-90d1-f9186718ad2d','0069-3060','HUMAN PRESCRIPTION DRUG','Zithromax','','azithromycin dihydrate','TABLET, FILM COATED','ORAL','19960718','','NDA','NDA050711','Pfizer Laboratories Div Pfizer Inc','AZITHROMYCIN DIHYDRATE','250','mg/1','Macrolide Antimicrobial [EPC], Macrolides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-3070_5b33b535-1d78-43b3-90d1-f9186718ad2d','0069-3070','HUMAN PRESCRIPTION DRUG','Zithromax','','azithromycin dihydrate','TABLET, FILM COATED','ORAL','20020524','','NDA','NDA050784','Pfizer Laboratories Div Pfizer Inc','AZITHROMYCIN DIHYDRATE','500','mg/1','Macrolide Antimicrobial [EPC], Macrolides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-3110_5b33b535-1d78-43b3-90d1-f9186718ad2d','0069-3110','HUMAN PRESCRIPTION DRUG','Zithromax','','azithromycin dihydrate','POWDER, FOR SUSPENSION','ORAL','19951019','','NDA','NDA050710','Pfizer Laboratories Div Pfizer Inc','AZITHROMYCIN DIHYDRATE','100','mg/5mL','Macrolide Antimicrobial [EPC], Macrolides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-3120_5b33b535-1d78-43b3-90d1-f9186718ad2d','0069-3120','HUMAN PRESCRIPTION DRUG','Zithromax','','azithromycin dihydrate','POWDER, FOR SUSPENSION','ORAL','19951019','','NDA','NDA050710','Pfizer Laboratories Div Pfizer Inc','AZITHROMYCIN DIHYDRATE','200','mg/5mL','Macrolide Antimicrobial [EPC], Macrolides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-3130_5b33b535-1d78-43b3-90d1-f9186718ad2d','0069-3130','HUMAN PRESCRIPTION DRUG','Zithromax','','azithromycin dihydrate','POWDER, FOR SUSPENSION','ORAL','19951019','','NDA','NDA050710','Pfizer Laboratories Div Pfizer Inc','AZITHROMYCIN DIHYDRATE','200','mg/5mL','Macrolide Antimicrobial [EPC], Macrolides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-3140_5b33b535-1d78-43b3-90d1-f9186718ad2d','0069-3140','HUMAN PRESCRIPTION DRUG','Zithromax','','azithromycin dihydrate','POWDER, FOR SUSPENSION','ORAL','19951019','','NDA','NDA050710','Pfizer Laboratories Div Pfizer Inc','AZITHROMYCIN DIHYDRATE','200','mg/5mL','Macrolide Antimicrobial [EPC], Macrolides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-3150_baf6074e-2528-4dbe-8c95-1c47d6e8b36f','0069-3150','HUMAN PRESCRIPTION DRUG','Zithromax','','azithromycin dihydrate','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','19970130','','NDA','NDA050733','Pfizer Laboratories Div Pfizer Inc','AZITHROMYCIN DIHYDRATE','500','mg/5mL','Macrolide Antimicrobial [EPC], Macrolides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-3220_727bf64f-108d-47b5-b073-e1c56bd92640','0069-3220','HUMAN PRESCRIPTION DRUG','Feldene','','piroxicam','CAPSULE','ORAL','19940525','','NDA','NDA018147','Pfizer Laboratories Div Pfizer Inc','PIROXICAM','10','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-3230_727bf64f-108d-47b5-b073-e1c56bd92640','0069-3230','HUMAN PRESCRIPTION DRUG','Feldene','','piroxicam','CAPSULE','ORAL','19940525','','NDA','NDA018147','Pfizer Laboratories Div Pfizer Inc','PIROXICAM','20','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-4004_7de0221b-3903-4ec6-a5ba-9ede8e8a45a6','0069-4004','HUMAN PRESCRIPTION DRUG','Doxorubicin Hydrochloride','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','20130317','','NDA','NDA050629','Pfizer Laboratories Div Pfizer Inc','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-4015_7de0221b-3903-4ec6-a5ba-9ede8e8a45a6','0069-4015','HUMAN PRESCRIPTION DRUG','Doxorubicin Hydrochloride','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','20140317','','NDA','NDA050629','Pfizer Laboratories Div Pfizer Inc','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-4026_7de0221b-3903-4ec6-a5ba-9ede8e8a45a6','0069-4026','HUMAN PRESCRIPTION DRUG','Doxorubicin Hydrochloride','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','20140317','','NDA','NDA050629','Pfizer Laboratories Div Pfizer Inc','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-4037_7de0221b-3903-4ec6-a5ba-9ede8e8a45a6','0069-4037','HUMAN PRESCRIPTION DRUG','Doxorubicin Hydrochloride','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','20140317','','NDA','NDA050629','Pfizer Laboratories Div Pfizer Inc','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-4061_5b33b535-1d78-43b3-90d1-f9186718ad2d','0069-4061','HUMAN PRESCRIPTION DRUG','Zithromax','','azithromycin dihydrate','TABLET, FILM COATED','ORAL','20190517','','NDA','NDA050711','Pfizer Laboratories Div Pfizer Inc','AZITHROMYCIN DIHYDRATE','250','mg/1','Macrolide Antimicrobial [EPC], Macrolides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-4190_0a7a0411-dfcf-43be-999b-558344c7bbe3','0069-4190','HUMAN PRESCRIPTION DRUG','Revatio','','sildenafil citrate','TABLET, FILM COATED','ORAL','20050603','','NDA','NDA021845','PFIZER LABORATORIES DIV PFIZER INC','SILDENAFIL CITRATE','20','mg/1','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-4200_40578e70-350a-4940-9630-55d90989c146','0069-4200','HUMAN PRESCRIPTION DRUG','Viagra','','sildenafil citrate','TABLET, FILM COATED','ORAL','19980327','','NDA','NDA020895','Pfizer Laboratories Div Pfizer Inc','SILDENAFIL CITRATE','25','mg/1','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-4210_40578e70-350a-4940-9630-55d90989c146','0069-4210','HUMAN PRESCRIPTION DRUG','Viagra','','sildenafil citrate','TABLET, FILM COATED','ORAL','19980327','','NDA','NDA020895','Pfizer Laboratories Div Pfizer Inc','SILDENAFIL CITRATE','50','mg/1','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-4220_40578e70-350a-4940-9630-55d90989c146','0069-4220','HUMAN PRESCRIPTION DRUG','Viagra','','sildenafil citrate','TABLET, FILM COATED','ORAL','19980327','','NDA','NDA020895','Pfizer Laboratories Div Pfizer Inc','SILDENAFIL CITRATE','100','mg/1','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-4310_23047548-9790-4916-82c0-af04fed6be95','0069-4310','HUMAN PRESCRIPTION DRUG','Minipress','','prazosin hydrochloride','CAPSULE','ORAL','19940510','','NDA','NDA017442','Pfizer Laboratories Div Pfizer Inc','PRAZOSIN HYDROCHLORIDE','1','mg/1','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-4370_23047548-9790-4916-82c0-af04fed6be95','0069-4370','HUMAN PRESCRIPTION DRUG','Minipress','','prazosin hydrochloride','CAPSULE','ORAL','19940510','','NDA','NDA017442','Pfizer Laboratories Div Pfizer Inc','PRAZOSIN HYDROCHLORIDE','2','mg/1','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-4380_23047548-9790-4916-82c0-af04fed6be95','0069-4380','HUMAN PRESCRIPTION DRUG','Minipress','','prazosin hydrochloride','CAPSULE','ORAL','19940510','','NDA','NDA017442','Pfizer Laboratories Div Pfizer Inc','PRAZOSIN HYDROCHLORIDE','5','mg/1','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-5410_1ef274bc-bb89-432e-b085-5d707ca372f3','0069-5410','HUMAN PRESCRIPTION DRUG','Vistaril','','hydroxyzine pamoate','CAPSULE','ORAL','19941128','','NDA','NDA011459','Pfizer Laboratories Div Pfizer Inc','HYDROXYZINE PAMOATE','25','mg/1','Antihistamine [EPC], Histamine Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-5420_1ef274bc-bb89-432e-b085-5d707ca372f3','0069-5420','HUMAN PRESCRIPTION DRUG','Vistaril','','hydroxyzine pamoate','CAPSULE','ORAL','19681115','','NDA','NDA011459','Pfizer Laboratories Div Pfizer Inc','HYDROXYZINE PAMOATE','50','mg/1','Antihistamine [EPC], Histamine Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-5471_3c7f9456-331d-4abd-a751-b47eafd68f38','0069-5471','HUMAN PRESCRIPTION DRUG','CEREBYX','','Fosphenytoin Sodium','INJECTION, SOLUTION','INTRAMUSCULAR; INTRAVENOUS','20131028','','NDA','NDA020450','Pfizer Laboratories Div Pfizer Inc','FOSPHENYTOIN SODIUM','50','mg/mL','Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-5474_3c7f9456-331d-4abd-a751-b47eafd68f38','0069-5474','HUMAN PRESCRIPTION DRUG','CEREBYX','','Fosphenytoin Sodium','INJECTION, SOLUTION','INTRAMUSCULAR; INTRAVENOUS','20131028','','NDA','NDA020450','Pfizer Laboratories Div Pfizer Inc','FOSPHENYTOIN SODIUM','50','mg/mL','Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-5800_c16c9652-9114-4b39-b240-bc0cb85b8b8d','0069-5800','HUMAN PRESCRIPTION DRUG','Tikosyn','','dofetilide','CAPSULE','ORAL','19991001','','NDA','NDA020931','Pfizer Laboratories Div Pfizer Inc','DOFETILIDE','0.125','mg/1','Antiarrhythmic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-5810_c16c9652-9114-4b39-b240-bc0cb85b8b8d','0069-5810','HUMAN PRESCRIPTION DRUG','Tikosyn','','dofetilide','CAPSULE','ORAL','19991001','','NDA','NDA020931','Pfizer Laboratories Div Pfizer Inc','DOFETILIDE','0.25','mg/1','Antiarrhythmic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-5820_c16c9652-9114-4b39-b240-bc0cb85b8b8d','0069-5820','HUMAN PRESCRIPTION DRUG','Tikosyn','','dofetilide','CAPSULE','ORAL','19991001','','NDA','NDA020931','Pfizer Laboratories Div Pfizer Inc','DOFETILIDE','0.5','mg/1','Antiarrhythmic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-6001_b6e28a06-abe9-4ee3-ab1e-85fdf36e7c22','0069-6001','HUMAN PRESCRIPTION DRUG','CEREBYX','','Fosphenytoin Sodium','INJECTION, SOLUTION','INTRAMUSCULAR; INTRAVENOUS','20131028','','NDA','NDA020450','Pfizer Laboratories Div Pfizer Inc','FOSPHENYTOIN SODIUM','50','mg/mL','Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-6180_f6d65460-2cca-4fe6-a965-1d9b6c884665','0069-6180','HUMAN PRESCRIPTION DRUG','Caduet','','amlodipine and atorvastatin','TABLET, FILM COATED','ORAL','20220831','','NDA','NDA021540','Pfizer Laboratories Div Pfizer Inc','AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE','5; 10','mg/1; mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-6323_f6d65460-2cca-4fe6-a965-1d9b6c884665','0069-6323','HUMAN PRESCRIPTION DRUG','Caduet','','amlodipine and atorvastatin','TABLET, FILM COATED','ORAL','20220831','','NDA','NDA021540','Pfizer Laboratories Div Pfizer Inc','AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE','5; 20','mg/1; mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-6565_f6d65460-2cca-4fe6-a965-1d9b6c884665','0069-6565','HUMAN PRESCRIPTION DRUG','Caduet','','amlodipine and atorvastatin','TABLET, FILM COATED','ORAL','20220831','','NDA','NDA021540','Pfizer Laboratories Div Pfizer Inc','AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE','5; 40','mg/1; mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-6747_f6d65460-2cca-4fe6-a965-1d9b6c884665','0069-6747','HUMAN PRESCRIPTION DRUG','Caduet','','amlodipine and atorvastatin','TABLET, FILM COATED','ORAL','20220831','','NDA','NDA021540','Pfizer Laboratories Div Pfizer Inc','AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE','5; 80','mg/1; mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-7232_f6d65460-2cca-4fe6-a965-1d9b6c884665','0069-7232','HUMAN PRESCRIPTION DRUG','Caduet','','amlodipine and atorvastatin','TABLET, FILM COATED','ORAL','20220831','','NDA','NDA021540','Pfizer Laboratories Div Pfizer Inc','AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE','10; 20','mg/1; mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-7476_f6d65460-2cca-4fe6-a965-1d9b6c884665','0069-7476','HUMAN PRESCRIPTION DRUG','Caduet','','amlodipine and atorvastatin','TABLET, FILM COATED','ORAL','20220831','','NDA','NDA021540','Pfizer Laboratories Div Pfizer Inc','AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE','10; 80','mg/1; mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-7654_f6d65460-2cca-4fe6-a965-1d9b6c884665','0069-7654','HUMAN PRESCRIPTION DRUG','Caduet','','amlodipine and atorvastatin','TABLET, FILM COATED','ORAL','20220831','','NDA','NDA021540','Pfizer Laboratories Div Pfizer Inc','AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE','10; 40','mg/1; mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-7810_f6d65460-2cca-4fe6-a965-1d9b6c884665','0069-7810','HUMAN PRESCRIPTION DRUG','Caduet','','amlodipine and atorvastatin','TABLET, FILM COATED','ORAL','20220606','','NDA','NDA021540','Pfizer Laboratories Div Pfizer Inc','AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE','10; 10','mg/1; mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-8140_f74e81cd-b88f-4c38-8656-266c04b4d859','0069-8140','HUMAN PRESCRIPTION DRUG','Xalkori','','CRIZOTINIB','CAPSULE','ORAL','20110826','','NDA','NDA202570','Pfizer Laboratories Div Pfizer Inc','CRIZOTINIB','250','mg/1','Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Organic Cation Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Receptor Tyrosine Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-8141_f74e81cd-b88f-4c38-8656-266c04b4d859','0069-8141','HUMAN PRESCRIPTION DRUG','Xalkori','','CRIZOTINIB','CAPSULE','ORAL','20110826','','NDA','NDA202570','Pfizer Laboratories Div Pfizer Inc','CRIZOTINIB','200','mg/1','Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Organic Cation Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Receptor Tyrosine Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-8730_6d777993-e6a4-4882-822d-5351be3f501a','0069-8730','HUMAN PRESCRIPTION DRUG','Vyndamax','','tafamidis','CAPSULE, LIQUID FILLED','ORAL','20190827','','NDA','NDA212161','Pfizer Laboratories Div Pfizer Inc','TAFAMIDIS','61','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0069-9500_6ea307ee-5dc2-4ef8-9520-5dffec6a3e55','0069-9500','HUMAN PRESCRIPTION DRUG','Zithromax','','azithromycin dihydrate','TABLET, FILM COATED','ORAL','20200430','','UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE','','Pfizer Laboratories Div Pfizer Inc','AZITHROMYCIN DIHYDRATE','250','mg/1','Macrolide Antimicrobial [EPC], Macrolides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0007_b19c54f4-edc0-4088-b859-90569279241e','0071-0007','HUMAN PRESCRIPTION DRUG','Dilantin Infatabs','','Phenytoin','TABLET, CHEWABLE','ORAL','19790226','','ANDA','ANDA084427','Parke-Davis Div of Pfizer Inc','PHENYTOIN','50','mg/1','Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0155_57b2c466-7b70-45ac-97da-f2644fe8ef61','0071-0155','HUMAN PRESCRIPTION DRUG','Lipitor','','atorvastatin calcium','TABLET, FILM COATED','ORAL','19961217','','NDA','NDA020702','Parke-Davis Div of Pfizer Inc','ATORVASTATIN CALCIUM TRIHYDRATE','10','mg/1','HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0156_57b2c466-7b70-45ac-97da-f2644fe8ef61','0071-0156','HUMAN PRESCRIPTION DRUG','Lipitor','','atorvastatin calcium','TABLET, FILM COATED','ORAL','19961217','','NDA','NDA020702','Parke-Davis Div of Pfizer Inc','ATORVASTATIN CALCIUM TRIHYDRATE','20','mg/1','HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0157_57b2c466-7b70-45ac-97da-f2644fe8ef61','0071-0157','HUMAN PRESCRIPTION DRUG','Lipitor','','atorvastatin calcium','TABLET, FILM COATED','ORAL','19961217','','NDA','NDA020702','Parke-Davis Div of Pfizer Inc','ATORVASTATIN CALCIUM TRIHYDRATE','40','mg/1','HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0158_57b2c466-7b70-45ac-97da-f2644fe8ef61','0071-0158','HUMAN PRESCRIPTION DRUG','Lipitor','','atorvastatin calcium','TABLET, FILM COATED','ORAL','20000407','','NDA','NDA020702','Parke-Davis Div of Pfizer Inc','ATORVASTATIN CALCIUM TRIHYDRATE','80','mg/1','HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0237_d6755f4b-428f-420a-a628-27f3f9b8f2bb','0071-0237','HUMAN PRESCRIPTION DRUG','Zarontin','','Ethosuximide','CAPSULE','ORAL','20000922','','NDA','NDA012380','Parke-Davis Div of Pfizer Inc','ETHOSUXIMIDE','250','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0350_fb832db5-b964-43c1-b52f-c2b701b0ce94','0071-0350','HUMAN PRESCRIPTION DRUG','Nardil','','Phenelzine Sulfate','TABLET, FILM COATED','ORAL','19610609','','NDA','NDA011909','Parke-Davis Div of Pfizer Inc','PHENELZINE SULFATE','15','mg/1','Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0369_06311c9f-47af-4aae-a7a4-a0a40182ee7c','0071-0369','HUMAN PRESCRIPTION DRUG','Dilantin','','Extended Phenytoin Sodium','CAPSULE','ORAL','19760827','','ANDA','ANDA084349','Parke-Davis Div of Pfizer Inc','PHENYTOIN SODIUM','100','mg/1','Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0401_20876c74-5c0b-472c-a19a-d79987402df2','0071-0401','HUMAN PRESCRIPTION DRUG','Neurontin','','gabapentin','TABLET, FILM COATED','ORAL','19981009','','NDA','NDA020882','Parke-Davis Div of Pfizer Inc','GABAPENTIN','800','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0417_b21bdc0d-86ca-4a5f-9695-a7a8064f5bed','0071-0417','HUMAN PRESCRIPTION DRUG','Nitrostat','','nitroglycerin','TABLET','SUBLINGUAL','20000501','','NDA','NDA021134','Parke-Davis Div of Pfizer Inc','NITROGLYCERIN','0.3','mg/1','Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0418_b21bdc0d-86ca-4a5f-9695-a7a8064f5bed','0071-0418','HUMAN PRESCRIPTION DRUG','Nitrostat','','nitroglycerin','TABLET','SUBLINGUAL','20000501','','NDA','NDA021134','Parke-Davis Div of Pfizer Inc','NITROGLYCERIN','0.4','mg/1','Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0419_b21bdc0d-86ca-4a5f-9695-a7a8064f5bed','0071-0419','HUMAN PRESCRIPTION DRUG','Nitrostat','','nitroglycerin','TABLET','SUBLINGUAL','20000501','','NDA','NDA021134','Parke-Davis Div of Pfizer Inc','NITROGLYCERIN','0.6','mg/1','Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0513_20876c74-5c0b-472c-a19a-d79987402df2','0071-0513','HUMAN PRESCRIPTION DRUG','Neurontin','','gabapentin','TABLET, FILM COATED','ORAL','19981009','','NDA','NDA020882','Parke-Davis Div of Pfizer Inc','GABAPENTIN','600','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0525_aae60e0d-e70b-44b4-8d19-3411f359a00a','0071-0525','HUMAN PRESCRIPTION DRUG','Celontin','','methsuximide','CAPSULE','ORAL','19570208','','NDA','NDA010596','Parke-Davis Div of Pfizer Inc','METHSUXIMIDE','300','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0527_140c689b-e8c8-4db9-9bcf-c68869e0d762','0071-0527','HUMAN PRESCRIPTION DRUG','Accupril','','quinapril hydrochloride','TABLET, FILM COATED','ORAL','19911119','','NDA','NDA019885','Parke-Davis Div of Pfizer Inc','QUINAPRIL HYDROCHLORIDE','5','mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0530_140c689b-e8c8-4db9-9bcf-c68869e0d762','0071-0530','HUMAN PRESCRIPTION DRUG','Accupril','','quinapril hydrochloride','TABLET, FILM COATED','ORAL','19911119','','NDA','NDA019885','Parke-Davis Div of Pfizer Inc','QUINAPRIL HYDROCHLORIDE','10','mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0532_140c689b-e8c8-4db9-9bcf-c68869e0d762','0071-0532','HUMAN PRESCRIPTION DRUG','Accupril','','quinapril hydrochloride','TABLET, FILM COATED','ORAL','19911119','','NDA','NDA019885','Parke-Davis Div of Pfizer Inc','QUINAPRIL HYDROCHLORIDE','20','mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0535_140c689b-e8c8-4db9-9bcf-c68869e0d762','0071-0535','HUMAN PRESCRIPTION DRUG','Accupril','','quinapril hydrochloride','TABLET, FILM COATED','ORAL','19911119','','NDA','NDA019885','Parke-Davis Div of Pfizer Inc','QUINAPRIL HYDROCHLORIDE','40','mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0737_ef2b3c7e-b287-4cae-9bc3-86fb6ccbe9ae','0071-0737','HUMAN PRESCRIPTION DRUG','Lopid','','gemfibrozil','TABLET, FILM COATED','ORAL','20040330','','NDA','NDA018422','Parke-Davis Div of Pfizer Inc','GEMFIBROZIL','600','mg/1','PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0803_20876c74-5c0b-472c-a19a-d79987402df2','0071-0803','HUMAN PRESCRIPTION DRUG','Neurontin','','gabapentin','CAPSULE','ORAL','19931230','','NDA','NDA020235','Parke-Davis Div of Pfizer Inc','GABAPENTIN','100','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0805_20876c74-5c0b-472c-a19a-d79987402df2','0071-0805','HUMAN PRESCRIPTION DRUG','Neurontin','','gabapentin','CAPSULE','ORAL','19931230','','NDA','NDA020235','Parke-Davis Div of Pfizer Inc','GABAPENTIN','300','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-0806_20876c74-5c0b-472c-a19a-d79987402df2','0071-0806','HUMAN PRESCRIPTION DRUG','Neurontin','','gabapentin','CAPSULE','ORAL','19931230','','NDA','NDA020235','Parke-Davis Div of Pfizer Inc','GABAPENTIN','400','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-1012_b9b1285a-2cb3-4789-8b0e-8d5e1b253534','0071-1012','HUMAN PRESCRIPTION DRUG','Lyrica','','PREGABALIN','CAPSULE','ORAL','20041230','','NDA','NDA021446','Parke-Davis Div of Pfizer Inc','PREGABALIN','25','mg/1','','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-1013_b9b1285a-2cb3-4789-8b0e-8d5e1b253534','0071-1013','HUMAN PRESCRIPTION DRUG','Lyrica','','PREGABALIN','CAPSULE','ORAL','20041230','','NDA','NDA021446','Parke-Davis Div of Pfizer Inc','PREGABALIN','50','mg/1','','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-1014_b9b1285a-2cb3-4789-8b0e-8d5e1b253534','0071-1014','HUMAN PRESCRIPTION DRUG','Lyrica','','PREGABALIN','CAPSULE','ORAL','20041230','','NDA','NDA021446','Parke-Davis Div of Pfizer Inc','PREGABALIN','75','mg/1','','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-1015_b9b1285a-2cb3-4789-8b0e-8d5e1b253534','0071-1015','HUMAN PRESCRIPTION DRUG','Lyrica','','PREGABALIN','CAPSULE','ORAL','20041230','','NDA','NDA021446','Parke-Davis Div of Pfizer Inc','PREGABALIN','100','mg/1','','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-1016_b9b1285a-2cb3-4789-8b0e-8d5e1b253534','0071-1016','HUMAN PRESCRIPTION DRUG','Lyrica','','PREGABALIN','CAPSULE','ORAL','20041230','','NDA','NDA021446','Parke-Davis Div of Pfizer Inc','PREGABALIN','150','mg/1','','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-1017_b9b1285a-2cb3-4789-8b0e-8d5e1b253534','0071-1017','HUMAN PRESCRIPTION DRUG','Lyrica','','PREGABALIN','CAPSULE','ORAL','20041230','','NDA','NDA021446','Parke-Davis Div of Pfizer Inc','PREGABALIN','200','mg/1','','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-1018_b9b1285a-2cb3-4789-8b0e-8d5e1b253534','0071-1018','HUMAN PRESCRIPTION DRUG','Lyrica','','PREGABALIN','CAPSULE','ORAL','20041230','','NDA','NDA021446','Parke-Davis Div of Pfizer Inc','PREGABALIN','300','mg/1','','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-1019_b9b1285a-2cb3-4789-8b0e-8d5e1b253534','0071-1019','HUMAN PRESCRIPTION DRUG','Lyrica','','PREGABALIN','CAPSULE','ORAL','20041230','','NDA','NDA021446','Parke-Davis Div of Pfizer Inc','PREGABALIN','225','mg/1','','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-1020_b9b1285a-2cb3-4789-8b0e-8d5e1b253534','0071-1020','HUMAN PRESCRIPTION DRUG','Lyrica','','PREGABALIN','SOLUTION','ORAL','20100104','','NDA','NDA022488','Parke-Davis Div of Pfizer Inc','PREGABALIN','20','mg/mL','','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-1026_df981020-42d9-41ff-b37d-3ddcbf354a86','0071-1026','HUMAN PRESCRIPTION DRUG','Lyrica CR','','PREGABALIN','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20180101','','NDA','NDA209501','Parke-Davis Div of Pfizer Inc','PREGABALIN','82.5','mg/1','','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-1027_df981020-42d9-41ff-b37d-3ddcbf354a86','0071-1027','HUMAN PRESCRIPTION DRUG','Lyrica CR','','PREGABALIN','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20180101','','NDA','NDA209501','Parke-Davis Div of Pfizer Inc','PREGABALIN','165','mg/1','','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-1029_df981020-42d9-41ff-b37d-3ddcbf354a86','0071-1029','HUMAN PRESCRIPTION DRUG','Lyrica CR','','PREGABALIN','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20180101','','NDA','NDA209501','Parke-Davis Div of Pfizer Inc','PREGABALIN','330','mg/1','','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-2012_20876c74-5c0b-472c-a19a-d79987402df2','0071-2012','HUMAN PRESCRIPTION DRUG','Neurontin','','gabapentin','SOLUTION','ORAL','20000302','','NDA','NDA021129','Parke-Davis Div of Pfizer Inc','GABAPENTIN','250','mg/5mL','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-2214_2290658d-13e5-43f6-805f-614c8baa613c','0071-2214','HUMAN PRESCRIPTION DRUG','Dilantin-125','','Phenytoin','SUSPENSION','ORAL','19530106','','NDA','NDA008762','Parke-Davis Div of Pfizer Inc','PHENYTOIN','125','mg/5mL','Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-2418_a715f83d-739d-4fc2-a043-62569ddf8e8e','0071-2418','HUMAN PRESCRIPTION DRUG','Zarontin','','Ethosuximide','SOLUTION','ORAL','20200310','','ANDA','ANDA080258','Parke-Davis Div of Pfizer Inc','ETHOSUXIMIDE','250','mg/5mL','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-3112_5d45c736-6441-48cd-8cfb-23ff673aa4f7','0071-3112','HUMAN PRESCRIPTION DRUG','ACCURETIC','','quinapril and hydrochlorothiazide','TABLET, FILM COATED','ORAL','20211129','','NDA','NDA020125','Parke-Davis Div of Pfizer Inc','HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE','12.5; 10','mg/1; mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-3740_06311c9f-47af-4aae-a7a4-a0a40182ee7c','0071-3740','HUMAN PRESCRIPTION DRUG','Dilantin','','Extended Phenytoin Sodium','CAPSULE','ORAL','19760827','','ANDA','ANDA084349','Parke-Davis Div of Pfizer Inc','PHENYTOIN SODIUM','30','mg/1','Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0071-5212_5d45c736-6441-48cd-8cfb-23ff673aa4f7','0071-5212','HUMAN PRESCRIPTION DRUG','ACCURETIC','','quinapril and hydrochlorothiazide','TABLET, FILM COATED','ORAL','20211206','','NDA','NDA020125','Parke-Davis Div of Pfizer Inc','HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE','12.5; 20','mg/1; mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-0038_5ef2e02f-81f5-4111-a72a-ebfe7c93be1c','0074-0038','HUMAN PRESCRIPTION DRUG','Orilissa','','Elagolix','TABLET, FILM COATED','ORAL','20180723','','NDA','NDA210450','AbbVie Inc.','ELAGOLIX SODIUM','150','mg/1','Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Decreased GnRH Secretion [PE], Gonadotropin Releasing Hormone Receptor Antagonist [EPC], Gonadotropin Releasing Hormone Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-0039_5ef2e02f-81f5-4111-a72a-ebfe7c93be1c','0074-0039','HUMAN PRESCRIPTION DRUG','Orilissa','','Elagolix','TABLET, FILM COATED','ORAL','20180723','','NDA','NDA210450','AbbVie Inc.','ELAGOLIX SODIUM','200','mg/1','Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Decreased GnRH Secretion [PE], Gonadotropin Releasing Hormone Receptor Antagonist [EPC], Gonadotropin Releasing Hormone Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-0067_ad5c53d6-3ba4-4130-aa33-a9ace68e09f0','0074-0067','HUMAN PRESCRIPTION DRUG','Humira','','Adalimumab','KIT','','20161017','','BLA','BLA125057','AbbVie Inc.','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-0124_ad5c53d6-3ba4-4130-aa33-a9ace68e09f0','0074-0124','HUMAN PRESCRIPTION DRUG','Humira','','Adalimumab','KIT','','20170421','','BLA','BLA125057','AbbVie Inc.','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-0243_ad5c53d6-3ba4-4130-aa33-a9ace68e09f0','0074-0243','HUMAN PRESCRIPTION DRUG','Humira','','Adalimumab','KIT','','20151123','','BLA','BLA125057','AbbVie Inc.','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-0522_0195c057-8795-448e-b1e4-c168d23e4301','0074-0522','HUMAN PRESCRIPTION DRUG','Kaletra','','Lopinavir and Ritonavir','TABLET, FILM COATED','ORAL','20100618','','NDA','NDA021906','AbbVie Inc.','LOPINAVIR; RITONAVIR','100; 25','mg/1; mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-0554_ad5c53d6-3ba4-4130-aa33-a9ace68e09f0','0074-0554','HUMAN PRESCRIPTION DRUG','Humira','','Adalimumab','KIT','','20160309','','BLA','BLA125057','AbbVie Inc.','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-0561_e1a62e40-c7f8-43d3-84fa-a7f3d775a8c5','0074-0561','HUMAN PRESCRIPTION DRUG','Venclexta','','Venetoclax','TABLET, FILM COATED','ORAL','20160411','','NDA','NDA208573','AbbVie Inc.','VENETOCLAX','10','mg/1','BCL-2 Inhibitor [EPC], Increased Cellular Death [PE], P-Glycoprotein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-0566_e1a62e40-c7f8-43d3-84fa-a7f3d775a8c5','0074-0566','HUMAN PRESCRIPTION DRUG','Venclexta','','Venetoclax','TABLET, FILM COATED','ORAL','20160411','','NDA','NDA208573','AbbVie Inc.','VENETOCLAX','50','mg/1','BCL-2 Inhibitor [EPC], Increased Cellular Death [PE], P-Glycoprotein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-0576_e1a62e40-c7f8-43d3-84fa-a7f3d775a8c5','0074-0576','HUMAN PRESCRIPTION DRUG','Venclexta','','Venetoclax','TABLET, FILM COATED','ORAL','20160411','','NDA','NDA208573','AbbVie Inc.','VENETOCLAX','100','mg/1','BCL-2 Inhibitor [EPC], Increased Cellular Death [PE], P-Glycoprotein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-0579_e1a62e40-c7f8-43d3-84fa-a7f3d775a8c5','0074-0579','HUMAN PRESCRIPTION DRUG','Venclexta','','Venetoclax','KIT','','20160411','','NDA','NDA208573','AbbVie Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-0616_ad5c53d6-3ba4-4130-aa33-a9ace68e09f0','0074-0616','HUMAN PRESCRIPTION DRUG','Humira','','Adalimumab','KIT','','20170428','','BLA','BLA125057','AbbVie Inc.','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-0817_ad5c53d6-3ba4-4130-aa33-a9ace68e09f0','0074-0817','HUMAN PRESCRIPTION DRUG','Humira','','Adalimumab','KIT','','20170428','','BLA','BLA125057','AbbVie Inc.','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-1017_1d1a569f-cbfa-4604-a150-b135363e0576','0074-1017','HUMAN PRESCRIPTION DRUG','Oriahnn','','Elagolix and Estradiol and Norethisterone','KIT','','20200529','','NDA','NDA213388','AbbVie Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-1040_ea24a074-489e-413a-a3e0-889a4af5f0a6','0074-1040','HUMAN PRESCRIPTION DRUG','Survanta','','Beractant','SUSPENSION','ENDOTRACHEAL','19910701','','BLA','BLA020032','AbbVie Inc.','BERACTANT','25','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-1043_5b0d3f92-32ff-4ce8-aadb-1e727dcab17f','0074-1043','HUMAN PRESCRIPTION DRUG','Rinvoq','','Upadacitinib','TABLET, EXTENDED RELEASE','ORAL','20190816','','NDA','NDA211675','AbbVie Inc.','UPADACITINIB','45','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-1050_e8bbdb9e-3e1c-4191-8025-6739e960943d','0074-1050','HUMAN PRESCRIPTION DRUG','Skyrizi','','risankizumab-rzaa','INJECTION','SUBCUTANEOUS','20210426','','BLA','BLA761105','AbbVie Inc.','RISANKIZUMAB','150','mg/mL','Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-1065_e8bbdb9e-3e1c-4191-8025-6739e960943d','0074-1065','HUMAN PRESCRIPTION DRUG','Skyrizi','','Risankizumab-rzaa','KIT','','20220923','','BLA','BLA761105','AbbVie Inc.','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-1070_e8bbdb9e-3e1c-4191-8025-6739e960943d','0074-1070','HUMAN PRESCRIPTION DRUG','Skyrizi','','Risankizumab-rzaa','KIT','','20220616','','BLA','BLA761105','AbbVie Inc.','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-1539_ad5c53d6-3ba4-4130-aa33-a9ace68e09f0','0074-1539','HUMAN PRESCRIPTION DRUG','Humira','','Adalimumab','KIT','','20170421','','BLA','BLA125057','AbbVie Inc.','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-1575_0195c057-8795-448e-b1e4-c168d23e4301','0074-1575','HUMAN PRESCRIPTION DRUG','Kaletra','','Lopinavir and Ritonavir','TABLET, FILM COATED','ORAL','20200408','','NDA','NDA021906','AbbVie Inc.','LOPINAVIR; RITONAVIR','100; 25','mg/1; mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-1658_34ce3eec-a796-40f8-8902-127f8c47a980','0074-1658','HUMAN PRESCRIPTION DRUG','Zemplar','','Paricalcitol','INJECTION, SOLUTION','INTRAVENOUS','19980417','','NDA','NDA020819','AbbVie Inc.','PARICALCITOL','5','ug/mL','Ergocalciferols [CS], Vitamin D2 Analog [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-2100_e8bbdb9e-3e1c-4191-8025-6739e960943d','0074-2100','HUMAN PRESCRIPTION DRUG','Skyrizi','','risankizumab-rzaa','INJECTION','SUBCUTANEOUS','20210426','','BLA','BLA761105','AbbVie Inc.','RISANKIZUMAB','150','mg/mL','Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-2108_b92899b0-34ae-4ace-8487-300e4bc074ac','0074-2108','HUMAN PRESCRIPTION DRUG','Lupron Depot-PED','','leuprolide acetate','KIT','','19930416','','NDA','NDA020263','AbbVie Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-2282_b92899b0-34ae-4ace-8487-300e4bc074ac','0074-2282','HUMAN PRESCRIPTION DRUG','Lupron Depot-PED','','leuprolide acetate','KIT','','19930416','','NDA','NDA020263','AbbVie Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-2306_5b0d3f92-32ff-4ce8-aadb-1e727dcab17f','0074-2306','HUMAN PRESCRIPTION DRUG','Rinvoq','','Upadacitinib','TABLET, EXTENDED RELEASE','ORAL','20190816','','NDA','NDA211675','AbbVie Inc.','UPADACITINIB','15','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-2310_5b0d3f92-32ff-4ce8-aadb-1e727dcab17f','0074-2310','HUMAN PRESCRIPTION DRUG','Rinvoq','','Upadacitinib','TABLET, EXTENDED RELEASE','ORAL','20190816','','NDA','NDA211675','AbbVie Inc.','UPADACITINIB','30','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-2340_4fac307e-e822-429d-9516-d95e86529dc9','0074-2340','HUMAN PRESCRIPTION DRUG','Norvir','','Ritonavir','TABLET, FILM COATED','ORAL','20220816','','NDA','NDA022417','AbbVie Inc.','RITONAVIR','100','mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-2440_b92899b0-34ae-4ace-8487-300e4bc074ac','0074-2440','HUMAN PRESCRIPTION DRUG','Lupron Depot-PED','','leuprolide acetate','KIT','','19930416','','NDA','NDA020263','AbbVie Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-2540_ad5c53d6-3ba4-4130-aa33-a9ace68e09f0','0074-2540','HUMAN PRESCRIPTION DRUG','Humira','','Adalimumab','KIT','','20161017','','BLA','BLA125057','AbbVie Inc.','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-2600_c6dbffcb-f5e7-4caa-b789-33ce29d95531','0074-2600','HUMAN PRESCRIPTION DRUG','Mavyret','','Glecaprevir and Pibrentasvir','PELLET','ORAL','20210610','','NDA','NDA215110','AbbVie Inc.','GLECAPREVIR; PIBRENTASVIR','50; 20','mg/1; mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HCV NS3/4A Protease Inhibitors [MoA], Hepatitis C Virus NS3/4A Protease Inhibitor [EPC], Hepatitis C Virus NS5A Inhibitor [EPC], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], UGT1A1 Inhibitors [MoA], UGT1A1 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-2605_0195c057-8795-448e-b1e4-c168d23e4301','0074-2605','HUMAN PRESCRIPTION DRUG','Kaletra','','Lopinavir and Ritonavir','TABLET, FILM COATED','ORAL','20200408','','NDA','NDA021906','AbbVie Inc.','LOPINAVIR; RITONAVIR','200; 50','mg/1; mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-2625_c6dbffcb-f5e7-4caa-b789-33ce29d95531','0074-2625','HUMAN PRESCRIPTION DRUG','Mavyret','','Glecaprevir and Pibrentasvir','TABLET, FILM COATED','ORAL','20170803','','NDA','NDA209394','AbbVie Inc.','GLECAPREVIR; PIBRENTASVIR','100; 40','mg/1; mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HCV NS3/4A Protease Inhibitors [MoA], Hepatitis C Virus NS3/4A Protease Inhibitor [EPC], Hepatitis C Virus NS5A Inhibitor [EPC], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], UGT1A1 Inhibitors [MoA], UGT1A1 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3012_8c1ec985-67dd-4352-b492-9819050ebb69','0074-3012','HUMAN PRESCRIPTION DRUG','Duopa','','Carbidopa and Levodopa','SUSPENSION','ENTERAL','20150115','','NDA','NDA203952','AbbVie Inc.','CARBIDOPA; LEVODOPA','4.63; 20','mg/mL; mg/mL','Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3023_91a88355-2985-464a-ae70-f75e0ae09ae5','0074-3023','HUMAN PRESCRIPTION DRUG','K-Tab','','Potassium Chloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','19800609','20250215','NDA','NDA018279','AbbVie Inc.','POTASSIUM CHLORIDE','1500','mg/1','Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3093_d2f87bf8-2610-4486-940f-00f4f670e1bb','0074-3093','HUMAN PRESCRIPTION DRUG','Viekira Pak','','Dasabuvir and Ombitasvir and Paritaprevir and Ritonavir','KIT','','20141219','','NDA','NDA206619','AbbVie Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3108_b4988e79-5738-42c0-b260-2fd071bb7a5d','0074-3108','HUMAN PRESCRIPTION DRUG','Gengraf','','Cyclosporine','CAPSULE','ORAL','20151101','','ANDA','ANDA065003','AbbVie Inc.','CYCLOSPORINE','25','mg/1','Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3109_b4988e79-5738-42c0-b260-2fd071bb7a5d','0074-3109','HUMAN PRESCRIPTION DRUG','Gengraf','','Cyclosporine','CAPSULE','ORAL','20151101','','ANDA','ANDA065003','AbbVie Inc.','CYCLOSPORINE','100','mg/1','Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3161_45d3b5e3-12f2-486c-87b6-d2e529e5017c','0074-3161','HUMAN PRESCRIPTION DRUG','Trilipix','','Fenofibric Acid','CAPSULE, DELAYED RELEASE','ORAL','20160912','','NDA','NDA022224','AbbVie Inc.','FENOFIBRIC ACID','45','mg/1','Peroxisome Proliferator Receptor alpha Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3162_45d3b5e3-12f2-486c-87b6-d2e529e5017c','0074-3162','HUMAN PRESCRIPTION DRUG','Trilipix','','Fenofibric Acid','CAPSULE, DELAYED RELEASE','ORAL','20160912','','NDA','NDA022224','AbbVie Inc.','FENOFIBRIC ACID','135','mg/1','Peroxisome Proliferator Receptor alpha Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3173_7d6fd4ec-c931-458a-8687-fd3a96dfda2c','0074-3173','HUMAN PRESCRIPTION DRUG','Tricor','','Fenofibrate','TABLET','ORAL','20160205','','NDA','NDA021656','AbbVie Inc.','FENOFIBRATE','48','mg/1','Peroxisome Proliferator Receptor alpha Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3189_7d6fd4ec-c931-458a-8687-fd3a96dfda2c','0074-3189','HUMAN PRESCRIPTION DRUG','Tricor','','Fenofibrate','TABLET','ORAL','20160205','','NDA','NDA021656','AbbVie Inc.','FENOFIBRATE','145','mg/1','Peroxisome Proliferator Receptor alpha Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3278_91a88355-2985-464a-ae70-f75e0ae09ae5','0074-3278','HUMAN PRESCRIPTION DRUG','K-Tab','','Potassium Chloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20170601','20231104','NDA','NDA018279','AbbVie Inc.','POTASSIUM CHLORIDE','750','mg/1','Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3333_4fac307e-e822-429d-9516-d95e86529dc9','0074-3333','HUMAN PRESCRIPTION DRUG','Norvir','','Ritonavir','TABLET, FILM COATED','ORAL','20100506','20240214','NDA','NDA022417','AbbVie Inc.','RITONAVIR','100','mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3346_5aed3ea2-de6d-4f33-b6de-7250fe1993f4','0074-3346','HUMAN PRESCRIPTION DRUG','Lupron Depot','','leuprolide acetate','KIT','','19951222','','NDA','NDA020517','AbbVie Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3399_4fac307e-e822-429d-9516-d95e86529dc9','0074-3399','HUMAN PRESCRIPTION DRUG','Norvir','','Ritonavir','POWDER','ORAL','20170607','','NDA','NDA209512','AbbVie Inc.','RITONAVIR','100','mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3473_5aed3ea2-de6d-4f33-b6de-7250fe1993f4','0074-3473','HUMAN PRESCRIPTION DRUG','Lupron Depot','','leuprolide acetate','KIT','','19951222','','NDA','NDA020517','AbbVie Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3641_a369eae7-6758-42c0-9068-6a8b16aeaffd','0074-3641','HUMAN PRESCRIPTION DRUG','Lupron Depot','','leuprolide acetate','KIT','','19901022','','NDA','NDA020011','AbbVie Inc.','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3642_5aed3ea2-de6d-4f33-b6de-7250fe1993f4','0074-3642','HUMAN PRESCRIPTION DRUG','Lupron Depot','','leuprolide acetate','KIT','','19890126','','NDA','NDA019732','AbbVie Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3663_c2305b5e-3504-4519-bcb0-eda2ec737117','0074-3663','HUMAN PRESCRIPTION DRUG','Lupron Depot','','leuprolide acetate','KIT','','20101108','','NDA','NDA020708','AbbVie Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3683_5aed3ea2-de6d-4f33-b6de-7250fe1993f4','0074-3683','HUMAN PRESCRIPTION DRUG','Lupron Depot','','leuprolide acetate','KIT','','19951222','','NDA','NDA020517','AbbVie Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3727_872c70fd-ed64-4f07-b811-5eaa08924982','0074-3727','HUMAN PRESCRIPTION DRUG','Synthroid','','Levothyroxine Sodium','TABLET','ORAL','20020724','','NDA','NDA021402','AbbVie Inc.','LEVOTHYROXINE SODIUM','137','ug/1','Thyroxine [CS], l-Thyroxine [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3779_b92899b0-34ae-4ace-8487-300e4bc074ac','0074-3779','HUMAN PRESCRIPTION DRUG','Lupron Depot-PED','','leuprolide acetate','KIT','','19930416','','NDA','NDA020263','AbbVie Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3799_ad5c53d6-3ba4-4130-aa33-a9ace68e09f0','0074-3799','HUMAN PRESCRIPTION DRUG','Humira','','Adalimumab','KIT','','20021231','','BLA','BLA125057','AbbVie Inc.','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3826_c7f33a5e-be13-45a6-8edd-8f6cd7618e1e','0074-3826','HUMAN PRESCRIPTION DRUG','Depakote','ER','Divalproex Sodium','TABLET, EXTENDED RELEASE','ORAL','20000804','20240621','NDA','NDA021168','AbbVie Inc.','DIVALPROEX SODIUM','250','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-3956_0195c057-8795-448e-b1e4-c168d23e4301','0074-3956','HUMAN PRESCRIPTION DRUG','Kaletra','','Lopinavir and Ritonavir','SOLUTION','ORAL','20100618','','NDA','NDA021251','AbbVie Inc.','LOPINAVIR; RITONAVIR','80; 20','mg/mL; mg/mL','Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-4339_ad5c53d6-3ba4-4130-aa33-a9ace68e09f0','0074-4339','HUMAN PRESCRIPTION DRUG','Humira','','Adalimumab','KIT','','20060623','','BLA','BLA125057','AbbVie Inc.','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-4341_872c70fd-ed64-4f07-b811-5eaa08924982','0074-4341','HUMAN PRESCRIPTION DRUG','Synthroid','','Levothyroxine Sodium','TABLET','ORAL','20020724','','NDA','NDA021402','AbbVie Inc.','LEVOTHYROXINE SODIUM','25','ug/1','Thyroxine [CS], l-Thyroxine [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-4378_d6a0b0a7-e7f2-4496-9611-dddd169b6e14','0074-4378','HUMAN PRESCRIPTION DRUG','Nimbex','','Cisatracurium besylate','INJECTION','INTRAVENOUS','20101209','','NDA','NDA020551','AbbVie Inc.','CISATRACURIUM BESYLATE','2','mg/mL','Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-4380_d6a0b0a7-e7f2-4496-9611-dddd169b6e14','0074-4380','HUMAN PRESCRIPTION DRUG','Nimbex','','Cisatracurium besylate','INJECTION','INTRAVENOUS','20101209','','NDA','NDA020551','AbbVie Inc.','CISATRACURIUM BESYLATE','2','mg/mL','Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-4382_d6a0b0a7-e7f2-4496-9611-dddd169b6e14','0074-4382','HUMAN PRESCRIPTION DRUG','Nimbex','','Cisatracurium besylate','INJECTION','INTRAVENOUS','19951215','','NDA','NDA020551','AbbVie Inc.','CISATRACURIUM BESYLATE','10','mg/mL','Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-4456_048607d6-77e3-4d40-83c2-d7e0a8dfdc60','0074-4456','HUMAN PRESCRIPTION DRUG','Ultane','','Sevoflurane','LIQUID','RESPIRATORY (INHALATION)','19950607','','NDA','NDA020478','AbbVie Inc.','SEVOFLURANE','250','mL/250mL','General Anesthesia [PE], General Anesthetic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-4456_acc4e05d-c8ef-4838-a942-792d6b98d286','0074-4456','HUMAN PRESCRIPTION DRUG','Ultane','','Sevoflurane','LIQUID','RESPIRATORY (INHALATION)','19950607','','NDA','NDA020478','AbbVie Inc.','SEVOFLURANE','250','mL/250mL','General Anesthesia [PE], General Anesthetic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-4552_872c70fd-ed64-4f07-b811-5eaa08924982','0074-4552','HUMAN PRESCRIPTION DRUG','Synthroid','','Levothyroxine Sodium','TABLET','ORAL','20020724','','NDA','NDA021402','AbbVie Inc.','LEVOTHYROXINE SODIUM','50','ug/1','Thyroxine [CS], l-Thyroxine [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-4637_34ce3eec-a796-40f8-8902-127f8c47a980','0074-4637','HUMAN PRESCRIPTION DRUG','Zemplar','','Paricalcitol','INJECTION, SOLUTION','INTRAVENOUS','19980417','','NDA','NDA020819','AbbVie Inc.','PARICALCITOL','2','ug/mL','Ergocalciferols [CS], Vitamin D2 Analog [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-5015_e8bbdb9e-3e1c-4191-8025-6739e960943d','0074-5015','HUMAN PRESCRIPTION DRUG','Skyrizi','','risankizumab-rzaa','INJECTION','INTRAVENOUS','20220616','','BLA','BLA761262','AbbVie Inc.','RISANKIZUMAB','600','mg/10mL','Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-5182_872c70fd-ed64-4f07-b811-5eaa08924982','0074-5182','HUMAN PRESCRIPTION DRUG','Synthroid','','Levothyroxine Sodium','TABLET','ORAL','20020724','','NDA','NDA021402','AbbVie Inc.','LEVOTHYROXINE SODIUM','75','ug/1','Thyroxine [CS], l-Thyroxine [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-6114_c4f87cf0-f300-479b-89ed-9234d530b574','0074-6114','HUMAN PRESCRIPTION DRUG','Depakote','Sprinkles','Divalproex Sodium','CAPSULE','ORAL','19890912','','NDA','NDA019680','AbbVie Inc.','DIVALPROEX SODIUM','125','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-6214_031dba36-cb97-4687-a4d0-88bd9fb595d0','0074-6214','HUMAN PRESCRIPTION DRUG','Depakote','','Divalproex Sodium','TABLET, DELAYED RELEASE','ORAL','19830310','','NDA','NDA018723','AbbVie Inc.','DIVALPROEX SODIUM','250','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-6215_031dba36-cb97-4687-a4d0-88bd9fb595d0','0074-6215','HUMAN PRESCRIPTION DRUG','Depakote','','Divalproex Sodium','TABLET, DELAYED RELEASE','ORAL','19830310','20240225','NDA','NDA018723','AbbVie Inc.','DIVALPROEX SODIUM','500','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-6594_872c70fd-ed64-4f07-b811-5eaa08924982','0074-6594','HUMAN PRESCRIPTION DRUG','Synthroid','','Levothyroxine Sodium','TABLET','ORAL','20020724','','NDA','NDA021402','AbbVie Inc.','LEVOTHYROXINE SODIUM','88','ug/1','Thyroxine [CS], l-Thyroxine [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-6624_872c70fd-ed64-4f07-b811-5eaa08924982','0074-6624','HUMAN PRESCRIPTION DRUG','Synthroid','','Levothyroxine Sodium','TABLET','ORAL','20020724','','NDA','NDA021402','AbbVie Inc.','LEVOTHYROXINE SODIUM','100','ug/1','Thyroxine [CS], l-Thyroxine [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-6799_0195c057-8795-448e-b1e4-c168d23e4301','0074-6799','HUMAN PRESCRIPTION DRUG','Kaletra','','Lopinavir and Ritonavir','TABLET, FILM COATED','ORAL','20100618','','NDA','NDA021906','AbbVie Inc.','LOPINAVIR; RITONAVIR','200; 50','mg/1; mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-7068_872c70fd-ed64-4f07-b811-5eaa08924982','0074-7068','HUMAN PRESCRIPTION DRUG','Synthroid','','Levothyroxine Sodium','TABLET','ORAL','20020724','','NDA','NDA021402','AbbVie Inc.','LEVOTHYROXINE SODIUM','125','ug/1','Thyroxine [CS], l-Thyroxine [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-7069_872c70fd-ed64-4f07-b811-5eaa08924982','0074-7069','HUMAN PRESCRIPTION DRUG','Synthroid','','Levothyroxine Sodium','TABLET','ORAL','20020724','','NDA','NDA021402','AbbVie Inc.','LEVOTHYROXINE SODIUM','150','ug/1','Thyroxine [CS], l-Thyroxine [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-7070_872c70fd-ed64-4f07-b811-5eaa08924982','0074-7070','HUMAN PRESCRIPTION DRUG','Synthroid','','Levothyroxine Sodium','TABLET','ORAL','20020724','','NDA','NDA021402','AbbVie Inc.','LEVOTHYROXINE SODIUM','175','ug/1','Thyroxine [CS], l-Thyroxine [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-7094_c4464c43-8a63-4c38-9395-c1f8a78bd03f','0074-7094','HUMAN PRESCRIPTION DRUG','Qulipta','','Atogepant','TABLET','ORAL','20210930','','NDA','NDA215206','AbbVie Inc.','ATOGEPANT','60','mg/1','Calcitonin Gene-related Peptide Receptor Antagonist [EPC], Calcitonin Gene-related Peptide Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-7095_c4464c43-8a63-4c38-9395-c1f8a78bd03f','0074-7095','HUMAN PRESCRIPTION DRUG','Qulipta','','Atogepant','TABLET','ORAL','20210930','','NDA','NDA215206','AbbVie Inc.','ATOGEPANT','10','mg/1','Calcitonin Gene-related Peptide Receptor Antagonist [EPC], Calcitonin Gene-related Peptide Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-7096_c4464c43-8a63-4c38-9395-c1f8a78bd03f','0074-7096','HUMAN PRESCRIPTION DRUG','Qulipta','','Atogepant','TABLET','ORAL','20210930','','NDA','NDA215206','AbbVie Inc.','ATOGEPANT','30','mg/1','Calcitonin Gene-related Peptide Receptor Antagonist [EPC], Calcitonin Gene-related Peptide Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-7098_8fbc0d52-3f63-4c8f-a5d4-6cfb8fb8d614','0074-7098','HUMAN PRESCRIPTION DRUG','VUITY','','Pilocarpine Hydrochloride','SOLUTION/ DROPS','OPHTHALMIC','20211028','','NDA','NDA214028','AbbVie Inc.','PILOCARPINE HYDROCHLORIDE','12.5','mg/mL','Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-7126_c7f33a5e-be13-45a6-8edd-8f6cd7618e1e','0074-7126','HUMAN PRESCRIPTION DRUG','Depakote','ER','Divalproex Sodium','TABLET, EXTENDED RELEASE','ORAL','20000804','20240326','NDA','NDA021168','AbbVie Inc.','DIVALPROEX SODIUM','500','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-7148_872c70fd-ed64-4f07-b811-5eaa08924982','0074-7148','HUMAN PRESCRIPTION DRUG','Synthroid','','Levothyroxine Sodium','TABLET','ORAL','20020224','','NDA','NDA021402','AbbVie Inc.','LEVOTHYROXINE SODIUM','200','ug/1','Thyroxine [CS], l-Thyroxine [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-7149_872c70fd-ed64-4f07-b811-5eaa08924982','0074-7149','HUMAN PRESCRIPTION DRUG','Synthroid','','Levothyroxine Sodium','TABLET','ORAL','20020724','','NDA','NDA021402','AbbVie Inc.','LEVOTHYROXINE SODIUM','300','ug/1','Thyroxine [CS], l-Thyroxine [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-7269_58130bbd-f2d6-4dc8-a4e1-d00fa272fe2a','0074-7269','HUMAN PRESCRIPTION DRUG','Gengraf','','Cyclosporine','SOLUTION','ORAL','20100525','','ANDA','ANDA065025','AbbVie Inc.','CYCLOSPORINE','100','mg/mL','Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-7325_031dba36-cb97-4687-a4d0-88bd9fb595d0','0074-7325','HUMAN PRESCRIPTION DRUG','Depakote','','Divalproex Sodium','TABLET, DELAYED RELEASE','ORAL','19830310','','NDA','NDA018723','AbbVie Inc.','DIVALPROEX SODIUM','125','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-7327_031dba36-cb97-4687-a4d0-88bd9fb595d0','0074-7327','HUMAN PRESCRIPTION DRUG','Depakote','','Divalproex Sodium','TABLET, DELAYED RELEASE','ORAL','19830310','','NDA','NDA018723','AbbVie Inc.','DIVALPROEX SODIUM','500','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-7401_c7f33a5e-be13-45a6-8edd-8f6cd7618e1e','0074-7401','HUMAN PRESCRIPTION DRUG','Depakote','ER','Divalproex Sodium','TABLET, EXTENDED RELEASE','ORAL','20000804','','NDA','NDA021168','AbbVie Inc.','DIVALPROEX SODIUM','250','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-7402_c7f33a5e-be13-45a6-8edd-8f6cd7618e1e','0074-7402','HUMAN PRESCRIPTION DRUG','Depakote','ER','Divalproex Sodium','TABLET, EXTENDED RELEASE','ORAL','20000804','','NDA','NDA021168','AbbVie Inc.','DIVALPROEX SODIUM','500','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-9036_2a2432ff-542c-4fb4-aeba-2ece1d7cb8ad','0074-9036','HUMAN PRESCRIPTION DRUG','Zemplar','','Paricalcitol','CAPSULE, LIQUID FILLED','ORAL','20180420','','NDA','NDA021606','AbbVie Inc.','PARICALCITOL','1','ug/1','Ergocalciferols [CS], Vitamin D2 Analog [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-9037_2a2432ff-542c-4fb4-aeba-2ece1d7cb8ad','0074-9037','HUMAN PRESCRIPTION DRUG','Zemplar','','Paricalcitol','CAPSULE, LIQUID FILLED','ORAL','20180420','','NDA','NDA021606','AbbVie Inc.','PARICALCITOL','2','ug/1','Ergocalciferols [CS], Vitamin D2 Analog [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-9296_872c70fd-ed64-4f07-b811-5eaa08924982','0074-9296','HUMAN PRESCRIPTION DRUG','Synthroid','','Levothyroxine Sodium','TABLET','ORAL','20020724','','NDA','NDA021402','AbbVie Inc.','LEVOTHYROXINE SODIUM','112','ug/1','Thyroxine [CS], l-Thyroxine [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0074-9694_b92899b0-34ae-4ace-8487-300e4bc074ac','0074-9694','HUMAN PRESCRIPTION DRUG','Lupron Depot-PED','','leuprolide acetate','KIT','','19930416','','NDA','NDA020263','AbbVie Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0075-0620_3aafdd4d-7816-40f2-a675-af0e97fa0552','0075-0620','HUMAN PRESCRIPTION DRUG','Lovenox','','enoxaparin sodium','INJECTION','SUBCUTANEOUS','19930329','','NDA','NDA020164','Sanofi-Aventis U.S. LLC','ENOXAPARIN SODIUM','40','mg/.4mL','Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0075-0621_3aafdd4d-7816-40f2-a675-af0e97fa0552','0075-0621','HUMAN PRESCRIPTION DRUG','Lovenox','','enoxaparin sodium','INJECTION','SUBCUTANEOUS','19930329','','NDA','NDA020164','Sanofi-Aventis U.S. LLC','ENOXAPARIN SODIUM','60','mg/.6mL','Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0075-0622_3aafdd4d-7816-40f2-a675-af0e97fa0552','0075-0622','HUMAN PRESCRIPTION DRUG','Lovenox','','enoxaparin sodium','INJECTION','SUBCUTANEOUS','19930329','','NDA','NDA020164','Sanofi-Aventis U.S. LLC','ENOXAPARIN SODIUM','80','mg/.8mL','Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0075-0623_3aafdd4d-7816-40f2-a675-af0e97fa0552','0075-0623','HUMAN PRESCRIPTION DRUG','Lovenox','','enoxaparin sodium','INJECTION','SUBCUTANEOUS','19930329','','NDA','NDA020164','Sanofi-Aventis U.S. LLC','ENOXAPARIN SODIUM','100','mg/mL','Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0075-0624_3aafdd4d-7816-40f2-a675-af0e97fa0552','0075-0624','HUMAN PRESCRIPTION DRUG','Lovenox','','enoxaparin sodium','INJECTION','SUBCUTANEOUS','19930329','','NDA','NDA020164','Sanofi-Aventis U.S. LLC','ENOXAPARIN SODIUM','30','mg/.3mL','Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0075-0626_3aafdd4d-7816-40f2-a675-af0e97fa0552','0075-0626','HUMAN PRESCRIPTION DRUG','Lovenox','','enoxaparin sodium','INJECTION','INTRAVENOUS; SUBCUTANEOUS','19930329','','NDA','NDA020164','Sanofi-Aventis U.S. LLC','ENOXAPARIN SODIUM','300','mg/3mL','Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0075-2912_3aafdd4d-7816-40f2-a675-af0e97fa0552','0075-2912','HUMAN PRESCRIPTION DRUG','Lovenox','','enoxaparin sodium','INJECTION','SUBCUTANEOUS','19930329','','NDA','NDA020164','Sanofi-Aventis U.S. LLC','ENOXAPARIN SODIUM','120','mg/.8mL','Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0075-2915_3aafdd4d-7816-40f2-a675-af0e97fa0552','0075-2915','HUMAN PRESCRIPTION DRUG','Lovenox','','enoxaparin sodium','INJECTION','SUBCUTANEOUS','19930329','','NDA','NDA020164','Sanofi-Aventis U.S. LLC','ENOXAPARIN SODIUM','150','mg/mL','Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0075-8013_5651b020-2238-46af-9068-dd3b2795928d','0075-8013','HUMAN PRESCRIPTION DRUG','Lovenox','','enoxaparin sodium','INJECTION','SUBCUTANEOUS','19930329','','NDA','NDA020164','Sanofi-Aventis U.S. LLC','ENOXAPARIN SODIUM','30','mg/.3mL','Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0075-8014_5651b020-2238-46af-9068-dd3b2795928d','0075-8014','HUMAN PRESCRIPTION DRUG','Lovenox','','enoxaparin sodium','INJECTION','SUBCUTANEOUS','19930329','','NDA','NDA020164','Sanofi-Aventis U.S. LLC','ENOXAPARIN SODIUM','40','mg/.4mL','Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0075-8016_5651b020-2238-46af-9068-dd3b2795928d','0075-8016','HUMAN PRESCRIPTION DRUG','Lovenox','','enoxaparin sodium','INJECTION','SUBCUTANEOUS','19930329','','NDA','NDA020164','Sanofi-Aventis U.S. LLC','ENOXAPARIN SODIUM','60','mg/.6mL','Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0075-8018_5651b020-2238-46af-9068-dd3b2795928d','0075-8018','HUMAN PRESCRIPTION DRUG','Lovenox','','enoxaparin sodium','INJECTION','SUBCUTANEOUS','19930329','','NDA','NDA020164','Sanofi-Aventis U.S. LLC','ENOXAPARIN SODIUM','80','mg/.8mL','Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0075-8020_5651b020-2238-46af-9068-dd3b2795928d','0075-8020','HUMAN PRESCRIPTION DRUG','Lovenox','','enoxaparin sodium','INJECTION','SUBCUTANEOUS','19930329','','NDA','NDA020164','Sanofi-Aventis U.S. LLC','ENOXAPARIN SODIUM','100','mg/mL','Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0075-8022_5651b020-2238-46af-9068-dd3b2795928d','0075-8022','HUMAN PRESCRIPTION DRUG','Lovenox','','enoxaparin sodium','INJECTION','SUBCUTANEOUS','19930329','','NDA','NDA020164','Sanofi-Aventis U.S. LLC','ENOXAPARIN SODIUM','120','mg/.8mL','Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0075-8025_5651b020-2238-46af-9068-dd3b2795928d','0075-8025','HUMAN PRESCRIPTION DRUG','Lovenox','','enoxaparin sodium','INJECTION','SUBCUTANEOUS','19930329','','NDA','NDA020164','Sanofi-Aventis U.S. LLC','ENOXAPARIN SODIUM','150','mg/mL','Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0075-8030_5651b020-2238-46af-9068-dd3b2795928d','0075-8030','HUMAN PRESCRIPTION DRUG','Lovenox','','enoxaparin sodium','INJECTION','INTRAVENOUS; SUBCUTANEOUS','19930329','','NDA','NDA020164','Sanofi-Aventis U.S. LLC','ENOXAPARIN SODIUM','300','mg/3mL','Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0109_f37a7aa9-53ff-43e1-b41d-3881b80ea1e9','0078-0109','HUMAN PRESCRIPTION DRUG','Sandimmune','','cyclosporine','INJECTION','INTRAVENOUS','19831114','','NDA','NDA050573','Novartis Pharmaceuticals Corporation','CYCLOSPORINE','50','mg/mL','Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0110_f37a7aa9-53ff-43e1-b41d-3881b80ea1e9','0078-0110','HUMAN PRESCRIPTION DRUG','Sandimmune','','cyclosporine','SOLUTION','ORAL','19831114','','NDA','NDA050574','Novartis Pharmaceuticals Corporation','CYCLOSPORINE','100','mg/mL','Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0180_ddf016ad-6841-4fbc-8c7f-d69d4fc0dc4f','0078-0180','HUMAN PRESCRIPTION DRUG','Sandostatin','','octreotide acetate','INJECTION, SOLUTION','INTRAVENOUS; SUBCUTANEOUS','19881021','','NDA','NDA019667','Novartis Pharmaceuticals Corporation','OCTREOTIDE ACETATE','50','ug/mL','Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0181_ddf016ad-6841-4fbc-8c7f-d69d4fc0dc4f','0078-0181','HUMAN PRESCRIPTION DRUG','Sandostatin','','octreotide acetate','INJECTION, SOLUTION','INTRAVENOUS; SUBCUTANEOUS','19881021','','NDA','NDA019667','Novartis Pharmaceuticals Corporation','OCTREOTIDE ACETATE','100','ug/mL','Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0182_ddf016ad-6841-4fbc-8c7f-d69d4fc0dc4f','0078-0182','HUMAN PRESCRIPTION DRUG','Sandostatin','','octreotide acetate','INJECTION, SOLUTION','INTRAVENOUS; SUBCUTANEOUS','19881021','','NDA','NDA019667','Novartis Pharmaceuticals Corporation','OCTREOTIDE ACETATE','500','ug/mL','Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0240_f37a7aa9-53ff-43e1-b41d-3881b80ea1e9','0078-0240','HUMAN PRESCRIPTION DRUG','Sandimmune','','cyclosporine','CAPSULE, LIQUID FILLED','ORAL','19900302','','NDA','NDA050625','Novartis Pharmaceuticals Corporation','CYCLOSPORINE','25','mg/1','Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0241_f37a7aa9-53ff-43e1-b41d-3881b80ea1e9','0078-0241','HUMAN PRESCRIPTION DRUG','Sandimmune','','cyclosporine','CAPSULE, LIQUID FILLED','ORAL','19900302','','NDA','NDA050625','Novartis Pharmaceuticals Corporation','CYCLOSPORINE','100','mg/1','Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0246_06576850-10a7-4bc8-a8e4-2605b40448e4','0078-0246','HUMAN PRESCRIPTION DRUG','Neoral','','cyclosporine','CAPSULE, LIQUID FILLED','ORAL','19950714','','NDA','NDA050715','Novartis Pharmaceuticals Corporation','CYCLOSPORINE','25','mg/1','Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0248_06576850-10a7-4bc8-a8e4-2605b40448e4','0078-0248','HUMAN PRESCRIPTION DRUG','Neoral','','cyclosporine','CAPSULE, LIQUID FILLED','ORAL','19950714','','NDA','NDA050715','Novartis Pharmaceuticals Corporation','CYCLOSPORINE','100','mg/1','Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0249_196300e0-edad-47f9-8336-146ac7f338db','0078-0249','HUMAN PRESCRIPTION DRUG','Femara','','letrozole','TABLET, FILM COATED','ORAL','19970731','','NDA','NDA020726','Novartis Pharmaceuticals Corporation','LETROZOLE','2.5','mg/1','Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0274_06576850-10a7-4bc8-a8e4-2605b40448e4','0078-0274','HUMAN PRESCRIPTION DRUG','Neoral','','cyclosporine','SOLUTION','ORAL','19950714','','NDA','NDA050716','Novartis Pharmaceuticals Corporation','CYCLOSPORINE','100','mg/mL','Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0314_3f1a38fe-d886-46d1-9a62-fb96b0dcc29f','0078-0314','HUMAN PRESCRIPTION DRUG','Diovan HCT','','valsartan and hydrochlorothiazide','TABLET, FILM COATED','ORAL','19980306','','NDA','NDA020818','Novartis Pharmaceuticals Corporation','HYDROCHLOROTHIAZIDE; VALSARTAN','12.5; 80','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0315_3f1a38fe-d886-46d1-9a62-fb96b0dcc29f','0078-0315','HUMAN PRESCRIPTION DRUG','Diovan HCT','','valsartan and hydrochlorothiazide','TABLET, FILM COATED','ORAL','19980306','','NDA','NDA020818','Novartis Pharmaceuticals Corporation','HYDROCHLOROTHIAZIDE; VALSARTAN','12.5; 160','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0331_fe330b7a-adde-4c02-b220-1e1f004cb321','0078-0331','HUMAN PRESCRIPTION DRUG','Simulect','','basiliximab','INJECTION, POWDER, FOR SOLUTION','INTRAVENOUS','19980512','','BLA','BLA103764','Novartis Pharmaceuticals Corporation','BASILIXIMAB','20','mg/5mL','Interleukin 2 Receptor Antagonists [MoA], Interleukin 2 Receptor-directed Antibody Interactions [MoA], Interleukin-2 Receptor Blocking Antibody [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0337_dd449c5a-e6b3-4d0b-801e-3b3ed2d02f6f','0078-0337','HUMAN PRESCRIPTION DRUG','Trileptal','','oxcarbazepine','TABLET, FILM COATED','ORAL','20000130','','NDA','NDA021014','Novartis Pharmaceuticals Corporation','OXCARBAZEPINE','300','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0343_2740040f-a14a-4b53-83f7-842dd443081f','0078-0343','HUMAN PRESCRIPTION DRUG','Vivelle-Dot','','estradiol','PATCH, EXTENDED RELEASE','TRANSDERMAL','19990108','','NDA','NDA020538','Novartis Pharmaceuticals Corporation','ESTRADIOL','0.0375','mg/d','Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0344_2740040f-a14a-4b53-83f7-842dd443081f','0078-0344','HUMAN PRESCRIPTION DRUG','Vivelle-Dot','','estradiol','PATCH, EXTENDED RELEASE','TRANSDERMAL','19990108','','NDA','NDA020538','Novartis Pharmaceuticals Corporation','ESTRADIOL','0.05','mg/d','Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0345_2740040f-a14a-4b53-83f7-842dd443081f','0078-0345','HUMAN PRESCRIPTION DRUG','Vivelle-Dot','','estradiol','PATCH, EXTENDED RELEASE','TRANSDERMAL','19990108','','NDA','NDA020538','Novartis Pharmaceuticals Corporation','ESTRADIOL','0.075','mg/d','Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0346_2740040f-a14a-4b53-83f7-842dd443081f','0078-0346','HUMAN PRESCRIPTION DRUG','Vivelle-Dot','','estradiol','PATCH, EXTENDED RELEASE','TRANSDERMAL','19990108','','NDA','NDA020538','Novartis Pharmaceuticals Corporation','ESTRADIOL','0.1','mg/d','Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0354_04f77269-0504-4ffb-88cf-5834cfc6b173','0078-0354','HUMAN PRESCRIPTION DRUG','Lescol','XL','fluvastatin sodium','TABLET, EXTENDED RELEASE','ORAL','20001006','','NDA','NDA021192','Novartis Pharmaceuticals Corporation','FLUVASTATIN SODIUM','80','mg/1','HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0357_dd449c5a-e6b3-4d0b-801e-3b3ed2d02f6f','0078-0357','HUMAN PRESCRIPTION DRUG','Trileptal','','oxcarbazepine','SUSPENSION','ORAL','20010530','','NDA','NDA021285','Novartis Pharmaceuticals Corporation','OXCARBAZEPINE','60','mg/mL','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0358_ac202414-fac4-4db2-8e6d-8c797f74232a','0078-0358','HUMAN PRESCRIPTION DRUG','Diovan','','valsartan','TABLET','ORAL','20010701','','NDA','NDA021283','Novartis Pharmaceuticals Corporation','VALSARTAN','80','mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0359_ac202414-fac4-4db2-8e6d-8c797f74232a','0078-0359','HUMAN PRESCRIPTION DRUG','Diovan','','valsartan','TABLET','ORAL','20010701','','NDA','NDA021283','Novartis Pharmaceuticals Corporation','VALSARTAN','160','mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0360_ac202414-fac4-4db2-8e6d-8c797f74232a','0078-0360','HUMAN PRESCRIPTION DRUG','Diovan','','valsartan','TABLET','ORAL','20010701','','NDA','NDA021283','Novartis Pharmaceuticals Corporation','VALSARTAN','320','mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0364_2944a0ae-9822-463a-9e58-2bb73e86e607','0078-0364','HUMAN PRESCRIPTION DRUG','Lotrel','','amlodipine besylate and benazepril hydrochloride','CAPSULE','ORAL','19950303','','NDA','NDA020364','Novartis Pharmaceuticals Corporation','AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE','10; 20','mg/1; mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0365_2740040f-a14a-4b53-83f7-842dd443081f','0078-0365','HUMAN PRESCRIPTION DRUG','Vivelle-Dot','','estradiol','PATCH, EXTENDED RELEASE','TRANSDERMAL','19990108','','NDA','NDA020538','Novartis Pharmaceuticals Corporation','ESTRADIOL','0.025','mg/d','Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0370_238e17d0-f928-47d5-a6c8-1b846f994b9f','0078-0370','HUMAN PRESCRIPTION DRUG','Ritalin','LA','methylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20020605','','NDA','NDA021284','Novartis Pharmaceuticals Corporation','METHYLPHENIDATE HYDROCHLORIDE','20','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0371_238e17d0-f928-47d5-a6c8-1b846f994b9f','0078-0371','HUMAN PRESCRIPTION DRUG','Ritalin','LA','methylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20020605','','NDA','NDA021284','Novartis Pharmaceuticals Corporation','METHYLPHENIDATE HYDROCHLORIDE','30','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0372_238e17d0-f928-47d5-a6c8-1b846f994b9f','0078-0372','HUMAN PRESCRIPTION DRUG','Ritalin','LA','methylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20020605','','NDA','NDA021284','Novartis Pharmaceuticals Corporation','METHYLPHENIDATE HYDROCHLORIDE','40','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0379_2944a0ae-9822-463a-9e58-2bb73e86e607','0078-0379','HUMAN PRESCRIPTION DRUG','Lotrel','','amlodipine besylate and benazepril hydrochloride','CAPSULE','ORAL','19950303','','NDA','NDA020364','Novartis Pharmaceuticals Corporation','AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE','10; 40','mg/1; mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0380_ec3fc5c6-f1a7-4c96-b5b9-4a8068dbf2a5','0078-0380','HUMAN PRESCRIPTION DRUG','Focalin','','dexmethylphenidate hydrochloride','TABLET','ORAL','20011130','','NDA','NDA021278','Novartis Pharmaceuticals Corporation','DEXMETHYLPHENIDATE HYDROCHLORIDE','2.5','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0381_ec3fc5c6-f1a7-4c96-b5b9-4a8068dbf2a5','0078-0381','HUMAN PRESCRIPTION DRUG','Focalin','','dexmethylphenidate hydrochloride','TABLET','ORAL','20011130','','NDA','NDA021278','Novartis Pharmaceuticals Corporation','DEXMETHYLPHENIDATE HYDROCHLORIDE','5','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0382_ec3fc5c6-f1a7-4c96-b5b9-4a8068dbf2a5','0078-0382','HUMAN PRESCRIPTION DRUG','Focalin','','dexmethylphenidate hydrochloride','TABLET','ORAL','20011130','','NDA','NDA021278','Novartis Pharmaceuticals Corporation','DEXMETHYLPHENIDATE HYDROCHLORIDE','10','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0383_3f1a38fe-d886-46d1-9a62-fb96b0dcc29f','0078-0383','HUMAN PRESCRIPTION DRUG','Diovan HCT','','valsartan and hydrochlorothiazide','TABLET, FILM COATED','ORAL','19980306','','NDA','NDA020818','Novartis Pharmaceuticals Corporation','HYDROCHLOROTHIAZIDE; VALSARTAN','25; 160','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0385_bb2b27e6-0680-4625-89c7-d56def2ddee0','0078-0385','HUMAN PRESCRIPTION DRUG','Myfortic','','mycophenolic acid','TABLET, DELAYED RELEASE','ORAL','20040227','','NDA','NDA050791','Novartis Pharmaceuticals Corporation','MYCOPHENOLATE SODIUM','180','mg/1','Antimetabolite Immunosuppressant [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0386_bb2b27e6-0680-4625-89c7-d56def2ddee0','0078-0386','HUMAN PRESCRIPTION DRUG','Myfortic','','mycophenolic acid','TABLET, DELAYED RELEASE','ORAL','20040227','','NDA','NDA050791','Novartis Pharmaceuticals Corporation','MYCOPHENOLATE SODIUM','360','mg/1','Antimetabolite Immunosuppressant [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0393_fe330b7a-adde-4c02-b220-1e1f004cb321','0078-0393','HUMAN PRESCRIPTION DRUG','Simulect','','basiliximab','INJECTION, POWDER, FOR SOLUTION','INTRAVENOUS','19980512','','BLA','BLA103764','Novartis Pharmaceuticals Corporation','BASILIXIMAB','10','mg/2.5mL','Interleukin 2 Receptor Antagonists [MoA], Interleukin 2 Receptor-directed Antibody Interactions [MoA], Interleukin-2 Receptor Blocking Antibody [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0401_8f1a0563-cb1e-4846-9154-f45653784c7a','0078-0401','HUMAN PRESCRIPTION DRUG','Gleevec','','imatinib mesylate','TABLET','ORAL','20010515','','NDA','NDA021588','Novartis Pharmaceuticals Corporation','IMATINIB MESYLATE','100','mg/1','Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0405_2944a0ae-9822-463a-9e58-2bb73e86e607','0078-0405','HUMAN PRESCRIPTION DRUG','Lotrel','','amlodipine besylate and benazepril hydrochloride','CAPSULE','ORAL','19950303','','NDA','NDA020364','Novartis Pharmaceuticals Corporation','AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE','5; 10','mg/1; mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0406_2944a0ae-9822-463a-9e58-2bb73e86e607','0078-0406','HUMAN PRESCRIPTION DRUG','Lotrel','','amlodipine besylate and benazepril hydrochloride','CAPSULE','ORAL','19950303','','NDA','NDA020364','Novartis Pharmaceuticals Corporation','AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE','5; 20','mg/1; mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0414_6ea294e2-00c3-41bc-8c85-85cfbc7d61ef','0078-0414','HUMAN PRESCRIPTION DRUG','Zortress','','everolimus','TABLET','ORAL','20100422','','NDA','NDA021560','Novartis Pharmaceuticals Corporation','EVEROLIMUS','0.5','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0415_6ea294e2-00c3-41bc-8c85-85cfbc7d61ef','0078-0415','HUMAN PRESCRIPTION DRUG','Zortress','','everolimus','TABLET','ORAL','20100422','','NDA','NDA021560','Novartis Pharmaceuticals Corporation','EVEROLIMUS','0.75','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0417_6ea294e2-00c3-41bc-8c85-85cfbc7d61ef','0078-0417','HUMAN PRESCRIPTION DRUG','Zortress','','everolimus','TABLET','ORAL','20100422','','NDA','NDA021560','Novartis Pharmaceuticals Corporation','EVEROLIMUS','0.25','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0422_6ea294e2-00c3-41bc-8c85-85cfbc7d61ef','0078-0422','HUMAN PRESCRIPTION DRUG','Zortress','','everolimus','TABLET','ORAL','20100422','','NDA','NDA021560','Novartis Pharmaceuticals Corporation','EVEROLIMUS','1','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0423_ac202414-fac4-4db2-8e6d-8c797f74232a','0078-0423','HUMAN PRESCRIPTION DRUG','Diovan','','valsartan','TABLET','ORAL','20010701','','NDA','NDA021283','Novartis Pharmaceuticals Corporation','VALSARTAN','40','mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0424_238e17d0-f928-47d5-a6c8-1b846f994b9f','0078-0424','HUMAN PRESCRIPTION DRUG','Ritalin','LA','methylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20020605','','NDA','NDA021284','Novartis Pharmaceuticals Corporation','METHYLPHENIDATE HYDROCHLORIDE','10','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0430_1994ede6-bb5d-43ea-9d09-ed27a81578dd','0078-0430','HUMAN PRESCRIPTION DRUG','Focalin','XR','dexmethylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20050531','','NDA','NDA021802','Novartis Pharmaceuticals Corporation','DEXMETHYLPHENIDATE HYDROCHLORIDE','5','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0431_1994ede6-bb5d-43ea-9d09-ed27a81578dd','0078-0431','HUMAN PRESCRIPTION DRUG','Focalin','XR','dexmethylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20050531','','NDA','NDA021802','Novartis Pharmaceuticals Corporation','DEXMETHYLPHENIDATE HYDROCHLORIDE','10','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0432_1994ede6-bb5d-43ea-9d09-ed27a81578dd','0078-0432','HUMAN PRESCRIPTION DRUG','Focalin','XR','dexmethylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20050531','','NDA','NDA021802','Novartis Pharmaceuticals Corporation','DEXMETHYLPHENIDATE HYDROCHLORIDE','20','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0433_1994ede6-bb5d-43ea-9d09-ed27a81578dd','0078-0433','HUMAN PRESCRIPTION DRUG','Focalin','XR','dexmethylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20050531','','NDA','NDA021802','Novartis Pharmaceuticals Corporation','DEXMETHYLPHENIDATE HYDROCHLORIDE','30','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0434_1994ede6-bb5d-43ea-9d09-ed27a81578dd','0078-0434','HUMAN PRESCRIPTION DRUG','Focalin','XR','dexmethylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20050531','','NDA','NDA021802','Novartis Pharmaceuticals Corporation','DEXMETHYLPHENIDATE HYDROCHLORIDE','40','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0435_ae5a6cfc-93e8-4095-be3d-b4db71b57545','0078-0435','HUMAN PRESCRIPTION DRUG','Reclast','','zoledronic acid','INJECTION, SOLUTION','INTRAVENOUS','20070401','','NDA','NDA021817','Novartis Pharmaceuticals Corporation','ZOLEDRONIC ACID','5','mg/100mL','Bisphosphonate [EPC], Diphosphonates [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0439_8bba01ec-b982-4467-9e95-b9f40be13d24','0078-0439','HUMAN PRESCRIPTION DRUG','Ritalin','','methylphenidate hydrochloride','TABLET','ORAL','19551231','','NDA','NDA010187','Novartis Pharmaceuticals Corporation','METHYLPHENIDATE HYDROCHLORIDE','5','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0440_8bba01ec-b982-4467-9e95-b9f40be13d24','0078-0440','HUMAN PRESCRIPTION DRUG','Ritalin','','methylphenidate hydrochloride','TABLET','ORAL','19551231','','NDA','NDA010187','Novartis Pharmaceuticals Corporation','METHYLPHENIDATE HYDROCHLORIDE','10','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0441_8bba01ec-b982-4467-9e95-b9f40be13d24','0078-0441','HUMAN PRESCRIPTION DRUG','Ritalin','','methylphenidate hydrochloride','TABLET','ORAL','19551231','','NDA','NDA010187','Novartis Pharmaceuticals Corporation','METHYLPHENIDATE HYDROCHLORIDE','20','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0456_dd449c5a-e6b3-4d0b-801e-3b3ed2d02f6f','0078-0456','HUMAN PRESCRIPTION DRUG','Trileptal','','oxcarbazepine','TABLET, FILM COATED','ORAL','20000130','','NDA','NDA021014','Novartis Pharmaceuticals Corporation','OXCARBAZEPINE','150','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0457_dd449c5a-e6b3-4d0b-801e-3b3ed2d02f6f','0078-0457','HUMAN PRESCRIPTION DRUG','Trileptal','','oxcarbazepine','TABLET, FILM COATED','ORAL','20000130','','NDA','NDA021014','Novartis Pharmaceuticals Corporation','OXCARBAZEPINE','600','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0467_b3a62c15-7a08-4772-9c00-152f1f5a887a','0078-0467','HUMAN PRESCRIPTION DRUG','Desferal','','deferoxamine mesylate','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS','19680402','','NDA','NDA016267','Novartis Pharmaceuticals Corporation','DEFEROXAMINE MESYLATE','500','mg/1','Iron Chelating Activity [MoA], Iron Chelator [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0468_64486adb-14b2-4496-80fa-6f46f004b014','0078-0468','HUMAN PRESCRIPTION DRUG','Exjade','','deferasirox','TABLET, FOR SUSPENSION','ORAL','20051130','','NDA','NDA021882','Novartis Pharmaceuticals Corporation','DEFERASIROX','125','mg/1','Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0469_64486adb-14b2-4496-80fa-6f46f004b014','0078-0469','HUMAN PRESCRIPTION DRUG','Exjade','','deferasirox','TABLET, FOR SUSPENSION','ORAL','20051130','','NDA','NDA021882','Novartis Pharmaceuticals Corporation','DEFERASIROX','250','mg/1','Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0470_64486adb-14b2-4496-80fa-6f46f004b014','0078-0470','HUMAN PRESCRIPTION DRUG','Exjade','','deferasirox','TABLET, FOR SUSPENSION','ORAL','20051130','','NDA','NDA021882','Novartis Pharmaceuticals Corporation','DEFERASIROX','500','mg/1','Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0471_3f1a38fe-d886-46d1-9a62-fb96b0dcc29f','0078-0471','HUMAN PRESCRIPTION DRUG','Diovan HCT','','valsartan and hydrochlorothiazide','TABLET, FILM COATED','ORAL','20060428','','NDA','NDA020818','Novartis Pharmaceuticals Corporation','HYDROCHLOROTHIAZIDE; VALSARTAN','12.5; 320','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0472_3f1a38fe-d886-46d1-9a62-fb96b0dcc29f','0078-0472','HUMAN PRESCRIPTION DRUG','Diovan HCT','','valsartan and hydrochlorothiazide','TABLET, FILM COATED','ORAL','20060428','','NDA','NDA020818','Novartis Pharmaceuticals Corporation','HYDROCHLOROTHIAZIDE; VALSARTAN','25; 320','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0488_d6c63540-b569-446a-83a2-3e13a7a246cb','0078-0488','HUMAN PRESCRIPTION DRUG','Exforge','','amlodipine besylate and valsartan','TABLET, FILM COATED','ORAL','20070620','','NDA','NDA021990','Novartis Pharmaceuticals Corporation','AMLODIPINE BESYLATE; VALSARTAN','5; 160','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0489_d6c63540-b569-446a-83a2-3e13a7a246cb','0078-0489','HUMAN PRESCRIPTION DRUG','Exforge','','amlodipine besylate and valsartan','TABLET, FILM COATED','ORAL','20070620','','NDA','NDA021990','Novartis Pharmaceuticals Corporation','AMLODIPINE BESYLATE; VALSARTAN','10; 160','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0490_d6c63540-b569-446a-83a2-3e13a7a246cb','0078-0490','HUMAN PRESCRIPTION DRUG','Exforge','','amlodipine besylate and valsartan','TABLET, FILM COATED','ORAL','20070620','','NDA','NDA021990','Novartis Pharmaceuticals Corporation','AMLODIPINE BESYLATE; VALSARTAN','5; 320','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0491_d6c63540-b569-446a-83a2-3e13a7a246cb','0078-0491','HUMAN PRESCRIPTION DRUG','Exforge','','amlodipine besylate and valsartan','TABLET, FILM COATED','ORAL','20070620','','NDA','NDA021990','Novartis Pharmaceuticals Corporation','AMLODIPINE BESYLATE; VALSARTAN','10; 320','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0493_1994ede6-bb5d-43ea-9d09-ed27a81578dd','0078-0493','HUMAN PRESCRIPTION DRUG','Focalin','XR','dexmethylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20050531','','NDA','NDA021802','Novartis Pharmaceuticals Corporation','DEXMETHYLPHENIDATE HYDROCHLORIDE','15','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0501_e8c3c8bb-dea2-41ba-9bfc-e98249813151','0078-0501','HUMAN PRESCRIPTION DRUG','Exelon','','rivastigmine','PATCH, EXTENDED RELEASE','TRANSDERMAL','20070706','','NDA','NDA022083','Novartis Pharmaceuticals Corporation','RIVASTIGMINE','4.6','mg/24h','Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0502_e8c3c8bb-dea2-41ba-9bfc-e98249813151','0078-0502','HUMAN PRESCRIPTION DRUG','Exelon','','rivastigmine','PATCH, EXTENDED RELEASE','TRANSDERMAL','20070706','','NDA','NDA022083','Novartis Pharmaceuticals Corporation','RIVASTIGMINE','9.5','mg/24h','Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0503_e8c3c8bb-dea2-41ba-9bfc-e98249813151','0078-0503','HUMAN PRESCRIPTION DRUG','Exelon','','rivastigmine','PATCH, EXTENDED RELEASE','TRANSDERMAL','20070706','','NDA','NDA022083','Novartis Pharmaceuticals Corporation','RIVASTIGMINE','13.3','mg/24h','Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0508_d20cd365-fb00-427d-83f1-55ea8ba4b2a2','0078-0508','HUMAN PRESCRIPTION DRUG','Tegretol','','carbamazepine','SUSPENSION','ORAL','19871218','','NDA','NDA018927','Novartis Pharmaceuticals Corporation','CARBAMAZEPINE','100','mg/5mL','Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0509_d20cd365-fb00-427d-83f1-55ea8ba4b2a2','0078-0509','HUMAN PRESCRIPTION DRUG','Tegretol','','carbamazepine','TABLET','ORAL','19680311','','NDA','NDA016608','Novartis Pharmaceuticals Corporation','CARBAMAZEPINE','200','mg/1','Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0510_d20cd365-fb00-427d-83f1-55ea8ba4b2a2','0078-0510','HUMAN PRESCRIPTION DRUG','Tegretol','XR','carbamazepine','TABLET, EXTENDED RELEASE','ORAL','19960325','','NDA','NDA020234','Novartis Pharmaceuticals Corporation','CARBAMAZEPINE','100','mg/1','Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0511_d20cd365-fb00-427d-83f1-55ea8ba4b2a2','0078-0511','HUMAN PRESCRIPTION DRUG','Tegretol','XR','carbamazepine','TABLET, EXTENDED RELEASE','ORAL','19960325','','NDA','NDA020234','Novartis Pharmaceuticals Corporation','CARBAMAZEPINE','200','mg/1','Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0512_d20cd365-fb00-427d-83f1-55ea8ba4b2a2','0078-0512','HUMAN PRESCRIPTION DRUG','Tegretol','XR','carbamazepine','TABLET, EXTENDED RELEASE','ORAL','19960325','','NDA','NDA020234','Novartis Pharmaceuticals Corporation','CARBAMAZEPINE','400','mg/1','Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0526_f70beb7d-4494-40e1-a57b-c85d492b30cd','0078-0526','HUMAN PRESCRIPTION DRUG','Tasigna','','nilotinib','CAPSULE','ORAL','20071029','','NDA','NDA022068','Novartis Pharmaceuticals Corporation','NILOTINIB','200','mg/1','Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], UGT1A1 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0559_f278250b-9fea-461d-ab29-8727c3a08554','0078-0559','HUMAN PRESCRIPTION DRUG','Exforge HCT','','amlodipine valsartan and hydrochlorothiazide','TABLET, FILM COATED','ORAL','20090404','','NDA','NDA022314','Novartis Pharmaceuticals Corporation','AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN','5; 12.5; 160','mg/1; mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0560_f278250b-9fea-461d-ab29-8727c3a08554','0078-0560','HUMAN PRESCRIPTION DRUG','Exforge HCT','','amlodipine valsartan and hydrochlorothiazide','TABLET, FILM COATED','ORAL','20090404','','NDA','NDA022314','Novartis Pharmaceuticals Corporation','AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN','5; 25; 160','mg/1; mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0561_f278250b-9fea-461d-ab29-8727c3a08554','0078-0561','HUMAN PRESCRIPTION DRUG','Exforge HCT','','amlodipine valsartan and hydrochlorothiazide','TABLET, FILM COATED','ORAL','20090404','','NDA','NDA022314','Novartis Pharmaceuticals Corporation','AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN','10; 12.5; 160','mg/1; mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0562_f278250b-9fea-461d-ab29-8727c3a08554','0078-0562','HUMAN PRESCRIPTION DRUG','Exforge HCT','','amlodipine valsartan and hydrochlorothiazide','TABLET, FILM COATED','ORAL','20090404','','NDA','NDA022314','Novartis Pharmaceuticals Corporation','AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN','10; 25; 160','mg/1; mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0563_f278250b-9fea-461d-ab29-8727c3a08554','0078-0563','HUMAN PRESCRIPTION DRUG','Exforge HCT','','amlodipine valsartan and hydrochlorothiazide','TABLET, FILM COATED','ORAL','20090404','','NDA','NDA022314','Novartis Pharmaceuticals Corporation','AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN','10; 25; 320','mg/1; mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0566_73c94ba1-e426-488a-88f9-8e47f0142972','0078-0566','HUMAN PRESCRIPTION DRUG','Afinitor','','everolimus','TABLET','ORAL','20090331','','NDA','NDA022334','Novartis Pharmaceuticals Corporation','EVEROLIMUS','5','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0567_73c94ba1-e426-488a-88f9-8e47f0142972','0078-0567','HUMAN PRESCRIPTION DRUG','Afinitor','','everolimus','TABLET','ORAL','20090331','','NDA','NDA022334','Novartis Pharmaceuticals Corporation','EVEROLIMUS','10','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0568_f663321b-b5e3-4633-add3-28276edd522f','0078-0568','HUMAN PRESCRIPTION DRUG','COARTEM','','artemether and lumefantrine','TABLET','ORAL','20090407','','NDA','NDA022268','Novartis Pharmaceuticals Corporation','ARTEMETHER; LUMEFANTRINE','20; 120','mg/1; mg/1','Antimalarial [EPC], Antimalarial [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0569_4e7c467e-e094-4687-9c49-87d4f4de61df','0078-0569','HUMAN PRESCRIPTION DRUG','EXTAVIA','','Interferon beta-1b','KIT','','20090814','','BLA','BLA125290','Novartis Pharmaceuticals Corporation','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0592_f70beb7d-4494-40e1-a57b-c85d492b30cd','0078-0592','HUMAN PRESCRIPTION DRUG','Tasigna','','nilotinib','CAPSULE','ORAL','20071029','','NDA','NDA022068','Novartis Pharmaceuticals Corporation','NILOTINIB','150','mg/1','Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], UGT1A1 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0594_73c94ba1-e426-488a-88f9-8e47f0142972','0078-0594','HUMAN PRESCRIPTION DRUG','Afinitor','','everolimus','TABLET','ORAL','20100709','','NDA','NDA022334','Novartis Pharmaceuticals Corporation','EVEROLIMUS','2.5','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0607_5d9d7cf4-106e-463c-8f26-c2c404d8552a','0078-0607','HUMAN PRESCRIPTION DRUG','Gilenya','','Fingolimod hcl','CAPSULE','ORAL','20100921','','NDA','NDA022527','Novartis Pharmaceuticals Corporation','FINGOLIMOD HYDROCHLORIDE','0.5','mg/1','Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0608_1994ede6-bb5d-43ea-9d09-ed27a81578dd','0078-0608','HUMAN PRESCRIPTION DRUG','Focalin','XR','dexmethylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20050531','','NDA','NDA021802','Novartis Pharmaceuticals Corporation','DEXMETHYLPHENIDATE HYDROCHLORIDE','25','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0609_1994ede6-bb5d-43ea-9d09-ed27a81578dd','0078-0609','HUMAN PRESCRIPTION DRUG','Focalin','XR','dexmethylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20050531','','NDA','NDA021802','Novartis Pharmaceuticals Corporation','DEXMETHYLPHENIDATE HYDROCHLORIDE','35','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0620_73c94ba1-e426-488a-88f9-8e47f0142972','0078-0620','HUMAN PRESCRIPTION DRUG','Afinitor','','everolimus','TABLET','ORAL','20110729','','NDA','NDA022334','Novartis Pharmaceuticals Corporation','EVEROLIMUS','7.5','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0626_73c94ba1-e426-488a-88f9-8e47f0142972','0078-0626','HUMAN PRESCRIPTION DRUG','Afinitor','Disperz','everolimus','TABLET, FOR SUSPENSION','ORAL','20120829','','NDA','NDA203985','Novartis Pharmaceuticals Corporation','EVEROLIMUS','2','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0627_73c94ba1-e426-488a-88f9-8e47f0142972','0078-0627','HUMAN PRESCRIPTION DRUG','Afinitor','Disperz','everolimus','TABLET, FOR SUSPENSION','ORAL','20120829','','NDA','NDA203985','Novartis Pharmaceuticals Corporation','EVEROLIMUS','3','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0628_73c94ba1-e426-488a-88f9-8e47f0142972','0078-0628','HUMAN PRESCRIPTION DRUG','Afinitor','Disperz','everolimus','TABLET, FOR SUSPENSION','ORAL','20120829','','NDA','NDA203985','Novartis Pharmaceuticals Corporation','EVEROLIMUS','5','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0639_1b52f8f5-c6db-4d83-ac31-f566d2bf99a4','0078-0639','HUMAN PRESCRIPTION DRUG','COSENTYX','','secukinumab','INJECTION','SUBCUTANEOUS','20150121','','BLA','BLA125504','Novartis Pharmaceuticals Corporation','SECUKINUMAB','150','mg/mL','Interleukin-17A Antagonist [EPC], Interleukin-17A Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0649_8f1a0563-cb1e-4846-9154-f45653784c7a','0078-0649','HUMAN PRESCRIPTION DRUG','Gleevec','','imatinib mesylate','TABLET','ORAL','20141223','','NDA','NDA021588','Novartis Pharmaceuticals Corporation','IMATINIB MESYLATE','400','mg/1','Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0654_d2bbabee-c3c6-4fda-8863-4418ad96d38e','0078-0654','HUMAN PRESCRIPTION DRUG','Jadenu','','deferasirox','TABLET, FILM COATED','ORAL','20150330','','NDA','NDA206910','Novartis Pharmaceuticals Corporation','DEFERASIROX','90','mg/1','Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0655_d2bbabee-c3c6-4fda-8863-4418ad96d38e','0078-0655','HUMAN PRESCRIPTION DRUG','Jadenu','','deferasirox','TABLET, FILM COATED','ORAL','20150330','','NDA','NDA206910','Novartis Pharmaceuticals Corporation','DEFERASIROX','180','mg/1','Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0656_d2bbabee-c3c6-4fda-8863-4418ad96d38e','0078-0656','HUMAN PRESCRIPTION DRUG','Jadenu','','deferasirox','TABLET, FILM COATED','ORAL','20150330','','NDA','NDA206910','Novartis Pharmaceuticals Corporation','DEFERASIROX','360','mg/1','Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0659_93d45aeb-b1b4-464d-898b-529d3cbd35c2','0078-0659','HUMAN PRESCRIPTION DRUG','ENTRESTO','','Sacubitril and Valsartan','TABLET, FILM COATED','ORAL','20150707','','NDA','NDA207620','Novartis Pharmaceuticals Corporation','SACUBITRIL; VALSARTAN','24; 26','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Neprilysin Inhibitor [EPC], Neprilysin Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0666_58ebc072-df4c-4e0e-86ff-5c992a0ab1c1','0078-0666','HUMAN PRESCRIPTION DRUG','Mekinist','','trametinib','TABLET, FILM COATED','ORAL','20160317','','NDA','NDA204114','Novartis Pharmaceuticals Corporation','TRAMETINIB DIMETHYL SULFOXIDE','0.5','mg/1','Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0668_58ebc072-df4c-4e0e-86ff-5c992a0ab1c1','0078-0668','HUMAN PRESCRIPTION DRUG','Mekinist','','trametinib','TABLET, FILM COATED','ORAL','20160317','','NDA','NDA204114','Novartis Pharmaceuticals Corporation','TRAMETINIB DIMETHYL SULFOXIDE','2','mg/1','Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0669_56665f95-5c96-4177-b65b-17928bb90b80','0078-0669','HUMAN PRESCRIPTION DRUG','ARZERRA','','ofatumumab','INJECTION, SOLUTION','INTRAVENOUS','20160201','','BLA','BLA125326','Novartis Pharmaceuticals Corporation','OFATUMUMAB','20','mg/mL','CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0670_d64a4078-2cff-48a7-a621-c31d82703ae6','0078-0670','HUMAN PRESCRIPTION DRUG','VOTRIENT','','pazopanib hydrochloride','TABLET, FILM COATED','ORAL','20160712','','NDA','NDA022465','Novartis Pharmaceuticals Corporation','PAZOPANIB HYDROCHLORIDE','200','mg/1','Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0671_71b68187-04b6-4d83-a854-efc04e380768','0078-0671','HUMAN PRESCRIPTION DRUG','TYKERB','','lapatinib','TABLET','ORAL','20160803','','NDA','NDA022059','Novartis Pharmaceuticals Corporation','LAPATINIB DITOSYLATE','250','mg/1','Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0672_bf2754e4-bfee-452c-a095-3038c45d56c0','0078-0672','HUMAN PRESCRIPTION DRUG','HYCAMTIN','','topotecan','CAPSULE','ORAL','20170707','','NDA','NDA020981','Novartis Pharmaceuticals Corporation','TOPOTECAN HYDROCHLORIDE','0.25','mg/1','Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0673_bf2754e4-bfee-452c-a095-3038c45d56c0','0078-0673','HUMAN PRESCRIPTION DRUG','HYCAMTIN','','topotecan','CAPSULE','ORAL','20170224','','NDA','NDA020981','Novartis Pharmaceuticals Corporation','TOPOTECAN HYDROCHLORIDE','1','mg/1','Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0674_e6e4f66b-e398-44d3-a832-e5a809f3e861','0078-0674','HUMAN PRESCRIPTION DRUG','HYCAMTIN','','topotecan hydrochloride','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20161221','','NDA','NDA020671','Novartis Pharmaceuticals Corporation','TOPOTECAN HYDROCHLORIDE','4','mg/4mL','Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0681_74a974e3-25c6-4baa-8052-8027e474e99b','0078-0681','HUMAN PRESCRIPTION DRUG','Tafinlar','','dabrafenib','CAPSULE','ORAL','20160401','','NDA','NDA202806','Novartis Pharmaceuticals Corporation','DABRAFENIB MESYLATE','75','mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Kinase Inhibitor [EPC], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Protein Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0682_74a974e3-25c6-4baa-8052-8027e474e99b','0078-0682','HUMAN PRESCRIPTION DRUG','Tafinlar','','dabrafenib','CAPSULE','ORAL','20160412','','NDA','NDA202806','Novartis Pharmaceuticals Corporation','DABRAFENIB MESYLATE','50','mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Kinase Inhibitor [EPC], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Protein Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0683_6b71b057-dcb0-4ef0-8f20-887b870c4590','0078-0683','HUMAN PRESCRIPTION DRUG','Arranon','','nelarabine','INJECTION','INTRAVENOUS','20161005','','NDA','NDA021877','Novartis Pharmaceuticals Corporation','NELARABINE','5','mg/mL','Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0684_b3e99de4-ec27-4b94-8d32-96be0aa7546d','0078-0684','HUMAN PRESCRIPTION DRUG','PROMACTA','','eltrombopag olamine','TABLET, FILM COATED','ORAL','20160822','','NDA','NDA022291','Novartis Pharmaceuticals Corporation','ELTROMBOPAG OLAMINE','12.5','mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0685_b3e99de4-ec27-4b94-8d32-96be0aa7546d','0078-0685','HUMAN PRESCRIPTION DRUG','PROMACTA','','eltrombopag olamine','TABLET, FILM COATED','ORAL','20160524','','NDA','NDA022291','Novartis Pharmaceuticals Corporation','ELTROMBOPAG OLAMINE','25','mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0686_b3e99de4-ec27-4b94-8d32-96be0aa7546d','0078-0686','HUMAN PRESCRIPTION DRUG','PROMACTA','','eltrombopag olamine','TABLET, FILM COATED','ORAL','20160407','','NDA','NDA022291','Novartis Pharmaceuticals Corporation','ELTROMBOPAG OLAMINE','50','mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0687_b3e99de4-ec27-4b94-8d32-96be0aa7546d','0078-0687','HUMAN PRESCRIPTION DRUG','PROMACTA','','eltrombopag olamine','TABLET, FILM COATED','ORAL','20160401','','NDA','NDA022291','Novartis Pharmaceuticals Corporation','ELTROMBOPAG OLAMINE','75','mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0690_56665f95-5c96-4177-b65b-17928bb90b80','0078-0690','HUMAN PRESCRIPTION DRUG','ARZERRA','','ofatumumab','INJECTION, SOLUTION','INTRAVENOUS','20160201','','BLA','BLA125326','Novartis Pharmaceuticals Corporation','OFATUMUMAB','20','mg/mL','CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0694_8e2b887c-cfc1-4d85-a3be-551c11e6fc6f','0078-0694','HUMAN PRESCRIPTION DRUG','ZYKADIA','','ceritinib','TABLET, FILM COATED','ORAL','20190318','','NDA','NDA211225','Novartis Pharmaceuticals Corporation','CERITINIB','150','mg/1','Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Tyrosine Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0696_93d45aeb-b1b4-464d-898b-529d3cbd35c2','0078-0696','HUMAN PRESCRIPTION DRUG','ENTRESTO','','Sacubitril and Valsartan','TABLET, FILM COATED','ORAL','20150707','','NDA','NDA207620','Novartis Pharmaceuticals Corporation','SACUBITRIL; VALSARTAN','97; 103','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Neprilysin Inhibitor [EPC], Neprilysin Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0697_b3e99de4-ec27-4b94-8d32-96be0aa7546d','0078-0697','HUMAN PRESCRIPTION DRUG','PROMACTA','','eltrombopag olamine','POWDER, FOR SUSPENSION','ORAL','20180927','','NDA','NDA207027','Novartis Pharmaceuticals Corporation','ELTROMBOPAG OLAMINE','25','mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0698_acbd6dc8-dbee-4b62-aae7-ba99d14c4d80','0078-0698','HUMAN PRESCRIPTION DRUG','RYDAPT','','RYDAPT','CAPSULE, LIQUID FILLED','ORAL','20170428','','NDA','NDA207997','Novartis Pharmaceuticals Corporation','MIDOSTAURIN','25','mg/1','Kinase Inhibitor [EPC], Receptor Tyrosine Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0701_635b9869-efc1-4c7c-a1b5-aac0210329ad','0078-0701','HUMAN PRESCRIPTION DRUG','PIQRAY','','alpelisib','TABLET','ORAL','20190524','','NDA','NDA212526','Novartis Pharmaceuticals Corporation','ALPELISIB','200','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0708_635b9869-efc1-4c7c-a1b5-aac0210329ad','0078-0708','HUMAN PRESCRIPTION DRUG','PIQRAY','','alpelisib','TABLET','ORAL','20190524','','NDA','NDA212526','Novartis Pharmaceuticals Corporation','ALPELISIB','150','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0709_ae2c4d9b-dce1-4cf5-93ac-b5d418e06e50','0078-0709','HUMAN PRESCRIPTION DRUG','TABRECTA','','capmatinib','TABLET, FILM COATED','ORAL','20200506','','NDA','NDA213591','Novartis Pharmaceuticals Corporation','CAPMATINIB','150','mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Kinase Inhibitor [EPC], Mesenchymal Epithelial Transition Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0713_d2bbabee-c3c6-4fda-8863-4418ad96d38e','0078-0713','HUMAN PRESCRIPTION DRUG','Jadenu','','deferasirox','GRANULE','ORAL','20170518','','NDA','NDA207968','Novartis Pharmaceuticals Corporation','DEFERASIROX','180','mg/1','Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0715_635b9869-efc1-4c7c-a1b5-aac0210329ad','0078-0715','HUMAN PRESCRIPTION DRUG','PIQRAY','','alpelisib','KIT','','20190524','','NDA','NDA212526','Novartis Pharmaceuticals Corporation','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0716_ae2c4d9b-dce1-4cf5-93ac-b5d418e06e50','0078-0716','HUMAN PRESCRIPTION DRUG','TABRECTA','','capmatinib','TABLET, FILM COATED','ORAL','20200506','','NDA','NDA213591','Novartis Pharmaceuticals Corporation','CAPMATINIB','200','mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Kinase Inhibitor [EPC], Mesenchymal Epithelial Transition Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0720_d2bbabee-c3c6-4fda-8863-4418ad96d38e','0078-0720','HUMAN PRESCRIPTION DRUG','Jadenu','','deferasirox','GRANULE','ORAL','20170518','','NDA','NDA207968','Novartis Pharmaceuticals Corporation','DEFERASIROX','360','mg/1','Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0722_4a9f4516-bb9d-49a5-a8c6-fcd82063b63f','0078-0722','HUMAN PRESCRIPTION DRUG','Azopt','','brinzolamide','SUSPENSION/ DROPS','OPHTHALMIC','19980430','','NDA','NDA020816','Novartis Pharmaceuticals Corporation','BRINZOLAMIDE','10','mg/mL','Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0727_d2bbabee-c3c6-4fda-8863-4418ad96d38e','0078-0727','HUMAN PRESCRIPTION DRUG','Jadenu','','deferasirox','GRANULE','ORAL','20170518','','NDA','NDA207968','Novartis Pharmaceuticals Corporation','DEFERASIROX','90','mg/1','Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0729_905ba189-456c-4aa4-8231-39a971374ad8','0078-0729','HUMAN PRESCRIPTION DRUG','Betoptic S','','betaxolol hydrochloride','SUSPENSION/ DROPS','OPHTHALMIC','19960115','','NDA','NDA019845','Novartis Pharmaceuticals Corporation','BETAXOLOL HYDROCHLORIDE','2.8','mg/mL','Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0734_22a23eaf-86d8-4f25-be85-6357d0026651','0078-0734','HUMAN PRESCRIPTION DRUG','Ilaris','','canakinumab','INJECTION, SOLUTION','SUBCUTANEOUS','20161222','','BLA','BLA125319','Novartis Pharmaceuticals Corporation','CANAKINUMAB','150','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0736_74317375-53a5-44f7-91ea-aa5f5cfe1851','0078-0736','HUMAN PRESCRIPTION DRUG','ALOMIDE','','lodoxamide tromethamine','SOLUTION/ DROPS','OPHTHALMIC','19930930','','NDA','NDA020191','Novartis Pharmaceuticals Corporation','LODOXAMIDE TROMETHAMINE','1','mg/mL','Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0743_0cb21156-4f4a-4e49-bc0c-7d2eab045f86','0078-0743','HUMAN PRESCRIPTION DRUG','ILEVRO','','nepafenac','SUSPENSION/ DROPS','OPHTHALMIC','20121220','','NDA','NDA203491','Novartis Pharmaceuticals Corporation','NEPAFENAC','3','mg/mL','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0771_81e79cdf-e6c9-46c8-a43b-7c180c1a9d24','0078-0771','HUMAN PRESCRIPTION DRUG','MAXITROL','','neomycin sulfate, polymyxin b sulfate and dexamethasone','OINTMENT','OPHTHALMIC','19720117','','NDA','NDA050065','Novartis Pharmaceuticals Corporation','DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE','1; 3.5; 10000','mg/g; mg/g; [USP''''U]/g','Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0777_93d45aeb-b1b4-464d-898b-529d3cbd35c2','0078-0777','HUMAN PRESCRIPTION DRUG','ENTRESTO','','Sacubitril and Valsartan','TABLET, FILM COATED','ORAL','20150707','','NDA','NDA207620','Novartis Pharmaceuticals Corporation','SACUBITRIL; VALSARTAN','49; 51','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Neprilysin Inhibitor [EPC], Neprilysin Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0778_a2909252-c5f1-421f-9073-b7be90b45b51','0078-0778','HUMAN PRESCRIPTION DRUG','NEVANAC','','nepafenac','SUSPENSION/ DROPS','OPHTHALMIC','20050906','','NDA','NDA021862','Novartis Pharmaceuticals Corporation','NEPAFENAC','1','mg/mL','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0792_ed267dc5-9db2-ee5f-e053-2a95a90af111','0078-0792','HUMAN PRESCRIPTION DRUG','Maxitrol','','neomycin sulfate, polymyxin b sulfate and dexamethasone','SUSPENSION','OPHTHALMIC','19641115','','NDA','NDA050023','Novartis Pharmaceuticals Corporation','DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE','1; 3.5; 10000','mg/mL; mg/mL; [USP''''U]/mL','Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0799_535b147b-58b1-4027-8126-0b64be0ed6b3','0078-0799','HUMAN PRESCRIPTION DRUG','CIPRODEX','','ciprofloxacin and dexamethasone','SUSPENSION/ DROPS','AURICULAR (OTIC)','20030804','','NDA','NDA021537','Novartis Pharmaceuticals Corporation','CIPROFLOXACIN HYDROCHLORIDE; DEXAMETHASONE','3; 1','mg/mL; mg/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Quinolone Antimicrobial [EPC], Quinolones [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0811_ba64ca6d-ff03-45f4-b723-38b1d7c50f22','0078-0811','HUMAN PRESCRIPTION DRUG','Sandostatin LAR Depot','','octreotide acetate','KIT','','20160722','','NDA','NDA021008','Novartis Pharmaceuticals Corporation','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0813_5b66bba3-cf97-4a9c-b618-ba5f277f20f6','0078-0813','HUMAN PRESCRIPTION DRUG','TOBREX','','tobramycin','OINTMENT','OPHTHALMIC','19810628','','NDA','NDA050555','Novartis Pharmaceuticals Corporation','TOBRAMYCIN','3','mg/g','Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0818_ba64ca6d-ff03-45f4-b723-38b1d7c50f22','0078-0818','HUMAN PRESCRIPTION DRUG','Sandostatin LAR Depot','','octreotide acetate','KIT','','20160722','','NDA','NDA021008','Novartis Pharmaceuticals Corporation','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0825_ba64ca6d-ff03-45f4-b723-38b1d7c50f22','0078-0825','HUMAN PRESCRIPTION DRUG','Sandostatin LAR Depot','','octreotide acetate','KIT','','20160722','','NDA','NDA021008','Novartis Pharmaceuticals Corporation','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0827_f27a96dc-c815-4a44-b600-36b00b460f9c','0078-0827','HUMAN PRESCRIPTION DRUG','BEOVU','','brolucizumab','INJECTION, SOLUTION','INTRAVITREAL','20191007','','BLA','BLA761125','Novartis Pharmaceuticals Corporation','BROLUCIZUMAB','6','mg/.05mL','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0834_3cbeda75-be25-4d55-83ea-ace367ab7332','0078-0834','HUMAN PRESCRIPTION DRUG','PATANASE','','olopatadine hydrochloride','SPRAY, METERED','NASAL','20080428','','NDA','NDA021861','Novartis Pharmaceuticals Corporation','OLOPATADINE HYDROCHLORIDE','600','ug/1','Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0841_bae31988-364f-40e1-aaf4-c93248214781','0078-0841','HUMAN PRESCRIPTION DRUG','CILOXAN','','ciprofloxacin hydrochloride','OINTMENT','OPHTHALMIC','19980602','','NDA','NDA020369','Novartis Pharmaceuticals Corporation','CIPROFLOXACIN HYDROCHLORIDE','3','mg/g','Quinolone Antimicrobial [EPC], Quinolones [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0846_2e87c9ed-a6a3-4a42-874b-86b8ec0681f8','0078-0846','CELLULAR THERAPY','KYMRIAH','','tisagenlecleucel','INJECTION, SUSPENSION','INTRAVENOUS','20170830','','BLA','BLA125646','Novartis Pharmaceuticals Corporation','TISAGENLECLEUCEL','2000000','44927','CD19 Receptor Interactions [MoA], CD19-directed Chimeric Antigen Receptor [EPC], CD19-specific Chimeric Antigen Receptor [CS], Genetically-modified Autologous T Cells [EPC], Increased T Lymphocyte Activation [PE], T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0855_eff6ee40-6e52-4f61-b54d-edc612543f71','0078-0855','HUMAN PRESCRIPTION DRUG','CIPRO','HC','ciprofloxacin hydrochloride and hydrocortisone','SUSPENSION/ DROPS','AURICULAR (OTIC)','19990315','','NDA','NDA020805','Novartis Pharmaceuticals Corporation','CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE','2; 10','mg/mL; mg/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Quinolone Antimicrobial [EPC], Quinolones [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0860_fd71f2f3-cc60-4c16-92d7-f1e8bd36e56e','0078-0860','HUMAN PRESCRIPTION DRUG','KISQALI','','ribociclib','TABLET, FILM COATED','ORAL','20170313','','NDA','NDA209092','Novartis Pharmaceuticals Corporation','RIBOCICLIB SUCCINATE','200','mg/1','Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0862_830dd64e-8b1a-4bc4-86bd-e0a0915b59e7','0078-0862','HUMAN PRESCRIPTION DRUG','DUREZOL','','difluprednate','EMULSION','OPHTHALMIC','20110125','','NDA','NDA022212','Novartis Pharmaceuticals Corporation','DIFLUPREDNATE','0.5','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0867_fd71f2f3-cc60-4c16-92d7-f1e8bd36e56e','0078-0867','HUMAN PRESCRIPTION DRUG','KISQALI','','ribociclib','TABLET, FILM COATED','ORAL','20170313','','NDA','NDA209092','Novartis Pharmaceuticals Corporation','RIBOCICLIB SUCCINATE','200','mg/1','Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0874_fd71f2f3-cc60-4c16-92d7-f1e8bd36e56e','0078-0874','HUMAN PRESCRIPTION DRUG','KISQALI','','ribociclib','TABLET, FILM COATED','ORAL','20170313','','NDA','NDA209092','Novartis Pharmaceuticals Corporation','RIBOCICLIB SUCCINATE','200','mg/1','Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0876_38e160ce-912e-4457-a294-2a6a4bf4a068','0078-0876','HUMAN PRESCRIPTION DRUG','TobraDex','','tobramycin and dexamethasone','OINTMENT','OPHTHALMIC','19881015','','NDA','NDA050616','Novartis Pharmaceuticals Corporation','DEXAMETHASONE; TOBRAMYCIN','1; 3','mg/g; mg/g','Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0883_aab773f7-5149-4f25-8e1e-0910353c2f50','0078-0883','HUMAN PRESCRIPTION DRUG','ADAKVEO','','crizanlizumab','INJECTION','INTRAVENOUS','20191115','','BLA','BLA761128','Novartis Pharmaceuticals Corporation','CRIZANLIZUMAB','10','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0909_3aefc518-5d20-4cb2-8103-0cf2f55ff5ea','0078-0909','HUMAN PRESCRIPTION DRUG','KISQALI FEMARA CO-PACK','','letrozole and ribociclib','KIT','','20170504','','NDA','NDA209935','Novartis Pharmaceuticals Corporation','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0911_76e96acc-62cc-46d2-8478-32cb24ff36bb','0078-0911','HUMAN PRESCRIPTION DRUG','Xiidra','','Lifitegrast','SOLUTION/ DROPS','OPHTHALMIC','20160711','','NDA','NDA208073','Novartis Pharmaceuticals Corporation','LIFITEGRAST','50','mg/mL','Lymphocyte Function-Associated Antigen-1 Antagonist [EPC], Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0916_3aefc518-5d20-4cb2-8103-0cf2f55ff5ea','0078-0916','HUMAN PRESCRIPTION DRUG','KISQALI FEMARA CO-PACK','','letrozole and ribociclib','KIT','','20170504','','NDA','NDA209935','Novartis Pharmaceuticals Corporation','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0923_3aefc518-5d20-4cb2-8103-0cf2f55ff5ea','0078-0923','HUMAN PRESCRIPTION DRUG','KISQALI FEMARA CO-PACK','','letrozole and ribociclib','KIT','','20170504','','NDA','NDA209935','Novartis Pharmaceuticals Corporation','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0925_603f0bac-16b8-42f5-985e-fb0d73ee284d','0078-0925','HUMAN PRESCRIPTION DRUG','Maxidex','','dexamethasone','SUSPENSION/ DROPS','OPHTHALMIC','19660515','','NDA','NDA013422','Novartis Pharmaceuticals Corporation','DEXAMETHASONE','1','mg/mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0937_9883f3fe-4881-47cc-a795-ce9245fe0645','0078-0937','HUMAN PRESCRIPTION DRUG','EGATEN','','triclabendazole','TABLET','ORAL','20190213','','NDA','NDA208711','Novartis Pharmaceuticals Corporation','TRICLABENDAZOLE','250','mg/1','Anthelmintic [EPC], Anthelmintics [CS], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2A6 Inhibitors [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0939_5f83352b-a62b-4611-8f74-5826d26749a2','0078-0939','HUMAN PRESCRIPTION DRUG','VIGAMOX','','moxifloxacin hydrochloride','SOLUTION/ DROPS','OPHTHALMIC','20030507','','NDA','NDA021598','Novartis Pharmaceuticals Corporation','MOXIFLOXACIN HYDROCHLORIDE','5','mg/mL','Quinolone Antimicrobial [EPC], Quinolones [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0946_2c78d995-b1a5-4532-ae21-d291944ab6a4','0078-0946','HUMAN PRESCRIPTION DRUG','Travatan Z','','travoprost','SOLUTION/ DROPS','OPHTHALMIC','20061020','','NDA','NDA021994','Novartis Pharmaceuticals Corporation','TRAVOPROST','0.04','mg/mL','Prostaglandin Analog [EPC], Prostaglandins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0951_f70beb7d-4494-40e1-a57b-c85d492b30cd','0078-0951','HUMAN PRESCRIPTION DRUG','Tasigna','','nilotinib','CAPSULE','ORAL','20071029','','NDA','NDA022068','Novartis Pharmaceuticals Corporation','NILOTINIB','50','mg/1','Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], UGT1A1 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0953_c662bb23-f30c-451d-aa6c-f3f26fb72377','0078-0953','HUMAN PRESCRIPTION DRUG','TobraDex','','tobramycin and dexamethasone','SUSPENSION/ DROPS','OPHTHALMIC','19880915','','NDA','NDA050592','Novartis Pharmaceuticals Corporation','DEXAMETHASONE; TOBRAMYCIN','1; 3','mg/mL; mg/mL','Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0958_2e87c9ed-a6a3-4a42-874b-86b8ec0681f8','0078-0958','CELLULAR THERAPY','KYMRIAH','','tisagenlecleucel','INJECTION, SUSPENSION','INTRAVENOUS','20180501','','BLA','BLA125646','Novartis Pharmaceuticals Corporation','TISAGENLECLEUCEL','60000000','44927','CD19 Receptor Interactions [MoA], CD19-directed Chimeric Antigen Receptor [EPC], CD19-specific Chimeric Antigen Receptor [CS], Genetically-modified Autologous T Cells [EPC], Increased T Lymphocyte Activation [PE], T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0965_5d9d7cf4-106e-463c-8f26-c2c404d8552a','0078-0965','HUMAN PRESCRIPTION DRUG','Gilenya','','Fingolimod hcl','CAPSULE','ORAL','20100921','','NDA','NDA022527','Novartis Pharmaceuticals Corporation','FINGOLIMOD HYDROCHLORIDE','0.25','mg/1','Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0972_b3e99de4-ec27-4b94-8d32-96be0aa7546d','0078-0972','HUMAN PRESCRIPTION DRUG','PROMACTA','','eltrombopag olamine','POWDER, FOR SUSPENSION','ORAL','20180927','','NDA','NDA207027','Novartis Pharmaceuticals Corporation','ELTROMBOPAG OLAMINE','12.5','mg/1','Breast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0979_9fa58ad9-17ef-43da-b9e9-42289f5b54c2','0078-0979','HUMAN PRESCRIPTION DRUG','MAYZENT','','siponimod','TABLET, FILM COATED','ORAL','20190326','','NDA','NDA209884','Novartis Pharmaceuticals Corporation','SIPONIMOD','0.25','mg/1','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-0986_9fa58ad9-17ef-43da-b9e9-42289f5b54c2','0078-0986','HUMAN PRESCRIPTION DRUG','MAYZENT','','siponimod','TABLET, FILM COATED','ORAL','20190326','','NDA','NDA209884','Novartis Pharmaceuticals Corporation','SIPONIMOD','2','mg/1','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-1000_d4c980ad-88f8-440d-9caf-28e6a259d9c4','0078-1000','HUMAN PRESCRIPTION DRUG','LEQVIO','','inclisiran','INJECTION, SOLUTION','SUBCUTANEOUS','20211222','','NDA','NDA214012','Novartis Pharmaceuticals Corporation','INCLISIRAN SODIUM','284','mg/1.5mL','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-1007_3d92e626-19d1-4800-8d68-f3380a00787c','0078-1007','HUMAN PRESCRIPTION DRUG','KESIMPTA','','ofatumumab','INJECTION, SOLUTION','SUBCUTANEOUS','20091026','','BLA','BLA125326','Novartis Pharmaceuticals Corporation','OFATUMUMAB','20','mg/.4mL','CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-1014_9fa58ad9-17ef-43da-b9e9-42289f5b54c2','0078-1014','HUMAN PRESCRIPTION DRUG','MAYZENT','','siponimod','TABLET, FILM COATED','ORAL','20190326','','NDA','NDA209884','Novartis Pharmaceuticals Corporation','SIPONIMOD','1','mg/1','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-1021_0cb830fe-2016-49d1-a5d6-e61fe3faffd2','0078-1021','HUMAN PRESCRIPTION DRUG','VIJOICE','','alpelisib','TABLET','ORAL','20220405','','NDA','NDA215039','Novartis Pharmaceuticals Corporation','ALPELISIB','50','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-1028_0cb830fe-2016-49d1-a5d6-e61fe3faffd2','0078-1028','HUMAN PRESCRIPTION DRUG','VIJOICE','','alpelisib','TABLET','ORAL','20220405','','NDA','NDA215039','Novartis Pharmaceuticals Corporation','ALPELISIB','125','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-1035_0cb830fe-2016-49d1-a5d6-e61fe3faffd2','0078-1035','HUMAN PRESCRIPTION DRUG','VIJOICE','','alpelisib','KIT','','20220405','','NDA','NDA215039','Novartis Pharmaceuticals Corporation','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-1056_1b52f8f5-c6db-4d83-ac31-f566d2bf99a4','0078-1056','HUMAN PRESCRIPTION DRUG','COSENTYX','','secukinumab','INJECTION','SUBCUTANEOUS','20150121','','BLA','BLA125504','Novartis Pharmaceuticals Corporation','SECUKINUMAB','75','mg/.5mL','Interleukin-17A Antagonist [EPC], Interleukin-17A Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-1077_d64a4078-2cff-48a7-a621-c31d82703ae6','0078-1077','HUMAN PRESCRIPTION DRUG','VOTRIENT','','pazopanib hydrochloride','TABLET, FILM COATED','ORAL','20160712','','NDA','NDA022465','Novartis Pharmaceuticals Corporation','PAZOPANIB HYDROCHLORIDE','200','mg/1','Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-1091_603416c5-f2d1-4d03-a437-71be34553988','0078-1091','HUMAN PRESCRIPTION DRUG','SCEMBLIX','','asciminib','TABLET, FILM COATED','ORAL','20211029','','NDA','NDA215358','Novartis Pharmaceuticals Corporation','ASCIMINIB HYDROCHLORIDE','20','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-1098_603416c5-f2d1-4d03-a437-71be34553988','0078-1098','HUMAN PRESCRIPTION DRUG','SCEMBLIX','','asciminib','TABLET, FILM COATED','ORAL','20211029','','NDA','NDA215358','Novartis Pharmaceuticals Corporation','ASCIMINIB HYDROCHLORIDE','40','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-1105_58ebc072-df4c-4e0e-86ff-5c992a0ab1c1','0078-1105','HUMAN PRESCRIPTION DRUG','Mekinist','','trametinib','TABLET, FILM COATED','ORAL','20160317','','NDA','NDA204114','Novartis Pharmaceuticals Corporation','TRAMETINIB DIMETHYL SULFOXIDE','0.5','mg/1','Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-1112_58ebc072-df4c-4e0e-86ff-5c992a0ab1c1','0078-1112','HUMAN PRESCRIPTION DRUG','Mekinist','','trametinib','TABLET, FILM COATED','ORAL','20160317','','NDA','NDA204114','Novartis Pharmaceuticals Corporation','TRAMETINIB DIMETHYL SULFOXIDE','2','mg/1','Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-9659_93d45aeb-b1b4-464d-898b-529d3cbd35c2','0078-9659','HUMAN PRESCRIPTION DRUG','ENTRESTO','','Sacubitril and Valsartan','TABLET, FILM COATED','ORAL','20150707','','NDA','NDA207620','Novartis Pharmaceuticals Corporation','SACUBITRIL; VALSARTAN','24; 26','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Neprilysin Inhibitor [EPC], Neprilysin Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0078-9777_93d45aeb-b1b4-464d-898b-529d3cbd35c2','0078-9777','HUMAN PRESCRIPTION DRUG','ENTRESTO','','Sacubitril and Valsartan','TABLET, FILM COATED','ORAL','20150707','','NDA','NDA207620','Novartis Pharmaceuticals Corporation','SACUBITRIL; VALSARTAN','49; 51','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Neprilysin Inhibitor [EPC], Neprilysin Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0085-1133_1353cc19-005b-4bb0-ba0c-eeacedeb1ca1','0085-1133','HUMAN PRESCRIPTION DRUG','INTRON A','','Interferon alfa-2b','INJECTION, SOLUTION','INTRALESIONAL; INTRAMUSCULAR; SUBCUTANEOUS','19860604','','BLA','BLA103132','Merck Sharp & Dohme LLC','INTERFERON ALFA-2B','19.2','ug/.5mL','Interferon alpha [EPC], Interferon-alpha [CS], Interferon-alpha [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0085-1168_1353cc19-005b-4bb0-ba0c-eeacedeb1ca1','0085-1168','HUMAN PRESCRIPTION DRUG','INTRON A','','Interferon alfa-2b','INJECTION, SOLUTION','INTRAMUSCULAR; SUBCUTANEOUS','19860604','','BLA','BLA103132','Merck Sharp & Dohme LLC','INTERFERON ALFA-2B','11.6','ug/.5mL','Interferon alpha [EPC], Interferon-alpha [CS], Interferon-alpha [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0085-1328_48f14402-f4c4-45b8-82c0-8f3beba2719f','0085-1328','HUMAN PRESCRIPTION DRUG','NOXAFIL','','posaconazole','SUSPENSION','ORAL','20060915','','NDA','NDA022003','Merck Sharp & Dohme LLC','POSACONAZOLE','40','mg/mL','Azole Antifungal [EPC], Azoles [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0085-1366_355f512c-5dd9-4cb3-a423-3764112d36b5','0085-1366','HUMAN PRESCRIPTION DRUG','TEMODAR','','Temozolomide','CAPSULE','ORAL','19990811','','NDA','NDA021029','Merck Sharp & Dohme LLC','TEMOZOLOMIDE','100','mg/1','Alkylating Activity [MoA], Alkylating Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0085-1381_355f512c-5dd9-4cb3-a423-3764112d36b5','0085-1381','HUMAN PRESCRIPTION DRUG','TEMODAR','','Temozolomide','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20090227','','NDA','NDA022277','Merck Sharp & Dohme LLC','TEMOZOLOMIDE','2.5','mg/mL','Alkylating Activity [MoA], Alkylating Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0085-1417_355f512c-5dd9-4cb3-a423-3764112d36b5','0085-1417','HUMAN PRESCRIPTION DRUG','TEMODAR','','Temozolomide','CAPSULE','ORAL','19990811','','NDA','NDA021029','Merck Sharp & Dohme LLC','TEMOZOLOMIDE','250','mg/1','Alkylating Activity [MoA], Alkylating Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0085-1425_355f512c-5dd9-4cb3-a423-3764112d36b5','0085-1425','HUMAN PRESCRIPTION DRUG','TEMODAR','','Temozolomide','CAPSULE','ORAL','19990811','','NDA','NDA021029','Merck Sharp & Dohme LLC','TEMOZOLOMIDE','140','mg/1','Alkylating Activity [MoA], Alkylating Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0085-1430_355f512c-5dd9-4cb3-a423-3764112d36b5','0085-1430','HUMAN PRESCRIPTION DRUG','TEMODAR','','Temozolomide','CAPSULE','ORAL','19990811','','NDA','NDA021029','Merck Sharp & Dohme LLC','TEMOZOLOMIDE','180','mg/1','Alkylating Activity [MoA], Alkylating Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0085-1519_355f512c-5dd9-4cb3-a423-3764112d36b5','0085-1519','HUMAN PRESCRIPTION DRUG','TEMODAR','','Temozolomide','CAPSULE','ORAL','19990811','','NDA','NDA021029','Merck Sharp & Dohme LLC','TEMOZOLOMIDE','20','mg/1','Alkylating Activity [MoA], Alkylating Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0085-2224_48f14402-f4c4-45b8-82c0-8f3beba2719f','0085-2224','HUMAN PRESCRIPTION DRUG','NOXAFIL','','posaconazole','POWDER, FOR SUSPENSION','ORAL','20210608','','NDA','NDA214770','Merck Sharp & Dohme LLC','POSACONAZOLE','300','mg/1','Azole Antifungal [EPC], Azoles [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0085-3004_355f512c-5dd9-4cb3-a423-3764112d36b5','0085-3004','HUMAN PRESCRIPTION DRUG','TEMODAR','','Temozolomide','CAPSULE','ORAL','19990811','','NDA','NDA021029','Merck Sharp & Dohme LLC','TEMOZOLOMIDE','5','mg/1','Alkylating Activity [MoA], Alkylating Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0085-4324_48f14402-f4c4-45b8-82c0-8f3beba2719f','0085-4324','HUMAN PRESCRIPTION DRUG','NOXAFIL','','posaconazole','TABLET, COATED','ORAL','20131125','','NDA','NDA205053','Merck Sharp & Dohme LLC','POSACONAZOLE','100','mg/1','Azole Antifungal [EPC], Azoles [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0085-4331_48f14402-f4c4-45b8-82c0-8f3beba2719f','0085-4331','HUMAN PRESCRIPTION DRUG','NOXAFIL','','posaconazole','SOLUTION','INTRAVENOUS','20140313','','NDA','NDA205596','Merck Sharp & Dohme LLC','POSACONAZOLE','18','mg/mL','Azole Antifungal [EPC], Azoles [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0085-4350_1353cc19-005b-4bb0-ba0c-eeacedeb1ca1','0085-4350','HUMAN PRESCRIPTION DRUG','INTRON A','','interferon alfa-2b','KIT','','20140811','','BLA','BLA103132','Merck Sharp & Dohme LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0085-4351_1353cc19-005b-4bb0-ba0c-eeacedeb1ca1','0085-4351','HUMAN PRESCRIPTION DRUG','INTRON A','','interferon alfa-2b','KIT','','20140811','','BLA','BLA103132','Merck Sharp & Dohme LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0085-4352_1353cc19-005b-4bb0-ba0c-eeacedeb1ca1','0085-4352','HUMAN PRESCRIPTION DRUG','INTRON A','','interferon alfa-2b','KIT','','20140811','','BLA','BLA103132','Merck Sharp & Dohme LLC','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0088-2102_2e1e7c6d-2c23-44fd-a775-cd89896f8b7d','0088-2102','HUMAN PRESCRIPTION DRUG','Priftin','','rifapentine','TABLET, FILM COATED','ORAL','20170208','','NDA','NDA021024','sanofi-aventis U.S. LLC','RIFAPENTINE','150','mg/1','Rifamycin Antimycobacterial [EPC], Rifamycins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0088-2160_ea39cd13-cad1-3d69-e053-2995a90a7906','0088-2160','HUMAN PRESCRIPTION DRUG','Arava','','leflunomide','TABLET, FILM COATED','ORAL','19980910','','NDA','NDA020905','sanofi-aventis U.S. LLC','LEFLUNOMIDE','10','mg/1','Antirheumatic Agent [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0088-2161_ea39cd13-cad1-3d69-e053-2995a90a7906','0088-2161','HUMAN PRESCRIPTION DRUG','Arava','','leflunomide','TABLET, FILM COATED','ORAL','19980910','','NDA','NDA020905','sanofi-aventis U.S. LLC','LEFLUNOMIDE','20','mg/1','Antirheumatic Agent [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0088-2162_ea39cd13-cad1-3d69-e053-2995a90a7906','0088-2162','HUMAN PRESCRIPTION DRUG','Arava','','leflunomide','TABLET, FILM COATED','ORAL','19980910','','NDA','NDA020905','sanofi-aventis U.S. LLC','LEFLUNOMIDE','100','mg/1','Antirheumatic Agent [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0088-2219_5ba9a956-7c91-4f27-821a-1ddd54b70ffe','0088-2219','HUMAN PRESCRIPTION DRUG','Lantus Solostar','','insulin glargine','INJECTION, SOLUTION','SUBCUTANEOUS','20090923','','BLA','BLA021081','sanofi-aventis U.S. LLC','INSULIN GLARGINE','100','[iU]/mL','Insulin Analog [EPC], Insulin [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0088-2220_5ba9a956-7c91-4f27-821a-1ddd54b70ffe','0088-2220','HUMAN PRESCRIPTION DRUG','Lantus','','insulin glargine','INJECTION, SOLUTION','SUBCUTANEOUS','20090923','','BLA','BLA021081','sanofi-aventis U.S. LLC','INSULIN GLARGINE','100','[iU]/mL','Insulin Analog [EPC], Insulin [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0088-2500_75c5abba-b4ee-4a36-a5b7-186265599fad','0088-2500','HUMAN PRESCRIPTION DRUG','Apidra','','insulin glulisine','INJECTION, SOLUTION','INTRAVENOUS; SUBCUTANEOUS','20090224','','BLA','BLA021629','sanofi-aventis U.S. LLC','INSULIN GLULISINE','100','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0088-2502_75c5abba-b4ee-4a36-a5b7-186265599fad','0088-2502','HUMAN PRESCRIPTION DRUG','Apidra SoloStar','','insulin glulisine','INJECTION, SOLUTION','SUBCUTANEOUS','20090224','','BLA','BLA021629','sanofi-aventis U.S. LLC','INSULIN GLULISINE','100','[iU]/mL','Insulin Analog [EPC], Insulin [Chemical/Ingredient]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0088-5020_7bfa39ee-1e03-4743-bf22-27cf983343c2','0088-5020','HUMAN PRESCRIPTION DRUG','Lantus Solostar','','insulin glargine','INJECTION, SOLUTION','SUBCUTANEOUS','20170604','','BLA','BLA021081','sanofi-aventis U.S. LLC','INSULIN GLARGINE','100','[iU]/mL','Insulin Analog [EPC], Insulin [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0088-5021_7bfa39ee-1e03-4743-bf22-27cf983343c2','0088-5021','HUMAN PRESCRIPTION DRUG','Lantus','','insulin glargine','INJECTION, SOLUTION','SUBCUTANEOUS','20170604','','BLA','BLA021081','sanofi-aventis U.S. LLC','INSULIN GLARGINE','100','[iU]/mL','Insulin Analog [EPC], Insulin [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0010_2f429822-d6d2-43c0-9aaf-1270b3e92a2f','0093-0010','HUMAN PRESCRIPTION DRUG','Tolterodine Tartrate','','Tolterodine Tartrate','TABLET, FILM COATED','ORAL','20151101','','ANDA','ANDA077006','Teva Pharmaceuticals USA, Inc.','TOLTERODINE TARTRATE','1','mg/1','Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0017_47bb5b1f-0ee0-469f-9fcc-fc3087b2e865','0093-0017','HUMAN PRESCRIPTION DRUG','Moexipril Hydrochloride','','Moexipril Hydrochloride','TABLET, FILM COATED','ORAL','20030508','','ANDA','ANDA076204','Teva Pharmaceuticals USA, Inc.','MOEXIPRIL HYDROCHLORIDE','7.5','mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0018_2f429822-d6d2-43c0-9aaf-1270b3e92a2f','0093-0018','HUMAN PRESCRIPTION DRUG','Tolterodine Tartrate','','Tolterodine Tartrate','TABLET, FILM COATED','ORAL','20151101','','ANDA','ANDA077006','Teva Pharmaceuticals USA, Inc.','TOLTERODINE TARTRATE','2','mg/1','Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0051_a369c0d5-8f93-4b0d-a5a0-8125af1309f7','0093-0051','HUMAN PRESCRIPTION DRUG','Carvedilol','','Carvedilol','TABLET, FILM COATED','ORAL','20070906','','ANDA','ANDA076373','Teva Pharmaceuticals USA, Inc.','CARVEDILOL','3.125','mg/1','Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0053_693fd871-7d24-4743-b402-fa1d0e839e6a','0093-0053','HUMAN PRESCRIPTION DRUG','Buspirone Hydrochloride','','Buspirone Hydrochloride','TABLET','ORAL','20020228','','ANDA','ANDA075022','Teva Pharmaceuticals USA, Inc.','BUSPIRONE HYDROCHLORIDE','5','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0054_693fd871-7d24-4743-b402-fa1d0e839e6a','0093-0054','HUMAN PRESCRIPTION DRUG','Buspirone Hydrochloride','','Buspirone Hydrochloride','TABLET','ORAL','20020228','','ANDA','ANDA075022','Teva Pharmaceuticals USA, Inc.','BUSPIRONE HYDROCHLORIDE','10','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0058_c74a886e-2684-4279-8c05-ad608245d856','0093-0058','HUMAN PRESCRIPTION DRUG','Tramadol Hydrochloride','','Tramadol Hydrochloride','TABLET, FILM COATED','ORAL','20020620','','ANDA','ANDA075977','Teva Pharmaceuticals USA, Inc.','TRAMADOL HYDROCHLORIDE','50','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0073_2d5139eb-e369-43f7-951b-666cf006ba33','0093-0073','HUMAN PRESCRIPTION DRUG','Zolpidem Tartrate','','Zolpidem Tartrate','TABLET, FILM COATED','ORAL','20070423','','ANDA','ANDA076410','Teva Pharmaceuticals USA, Inc.','ZOLPIDEM TARTRATE','5','mg/1','Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0074_2d5139eb-e369-43f7-951b-666cf006ba33','0093-0074','HUMAN PRESCRIPTION DRUG','Zolpidem Tartrate','','Zolpidem Tartrate','TABLET, FILM COATED','ORAL','20070423','','ANDA','ANDA076410','Teva Pharmaceuticals USA, Inc.','ZOLPIDEM TARTRATE','10','mg/1','Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0090_6a0fed95-b700-4a24-aa68-e23578be7c91','0093-0090','HUMAN PRESCRIPTION DRUG','Epitol','','Carbamazepine','TABLET','ORAL','19900930','','ANDA','ANDA070541','Teva Pharmaceuticals USA, Inc.','CARBAMAZEPINE','200','mg/1','Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0109_58b00f0d-faf9-43ee-8142-52bcb004fed3','0093-0109','HUMAN PRESCRIPTION DRUG','Carbamazepine','','Carbamazepine','TABLET','ORAL','19900930','','ANDA','ANDA070541','Teva Pharmaceuticals USA, Inc.','CARBAMAZEPINE','200','mg/1','Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0135_a369c0d5-8f93-4b0d-a5a0-8125af1309f7','0093-0135','HUMAN PRESCRIPTION DRUG','Carvedilol','','Carvedilol','TABLET, FILM COATED','ORAL','20070906','','ANDA','ANDA076373','Teva Pharmaceuticals USA, Inc.','CARVEDILOL','6.25','mg/1','Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0262_248c7df2-0095-44f4-b8b5-124605487476','0093-0262','HUMAN PRESCRIPTION DRUG','Fluocinonide','','Fluocinonide','CREAM','TOPICAL','19900930','','ANDA','ANDA072488','Teva Pharmaceuticals USA, Inc.','FLUOCINONIDE','0.5','mg/g','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0263_248c7df2-0095-44f4-b8b5-124605487476','0093-0263','HUMAN PRESCRIPTION DRUG','Fluocinonide','','Fluocinonide','CREAM','TOPICAL','19900930','','ANDA','ANDA072490','Teva Pharmaceuticals USA, Inc.','FLUOCINONIDE','0.5','mg/g','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0264_248c7df2-0095-44f4-b8b5-124605487476','0093-0264','HUMAN PRESCRIPTION DRUG','Fluocinonide','','Fluocinonide','OINTMENT','TOPICAL','19920501','','ANDA','ANDA073481','Teva Pharmaceuticals USA, Inc.','FLUOCINONIDE','0.5','mg/g','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0308_d4195d2d-40c5-4e06-8298-1ac90b0cbb3c','0093-0308','HUMAN PRESCRIPTION DRUG','Clemastine Fumarate','','Clemastine Fumarate','TABLET','ORAL','19920401','','ANDA','ANDA073283','Teva Pharmaceuticals USA, Inc.','CLEMASTINE FUMARATE','2.68','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0311_863c19d4-c0cd-455e-9a93-5c5157762d02','0093-0311','HUMAN PRESCRIPTION DRUG','Loperamide Hydrochloride','','Loperamide Hydrochloride','CAPSULE','ORAL','19930501','','ANDA','ANDA073192','Teva Pharmaceuticals USA, Inc.','LOPERAMIDE HYDROCHLORIDE','2','mg/1','Opioid Agonist [EPC], Opioid Agonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0314_535bed76-1f34-4f4e-b479-92ab7e52bfd5','0093-0314','HUMAN PRESCRIPTION DRUG','Ketorolac Tromethamine','','Ketorolac Tromethamine','TABLET, FILM COATED','ORAL','19980617','','ANDA','ANDA074754','Teva Pharmaceuticals USA, Inc.','KETOROLAC TROMETHAMINE','10','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0318_b5b12039-4294-42d8-a8a7-2c4b85f481df','0093-0318','HUMAN PRESCRIPTION DRUG','Diltiazem Hydrochloride','','Diltiazem Hydrochloride','TABLET, FILM COATED','ORAL','19951222','','ANDA','ANDA074185','Teva Pharmaceuticals USA, Inc.','DILTIAZEM HYDROCHLORIDE','30','mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0319_b5b12039-4294-42d8-a8a7-2c4b85f481df','0093-0319','HUMAN PRESCRIPTION DRUG','Diltiazem Hydrochloride','','Diltiazem Hydrochloride','TABLET, FILM COATED','ORAL','19951222','','ANDA','ANDA074185','Teva Pharmaceuticals USA, Inc.','DILTIAZEM HYDROCHLORIDE','60','mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0320_b5b12039-4294-42d8-a8a7-2c4b85f481df','0093-0320','HUMAN PRESCRIPTION DRUG','Diltiazem Hydrochloride','','Diltiazem Hydrochloride','TABLET, FILM COATED','ORAL','19951222','','ANDA','ANDA074185','Teva Pharmaceuticals USA, Inc.','DILTIAZEM HYDROCHLORIDE','90','mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0321_b5b12039-4294-42d8-a8a7-2c4b85f481df','0093-0321','HUMAN PRESCRIPTION DRUG','Diltiazem Hydrochloride','','Diltiazem Hydrochloride','TABLET, FILM COATED','ORAL','19951226','','ANDA','ANDA074185','Teva Pharmaceuticals USA, Inc.','DILTIAZEM HYDROCHLORIDE','120','mg/1','Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0576_ae2b21c6-efd3-42a8-aa6a-8ca2435030e9','0093-0576','HUMAN PRESCRIPTION DRUG','Lovastatin','','Lovastatin','TABLET','ORAL','20011217','','ANDA','ANDA075551','Teva Pharmaceuticals USA, Inc.','LOVASTATIN','20','mg/1','HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0711_ea4b1dbf-08e4-442d-a281-4c51712494b1','0093-0711','HUMAN PRESCRIPTION DRUG','Flurbiprofen','','Flurbiprofen','TABLET, FILM COATED','ORAL','19950602','','ANDA','ANDA074431','Teva Pharmaceuticals USA, Inc.','FLURBIPROFEN','100','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0752_12196485-731b-4f2a-9668-443454b9c3a2','0093-0752','HUMAN PRESCRIPTION DRUG','Atenolol','','Atenolol','TABLET','ORAL','19950222','','ANDA','ANDA074056','Teva Pharmaceuticals USA, Inc.','ATENOLOL','50','mg/1','Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0753_12196485-731b-4f2a-9668-443454b9c3a2','0093-0753','HUMAN PRESCRIPTION DRUG','Atenolol','','Atenolol','TABLET','ORAL','19950217','','ANDA','ANDA074056','Teva Pharmaceuticals USA, Inc.','ATENOLOL','100','mg/1','Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0756_aa935158-92a5-4998-add6-e90f9aaa2950','0093-0756','HUMAN PRESCRIPTION DRUG','Piroxicam','','Piroxicam','CAPSULE','ORAL','19941019','','ANDA','ANDA074131','Teva Pharmaceuticals USA, Inc.','PIROXICAM','10','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0757_aa935158-92a5-4998-add6-e90f9aaa2950','0093-0757','HUMAN PRESCRIPTION DRUG','Piroxicam','','Piroxicam','CAPSULE','ORAL','19940126','','ANDA','ANDA074131','Teva Pharmaceuticals USA, Inc.','PIROXICAM','20','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0771_29e8a7d8-9b93-44cb-b16c-0349d1552434','0093-0771','HUMAN PRESCRIPTION DRUG','Pravastatin Sodium','','Pravastatin Sodium','TABLET','ORAL','20060425','','ANDA','ANDA076056','Teva Pharmaceuticals USA, Inc.','PRAVASTATIN SODIUM','10','mg/1','HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0778_58b00f0d-faf9-43ee-8142-52bcb004fed3','0093-0778','HUMAN PRESCRIPTION DRUG','Carbamazepine','','Carbamazepine','TABLET, CHEWABLE','ORAL','19950918','','ANDA','ANDA073524','Teva Pharmaceuticals USA, Inc.','CARBAMAZEPINE','100','mg/1','Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0787_12196485-731b-4f2a-9668-443454b9c3a2','0093-0787','HUMAN PRESCRIPTION DRUG','Atenolol','','Atenolol','TABLET','ORAL','20041116','','ANDA','ANDA074056','Teva Pharmaceuticals USA, Inc.','ATENOLOL','25','mg/1','Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0807_36f18cc3-526a-4448-a4fb-803303acd103','0093-0807','HUMAN PRESCRIPTION DRUG','Fluoxetine','','Fluoxetine','TABLET, FILM COATED','ORAL','20190405','20231231','ANDA','ANDA075872','Teva Pharmaceuticals USA, Inc.','FLUOXETINE HYDROCHLORIDE','20','mg/1','Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0810_a8e5215a-8144-4227-914b-a7c92e4b4c36','0093-0810','HUMAN PRESCRIPTION DRUG','Nortriptyline Hydrochloride','','Nortriptyline Hydrochloride','CAPSULE','ORAL','19950405','','ANDA','ANDA074132','Teva Pharmaceuticals USA, Inc.','NORTRIPTYLINE HYDROCHLORIDE','10','mg/1','Tricyclic Antidepressant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0811_a8e5215a-8144-4227-914b-a7c92e4b4c36','0093-0811','HUMAN PRESCRIPTION DRUG','Nortriptyline Hydrochloride','','Nortriptyline Hydrochloride','CAPSULE','ORAL','19950406','','ANDA','ANDA074132','Teva Pharmaceuticals USA, Inc.','NORTRIPTYLINE HYDROCHLORIDE','25','mg/1','Tricyclic Antidepressant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0812_a8e5215a-8144-4227-914b-a7c92e4b4c36','0093-0812','HUMAN PRESCRIPTION DRUG','Nortriptyline Hydrochloride','','Nortriptyline Hydrochloride','CAPSULE','ORAL','19950405','','ANDA','ANDA074132','Teva Pharmaceuticals USA, Inc.','NORTRIPTYLINE HYDROCHLORIDE','50','mg/1','Tricyclic Antidepressant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0813_a8e5215a-8144-4227-914b-a7c92e4b4c36','0093-0813','HUMAN PRESCRIPTION DRUG','Nortriptyline Hydrochloride','','Nortriptyline Hydrochloride','CAPSULE','ORAL','19950405','','ANDA','ANDA074132','Teva Pharmaceuticals USA, Inc.','NORTRIPTYLINE HYDROCHLORIDE','75','mg/1','Tricyclic Antidepressant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0832_9a6e32a7-0ba7-45c9-9806-647c93f96a1c','0093-0832','HUMAN PRESCRIPTION DRUG','Clonazepam','','Clonazepam','TABLET','ORAL','19960918','','ANDA','ANDA074569','Teva Pharmaceuticals USA, Inc.','CLONAZEPAM','0.5','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0924_00bc35bd-6c7b-4259-8b53-cf08f10830f3','0093-0924','HUMAN PRESCRIPTION DRUG','Oxaprozin','','Oxaprozin','TABLET, FILM COATED','ORAL','20030512','','ANDA','ANDA075849','Teva Pharmaceuticals USA, Inc.','OXAPROZIN','600','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0926_ae2b21c6-efd3-42a8-aa6a-8ca2435030e9','0093-0926','HUMAN PRESCRIPTION DRUG','Lovastatin','','Lovastatin','TABLET','ORAL','20011217','','ANDA','ANDA075551','Teva Pharmaceuticals USA, Inc.','LOVASTATIN','10','mg/1','HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0928_ae2b21c6-efd3-42a8-aa6a-8ca2435030e9','0093-0928','HUMAN PRESCRIPTION DRUG','Lovastatin','','Lovastatin','TABLET','ORAL','20011217','','ANDA','ANDA075551','Teva Pharmaceuticals USA, Inc.','LOVASTATIN','40','mg/1','HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0948_b6e73f02-96ee-4845-bc84-211ffeb53b7f','0093-0948','HUMAN PRESCRIPTION DRUG','Diclofenac Potassium','','Diclofenac Potassium','TABLET, FILM COATED','ORAL','19980811','','ANDA','ANDA075219','Teva Pharmaceuticals USA, Inc.','DICLOFENAC POTASSIUM','50','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-0983_ec0b6594-283b-438e-b63a-fd12df88ccf4','0093-0983','HUMAN PRESCRIPTION DRUG','Nystatin','','Nystatin','TABLET, FILM COATED','ORAL','19900930','','ANDA','ANDA062506','Teva Pharmaceuticals USA, Inc.','NYSTATIN','500000','[USP''''U]/1','Polyene Antifungal [EPC], Polyenes [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1003_693fd871-7d24-4743-b402-fa1d0e839e6a','0093-1003','HUMAN PRESCRIPTION DRUG','Buspirone Hydrochloride','','Buspirone Hydrochloride','TABLET','ORAL','20020301','','ANDA','ANDA075022','Teva Pharmaceuticals USA, Inc.','BUSPIRONE HYDROCHLORIDE','15','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1005_7adf6304-d32e-4642-94dc-5f2d906b9a27','0093-1005','HUMAN PRESCRIPTION DRUG','Naproxen','','Naproxen','TABLET, DELAYED RELEASE','ORAL','19980731','','ANDA','ANDA075227','Teva Pharmaceuticals USA, Inc.','NAPROXEN','375','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1006_7adf6304-d32e-4642-94dc-5f2d906b9a27','0093-1006','HUMAN PRESCRIPTION DRUG','Naproxen','','Naproxen','TABLET, DELAYED RELEASE','ORAL','19980729','','ANDA','ANDA075227','Teva Pharmaceuticals USA, Inc.','NAPROXEN','500','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1010_fbef9813-87db-4aa3-90cf-c43c0587ec34','0093-1010','HUMAN PRESCRIPTION DRUG','Mupirocin','','Mupirocin','OINTMENT','TOPICAL','20031107','','ANDA','ANDA065085','Teva Pharmaceuticals USA, Inc.','MUPIROCIN','20','mg/g','RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1024_810dfc46-2484-4215-83d7-c683495a18c5','0093-1024','HUMAN PRESCRIPTION DRUG','Nefazodone Hydrochloride','','Nefazodone Hydrochloride','TABLET','ORAL','20030916','','ANDA','ANDA076037','Teva Pharmaceuticals USA, Inc.','NEFAZODONE HYDROCHLORIDE','100','mg/1','Serotonin Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1025_810dfc46-2484-4215-83d7-c683495a18c5','0093-1025','HUMAN PRESCRIPTION DRUG','Nefazodone Hydrochloride','','Nefazodone Hydrochloride','TABLET','ORAL','20030916','','ANDA','ANDA076037','Teva Pharmaceuticals USA, Inc.','NEFAZODONE HYDROCHLORIDE','200','mg/1','Serotonin Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1026_810dfc46-2484-4215-83d7-c683495a18c5','0093-1026','HUMAN PRESCRIPTION DRUG','Nefazodone Hydrochloride','','Nefazodone Hydrochloride','TABLET','ORAL','20030916','','ANDA','ANDA076037','Teva Pharmaceuticals USA, Inc.','NEFAZODONE HYDROCHLORIDE','250','mg/1','Serotonin Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1060_e524b89d-4ddd-42f5-a0af-8b4945aec7b4','0093-1060','HUMAN PRESCRIPTION DRUG','Sotalol Hydrochloride','','Sotalol Hydrochloride','TABLET','ORAL','20000505','','ANDA','ANDA075429','Teva Pharmaceuticals USA, Inc.','SOTALOL HYDROCHLORIDE','120','mg/1','Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1061_e524b89d-4ddd-42f5-a0af-8b4945aec7b4','0093-1061','HUMAN PRESCRIPTION DRUG','Sotalol Hydrochloride','','Sotalol Hydrochloride','TABLET','ORAL','20000504','','ANDA','ANDA075429','Teva Pharmaceuticals USA, Inc.','SOTALOL HYDROCHLORIDE','80','mg/1','Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1062_e524b89d-4ddd-42f5-a0af-8b4945aec7b4','0093-1062','HUMAN PRESCRIPTION DRUG','Sotalol Hydrochloride','','Sotalol Hydrochloride','TABLET','ORAL','20000505','','ANDA','ANDA075429','Teva Pharmaceuticals USA, Inc.','SOTALOL HYDROCHLORIDE','160','mg/1','Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1063_e524b89d-4ddd-42f5-a0af-8b4945aec7b4','0093-1063','HUMAN PRESCRIPTION DRUG','Sotalol Hydrochloride','','Sotalol Hydrochloride','TABLET','ORAL','20000505','','ANDA','ANDA075429','Teva Pharmaceuticals USA, Inc.','SOTALOL HYDROCHLORIDE','240','mg/1','Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1077_c226712f-00c2-407f-8b40-5ed1be54dfb8','0093-1077','HUMAN PRESCRIPTION DRUG','Cefprozil','','Cefprozil','TABLET, FILM COATED','ORAL','20051223','','ANDA','ANDA065208','Teva Pharmaceuticals USA, Inc.','CEFPROZIL','250','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1078_c226712f-00c2-407f-8b40-5ed1be54dfb8','0093-1078','HUMAN PRESCRIPTION DRUG','Cefprozil','','Cefprozil','TABLET, FILM COATED','ORAL','20051223','','ANDA','ANDA065208','Teva Pharmaceuticals USA, Inc.','CEFPROZIL','500','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1087_61ec00e0-d37d-4aa4-8f50-031ee7a37ecc','0093-1087','HUMAN PRESCRIPTION DRUG','Cefaclor','','Cefaclor','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20020926','','ANDA','ANDA065058','Teva Pharmaceuticals USA, Inc.','CEFACLOR','500','mg/1','Cephalosporin Antibacterial [EPC], Cephalosporins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1118_e96eb1a8-49e6-40e3-8e3f-66977e80e92d','0093-1118','HUMAN PRESCRIPTION DRUG','Etodolac','','Etodolac','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20000817','','ANDA','ANDA075665','Teva Pharmaceuticals USA, Inc.','ETODOLAC','600','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1122_e96eb1a8-49e6-40e3-8e3f-66977e80e92d','0093-1122','HUMAN PRESCRIPTION DRUG','Etodolac','','Etodolac','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20010209','','ANDA','ANDA075665','Teva Pharmaceuticals USA, Inc.','ETODOLAC','400','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1125_81772086-cab1-4658-8132-d0650a06a4c7','0093-1125','HUMAN PRESCRIPTION DRUG','Abiraterone Acetate','','Abiraterone Acetate','TABLET, FILM COATED','ORAL','20181121','','ANDA','ANDA208432','Teva Pharmaceuticals USA, Inc.','ABIRATERONE ACETATE','250','mg/1','Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1135_ba11783f-b2ad-49e8-b3a3-e96d29d1b369','0093-1135','HUMAN PRESCRIPTION DRUG','Acitretin','','Acitretin','CAPSULE','ORAL','20130719','','ANDA','ANDA091455','Teva Pharmaceuticals USA, Inc.','ACITRETIN','10','mg/1','Retinoid [EPC], Retinoids [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1136_ba11783f-b2ad-49e8-b3a3-e96d29d1b369','0093-1136','HUMAN PRESCRIPTION DRUG','Acitretin','','Acitretin','CAPSULE','ORAL','20130719','','ANDA','ANDA091455','Teva Pharmaceuticals USA, Inc.','ACITRETIN','25','mg/1','Retinoid [EPC], Retinoids [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1138_ba11783f-b2ad-49e8-b3a3-e96d29d1b369','0093-1138','HUMAN PRESCRIPTION DRUG','Acitretin','','Acitretin','CAPSULE','ORAL','20130719','','ANDA','ANDA202897','Teva Pharmaceuticals USA, Inc.','ACITRETIN','17.5','mg/1','Retinoid [EPC], Retinoids [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1172_288bb7b9-69d7-452a-8c33-cd2b2ac63de8','0093-1172','HUMAN PRESCRIPTION DRUG','Penicillin V Potassium','','Penicillin V Potassium','TABLET','ORAL','19900930','','ANDA','ANDA060711','Teva Pharmaceuticals USA, Inc.','PENICILLIN V POTASSIUM','250','mg/1','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1174_288bb7b9-69d7-452a-8c33-cd2b2ac63de8','0093-1174','HUMAN PRESCRIPTION DRUG','Penicillin V Potassium','','Penicillin V Potassium','TABLET','ORAL','19900930','','ANDA','ANDA060711','Teva Pharmaceuticals USA, Inc.','PENICILLIN V POTASSIUM','500','mg/1','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1177_18e9e5b7-e08c-445e-86bb-90bc0953eda9','0093-1177','HUMAN PRESCRIPTION DRUG','Neomycin Sulfate','','Neomycin Sulfate','TABLET','ORAL','19900930','','ANDA','ANDA060304','Teva Pharmaceuticals USA, Inc.','NEOMYCIN SULFATE','500','mg/1','Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1712_0f94f9e0-7215-4b46-b12a-33eae411c533','0093-1712','HUMAN PRESCRIPTION DRUG','Warfarin Sodium','','Warfarin Sodium','TABLET','ORAL','20151019','','ANDA','ANDA040616','Teva Pharmaceuticals USA, Inc.','WARFARIN SODIUM','1','mg/1','Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1713_0f94f9e0-7215-4b46-b12a-33eae411c533','0093-1713','HUMAN PRESCRIPTION DRUG','Warfarin Sodium','','Warfarin Sodium','TABLET','ORAL','20150505','','ANDA','ANDA040616','Teva Pharmaceuticals USA, Inc.','WARFARIN SODIUM','2','mg/1','Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1714_0f94f9e0-7215-4b46-b12a-33eae411c533','0093-1714','HUMAN PRESCRIPTION DRUG','Warfarin Sodium','','Warfarin Sodium','TABLET','ORAL','20150407','','ANDA','ANDA040616','Teva Pharmaceuticals USA, Inc.','WARFARIN SODIUM','2.5','mg/1','Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1715_0f94f9e0-7215-4b46-b12a-33eae411c533','0093-1715','HUMAN PRESCRIPTION DRUG','Warfarin Sodium','','Warfarin Sodium','TABLET','ORAL','20150714','','ANDA','ANDA040616','Teva Pharmaceuticals USA, Inc.','WARFARIN SODIUM','3','mg/1','Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1716_0f94f9e0-7215-4b46-b12a-33eae411c533','0093-1716','HUMAN PRESCRIPTION DRUG','Warfarin Sodium','','Warfarin Sodium','TABLET','ORAL','20150609','','ANDA','ANDA040616','Teva Pharmaceuticals USA, Inc.','WARFARIN SODIUM','4','mg/1','Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1718_0f94f9e0-7215-4b46-b12a-33eae411c533','0093-1718','HUMAN PRESCRIPTION DRUG','Warfarin Sodium','','Warfarin Sodium','TABLET','ORAL','20150722','','ANDA','ANDA040616','Teva Pharmaceuticals USA, Inc.','WARFARIN SODIUM','6','mg/1','Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1720_0f94f9e0-7215-4b46-b12a-33eae411c533','0093-1720','HUMAN PRESCRIPTION DRUG','Warfarin Sodium','','Warfarin Sodium','TABLET','ORAL','20150512','','ANDA','ANDA040616','Teva Pharmaceuticals USA, Inc.','WARFARIN SODIUM','10','mg/1','Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1721_0f94f9e0-7215-4b46-b12a-33eae411c533','0093-1721','HUMAN PRESCRIPTION DRUG','Warfarin Sodium','','Warfarin Sodium','TABLET','ORAL','20150407','','ANDA','ANDA040616','Teva Pharmaceuticals USA, Inc.','WARFARIN SODIUM','5','mg/1','Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1723_0f94f9e0-7215-4b46-b12a-33eae411c533','0093-1723','HUMAN PRESCRIPTION DRUG','Warfarin Sodium','','Warfarin Sodium','TABLET','ORAL','20180827','','ANDA','ANDA040616','Teva Pharmaceuticals USA, Inc.','WARFARIN SODIUM','7.5','mg/1','Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1920_69f451c5-8462-4717-b3de-699fce9e009f','0093-1920','HUMAN PRESCRIPTION DRUG','Cyclobenzaprine Hydrochloride','','Cyclobenzaprine Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20190304','','NDA AUTHORIZED GENERIC','NDA021777','Teva Pharmaceuticals USA, Inc.','CYCLOBENZAPRINE HYDROCHLORIDE','15','mg/1','Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-1921_69f451c5-8462-4717-b3de-699fce9e009f','0093-1921','HUMAN PRESCRIPTION DRUG','Cyclobenzaprine Hydrochloride','','Cyclobenzaprine Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20190304','','NDA AUTHORIZED GENERIC','NDA021777','Teva Pharmaceuticals USA, Inc.','CYCLOBENZAPRINE HYDROCHLORIDE','30','mg/1','Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2013_c70368a4-4b28-4d08-aff9-85f4106834ff','0093-2013','HUMAN PRESCRIPTION DRUG','Sumatriptan','','sumatriptan succinate','INJECTION','SUBCUTANEOUS','20160601','','ANDA','ANDA078319','Teva Pharmaceuticals USA Inc','SUMATRIPTAN SUCCINATE','4','mg/.5mL','Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2014_c70368a4-4b28-4d08-aff9-85f4106834ff','0093-2014','HUMAN PRESCRIPTION DRUG','Sumatriptan','','sumatriptan succinate','INJECTION','SUBCUTANEOUS','20160601','','ANDA','ANDA078319','Teva Pharmaceuticals USA Inc','SUMATRIPTAN SUCCINATE','6','mg/.5mL','Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2026_44ec7e09-784b-41f7-a482-3be1d309e95b','0093-2026','HUMAN PRESCRIPTION DRUG','Azithromycin','','Azithromycin','POWDER, FOR SUSPENSION','ORAL','20101217','','ANDA','ANDA065246','Teva Pharmaceuticals USA, Inc.','AZITHROMYCIN MONOHYDRATE','200','mg/5mL','Macrolide Antimicrobial [EPC], Macrolides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2027_44ec7e09-784b-41f7-a482-3be1d309e95b','0093-2027','HUMAN PRESCRIPTION DRUG','Azithromycin','','Azithromycin','POWDER, FOR SUSPENSION','ORAL','20101228','','ANDA','ANDA065246','Teva Pharmaceuticals USA, Inc.','AZITHROMYCIN MONOHYDRATE','100','mg/5mL','Macrolide Antimicrobial [EPC], Macrolides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2063_c6af23d2-0b74-49fd-8c04-549988b0eb23','0093-2063','HUMAN PRESCRIPTION DRUG','Quetiapine','','Quetiapine','TABLET, FILM COATED','ORAL','20140312','','ANDA','ANDA077745','Teva Pharmaceuticals USA, Inc.','QUETIAPINE FUMARATE','25','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2064_393b107e-e45e-4d7e-a58c-e7b1a550f121','0093-2064','HUMAN PRESCRIPTION DRUG','Cilostazol','','Cilostazol','TABLET','ORAL','20121024','','ANDA','ANDA077027','Teva Pharmaceuticals USA, Inc.','CILOSTAZOL','100','mg/1','Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2065_393b107e-e45e-4d7e-a58c-e7b1a550f121','0093-2065','HUMAN PRESCRIPTION DRUG','Cilostazol','','Cilostazol','TABLET','ORAL','20120424','','ANDA','ANDA077027','Teva Pharmaceuticals USA, Inc.','CILOSTAZOL','50','mg/1','Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2067_69a65fb3-443c-4b78-bb8b-9d8feff93fed','0093-2067','HUMAN PRESCRIPTION DRUG','Doxazosin','','Doxazosin Mesylate','TABLET','ORAL','20141205','','ANDA','ANDA075536','Teva Pharmaceuticals USA, Inc.','DOXAZOSIN MESYLATE','8','mg/1','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2068_69a65fb3-443c-4b78-bb8b-9d8feff93fed','0093-2068','HUMAN PRESCRIPTION DRUG','Doxazosin','','Doxazosin Mesylate','TABLET','ORAL','20140909','','ANDA','ANDA075536','Teva Pharmaceuticals USA, Inc.','DOXAZOSIN MESYLATE','4','mg/1','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2069_69a65fb3-443c-4b78-bb8b-9d8feff93fed','0093-2069','HUMAN PRESCRIPTION DRUG','Doxazosin','','Doxazosin Mesylate','TABLET','ORAL','20140806','','ANDA','ANDA075536','Teva Pharmaceuticals USA, Inc.','DOXAZOSIN MESYLATE','2','mg/1','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2070_69a65fb3-443c-4b78-bb8b-9d8feff93fed','0093-2070','HUMAN PRESCRIPTION DRUG','Doxazosin','','Doxazosin Mesylate','TABLET','ORAL','20140806','','ANDA','ANDA075536','Teva Pharmaceuticals USA, Inc.','DOXAZOSIN MESYLATE','1','mg/1','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2140_204ad27b-376e-4d07-bf27-1db57f446045','0093-2140','HUMAN PRESCRIPTION DRUG','Tri-Lo-Sprintec','','Norgestimate and Ethinyl Estradiol','KIT','','20151230','','ANDA','ANDA076784','Teva Pharmaceuticals USA, Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2165_7743953e-649b-4abf-bacd-71dfdd62968b','0093-2165','HUMAN PRESCRIPTION DRUG','Naloxone Hydrochloride','','Naloxone Hydrochloride','SPRAY, METERED','NASAL','20211222','','ANDA','ANDA209522','Teva Pharmaceuticals USA, Inc.','NALOXONE HYDROCHLORIDE','4','mg/.1mL','Opioid Antagonist [EPC], Opioid Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2178_22ed1e76-c20a-481e-bc00-2b531d14c3e4','0093-2178','HUMAN PRESCRIPTION DRUG','Liothyronine Sodium','','Liothyronine Sodium','TABLET','ORAL','20210226','','ANDA','ANDA211510','Teva Pharmaceuticals USA, Inc.','LIOTHYRONINE SODIUM','25','ug/1','Triiodothyronine [CS], l-Triiodothyronine [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2179_22ed1e76-c20a-481e-bc00-2b531d14c3e4','0093-2179','HUMAN PRESCRIPTION DRUG','Liothyronine Sodium','','Liothyronine Sodium','TABLET','ORAL','20210226','','ANDA','ANDA211510','Teva Pharmaceuticals USA, Inc.','LIOTHYRONINE SODIUM','5','ug/1','Triiodothyronine [CS], l-Triiodothyronine [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2180_22ed1e76-c20a-481e-bc00-2b531d14c3e4','0093-2180','HUMAN PRESCRIPTION DRUG','Liothyronine Sodium','','Liothyronine Sodium','TABLET','ORAL','20210226','','ANDA','ANDA211510','Teva Pharmaceuticals USA, Inc.','LIOTHYRONINE SODIUM','50','ug/1','Triiodothyronine [CS], l-Triiodothyronine [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2203_8f208d35-b19b-40a1-b363-f44ff08ec3d6','0093-2203','HUMAN PRESCRIPTION DRUG','Metoclopramide','','Metoclopramide','TABLET','ORAL','19900930','','ANDA','ANDA070184','Teva Pharmaceuticals USA, Inc.','METOCLOPRAMIDE HYDROCHLORIDE','10','mg/1','Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2204_8f208d35-b19b-40a1-b363-f44ff08ec3d6','0093-2204','HUMAN PRESCRIPTION DRUG','Metoclopramide','','Metoclopramide','TABLET','ORAL','19930701','','ANDA','ANDA072801','Teva Pharmaceuticals USA, Inc.','METOCLOPRAMIDE HYDROCHLORIDE','5','mg/1','Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2210_40bf98b4-12b3-4ccc-8ff8-5097f2c18fd2','0093-2210','HUMAN PRESCRIPTION DRUG','Sucralfate','','Sucralfate','TABLET','ORAL','19961111','','ANDA','ANDA070848','Teva Pharmaceuticals USA, Inc.','SUCRALFATE','1','g/1','Aluminum Complex [EPC], Organometallic Compounds [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2238_53412318-db3b-446d-9b4f-2e5ddb74190a','0093-2238','HUMAN PRESCRIPTION DRUG','Cephalexin','','Cephalexin','TABLET','ORAL','19900930','','ANDA','ANDA063023','Teva Pharmaceuticals USA, Inc.','CEPHALEXIN','250','mg/1','Cephalosporin Antibacterial [EPC], Cephalosporins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2240_53412318-db3b-446d-9b4f-2e5ddb74190a','0093-2240','HUMAN PRESCRIPTION DRUG','Cephalexin','','Cephalexin','TABLET','ORAL','19900930','','ANDA','ANDA063024','Teva Pharmaceuticals USA, Inc.','CEPHALEXIN','500','mg/1','Cephalosporin Antibacterial [EPC], Cephalosporins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2263_bb81d117-eb9a-4043-94a9-da52ee047a8b','0093-2263','HUMAN PRESCRIPTION DRUG','Amoxicillin','','Amoxicillin','TABLET, FILM COATED','ORAL','20001121','','ANDA','ANDA065056','Teva Pharmaceuticals USA, Inc.','AMOXICILLIN','500','mg/1','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2264_bb81d117-eb9a-4043-94a9-da52ee047a8b','0093-2264','HUMAN PRESCRIPTION DRUG','Amoxicillin','','Amoxicillin','TABLET, FILM COATED','ORAL','20000926','','ANDA','ANDA065056','Teva Pharmaceuticals USA, Inc.','AMOXICILLIN','875','mg/1','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2267_bb81d117-eb9a-4043-94a9-da52ee047a8b','0093-2267','HUMAN PRESCRIPTION DRUG','Amoxicillin','','Amoxicillin','TABLET, CHEWABLE','ORAL','19951001','','ANDA','ANDA064013','Teva Pharmaceuticals USA, Inc.','AMOXICILLIN','125','mg/1','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2268_bb81d117-eb9a-4043-94a9-da52ee047a8b','0093-2268','HUMAN PRESCRIPTION DRUG','Amoxicillin','','Amoxicillin','TABLET, CHEWABLE','ORAL','19930101','','ANDA','ANDA064013','Teva Pharmaceuticals USA, Inc.','AMOXICILLIN','250','mg/1','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2270_f7eeea58-2ba1-4ec1-a3b1-dbad63d1822c','0093-2270','HUMAN PRESCRIPTION DRUG','Amoxicillin and Clavulanate Potassium','','Amoxicillin and Clavulanate Potassium','TABLET, CHEWABLE','ORAL','20050322','','ANDA','ANDA065205','Teva Pharmaceuticals USA, Inc.','AMOXICILLIN; CLAVULANATE POTASSIUM','200; 28.5','mg/1; mg/1','Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2272_f7eeea58-2ba1-4ec1-a3b1-dbad63d1822c','0093-2272','HUMAN PRESCRIPTION DRUG','Amoxicillin and Clavulanate Potassium','','Amoxicillin and Clavulanate Potassium','TABLET, CHEWABLE','ORAL','20050210','','ANDA','ANDA065205','Teva Pharmaceuticals USA, Inc.','AMOXICILLIN; CLAVULANATE POTASSIUM','400; 57','mg/1; mg/1','Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2274_f7eeea58-2ba1-4ec1-a3b1-dbad63d1822c','0093-2274','HUMAN PRESCRIPTION DRUG','Amoxicillin and Clavulanate Potassium','','Amoxicillin and Clavulanate Potassium','TABLET, FILM COATED','ORAL','20021031','','ANDA','ANDA065101','Teva Pharmaceuticals USA, Inc.','AMOXICILLIN; CLAVULANATE POTASSIUM','500; 125','mg/1; mg/1','Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2275_f7eeea58-2ba1-4ec1-a3b1-dbad63d1822c','0093-2275','HUMAN PRESCRIPTION DRUG','Amoxicillin and Clavulanate Potassium','','Amoxicillin and Clavulanate Potassium','TABLET, FILM COATED','ORAL','20021031','','ANDA','ANDA065096','Teva Pharmaceuticals USA, Inc.','AMOXICILLIN; CLAVULANATE POTASSIUM','875; 125','mg/1; mg/1','Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2277_f7eeea58-2ba1-4ec1-a3b1-dbad63d1822c','0093-2277','HUMAN PRESCRIPTION DRUG','Amoxicillin and Clavulanate Potassium','','Amoxicillin and Clavulanate Potassium','POWDER, FOR SUSPENSION','ORAL','20050113','','ANDA','ANDA065089','Teva Pharmaceuticals USA, Inc.','AMOXICILLIN; CLAVULANATE POTASSIUM','200; 28.5','mg/5mL; mg/5mL','Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2279_f7eeea58-2ba1-4ec1-a3b1-dbad63d1822c','0093-2279','HUMAN PRESCRIPTION DRUG','Amoxicillin and Clavulanate Potassium','','Amoxicillin and Clavulanate Potassium','POWDER, FOR SUSPENSION','ORAL','20050113','','ANDA','ANDA065089','Teva Pharmaceuticals USA, Inc.','AMOXICILLIN; CLAVULANATE POTASSIUM','400; 57','mg/5mL; mg/5mL','Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-2401_a2897a74-f746-42aa-b752-ea4fc195d28d','0093-2401','HUMAN PRESCRIPTION DRUG','Hydroxychloroquine Sulfate','','Hydroxychloroquine Sulfate','TABLET, FILM COATED','ORAL','20201008','','ANDA','ANDA040081','Teva Pharmaceuticals USA, Inc.','HYDROXYCHLOROQUINE SULFATE','200','mg/1','Antimalarial [EPC], Antirheumatic Agent [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3002_b87c29c4-4dd9-4095-85a5-af8833ae2b4f','0093-3002','HUMAN PRESCRIPTION DRUG','Quinine Sulfate','','Quinine Sulfate','CAPSULE','ORAL','20120928','','ANDA','ANDA091661','Teva Pharmaceuticals USA, Inc.','QUININE SULFATE','324','mg/1','Antimalarial [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3008_eaa2693b-b9df-4cf3-b212-5de87110aa89','0093-3008','HUMAN PRESCRIPTION DRUG','Lansoprazole','','Lansoprazole','TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE','ORAL','20180308','','ANDA','ANDA208784','Teva Pharmaceuticals USA, Inc.','LANSOPRAZOLE','15','mg/1','Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3009_eaa2693b-b9df-4cf3-b212-5de87110aa89','0093-3009','HUMAN PRESCRIPTION DRUG','Lansoprazole','','Lansoprazole','TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE','ORAL','20180308','','ANDA','ANDA208784','Teva Pharmaceuticals USA, Inc.','LANSOPRAZOLE','30','mg/1','Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3016_08e8069b-c417-4cb8-8423-ffc540232a6a','0093-3016','HUMAN PRESCRIPTION DRUG','Tadalafil','','Tadalafil','TABLET, FILM COATED','ORAL','20180927','','ANDA','ANDA090141','Teva Pharmaceuticals USA, Inc.','TADALAFIL','2.5','mg/1','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3017_08e8069b-c417-4cb8-8423-ffc540232a6a','0093-3017','HUMAN PRESCRIPTION DRUG','Tadalafil','','Tadalafil','TABLET, FILM COATED','ORAL','20180927','','ANDA','ANDA090141','Teva Pharmaceuticals USA, Inc.','TADALAFIL','5','mg/1','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3018_08e8069b-c417-4cb8-8423-ffc540232a6a','0093-3018','HUMAN PRESCRIPTION DRUG','Tadalafil','','Tadalafil','TABLET, FILM COATED','ORAL','20180927','','ANDA','ANDA090141','Teva Pharmaceuticals USA, Inc.','TADALAFIL','10','mg/1','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3019_08e8069b-c417-4cb8-8423-ffc540232a6a','0093-3019','HUMAN PRESCRIPTION DRUG','Tadalafil','','Tadalafil','TABLET, FILM COATED','ORAL','20180927','','ANDA','ANDA090141','Teva Pharmaceuticals USA, Inc.','TADALAFIL','20','mg/1','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3060_f4e29bde-d4fe-429a-8af3-d3fe3743a49a','0093-3060','HUMAN PRESCRIPTION DRUG','Rasagiline','','Rasagiline','TABLET','ORAL','20170103','','NDA AUTHORIZED GENERIC','NDA021641','Teva Pharmaceuticals USA, Inc.','RASAGILINE MESYLATE','0.5','mg/1','Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3061_f4e29bde-d4fe-429a-8af3-d3fe3743a49a','0093-3061','HUMAN PRESCRIPTION DRUG','Rasagiline','','Rasagiline','TABLET','ORAL','20170103','','NDA AUTHORIZED GENERIC','NDA021641','Teva Pharmaceuticals USA, Inc.','RASAGILINE MESYLATE','1','mg/1','Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3066_ea64720c-2b46-4ff1-9231-3f2b20968fcd','0093-3066','HUMAN PRESCRIPTION DRUG','Icatibant','','Icatibant','INJECTION, SOLUTION','SUBCUTANEOUS','20190715','','ANDA','ANDA210118','Teva Pharmaceuticals USA, Inc.','ICATIBANT ACETATE','10','mg/mL','Bradykinin B2 Receptor Antagonist [EPC], Bradykinin B2 Receptor Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3090_b982d3cc-e35f-4715-beb3-4f08650ff582','0093-3090','HUMAN PRESCRIPTION DRUG','Armodafinil','','Armodafinil','TABLET','ORAL','20161129','','NDA AUTHORIZED GENERIC','NDA021875','Teva Pharmaceuticals USA, Inc.','ARMODAFINIL','50','mg/1','','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3092_b982d3cc-e35f-4715-beb3-4f08650ff582','0093-3092','HUMAN PRESCRIPTION DRUG','Armodafinil','','Armodafinil','TABLET','ORAL','20161129','','NDA AUTHORIZED GENERIC','NDA021875','Teva Pharmaceuticals USA, Inc.','ARMODAFINIL','150','mg/1','','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3093_b982d3cc-e35f-4715-beb3-4f08650ff582','0093-3093','HUMAN PRESCRIPTION DRUG','Armodafinil','','Armodafinil','TABLET','ORAL','20161129','','NDA AUTHORIZED GENERIC','NDA021875','Teva Pharmaceuticals USA, Inc.','ARMODAFINIL','200','mg/1','','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3094_b982d3cc-e35f-4715-beb3-4f08650ff582','0093-3094','HUMAN PRESCRIPTION DRUG','Armodafinil','','Armodafinil','TABLET','ORAL','20161129','','NDA AUTHORIZED GENERIC','NDA021875','Teva Pharmaceuticals USA, Inc.','ARMODAFINIL','250','mg/1','','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3098_fc389faf-d921-44b1-ab48-b0b14a2a47a5','0093-3098','HUMAN PRESCRIPTION DRUG','Risedronate Sodium','','Risedronate Sodium','TABLET, FILM COATED','ORAL','20150601','','ANDA','ANDA077132','Teva Pharmaceuticals USA, Inc.','RISEDRONATE SODIUM MONOHYDRATE','35','mg/1','Bisphosphonate [EPC], Diphosphonates [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3099_fc389faf-d921-44b1-ab48-b0b14a2a47a5','0093-3099','HUMAN PRESCRIPTION DRUG','Risedronate Sodium','','Risedronate Sodium','TABLET, FILM COATED','ORAL','20150601','','ANDA','ANDA077132','Teva Pharmaceuticals USA, Inc.','RISEDRONATE SODIUM MONOHYDRATE','5','mg/1','Bisphosphonate [EPC], Diphosphonates [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3100_fc389faf-d921-44b1-ab48-b0b14a2a47a5','0093-3100','HUMAN PRESCRIPTION DRUG','Risedronate Sodium','','Risedronate Sodium','TABLET, FILM COATED','ORAL','20150601','','ANDA','ANDA077132','Teva Pharmaceuticals USA, Inc.','RISEDRONATE SODIUM MONOHYDRATE','30','mg/1','Bisphosphonate [EPC], Diphosphonates [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3107_bb81d117-eb9a-4043-94a9-da52ee047a8b','0093-3107','HUMAN PRESCRIPTION DRUG','Amoxicillin','','Amoxicillin','CAPSULE','ORAL','19900930','','ANDA','ANDA061926','Teva Pharmaceuticals USA, Inc.','AMOXICILLIN','250','mg/1','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3109_bb81d117-eb9a-4043-94a9-da52ee047a8b','0093-3109','HUMAN PRESCRIPTION DRUG','Amoxicillin','','Amoxicillin','CAPSULE','ORAL','19900930','','ANDA','ANDA061926','Teva Pharmaceuticals USA, Inc.','AMOXICILLIN','500','mg/1','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3122_abd9820a-4a42-4700-bd5a-3da56ee2b252','0093-3122','HUMAN PRESCRIPTION DRUG','Jinteli','','norethindrone acetate and ethinyl estradiol','TABLET','ORAL','20110217','','ANDA','ANDA076221','Teva Pharmaceuticals USA, Inc.','ETHINYL ESTRADIOL; NORETHINDRONE ACETATE','5; 1','ug/1; mg/1','Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3123_eafdab47-957b-44cb-88d5-7c1a428a5daf','0093-3123','HUMAN PRESCRIPTION DRUG','Dicloxacillin Sodium','','Dicloxacillin Sodium','CAPSULE','ORAL','19900930','','ANDA','ANDA062286','Teva Pharmaceuticals USA, Inc.','DICLOXACILLIN SODIUM','250','mg/1','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3125_eafdab47-957b-44cb-88d5-7c1a428a5daf','0093-3125','HUMAN PRESCRIPTION DRUG','Dicloxacillin Sodium','','Dicloxacillin Sodium','CAPSULE','ORAL','19900930','','ANDA','ANDA062286','Teva Pharmaceuticals USA, Inc.','DICLOXACILLIN SODIUM','500','mg/1','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3127_71a441c5-5c53-433e-84b9-f7b25818a077','0093-3127','HUMAN PRESCRIPTION DRUG','Disopyramide Phosphate','','Disopyramide Phosphate','CAPSULE','ORAL','19900930','','ANDA','ANDA070101','Teva Pharmaceuticals USA, Inc.','DISOPYRAMIDE PHOSPHATE','100','mg/1','Antiarrhythmic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3129_71a441c5-5c53-433e-84b9-f7b25818a077','0093-3129','HUMAN PRESCRIPTION DRUG','Disopyramide Phosphate','','Disopyramide Phosphate','CAPSULE','ORAL','19900930','','ANDA','ANDA070102','Teva Pharmaceuticals USA, Inc.','DISOPYRAMIDE PHOSPHATE','150','mg/1','Antiarrhythmic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3133_7393b310-0b4d-4558-a927-c81266bb73e5','0093-3133','HUMAN PRESCRIPTION DRUG','Imiquimod','','imiquimod','CREAM','TOPICAL','20200730','','NDA AUTHORIZED GENERIC','NDA022483','Teva Pharmaceuticals USA, Inc.','IMIQUIMOD','37.5','mg/g','Increased Cytokine Activity [PE], Increased Cytokine Production [PE], Interferon Inducers [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3134_ac71015b-7443-482d-9602-8381de3d57f4','0093-3134','HUMAN PRESCRIPTION DRUG','Camrese','','Levonorgestrel / Ethinyl Estradiol and Ethinyl Estradiol','KIT','','20110728','','NDA AUTHORIZED GENERIC','NDA021840','Teva Pharmaceuticals USA, Inc.','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3145_c75c0bb6-fe3e-43c6-bdde-edd904731795','0093-3145','HUMAN PRESCRIPTION DRUG','Cephalexin','','Cephalexin','CAPSULE','ORAL','19900930','','ANDA','ANDA062702','Teva Pharmaceuticals USA, Inc.','CEPHALEXIN','250','mg/1','Cephalosporin Antibacterial [EPC], Cephalosporins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3147_c75c0bb6-fe3e-43c6-bdde-edd904731795','0093-3147','HUMAN PRESCRIPTION DRUG','Cephalexin','','Cephalexin','CAPSULE','ORAL','19900930','','ANDA','ANDA062702','Teva Pharmaceuticals USA, Inc.','CEPHALEXIN','500','mg/1','Cephalosporin Antibacterial [EPC], Cephalosporins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3160_d43379bc-861f-4f3f-9ddd-68eba5708143','0093-3160','HUMAN PRESCRIPTION DRUG','Cefdinir','','Cefdinir','CAPSULE','ORAL','20070509','','ANDA','ANDA065368','Teva Pharmaceuticals USA, Inc.','CEFDINIR','300','mg/1','Cephalosporin Antibacterial [EPC], Cephalosporins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3174_d9fc7dd4-8c8c-4c83-a6b7-02d984f4135b','0093-3174','HUMAN PRESCRIPTION DRUG','Albuterol Sulfate','HFA','Albuterol Sulfate','AEROSOL, METERED','RESPIRATORY (INHALATION)','20190116','','NDA AUTHORIZED GENERIC','NDA021457','Teva Pharmaceuticals USA, Inc.','ALBUTEROL SULFATE','90','ug/1','Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3186_e6116cf2-000d-461f-a8cb-47f4c4ec8d34','0093-3186','HUMAN PRESCRIPTION DRUG','Penciclovir','','Penciclovir','CREAM','TOPICAL','20221114','','ANDA','ANDA212710','Teva Pharmaceuticals USA, Inc.','PENCICLOVIR','10','mg/g','DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3196_b5585275-ba06-4ffd-9fa5-82e2603433ec','0093-3196','HUMAN PRESCRIPTION DRUG','Cefadroxil','','Cefadroxil','CAPSULE','ORAL','20070131','','ANDA','ANDA065282','Teva Pharmaceuticals USA, Inc.','CEFADROXIL','500','mg/1','Cephalosporin Antibacterial [EPC], Cephalosporins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3204_d3c2ca4e-595a-4079-a95e-90d24dcc8816','0093-3204','HUMAN OTC DRUG','Moisturel','','Dimethicone','LOTION','TOPICAL','20181112','20230825','OTC MONOGRAPH FINAL','part347','Teva Pharmaceuticals USA, Inc.','DIMETHICONE','30','g/g','Skin Barrier Activity [PE]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3212_9a6e32a7-0ba7-45c9-9806-647c93f96a1c','0093-3212','HUMAN PRESCRIPTION DRUG','Clonazepam','','Clonazepam','TABLET','ORAL','19960917','','ANDA','ANDA074569','Teva Pharmaceuticals USA, Inc.','CLONAZEPAM','1','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3213_9a6e32a7-0ba7-45c9-9806-647c93f96a1c','0093-3213','HUMAN PRESCRIPTION DRUG','Clonazepam','','Clonazepam','TABLET','ORAL','19960918','','ANDA','ANDA074569','Teva Pharmaceuticals USA, Inc.','CLONAZEPAM','2','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3219_3027539e-261c-4ac2-a25d-c41fcce3da0f','0093-3219','HUMAN PRESCRIPTION DRUG','Ketoconazole','','Ketoconazole','CREAM','TOPICAL','20190208','','ANDA','ANDA075581','Teva Pharmaceuticals USA, Inc.','KETOCONAZOLE','20','mg/g','Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3223_298666b0-57a0-464e-b349-a708aa4f63a2','0093-3223','HUMAN PRESCRIPTION DRUG','Estradiol','','Estradiol','INSERT','VAGINAL','20170724','','ANDA','ANDA206388','Teva Pharmaceuticals USA, Inc.','ESTRADIOL','10','ug/1','Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3234_86815d9e-100d-4a63-b2b5-c59354533514','0093-3234','HUMAN PRESCRIPTION DRUG','Sulfasalazine','','Sulfasalazine','TABLET','ORAL','20221215','','ANDA','ANDA085828','Teva Pharmaceuticals USA, Inc.','SULFASALAZINE','500','mg/1','Aminosalicylate [EPC], Aminosalicylic Acids [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3239_8f10fadb-5d69-45b2-bc95-af8f6e346d39','0093-3239','HUMAN PRESCRIPTION DRUG','Buprenorphine','','Buprenorphine','PATCH, EXTENDED RELEASE','TRANSDERMAL','20211227','','ANDA','ANDA204937','Teva Pharmaceuticals USA, Inc.','BUPRENORPHINE','7.5','ug/h','Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]','CIII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3241_83a1c39a-813c-4510-8d5e-33835a2ae902','0093-3241','HUMAN PRESCRIPTION DRUG','bisoprolol fumarate and hydrochlorothiazide','','bisoprolol fumarate and hydrochlorothiazide','TABLET, FILM COATED','ORAL','20190807','','NDA AUTHORIZED GENERIC','NDA020186','Teva Pharmaceuticals USA, Inc.','BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE','2.5; 6.25','mg/1; mg/1','Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3242_83a1c39a-813c-4510-8d5e-33835a2ae902','0093-3242','HUMAN PRESCRIPTION DRUG','bisoprolol fumarate and hydrochlorothiazide','','bisoprolol fumarate and hydrochlorothiazide','TABLET, FILM COATED','ORAL','20190807','','NDA AUTHORIZED GENERIC','NDA020186','Teva Pharmaceuticals USA, Inc.','BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE','5; 6.25','mg/1; mg/1','Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3243_83a1c39a-813c-4510-8d5e-33835a2ae902','0093-3243','HUMAN PRESCRIPTION DRUG','bisoprolol fumarate and hydrochlorothiazide','','bisoprolol fumarate and hydrochlorothiazide','TABLET, FILM COATED','ORAL','20190807','','NDA AUTHORIZED GENERIC','NDA020186','Teva Pharmaceuticals USA, Inc.','BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE','10; 6.25','mg/1; mg/1','Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3304_6b24007e-0560-443d-9bca-894487c931af','0093-3304','HUMAN PRESCRIPTION DRUG','Reclipsen','28 Day','Desogestrel and Ethinyl Estradiol','KIT','','20170101','','ANDA','ANDA075256','Teva Pharmaceuticals USA, Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3334_aff8cfda-2692-4975-af57-831a194d25d2','0093-3334','HUMAN PRESCRIPTION DRUG','ALYQ','','Tadalafil','TABLET, FILM COATED','ORAL','20190206','','ANDA','ANDA209942','Teva Pharmaceuticals USA, Inc.','TADALAFIL','20','mg/1','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3420_e17eb9ef-7a98-4e37-8f13-62c870d6a767','0093-3420','HUMAN PRESCRIPTION DRUG','Cyclobenzaprine Hydrochloride','','Cyclobenzaprine Hydrochloride','TABLET, FILM COATED','ORAL','20210720','','ANDA','ANDA071611','Teva Pharmaceuticals USA, Inc.','CYCLOBENZAPRINE HYDROCHLORIDE','5','mg/1','Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3421_e17eb9ef-7a98-4e37-8f13-62c870d6a767','0093-3421','HUMAN PRESCRIPTION DRUG','Cyclobenzaprine Hydrochloride','','Cyclobenzaprine Hydrochloride','TABLET, FILM COATED','ORAL','20210720','','ANDA','ANDA071611','Teva Pharmaceuticals USA, Inc.','CYCLOBENZAPRINE HYDROCHLORIDE','7.5','mg/1','Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3422_e17eb9ef-7a98-4e37-8f13-62c870d6a767','0093-3422','HUMAN PRESCRIPTION DRUG','Cyclobenzaprine Hydrochloride','','Cyclobenzaprine Hydrochloride','TABLET, FILM COATED','ORAL','20210720','','ANDA','ANDA071611','Teva Pharmaceuticals USA, Inc.','CYCLOBENZAPRINE HYDROCHLORIDE','10','mg/1','Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3425_321d3810-4d3c-416d-be97-dcdc8c036709','0093-3425','HUMAN PRESCRIPTION DRUG','Lorazepam','','Lorazepam','TABLET','ORAL','20211011','','ANDA','ANDA072926','Teva Pharmaceuticals USA, Inc.','LORAZEPAM','0.5','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3426_321d3810-4d3c-416d-be97-dcdc8c036709','0093-3426','HUMAN PRESCRIPTION DRUG','Lorazepam','','Lorazepam','TABLET','ORAL','20211209','','ANDA','ANDA072927','Teva Pharmaceuticals USA, Inc.','LORAZEPAM','1','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3427_321d3810-4d3c-416d-be97-dcdc8c036709','0093-3427','HUMAN PRESCRIPTION DRUG','Lorazepam','','Lorazepam','TABLET','ORAL','20210720','','ANDA','ANDA072928','Teva Pharmaceuticals USA, Inc.','LORAZEPAM','2','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3428_1c77624d-dc7e-47ee-81db-87ce792c54cd','0093-3428','HUMAN PRESCRIPTION DRUG','Tacrolimus','','tacrolimus','OINTMENT','TOPICAL','20220909','','ANDA','ANDA200744','Teva Pharmaceuticals USA, Inc.','TACROLIMUS','0.3','mg/g','Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3429_1c77624d-dc7e-47ee-81db-87ce792c54cd','0093-3429','HUMAN PRESCRIPTION DRUG','Tacrolimus','','tacrolimus','OINTMENT','TOPICAL','20220909','','ANDA','ANDA200744','Teva Pharmaceuticals USA, Inc.','TACROLIMUS','1','mg/g','Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3541_5e253304-f297-4cb5-bfe3-f0f65dac629b','0093-3541','HUMAN PRESCRIPTION DRUG','Estradiol','','Estradiol','CREAM','VAGINAL','20180102','','ANDA','ANDA086069','Teva Pharmaceuticals USA, Inc.','ESTRADIOL','0.1','mg/g','Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3542_78a3a89a-7312-44f4-b7eb-ddf2c8d4e071','0093-3542','HUMAN PRESCRIPTION DRUG','Atomoxetine','','Atomoxetine','CAPSULE','ORAL','20170530','','ANDA','ANDA079022','Teva Pharmaceuticals USA, Inc.','ATOMOXETINE HYDROCHLORIDE','10','mg/1','Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3543_78a3a89a-7312-44f4-b7eb-ddf2c8d4e071','0093-3543','HUMAN PRESCRIPTION DRUG','Atomoxetine','','Atomoxetine','CAPSULE','ORAL','20170530','','ANDA','ANDA079022','Teva Pharmaceuticals USA, Inc.','ATOMOXETINE HYDROCHLORIDE','18','mg/1','Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3544_78a3a89a-7312-44f4-b7eb-ddf2c8d4e071','0093-3544','HUMAN PRESCRIPTION DRUG','Atomoxetine','','Atomoxetine','CAPSULE','ORAL','20170530','','ANDA','ANDA079022','Teva Pharmaceuticals USA, Inc.','ATOMOXETINE HYDROCHLORIDE','25','mg/1','Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3545_78a3a89a-7312-44f4-b7eb-ddf2c8d4e071','0093-3545','HUMAN PRESCRIPTION DRUG','Atomoxetine','','Atomoxetine','CAPSULE','ORAL','20170530','','ANDA','ANDA079022','Teva Pharmaceuticals USA, Inc.','ATOMOXETINE HYDROCHLORIDE','40','mg/1','Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3546_78a3a89a-7312-44f4-b7eb-ddf2c8d4e071','0093-3546','HUMAN PRESCRIPTION DRUG','Atomoxetine','','Atomoxetine','CAPSULE','ORAL','20170530','','ANDA','ANDA079022','Teva Pharmaceuticals USA, Inc.','ATOMOXETINE HYDROCHLORIDE','60','mg/1','Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3547_78a3a89a-7312-44f4-b7eb-ddf2c8d4e071','0093-3547','HUMAN PRESCRIPTION DRUG','Atomoxetine','','Atomoxetine','CAPSULE','ORAL','20170530','','ANDA','ANDA079022','Teva Pharmaceuticals USA, Inc.','ATOMOXETINE HYDROCHLORIDE','80','mg/1','Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3548_78a3a89a-7312-44f4-b7eb-ddf2c8d4e071','0093-3548','HUMAN PRESCRIPTION DRUG','Atomoxetine','','Atomoxetine','CAPSULE','ORAL','20170530','','ANDA','ANDA079022','Teva Pharmaceuticals USA, Inc.','ATOMOXETINE HYDROCHLORIDE','100','mg/1','Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3560_46e37694-3149-46b3-a949-fad3ccbb8052','0093-3560','HUMAN PRESCRIPTION DRUG','PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID','','PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID','KIT','','20200831','','ANDA','ANDA090145','Teva Pharmaceuticals USA, Inc.','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3607_0378204f-cc72-4a54-8ad7-ee9b93825261','0093-3607','HUMAN PRESCRIPTION DRUG','Fluticasone Propionate and Salmeterol','','Fluticasone Propionate and Salmeterol','POWDER, METERED','RESPIRATORY (INHALATION)','20170428','','NDA AUTHORIZED GENERIC','NDA208799','Teva Pharmaceuticals USA, Inc.','FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE','55; 14','ug/1; ug/1','Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3608_0378204f-cc72-4a54-8ad7-ee9b93825261','0093-3608','HUMAN PRESCRIPTION DRUG','Fluticasone Propionate and Salmeterol','','Fluticasone Propionate and Salmeterol','POWDER, METERED','RESPIRATORY (INHALATION)','20170428','','NDA AUTHORIZED GENERIC','NDA208799','Teva Pharmaceuticals USA, Inc.','FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE','113; 14','ug/1; ug/1','Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3609_0378204f-cc72-4a54-8ad7-ee9b93825261','0093-3609','HUMAN PRESCRIPTION DRUG','Fluticasone Propionate and Salmeterol','','Fluticasone Propionate and Salmeterol','POWDER, METERED','RESPIRATORY (INHALATION)','20170428','','NDA AUTHORIZED GENERIC','NDA208799','Teva Pharmaceuticals USA, Inc.','FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE','232; 14','ug/1; ug/1','Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3630_8c3d75a1-fe85-49ca-9bb4-af670f910bf8','0093-3630','HUMAN PRESCRIPTION DRUG','Acyclovir','','acyclovir','CREAM','TOPICAL','20190829','','NDA AUTHORIZED GENERIC','NDA021478','Teva Pharmaceuticals, Inc.','ACYCLOVIR','50','mg/g','DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3655_1c463f0a-7bee-4c90-871d-b69e85b0dc52','0093-3655','HUMAN PRESCRIPTION DRUG','Methylergonovine Maleate','','Methylergonovine Maleate','TABLET','ORAL','20190326','','ANDA','ANDA211455','Teva Pharmaceuticals USA, Inc.','METHYLERGONOVINE MALEATE','0.2','mg/1','Ergolines [CS], Ergot Derivative [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3656_8f10fadb-5d69-45b2-bc95-af8f6e346d39','0093-3656','HUMAN PRESCRIPTION DRUG','Buprenorphine','','Buprenorphine','PATCH, EXTENDED RELEASE','TRANSDERMAL','20181126','','ANDA','ANDA204937','Teva Pharmaceuticals USA, Inc.','BUPRENORPHINE','5','ug/h','Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]','CIII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3657_8f10fadb-5d69-45b2-bc95-af8f6e346d39','0093-3657','HUMAN PRESCRIPTION DRUG','Buprenorphine','','Buprenorphine','PATCH, EXTENDED RELEASE','TRANSDERMAL','20181126','','ANDA','ANDA204937','Teva Pharmaceuticals USA, Inc.','BUPRENORPHINE','10','ug/h','Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]','CIII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3658_8f10fadb-5d69-45b2-bc95-af8f6e346d39','0093-3658','HUMAN PRESCRIPTION DRUG','Buprenorphine','','Buprenorphine','PATCH, EXTENDED RELEASE','TRANSDERMAL','20181126','','ANDA','ANDA204937','Teva Pharmaceuticals USA, Inc.','BUPRENORPHINE','15','ug/h','Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]','CIII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3659_8f10fadb-5d69-45b2-bc95-af8f6e346d39','0093-3659','HUMAN PRESCRIPTION DRUG','Buprenorphine','','Buprenorphine','PATCH, EXTENDED RELEASE','TRANSDERMAL','20181126','','ANDA','ANDA204937','Teva Pharmaceuticals USA, Inc.','BUPRENORPHINE','20','ug/h','Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]','CIII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3727_e91c51e1-10a0-fb8f-e053-2a95a90a725e','0093-3727','HUMAN PRESCRIPTION DRUG','diclofenac epolamine','','diclofenac epolamine','SYSTEM','TOPICAL','20200501','','NDA AUTHORIZED GENERIC','NDA021234','Teva Pharmaceuticals USA Inc.','DICLOFENAC EPOLAMINE','0.013','g/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-3750_86ed4ffe-0f15-4e27-a0a7-8e6d58802194','0093-3750','HUMAN PRESCRIPTION DRUG','Tobramycin','','Tobramycin','SOLUTION','RESPIRATORY (INHALATION)','20200915','','ANDA','ANDA210915','Teva Pharmaceuticals USA, Inc.','TOBRAMYCIN','300','mg/4mL','Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-4000_42a53024-aa2f-483f-b91c-ac07ae2dca7f','0093-4000','HUMAN PRESCRIPTION DRUG','Vestura','','Drospirenone and Ethinyl Estradiol','KIT','','20210302','','ANDA','ANDA078833','Teva Pharmaceuticals USA, Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-4059_2c394dcd-12d1-4f3d-9696-dc737687b0cb','0093-4059','HUMAN PRESCRIPTION DRUG','Cefadroxil','','Cefadroxil','TABLET','ORAL','20070131','','ANDA','ANDA062774','Teva Pharmaceuticals USA, Inc.','CEFADROXIL','1000','mg/1','Cephalosporin Antibacterial [EPC], Cephalosporins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-4061_0ecd7fc0-7e29-4502-91ff-a0ead5a5a1f8','0093-4061','HUMAN PRESCRIPTION DRUG','Formoterol fumarate','','Formoterol fumarate','SOLUTION','RESPIRATORY (INHALATION)','20210622','','ANDA','ANDA091141','Teva Pharmaceuticals USA, Inc.','FORMOTEROL FUMARATE','20','ug/2mL','Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-4067_d4823dac-88af-46cc-95f0-4944d17ffd9f','0093-4067','HUMAN PRESCRIPTION DRUG','Prazosin Hydrochloride','','Prazosin Hydrochloride','CAPSULE','ORAL','20070222','','ANDA','ANDA071745','Teva Pharmaceuticals USA, Inc.','PRAZOSIN HYDROCHLORIDE','1','mg/1','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-4068_d4823dac-88af-46cc-95f0-4944d17ffd9f','0093-4068','HUMAN PRESCRIPTION DRUG','Prazosin Hydrochloride','','Prazosin Hydrochloride','CAPSULE','ORAL','20070222','','ANDA','ANDA071745','Teva Pharmaceuticals USA, Inc.','PRAZOSIN HYDROCHLORIDE','2','mg/1','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-4069_d4823dac-88af-46cc-95f0-4944d17ffd9f','0093-4069','HUMAN PRESCRIPTION DRUG','Prazosin Hydrochloride','','Prazosin Hydrochloride','CAPSULE','ORAL','20070118','','ANDA','ANDA071745','Teva Pharmaceuticals USA, Inc.','PRAZOSIN HYDROCHLORIDE','5','mg/1','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-4085_03a5b4ed-ea46-44a9-b33c-b9c08f3030fe','0093-4085','HUMAN PRESCRIPTION DRUG','Tobramycin','','Tobramycin','SOLUTION','RESPIRATORY (INHALATION)','20131119','','ANDA','ANDA091589','Teva Pharmaceuticals USA, Inc.','TOBRAMYCIN','300','mg/5mL','Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-4125_288bb7b9-69d7-452a-8c33-cd2b2ac63de8','0093-4125','HUMAN PRESCRIPTION DRUG','Penicillin V Potassium','','Penicillin V Potassium','POWDER, FOR SOLUTION','ORAL','19900930','','ANDA','ANDA060456','Teva Pharmaceuticals USA, Inc.','PENICILLIN V POTASSIUM','125','mg/5mL','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-4127_288bb7b9-69d7-452a-8c33-cd2b2ac63de8','0093-4127','HUMAN PRESCRIPTION DRUG','Penicillin V Potassium','','Penicillin V Potassium','POWDER, FOR SOLUTION','ORAL','19900930','','ANDA','ANDA060456','Teva Pharmaceuticals USA, Inc.','PENICILLIN V POTASSIUM','250','mg/5mL','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-4136_d2c15629-9e81-4a12-9d90-50e1ca6013af','0093-4136','HUMAN PRESCRIPTION DRUG','Cefdinir','','Cefdinir','POWDER, FOR SUSPENSION','ORAL','20070508','','ANDA','ANDA065332','Teva Pharmaceuticals USA, Inc.','CEFDINIR MONOHYDRATE','125','mg/5mL','Cephalosporin Antibacterial [EPC], Cephalosporins [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-4137_d2c15629-9e81-4a12-9d90-50e1ca6013af','0093-4137','HUMAN PRESCRIPTION DRUG','Cefdinir','','Cefdinir','POWDER, FOR SUSPENSION','ORAL','20070508','','ANDA','ANDA065332','Teva Pharmaceuticals USA, Inc.','CEFDINIR MONOHYDRATE','250','mg/5mL','Cephalosporin Antibacterial [EPC], Cephalosporins [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-4145_c4bbe9ea-2824-4b67-8557-830bbb80ba5d','0093-4145','HUMAN PRESCRIPTION DRUG','Levalbuterol','','Levalbuterol','SOLUTION','RESPIRATORY (INHALATION)','20130429','','ANDA','ANDA090297','Teva Pharmaceuticals USA, Inc.','LEVALBUTEROL HYDROCHLORIDE','0.31','mg/3mL','Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-4146_c4bbe9ea-2824-4b67-8557-830bbb80ba5d','0093-4146','HUMAN PRESCRIPTION DRUG','Levalbuterol','','Levalbuterol','SOLUTION','RESPIRATORY (INHALATION)','20130429','','ANDA','ANDA090297','Teva Pharmaceuticals USA, Inc.','LEVALBUTEROL HYDROCHLORIDE','0.63','mg/3mL','Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-4147_9991cb94-c878-4ec9-aacd-8a2534ac60c8','0093-4147','HUMAN PRESCRIPTION DRUG','Levalbuterol','','Levalbuterol','SOLUTION, CONCENTRATE','RESPIRATORY (INHALATION)','20141216','','ANDA','ANDA200875','Teva Pharmaceuticals USA, Inc.','LEVALBUTEROL HYDROCHLORIDE','1.25','mg/.5mL','Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-4148_c4bbe9ea-2824-4b67-8557-830bbb80ba5d','0093-4148','HUMAN PRESCRIPTION DRUG','Levalbuterol','','Levalbuterol','SOLUTION','RESPIRATORY (INHALATION)','20130429','','ANDA','ANDA090297','Teva Pharmaceuticals USA, Inc.','LEVALBUTEROL HYDROCHLORIDE','1.25','mg/3mL','Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-4155_bb81d117-eb9a-4043-94a9-da52ee047a8b','0093-4155','HUMAN PRESCRIPTION DRUG','Amoxicillin','','Amoxicillin','POWDER, FOR SUSPENSION','ORAL','19900930','','ANDA','ANDA061931','Teva Pharmaceuticals USA, Inc.','AMOXICILLIN','250','mg/5mL','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-4160_bb81d117-eb9a-4043-94a9-da52ee047a8b','0093-4160','HUMAN PRESCRIPTION DRUG','Amoxicillin','','Amoxicillin','POWDER, FOR SUSPENSION','ORAL','20030402','','ANDA','ANDA065119','Teva Pharmaceuticals USA, Inc.','AMOXICILLIN','200','mg/5mL','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-4161_bb81d117-eb9a-4043-94a9-da52ee047a8b','0093-4161','HUMAN PRESCRIPTION DRUG','Amoxicillin','','Amoxicillin','POWDER, FOR SUSPENSION','ORAL','20030226','','ANDA','ANDA065119','Teva Pharmaceuticals USA, Inc.','AMOXICILLIN','400','mg/5mL','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-4175_c75c0bb6-fe3e-43c6-bdde-edd904731795','0093-4175','HUMAN PRESCRIPTION DRUG','Cephalexin','','Cephalexin','POWDER, FOR SUSPENSION','ORAL','19900930','','ANDA','ANDA062703','Teva Pharmaceuticals USA, Inc.','CEPHALEXIN','125','mg/5mL','Cephalosporin Antibacterial [EPC], Cephalosporins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-4177_c75c0bb6-fe3e-43c6-bdde-edd904731795','0093-4177','HUMAN PRESCRIPTION DRUG','Cephalexin','','Cephalexin','POWDER, FOR SUSPENSION','ORAL','19900930','','ANDA','ANDA062703','Teva Pharmaceuticals USA, Inc.','CEPHALEXIN','250','mg/5mL','Cephalosporin Antibacterial [EPC], Cephalosporins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5002_8507a7e6-dd16-4064-8a4e-cb2d8fadea80','0093-5002','HUMAN PRESCRIPTION DRUG','Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide','','Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide','TABLET, FILM COATED','ORAL','20161114','','ANDA','ANDA202491','Teva Pharmaceuticals USA, Inc.','AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL','10; 25; 40','mg/1; mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5003_8507a7e6-dd16-4064-8a4e-cb2d8fadea80','0093-5003','HUMAN PRESCRIPTION DRUG','Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide','','Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide','TABLET, FILM COATED','ORAL','20161114','','ANDA','ANDA202491','Teva Pharmaceuticals USA, Inc.','AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL','10; 12.5; 40','mg/1; mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5004_8507a7e6-dd16-4064-8a4e-cb2d8fadea80','0093-5004','HUMAN PRESCRIPTION DRUG','Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide','','Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide','TABLET, FILM COATED','ORAL','20161114','','ANDA','ANDA202491','Teva Pharmaceuticals USA, Inc.','AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL','5; 25; 40','mg/1; mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5005_8507a7e6-dd16-4064-8a4e-cb2d8fadea80','0093-5005','HUMAN PRESCRIPTION DRUG','Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide','','Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide','TABLET, FILM COATED','ORAL','20161114','','ANDA','ANDA202491','Teva Pharmaceuticals USA, Inc.','AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL','5; 12.5; 20','mg/1; mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5006_8507a7e6-dd16-4064-8a4e-cb2d8fadea80','0093-5006','HUMAN PRESCRIPTION DRUG','Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide','','Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide','TABLET, FILM COATED','ORAL','20161114','','ANDA','ANDA202491','Teva Pharmaceuticals USA, Inc.','AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL','5; 12.5; 40','mg/1; mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5030_f43e8eb6-a411-4f73-830b-b7e1bce61b41','0093-5030','HUMAN PRESCRIPTION DRUG','Tiagabine Hydrochloride','','Tiagabine Hydrochloride','TABLET, FILM COATED','ORAL','20160603','','NDA AUTHORIZED GENERIC','NDA020646','Teva Pharmaceuticals USA, Inc.','TIAGABINE HYDROCHLORIDE','2','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5031_f43e8eb6-a411-4f73-830b-b7e1bce61b41','0093-5031','HUMAN PRESCRIPTION DRUG','Tiagabine Hydrochloride','','Tiagabine Hydrochloride','TABLET, FILM COATED','ORAL','20160603','','NDA AUTHORIZED GENERIC','NDA020646','Teva Pharmaceuticals USA, Inc.','TIAGABINE HYDROCHLORIDE','4','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5045_a85e649d-b286-40a5-96ce-081db2b03505','0093-5045','HUMAN PRESCRIPTION DRUG','Dexmethylphenidate Hydrochloride','','Dexmethylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20170705','','ANDA','ANDA202731','Teva Pharmaceuticals USA, Inc.','DEXMETHYLPHENIDATE HYDROCHLORIDE','25','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5046_a85e649d-b286-40a5-96ce-081db2b03505','0093-5046','HUMAN PRESCRIPTION DRUG','Dexmethylphenidate Hydrochloride','','Dexmethylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20170705','','ANDA','ANDA202731','Teva Pharmaceuticals USA, Inc.','DEXMETHYLPHENIDATE HYDROCHLORIDE','35','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5056_fa0c0b99-4d67-4f13-8d65-212871901227','0093-5056','HUMAN PRESCRIPTION DRUG','Atorvastatin Calcium','','Atorvastatin Calcium','TABLET, FILM COATED','ORAL','20170504','','ANDA','ANDA205300','Teva Pharmaceuticals USA, Inc.','ATORVASTATIN CALCIUM TRIHYDRATE','10','mg/1','HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5057_fa0c0b99-4d67-4f13-8d65-212871901227','0093-5057','HUMAN PRESCRIPTION DRUG','Atorvastatin Calcium','','Atorvastatin Calcium','TABLET, FILM COATED','ORAL','20170504','','ANDA','ANDA205300','Teva Pharmaceuticals USA, Inc.','ATORVASTATIN CALCIUM TRIHYDRATE','80','mg/1','HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5058_fa0c0b99-4d67-4f13-8d65-212871901227','0093-5058','HUMAN PRESCRIPTION DRUG','Atorvastatin Calcium','','Atorvastatin Calcium','TABLET, FILM COATED','ORAL','20170504','','ANDA','ANDA205300','Teva Pharmaceuticals USA, Inc.','ATORVASTATIN CALCIUM TRIHYDRATE','40','mg/1','HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5059_fa0c0b99-4d67-4f13-8d65-212871901227','0093-5059','HUMAN PRESCRIPTION DRUG','Atorvastatin Calcium','','Atorvastatin Calcium','TABLET, FILM COATED','ORAL','20170504','','ANDA','ANDA205300','Teva Pharmaceuticals USA, Inc.','ATORVASTATIN CALCIUM TRIHYDRATE','20','mg/1','HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5060_cce6c295-d186-4bff-8b05-a9e941623257','0093-5060','HUMAN PRESCRIPTION DRUG','Hydroxyzine Hydrochloride','','Hydroxyzine Hydrochloride','TABLET, FILM COATED','ORAL','20130219','','ANDA','ANDA088617','Teva Pharmaceuticals USA, Inc.','HYDROXYZINE DIHYDROCHLORIDE','10','mg/1','Antihistamine [EPC], Histamine Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5061_cce6c295-d186-4bff-8b05-a9e941623257','0093-5061','HUMAN PRESCRIPTION DRUG','Hydroxyzine Hydrochloride','','Hydroxyzine Hydrochloride','TABLET, FILM COATED','ORAL','20121009','','ANDA','ANDA088618','Teva Pharmaceuticals USA, Inc.','HYDROXYZINE DIHYDROCHLORIDE','25','mg/1','Antihistamine [EPC], Histamine Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5062_cce6c295-d186-4bff-8b05-a9e941623257','0093-5062','HUMAN PRESCRIPTION DRUG','Hydroxyzine Hydrochloride','','Hydroxyzine Hydrochloride','TABLET, FILM COATED','ORAL','20121022','','ANDA','ANDA088619','Teva Pharmaceuticals USA, Inc.','HYDROXYZINE DIHYDROCHLORIDE','50','mg/1','Antihistamine [EPC], Histamine Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5150_47bb5b1f-0ee0-469f-9fcc-fc3087b2e865','0093-5150','HUMAN PRESCRIPTION DRUG','Moexipril Hydrochloride','','Moexipril Hydrochloride','TABLET, FILM COATED','ORAL','20030508','','ANDA','ANDA076204','Teva Pharmaceuticals USA, Inc.','MOEXIPRIL HYDROCHLORIDE','15','mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5200_693fd871-7d24-4743-b402-fa1d0e839e6a','0093-5200','HUMAN PRESCRIPTION DRUG','Buspirone Hydrochloride','','Buspirone Hydrochloride','TABLET','ORAL','20040326','','ANDA','ANDA075022','Teva Pharmaceuticals USA, Inc.','BUSPIRONE HYDROCHLORIDE','30','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5234_0f30b19a-e509-464e-a83e-4e1499fd060c','0093-5234','HUMAN PRESCRIPTION DRUG','Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate','','Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate','TABLET, FILM COATED','ORAL','20201001','','ANDA','ANDA091215','Teva Pharmaceuticals USA, Inc.','EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE','600; 200; 300','mg/1; mg/1; mg/1','Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5245_a55a091b-2e1e-480a-aac1-3c9d9cc56dc2','0093-5245','HUMAN PRESCRIPTION DRUG','Olanzapine','','Olanzapine','TABLET, ORALLY DISINTEGRATING','ORAL','20120217','','ANDA','ANDA077243','Teva Pharmaceuticals USA, Inc.','OLANZAPINE','5','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5246_a55a091b-2e1e-480a-aac1-3c9d9cc56dc2','0093-5246','HUMAN PRESCRIPTION DRUG','Olanzapine','','Olanzapine','TABLET, ORALLY DISINTEGRATING','ORAL','20120217','','ANDA','ANDA077243','Teva Pharmaceuticals USA, Inc.','OLANZAPINE','10','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5247_a55a091b-2e1e-480a-aac1-3c9d9cc56dc2','0093-5247','HUMAN PRESCRIPTION DRUG','Olanzapine','','Olanzapine','TABLET, ORALLY DISINTEGRATING','ORAL','20120124','','ANDA','ANDA077243','Teva Pharmaceuticals USA, Inc.','OLANZAPINE','15','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5248_a55a091b-2e1e-480a-aac1-3c9d9cc56dc2','0093-5248','HUMAN PRESCRIPTION DRUG','Olanzapine','','Olanzapine','TABLET, ORALLY DISINTEGRATING','ORAL','20120124','','ANDA','ANDA077243','Teva Pharmaceuticals USA, Inc.','OLANZAPINE','20','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5260_3c9afddb-516b-43a3-9a28-9a3b3aca6340','0093-5260','HUMAN PRESCRIPTION DRUG','Almotriptan Malate','','Almotriptan Malate','TABLET, FILM COATED','ORAL','20150707','','ANDA','ANDA078027','Teva Pharmaceuticals USA, Inc.','ALMOTRIPTAN MALATE','6.25','mg/1','Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5261_3c9afddb-516b-43a3-9a28-9a3b3aca6340','0093-5261','HUMAN PRESCRIPTION DRUG','Almotriptan Malate','','Almotriptan Malate','TABLET, FILM COATED','ORAL','20150707','','ANDA','ANDA078027','Teva Pharmaceuticals USA, Inc.','ALMOTRIPTAN MALATE','12.5','mg/1','Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5262_7ccff84b-5001-4ae2-a651-e82c5ad07fe4','0093-5262','HUMAN PRESCRIPTION DRUG','Fluoxetine','','Fluoxetine','TABLET, FILM COATED','ORAL','20181213','20230531','ANDA','ANDA211051','Teva Pharmaceuticals USA, Inc.','FLUOXETINE HYDROCHLORIDE','60','mg/1','Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5292_cdbc33ef-8684-42b1-81bf-3e61b299f174','0093-5292','HUMAN PRESCRIPTION DRUG','Methylphenidate Hydrochloride','(CD)','Methylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20120927','','ANDA','ANDA078873','Teva Pharmaceuticals USA, Inc.','METHYLPHENIDATE HYDROCHLORIDE','50','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5293_cdbc33ef-8684-42b1-81bf-3e61b299f174','0093-5293','HUMAN PRESCRIPTION DRUG','Methylphenidate Hydrochloride','(CD)','Methylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20120927','','ANDA','ANDA078873','Teva Pharmaceuticals USA, Inc.','METHYLPHENIDATE HYDROCHLORIDE','60','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5295_cdbc33ef-8684-42b1-81bf-3e61b299f174','0093-5295','HUMAN PRESCRIPTION DRUG','Methylphenidate Hydrochloride','(CD)','Methylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20120927','','ANDA','ANDA077707','Teva Pharmaceuticals USA, Inc.','METHYLPHENIDATE HYDROCHLORIDE','10','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5296_cdbc33ef-8684-42b1-81bf-3e61b299f174','0093-5296','HUMAN PRESCRIPTION DRUG','Methylphenidate Hydrochloride','(CD)','Methylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20120927','','ANDA','ANDA077707','Teva Pharmaceuticals USA, Inc.','METHYLPHENIDATE HYDROCHLORIDE','20','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5297_cdbc33ef-8684-42b1-81bf-3e61b299f174','0093-5297','HUMAN PRESCRIPTION DRUG','Methylphenidate Hydrochloride','(CD)','Methylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20120927','','ANDA','ANDA077707','Teva Pharmaceuticals USA, Inc.','METHYLPHENIDATE HYDROCHLORIDE','30','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5298_cdbc33ef-8684-42b1-81bf-3e61b299f174','0093-5298','HUMAN PRESCRIPTION DRUG','Methylphenidate Hydrochloride','(CD)','Methylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20120927','','ANDA','ANDA078873','Teva Pharmaceuticals USA, Inc.','METHYLPHENIDATE HYDROCHLORIDE','40','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5328_8926360d-71a7-403d-bf86-608ffca92efb','0093-5328','HUMAN PRESCRIPTION DRUG','Junel Fe','24','Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate','KIT','','20150608','','ANDA','ANDA090938','Teva Pharmaceuticals USA, Inc.','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5341_44301615-f3ab-4456-9c91-81349cb8d1ea','0093-5341','HUMAN PRESCRIPTION DRUG','Sildenafil','','Sildenafil','TABLET, FILM COATED','ORAL','20171211','','ANDA','ANDA077342','Teva Pharmaceuticals USA, Inc.','SILDENAFIL CITRATE','25','mg/1','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5342_44301615-f3ab-4456-9c91-81349cb8d1ea','0093-5342','HUMAN PRESCRIPTION DRUG','Sildenafil','','Sildenafil','TABLET, FILM COATED','ORAL','20171211','','ANDA','ANDA077342','Teva Pharmaceuticals USA, Inc.','SILDENAFIL CITRATE','50','mg/1','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5343_44301615-f3ab-4456-9c91-81349cb8d1ea','0093-5343','HUMAN PRESCRIPTION DRUG','Sildenafil','','Sildenafil','TABLET, FILM COATED','ORAL','20171211','','ANDA','ANDA077342','Teva Pharmaceuticals USA, Inc.','SILDENAFIL CITRATE','100','mg/1','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5346_663ba889-95b5-45c2-af06-c90459d30d6d','0093-5346','HUMAN PRESCRIPTION DRUG','Methylphenidate Hydrochloride','(LA)','Methylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20120716','','ANDA','ANDA079031','Teva Pharmaceuticals USA, Inc.','METHYLPHENIDATE HYDROCHLORIDE','20','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5347_663ba889-95b5-45c2-af06-c90459d30d6d','0093-5347','HUMAN PRESCRIPTION DRUG','Methylphenidate Hydrochloride','(LA)','Methylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20120716','','ANDA','ANDA079031','Teva Pharmaceuticals USA, Inc.','METHYLPHENIDATE HYDROCHLORIDE','30','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5348_663ba889-95b5-45c2-af06-c90459d30d6d','0093-5348','HUMAN PRESCRIPTION DRUG','Methylphenidate Hydrochloride','(LA)','Methylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20120716','','ANDA','ANDA079031','Teva Pharmaceuticals USA, Inc.','METHYLPHENIDATE HYDROCHLORIDE','40','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5376_247ca285-2a0e-4afc-af76-e0065e28d3f3','0093-5376','HUMAN PRESCRIPTION DRUG','Clozapine','','Clozapine','TABLET, ORALLY DISINTEGRATING','ORAL','20200730','','ANDA','ANDA203039','Teva Pharmaceuticals USA, Inc.','CLOZAPINE','150','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5377_247ca285-2a0e-4afc-af76-e0065e28d3f3','0093-5377','HUMAN PRESCRIPTION DRUG','Clozapine','','Clozapine','TABLET, ORALLY DISINTEGRATING','ORAL','20200730','','ANDA','ANDA203039','Teva Pharmaceuticals USA, Inc.','CLOZAPINE','200','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5416_c6e500d6-78be-4ef1-a102-4f1681aef7b3','0093-5416','HUMAN PRESCRIPTION DRUG','Clozapine','','Clozapine','TABLET, ORALLY DISINTEGRATING','ORAL','20180417','','ANDA','ANDA090308','Teva Pharmaceuticals USA, Inc.','CLOZAPINE','12.5','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5417_c6e500d6-78be-4ef1-a102-4f1681aef7b3','0093-5417','HUMAN PRESCRIPTION DRUG','Clozapine','','Clozapine','TABLET, ORALLY DISINTEGRATING','ORAL','20170725','','ANDA','ANDA090308','Teva Pharmaceuticals USA, Inc.','CLOZAPINE','25','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5419_c6e500d6-78be-4ef1-a102-4f1681aef7b3','0093-5419','HUMAN PRESCRIPTION DRUG','Clozapine','','Clozapine','TABLET, ORALLY DISINTEGRATING','ORAL','20170725','','ANDA','ANDA090308','Teva Pharmaceuticals USA, Inc.','CLOZAPINE','100','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5420_cb353e73-33cb-4c45-8770-2ee2205abc85','0093-5420','HUMAN PRESCRIPTION DRUG','Cabergoline','','Cabergoline','TABLET','ORAL','20070307','','ANDA','ANDA077750','Teva Pharmaceuticals USA, Inc.','CABERGOLINE','0.5','mg/1','Ergolines [CS], Ergot Derivative [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5423_86b80f5a-a800-4c2c-b5ad-41b5fb0f15d5','0093-5423','HUMAN PRESCRIPTION DRUG','Gianvi','','Drospirenone and ethinyl estradiol','KIT','','20110330','20250331','NDA AUTHORIZED GENERIC','NDA021676','Teva Pharmaceuticals USA Inc','','','','','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5455_eedfb5dd-653b-455f-86ec-93ab76f187fd','0093-5455','HUMAN PRESCRIPTION DRUG','Mimvey','','Estradiol and Norethindrone Acetate','TABLET, FILM COATED','ORAL','20100602','','ANDA','ANDA079193','Teva Pharmaceuticals USA, Inc.','ESTRADIOL; NORETHINDRONE ACETATE','1; .5','mg/1; mg/1','Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5503_c5bdc2f8-6b55-4eae-911e-a065341d2585','0093-5503','HUMAN PRESCRIPTION DRUG','Olanzapine and Fluoxetine','','Olanzapine and Fluoxetine','CAPSULE','ORAL','20130410','','ANDA','ANDA202074','Teva Pharmaceuticals USA, Inc.','FLUOXETINE HYDROCHLORIDE; OLANZAPINE','25; 3','mg/1; mg/1','Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5504_c5bdc2f8-6b55-4eae-911e-a065341d2585','0093-5504','HUMAN PRESCRIPTION DRUG','Olanzapine and Fluoxetine','','Olanzapine and Fluoxetine','CAPSULE','ORAL','20120619','','ANDA','ANDA077528','Teva Pharmaceuticals USA, Inc.','FLUOXETINE HYDROCHLORIDE; OLANZAPINE','25; 6','mg/1; mg/1','Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5505_c5bdc2f8-6b55-4eae-911e-a065341d2585','0093-5505','HUMAN PRESCRIPTION DRUG','Olanzapine and Fluoxetine','','Olanzapine and Fluoxetine','CAPSULE','ORAL','20120619','','ANDA','ANDA077528','Teva Pharmaceuticals USA, Inc.','FLUOXETINE HYDROCHLORIDE; OLANZAPINE','50; 6','mg/1; mg/1','Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5506_c5bdc2f8-6b55-4eae-911e-a065341d2585','0093-5506','HUMAN PRESCRIPTION DRUG','Olanzapine and Fluoxetine','','Olanzapine and Fluoxetine','CAPSULE','ORAL','20120619','','ANDA','ANDA077528','Teva Pharmaceuticals USA, Inc.','FLUOXETINE HYDROCHLORIDE; OLANZAPINE','25; 12','mg/1; mg/1','Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5507_c5bdc2f8-6b55-4eae-911e-a065341d2585','0093-5507','HUMAN PRESCRIPTION DRUG','Olanzapine and Fluoxetine','','Olanzapine and Fluoxetine','CAPSULE','ORAL','20120619','','ANDA','ANDA077528','Teva Pharmaceuticals USA, Inc.','FLUOXETINE HYDROCHLORIDE; OLANZAPINE','50; 12','mg/1; mg/1','Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5517_7333aab6-b5ad-4345-b8dc-4c89676c7660','0093-5517','HUMAN PRESCRIPTION DRUG','Sildenafil','','Sildenafil','TABLET, FILM COATED','ORAL','20130531','','ANDA','ANDA078380','Teva Pharmaceuticals USA, Inc.','SILDENAFIL CITRATE','20','mg/1','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5526_73941d8f-10d9-4e99-8a9b-e5cb9cd0d489','0093-5526','HUMAN PRESCRIPTION DRUG','Atazanavir Sulfate','','Atazanavir Sulfate','CAPSULE','ORAL','20171227','','ANDA','ANDA091673','Teva Pharmaceuticals USA, Inc.','ATAZANAVIR SULFATE','150','mg/1','Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5527_73941d8f-10d9-4e99-8a9b-e5cb9cd0d489','0093-5527','HUMAN PRESCRIPTION DRUG','Atazanavir Sulfate','','Atazanavir Sulfate','CAPSULE','ORAL','20171227','','ANDA','ANDA091673','Teva Pharmaceuticals USA, Inc.','ATAZANAVIR SULFATE','200','mg/1','Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5528_73941d8f-10d9-4e99-8a9b-e5cb9cd0d489','0093-5528','HUMAN PRESCRIPTION DRUG','Atazanavir Sulfate','','Atazanavir Sulfate','CAPSULE','ORAL','20171227','','ANDA','ANDA091673','Teva Pharmaceuticals USA, Inc.','ATAZANAVIR SULFATE','300','mg/1','Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5537_359cf2e6-4461-4ebf-a542-06736029d9d0','0093-5537','HUMAN PRESCRIPTION DRUG','Eszopiclone','','Eszopiclone','TABLET, FILM COATED','ORAL','20140414','','ANDA','ANDA091169','Teva Pharmaceuticals USA, Inc.','ESZOPICLONE','1','mg/1','','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5538_359cf2e6-4461-4ebf-a542-06736029d9d0','0093-5538','HUMAN PRESCRIPTION DRUG','Eszopiclone','','Eszopiclone','TABLET, FILM COATED','ORAL','20140414','','ANDA','ANDA091169','Teva Pharmaceuticals USA, Inc.','ESZOPICLONE','2','mg/1','','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5539_359cf2e6-4461-4ebf-a542-06736029d9d0','0093-5539','HUMAN PRESCRIPTION DRUG','Eszopiclone','','Eszopiclone','TABLET, FILM COATED','ORAL','20140414','','ANDA','ANDA091169','Teva Pharmaceuticals USA, Inc.','ESZOPICLONE','3','mg/1','','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5550_a85e649d-b286-40a5-96ce-081db2b03505','0093-5550','HUMAN PRESCRIPTION DRUG','Dexmethylphenidate Hydrochloride','','Dexmethylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20141110','','ANDA','ANDA078908','Teva Pharmaceuticals USA, Inc.','DEXMETHYLPHENIDATE HYDROCHLORIDE','5','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5551_a85e649d-b286-40a5-96ce-081db2b03505','0093-5551','HUMAN PRESCRIPTION DRUG','Dexmethylphenidate Hydrochloride','','Dexmethylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20150202','','ANDA','ANDA078908','Teva Pharmaceuticals USA, Inc.','DEXMETHYLPHENIDATE HYDROCHLORIDE','10','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5552_a85e649d-b286-40a5-96ce-081db2b03505','0093-5552','HUMAN PRESCRIPTION DRUG','Dexmethylphenidate Hydrochloride','','Dexmethylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20140521','','ANDA','ANDA078908','Teva Pharmaceuticals USA, Inc.','DEXMETHYLPHENIDATE HYDROCHLORIDE','15','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5553_a85e649d-b286-40a5-96ce-081db2b03505','0093-5553','HUMAN PRESCRIPTION DRUG','Dexmethylphenidate Hydrochloride','','Dexmethylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20150622','','ANDA','ANDA078908','Teva Pharmaceuticals USA, Inc.','DEXMETHYLPHENIDATE HYDROCHLORIDE','20','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5554_a85e649d-b286-40a5-96ce-081db2b03505','0093-5554','HUMAN PRESCRIPTION DRUG','Dexmethylphenidate Hydrochloride','','Dexmethylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20140522','','ANDA','ANDA202731','Teva Pharmaceuticals USA, Inc.','DEXMETHYLPHENIDATE HYDROCHLORIDE','30','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5562_a85e649d-b286-40a5-96ce-081db2b03505','0093-5562','HUMAN PRESCRIPTION DRUG','Dexmethylphenidate Hydrochloride','','Dexmethylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20131121','','ANDA','ANDA202731','Teva Pharmaceuticals USA, Inc.','DEXMETHYLPHENIDATE HYDROCHLORIDE','40','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5571_ae45bc79-d364-47fb-ba1e-b6204757d7aa','0093-5571','HUMAN PRESCRIPTION DRUG','Erythromycin','','Erythromycin','TABLET, FILM COATED','ORAL','20210504','','ANDA','ANDA214549','Teva Pharmaceuticals USA, Inc.','ERYTHROMYCIN','250','mg/1','Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5572_ae45bc79-d364-47fb-ba1e-b6204757d7aa','0093-5572','HUMAN PRESCRIPTION DRUG','Erythromycin','','Erythromycin','TABLET, FILM COATED','ORAL','20210504','','ANDA','ANDA214549','Teva Pharmaceuticals USA, Inc.','ERYTHROMYCIN','500','mg/1','Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5731_7331dcb7-b48a-4c89-91fc-9119a4af0aa6','0093-5731','HUMAN PRESCRIPTION DRUG','Oxycodone Hydrochloride','','Oxycodone Hydrochloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20151012','20241231','NDA AUTHORIZED GENERIC','NDA022272','Teva Pharmaceuticals USA, Inc.','OXYCODONE HYDROCHLORIDE','10','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5732_7331dcb7-b48a-4c89-91fc-9119a4af0aa6','0093-5732','HUMAN PRESCRIPTION DRUG','Oxycodone Hydrochloride','','Oxycodone Hydrochloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20151012','20241231','NDA AUTHORIZED GENERIC','NDA022272','Teva Pharmaceuticals USA, Inc.','OXYCODONE HYDROCHLORIDE','20','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5733_7331dcb7-b48a-4c89-91fc-9119a4af0aa6','0093-5733','HUMAN PRESCRIPTION DRUG','Oxycodone Hydrochloride','','Oxycodone Hydrochloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20151014','20250131','NDA AUTHORIZED GENERIC','NDA022272','Teva Pharmaceuticals USA, Inc.','OXYCODONE HYDROCHLORIDE','40','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5734_7331dcb7-b48a-4c89-91fc-9119a4af0aa6','0093-5734','HUMAN PRESCRIPTION DRUG','Oxycodone Hydrochloride','','Oxycodone Hydrochloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20151014','20250131','NDA AUTHORIZED GENERIC','NDA022272','Teva Pharmaceuticals USA, Inc.','OXYCODONE HYDROCHLORIDE','80','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5907_b533e378-1ae4-4110-9de6-10a94f325b16','0093-5907','HUMAN PRESCRIPTION DRUG','Mesalamine','','Mesalamine','CAPSULE, DELAYED RELEASE','ORAL','20190509','','ANDA','ANDA207873','Teva Pharmaceuticals USA, Inc.','MESALAMINE','400','mg/1','Aminosalicylate [EPC], Aminosalicylic Acids [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5938_8163ce67-12e4-4d55-840c-2036521e1826','0093-5938','HUMAN PRESCRIPTION DRUG','Lanthanum carbonate','','Lanthanum carbonate','TABLET, CHEWABLE','ORAL','20220525','','ANDA','ANDA090977','Teva Pharmaceuticals USA, Inc.','LANTHANUM CARBONATE','500','mg/1','Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5939_8163ce67-12e4-4d55-840c-2036521e1826','0093-5939','HUMAN PRESCRIPTION DRUG','Lanthanum carbonate','','Lanthanum carbonate','TABLET, CHEWABLE','ORAL','20220525','','ANDA','ANDA090977','Teva Pharmaceuticals USA, Inc.','LANTHANUM CARBONATE','750','mg/1','Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5940_8163ce67-12e4-4d55-840c-2036521e1826','0093-5940','HUMAN PRESCRIPTION DRUG','Lanthanum carbonate','','Lanthanum carbonate','TABLET, CHEWABLE','ORAL','20220525','','ANDA','ANDA090977','Teva Pharmaceuticals USA, Inc.','LANTHANUM CARBONATE','1000','mg/1','Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5955_98de9422-52ec-42d8-b4c4-f3ad3b11460f','0093-5955','HUMAN PRESCRIPTION DRUG','Arformoterol tartrate','','Arformoterol tartrate','SOLUTION','RESPIRATORY (INHALATION)','20211206','','ANDA','ANDA200293','Teva Pharmaceuticals USA, Inc.','ARFORMOTEROL TARTRATE','15','ug/2mL','Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5985_f96bd477-2239-4453-aaa4-e20d16c6e49e','0093-5985','HUMAN PRESCRIPTION DRUG','Epinephrine','','Epinephrine','INJECTION','INTRAMUSCULAR; SUBCUTANEOUS','20190819','','ANDA','ANDA090589','Teva Pharmaceuticals USA, Inc.','EPINEPHRINE','0.15','mg/.3mL','Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-5986_f96bd477-2239-4453-aaa4-e20d16c6e49e','0093-5986','HUMAN PRESCRIPTION DRUG','Epinephrine','','Epinephrine','INJECTION','INTRAMUSCULAR; SUBCUTANEOUS','20181127','','ANDA','ANDA090589','Teva Pharmaceuticals USA, Inc.','EPINEPHRINE','0.3','mg/.3mL','Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-6031_b478920e-f929-4c2b-a013-de61baa3bfc3','0093-6031','HUMAN PRESCRIPTION DRUG','Rivelsa','','Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol','KIT','','20170403','','NDA AUTHORIZED GENERIC','NDA204061','Teva Pharmaceuticals USA, Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-6148_7ba6f689-ece9-4fd3-9360-a764b2da86c2','0093-6148','HUMAN PRESCRIPTION DRUG','camrese Lo','','Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol','KIT','','20111207','','NDA AUTHORIZED GENERIC','NDA022262','Teva Pharmaceuticals USA, Inc.','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-6303_f82cf147-67cb-4716-a9a4-a5e9cd8fdbf9','0093-6303','HUMAN PRESCRIPTION DRUG','adapalene and benzoyl peroxide','','adapalene and benzoyl peroxide','GEL','TOPICAL','20211201','20240131','NDA AUTHORIZED GENERIC','NDA207917','TEVA PHARMACEUTICALS USA, INC','ADAPALENE; BENZOYL PEROXIDE','3; 25','mg/g; mg/g','Retinoid [EPC], Retinoids [CS]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-6450_1f9c3fef-e926-4b18-9935-4df699ebb76e','0093-6450','HUMAN PRESCRIPTION DRUG','Esomeprazole Magnesium','','Esomeprazole Magnesium','CAPSULE, DELAYED RELEASE','ORAL','20150217','','ANDA','ANDA078003','Teva Pharmaceuticals USA, Inc.','ESOMEPRAZOLE MAGNESIUM DIHYDRATE','20','mg/1','Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-6451_1f9c3fef-e926-4b18-9935-4df699ebb76e','0093-6451','HUMAN PRESCRIPTION DRUG','Esomeprazole Magnesium','','Esomeprazole Magnesium','CAPSULE, DELAYED RELEASE','ORAL','20150217','','ANDA','ANDA078003','Teva Pharmaceuticals USA, Inc.','ESOMEPRAZOLE MAGNESIUM DIHYDRATE','40','mg/1','Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-6815_551a929a-3517-4e58-9df6-f9bfb0f2f3be','0093-6815','HUMAN PRESCRIPTION DRUG','Budesonide','','Budesonide','SUSPENSION','RESPIRATORY (INHALATION)','20190111','','ANDA','ANDA077519','Teva Pharmaceuticals USA, Inc.','BUDESONIDE','0.25','mg/2mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-6815_c51e584e-be7e-4807-aa09-ef3eca459a2f','0093-6815','HUMAN PRESCRIPTION DRUG','Budesonide','','Budesonide','SUSPENSION','RESPIRATORY (INHALATION)','20081119','','ANDA','ANDA077519','Teva Pharmaceuticals USA, Inc.','BUDESONIDE','0.25','mg/2mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-6816_551a929a-3517-4e58-9df6-f9bfb0f2f3be','0093-6816','HUMAN PRESCRIPTION DRUG','Budesonide','','Budesonide','SUSPENSION','RESPIRATORY (INHALATION)','20190111','','ANDA','ANDA077519','Teva Pharmaceuticals USA, Inc.','BUDESONIDE','0.5','mg/2mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-6816_c51e584e-be7e-4807-aa09-ef3eca459a2f','0093-6816','HUMAN PRESCRIPTION DRUG','Budesonide','','Budesonide','SUSPENSION','RESPIRATORY (INHALATION)','20081119','','ANDA','ANDA077519','Teva Pharmaceuticals USA, Inc.','BUDESONIDE','0.5','mg/2mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-6817_e505244f-d53f-4dc0-acd7-45dc98034b97','0093-6817','HUMAN PRESCRIPTION DRUG','Budesonide','','Budesonide','SUSPENSION','RESPIRATORY (INHALATION)','20160311','','ANDA','ANDA204548','Teva Pharmaceuticals USA, Inc.','BUDESONIDE','1','mg/2mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7113_810dfc46-2484-4215-83d7-c683495a18c5','0093-7113','HUMAN PRESCRIPTION DRUG','Nefazodone Hydrochloride','','Nefazodone Hydrochloride','TABLET','ORAL','20030916','','ANDA','ANDA076037','Teva Pharmaceuticals USA, Inc.','NEFAZODONE HYDROCHLORIDE','150','mg/1','Serotonin Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7163_52c595f5-a265-479b-a7bb-086703e2bbe7','0093-7163','HUMAN PRESCRIPTION DRUG','Tolterodine Tartrate','','Tolterodine Tartrate','CAPSULE, EXTENDED RELEASE','ORAL','20170320','','ANDA','ANDA079141','Teva Pharmaceuticals USA, Inc.','TOLTERODINE TARTRATE','2','mg/1','Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7164_52c595f5-a265-479b-a7bb-086703e2bbe7','0093-7164','HUMAN PRESCRIPTION DRUG','Tolterodine Tartrate','','Tolterodine Tartrate','CAPSULE, EXTENDED RELEASE','ORAL','20170320','','ANDA','ANDA079141','Teva Pharmaceuticals USA, Inc.','TOLTERODINE TARTRATE','4','mg/1','Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7165_6fff9b26-6a00-4968-b7c8-d7b33f6915f4','0093-7165','HUMAN PRESCRIPTION DRUG','Celecoxib','','Celecoxib','CAPSULE','ORAL','20141210','','ANDA','ANDA076898','Teva Pharmaceuticals USA, Inc.','CELECOXIB','100','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7166_6fff9b26-6a00-4968-b7c8-d7b33f6915f4','0093-7166','HUMAN PRESCRIPTION DRUG','Celecoxib','','Celecoxib','CAPSULE','ORAL','20141210','','ANDA','ANDA076898','Teva Pharmaceuticals USA, Inc.','CELECOXIB','200','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7170_6fff9b26-6a00-4968-b7c8-d7b33f6915f4','0093-7170','HUMAN PRESCRIPTION DRUG','Celecoxib','','Celecoxib','CAPSULE','ORAL','20141210','','ANDA','ANDA076898','Teva Pharmaceuticals USA, Inc.','CELECOXIB','400','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7172_e96eb1a8-49e6-40e3-8e3f-66977e80e92d','0093-7172','HUMAN PRESCRIPTION DRUG','Etodolac','','Etodolac','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20000811','','ANDA','ANDA075665','Teva Pharmaceuticals USA, Inc.','ETODOLAC','500','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7178_810dfc46-2484-4215-83d7-c683495a18c5','0093-7178','HUMAN PRESCRIPTION DRUG','Nefazodone Hydrochloride','','Nefazodone Hydrochloride','TABLET','ORAL','20030916','','ANDA','ANDA076037','Teva Pharmaceuticals USA, Inc.','NEFAZODONE HYDROCHLORIDE','50','mg/1','Serotonin Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7188_36f18cc3-526a-4448-a4fb-803303acd103','0093-7188','HUMAN PRESCRIPTION DRUG','Fluoxetine','','Fluoxetine','TABLET, FILM COATED','ORAL','20020130','20230531','ANDA','ANDA075872','Teva Pharmaceuticals USA, Inc.','FLUOXETINE HYDROCHLORIDE','10','mg/1','Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7198_d946d01f-056d-4efb-9726-b8de323291bb','0093-7198','HUMAN PRESCRIPTION DRUG','Fluoxetine','','Fluoxetine','CAPSULE','ORAL','20020130','','ANDA','ANDA075452','Teva Pharmaceuticals USA, Inc.','FLUOXETINE HYDROCHLORIDE','40','mg/1','Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7201_29e8a7d8-9b93-44cb-b16c-0349d1552434','0093-7201','HUMAN PRESCRIPTION DRUG','Pravastatin Sodium','','Pravastatin Sodium','TABLET','ORAL','20060425','','ANDA','ANDA076056','Teva Pharmaceuticals USA, Inc.','PRAVASTATIN SODIUM','20','mg/1','HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7202_29e8a7d8-9b93-44cb-b16c-0349d1552434','0093-7202','HUMAN PRESCRIPTION DRUG','Pravastatin Sodium','','Pravastatin Sodium','TABLET','ORAL','20060425','','ANDA','ANDA076056','Teva Pharmaceuticals USA, Inc.','PRAVASTATIN SODIUM','40','mg/1','HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7270_4435de1d-cdee-4936-988c-9ca837ec6835','0093-7270','HUMAN PRESCRIPTION DRUG','Pravastatin Sodium','','Pravastatin Sodium','TABLET','ORAL','20080929','','ANDA','ANDA077793','Teva Pharmaceuticals USA, Inc.','PRAVASTATIN SODIUM','80','mg/1','HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7271_b5d757a4-7f61-4f9d-bd2a-0ebf9892398d','0093-7271','HUMAN PRESCRIPTION DRUG','Pioglitazone','','Pioglitazone','TABLET','ORAL','20150204','','ANDA','ANDA077210','Teva Pharmaceuticals USA, Inc.','PIOGLITAZONE HYDROCHLORIDE','15','mg/1','PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7272_b5d757a4-7f61-4f9d-bd2a-0ebf9892398d','0093-7272','HUMAN PRESCRIPTION DRUG','Pioglitazone','','Pioglitazone','TABLET','ORAL','20150204','','ANDA','ANDA077210','Teva Pharmaceuticals USA, Inc.','PIOGLITAZONE HYDROCHLORIDE','30','mg/1','PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7273_b5d757a4-7f61-4f9d-bd2a-0ebf9892398d','0093-7273','HUMAN PRESCRIPTION DRUG','Pioglitazone','','Pioglitazone','TABLET','ORAL','20150522','','ANDA','ANDA077210','Teva Pharmaceuticals USA, Inc.','PIOGLITAZONE HYDROCHLORIDE','45','mg/1','PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7290_3641edbc-4bae-45d0-8afb-8db02f401f66','0093-7290','HUMAN PRESCRIPTION DRUG','Raloxifene Hydrochloride','','Raloxifene Hydrochloride','TABLET, FILM COATED','ORAL','20140328','','ANDA','ANDA078193','Teva Pharmaceuticals USA, Inc.','RALOXIFENE HYDROCHLORIDE','60','mg/1','Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7295_a369c0d5-8f93-4b0d-a5a0-8125af1309f7','0093-7295','HUMAN PRESCRIPTION DRUG','Carvedilol','','Carvedilol','TABLET, FILM COATED','ORAL','20070906','','ANDA','ANDA076373','Teva Pharmaceuticals USA, Inc.','CARVEDILOL','12.5','mg/1','Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7296_a369c0d5-8f93-4b0d-a5a0-8125af1309f7','0093-7296','HUMAN PRESCRIPTION DRUG','Carvedilol','','Carvedilol','TABLET, FILM COATED','ORAL','20070906','','ANDA','ANDA076373','Teva Pharmaceuticals USA, Inc.','CARVEDILOL','25','mg/1','Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7306_6fff9b26-6a00-4968-b7c8-d7b33f6915f4','0093-7306','HUMAN PRESCRIPTION DRUG','Celecoxib','','Celecoxib','CAPSULE','ORAL','20141210','','ANDA','ANDA076898','Teva Pharmaceuticals USA, Inc.','CELECOXIB','50','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7314_a9df5ba4-ab12-4f72-9264-a1f7f377e35b','0093-7314','HUMAN PRESCRIPTION DRUG','Clopidogrel','','Clopidogrel','TABLET, FILM COATED','ORAL','20120517','','ANDA','ANDA076999','Teva Pharmaceuticals USA, Inc.','CLOPIDOGREL BISULFATE','75','mg/1','Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7334_e135ee8a-6e37-4be3-8f6a-4b1dbfce830f','0093-7334','HUMAN PRESCRIPTION DRUG','Mycophenolate Mofetil','','Mycophenolate Mofetil','CAPSULE','ORAL','20090506','','ANDA','ANDA065491','Teva Pharmaceuticals USA, Inc.','MYCOPHENOLATE MOFETIL','250','mg/1','Antimetabolite Immunosuppressant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7335_da6731ca-e37e-4727-bc67-acd9d6625cbb','0093-7335','HUMAN PRESCRIPTION DRUG','Topiramate','','Topiramate','CAPSULE, COATED PELLETS','ORAL','20090417','','ANDA','ANDA076575','Teva Pharmaceuticals USA, Inc.','TOPIRAMATE','15','mg/1','Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7336_da6731ca-e37e-4727-bc67-acd9d6625cbb','0093-7336','HUMAN PRESCRIPTION DRUG','Topiramate','','Topiramate','CAPSULE, COATED PELLETS','ORAL','20090417','','ANDA','ANDA076575','Teva Pharmaceuticals USA, Inc.','TOPIRAMATE','25','mg/1','Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7350_cff4a734-b698-4be2-88f2-058914575919','0093-7350','HUMAN PRESCRIPTION DRUG','Lansoprazole','','Lansoprazole','CAPSULE, DELAYED RELEASE','ORAL','20091111','','ANDA','ANDA077255','Teva Pharmaceuticals USA, Inc.','LANSOPRAZOLE','15','mg/1','Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7351_cff4a734-b698-4be2-88f2-058914575919','0093-7351','HUMAN PRESCRIPTION DRUG','Lansoprazole','','Lansoprazole','CAPSULE, DELAYED RELEASE','ORAL','20091111','','ANDA','ANDA077255','Teva Pharmaceuticals USA, Inc.','LANSOPRAZOLE','30','mg/1','Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7352_ffd12b6d-fd6c-43df-9c30-e72ead74a903','0093-7352','HUMAN PRESCRIPTION DRUG','Calcitriol','','Calcitriol','CAPSULE, LIQUID FILLED','ORAL','20160825','','ANDA','ANDA075765','Teva Pharmaceuticals USA, Inc.','CALCITRIOL','0.25','ug/1','Cholecalciferol [CS], Vitamin D3 Analog [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7353_ffd12b6d-fd6c-43df-9c30-e72ead74a903','0093-7353','HUMAN PRESCRIPTION DRUG','Calcitriol','','Calcitriol','CAPSULE, LIQUID FILLED','ORAL','20160701','','ANDA','ANDA075765','Teva Pharmaceuticals USA, Inc.','CALCITRIOL','0.5','ug/1','Cholecalciferol [CS], Vitamin D3 Analog [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7355_e0e9be8c-8610-4630-8676-8b2ab8d7ee3a','0093-7355','HUMAN PRESCRIPTION DRUG','Finasteride','','Finasteride','TABLET, FILM COATED','ORAL','20061215','','ANDA','ANDA076511','Teva Pharmaceuticals USA, Inc.','FINASTERIDE','5','mg/1','5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7367_f6708dca-eace-4b42-95f8-04bf90e8847b','0093-7367','HUMAN PRESCRIPTION DRUG','Losartan Potassium and Hydrochlorothiazide','','Losartan Potassium and Hydrochlorothiazide','TABLET, FILM COATED','ORAL','20100406','','ANDA','ANDA077157','Teva Pharmaceuticals USA, Inc.','HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM','12.5; 50','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7368_f6708dca-eace-4b42-95f8-04bf90e8847b','0093-7368','HUMAN PRESCRIPTION DRUG','Losartan Potassium and Hydrochlorothiazide','','Losartan Potassium and Hydrochlorothiazide','TABLET, FILM COATED','ORAL','20100406','','ANDA','ANDA077157','Teva Pharmaceuticals USA, Inc.','HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM','25; 100','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7369_f6708dca-eace-4b42-95f8-04bf90e8847b','0093-7369','HUMAN PRESCRIPTION DRUG','Losartan Potassium and Hydrochlorothiazide','','Losartan Potassium and Hydrochlorothiazide','TABLET, FILM COATED','ORAL','20100406','','ANDA','ANDA077157','Teva Pharmaceuticals USA, Inc.','HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM','12.5; 100','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7384_79d62d73-0002-4826-8ef3-d9872d14aa4c','0093-7384','HUMAN PRESCRIPTION DRUG','Venlafaxine Hydrochloride','','Venlafaxine Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20100701','','ANDA','ANDA076565','Teva Pharmaceuticals USA, Inc.','VENLAFAXINE HYDROCHLORIDE','37.5','mg/1','Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7385_79d62d73-0002-4826-8ef3-d9872d14aa4c','0093-7385','HUMAN PRESCRIPTION DRUG','Venlafaxine Hydrochloride','','Venlafaxine Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20100701','','ANDA','ANDA076565','Teva Pharmaceuticals USA, Inc.','VENLAFAXINE HYDROCHLORIDE','75','mg/1','Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7386_79d62d73-0002-4826-8ef3-d9872d14aa4c','0093-7386','HUMAN PRESCRIPTION DRUG','Venlafaxine Hydrochloride','','Venlafaxine Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20100701','','ANDA','ANDA076565','Teva Pharmaceuticals USA, Inc.','VENLAFAXINE HYDROCHLORIDE','150','mg/1','Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7387_4629423b-1b57-457c-8ae8-a8818389170b','0093-7387','HUMAN PRESCRIPTION DRUG','Moxifloxacin Hydrochloride','','Moxifloxacin Hydrochloride','TABLET, FILM COATED','ORAL','20140219','','ANDA','ANDA077437','Teva Pharmaceuticals USA, Inc.','MOXIFLOXACIN HYDROCHLORIDE','400','mg/1','Quinolone Antimicrobial [EPC], Quinolones [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7442_d188d01d-b6d2-4281-b7c3-2fc3479a5288','0093-7442','HUMAN PRESCRIPTION DRUG','Fluvastatin','','Fluvastatin','CAPSULE','ORAL','20120705','','ANDA','ANDA078407','Teva Pharmaceuticals USA, Inc.','FLUVASTATIN SODIUM','20','mg/1','HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7443_d188d01d-b6d2-4281-b7c3-2fc3479a5288','0093-7443','HUMAN PRESCRIPTION DRUG','Fluvastatin','','Fluvastatin','CAPSULE','ORAL','20120705','','ANDA','ANDA078407','Teva Pharmaceuticals USA, Inc.','FLUVASTATIN SODIUM','40','mg/1','HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7446_a962cd67-2b8a-4d30-aa2b-1ce0b2307346','0093-7446','HUMAN PRESCRIPTION DRUG','Fluvastatin Sodium','','Fluvastatin Sodium','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20160602','','ANDA','ANDA079011','Teva Pharmaceuticals USA, Inc.','FLUVASTATIN SODIUM','80','mg/1','HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7455_50580ebe-be6b-439b-a39d-6536b9125fc1','0093-7455','HUMAN PRESCRIPTION DRUG','Glipizide and Metformin Hydrochloride','','Glipizide and Metformin Hydrochloride','TABLET, FILM COATED','ORAL','20051028','','ANDA','ANDA077270','Teva Pharmaceuticals USA, Inc.','GLIPIZIDE; METFORMIN HYDROCHLORIDE','2.5; 250','mg/1; mg/1','Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7456_50580ebe-be6b-439b-a39d-6536b9125fc1','0093-7456','HUMAN PRESCRIPTION DRUG','Glipizide and Metformin Hydrochloride','','Glipizide and Metformin Hydrochloride','TABLET, FILM COATED','ORAL','20051028','','ANDA','ANDA077270','Teva Pharmaceuticals USA, Inc.','GLIPIZIDE; METFORMIN HYDROCHLORIDE','2.5; 500','mg/1; mg/1','Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7457_50580ebe-be6b-439b-a39d-6536b9125fc1','0093-7457','HUMAN PRESCRIPTION DRUG','Glipizide and Metformin Hydrochloride','','Glipizide and Metformin Hydrochloride','TABLET, FILM COATED','ORAL','20051028','','ANDA','ANDA077270','Teva Pharmaceuticals USA, Inc.','GLIPIZIDE; METFORMIN HYDROCHLORIDE','5; 500','mg/1; mg/1','Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7471_63dc74cd-a3d8-496c-8a3d-ed686a4b4e14','0093-7471','HUMAN PRESCRIPTION DRUG','Rizatriptan Benzoate','','Rizatriptan Benzoate','TABLET','ORAL','20130212','','ANDA','ANDA077263','Teva Pharmaceuticals USA, Inc.','RIZATRIPTAN BENZOATE','5','mg/1','Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7472_63dc74cd-a3d8-496c-8a3d-ed686a4b4e14','0093-7472','HUMAN PRESCRIPTION DRUG','Rizatriptan Benzoate','','Rizatriptan Benzoate','TABLET','ORAL','20130212','','ANDA','ANDA077263','Teva Pharmaceuticals USA, Inc.','RIZATRIPTAN BENZOATE','10','mg/1','Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7473_a37697f4-c9a0-4309-a304-bf69c51d51b5','0093-7473','HUMAN PRESCRIPTION DRUG','Capecitabine','','Capecitabine','TABLET, FILM COATED','ORAL','20140307','','ANDA','ANDA091649','Teva Pharmaceuticals USA, Inc.','CAPECITABINE','150','mg/1','Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7474_a37697f4-c9a0-4309-a304-bf69c51d51b5','0093-7474','HUMAN PRESCRIPTION DRUG','Capecitabine','','Capecitabine','TABLET, FILM COATED','ORAL','20140307','','ANDA','ANDA091649','Teva Pharmaceuticals USA, Inc.','CAPECITABINE','500','mg/1','Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7487_e439ab83-caf7-4853-981d-e648277733b3','0093-7487','HUMAN PRESCRIPTION DRUG','Montelukast Sodium','','Montelukast Sodium','GRANULE','ORAL','20171213','','ANDA','ANDA090955','Teva Pharmaceuticals USA, Inc.','MONTELUKAST SODIUM','4','mg/1','Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7516_2c0a7e7d-224f-4fd8-abf1-05f65fb12f5b','0093-7516','HUMAN PRESCRIPTION DRUG','fluticasone propionate and salmeterol','','fluticasone propionate and salmeterol','POWDER','RESPIRATORY (INHALATION)','20220323','','ANDA','ANDA213948','Teva Pharmaceuticals USA, Inc.','FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE','500; 50','ug/1; ug/1','Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7517_2c0a7e7d-224f-4fd8-abf1-05f65fb12f5b','0093-7517','HUMAN PRESCRIPTION DRUG','fluticasone propionate and salmeterol','','fluticasone propionate and salmeterol','POWDER','RESPIRATORY (INHALATION)','20220323','','ANDA','ANDA213948','Teva Pharmaceuticals USA, Inc.','FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE','100; 50','ug/1; ug/1','Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7518_2c0a7e7d-224f-4fd8-abf1-05f65fb12f5b','0093-7518','HUMAN PRESCRIPTION DRUG','fluticasone propionate and salmeterol','','fluticasone propionate and salmeterol','POWDER','RESPIRATORY (INHALATION)','20220323','','ANDA','ANDA213948','Teva Pharmaceuticals USA, Inc.','FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE','250; 50','ug/1; ug/1','Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7536_1ca18241-558c-4e09-b858-64b6e678be16','0093-7536','HUMAN PRESCRIPTION DRUG','Anastrozole','','Anastrozole','TABLET, FILM COATED','ORAL','20100628','','ANDA','ANDA078058','Teva Pharmaceuticals USA, Inc.','ANASTROZOLE','1','mg/1','Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7620_df8747c3-d774-467b-a861-6430ac1d568a','0093-7620','HUMAN PRESCRIPTION DRUG','Letrozole','','Letrozole','TABLET, FILM COATED','ORAL','20110603','','ANDA','ANDA090289','Teva Pharmaceuticals USA, Inc.','LETROZOLE','2.5','mg/1','Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7629_0f0cb35d-1de1-4031-bfbf-5773fe33ebbe','0093-7629','HUMAN PRESCRIPTION DRUG','Imatinib Mesylate','','Imatinib Mesylate','TABLET, FILM COATED','ORAL','20160804','','ANDA','ANDA204285','Teva Pharmaceuticals USA, Inc.','IMATINIB MESYLATE','100','mg/1','Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7630_0f0cb35d-1de1-4031-bfbf-5773fe33ebbe','0093-7630','HUMAN PRESCRIPTION DRUG','Imatinib Mesylate','','Imatinib Mesylate','TABLET, FILM COATED','ORAL','20160804','','ANDA','ANDA204285','Teva Pharmaceuticals USA, Inc.','IMATINIB MESYLATE','400','mg/1','Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7652_1e8c8eb3-da00-4bb0-b086-fefea38d2c58','0093-7652','HUMAN PRESCRIPTION DRUG','Vardenafil Hydrochloride','','Vardenafil Hydrochloride','TABLET, FILM COATED','ORAL','20190103','','ANDA','ANDA091347','Teva Pharmaceuticals USA, Inc.','VARDENAFIL HYDROCHLORIDE','2.5','mg/1','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7653_1e8c8eb3-da00-4bb0-b086-fefea38d2c58','0093-7653','HUMAN PRESCRIPTION DRUG','Vardenafil Hydrochloride','','Vardenafil Hydrochloride','TABLET, FILM COATED','ORAL','20190103','','ANDA','ANDA091347','Teva Pharmaceuticals USA, Inc.','VARDENAFIL HYDROCHLORIDE','5','mg/1','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7654_1e8c8eb3-da00-4bb0-b086-fefea38d2c58','0093-7654','HUMAN PRESCRIPTION DRUG','Vardenafil Hydrochloride','','Vardenafil Hydrochloride','TABLET, FILM COATED','ORAL','20190103','','ANDA','ANDA091347','Teva Pharmaceuticals USA, Inc.','VARDENAFIL HYDROCHLORIDE','10','mg/1','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7655_1e8c8eb3-da00-4bb0-b086-fefea38d2c58','0093-7655','HUMAN PRESCRIPTION DRUG','Vardenafil Hydrochloride','','Vardenafil Hydrochloride','TABLET, FILM COATED','ORAL','20190103','','ANDA','ANDA091347','Teva Pharmaceuticals USA, Inc.','VARDENAFIL HYDROCHLORIDE','20','mg/1','Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7662_4368f7b2-5bdb-4232-90b0-f6a769d71e9b','0093-7662','HUMAN PRESCRIPTION DRUG','Erlotinib','','Erlotinib','TABLET, FILM COATED','ORAL','20211208','','ANDA','ANDA091059','Teva Pharmaceuticals USA, Inc.','ERLOTINIB HYDROCHLORIDE','25','mg/1','Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7663_4368f7b2-5bdb-4232-90b0-f6a769d71e9b','0093-7663','HUMAN PRESCRIPTION DRUG','Erlotinib','','Erlotinib','TABLET, FILM COATED','ORAL','20190509','','ANDA','ANDA091059','Teva Pharmaceuticals USA, Inc.','ERLOTINIB HYDROCHLORIDE','100','mg/1','Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7664_4368f7b2-5bdb-4232-90b0-f6a769d71e9b','0093-7664','HUMAN PRESCRIPTION DRUG','Erlotinib','','Erlotinib','TABLET, FILM COATED','ORAL','20190509','','ANDA','ANDA091059','Teva Pharmaceuticals USA, Inc.','ERLOTINIB HYDROCHLORIDE','150','mg/1','Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7679_9d64a739-ee53-45dd-a534-89d933d08083','0093-7679','HUMAN PRESCRIPTION DRUG','Etonogestrel and Ethinyl Estradiol','','Etonogestrel and Ethinyl Estradiol','INSERT, EXTENDED RELEASE','VAGINAL','20210119','','ANDA','ANDA204305','Teva Pharmaceuticals USA, Inc.','ETHINYL ESTRADIOL; ETONOGESTREL','.015; .12','mg/d; mg/d','Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7701_97f5e962-56ab-48e7-8b59-c38a44a5ada4','0093-7701','HUMAN PRESCRIPTION DRUG','Levocetirizine Dihydrochloride','','Levocetirizine Dihydrochloride','TABLET, FILM COATED','ORAL','20110906','','ANDA','ANDA090199','Teva Pharmaceuticals USA, Inc.','LEVOCETIRIZINE DIHYDROCHLORIDE','5','mg/1','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7704_639d6ae5-53c6-4b8c-88f0-dccdf9ddb526','0093-7704','HUMAN PRESCRIPTION DRUG','Emtricitabine and Tenofovir Disoproxil Fumarate','','Emtricitabine and Tenofovir Disoproxil Fumarate','TABLET, FILM COATED','ORAL','20210120','','ANDA','ANDA090894','Teva Pharmaceuticals USA, Inc.','EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE','200; 300','mg/1; mg/1','Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7766_fcac6d18-baba-4f1c-b765-ff3077758ec3','0093-7766','HUMAN PRESCRIPTION DRUG','Everolimus','','Everolimus','TABLET','ORAL','20200610','','ANDA','ANDA210050','Teva Pharmaceuticals USA, Inc.','EVEROLIMUS','2.5','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7767_fcac6d18-baba-4f1c-b765-ff3077758ec3','0093-7767','HUMAN PRESCRIPTION DRUG','Everolimus','','Everolimus','TABLET','ORAL','20200610','','ANDA','ANDA210050','Teva Pharmaceuticals USA, Inc.','EVEROLIMUS','5','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7768_fcac6d18-baba-4f1c-b765-ff3077758ec3','0093-7768','HUMAN PRESCRIPTION DRUG','Everolimus','','Everolimus','TABLET','ORAL','20200610','','ANDA','ANDA210050','Teva Pharmaceuticals USA, Inc.','EVEROLIMUS','7.5','mg/1','Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7771_56853f43-4961-40ff-a5e8-d99b505380a1','0093-7771','HUMAN PRESCRIPTION DRUG','Risedronate Sodium','','Risedronate Sodium','TABLET, FILM COATED','ORAL','20161128','','ANDA','ANDA079215','Teva Pharmaceuticals USA, Inc.','RISEDRONATE SODIUM MONOHYDRATE','150','mg/1','Bisphosphonate [EPC], Diphosphonates [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7865_841d104f-e7c9-470f-9887-2533302348e4','0093-7865','HUMAN PRESCRIPTION DRUG','Fentanyl Citrate','','Fentanyl Citrate','LOZENGE','ORAL; TRANSMUCOSAL','20151208','','NDA AUTHORIZED GENERIC','NDA020747','Teva Pharmaceuticals USA, Inc.','FENTANYL CITRATE','200','ug/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7866_841d104f-e7c9-470f-9887-2533302348e4','0093-7866','HUMAN PRESCRIPTION DRUG','Fentanyl Citrate','','Fentanyl Citrate','LOZENGE','ORAL; TRANSMUCOSAL','20151208','','NDA AUTHORIZED GENERIC','NDA020747','Teva Pharmaceuticals USA, Inc.','FENTANYL CITRATE','400','ug/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7867_841d104f-e7c9-470f-9887-2533302348e4','0093-7867','HUMAN PRESCRIPTION DRUG','Fentanyl Citrate','','Fentanyl Citrate','LOZENGE','ORAL; TRANSMUCOSAL','20151208','','NDA AUTHORIZED GENERIC','NDA020747','Teva Pharmaceuticals USA, Inc.','FENTANYL CITRATE','600','ug/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7868_841d104f-e7c9-470f-9887-2533302348e4','0093-7868','HUMAN PRESCRIPTION DRUG','Fentanyl Citrate','','Fentanyl Citrate','LOZENGE','ORAL; TRANSMUCOSAL','20151208','','NDA AUTHORIZED GENERIC','NDA020747','Teva Pharmaceuticals USA, Inc.','FENTANYL CITRATE','800','ug/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7869_841d104f-e7c9-470f-9887-2533302348e4','0093-7869','HUMAN PRESCRIPTION DRUG','Fentanyl Citrate','','Fentanyl Citrate','LOZENGE','ORAL; TRANSMUCOSAL','20151208','','NDA AUTHORIZED GENERIC','NDA020747','Teva Pharmaceuticals USA, Inc.','FENTANYL CITRATE','1200','ug/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7870_841d104f-e7c9-470f-9887-2533302348e4','0093-7870','HUMAN PRESCRIPTION DRUG','Fentanyl Citrate','','Fentanyl Citrate','LOZENGE','ORAL; TRANSMUCOSAL','20151208','','NDA AUTHORIZED GENERIC','NDA020747','Teva Pharmaceuticals USA, Inc.','FENTANYL CITRATE','1600','ug/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-7909_75f047b7-2fe4-46c5-93df-251e5a337f62','0093-7909','HUMAN PRESCRIPTION DRUG','Tiopronin','','Tiopronin','TABLET, SUGAR COATED','ORAL','20210517','','ANDA','ANDA214326','Teva Pharmaceuticals USA, Inc.','TIOPRONIN','100','mg/1','Cystine Disulfide Reduction [MoA], N-substituted Glycines [CS], Reducing and Complexing Thiol [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8034_26a9fe66-649b-44c3-a80f-14ab5d141d1a','0093-8034','HUMAN PRESCRIPTION DRUG','Glyburide','','Glyburide','TABLET','ORAL','19990511','','ANDA','ANDA074686','Teva Pharmaceuticals USA, Inc.','GLYBURIDE','1.5','mg/1','Sulfonylurea Compounds [CS], Sulfonylurea [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8035_26a9fe66-649b-44c3-a80f-14ab5d141d1a','0093-8035','HUMAN PRESCRIPTION DRUG','Glyburide','','Glyburide','TABLET','ORAL','19990511','','ANDA','ANDA074686','Teva Pharmaceuticals USA, Inc.','GLYBURIDE','3','mg/1','Sulfonylurea Compounds [CS], Sulfonylurea [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8036_26a9fe66-649b-44c3-a80f-14ab5d141d1a','0093-8036','HUMAN PRESCRIPTION DRUG','Glyburide','','Glyburide','TABLET','ORAL','19990512','','ANDA','ANDA074686','Teva Pharmaceuticals USA, Inc.','GLYBURIDE','6','mg/1','Sulfonylurea Compounds [CS], Sulfonylurea [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8072_f43e8eb6-a411-4f73-830b-b7e1bce61b41','0093-8072','HUMAN PRESCRIPTION DRUG','Tiagabine Hydrochloride','','Tiagabine Hydrochloride','TABLET, FILM COATED','ORAL','20180309','','NDA AUTHORIZED GENERIC','NDA020646','Teva Pharmaceuticals USA, Inc.','TIAGABINE HYDROCHLORIDE','12','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8073_1c348c6c-a19b-4034-b3c5-f452fb80e140','0093-8073','HUMAN PRESCRIPTION DRUG','Kelnor 1/50','','Ethynodiol Diacetate and Ethinyl Estradiol','KIT','','20180301','','ANDA','ANDA072723','Teva Pharmaceuticals USA, Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8076_f43e8eb6-a411-4f73-830b-b7e1bce61b41','0093-8076','HUMAN PRESCRIPTION DRUG','Tiagabine Hydrochloride','','Tiagabine Hydrochloride','TABLET, FILM COATED','ORAL','20180309','','NDA AUTHORIZED GENERIC','NDA020646','Teva Pharmaceuticals USA, Inc.','TIAGABINE HYDROCHLORIDE','16','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8107_103e496e-b449-4f27-800f-5059465f774a','0093-8107','HUMAN PRESCRIPTION DRUG','Ibuprofen and famotidine','','Ibuprofen and famotidine','TABLET, FILM COATED','ORAL','20211215','','ANDA','ANDA211278','Teva Pharmaceuticals USA, Inc.','FAMOTIDINE; IBUPROFEN','26.6; 800','mg/1; mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8117_8de7e017-c10e-44cd-aff5-8c812474618e','0093-8117','HUMAN PRESCRIPTION DRUG','Famciclovir','','Famciclovir','TABLET, FILM COATED','ORAL','20070905','','ANDA','ANDA077487','Teva Pharmaceuticals USA, Inc.','FAMCICLOVIR','125','mg/1','DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8118_8de7e017-c10e-44cd-aff5-8c812474618e','0093-8118','HUMAN PRESCRIPTION DRUG','Famciclovir','','Famciclovir','TABLET, FILM COATED','ORAL','20070905','','ANDA','ANDA077487','Teva Pharmaceuticals USA, Inc.','FAMCICLOVIR','250','mg/1','DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8119_8de7e017-c10e-44cd-aff5-8c812474618e','0093-8119','HUMAN PRESCRIPTION DRUG','Famciclovir','','Famciclovir','TABLET, FILM COATED','ORAL','20070905','','ANDA','ANDA077487','Teva Pharmaceuticals USA, Inc.','FAMCICLOVIR','500','mg/1','DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8162_c6af23d2-0b74-49fd-8c04-549988b0eb23','0093-8162','HUMAN PRESCRIPTION DRUG','Quetiapine','','Quetiapine','TABLET, FILM COATED','ORAL','20120327','','ANDA','ANDA077745','Teva Pharmaceuticals USA, Inc.','QUETIAPINE FUMARATE','100','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8163_c6af23d2-0b74-49fd-8c04-549988b0eb23','0093-8163','HUMAN PRESCRIPTION DRUG','Quetiapine','','Quetiapine','TABLET, FILM COATED','ORAL','20120327','','ANDA','ANDA077745','Teva Pharmaceuticals USA, Inc.','QUETIAPINE FUMARATE','200','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8164_c6af23d2-0b74-49fd-8c04-549988b0eb23','0093-8164','HUMAN PRESCRIPTION DRUG','Quetiapine','','Quetiapine','TABLET, FILM COATED','ORAL','20120327','','ANDA','ANDA077745','Teva Pharmaceuticals USA, Inc.','QUETIAPINE FUMARATE','300','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8165_c6af23d2-0b74-49fd-8c04-549988b0eb23','0093-8165','HUMAN PRESCRIPTION DRUG','Quetiapine','','Quetiapine','TABLET, FILM COATED','ORAL','20120327','','ANDA','ANDA077745','Teva Pharmaceuticals USA, Inc.','QUETIAPINE FUMARATE','400','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8166_c6af23d2-0b74-49fd-8c04-549988b0eb23','0093-8166','HUMAN PRESCRIPTION DRUG','Quetiapine','','Quetiapine','TABLET, FILM COATED','ORAL','20120327','','ANDA','ANDA077745','Teva Pharmaceuticals USA, Inc.','QUETIAPINE FUMARATE','50','mg/1','Atypical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8180_bfd7c5ac-8914-4e26-a6f6-aa0c0462b1ca','0093-8180','HUMAN PRESCRIPTION DRUG','Oseltamivir Phosphate','','Oseltamivir Phosphate','POWDER, FOR SUSPENSION','ORAL','20190710','','ANDA','ANDA211125','Teva Pharmaceuticals USA, Inc.','OSELTAMIVIR PHOSPHATE','6','mg/mL','Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8192_ee7b322c-35d7-4917-8c1b-cdd465519220','0093-8192','HUMAN PRESCRIPTION DRUG','Cimetidine','','Cimetidine','TABLET, FILM COATED','ORAL','20031124','','ANDA','ANDA074151','Teva Pharmaceuticals USA, Inc.','CIMETIDINE','300','mg/1','Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8199_6e0b6eab-b0e5-4ef9-9e65-e28159258c67','0093-8199','HUMAN PRESCRIPTION DRUG','Sunitinib Malate','','Sunitinib Malate','CAPSULE','ORAL','20211222','','ANDA','ANDA213803','Teva Pharmaceuticals USA, Inc.','SUNITINIB MALATE','12.5','mg/1','Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8204_ee7b322c-35d7-4917-8c1b-cdd465519220','0093-8204','HUMAN PRESCRIPTION DRUG','Cimetidine','','Cimetidine','TABLET, FILM COATED','ORAL','20040202','','ANDA','ANDA074151','Teva Pharmaceuticals USA, Inc.','CIMETIDINE','400','mg/1','Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8210_ffab8779-70a1-40cb-9605-358263056d2d','0093-8210','HUMAN PRESCRIPTION DRUG','Finzala','','norethindrone acetate and ethinyl estradiol and ferrous fumarate','KIT','','20220804','','ANDA','ANDA210087','Teva Pharmaceuticals USA, Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8224_6e0b6eab-b0e5-4ef9-9e65-e28159258c67','0093-8224','HUMAN PRESCRIPTION DRUG','Sunitinib Malate','','Sunitinib Malate','CAPSULE','ORAL','20211222','','ANDA','ANDA213803','Teva Pharmaceuticals USA, Inc.','SUNITINIB MALATE','25','mg/1','Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8229_6e0b6eab-b0e5-4ef9-9e65-e28159258c67','0093-8229','HUMAN PRESCRIPTION DRUG','Sunitinib Malate','','Sunitinib Malate','CAPSULE','ORAL','20211222','','ANDA','ANDA213803','Teva Pharmaceuticals USA, Inc.','SUNITINIB MALATE','37.5','mg/1','Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8231_6e0b6eab-b0e5-4ef9-9e65-e28159258c67','0093-8231','HUMAN PRESCRIPTION DRUG','Sunitinib Malate','','Sunitinib Malate','CAPSULE','ORAL','20211222','','ANDA','ANDA213803','Teva Pharmaceuticals USA, Inc.','SUNITINIB MALATE','50','mg/1','Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8232_8413c0d9-41db-4717-8738-883964e26856','0093-8232','HUMAN PRESCRIPTION DRUG','Irbesartan and Hydrochlorothiazide','','Irbesartan and Hydrochlorothiazide','TABLET, FILM COATED','ORAL','20130827','','ANDA','ANDA077369','Teva Pharmaceuticals USA, Inc.','HYDROCHLOROTHIAZIDE; IRBESARTAN','12.5; 300','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8238_8413c0d9-41db-4717-8738-883964e26856','0093-8238','HUMAN PRESCRIPTION DRUG','Irbesartan and Hydrochlorothiazide','','Irbesartan and Hydrochlorothiazide','TABLET, FILM COATED','ORAL','20130124','','ANDA','ANDA077369','Teva Pharmaceuticals USA, Inc.','HYDROCHLOROTHIAZIDE; IRBESARTAN','12.5; 150','mg/1; mg/1','Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8305_ee7b322c-35d7-4917-8c1b-cdd465519220','0093-8305','HUMAN PRESCRIPTION DRUG','Cimetidine','','Cimetidine','TABLET, FILM COATED','ORAL','20031206','','ANDA','ANDA074463','Teva Pharmaceuticals USA, Inc.','CIMETIDINE','800','mg/1','Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8310_f267f72b-7037-4849-aba3-aab84ca23600','0093-8310','HUMAN PRESCRIPTION DRUG','Eletriptan Hydrobromide','','Eletriptan Hydrobromide','TABLET, FILM COATED','ORAL','20170721','','ANDA','ANDA202040','Teva Pharmaceuticals USA, Inc.','ELETRIPTAN HYDROBROMIDE','20','mg/1','Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8311_f267f72b-7037-4849-aba3-aab84ca23600','0093-8311','HUMAN PRESCRIPTION DRUG','Eletriptan Hydrobromide','','Eletriptan Hydrobromide','TABLET, FILM COATED','ORAL','20170721','','ANDA','ANDA202040','Teva Pharmaceuticals USA, Inc.','ELETRIPTAN HYDROBROMIDE','40','mg/1','Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8342_f4b5b433-1b6e-4af2-9d16-7194c2da041c','0093-8342','HUMAN PRESCRIPTION DRUG','Glyburide','','Glyburide','TABLET','ORAL','19950830','','ANDA','ANDA074388','Teva Pharmaceuticals USA, Inc.','GLYBURIDE','1.25','mg/1','Sulfonylurea Compounds [CS], Sulfonylurea [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8343_f4b5b433-1b6e-4af2-9d16-7194c2da041c','0093-8343','HUMAN PRESCRIPTION DRUG','Glyburide','','Glyburide','TABLET','ORAL','19950830','','ANDA','ANDA074388','Teva Pharmaceuticals USA, Inc.','GLYBURIDE','2.5','mg/1','Sulfonylurea Compounds [CS], Sulfonylurea [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8344_f4b5b433-1b6e-4af2-9d16-7194c2da041c','0093-8344','HUMAN PRESCRIPTION DRUG','Glyburide','','Glyburide','TABLET','ORAL','19950830','','ANDA','ANDA074388','Teva Pharmaceuticals USA, Inc.','GLYBURIDE','5','mg/1','Sulfonylurea Compounds [CS], Sulfonylurea [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8675_23a078e5-b3da-4ff1-b78c-c2c720ec1f1f','0093-8675','HUMAN PRESCRIPTION DRUG','Amoxicillin and Clavulanate Potassium','','Amoxicillin and Clavulanate Potassium','POWDER, FOR SUSPENSION','ORAL','20040923','','ANDA','ANDA065162','Teva Pharmaceuticals USA, Inc.','AMOXICILLIN; CLAVULANATE POTASSIUM','600; 42.9','mg/5mL; mg/5mL','Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8739_432e8b0e-6450-4f55-8ad8-d39c88ee7e26','0093-8739','HUMAN PRESCRIPTION DRUG','Mexiletine Hydrochloride','','Mexiletine Hydrochloride','CAPSULE','ORAL','19950605','','ANDA','ANDA074377','Teva Pharmaceuticals USA, Inc.','MEXILETINE HYDROCHLORIDE','150','mg/1','Antiarrhythmic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8740_432e8b0e-6450-4f55-8ad8-d39c88ee7e26','0093-8740','HUMAN PRESCRIPTION DRUG','Mexiletine Hydrochloride','','Mexiletine Hydrochloride','CAPSULE','ORAL','19950605','','ANDA','ANDA074377','Teva Pharmaceuticals USA, Inc.','MEXILETINE HYDROCHLORIDE','200','mg/1','Antiarrhythmic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-8741_432e8b0e-6450-4f55-8ad8-d39c88ee7e26','0093-8741','HUMAN PRESCRIPTION DRUG','Mexiletine Hydrochloride','','Mexiletine Hydrochloride','CAPSULE','ORAL','19950605','','ANDA','ANDA074377','Teva Pharmaceuticals USA, Inc.','MEXILETINE HYDROCHLORIDE','250','mg/1','Antiarrhythmic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9018_0d006301-5ba4-46a1-a767-fbaa2a94bb75','0093-9018','HUMAN PRESCRIPTION DRUG','Cyclosporine','Modified','Cyclosporine','CAPSULE, LIQUID FILLED','ORAL','20210608','','ANDA','ANDA065110','Teva Pharmaceuticals USA, Inc.','CYCLOSPORINE','25','mg/1','Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9019_0d006301-5ba4-46a1-a767-fbaa2a94bb75','0093-9019','HUMAN PRESCRIPTION DRUG','Cyclosporine','Modified','Cyclosporine','CAPSULE, LIQUID FILLED','ORAL','20210608','','ANDA','ANDA065110','Teva Pharmaceuticals USA, Inc.','CYCLOSPORINE','50','mg/1','Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9020_0d006301-5ba4-46a1-a767-fbaa2a94bb75','0093-9020','HUMAN PRESCRIPTION DRUG','Cyclosporine','Modified','Cyclosporine','CAPSULE, LIQUID FILLED','ORAL','20210608','','ANDA','ANDA065110','Teva Pharmaceuticals USA, Inc.','CYCLOSPORINE','100','mg/1','Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9147_a2ec8288-040d-400a-aee5-99a29f41e476','0093-9147','HUMAN PRESCRIPTION DRUG','Venlafaxine Hydrochloride','','Venlafaxine Hydrochloride','TABLET','ORAL','20060804','','ANDA','ANDA076690','Teva Pharmaceuticals USA, Inc.','VENLAFAXINE HYDROCHLORIDE','25','mg/1','Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9148_a2ec8288-040d-400a-aee5-99a29f41e476','0093-9148','HUMAN PRESCRIPTION DRUG','Venlafaxine Hydrochloride','','Venlafaxine Hydrochloride','TABLET','ORAL','20060804','','ANDA','ANDA076690','Teva Pharmaceuticals USA, Inc.','VENLAFAXINE HYDROCHLORIDE','37.5','mg/1','Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9149_a2ec8288-040d-400a-aee5-99a29f41e476','0093-9149','HUMAN PRESCRIPTION DRUG','Venlafaxine Hydrochloride','','Venlafaxine Hydrochloride','TABLET','ORAL','20060804','','ANDA','ANDA076690','Teva Pharmaceuticals USA, Inc.','VENLAFAXINE HYDROCHLORIDE','50','mg/1','Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9157_a2ec8288-040d-400a-aee5-99a29f41e476','0093-9157','HUMAN PRESCRIPTION DRUG','Venlafaxine Hydrochloride','','Venlafaxine Hydrochloride','TABLET','ORAL','20060804','','ANDA','ANDA076690','Teva Pharmaceuticals USA, Inc.','VENLAFAXINE HYDROCHLORIDE','75','mg/1','Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9163_a2ec8288-040d-400a-aee5-99a29f41e476','0093-9163','HUMAN PRESCRIPTION DRUG','Venlafaxine Hydrochloride','','Venlafaxine Hydrochloride','TABLET','ORAL','20060804','','ANDA','ANDA076690','Teva Pharmaceuticals USA, Inc.','VENLAFAXINE HYDROCHLORIDE','100','mg/1','Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9218_9acda865-2177-4cdc-a314-75454c101c34','0093-9218','HUMAN PRESCRIPTION DRUG','dimethyl fumarate','','dimethyl fumarate','CAPSULE','ORAL','20200928','20230331','NDA AUTHORIZED GENERIC','NDA204063','TEVA PHARMACEUTICALS USA, INC.','DIMETHYL FUMARATE','120','mg/1','','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9219_9acda865-2177-4cdc-a314-75454c101c34','0093-9219','HUMAN PRESCRIPTION DRUG','dimethyl fumarate','','dimethyl fumarate','CAPSULE','ORAL','20200928','20240430','NDA AUTHORIZED GENERIC','NDA204063','TEVA PHARMACEUTICALS USA, INC.','DIMETHYL FUMARATE','240','mg/1','','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9222_8b62b5af-d2a9-4d06-a78b-23f92523c19f','0093-9222','HUMAN PRESCRIPTION DRUG','Diflunisal','','Diflunisal','TABLET, FILM COATED','ORAL','20210630','','ANDA','ANDA073673','Teva Pharmaceuticals USA, Inc.','DIFLUNISAL','500','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9224_7f372b9e-8d5d-4613-acbb-0e05c5d06761','0093-9224','HUMAN PRESCRIPTION DRUG','mesalamine','','mesalamine','CAPSULE, EXTENDED RELEASE','ORAL','20210105','','NDA AUTHORIZED GENERIC','NDA022301','Teva Pharmaceuticals USA, Inc.','MESALAMINE','375','mg/1','Aminosalicylate [EPC], Aminosalicylic Acids [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9290_6ea2adb9-cbef-4571-9623-62c31394a162','0093-9290','HUMAN PRESCRIPTION DRUG','Clonazepam','','Clonazepam','TABLET, ORALLY DISINTEGRATING','ORAL','20220302','','ANDA','ANDA077194','Teva Pharmaceuticals USA, Inc.','CLONAZEPAM','0.125','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9291_6ea2adb9-cbef-4571-9623-62c31394a162','0093-9291','HUMAN PRESCRIPTION DRUG','Clonazepam','','Clonazepam','TABLET, ORALLY DISINTEGRATING','ORAL','20220302','','ANDA','ANDA077194','Teva Pharmaceuticals USA, Inc.','CLONAZEPAM','0.25','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9292_6ea2adb9-cbef-4571-9623-62c31394a162','0093-9292','HUMAN PRESCRIPTION DRUG','Clonazepam','','Clonazepam','TABLET, ORALLY DISINTEGRATING','ORAL','20220302','','ANDA','ANDA077194','Teva Pharmaceuticals USA, Inc.','CLONAZEPAM','0.5','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9293_6ea2adb9-cbef-4571-9623-62c31394a162','0093-9293','HUMAN PRESCRIPTION DRUG','Clonazepam','','Clonazepam','TABLET, ORALLY DISINTEGRATING','ORAL','20211122','','ANDA','ANDA077194','Teva Pharmaceuticals USA, Inc.','CLONAZEPAM','1','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9294_6ea2adb9-cbef-4571-9623-62c31394a162','0093-9294','HUMAN PRESCRIPTION DRUG','Clonazepam','','Clonazepam','TABLET, ORALLY DISINTEGRATING','ORAL','20220302','','ANDA','ANDA077194','Teva Pharmaceuticals USA, Inc.','CLONAZEPAM','2','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9364_84b83205-8813-494e-933e-a70697393744','0093-9364','HUMAN PRESCRIPTION DRUG','Glyburide','','glyburide','TABLET','ORAL','19840501','','NDA AUTHORIZED GENERIC','NDA017532','TEVA Pharmaceuticals USA Inc','GLYBURIDE','5','mg/1','Sulfonylurea Compounds [CS], Sulfonylurea [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9433_84b83205-8813-494e-933e-a70697393744','0093-9433','HUMAN PRESCRIPTION DRUG','Glyburide','','glyburide','TABLET','ORAL','19840501','','NDA AUTHORIZED GENERIC','NDA017532','TEVA Pharmaceuticals USA Inc','GLYBURIDE','2.5','mg/1','Sulfonylurea Compounds [CS], Sulfonylurea [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9477_84b83205-8813-494e-933e-a70697393744','0093-9477','HUMAN PRESCRIPTION DRUG','Glyburide','','glyburide','TABLET','ORAL','19840501','','NDA AUTHORIZED GENERIC','NDA017532','TEVA Pharmaceuticals USA Inc','GLYBURIDE','1.25','mg/1','Sulfonylurea Compounds [CS], Sulfonylurea [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9609_7d22a419-3d33-492c-b054-fb29a82ce643','0093-9609','HUMAN PRESCRIPTION DRUG','doxepin hydrochloride','','doxepin hydrochloride','CREAM','TOPICAL','20230217','','ANDA','ANDA215408','Teva Pharmaceuticals USA, Inc.','DOXEPIN HYDROCHLORIDE','50','mg/g','Tricyclic Antidepressant [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9614_a661664e-57a8-4ef1-aa70-fa08e1c32a68','0093-9614','HUMAN PRESCRIPTION DRUG','Silver Nitrate','','Silver Nitrate','SOLUTION','TOPICAL','19910101','','UNAPPROVED DRUG OTHER','','Teva Pharmaceuticals USA, Inc.','SILVER NITRATE','0.005','g/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9701_42614a3c-7253-4348-a149-6130be7c69b6','0093-9701','HUMAN PRESCRIPTION DRUG','Carbidopa and levodopa','','Carbidopa and levodopa','TABLET','ORAL','20220118','','ANDA','ANDA074260','Teva Pharmaceuticals USA, Inc.','CARBIDOPA; LEVODOPA','10; 100','mg/1; mg/1','Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0093-9702_42614a3c-7253-4348-a149-6130be7c69b6','0093-9702','HUMAN PRESCRIPTION DRUG','Carbidopa and levodopa','','Carbidopa and levodopa','TABLET','ORAL','20220118','','ANDA','ANDA074260','Teva Pharmaceuticals USA, Inc.','CARBIDOPA; LEVODOPA','25; 100','mg/1; mg/1','Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0095-3000_16609ec3-578a-4f92-83d4-85d58e23cd8d','0095-3000','HUMAN PRESCRIPTION DRUG','BUPAP','','Butalbital and Acetaminophen Tablets','TABLET','ORAL','20130624','','ANDA','ANDA090956','Bausch Health US, LLC','ACETAMINOPHEN; BUTALBITAL','300; 50','mg/1; mg/1','Barbiturate [EPC], Barbiturates [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0096-0682_ec08d35c-6d87-0239-e053-2995a90a3139','0096-0682','HUMAN OTC DRUG','Solbar Shield SPF40','','Solbar Shield SPF40','CREAM','TOPICAL','19960601','','OTC MONOGRAPH FINAL','part352','Person and Covey','TITANIUM DIOXIDE; ZINC OXIDE','.05; .075','g/g; g/g','Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0096-0685_ec08d823-3d21-1499-e053-2995a90a00e6','0096-0685','HUMAN OTC DRUG','Solbar Thirty SPF 30','','Solbar Thirty SPF30','CREAM','TOPICAL','19960601','','OTC MONOGRAPH FINAL','part352','Person and Covey','AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE','.03; .12; .075; .015; .06','g/g; g/g; g/g; g/g; g/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0096-0687_ec08b2fe-995b-71ae-e053-2995a90a9651','0096-0687','HUMAN OTC DRUG','Solbar Avo SPF35','','Solbar Avo SPF35','CREAM','TOPICAL','19960601','','OTC MONOGRAPH FINAL','part352','Person and Covey','AVOBENZONE; HOMOSALATE; OCTINOXATE; OXYBENZONE','.03; .08; .075; .06','g/g; g/g; g/g; g/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0096-0688_ec08e191-cc75-1497-e053-2995a90aecb3','0096-0688','HUMAN OTC DRUG','Solbar Zinc SPF38','','Solbar Zinc SPF38','CREAM','TOPICAL','19960601','','OTC MONOGRAPH FINAL','part352','Person and Covey','HOMOSALATE; OCTINOXATE; ZINC OXIDE','.1015; .077; .077','g/g; g/g; g/g','Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0096-0709_ec08d823-3d30-1499-e053-2995a90a00e6','0096-0709','HUMAN OTC DRUG','Xerac AC','','Xerac AC','LIQUID','TOPICAL','19960601','','OTC MONOGRAPH FINAL','part350','Person and Covey','ALUMINUM CHLORIDE','0.0625','g/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0096-0732_ec08a5e6-0306-34da-e053-2995a90a3589','0096-0732','HUMAN OTC DRUG','Aquanil HC','','Hydrocortisone','LOTION','TOPICAL','19950108','','OTC MONOGRAPH NOT FINAL','part348','Person and Covey','HYDROCORTISONE','0.01','g/g','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0096-0736_ec08b2fe-995a-71ae-e053-2995a90a9651','0096-0736','HUMAN OTC DRUG','DHS tar gel','','coal tar','SHAMPOO','TOPICAL','19960601','','OTC MONOGRAPH FINAL','part358H','Person and Covey','COAL TAR','0.005','g/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0096-0737_ec08b193-a878-6978-e053-2a95a90a4691','0096-0737','HUMAN OTC DRUG','DHS TAR','','coal tar','SHAMPOO','TOPICAL','19950601','','OTC MONOGRAPH FINAL','part358H','Person and Covey','COAL TAR','0.005','g/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0096-0738_f1761704-4de3-f7d6-e053-2995a90a785b','0096-0738','HUMAN OTC DRUG','DHS SAL','4 oz.','DHS SAL','SHAMPOO','TOPICAL','19950601','','OTC MONOGRAPH FINAL','part333D','Person and Covey','SALICYLIC ACID','0.035','g/g','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0096-0741_ec08b2fe-995c-71ae-e053-2995a90a9651','0096-0741','HUMAN OTC DRUG','Solbar Fifty SPF50','','Solbar Fifty SPF50','CREAM','TOPICAL','19960601','','OTC MONOGRAPH FINAL','part352','Person and Covey','AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE','.011; .08; .1; .06','g/g; g/g; g/g; g/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0019_21fad873-3e4b-47ee-98d9-85f964bb9293','0113-0019','HUMAN OTC DRUG','Good Sense Severe NightTime','','Acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl','SOLUTION','ORAL','20151021','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE','650; 20; 12.5; 10','mg/30mL; mg/30mL; mg/30mL; mg/30mL','Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0020_fe2d2ffa-f511-4451-8911-4e1102c25ccc','0113-0020','HUMAN OTC DRUG','good sense childrens pain and fever','','Acetaminophen','SUSPENSION','ORAL','20140320','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN','160','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0022_8a4c54d0-c24b-4e16-8a7b-67a3a0e3b727','0113-0022','HUMAN OTC DRUG','Good Sense Heartburn Relief','','Cimetidine','TABLET, FILM COATED','ORAL','20021230','','ANDA','ANDA075285','L. Perrigo Company','CIMETIDINE','200','mg/1','Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0023_9bf3f9f1-7ea0-498f-a0f9-9a2bf417356f','0113-0023','HUMAN OTC DRUG','good sense multi symptom flu and severe cold','','Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl','POWDER, FOR SOLUTION','ORAL','20161026','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE','500; 20; 10','mg/1; mg/1; mg/1','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0025_d27c221a-b40f-48d2-9de5-8575e18a5fcf','0113-0025','HUMAN OTC DRUG','Good Sense Pain Relief','','Acetaminophen','TABLET, FILM COATED','ORAL','20151006','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN','500','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0028_92f51d8e-95ec-4777-aa82-dddbe5913c3c','0113-0028','HUMAN OTC DRUG','Good Sense 24 hour allergy nasal','','Fluticasone propionate','SPRAY, METERED','NASAL','20160803','','ANDA','ANDA207957','L. Perrigo Company','FLUTICASONE PROPIONATE','50','ug/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0029_078ff3ce-56ed-447f-a0fe-691a1cb96ba9','0113-0029','HUMAN OTC DRUG','Good Sense Nicotine','','Nicotine Polacrilex','GUM, CHEWING','ORAL','20050506','','ANDA','ANDA076775','L. Perrigo Company','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0032_3668ac3e-d4be-493f-8f89-913ce34e0b54','0113-0032','HUMAN OTC DRUG','Good Sense Dual Action Complete','','famotidine, calcium carbonate and magnesium hydroxide','TABLET, CHEWABLE','ORAL','20160106','','ANDA','ANDA077355','L. Perrigo Company','CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE','800; 10; 165','mg/1; mg/1; mg/1','Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0044_694143e8-301e-4825-91e7-716d1f9b3a14','0113-0044','HUMAN OTC DRUG','Good Sense Pain Relief','','Acetaminophen','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20170509','20240229','ANDA','ANDA075077','L. Perrigo Company','ACETAMINOPHEN','650','mg/1','','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0050_f1bafff0-f73f-456a-8c0a-d689f760d571','0113-0050','HUMAN OTC DRUG','good sense ibuprofen pm','','diphenhydramine citrate, ibuprofen','TABLET, FILM COATED','ORAL','20090305','','ANDA','ANDA079113','L. Perrigo Company','DIPHENHYDRAMINE CITRATE; IBUPROFEN','38; 200','mg/1; mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0052_e2346394-7edc-4922-89c5-6c9da56a8fec','0113-0052','HUMAN OTC DRUG','good sense sleep time','','Diphenhydramine HCl','CAPSULE, LIQUID FILLED','ORAL','20140206','','OTC MONOGRAPH FINAL','part338','L. Perrigo Company','DIPHENHYDRAMINE HYDROCHLORIDE','25','mg/1','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0053_902860bf-7d0f-433b-95ea-fae6e953ab07','0113-0053','HUMAN OTC DRUG','Good Sense Nicotine','','Nicotine Polacrilex','GUM, CHEWING','ORAL','20170427','','ANDA','ANDA206393','L. Perrigo Company','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0054_84b4baca-65a7-488d-ae42-8e4a03c04c58','0113-0054','HUMAN OTC DRUG','Good Sense Suphedrine','12 Hour','Pseudoephedrine Hydrochloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','19991029','','ANDA','ANDA075153','L. Perrigo Company','PSEUDOEPHEDRINE HYDROCHLORIDE','120','mg/1','Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0056_63cddeaa-828c-442a-8f2a-91ce264126b2','0113-0056','HUMAN OTC DRUG','good sense night time','','Acetaminophen, Dextromethorphan HBr, Doxylamine succinate','CAPSULE, LIQUID FILLED','ORAL','20140530','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE','325; 15; 6.25','mg/1; mg/1; mg/1','Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0057_13cdf9f9-e7f0-4dbb-bd4e-7aac8d42292f','0113-0057','HUMAN OTC DRUG','Good Sense ibuprofen','infants','ibuprofen','SUSPENSION','ORAL','20000208','','ANDA','ANDA075217','L. Perrigo Company','IBUPROFEN','50','mg/1.25mL','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0058_6916a481-6168-4c6f-8889-d8a207ce9d97','0113-0058','HUMAN OTC DRUG','Good Sense Omeprazole and Sodium Bicarbonate','','Omeprazole, sodium bicarbonate','CAPSULE, GELATIN COATED','ORAL','20170619','','ANDA','ANDA201361','L. Perrigo Company','OMEPRAZOLE; SODIUM BICARBONATE','20; 1100','mg/1; mg/1','Cytochrome P450 2C19 Inhibitors [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0061_ccbca601-b066-4332-8c93-cf3b00677365','0113-0061','HUMAN OTC DRUG','good sense tussin','mucus and chest congestion','Guaifenesin','SOLUTION','ORAL','19910115','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','GUAIFENESIN','200','mg/10mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0065_57806eef-5444-4241-ac28-3686d77ed637','0113-0065','HUMAN OTC DRUG','good sense nasal','','Oxymetazoline HCl','SPRAY','NASAL','19940323','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','OXYMETAZOLINE HYDROCHLORIDE','0.05','g/100mL','Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0074_673e46ce-81b7-4b19-a5fc-d3a05df97570','0113-0074','HUMAN OTC DRUG','Good Sense ibuprofen','','Ibuprofen','TABLET, FILM COATED','ORAL','20060310','','ANDA','ANDA077349','L. Perrigo Company','IBUPROFEN','200','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0081_717043cd-4457-4064-bb1b-2f2e64a2b461','0113-0081','HUMAN OTC DRUG','Good Sense Miconazole 3','','Miconazole nitrate','KIT','','20070402','','ANDA','ANDA075329','L. Perrigo Company','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0084_c81ea0cc-2cdf-43f0-b6d2-3a3fe9b66b41','0113-0084','HUMAN OTC DRUG','Good Sense First Aid Antibiotic','','bacitracin zinc, neomycin, polymyxin B','OINTMENT','TOPICAL','20140428','','OTC MONOGRAPH FINAL','part333B','L. Perrigo Company','BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE','400; 3.5; 5000','[USP''''U]/g; mg/g; [USP''''U]/g','Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0087_2969e412-6861-4d8e-bc16-b48bebf9ecec','0113-0087','HUMAN OTC DRUG','good sense anti diarrheal anti gas','','loperamide hydrochloride, simethicone','TABLET','ORAL','20181011','','ANDA','ANDA209837','L. Perrigo Company','DIMETHICONE; LOPERAMIDE HYDROCHLORIDE','125; 2','mg/1; mg/1','Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0094_35fa9514-4f7e-4d29-a8c7-c5404bf4d6cb','0113-0094','HUMAN OTC DRUG','Good Sense Nasal Decongestant PE','','Phenylephrine Hydrochloride','TABLET','ORAL','20050621','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','PHENYLEPHRINE HYDROCHLORIDE','10','mg/1','Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0096_ab05b903-d505-456c-a87d-d4a1cac3088f','0113-0096','HUMAN OTC DRUG','good sense flu and severe cold and cough','daytime','Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride','POWDER, FOR SOLUTION','ORAL','20110131','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE','650; 20; 10','mg/1; mg/1; mg/1','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0101_5f638cc1-870f-4577-b2ef-0bce61a2a9f3','0113-0101','HUMAN OTC DRUG','Good Sense complete Lice Treatment','','Piperonyl butoxide, pyrethrum extract','KIT','','20160607','','OTC MONOGRAPH FINAL','part358G','L. Perrigo Company','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0108_52ad31cb-c734-482d-90b1-54ad118288da','0113-0108','HUMAN OTC DRUG','Good Sense complete lice treatment kit','','piperonyl butoxide, pyrethrum extract','KIT','','20181120','','OTC MONOGRAPH FINAL','part358G','L. Perrigo Company','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0112_df446886-2749-40b2-936c-698d7557cb76','0113-0112','HUMAN OTC DRUG','good sense nausea relief','','Dextrose (glucose), Levulose (fructose), Phosphoric Acid','SOLUTION','ORAL','20141103','','UNAPPROVED DRUG OTHER','','L. Perrigo Company','DEXTROSE; FRUCTOSE; PHOSPHORIC ACID','1.87; 1.87; 21.5','g/5mL; g/5mL; mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0116_f0a7cb93-46a4-412c-97e5-e66306eacdd6','0113-0116','HUMAN OTC DRUG','Good Sense Lansoprazole','','Lansoprazole','TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE','ORAL','20171128','','NDA','NDA208025','L. Perrigo Company','LANSOPRAZOLE','15','mg/1','Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0117_ab82ad1c-efcf-49f1-a225-63ced226528a','0113-0117','HUMAN OTC DRUG','Good Sense lansoprazole','','Lansoprazole','CAPSULE, DELAYED RELEASE','ORAL','20120524','','ANDA','ANDA202319','L. Perrigo Company','LANSOPRAZOLE','15','mg/1','Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0141_e61dbd67-a07d-46f5-90d8-0f4e56f2fa21','0113-0141','HUMAN OTC DRUG','good sense acid reducer','','Famotidine','TABLET, FILM COATED','ORAL','20091023','','ANDA','ANDA075400','L. Perrigo Company','FAMOTIDINE','10','mg/1','Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0147_c7154370-5d91-4dc4-90ed-1d07d9bc5943','0113-0147','HUMAN OTC DRUG','good sense all day allergy d','','Cetirizine hydrochloride, Pseudoephedrine hydrochloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20201227','','ANDA','ANDA210719','L. Perrigo Company','CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE','5; 120','mg/1; mg/1','Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0161_b2ce8230-64a6-44d7-9866-95aad482299d','0113-0161','HUMAN OTC DRUG','Good Sense pain and fever','','Acetaminophen','SUSPENSION','ORAL','20110921','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN','160','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0166_b7c7422f-ba00-4bb2-9b75-546d996a1785','0113-0166','HUMAN OTC DRUG','good sense ibuprofen','childrens','Ibuprofen','SUSPENSION','ORAL','20020504','','ANDA','ANDA074937','L. Perrigo Company','IBUPROFEN','100','mg/5mL','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0170_dbbd9626-db04-4e8c-98c7-0cebbfb84c9d','0113-0170','HUMAN OTC DRUG','Good Sense Nicotine','','Nicotine Polacrilex','GUM, CHEWING','ORAL','20050506','','ANDA','ANDA076789','L. Perrigo Company','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0186_2776f989-4118-4821-8dc1-0c35229294eb','0113-0186','HUMAN OTC DRUG','Good Sense Sleep Time','','Diphenhydramine HCl','SOLUTION','ORAL','20130702','','OTC MONOGRAPH FINAL','part338','L. Perrigo Company','DIPHENHYDRAMINE HYDROCHLORIDE','50','mg/30mL','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0188_217aa2e7-e2d3-443c-a173-228531846015','0113-0188','HUMAN OTC DRUG','Good Sense Hemorrhoidal','','mineral oil, petrolatum, phenylephrine HCl','OINTMENT','RECTAL','20131121','','OTC MONOGRAPH FINAL','part346','L. Perrigo Company','MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE','14; 74.9; .25','g/100g; g/100g; g/100g','Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0189_462af1fb-e9bf-4e5f-a02e-df0399519a03','0113-0189','HUMAN OTC DRUG','Good Sense Childrens All Day Allergy','','Cetirizine HCl','SOLUTION','ORAL','20140103','','ANDA','ANDA204226','L. Perrigo Company','CETIRIZINE HYDROCHLORIDE','5','mg/5mL','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0194_36010138-bad1-4eac-9a9f-05f629532ab9','0113-0194','HUMAN OTC DRUG','Good Sense Acid Reducer','','Famotidine','TABLET, FILM COATED','ORAL','20070316','','ANDA','ANDA077351','L. Perrigo Company','FAMOTIDINE','20','mg/1','Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0206_4a2c1d77-3383-40df-9397-da3187e7b679','0113-0206','HUMAN OTC DRUG','good sense nicotine','mint','Nicotine Polacrilex','GUM, CHEWING','ORAL','19910415','','ANDA','ANDA078325','L. Perrigo Company','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0212_c41f8069-3649-4bfe-884c-2072c2006afd','0113-0212','HUMAN OTC DRUG','Good Sense Childrens Pain and Fever','','Acetaminophen','SUSPENSION','ORAL','19930225','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN','160','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0214_94cc97a6-7075-4e80-86de-71b32d366186','0113-0214','HUMAN OTC DRUG','Good Sense Miconazole 7','','Miconazole nitrate','CREAM','VAGINAL','19990730','','ANDA','ANDA074760','L Perrigo Company','MICONAZOLE NITRATE','2','g/100g','Azole Antifungal [EPC], Azoles [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0224_db104321-d5d0-4e02-a542-f604bd486ba4','0113-0224','HUMAN OTC DRUG','Good Sense anti diarrheal','','Loperamide Hydrochloride','TABLET, FILM COATED','ORAL','20030225','','ANDA','ANDA075232','L. Perrigo Company','LOPERAMIDE HYDROCHLORIDE','2','mg/1','Opioid Agonist [EPC], Opioid Agonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0227_d1d3295c-be50-472d-b5e5-4157c9c422a5','0113-0227','HUMAN OTC DRUG','Good Sense Pain Relief','Extra Strength','Acetaminophen','TABLET, COATED','ORAL','20060213','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN','500','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0241_0b482364-a00a-4b95-975a-f403a3ae4d2e','0113-0241','HUMAN OTC DRUG','good sense levocetirizine','','levocetirizine dihydrochloride','TABLET, FILM COATED','ORAL','20200911','','ANDA','ANDA211983','L. Perrigo Company','LEVOCETIRIZINE DIHYDROCHLORIDE','5','mg/1','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0274_bb21f974-49a0-49f1-b673-d3369831f488','0113-0274','HUMAN OTC DRUG','Good Sense aspirin','','Aspirin','TABLET, CHEWABLE','ORAL','19970808','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ASPIRIN','81','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0279_d0a3c9b6-0e55-4630-b76c-4b2de5e802f6','0113-0279','HUMAN OTC DRUG','Good Sense Hemorrhoidal','','cocoa butter, phenylephrine HCl','SUPPOSITORY','RECTAL','20140904','','OTC MONOGRAPH FINAL','part346','L. Perrigo Company','COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE','2211; 6.5','mg/1; mg/1','Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0285_7c10d357-5137-42f1-8abb-bd05ce9f9b9e','0113-0285','HUMAN OTC DRUG','Good Sense 24 hour allergy nasal','','Fluticasone Propionate','SPRAY, METERED','NASAL','20171129','','ANDA','ANDA207957','L. Perrigo Company','FLUTICASONE PROPIONATE','50','ug/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0294_2b2a2be0-4c71-4762-be34-483d529061ec','0113-0294','HUMAN OTC DRUG','good sense hair regrowth treatment','','Minoxidil','AEROSOL, FOAM','TOPICAL','20120301','','ANDA','ANDA091344','L. Perrigo Company','MINOXIDIL','5','g/100g','Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0296_a86a3699-a768-439e-90ef-fa49a4bddf5d','0113-0296','HUMAN OTC DRUG','good sense tussin','cf max','dextromethorphan hbr, guaifenesin, phenylephrine hcl','SOLUTION','ORAL','20130111','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE','20; 400; 10','mg/10mL; mg/10mL; mg/10mL','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0298_21e17c7f-2dae-4e91-97b1-f442488a720d','0113-0298','HUMAN OTC DRUG','good sense ibuprofen','','Ibuprofen','CAPSULE, LIQUID FILLED','ORAL','20180220','','ANDA','ANDA203599','L. Perrigo Company','IBUPROFEN','200','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0304_3b8f4d52-14ec-4180-b431-aca505431b74','0113-0304','HUMAN OTC DRUG','Good Sense Nasal','','oxymetazoline hydrochloride','SPRAY','NASAL','19890915','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','OXYMETAZOLINE HYDROCHLORIDE','0.5','mg/mL','Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0306_ac9f4e3c-5a7f-4a60-baba-36b6c37f5d6e','0113-0306','HUMAN OTC DRUG','Good Sense Clear Lax','','Polyethylene Glycol 3350','POWDER, FOR SOLUTION','ORAL','20091007','','ANDA','ANDA090685','L. Perrigo Company','POLYETHYLENE GLYCOL 3350','17','g/17g','Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0323_c9d1ee54-8184-4ad7-a9f6-7936d2c2ddc0','0113-0323','HUMAN OTC DRUG','Good Sense Lubricating Plus','','carboxymethylcellulose sodium','SOLUTION, GEL FORMING / DROPS','OPHTHALMIC','20131111','','OTC MONOGRAPH FINAL','part349','L. Perrigo Company','CARBOXYMETHYLCELLULOSE SODIUM','0.5','g/100mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0325_21d817c7-887b-4e6d-a22b-0a9dc15bc822','0113-0325','HUMAN OTC DRUG','Good Sense Mucus ER','','Guaifenesin','TABLET, EXTENDED RELEASE','ORAL','20170919','','ANDA','ANDA091009','L. Perrigo Company','GUAIFENESIN','1200','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0335_f8798196-3ecc-450a-88ea-e0e0c69613a7','0113-0335','HUMAN OTC DRUG','good sense night time','','Acetaminophen, Dextromethorphan HBr, Doxylamine succinate','SOLUTION','ORAL','20110819','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE','650; 30; 12.5','mg/30mL; mg/30mL; mg/30mL','Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0344_dabc8be3-57d6-408d-83f6-b77b6f558b0d','0113-0344','HUMAN OTC DRUG','Good Sense Nicotine','','Nicotine Polacrilex','LOZENGE','ORAL','20060725','','ANDA','ANDA077007','L. Perrigo Company','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0359_e345de02-43e2-45f9-af6a-6085cd33ccbc','0113-0359','HUMAN OTC DRUG','good sense tussin dm','','Dextromethorphan Hydrobromide, Guaifenesin','SOLUTION','ORAL','19910918','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN','20; 200','mg/10mL; mg/10mL','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0374_caed078a-263c-49b9-8653-3c6aab20fefe','0113-0374','HUMAN OTC DRUG','good sense migraine formula','','Acetaminophen, Aspirin, Caffeine','TABLET, FILM COATED','ORAL','20020417','','ANDA','ANDA075794','L. Perrigo Company','ACETAMINOPHEN; ASPIRIN; CAFFEINE','250; 250; 65','mg/1; mg/1; mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0379_466179f1-5a47-4402-95fc-bdb03c990209','0113-0379','HUMAN OTC DRUG','good sense allergy','','Diphenhydramine HCl','SOLUTION','ORAL','19890915','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','DIPHENHYDRAMINE HYDROCHLORIDE','12.5','mg/5mL','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0384_dbc57b22-16cb-45b2-8f36-1fcc7c5a0093','0113-0384','HUMAN OTC DRUG','good sense cough dm','','dextromethorphan polistirex','SUSPENSION','ORAL','20130201','','ANDA','ANDA091135','L. Perrigo Company','DEXTROMETHORPHAN HYDROBROMIDE','30','mg/5mL','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0388_244eff85-348f-42a5-a26e-aaaee89bfc69','0113-0388','HUMAN OTC DRUG','good sense nasal','','Oxymetazoline HCl','SPRAY','NASAL','20020513','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','OXYMETAZOLINE HYDROCHLORIDE','0.05','g/100mL','Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0397_41c0db0e-4e26-4e6f-a3c2-7196becc38f1','0113-0397','HUMAN OTC DRUG','Good Sense Pain and Fever','','acetaminophen','SUSPENSION','ORAL','20120322','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN','160','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0401_ad24e53e-53b1-46e5-a135-1d35d6601ef0','0113-0401','HUMAN OTC DRUG','Zephrex D','','pseudoephedrine hydrochloride','CAPSULE, GELATIN COATED','ORAL','20161104','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','PSEUDOEPHEDRINE HYDROCHLORIDE','30','mg/1','Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0403_a6be230d-93ee-406b-8eba-b8dadf41e0f2','0113-0403','HUMAN OTC DRUG','good sense pain relief','','Acetaminophen','TABLET','ORAL','19890815','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN','325','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0416_5631f047-211a-4f65-8d2c-5276adffc0d9','0113-0416','HUMAN OTC DRUG','good sense aspirin','','Aspirin','TABLET, FILM COATED','ORAL','19910415','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ASPIRIN','325','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0419_0a2cee63-5cc7-452c-a183-1dd337e557cf','0113-0419','HUMAN OTC DRUG','Good Sense Childrens Mucus Relief Cough','','Dextromethorphan Hydrobromide, Guaifenesin','SOLUTION','ORAL','20071127','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN','5; 100','mg/5mL; mg/5mL','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0422_4a1988e4-44f8-4f67-b9c0-410f09e4a865','0113-0422','HUMAN OTC DRUG','Good Sense Nicotine','','Nicotine Polacrilex','GUM, CHEWING','ORAL','20050422','','ANDA','ANDA078326','L. Perrigo Company','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0426_d39ac447-6e1d-4b77-90c1-a9a653661f42','0113-0426','HUMAN OTC DRUG','good sense tioconazole 1','','Tioconazole','OINTMENT','VAGINAL','20191022','','ANDA','ANDA075915','L. Perrigo Company','TIOCONAZOLE','6.5','g/100g','Azole Antifungal [EPC], Azoles [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0428_4bb9659c-b4d0-44f5-93e8-307fc4964351','0113-0428','HUMAN OTC DRUG','Good Sense Gas Relief','Extra Strength','Simethicone','CAPSULE, LIQUID FILLED','ORAL','19990209','','OTC MONOGRAPH FINAL','part332','L. Perrigo Company','DIMETHICONE','125','mg/1','Skin Barrier Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0431_a20fd99d-d764-4152-a503-d5a4562a1196','0113-0431','HUMAN OTC DRUG','good sense nighttime sleep aid','','Diphenhydramine Hydrochloride','TABLET, FILM COATED','ORAL','20010425','','OTC MONOGRAPH FINAL','part338','L. Perrigo Company','DIPHENHYDRAMINE HYDROCHLORIDE','25','mg/1','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0432_44b5fcf0-1cc1-48be-804b-b732482d5caa','0113-0432','HUMAN OTC DRUG','Good Sense Nasal Decongestant','','Pseudoephedrine HCl','TABLET, FILM COATED','ORAL','19890915','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','PSEUDOEPHEDRINE HYDROCHLORIDE','30','mg/1','Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0437_fb1e6733-84d0-491f-badb-974a5e720c19','0113-0437','HUMAN OTC DRUG','good sense pain relief pm','extra strength','Acetaminophen, Diphenhydramine HCl','TABLET, FILM COATED','ORAL','19920723','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE','500; 25','mg/1; mg/1','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0441_109a2834-9fdd-4e6e-bce9-5639acc6b3ed','0113-0441','HUMAN OTC DRUG','Good sense sleep aid','','Doxylamine succinate','TABLET','ORAL','19970414','','ANDA','ANDA040167','L. Perrigo Company','DOXYLAMINE SUCCINATE','25','mg/1','Antihistamine [EPC], Histamine Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0443_164f6aaa-f280-4eeb-8837-606b8ff7283b','0113-0443','HUMAN OTC DRUG','Good Sense Nasal Allergy','','Triamcinolone acetonide','SPRAY, METERED','NASAL','20170209','','ANDA','ANDA078104','L. Perrigo Company','TRIAMCINOLONE ACETONIDE','55','ug/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0456_06546e70-d3e8-4e86-94d0-c19a899ad463','0113-0456','HUMAN OTC DRUG','Good Sense Nicotine','','Nicotine Polacrilex','GUM, CHEWING','ORAL','20070307','','ANDA','ANDA076777','L. Perrigo Company','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0459_fab13cb5-b480-44c0-a88a-de70d2b959b6','0113-0459','HUMAN OTC DRUG','good sense nighttime','','Acetaminophen, Dextromethorphan HBr, Doxylamine succinate','SOLUTION','ORAL','20110822','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE','650; 30; 12.5','mg/30mL; mg/30mL; mg/30mL','Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0467_f975afad-02ce-4488-be1c-9c36ecf1d704','0113-0467','HUMAN OTC DRUG','good sense aspirin','','Aspirin','TABLET, CHEWABLE','ORAL','19921104','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ASPIRIN','81','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0471_ecd6d841-40b9-42c9-825d-d172cd04824d','0113-0471','HUMAN OTC DRUG','Good Sense Anti Itch','','hydrocortisone','OINTMENT','TOPICAL','20210123','','OTC MONOGRAPH NOT FINAL','part348','L. Perrigo Company','HYDROCORTISONE','1','g/100g','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0479_afc2b077-21e7-4af6-9130-ac60575fa76e','0113-0479','HUMAN OTC DRUG','good sense allergy relief','','Diphenhydramine Hydrochloride','TABLET','ORAL','19910820','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','DIPHENHYDRAMINE HYDROCHLORIDE','25','mg/1','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0484_7688cfd4-2efa-4a56-8443-591e36ebc809','0113-0484','HUMAN OTC DRUG','Good Sense Pain Relief','','Acetaminophen','TABLET','ORAL','19890915','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN','500','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0486_91c7df63-441e-4435-9e76-fa0521a48af4','0113-0486','HUMAN OTC DRUG','good sense stool softener','','Docusate sodium','CAPSULE, LIQUID FILLED','ORAL','19911029','','OTC MONOGRAPH NOT FINAL','part334','L. Perrigo Company','DOCUSATE SODIUM','100','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0503_f3c1d41a-1538-4dca-912c-d7e787f48ff4','0113-0503','HUMAN OTC DRUG','Good Sense Childrens All Day Allergy','','Cetirizine HCl','SOLUTION','ORAL','20160111','','ANDA','ANDA204226','L. Perrigo Company','CETIRIZINE HYDROCHLORIDE','5','mg/5mL','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0517_8d5c8b80-17db-4b85-ada2-e828b5b6f185','0113-0517','HUMAN OTC DRUG','Good Sense ibuprofen','','Ibuprofen','TABLET, FILM COATED','ORAL','20060427','','ANDA','ANDA077349','L. Perrigo Company','IBUPROFEN','200','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0518_4f67bf99-e703-422d-baf5-b24b33634ea9','0113-0518','HUMAN OTC DRUG','good sense pain relief','','Acetaminophen','TABLET, FILM COATED','ORAL','20180928','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN','500','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0520_a4b86766-3372-492a-9065-2c2dcb9cfcc5','0113-0520','HUMAN OTC DRUG','good sense omeprazole','','omeprazole','TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE','ORAL','20180619','','NDA','NDA209400','L. Perrigo Company','OMEPRAZOLE','20','mg/1','Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0532_248438c4-dbf0-49d2-8682-54dd4ac4d523','0113-0532','HUMAN OTC DRUG','Good Sense Nicotine','','Nicotine Polacrilex','GUM, CHEWING','ORAL','19900715','','ANDA','ANDA076779','L. Perrigo Company','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0541_3a4751c0-676e-4875-8331-f701e905ebd1','0113-0541','HUMAN OTC DRUG','good sense anti itch','','Hydrocortisone','CREAM','TOPICAL','20060224','','OTC MONOGRAPH NOT FINAL','part348','L. Perrigo Company','HYDROCORTISONE','1','g/100g','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0544_45da619d-b51a-4363-8246-fff1f60ff34b','0113-0544','HUMAN OTC DRUG','good sense pain relief','arthritis pain','Acetaminophen','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20051121','','ANDA','ANDA075077','L. Perrigo Company','ACETAMINOPHEN','650','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0567_6c169871-e364-406d-800d-2a034c091ad4','0113-0567','HUMAN OTC DRUG','Good Sense NightTime DayTime Cold and Flu','','Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl','KIT','','20140103','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0571_a6f6ab69-e633-43ec-8064-734b73529c88','0113-0571','HUMAN OTC DRUG','good sense aller ease','','fexofenadine hydrochloride','TABLET, FILM COATED','ORAL','20110414','','ANDA','ANDA076447','L. Perrigo Company','FEXOFENADINE HYDROCHLORIDE','180','mg/1','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0578_603a3551-d2fc-4861-9a62-34caa2324def','0113-0578','HUMAN OTC DRUG','good sense tussin dm','cough and chest congestion','Dextromethorphan HBr, Guaifenesin','SOLUTION','ORAL','19940920','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN','20; 200','mg/10mL; mg/10mL','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0590_6b0cd804-6ccf-47b9-b233-a58ba4a8ed6b','0113-0590','HUMAN OTC DRUG','Good Sense Pain and Fever','','acetaminophen','SUSPENSION','ORAL','20111108','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN','160','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0603_a08c5fee-fd6e-48e6-aab0-13df2043c29a','0113-0603','HUMAN OTC DRUG','Good Sense Severe Daytime Cold and Flu','','acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl','SOLUTION','ORAL','20131119','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE','325; 10; 200; 5','mg/15mL; mg/15mL; mg/15mL; mg/15mL','Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0604_78126925-6a91-4837-84c4-404307955edc','0113-0604','HUMAN OTC DRUG','good sense ibuprofen','','Ibuprofen','TABLET, FILM COATED','ORAL','19890915','','ANDA','ANDA072096','L. Perrigo Company','IBUPROFEN','200','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0608_417939ae-0b75-4972-956e-2da0d99a2501','0113-0608','HUMAN OTC DRUG','good sense childrens pain and fever','','Acetaminophen','SUSPENSION','ORAL','19931008','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN','160','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0612_e82216ed-9b74-4ab6-a3c8-2aa7d87362c7','0113-0612','HUMAN OTC DRUG','good sense allergy relief','','Loratadine','TABLET','ORAL','20040921','','ANDA','ANDA076301','L. Perrigo Company','LORATADINE','10','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0622_c8bb8bb3-88c8-432e-80b7-a9a803f22010','0113-0622','HUMAN OTC DRUG','good sense itch relief','','Diphenhydramine Hydrochloride, Zinc Acetate','CREAM','TOPICAL','20060718','','OTC MONOGRAPH NOT FINAL','part348','L. Perrigo Company','DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE','2; .1','g/100g; g/100g','Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0647_1ed7b480-cc1e-477e-a5dc-e55dbbbf8751','0113-0647','HUMAN OTC DRUG','good sense ibuprofen','','Ibuprofen','TABLET, FILM COATED','ORAL','19910215','','ANDA','ANDA072096','L. Perrigo Company','IBUPROFEN','200','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0648_579b5597-9b70-4cdb-9cc4-c0e25460d126','0113-0648','HUMAN OTC DRUG','Good Sense Nasal Four','','Phenylephrine hydrochloride','SPRAY','NASAL','20020809','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','PHENYLEPHRINE HYDROCHLORIDE','1','g/100mL','Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0651_e54f2cc9-1d5f-4f0a-8bcf-bd5b917d98ec','0113-0651','HUMAN OTC DRUG','good sense esomeprazole magnesium','','esomeprazole','CAPSULE, DELAYED RELEASE','ORAL','20200405','','ANDA','ANDA207193','L. Perrigo Company','ESOMEPRAZOLE','20','mg/1','Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0656_202a8237-76aa-4649-b199-da62997ef4f3','0113-0656','HUMAN OTC DRUG','Good Sense Daytime','non drowsy cold and flu','acetaminophen, dextromethorphan Hbr, Phenylephrine HCl','SOLUTION','ORAL','20060725','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE','325; 10; 5','mg/15mL; mg/15mL; mg/15mL','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0657_a0077466-24bc-435a-a768-7651aa920c23','0113-0657','HUMAN OTC DRUG','good sense gas relief','','Simethicone','CAPSULE, LIQUID FILLED','ORAL','20020405','','OTC MONOGRAPH FINAL','part332','L. Perrigo Company','DIMETHICONE','180','mg/1','Skin Barrier Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0660_18236c8b-21ee-46eb-b0f2-2c5649d6736c','0113-0660','HUMAN OTC DRUG','Good Sense Ibuprofen','Childrens','Ibuprofen','SUSPENSION','ORAL','20020409','','ANDA','ANDA074937','L. Perrigo Company','IBUPROFEN','100','mg/5mL','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0668_3865028d-6ece-4633-aa41-a248cd171b4e','0113-0668','HUMAN OTC DRUG','Good Sense Nighttime Cough','','Dextromethorphan Hydrobromide, Doxylamine Succinate','SOLUTION','ORAL','20021103','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE','30; 12.5','mg/30mL; mg/30mL','Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0671_637e309d-9846-45a1-ad11-f67ea85c87b8','0113-0671','HUMAN OTC DRUG','Good Sense childrens allergy relief','','Loratadine','SOLUTION','ORAL','20200802','','ANDA','ANDA075728','L. Perrigo Company','LORATADINE','5','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0679_9bd1956f-ece5-4324-a7b9-4083f5db7937','0113-0679','HUMAN OTC DRUG','Good Sense Triple Antibiotic','and Pain Relief','Bacitracin, Neomycin, Polymyxin B, Pramoxine HCl','OINTMENT','TOPICAL','20060214','','OTC MONOGRAPH FINAL','part333B','L. Perrigo Company','BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE','500; 3.5; 10000; 10','[USP''''U]/g; mg/g; [USP''''U]/g; mg/g','Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0685_1fda427d-2145-4653-ad35-e78f2100c5c7','0113-0685','HUMAN OTC DRUG','Good Sense Ibuprofen','','Ibuprofen','SUSPENSION','ORAL','20110428','','ANDA','ANDA074937','L. Perrigo Company','IBUPROFEN','100','mg/5mL','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0701_f845cfe6-b9d9-4617-94ae-5e35736dfc8a','0113-0701','HUMAN OTC DRUG','basic care first aid antibiotic','','bacitracin zinc, neomycin, polymyxin B','OINTMENT','TOPICAL','20180205','','OTC MONOGRAPH FINAL','part333B','L. Perrigo Company','BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE','400; 3.5; 5000','[USP''''U]/g; mg/g; [USP''''U]/g','Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0703_b99aa597-e032-4240-83d6-3d207ea0f1de','0113-0703','HUMAN OTC DRUG','Good Sense Tussin CF','','Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride','SOLUTION','ORAL','20140729','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE','20; 200; 10','mg/10mL; mg/10mL; mg/10mL','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0704_8e9a1400-cfc9-47ef-9aab-3cbc5982dabc','0113-0704','HUMAN OTC DRUG','basic care nicotine','','Nicotine polacrilex','GUM, CHEWING','ORAL','20180122','','ANDA','ANDA206394','L. Perrigo Company','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0713_d5403a70-3b14-4e52-9eb4-804cef20aa1a','0113-0713','HUMAN OTC DRUG','basic care nicotine','','Nicotine Polacrilex','GUM, CHEWING','ORAL','20180109','','ANDA','ANDA206393','L. Perrigo Company','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0734_b33212e7-8e2d-4742-a88b-b776557d06c2','0113-0734','HUMAN OTC DRUG','Good Sense Nicotine','','Nicotine Polacrilex','LOZENGE','ORAL','20130422','','ANDA','ANDA203690','L. Perrigo Company','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0749_3ca879a9-5094-4e5d-92a2-ba3be96329e0','0113-0749','HUMAN OTC DRUG','basic care nicotine','','Nicotine Polacrilex','GUM, CHEWING','ORAL','20171227','','ANDA','ANDA078326','L. Perrigo Company','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0761_a243fe21-f302-4c39-b0c0-1cfe3cb5f28c','0113-0761','HUMAN OTC DRUG','basic care nicotine','','Nicotine Polacrilex','GUM, CHEWING','ORAL','20171219','','ANDA','ANDA078325','L. Perrigo Company','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0763_8bcff665-bb45-486b-b119-0cedb86568ca','0113-0763','HUMAN OTC DRUG','Good Sense Severe NightTime Cold and Flu','','Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl','SOLUTION','ORAL','20131119','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE','650; 20; 12.5; 10','mg/30mL; mg/30mL; mg/30mL; mg/30mL','Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0773_be8c6949-8378-4af2-b18e-9134c8826652','0113-0773','HUMAN OTC DRUG','Basic Care Aspirin','','Aspirin','TABLET, FILM COATED','ORAL','20171219','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ASPIRIN','325','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0791_0226c6f9-c974-4aec-b524-7ff09bdbaf0d','0113-0791','HUMAN OTC DRUG','tussin dm','','Dextromethorphan HBr, Guaifenesin','SOLUTION','ORAL','20180109','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN','20; 200','mg/10mL; mg/10mL','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0793_8d133c5e-a2d8-4d30-9bd4-5474491b3173','0113-0793','HUMAN OTC DRUG','basic care hydrocortisone','','hydrocortisone','CREAM','TOPICAL','20180202','','OTC MONOGRAPH NOT FINAL','part348','L. Perrigo Company','HYDROCORTISONE','1','g/100g','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0798_7f33f95b-eb15-4134-bdca-6150d6d2e873','0113-0798','HUMAN OTC DRUG','Good Sense Hair Regrowth Treatment','for Men','Minoxidil','SOLUTION','TOPICAL','20100210','','ANDA','ANDA075598','L. Perrigo Company','MINOXIDIL','3','g/60mL','Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0808_6f51e788-012d-41d6-94cd-b752c4e01325','0113-0808','HUMAN OTC DRUG','Childrens Night Time Cold and Cough','','Diphenhydramine HCl, Phenylephrine HCl','SOLUTION','ORAL','20220112','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE','6.25; 2.5','mg/5mL; mg/5mL','Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0812_3310344d-dabf-4f1b-900f-f85ff30524b0','0113-0812','HUMAN OTC DRUG','good sense mucus dm','','dextromethorphan HBr, guaifenesin','TABLET, EXTENDED RELEASE','ORAL','20180621','','ANDA','ANDA207602','L Perrigo Company','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN','60; 1200','mg/1; mg/1','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0817_bbbfb1cd-55c6-4b35-8c3d-48f9ad1ba7d3','0113-0817','HUMAN OTC DRUG','Good Sense Nasal','','oxymetazoline hydrochloride','SPRAY','NASAL','19960418','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','OXYMETAZOLINE HYDROCHLORIDE','0.05','g/100mL','Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0825_684d5988-5cf7-45ca-9918-612c7de46fce','0113-0825','HUMAN OTC DRUG','good sense miconazole 7','','Miconazole nitrate','CREAM','VAGINAL','20000222','','ANDA','ANDA074760','L. Perrigo Company','MICONAZOLE NITRATE','2','g/100g','Azole Antifungal [EPC], Azoles [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0839_fd178374-704c-4e22-ab38-4db738c35a17','0113-0839','HUMAN OTC DRUG','Good Sense Childrens Mucus Relief','','dextromethorphan HBr, guaifenesin, phenylephrine HCl','LIQUID','ORAL','20140325','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE','5; 100; 2.5','mg/5mL; mg/5mL; mg/5mL','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0847_e533a008-b437-401e-ab50-bda31e6662d3','0113-0847','HUMAN OTC DRUG','good sense aller ease','','fexofenadine hydrochloride','TABLET, FILM COATED','ORAL','20210910','','ANDA','ANDA212971','L. Perrigo Company','FEXOFENADINE HYDROCHLORIDE','180','mg/1','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0854_1a70768d-b4f6-4a32-9d1a-24022f7184fe','0113-0854','HUMAN OTC DRUG','Good Sense Nicotine','','Nicotine polacrilex','GUM, CHEWING','ORAL','20130514','','ANDA','ANDA078546','L. Perrigo Company','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0857_5ff06e61-512b-45a5-9a29-82c5ccdf75c2','0113-0857','HUMAN OTC DRUG','Good Sense Athletes Foot','antifungal','Clotrimazole','CREAM','TOPICAL','20060409','','OTC MONOGRAPH FINAL','part333C','L. Perrigo Company','CLOTRIMAZOLE','1','g/100g','Azole Antifungal [EPC], Azoles [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0866_2b64e417-83e4-4faf-9da8-9c0b504fac59','0113-0866','HUMAN OTC DRUG','good sense lice killing','','Piperonyl butoxide, Pyrethrum extract','SHAMPOO','TOPICAL','20071208','','OTC MONOGRAPH FINAL','part358G','L. Perrigo Company','PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT','4; .33','g/100mL; g/100mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0873_b5fea7eb-e206-4175-b719-8ca44c32c879','0113-0873','HUMAN OTC DRUG','good sense nicotine','','Nicotine Polacrilex','LOZENGE','ORAL','20061227','','ANDA','ANDA077007','L. Perrigo Company','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0897_0ce3c522-4b65-4cd5-b4a8-092714a0c4c4','0113-0897','HUMAN OTC DRUG','good sense ibuprofen','childrens','Ibuprofen','SUSPENSION','ORAL','19990107','','ANDA','ANDA074937','L. Perrigo Company','IBUPROFEN','100','mg/5mL','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0898_eaf22ec0-4bd2-434a-8a3a-3617279feb36','0113-0898','HUMAN OTC DRUG','Good Sense Esomeprazole Magnesium','','Esomeprazole','CAPSULE, DELAYED RELEASE','ORAL','20170922','','ANDA','ANDA207193','L. Perrigo Company','ESOMEPRAZOLE','20','mg/1','Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0901_c87f166e-aff7-41b7-9286-1360653967af','0113-0901','HUMAN OTC DRUG','Good Sense Naproxen Sodium','','Naproxen Sodium','TABLET, FILM COATED','ORAL','20140423','','ANDA','ANDA074661','L. Perrigo Company','NAPROXEN SODIUM','220','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0903_70ea16bb-1d1b-4ab6-8219-4bf49645f829','0113-0903','HUMAN OTC DRUG','good sense cold','','Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan HBr, Phenylephrine HCl','SUSPENSION','ORAL','20101222','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE','160; 1; 5; 2.5','mg/5mL; mg/5mL; mg/5mL; mg/5mL','Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0915_1a6d4adc-376d-4439-a292-24799b886cca','0113-0915','HUMAN OTC DRUG','Good Sense Omeprazole','','Omeprazole','TABLET, DELAYED RELEASE','ORAL','20080228','','NDA','NDA022032','L. Perrigo Company','OMEPRAZOLE','20','mg/1','Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0927_05990fb7-dadd-4df2-b6c3-4187022d3980','0113-0927','HUMAN OTC DRUG','Good Sense Tussin DM Max','','Dextromethorphan HBr, Guaifenesin','SOLUTION','ORAL','20180801','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN','20; 400','mg/20mL; mg/20mL','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0944_3a1500cd-56c3-4751-9370-0d101543c7e6','0113-0944','HUMAN OTC DRUG','Good Sense Hemorrhoidal','Maximum Strength Pain Relief','glycerin, phenylephrine HCl, pramoxine HCl, white petrolatum','CREAM','TOPICAL','20080228','','OTC MONOGRAPH FINAL','part346','L. Perrigo Company','GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE','14.4; 15; .25; 1','g/100g; g/100g; g/100g; g/100g','Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0946_549e04b4-c925-4b9c-9b4c-fea1df778676','0113-0946','HUMAN OTC DRUG','good sense pain and fever','infants','Acetaminophen','SUSPENSION','ORAL','20111108','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN','160','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0957_dbb85c5f-031c-4cd3-8791-3ec14cc49baf','0113-0957','HUMAN OTC DRUG','Good Sense Nicotine','','Nicotine Polacrilex','LOZENGE','ORAL','20130427','','ANDA','ANDA203690','L. Perrigo Company','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0958_79797a69-3564-46c2-b358-3aba1f986334','0113-0958','HUMAN OTC DRUG','Good Sense Cough DM','','dextromethorphan polistirex','SUSPENSION','ORAL','20130620','','ANDA','ANDA091135','L. Perrigo Company','DEXTROMETHORPHAN HYDROBROMIDE','30','mg/5mL','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0964_1645dc0a-e818-4a23-8277-5cf48283ba78','0113-0964','HUMAN OTC DRUG','good sense flu and severe cold and cough','nighttime','Acetaminophen, Diphenhydramine hydrochloride, Phenylephrine hydrochloride','POWDER, FOR SOLUTION','ORAL','20100917','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE','650; 25; 10','mg/1; mg/1; mg/1','Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0973_db7c35fa-99b2-4e94-93e5-f859af8e0bb9','0113-0973','HUMAN OTC DRUG','Good Sense Anti Itch','','hydrocortisone','CREAM','TOPICAL','20060307','','OTC MONOGRAPH NOT FINAL','part348','L. Perrigo Company','HYDROCORTISONE','1','g/100g','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0981_5b1203c7-9678-4cee-9d7b-6510da295561','0113-0981','HUMAN OTC DRUG','Good Sense All Day Allergy','','cetirizine hydrochloride','CAPSULE, LIQUID FILLED','ORAL','20220901','','ANDA','ANDA213105','L. Perrigo Company','CETIRIZINE HYDROCHLORIDE','10','mg/1','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0987_3bcb30cd-9bac-4974-bc3a-11908735e30a','0113-0987','HUMAN OTC DRUG','Good Sense Childrens Cold and Cough','','Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl','SOLUTION','ORAL','20070224','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE','2; 10; 5','mg/10mL; mg/10mL; mg/10mL','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0994_7c7709dc-7868-427a-b69c-d85c729ee362','0113-0994','HUMAN OTC DRUG','good sense daytime','','Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl','CAPSULE, LIQUID FILLED','ORAL','20070118','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE','325; 10; 5','mg/1; mg/1; mg/1','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-0998_39f34cb8-b1ee-406e-93d5-fbcaf0afde1e','0113-0998','HUMAN OTC DRUG','Good Sense Childrens Pain and Fever','','Acetaminophen','SUSPENSION','ORAL','20100729','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN','160','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1019_bf0ac006-ed30-4f8b-89ed-e71464f7e951','0113-1019','HUMAN OTC DRUG','good sense childrens allergy relief','','loratadine','TABLET, CHEWABLE','ORAL','20190731','','ANDA','ANDA210033','L. Perrigo Company','LORATADINE','5','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1023_9858edef-cdb2-4ac4-8e4b-ba0720a24e41','0113-1023','HUMAN OTC DRUG','good sense clearlax','','Polyethylene Glycol 3350','POWDER, FOR SOLUTION','ORAL','20221227','','ANDA','ANDA090685','L. Perrigo Company','POLYETHYLENE GLYCOL 3350','17','g/17g','Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1032_2dfdba22-7876-4f8f-97a6-aadb9c45fb28','0113-1032','HUMAN OTC DRUG','Good Sense Hair Regrowth Treatment','','minoxidil','SOLUTION','TOPICAL','20210525','','ANDA','ANDA075598','L. Perrigo Company','MINOXIDIL','5','g/100mL','Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1087_fcfd0b64-6876-4e6f-8a7b-ca1da9e03f00','0113-1087','HUMAN OTC DRUG','Good Sense Anti Diarrheal Anti Gas','','loperamide hydrochloride, simethicone','TABLET','ORAL','20190129','','ANDA','ANDA209837','L. Perrigo Company','DIMETHICONE; LOPERAMIDE HYDROCHLORIDE','125; 2','mg/1; mg/1','Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1114_91d69826-df5c-47a2-b852-3083629d1893','0113-1114','HUMAN OTC DRUG','Good Sense Lansoprazole','','Lansoprazole','CAPSULE, DELAYED RELEASE','ORAL','20211122','','ANDA','ANDA202319','L. Perrigo Company','LANSOPRAZOLE','15','mg/1','Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1125_dd334b2c-bbae-48e7-8f3d-2706d325f600','0113-1125','HUMAN OTC DRUG','Good Sense Nicotine','','Nicotine Polacrilex','LOZENGE','ORAL','20200707','','ANDA','ANDA090711','L. Perrigo Company','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1129_e591d9e0-87d9-475f-8958-5f5c32fdaa83','0113-1129','HUMAN OTC DRUG','Good Sense Hair Regrowth Treatment','','Minoxidil','AEROSOL, FOAM','TOPICAL','20190129','','ANDA','ANDA091344','L. Perrigo Company','MINOXIDIL','50','mg/g','Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1140_e9e913d8-8ec8-4465-ad3a-b524f6710a0f','0113-1140','HUMAN OTC DRUG','good sense triple antibiotic','','Bacitracin Zinc, Neomycin sulfate, Polymyxin B, Pramoxine HCl','OINTMENT','TOPICAL','20181229','','OTC MONOGRAPH FINAL','part333B','L. Perrigo Company','BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE','500; 3.5; 10000; 10','[USP''''U]/g; mg/g; [USP''''U]/g; mg/g','Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1189_b0176916-86ec-40a2-aa53-47b44c978e0f','0113-1189','HUMAN OTC DRUG','good sense arthritis pain','','diclofenac sodium','GEL','TOPICAL','20200822','','ANDA','ANDA211253','L. Perrigo Company','DICLOFENAC SODIUM','10','mg/g','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1190_69c7b6f8-7200-4b9e-ac85-2e2c5c5eeda7','0113-1190','HUMAN OTC DRUG','good sense nicotine','','Nicotine Polacrilex','LOZENGE','ORAL','20190227','','ANDA','ANDA090711','L. Perrigo Company','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1191_288efba1-b795-4272-a8b6-259c70be2f40','0113-1191','HUMAN OTC DRUG','good sense allergy relief','','loratadine','TABLET, ORALLY DISINTEGRATING','ORAL','20200806','','ANDA','ANDA076011','L. Perrigo Company','LORATADINE','10','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1212_aeb163b5-773d-4a07-b95a-898411d08b6f','0113-1212','HUMAN OTC DRUG','Good Sense Ibuprofen','','Ibuprofen','TABLET, FILM COATED','ORAL','20201019','','ANDA','ANDA072096','L. Perrigo Company','IBUPROFEN','200','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1352_32658477-e904-48ff-87f2-ec21ddb28df9','0113-1352','HUMAN OTC DRUG','good sense nicotine','','Nicotine Polacrilex','GUM, CHEWING','ORAL','20181129','','ANDA','ANDA078547','L. Perrigo Company','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1369_fe2be0f9-f563-4254-9a2c-b8d99f6b8ff1','0113-1369','HUMAN OTC DRUG','good sense anti itch','','Hydrocortisone','CREAM','TOPICAL','20190604','','OTC MONOGRAPH NOT FINAL','part348','L. Perrigo Company','HYDROCORTISONE','1','g/100g','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1412_a980b939-f74d-4e95-87a8-65ad5a783ac5','0113-1412','HUMAN OTC DRUG','good sense naproxen sodium','','naproxen sodium','TABLET, FILM COATED','ORAL','20211109','','ANDA','ANDA074661','L. Perrigo Company','NAPROXEN SODIUM','220','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1612_bf838a8e-a12d-4970-8613-56a8b1864f33','0113-1612','HUMAN OTC DRUG','good sense allergy relief','','Loratadine','TABLET','ORAL','20180926','','ANDA','ANDA076301','L. Perrigo Company','LORATADINE','10','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1619_93e7ba56-5682-4184-9a93-3b4b972b0e72','0113-1619','HUMAN OTC DRUG','good sense migraine formula','','acetaminophen, aspirin, caffeine','TABLET, FILM COATED','ORAL','20220624','','ANDA','ANDA075794','L. Perrigo Company','ACETAMINOPHEN; ASPIRIN; CAFFEINE','250; 250; 65','mg/1; mg/1; mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1645_d87b5c7e-a791-426b-a60e-fae9b46e2495','0113-1645','HUMAN OTC DRUG','Good Sense antidiarrheal','','loperamide HCl','SOLUTION','ORAL','20180521','','ANDA','ANDA091292','L. Perrigo Company','LOPERAMIDE HYDROCHLORIDE','1','mg/7.5mL','Opioid Agonist [EPC], Opioid Agonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1719_4ce244e2-9fbc-4371-8806-789fd3a61a09','0113-1719','HUMAN OTC DRUG','good sense childrens allergy relief','','Loratadine','SOLUTION','ORAL','20190530','','ANDA','ANDA075728','L. Perrigo Company','LORATADINE','5','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1720_e72e2a6f-78ac-4319-adae-2d40d1ac6490','0113-1720','HUMAN OTC DRUG','Nasonex','','mometasone furoate','SPRAY','NASAL','20220629','','NDA','NDA215712','L. Perrigo Company','MOMETASONE FUROATE MONOHYDRATE','50','ug/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1723_2726e5fd-0cd1-45b8-900b-1c296e9a794e','0113-1723','HUMAN OTC DRUG','Good Sense Omeprazole','','Omeprazole','TABLET, DELAYED RELEASE','ORAL','20190522','','NDA','NDA022032','L. Perrigo Company','OMEPRAZOLE','20','mg/1','Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1725_75272209-4a3d-45b1-a131-a8d52e479641','0113-1725','HUMAN OTC DRUG','good sense tussin dm','','dextromethorphan hydrobromide, guaifenesin','SOLUTION','ORAL','20220416','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN','20; 200','mg/20mL; mg/20mL','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1803_38082e59-c509-4be5-b29c-33a97565df1c','0113-1803','HUMAN OTC DRUG','good sense omeprazole delayed release','','omeprazole','TABLET, DELAYED RELEASE','ORAL','20211221','','NDA','NDA022032','L. Perrigo Company','OMEPRAZOLE','20','mg/1','Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1855_4cae0580-7ee3-4f38-8d13-79c7d7615f8f','0113-1855','HUMAN OTC DRUG','good sense headache relief','','acetaminophen, aspirin, caffeine','TABLET, FILM COATED','ORAL','20220218','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN; ASPIRIN; CAFFEINE','250; 250; 65','mg/1; mg/1; mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1889_d244abe3-6be3-4f25-8016-8c2ebc766152','0113-1889','HUMAN OTC DRUG','good sense pain relief','','acetaminophen','TABLET, FILM COATED','ORAL','20200122','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN','500','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1909_97d65237-0aa3-4a53-9b0b-d5fb5533f69b','0113-1909','HUMAN OTC DRUG','good sense sleep aid','','diphenhydramine hydrochloride','CAPSULE, LIQUID FILLED','ORAL','20190530','','OTC MONOGRAPH FINAL','part338','L. Perrigo Company','DIPHENHYDRAMINE HYDROCHLORIDE','50','mg/1','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1910_16e69f99-ef67-4d31-8f52-e792c0d73ca8','0113-1910','HUMAN OTC DRUG','good sense lice killing creme rinse','','Permethrin','LOTION','TOPICAL','20190724','','ANDA','ANDA076090','L. Perrigo Company','PERMETHRIN','1','mg/100mL','Pyrethrins [CS], Pyrethroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1913_ecabb6b9-e23b-45f9-9ff0-d9e4e2617e89','0113-1913','HUMAN OTC DRUG','good sense mucus relief cold flu and sore throat','','Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl','SOLUTION','ORAL','20201003','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE','650; 20; 400; 10','mg/20mL; mg/20mL; mg/20mL; mg/20mL','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1919_0e94ef2d-e608-4af5-bce2-729ef4dc2427','0113-1919','HUMAN OTC DRUG','Good Sense Aspirin','','aspirin','TABLET, FILM COATED','ORAL','20210310','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ASPIRIN','325','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-1975_7f2038d3-9c95-4d83-b459-49ba8a3cd0ad','0113-1975','HUMAN OTC DRUG','Good Sense Pain Relief','','Acetaminophen','TABLET','ORAL','20220123','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN','500','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-2003_81d8cf01-db5e-44c9-842b-eec3f3793ea1','0113-2003','HUMAN OTC DRUG','Option 2','','levonorgestrel','TABLET','ORAL','20160129','','ANDA','ANDA202334','L. Perrigo Company','LEVONORGESTREL','1.5','mg/1','Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-2004_ba075037-be24-4620-8359-a9576de43e97','0113-2004','HUMAN OTC DRUG','sinus PE','','Phenylephrine Hydrochloride','TABLET','ORAL','20150918','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','PHENYLEPHRINE HYDROCHLORIDE','10','mg/1','Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-2007_e37599d0-af3e-4951-8790-e15aeac23603','0113-2007','HUMAN OTC DRUG','Allergy and Congestion Relief','','loratadine, Pseudoephedrine sulfate','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20180412','','ANDA','ANDA076050','L. Perrigo Company','LORATADINE; PSEUDOEPHEDRINE SULFATE','5; 120','mg/1; mg/1','Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-2008_84ba172c-07a9-4153-8e4a-c2027bda8dc9','0113-2008','HUMAN OTC DRUG','sinus congestion','','Pseudoephedrine HCl','TABLET, FILM COATED','ORAL','20161004','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','PSEUDOEPHEDRINE HYDROCHLORIDE','30','mg/1','Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-2023_5eece352-cb88-42a4-9e3f-751c7c05756f','0113-2023','HUMAN OTC DRUG','good sense mucus er','','guaifenesin','TABLET, MULTILAYER, EXTENDED RELEASE','ORAL','20200704','','ANDA','ANDA078912','L. Perrigo Company','GUAIFENESIN','600','mg/1','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-2061_3b84e130-b3b9-4b5b-9e43-cef52e1ab513','0113-2061','HUMAN OTC DRUG','tussin','mucus plus chest congestion','Guaifenesin','SOLUTION','ORAL','19870715','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','GUAIFENESIN','200','mg/10mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-2077_9ca6b665-0c0e-4c06-a56b-a3c0303e0df6','0113-2077','HUMAN OTC DRUG','good sense severe daytime cold and flu severe nighttime cold and flu','','acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, doxylamine succinate','KIT','','20210204','20230630','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','','','','','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-2219_3af10c62-e3b1-4861-8460-74006698c3f9','0113-2219','HUMAN OTC DRUG','Good Sense Mucus DM','','dextromethorphan hydrobromide, guaifenesin','TABLET, EXTENDED RELEASE','ORAL','20190710','','ANDA','ANDA207602','L. Perrigo Company','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN','30; 600','mg/1; mg/1','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-2224_e47631c6-5e8d-48ce-a5f3-4482e9a7463c','0113-2224','HUMAN OTC DRUG','anti diarrheal','','Loperamide HCl','TABLET, FILM COATED','ORAL','20180625','','ANDA','ANDA075232','L. Perrigo Company','LOPERAMIDE HYDROCHLORIDE','2','mg/1','Opioid Agonist [EPC], Opioid Agonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-2461_a8fc1b0c-dd69-4567-8eea-de4d9b0c7740','0113-2461','HUMAN OTC DRUG','Good Sense Childrens Ibuprofen','','Ibuprofen','TABLET, CHEWABLE','ORAL','20191009','','ANDA','ANDA076359','L. Perrigo Company','IBUPROFEN','100','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-3650_159d4955-7b43-442f-9d80-918cc7f6546b','0113-3650','HUMAN OTC DRUG','Good Sense Mucus ER','','Guaifenesin','TABLET, MULTILAYER, EXTENDED RELEASE','ORAL','20210320','','ANDA','ANDA213420','L. Perrigo Company','GUAIFENESIN','1200','mg/1','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-4368_e36e9148-2c01-4874-807a-84297259f3c4','0113-4368','HUMAN OTC DRUG','Good Sense Naproxen Sodium','','Naproxen Sodium','TABLET, FILM COATED','ORAL','20140331','','ANDA','ANDA074661','L. Perrigo Company','NAPROXEN SODIUM','220','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-4500_7437e114-489b-4423-84a1-afe660921a5a','0113-4500','HUMAN OTC DRUG','good sense severe day time cold and flu','','acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride','TABLET, FILM COATED','ORAL','20191202','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE','325; 10; 200; 5','mg/1; mg/1; mg/1; mg/1','Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-4501_3bc065d0-8c21-4097-ab30-6ddc38f161c4','0113-4501','HUMAN OTC DRUG','good sense ibuprofen','','ibuprofen','CAPSULE, LIQUID FILLED','ORAL','20220123','','ANDA','ANDA203599','L. Perrigo Company','IBUPROFEN','200','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-5300_b117358c-f4ca-4ea8-95ee-88a42cc05040','0113-5300','HUMAN OTC DRUG','good sense dual action','','Acetaminophen, Ibuprofen','TABLET, FILM COATED','ORAL','20230301','','ANDA','ANDA214836','L Perrigo Company','ACETAMINOPHEN; IBUPROFEN','250; 125','mg/1; mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-6002_8d885228-ab78-46bf-993b-8639a7bbd824','0113-6002','HUMAN OTC DRUG','Prevacid 24 HR','','lansoprazole','CAPSULE, DELAYED RELEASE','ORAL','20201105','','NDA','NDA022327','L. Perrigo Company','LANSOPRAZOLE','15','mg/1','Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-6004_cf5ccdf8-ab27-429f-a1b4-c51ced021046','0113-6004','HUMAN OTC DRUG','injoy diarrhea relief','','Loperamide HCl','TABLET, FILM COATED','ORAL','20220809','','ANDA','ANDA075232','L. Perrigo Company','LOPERAMIDE HYDROCHLORIDE','2','mg/1','Opioid Agonist [EPC], Opioid Agonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-6011_9d87da79-e681-444b-b7a1-a1587577c9f2','0113-6011','HUMAN OTC DRUG','injoy gas relief','','Simethicone','CAPSULE, LIQUID FILLED','ORAL','20220809','','OTC MONOGRAPH FINAL','part332','L. Perrigo Company','DIMETHICONE','125','mg/1','Skin Barrier Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-6023_aca1b9e5-a35e-4eef-b55a-4189cd1b2a02','0113-6023','HUMAN OTC DRUG','injoy heartburn relief','','famotidine, calcium carbonate and magnesium hydroxide','TABLET, CHEWABLE','ORAL','20220809','','ANDA','ANDA077355','L. Perrigo Company','CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE','800; 10; 165','mg/1; mg/1; mg/1','Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-6044_6907ffd1-39cb-4cc5-9c8a-bd975a5b06bd','0113-6044','HUMAN OTC DRUG','good sense sleep aid ultra','','Doxylamine Succinate','TABLET','ORAL','20220806','','ANDA','ANDA040167','L. Perrigo Company','DOXYLAMINE SUCCINATE','25','mg/1','Antihistamine [EPC], Histamine Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-6900_6923ff1e-b81b-46bb-a5ca-43038eef6984','0113-6900','HUMAN OTC DRUG','injoy constipation relief','','Polyethylene Glycol 3350','POWDER, FOR SOLUTION','ORAL','20220809','','ANDA','ANDA090685','L. Perrigo Company','POLYETHYLENE GLYCOL 3350','17','g/17g','Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7000_7ae8ac2b-9214-4341-b6bd-53f1742b4668','0113-7000','HUMAN OTC DRUG','Basic Care acetaminophen','','Acetaminophen','TABLET, FILM COATED','ORAL','20170810','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN','500','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7002_8a4a8453-7dea-4e4a-8536-cdc4d08fed5f','0113-7002','HUMAN OTC DRUG','Basic Care All Day Allergy','','Cetirizine Hydrochloride','TABLET, FILM COATED','ORAL','20170808','','ANDA','ANDA078336','L. Perrigo Company','CETIRIZINE HYDROCHLORIDE','10','mg/1','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7003_41207e47-b4d7-411d-9ba9-ed3c12849bf1','0113-7003','HUMAN OTC DRUG','Basic Care Lansoprazole','','Lansoprazole','CAPSULE, DELAYED RELEASE','ORAL','20170903','','ANDA','ANDA202319','L. Perrigo Company','LANSOPRAZOLE','15','mg/1','Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7006_0cadf2cf-84a9-43bb-a9fb-e15c2bdc6f9f','0113-7006','HUMAN OTC DRUG','Basic Case Hydrocortisone Anti-Itch','','hydrocortisone','CREAM','TOPICAL','20190522','','OTC MONOGRAPH NOT FINAL','part348','L. Perrigo Company','HYDROCORTISONE','1','g/100g','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7007_a627391d-3692-46d2-b7b5-252a1778f382','0113-7007','HUMAN OTC DRUG','basic care nicotine','','Nicotine Polacrilex','LOZENGE','ORAL','20190522','','ANDA','ANDA203690','L. Perrigo Company','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7008_5ff9bec6-0935-4076-a64a-37b9e4feaba1','0113-7008','HUMAN OTC DRUG','basic care nicotine','','nicotine polacrilex','LOZENGE','ORAL','20200221','','ANDA','ANDA203690','L. Perrigo Company','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7029_34f3f58a-0e75-4cd0-a8a5-28e6553df27e','0113-7029','HUMAN OTC DRUG','basic care nicotine','','Nicotine Polacrilex','GUM, CHEWING','ORAL','20170823','','ANDA','ANDA076775','L. Perrigo Company','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7032_9e8d4d3e-44cd-4e46-b3d9-c8b4e6fe108d','0113-7032','HUMAN OTC DRUG','basic care hair regrowth treatment','','minoxidil','SOLUTION','TOPICAL','20210826','','ANDA','ANDA075598','L. Perrigo Company','MINOXIDIL','5','g/100mL','Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7033_b12355d8-c36f-4af9-b981-e382cf0cff49','0113-7033','HUMAN OTC DRUG','basic care naproxen sodium','','Naproxen Sodium','TABLET, FILM COATED','ORAL','20190123','','ANDA','ANDA074661','L. Perrigo Company','NAPROXEN SODIUM','220','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7056_45136d7a-e593-4614-bdb8-e18f821b1564','0113-7056','HUMAN OTC DRUG','Basic Care Nighttime Cold and Flu','','Acetaminophen, Dextromethorphan HBr, Doxylamine succinate','CAPSULE, LIQUID FILLED','ORAL','20190109','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE','325; 15; 6.25','mg/1; mg/1; mg/1','Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7070_38f76beb-1cb7-4734-a393-9da28e7f1cc9','0113-7070','HUMAN OTC DRUG','basic care miconazole 3','','miconazole nitrate','CREAM','VAGINAL','20181107','','ANDA','ANDA091366','L. Perrigo Company','MICONAZOLE NITRATE','40','mg/g','Azole Antifungal [EPC], Azoles [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7094_75b0e885-22b4-4204-bcc8-7b49c58e2b95','0113-7094','HUMAN OTC DRUG','basic care sinus pe','','Phenylephrine Hydrochloride','TABLET, FILM COATED','ORAL','20191202','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','PHENYLEPHRINE HYDROCHLORIDE','10','mg/1','Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7101_600696d0-d111-44b6-9ab4-68f4d99af195','0113-7101','HUMAN OTC DRUG','Basic Care childrens cold and cough and sore throat','','acetaminophen, dextromethorphan hydrobromide','SUSPENSION','ORAL','20190116','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE','160; 5','mg/5mL; mg/5mL','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7116_9b09acc9-656c-4764-a2d1-5606f1e10e4d','0113-7116','HUMAN OTC DRUG','basic care lansoprazole','','Lansoprazole','TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE','ORAL','20181229','','NDA','NDA208025','L. Perrigo Company','LANSOPRAZOLE','15','mg/1','Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7117_37451c78-0305-42f0-a2bc-a6aae002d75b','0113-7117','HUMAN OTC DRUG','basic care allergy relief nasal','','Fluticasone propionate','SPRAY, METERED','NASAL','20180320','','ANDA','ANDA207957','L. Perrigo Company','FLUTICASONE PROPIONATE','50','ug/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7124_ecec36bb-87d6-416f-8e44-928d885c52b6','0113-7124','HUMAN OTC DRUG','basic care nicotine','','Nicotine Polacrilex','LOZENGE','ORAL','20181011','','ANDA','ANDA090711','L. Perrigo Company','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7129_60120865-176f-42e8-ab85-d458bcf1d6dd','0113-7129','HUMAN OTC DRUG','basic care hair regrowth treatment','','Minoxidil','AEROSOL, FOAM','TOPICAL','20190214','','ANDA','ANDA091344','L. Perrigo Company','MINOXIDIL','50','mg/g','Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7130_4c0f0249-fd10-4b80-aa58-c0426875e5a8','0113-7130','HUMAN OTC DRUG','basic care childrens pain and fever','','Acetaminophen','SUSPENSION','ORAL','20170808','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN','160','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7170_cb822452-a6aa-414e-beaf-733e2d36e366','0113-7170','HUMAN OTC DRUG','basic care nicotine','','Nicotine Polacrilex','GUM, CHEWING','ORAL','20170823','','ANDA','ANDA076789','L. Perrigo Company','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7186_5dea060a-1ba9-4619-a911-63d92b4248ff','0113-7186','HUMAN OTC DRUG','basic care nighttime sleep aid','','Diphenhydramine HCl','SOLUTION','ORAL','20191202','','OTC MONOGRAPH FINAL','part338','L. Perrigo Company','DIPHENHYDRAMINE HYDROCHLORIDE','50','mg/30mL','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7189_82fe9646-0149-433a-884c-b0f767eff3e3','0113-7189','HUMAN OTC DRUG','basic care childrens all day allergy','','Cetirizine HCl','SOLUTION','ORAL','20190410','','ANDA','ANDA204226','L. Perrigo Company','CETIRIZINE HYDROCHLORIDE','5','mg/5mL','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7190_ecd5d209-4167-4ead-a042-73a9049fa0b9','0113-7190','HUMAN OTC DRUG','basic care nicotine','','Nicotine Polacrilex','LOZENGE','ORAL','20181016','','ANDA','ANDA090711','L. Perrigo Company','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7194_38db1dfe-5d2e-42fb-a161-319db1a68175','0113-7194','HUMAN OTC DRUG','Basic Care famotidine','','Famotidine','TABLET, FILM COATED','ORAL','20170810','','ANDA','ANDA077351','L. Perrigo Company','FAMOTIDINE','20','mg/1','Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7199_94fdfe2b-cd6e-4512-a0f4-afb92439808f','0113-7199','HUMAN OTC DRUG','Basic Care miconazole 1','','Miconazole nitrate','KIT','','20170829','','ANDA','ANDA079114','L. Perrigo Company','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7201_2f6e282a-8bfe-46b6-9053-7caa2065f2b8','0113-7201','HUMAN OTC DRUG','Basic Care nicotine','','nicotine polacrilex','LOZENGE','ORAL','20190522','','ANDA','ANDA203690','L. Perrigo Company','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7202_b66b7801-f2e0-4ff1-94c3-fe2ded5c084b','0113-7202','HUMAN OTC DRUG','basic care hair regrowth treatment','','minoxidil','SOLUTION','TOPICAL','20190206','','ANDA','ANDA075357','L. Perrigo Company','MINOXIDIL','2','g/100mL','Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7203_400d181c-fba5-4e32-aa09-8e1d59bdbc58','0113-7203','HUMAN OTC DRUG','Basic Care nicotine','','nicotine polacrilex','LOZENGE','ORAL','20200221','','ANDA','ANDA203690','L. Perrigo Company','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7219_e3e4772c-e945-4302-acfc-e3f8ae96a2fc','0113-7219','HUMAN OTC DRUG','basic care lidocaine','','Lidocaine','PATCH','PERCUTANEOUS; TOPICAL; TRANSDERMAL','20190823','20230601','OTC MONOGRAPH NOT FINAL','part348','L. Perrigo Company','LIDOCAINE','560','mg/1','Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7223_17e3ceac-18cd-48fa-a7f6-515050ff7769','0113-7223','HUMAN OTC DRUG','basic care childrens cold plus flu','','Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan HBr, Phenylephrine HCl','SUSPENSION','ORAL','20181212','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE','160; 1; 5; 2.5','mg/5mL; mg/5mL; mg/5mL; mg/5mL','Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7224_b73b0a49-1219-4301-92a8-eb6c8b9e18b9','0113-7224','HUMAN OTC DRUG','Basic Care loperamide hydrochloride','','Loperamide HCl','TABLET, FILM COATED','ORAL','20171003','','ANDA','ANDA075232','L. Perrigo Company','LOPERAMIDE HYDROCHLORIDE','2','mg/1','Opioid Agonist [EPC], Opioid Agonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7264_6431fba1-429b-43ab-9ac1-3e8d1669bffd','0113-7264','HUMAN OTC DRUG','basic care naproxen sodium pm','','diphenhydramine hydrochloride, naproxen sodium','TABLET, FILM COATED','ORAL','20200109','','ANDA','ANDA208499','L. Perrigo Company','DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM','25; 220','mg/1; mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7272_96a18d75-63c8-4516-a219-8ba1abe11212','0113-7272','HUMAN OTC DRUG','basic care sinus plus headahce','','Acetaminophen, Phenylephrine HCl','TABLET, FILM COATED','ORAL','20200109','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE','325; 5','mg/1; mg/1','Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7280_4fe17fff-543f-401b-b1fc-f668a85ac7c0','0113-7280','HUMAN OTC DRUG','basic care daytime nighttime cold and flu','','Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine Hydrochloride,Guaifenesin','KIT','','20200225','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7294_d34220de-6c0b-4ba8-9b22-51f891f05750','0113-7294','HUMAN OTC DRUG','basic care hair regrowth treatment','','Minoxidil','AEROSOL, FOAM','TOPICAL','20190206','','ANDA','ANDA091344','L. Perrigo Company','MINOXIDIL','5','g/100g','Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7301_74179600-f7c5-4872-9b71-548f63ea6666','0113-7301','HUMAN OTC DRUG','basic care daytime nighttime severe cold and flu','','Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Guaifenesin, Phenylephrine Hydrochloride','KIT','','20190116','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7303_21eeb451-1c58-4023-99bf-c429df433156','0113-7303','HUMAN OTC DRUG','basic care mucus relief cold flu and sore throat','','Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl','SOLUTION','ORAL','20181229','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE','650; 20; 400; 10','mg/20mL; mg/20mL; mg/20mL; mg/20mL','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7306_8819a418-4e8c-463f-b58a-fd97f806585f','0113-7306','HUMAN OTC DRUG','Basic Care Clearlax','','Polyethylene Glycol 3350','POWDER, FOR SOLUTION','ORAL','20170810','','ANDA','ANDA090685','L. Perrigo Company','POLYETHYLENE GLYCOL 3350','17','g/17g','Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7321_e57f4fb8-894b-401f-9f65-e62a4f8e3315','0113-7321','HUMAN OTC DRUG','basic care dual action complete','','famotidine, calcium carbonate and magnesium hydroxide','TABLET, CHEWABLE','ORAL','20181227','','ANDA','ANDA077355','L. Perrigo Company','CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE','800; 10; 165','mg/1; mg/1; mg/1','Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7332_9a8aba98-e260-401b-8d0c-14dfa0cc66b4','0113-7332','HUMAN OTC DRUG','basic care milk of magnesia','','Magnesium hydroxide','SUSPENSION','ORAL','20180928','','OTC MONOGRAPH NOT FINAL','part334','L. Perrigo Company','MAGNESIUM HYDROXIDE','1200','mg/15mL','Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7335_90059a53-9b30-465c-9c59-9355163e9101','0113-7335','HUMAN OTC DRUG','basic care nighttime cold and flu','','Acetaminophen, Dextromethorphan Hdrobromide, Doxylamine succinate','SOLUTION','ORAL','20190116','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE','650; 30; 12.5','mg/30mL; mg/30mL; mg/30mL','Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7352_aca88a77-d197-4d19-9859-733f7e9789f4','0113-7352','HUMAN OTC DRUG','basic care nicotine','','Nicotine Polacrilex','GUM, CHEWING','ORAL','20181212','','ANDA','ANDA078547','L. Perrigo Company','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7368_4e098ef6-e0aa-4732-bec5-e87ed56a67a1','0113-7368','HUMAN OTC DRUG','Basic Care Naproxen Sodium','','Naproxen Sodium','TABLET, FILM COATED','ORAL','20170913','','ANDA','ANDA074661','L. Perrigo Company','NAPROXEN SODIUM','220','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7369_399f960e-4db7-4e4a-88e6-640211923bf3','0113-7369','HUMAN OTC DRUG','basic care hydrocortisone','','Hydrocortisone','CREAM','TOPICAL','20190522','','OTC MONOGRAPH NOT FINAL','part348','L. Perrigo Company','HYDROCORTISONE','1','g/100g','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7379_2452f8d5-7575-4b7d-986d-f40d1dd48a70','0113-7379','HUMAN OTC DRUG','basic care childrens allergy relief','','Diphenhydramine HCl','SOLUTION','ORAL','20170829','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','DIPHENHYDRAMINE HYDROCHLORIDE','12.5','mg/5mL','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7384_deacee4a-8370-4ee0-a309-43263d491298','0113-7384','HUMAN OTC DRUG','basic care cough DM','','dextromethorphan polistirex','SUSPENSION','ORAL','20181129','','ANDA','ANDA091135','L. Perrigo Company','DEXTROMETHORPHAN HYDROBROMIDE','30','mg/5mL','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7400_1bb3aeea-2d49-40fb-a64b-b9df5240d9b1','0113-7400','HUMAN OTC DRUG','basic care mucus relief severe congestion and cough','','Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride','LIQUID','ORAL','20190204','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE','20; 400; 10','mg/20mL; mg/20mL; mg/20mL','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7401_ef9e606e-87b6-4468-92a4-52c0a3c870f5','0113-7401','HUMAN OTC DRUG','Basic Care Omeprazole','','Omeprazole','TABLET, DELAYED RELEASE','ORAL','20170808','','NDA','NDA022032','L. Perrigo Company','OMEPRAZOLE','20','mg/1','Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7419_08904e6b-0fb9-4d88-bb37-cf9e4e129514','0113-7419','HUMAN OTC DRUG','basic care mucus dm','','dextromethorphan hydrobromide, guaifenesin','TABLET, EXTENDED RELEASE','ORAL','20190214','','ANDA','ANDA207602','L. Perrigo Company','DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN','30; 600','mg/1; mg/1','Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7425_b7c1c103-38a3-4a59-95e9-be7b10f046ff','0113-7425','HUMAN OTC DRUG','basic care allergy','','Fexofenadine HCl','TABLET, FILM COATED','ORAL','20190410','','ANDA','ANDA076447','L. Perrigo Company','FEXOFENADINE HYDROCHLORIDE','60','mg/1','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7426_dfbcbf90-e41e-4abc-8ed7-11de473b196b','0113-7426','HUMAN OTC DRUG','basic care tioconazole 1','','Tioconazole','OINTMENT','VAGINAL','20190522','20230401','ANDA','ANDA075915','L. Perrigo Company','TIOCONAZOLE','6.5','g/100g','Azole Antifungal [EPC], Azoles [CS]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7437_00b9cd41-52de-4338-9b96-38d86b4f1235','0113-7437','HUMAN OTC DRUG','basic care acetaminophen PM','','Acetaminophen, Diphenhydramine HCl','TABLET, FILM COATED','ORAL','20171011','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE','500; 25','mg/1; mg/1','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7442_0602287a-381c-496a-9c56-0e2e6767b4dc','0113-7442','HUMAN OTC DRUG','basic care nicotine','','Nicotine polacrilex','GUM, CHEWING','ORAL','20190123','','ANDA','ANDA091354','L. Perrigo Company','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7456_53b5007b-e760-4f1d-9e22-75a3c7c1d758','0113-7456','HUMAN OTC DRUG','Basic Care nicotine','','Nicotine Polacrilex','GUM, CHEWING','ORAL','20170808','','ANDA','ANDA076777','L. Perrigo Company','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7459_c34c26b5-8d54-4eea-b943-782955212622','0113-7459','HUMAN OTC DRUG','Basic Care Nighttime','','Acetaminophen, Dextromethorphan HBr, Doxylamine succinate','SOLUTION','ORAL','20170823','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE','650; 30; 12.5','mg/30mL; mg/30mL; mg/30mL','Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7467_a58ce3fb-74c4-4756-89d5-5ef564151670','0113-7467','HUMAN OTC DRUG','basic care aspirin','','Aspirin','TABLET, CHEWABLE','ORAL','20191002','20230831','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ASPIRIN','81','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7469_ae971ed2-8230-4198-a6c1-5ec61b7ae6b5','0113-7469','HUMAN OTC DRUG','basic care stomach relief','','Bismuth subsalicylate','TABLET, CHEWABLE','ORAL','20190111','','OTC MONOGRAPH FINAL','part335','L. Perrigo Company','BISMUTH SUBSALICYLATE','262','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7475_21778a8c-862b-4775-b56e-dd7fddb80124','0113-7475','HUMAN OTC DRUG','basic care childrens all day allergy','','Cetirizine HCl','SOLUTION','ORAL','20170829','','ANDA','ANDA204226','L. Perrigo Company','CETIRIZINE HYDROCHLORIDE','5','mg/5mL','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7479_5edf3a94-01a5-49e9-97ff-e3df062eae64','0113-7479','HUMAN OTC DRUG','basic care allergy relief','','Diphenhydramine Hydrochloride','TABLET','ORAL','20170810','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','DIPHENHYDRAMINE HYDROCHLORIDE','25','mg/1','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7484_f66aaf61-cb1a-4179-b292-99ab6451c321','0113-7484','HUMAN OTC DRUG','basic care acetaminophen','','Acetaminophen','TABLET','ORAL','20170808','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN','500','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7499_75370a22-a18e-44b2-aad9-199a40b89db4','0113-7499','HUMAN OTC DRUG','Basic Care daytime nighttime severe cold and flu','','Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Guaifenesin, Phenylephrine HCl','KIT','','20190116','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7501_3d876814-f1e8-499a-9c57-8bf33a8ab337','0113-7501','HUMAN OTC DRUG','basic care nighttime cold and flu','','acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride','SOLUTION','ORAL','20200225','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE','650; 20; 12.5; 10','mg/30mL; mg/30mL; mg/30mL; mg/30mL','Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7511_7ae62588-43b3-4a4b-90fe-c8b886bebc28','0113-7511','HUMAN OTC DRUG','basic care daytime nighttime severe cold and flu','','acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, doxylamine succinate','KIT','','20200220','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7517_201e647c-47a6-4ced-ae52-92b1a38c569e','0113-7517','HUMAN OTC DRUG','basic care ibuprofen','','Ibuprofen','TABLET, FILM COATED','ORAL','20191002','20230531','ANDA','ANDA077349','L. Perrigo Company','IBUPROFEN','200','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7520_1abb9b6b-1b11-4fc9-beeb-3985edc5cf61','0113-7520','HUMAN OTC DRUG','basic care omeprazole','','omeprazole','TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE','ORAL','20180830','','NDA','NDA209400','L. Perrigo Company','OMEPRAZOLE','20','mg/1','Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7523_aced793a-2951-4fb5-9465-6bbed427349e','0113-7523','HUMAN OTC DRUG','basic care daytime nighttime severe cold and flu','','acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, doxylamine succinate','KIT','','20191015','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7532_145e0c83-1ccf-42c5-8668-7fa62c60e88a','0113-7532','HUMAN OTC DRUG','basic care nicotine','','Nicotine Polacrilex','GUM, CHEWING','ORAL','20170808','','ANDA','ANDA076779','L. Perrigo Company','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7544_9e77f997-c63b-4019-b762-c788c182b64c','0113-7544','HUMAN OTC DRUG','Basic Care Acetaminophen','','Acetaminophen','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20180222','20230331','ANDA','ANDA075077','L. Perrigo Company','ACETAMINOPHEN','650','mg/1','','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7571_20af7774-94ee-4bec-bb26-b728a096bc95','0113-7571','HUMAN OTC DRUG','basic care allergy','','fexofenadine hcl','TABLET, FILM COATED','ORAL','20180509','','ANDA','ANDA076447','L. Perrigo Company','FEXOFENADINE HYDROCHLORIDE','180','mg/1','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7580_eae8b198-7415-4815-ac4a-12f16837546b','0113-7580','HUMAN OTC DRUG','basic care daytime nighttime cold and flu','','Acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl','KIT','','20180425','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7603_97931806-1720-47ad-9764-381d0991f1c1','0113-7603','HUMAN OTC DRUG','Basic Care Daytime Cold and Flu Severe','','acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl','SOLUTION','ORAL','20190225','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE','325; 10; 200; 5','mg/15mL; mg/15mL; mg/15mL; mg/15mL','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7604_0df8a078-f04e-42a1-a677-c38c1c6e5ef5','0113-7604','HUMAN OTC DRUG','Basic Care Ibuprofen','','Ibuprofen','TABLET, FILM COATED','ORAL','20170810','','ANDA','ANDA072096','L. Perrigo Company','IBUPROFEN','200','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7612_522d055e-b52b-4554-b332-bbaebc481638','0113-7612','HUMAN OTC DRUG','Basic Care allergy relief','','Loratadine','TABLET','ORAL','20170824','','ANDA','ANDA076301','L. Perrigo Company','LORATADINE','10','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7619_05299d22-7241-4767-9fe0-97f84a1dc05e','0113-7619','HUMAN OTC DRUG','basic care childrens ibuprofen','','ibuprofen','TABLET, CHEWABLE','ORAL','20190219','','ANDA','ANDA076359','L. Perrigo Company','IBUPROFEN','100','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7656_f12806b8-abdd-4d89-a5b3-40e4e6c1fc59','0113-7656','HUMAN OTC DRUG','basic care daytime cold and flu','','acetaminophen, dextromethorphan hydrobromide, Phenylephrine hydrochloride','SOLUTION','ORAL','20190314','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE','325; 10; 5','mg/15mL; mg/15mL; mg/15mL','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7660_d4fa5121-507c-402b-bca7-1c437003b8db','0113-7660','HUMAN OTC DRUG','basic care childrens ibuprofen','','Ibuprofen','SUSPENSION','ORAL','20190410','','ANDA','ANDA074937','L. Perrigo Company','IBUPROFEN','100','mg/5mL','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7671_faf22fb1-75ee-460c-b433-2c50302b92d8','0113-7671','HUMAN OTC DRUG','Basic Care Childrens Allergy Relief','','Loratadine','SOLUTION','ORAL','20180823','','ANDA','ANDA075728','L. Perrigo Company','LORATADINE','5','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7679_7fef39aa-cd70-4075-8f1d-6720b9e240e7','0113-7679','HUMAN OTC DRUG','Basic Care First Aid Antibiotic Plus Pain Relief','','Bacitracin, Neomycin, Polymyxin B, Pramoxine HCl','OINTMENT','TOPICAL','20190612','','OTC MONOGRAPH FINAL','part333B','L. Perrigo Company','BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE','500; 3.5; 10000; 10','[USP''''U]/g; mg/g; [USP''''U]/g; mg/g','Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7734_596ae549-09ce-45c1-8589-79cb6d7cf3c2','0113-7734','HUMAN OTC DRUG','basic care nicotine mini','','Nicotine Polacrilex','LOZENGE','ORAL','20180306','','ANDA','ANDA203690','L. Perrigo Company','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7777_955c9f49-38af-4b48-b325-60fa94bfe60b','0113-7777','HUMAN OTC DRUG','perrigo allergy d','','loratadine, Pseudoephedrine sulfate','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20211008','','ANDA','ANDA076050','L. Perrigo Company','LORATADINE; PSEUDOEPHEDRINE SULFATE','5; 120','mg/1; mg/1','Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7798_f8dace4a-a95b-4a75-a797-adf02e87f88c','0113-7798','HUMAN OTC DRUG','Basic Care Hair Regrowth','','Minoxidil','SOLUTION','TOPICAL','20170810','','ANDA','ANDA075598','L. Perrigo Company','MINOXIDIL','3','g/60mL','Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7801_632a19af-5069-4e1e-8c94-72b61457794f','0113-7801','HUMAN OTC DRUG','basic care day time night time cold and flu','','Acetaminophen, dextromethorphan HBr, Doxylamine Succinate, Guaifenesin, Phenylephrine HCl','KIT','','20190314','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7825_a1238e85-81d5-4220-b245-622ff7cdab2f','0113-7825','HUMAN OTC DRUG','basic care miconazole 7','','Miconazole nitrate','CREAM','VAGINAL','20190522','','ANDA','ANDA074760','L. Perrigo Company','MICONAZOLE NITRATE','2','g/100g','Azole Antifungal [EPC], Azoles [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7897_3aeab4eb-7bb9-4447-8809-dbcbf2c7d8b3','0113-7897','HUMAN OTC DRUG','Basic Care childrens ibuprofen','','Ibuprofen','SUSPENSION','ORAL','20170810','','ANDA','ANDA074937','L Perrigo Company','IBUPROFEN','100','mg/5mL','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7901_ec3997fc-6246-44cf-b835-d1207c43fec5','0113-7901','HUMAN OTC DRUG','basic care naproxen sodium','','Naproxen Sodium','TABLET, FILM COATED','ORAL','20190410','','ANDA','ANDA074661','L. Perrigo Company','NAPROXEN SODIUM','200','mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7902_6fc27ed0-1f3b-4095-8fe5-be39446cac1f','0113-7902','HUMAN OTC DRUG','basic care daytime cold and flu','','acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride','SOLUTION','ORAL','20200225','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE','650; 20; 400; 10','mg/30mL; mg/30mL; mg/30mL; mg/30mL','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7911_f6aee0ed-00f8-4505-9fd5-019736d9dfea','0113-7911','HUMAN OTC DRUG','basic care daytime severe cold and flu nighttime severe cold, cough and flu','','acetaminophen, dextromethorphan hydrobrmide, phenylephrine hydrochloride, diphenhydramine hydrochloride','KIT','','20190513','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7915_3f8dd174-2e24-40b6-ae02-41061abe609e','0113-7915','HUMAN OTC DRUG','Basic Care Omeprazole','','Omeprazole','TABLET, DELAYED RELEASE','ORAL','20170808','','NDA','NDA022032','L. Perrigo Company','OMEPRAZOLE','20','mg/1','Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7951_070a5866-97cc-43a7-b1e1-547fc5a9bf91','0113-7951','HUMAN OTC DRUG','basic care daytime severe cold nighttime cold and flu','','Acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, diphenhydramine hydrochloride','KIT','','20190124','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7957_9accdafd-abf2-482f-b77d-8927a7b63f7b','0113-7957','HUMAN OTC DRUG','basic care nicotine mini','','Nicotine Polacrilex','LOZENGE','ORAL','20180306','','ANDA','ANDA203690','L. Perrigo Company','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-7994_75d97b8e-6c30-4ad0-ada1-ceaa91a2c333','0113-7994','HUMAN OTC DRUG','basic care daytime cold and flu','','Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl','CAPSULE, LIQUID FILLED','ORAL','20181129','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE','325; 10; 5','mg/1; mg/1; mg/1','Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-8002_b6d74a34-f128-4b00-83fa-35cafc2092f3','0113-8002','HUMAN OTC DRUG','burts bees throat soothing','','pectin','LOZENGE','ORAL','20210606','','OTC MONOGRAPH NOT FINAL','part356','L. Perrigo Company','PECTIN','10.5','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-8004_b4ba13c4-6e9c-4a2c-926e-e4f0ecfc6ccc','0113-8004','HUMAN OTC DRUG','burts bees throat soothing','','pectin','LOZENGE','ORAL','20210606','','OTC MONOGRAPH NOT FINAL','part356','L. Perrigo Company','PECTIN','10.5','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-8264_48ce03da-c8e7-45ec-9e1f-17a31b810956','0113-8264','HUMAN OTC DRUG','good sense naproxen sodium','','diphenhydramine hydrochloride, naproxen sodium','TABLET, FILM COATED','ORAL','20181228','','ANDA','ANDA208499','L. Perrigo Company','DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM','25; 220','mg/1; mg/1','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-8442_fd4b7159-8190-480e-b4c2-7cebc8f2ca0e','0113-8442','HUMAN OTC DRUG','Good Sense Nicotine','Stop Smoking Aid','Nicotine polacrilex','GUM, CHEWING','ORAL','20120119','','ANDA','ANDA091354','L. Perrigo Company','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-8959_8247de1f-26ab-4f77-8999-09bb18ad2778','0113-8959','HUMAN OTC DRUG','Good Sense Pain and Fever','','Acetaminophen','SUSPENSION','ORAL','20120322','','OTC MONOGRAPH NOT FINAL','part343','L. Perrigo Company','ACETAMINOPHEN','160','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-9007_987b2abc-adc8-4383-87dc-52392dd8af47','0113-9007','HUMAN OTC DRUG','Good Sense Severe Tussin CF Max','','Acetaminophen, dextromethorphan HBr, guaifenesin, phenylephrine HCl','SOLUTION','ORAL','20211111','','OTC MONOGRAPH FINAL','part341','L. Perrigo Company','ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE','650; 20; 400; 10','mg/20mL; mg/20mL; mg/20mL; mg/20mL','Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-9458_c9b5bba5-a2b6-4d77-941d-5c71969e2815','0113-9458','HUMAN OTC DRUG','Good Sense all day allergy','','Cetirizine Hydrochloride','TABLET, FILM COATED','ORAL','20080116','','ANDA','ANDA078336','L. Perrigo Company','CETIRIZINE HYDROCHLORIDE','10','mg/1','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0113-9755_3ef968b8-6732-4c80-b385-f471ed407817','0113-9755','HUMAN OTC DRUG','good sense allergy relief','','loratadine','TABLET, ORALLY DISINTEGRATING','ORAL','20200911','','ANDA','ANDA076011','L. Perrigo Company','LORATADINE','10','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-0511_4faa7be9-6cb4-4192-a287-555ad2ba3cbc','0115-0511','HUMAN PRESCRIPTION DRUG','Fenofibrate','','FENOFIBRATE','CAPSULE','ORAL','20100201','20231207','ANDA','ANDA075868','Amneal Pharmaceuticals of New York LLC','FENOFIBRATE','67','mg/1','Peroxisome Proliferator Receptor alpha Agonist [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-0522_4faa7be9-6cb4-4192-a287-555ad2ba3cbc','0115-0522','HUMAN PRESCRIPTION DRUG','Fenofibrate','','FENOFIBRATE','CAPSULE','ORAL','20100201','','ANDA','ANDA075868','Amneal Pharmaceuticals of New York LLC','FENOFIBRATE','134','mg/1','Peroxisome Proliferator Receptor alpha Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-0533_4faa7be9-6cb4-4192-a287-555ad2ba3cbc','0115-0533','HUMAN PRESCRIPTION DRUG','Fenofibrate','','FENOFIBRATE','CAPSULE','ORAL','20100201','','ANDA','ANDA075868','Amneal Pharmaceuticals of New York LLC','FENOFIBRATE','200','mg/1','Peroxisome Proliferator Receptor alpha Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1010_c9f07c77-925d-41ba-b5e8-d6e8665ef27c','0115-1010','HUMAN PRESCRIPTION DRUG','Baclofen','','Baclofen','TABLET','ORAL','20071027','','ANDA','ANDA077971','Amneal Pharmaceuticals of New York LLC','BACLOFEN','10','mg/1','GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1011_c9f07c77-925d-41ba-b5e8-d6e8665ef27c','0115-1011','HUMAN PRESCRIPTION DRUG','Baclofen','','Baclofen','TABLET','ORAL','20210601','','ANDA','ANDA077971','Amneal Pharmaceuticals of New York LLC','BACLOFEN','5','mg/1','GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1012_c9f07c77-925d-41ba-b5e8-d6e8665ef27c','0115-1012','HUMAN PRESCRIPTION DRUG','Baclofen','','Baclofen','TABLET','ORAL','20071027','','ANDA','ANDA077971','Amneal Pharmaceuticals of New York LLC','BACLOFEN','20','mg/1','GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1231_c1858b31-03d8-4020-af18-b46dd8472fb2','0115-1231','HUMAN PRESCRIPTION DRUG','Oxymorphone hydrochloride','','Oxymorphone hydrochloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20130102','','ANDA','ANDA079087','Amneal Pharmaceuticals of New York LLC','OXYMORPHONE HYDROCHLORIDE','5','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1232_c1858b31-03d8-4020-af18-b46dd8472fb2','0115-1232','HUMAN PRESCRIPTION DRUG','Oxymorphone hydrochloride','','Oxymorphone hydrochloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20130102','','ANDA','ANDA079087','Amneal Pharmaceuticals of New York LLC','OXYMORPHONE HYDROCHLORIDE','10','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1233_c1858b31-03d8-4020-af18-b46dd8472fb2','0115-1233','HUMAN PRESCRIPTION DRUG','Oxymorphone hydrochloride','','Oxymorphone hydrochloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20130102','','ANDA','ANDA079087','Amneal Pharmaceuticals of New York LLC','OXYMORPHONE HYDROCHLORIDE','20','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1234_c1858b31-03d8-4020-af18-b46dd8472fb2','0115-1234','HUMAN PRESCRIPTION DRUG','Oxymorphone hydrochloride','','Oxymorphone hydrochloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20130102','','ANDA','ANDA079087','Amneal Pharmaceuticals of New York LLC','OXYMORPHONE HYDROCHLORIDE','40','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1277_0dd1f46e-85a0-4b90-952d-da87dbdb5e61','0115-1277','HUMAN PRESCRIPTION DRUG','Morphine Sulfate','','MORPHINE SULFATE','CAPSULE, EXTENDED RELEASE','ORAL','20160412','','ANDA','ANDA200411','Amneal Pharmaceuticals of New York LLC','MORPHINE SULFATE','20','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1278_0dd1f46e-85a0-4b90-952d-da87dbdb5e61','0115-1278','HUMAN PRESCRIPTION DRUG','Morphine Sulfate','','MORPHINE SULFATE','CAPSULE, EXTENDED RELEASE','ORAL','20160412','','ANDA','ANDA200411','Amneal Pharmaceuticals of New York LLC','MORPHINE SULFATE','30','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1279_0dd1f46e-85a0-4b90-952d-da87dbdb5e61','0115-1279','HUMAN PRESCRIPTION DRUG','Morphine Sulfate','','MORPHINE SULFATE','CAPSULE, EXTENDED RELEASE','ORAL','20160412','','ANDA','ANDA200411','Amneal Pharmaceuticals of New York LLC','MORPHINE SULFATE','50','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1280_0dd1f46e-85a0-4b90-952d-da87dbdb5e61','0115-1280','HUMAN PRESCRIPTION DRUG','Morphine Sulfate','','MORPHINE SULFATE','CAPSULE, EXTENDED RELEASE','ORAL','20160412','','ANDA','ANDA200411','Amneal Pharmaceuticals of New York LLC','MORPHINE SULFATE','60','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1281_0dd1f46e-85a0-4b90-952d-da87dbdb5e61','0115-1281','HUMAN PRESCRIPTION DRUG','Morphine Sulfate','','MORPHINE SULFATE','CAPSULE, EXTENDED RELEASE','ORAL','20160412','','ANDA','ANDA200411','Amneal Pharmaceuticals of New York LLC','MORPHINE SULFATE','80','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1282_0dd1f46e-85a0-4b90-952d-da87dbdb5e61','0115-1282','HUMAN PRESCRIPTION DRUG','Morphine Sulfate','','MORPHINE SULFATE','CAPSULE, EXTENDED RELEASE','ORAL','20160412','','ANDA','ANDA200411','Amneal Pharmaceuticals of New York LLC','MORPHINE SULFATE','100','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1315_c1858b31-03d8-4020-af18-b46dd8472fb2','0115-1315','HUMAN PRESCRIPTION DRUG','Oxymorphone hydrochloride','','Oxymorphone hydrochloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20130102','','ANDA','ANDA079087','Amneal Pharmaceuticals of New York LLC','OXYMORPHONE HYDROCHLORIDE','7.5','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1316_c1858b31-03d8-4020-af18-b46dd8472fb2','0115-1316','HUMAN PRESCRIPTION DRUG','Oxymorphone hydrochloride','','Oxymorphone hydrochloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20130102','','ANDA','ANDA079087','Amneal Pharmaceuticals of New York LLC','OXYMORPHONE HYDROCHLORIDE','15','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1317_c1858b31-03d8-4020-af18-b46dd8472fb2','0115-1317','HUMAN PRESCRIPTION DRUG','Oxymorphone hydrochloride','','Oxymorphone hydrochloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20130102','','ANDA','ANDA079087','Amneal Pharmaceuticals of New York LLC','OXYMORPHONE HYDROCHLORIDE','30','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1320_3d4f5b2f-314d-4a7f-b580-0efb31a24812','0115-1320','HUMAN PRESCRIPTION DRUG','Colesevelam Hydrochloride','','COLESEVELAM HYDROCHLORIDE','TABLET, COATED','ORAL','20180517','','ANDA','ANDA091600','Amneal Pharmaceuticals of New York LLC','COLESEVELAM HYDROCHLORIDE','625','mg/1','Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1365_9d5d0362-fb22-4c0a-b8e0-24abe41b7659','0115-1365','HUMAN PRESCRIPTION DRUG','sevelamer carbonate','','sevelamer carbonate','POWDER, FOR SUSPENSION','ORAL','20201120','','ANDA','ANDA211316','Amneal Pharmaceuticals of New York LLC','SEVELAMER CARBONATE','800','mg/1','Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1366_9d5d0362-fb22-4c0a-b8e0-24abe41b7659','0115-1366','HUMAN PRESCRIPTION DRUG','sevelamer carbonate','','sevelamer carbonate','POWDER, FOR SUSPENSION','ORAL','20201120','','ANDA','ANDA211316','Amneal Pharmaceuticals of New York LLC','SEVELAMER CARBONATE','2400','mg/1','Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1404_cb2d3ee1-aeda-4c2c-85d2-3ff7d2de5689','0115-1404','HUMAN PRESCRIPTION DRUG','Pyridostigmine Bromide','','PYRIDOSTIGMINE BROMIDE','TABLET, EXTENDED RELEASE','ORAL','20150918','','ANDA','ANDA203184','Amneal Pharmaceuticals of New York LLC','PYRIDOSTIGMINE BROMIDE','180','mg/1','Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1408_893d1f7c-dbd2-457d-bd18-8eceff72ef3c','0115-1408','HUMAN PRESCRIPTION DRUG','MethylTESTOSTERone','','METHYLTESTOSTERONE','CAPSULE','ORAL','20150921','','ANDA','ANDA204851','Amneal Pharmaceuticals of New York LLC','METHYLTESTOSTERONE','10','mg/1','Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]','CIII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1436_7a66a6cc-e3ac-4d0d-a916-f402a8ade66f','0115-1436','HUMAN PRESCRIPTION DRUG','Cyclobenzaprine Hydrochloride','','Cyclobenzaprine Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20190301','','NDA AUTHORIZED GENERIC','NDA021777','Amneal Pharmaceuticals of New York LLC','CYCLOBENZAPRINE HYDROCHLORIDE','15','mg/1','Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1437_7a66a6cc-e3ac-4d0d-a916-f402a8ade66f','0115-1437','HUMAN PRESCRIPTION DRUG','Cyclobenzaprine Hydrochloride','','Cyclobenzaprine Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20190301','','NDA AUTHORIZED GENERIC','NDA021777','Amneal Pharmaceuticals of New York LLC','CYCLOBENZAPRINE HYDROCHLORIDE','30','mg/1','Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1468_ef0e52f0-eafb-4ccc-86f4-19672a142b3c','0115-1468','HUMAN PRESCRIPTION DRUG','Lidocaine and Prilocaine','','Lidocaine and Prilocaine','CREAM','TOPICAL','20030827','','ANDA','ANDA076320','Amneal Pharmaceuticals of New York LLC','LIDOCAINE; PRILOCAINE','25; 25','mg/g; mg/g','Amide Local Anesthetic [EPC], Amide Local Anesthetic [EPC], Amides [CS], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Local Anesthesia [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1474_943c4651-3d73-4af2-b4b7-b7d9027f73f4','0115-1474','HUMAN PRESCRIPTION DRUG','Metronidazole','','Metronidazole','GEL','TOPICAL','20060713','','ANDA','ANDA077547','Amneal Pharmaceuticals of New York LLC','METRONIDAZOLE','7.5','mg/g','Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1475_cfa7f830-7c38-4bfb-8454-6d4908302606','0115-1475','HUMAN PRESCRIPTION DRUG','Calcipotriene','','Calcipotriene','SOLUTION','TOPICAL','20091120','','ANDA','ANDA077029','Amneal Pharmaceuticals of New York LLC','CALCIPOTRIENE','0.05','mg/mL','Vitamin D Analog [EPC], Vitamin D [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1479_0dd1f46e-85a0-4b90-952d-da87dbdb5e61','0115-1479','HUMAN PRESCRIPTION DRUG','Morphine Sulfate','','MORPHINE SULFATE','CAPSULE, EXTENDED RELEASE','ORAL','20181005','','ANDA','ANDA200411','Amneal Pharmaceuticals of New York LLC','MORPHINE SULFATE','40','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1483_fe78e8f2-f47c-4114-9c32-98a3ca1ab512','0115-1483','HUMAN PRESCRIPTION DRUG','Diclofenac Sodium','','Diclofenac Sodium','GEL','TOPICAL','20131121','','ANDA','ANDA200936','Amneal Pharmaceuticals of New York LLC','DICLOFENAC SODIUM','30','mg/g','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1486_b5fef30f-f657-4429-8574-dcb0daebbda8','0115-1486','HUMAN PRESCRIPTION DRUG','Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate','','Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate','CAPSULE','ORAL','20160216','','ANDA','ANDA076852','Amneal Pharmaceuticals of New York LLC','AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE','1.25; 1.25; 1.25; 1.25','mg/1; mg/1; mg/1; mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1487_b5fef30f-f657-4429-8574-dcb0daebbda8','0115-1487','HUMAN PRESCRIPTION DRUG','Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate','','Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate','CAPSULE','ORAL','20160216','','ANDA','ANDA076852','Amneal Pharmaceuticals of New York LLC','AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE','2.5; 2.5; 2.5; 2.5','mg/1; mg/1; mg/1; mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1488_b5fef30f-f657-4429-8574-dcb0daebbda8','0115-1488','HUMAN PRESCRIPTION DRUG','Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate','','Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate','CAPSULE','ORAL','20160216','','ANDA','ANDA076852','Amneal Pharmaceuticals of New York LLC','AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE','3.75; 3.75; 3.75; 3.75','mg/1; mg/1; mg/1; mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1489_b5fef30f-f657-4429-8574-dcb0daebbda8','0115-1489','HUMAN PRESCRIPTION DRUG','Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate','','Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate','CAPSULE','ORAL','20160216','','ANDA','ANDA076852','Amneal Pharmaceuticals of New York LLC','AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE','5; 5; 5; 5','mg/1; mg/1; mg/1; mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1490_b5fef30f-f657-4429-8574-dcb0daebbda8','0115-1490','HUMAN PRESCRIPTION DRUG','Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate','','Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate','CAPSULE','ORAL','20160216','','ANDA','ANDA076852','Amneal Pharmaceuticals of New York LLC','AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE','6.25; 6.25; 6.25; 6.25','mg/1; mg/1; mg/1; mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1491_b5fef30f-f657-4429-8574-dcb0daebbda8','0115-1491','HUMAN PRESCRIPTION DRUG','Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate','','Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate','CAPSULE','ORAL','20160216','','ANDA','ANDA076852','Amneal Pharmaceuticals of New York LLC','AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE','7.5; 7.5; 7.5; 7.5','mg/1; mg/1; mg/1; mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1510_eaabbf9e-b49d-4d23-bd49-8bc5aaee3967','0115-1510','HUMAN PRESCRIPTION DRUG','NAFTIFINE HYDROCHLORIDE','','NAFTIFINE HYDROCHLORIDE','GEL','TOPICAL','20190320','','ANDA','ANDA206165','Amneal Pharmaceuticals of New York LLC','NAFTIFINE HYDROCHLORIDE','10','mg/g','Allylamine Antifungal [EPC], Allylamine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1512_6cf7b001-6ec3-4d9d-a6b0-7231ecbf3c2d','0115-1512','HUMAN PRESCRIPTION DRUG','NAFTIFINE HYDROCHLORIDE','','NAFTIFINE HYDROCHLORIDE','CREAM','TOPICAL','20170510','','ANDA','ANDA206960','Amneal Pharmaceuticals of New York LLC','NAFTIFINE HYDROCHLORIDE','20','mg/g','Allylamine Antifungal [EPC], Allylamine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1526_422236f7-d9d0-4035-ac31-b9f3ba15b11a','0115-1526','HUMAN PRESCRIPTION DRUG','Lamotrigine','','LAMOTRIGINE','TABLET, ORALLY DISINTEGRATING','ORAL','20150109','','ANDA','ANDA200828','Amneal Pharmaceuticals of New York LLC','LAMOTRIGINE','25','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1527_422236f7-d9d0-4035-ac31-b9f3ba15b11a','0115-1527','HUMAN PRESCRIPTION DRUG','Lamotrigine','','LAMOTRIGINE','TABLET, ORALLY DISINTEGRATING','ORAL','20150109','','ANDA','ANDA200828','Amneal Pharmaceuticals of New York LLC','LAMOTRIGINE','50','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1528_422236f7-d9d0-4035-ac31-b9f3ba15b11a','0115-1528','HUMAN PRESCRIPTION DRUG','Lamotrigine','','LAMOTRIGINE','TABLET, ORALLY DISINTEGRATING','ORAL','20150109','','ANDA','ANDA200828','Amneal Pharmaceuticals of New York LLC','LAMOTRIGINE','100','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1529_422236f7-d9d0-4035-ac31-b9f3ba15b11a','0115-1529','HUMAN PRESCRIPTION DRUG','Lamotrigine','','LAMOTRIGINE','TABLET, ORALLY DISINTEGRATING','ORAL','20150109','','ANDA','ANDA200828','Amneal Pharmaceuticals of New York LLC','LAMOTRIGINE','200','mg/1','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1554_0f408570-470d-4c2a-9224-699f230b0928','0115-1554','HUMAN PRESCRIPTION DRUG','Fenofibric Acid','','Fenofibric Acid','CAPSULE, DELAYED RELEASE','ORAL','20160912','','NDA AUTHORIZED GENERIC','NDA022224','Amneal Pharmaceuticals of New York LLC','FENOFIBRIC ACID','45','mg/1','Peroxisome Proliferator Receptor alpha Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1555_0f408570-470d-4c2a-9224-699f230b0928','0115-1555','HUMAN PRESCRIPTION DRUG','Fenofibric Acid','','Fenofibric Acid','CAPSULE, DELAYED RELEASE','ORAL','20160912','','NDA AUTHORIZED GENERIC','NDA022224','Amneal Pharmaceuticals of New York LLC','FENOFIBRIC ACID','135','mg/1','Peroxisome Proliferator Receptor alpha Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1556_8d745b1a-1fec-405f-a12f-482e5634252b','0115-1556','HUMAN PRESCRIPTION DRUG','OXYCODONE HYDROCHLORIDE','','OXYCODONE HYDROCHLORIDE','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20160222','','NDA AUTHORIZED GENERIC','NDA022272','Amneal Pharmaceuticals of New York LLC','OXYCODONE HYDROCHLORIDE','10','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1557_8d745b1a-1fec-405f-a12f-482e5634252b','0115-1557','HUMAN PRESCRIPTION DRUG','OXYCODONE HYDROCHLORIDE','','OXYCODONE HYDROCHLORIDE','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20160222','','NDA AUTHORIZED GENERIC','NDA022272','Amneal Pharmaceuticals of New York LLC','OXYCODONE HYDROCHLORIDE','15','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1558_8d745b1a-1fec-405f-a12f-482e5634252b','0115-1558','HUMAN PRESCRIPTION DRUG','OXYCODONE HYDROCHLORIDE','','OXYCODONE HYDROCHLORIDE','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20160222','','NDA AUTHORIZED GENERIC','NDA022272','Amneal Pharmaceuticals of New York LLC','OXYCODONE HYDROCHLORIDE','20','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1559_8d745b1a-1fec-405f-a12f-482e5634252b','0115-1559','HUMAN PRESCRIPTION DRUG','OXYCODONE HYDROCHLORIDE','','OXYCODONE HYDROCHLORIDE','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20160222','','NDA AUTHORIZED GENERIC','NDA022272','Amneal Pharmaceuticals of New York LLC','OXYCODONE HYDROCHLORIDE','30','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1560_8d745b1a-1fec-405f-a12f-482e5634252b','0115-1560','HUMAN PRESCRIPTION DRUG','OXYCODONE HYDROCHLORIDE','','OXYCODONE HYDROCHLORIDE','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20160222','','NDA AUTHORIZED GENERIC','NDA022272','Amneal Pharmaceuticals of New York LLC','OXYCODONE HYDROCHLORIDE','40','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1561_8d745b1a-1fec-405f-a12f-482e5634252b','0115-1561','HUMAN PRESCRIPTION DRUG','OXYCODONE HYDROCHLORIDE','','OXYCODONE HYDROCHLORIDE','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20160222','','NDA AUTHORIZED GENERIC','NDA022272','Amneal Pharmaceuticals of New York LLC','OXYCODONE HYDROCHLORIDE','60','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1562_8d745b1a-1fec-405f-a12f-482e5634252b','0115-1562','HUMAN PRESCRIPTION DRUG','OXYCODONE HYDROCHLORIDE','','OXYCODONE HYDROCHLORIDE','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20160222','','NDA AUTHORIZED GENERIC','NDA022272','Amneal Pharmaceuticals of New York LLC','OXYCODONE HYDROCHLORIDE','80','mg/1','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1624_8adcda98-4dc1-4379-84b8-c16b122c16d1','0115-1624','HUMAN PRESCRIPTION DRUG','Azelaic Acid','','Azelaic Acid','GEL','TOPICAL','20181119','','ANDA','ANDA208724','Amneal Pharmaceuticals of New York LLC','AZELAIC ACID','0.15','g/g','Decreased Protein Synthesis [PE], Decreased Sebaceous Gland Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1643_919638d1-dc91-4d4a-bcc2-86c5ba9d2cd7','0115-1643','HUMAN PRESCRIPTION DRUG','Nitrofurantoin Macrocrystals','','Nitrofurantoin Macrocrystals','CAPSULE','ORAL','20070308','','ANDA','ANDA073671','Amneal Pharmaceuticals of New York LLC','NITROFURANTOIN','50','mg/1','Nitrofuran Antibacterial [EPC], Nitrofurans [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1645_919638d1-dc91-4d4a-bcc2-86c5ba9d2cd7','0115-1645','HUMAN PRESCRIPTION DRUG','Nitrofurantoin Macrocrystals','','Nitrofurantoin Macrocrystals','CAPSULE','ORAL','20070308','','ANDA','ANDA073652','Amneal Pharmaceuticals of New York LLC','NITROFURANTOIN','100','mg/1','Nitrofuran Antibacterial [EPC], Nitrofurans [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1659_6f426f6a-1366-4752-b439-da9b82db3fdb','0115-1659','HUMAN PRESCRIPTION DRUG','Propranolol Hydrochloride','','Propranolol Hydrochloride','TABLET','ORAL','20160919','','ANDA','ANDA070175','Amneal Pharmaceuticals of New York LLC','PROPRANOLOL HYDROCHLORIDE','10','mg/1','Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1660_6f426f6a-1366-4752-b439-da9b82db3fdb','0115-1660','HUMAN PRESCRIPTION DRUG','Propranolol Hydrochloride','','Propranolol Hydrochloride','TABLET','ORAL','20160919','','ANDA','ANDA070176','Amneal Pharmaceuticals of New York LLC','PROPRANOLOL HYDROCHLORIDE','20','mg/1','Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1661_6f426f6a-1366-4752-b439-da9b82db3fdb','0115-1661','HUMAN PRESCRIPTION DRUG','Propranolol Hydrochloride','','Propranolol Hydrochloride','TABLET','ORAL','20160919','','ANDA','ANDA070177','Amneal Pharmaceuticals of New York LLC','PROPRANOLOL HYDROCHLORIDE','40','mg/1','Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1662_6f426f6a-1366-4752-b439-da9b82db3fdb','0115-1662','HUMAN PRESCRIPTION DRUG','Propranolol Hydrochloride','','Propranolol Hydrochloride','TABLET','ORAL','20160919','','ANDA','ANDA070178','Amneal Pharmaceuticals of New York LLC','PROPRANOLOL HYDROCHLORIDE','80','mg/1','Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1676_2dbd21c3-1d2b-41a8-a355-e9c265b4c131','0115-1676','HUMAN PRESCRIPTION DRUG','Alendronate Sodium','','Alendronate Sodium','TABLET','ORAL','20080206','','ANDA','ANDA075710','Amneal Pharmaceuticals of New York LLC','ALENDRONATE SODIUM','5','mg/1','Bisphosphonate [EPC], Diphosphonates [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1678_2dbd21c3-1d2b-41a8-a355-e9c265b4c131','0115-1678','HUMAN PRESCRIPTION DRUG','Alendronate Sodium','','Alendronate Sodium','TABLET','ORAL','20080206','','ANDA','ANDA075710','Amneal Pharmaceuticals of New York LLC','ALENDRONATE SODIUM','10','mg/1','Bisphosphonate [EPC], Diphosphonates [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1679_2dbd21c3-1d2b-41a8-a355-e9c265b4c131','0115-1679','HUMAN PRESCRIPTION DRUG','Alendronate Sodium','','Alendronate Sodium','TABLET','ORAL','20080206','','ANDA','ANDA075710','Amneal Pharmaceuticals of New York LLC','ALENDRONATE SODIUM','35','mg/1','Bisphosphonate [EPC], Diphosphonates [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1680_2dbd21c3-1d2b-41a8-a355-e9c265b4c131','0115-1680','HUMAN PRESCRIPTION DRUG','Alendronate Sodium','','Alendronate Sodium','TABLET','ORAL','20080206','','ANDA','ANDA075710','Amneal Pharmaceuticals of New York LLC','ALENDRONATE SODIUM','40','mg/1','Bisphosphonate [EPC], Diphosphonates [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1681_2dbd21c3-1d2b-41a8-a355-e9c265b4c131','0115-1681','HUMAN PRESCRIPTION DRUG','Alendronate Sodium','','Alendronate Sodium','TABLET','ORAL','20080206','','ANDA','ANDA075710','Amneal Pharmaceuticals of New York LLC','ALENDRONATE SODIUM','70','mg/1','Bisphosphonate [EPC], Diphosphonates [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1682_02b0ea7c-8309-488d-92ab-118a4f7119fa','0115-1682','HUMAN PRESCRIPTION DRUG','Dexmethylphenidate hydrochloride','','Dexmethylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20150806','','ANDA','ANDA079108','Amneal Pharmaceuticals of New York LLC','DEXMETHYLPHENIDATE HYDROCHLORIDE','5','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1683_02b0ea7c-8309-488d-92ab-118a4f7119fa','0115-1683','HUMAN PRESCRIPTION DRUG','Dexmethylphenidate hydrochloride','','Dexmethylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20150806','','ANDA','ANDA079108','Amneal Pharmaceuticals of New York LLC','DEXMETHYLPHENIDATE HYDROCHLORIDE','10','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1684_02b0ea7c-8309-488d-92ab-118a4f7119fa','0115-1684','HUMAN PRESCRIPTION DRUG','Dexmethylphenidate hydrochloride','','Dexmethylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20141111','','ANDA','ANDA079108','Amneal Pharmaceuticals of New York LLC','DEXMETHYLPHENIDATE HYDROCHLORIDE','15','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1685_02b0ea7c-8309-488d-92ab-118a4f7119fa','0115-1685','HUMAN PRESCRIPTION DRUG','Dexmethylphenidate hydrochloride','','Dexmethylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20151221','','ANDA','ANDA079108','Amneal Pharmaceuticals of New York LLC','DEXMETHYLPHENIDATE HYDROCHLORIDE','20','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1686_02b0ea7c-8309-488d-92ab-118a4f7119fa','0115-1686','HUMAN PRESCRIPTION DRUG','Dexmethylphenidate hydrochloride','','Dexmethylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20140224','','ANDA','ANDA079108','Amneal Pharmaceuticals of New York LLC','DEXMETHYLPHENIDATE HYDROCHLORIDE','30','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1687_c53923d0-263e-43ba-913a-b4589dda228c','0115-1687','HUMAN PRESCRIPTION DRUG','Budesonide Inhalation','','Budesonide','SUSPENSION','RESPIRATORY (INHALATION)','20160804','','ANDA','ANDA078404','Amneal Pharmaceuticals of New York LLC','BUDESONIDE','0.25','mg/2mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1689_c53923d0-263e-43ba-913a-b4589dda228c','0115-1689','HUMAN PRESCRIPTION DRUG','Budesonide Inhalation','','Budesonide','SUSPENSION','RESPIRATORY (INHALATION)','20160804','','ANDA','ANDA078404','Amneal Pharmaceuticals of New York LLC','BUDESONIDE','0.5','mg/2mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1694_0acab803-c1f6-4b5f-bf8f-35e9f90d57bb','0115-1694','HUMAN PRESCRIPTION DRUG','epinephrine','','epinephrine','INJECTION','SUBCUTANEOUS','20100401','','NDA AUTHORIZED GENERIC','NDA020800','Amneal Pharmaceuticals of New York LLC','EPINEPHRINE','0.3','mg/.3mL','Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1695_0acab803-c1f6-4b5f-bf8f-35e9f90d57bb','0115-1695','HUMAN PRESCRIPTION DRUG','epinephrine','','epinephrine','INJECTION','SUBCUTANEOUS','20100401','','NDA AUTHORIZED GENERIC','NDA020800','Amneal Pharmaceuticals of New York LLC','EPINEPHRINE','0.15','mg/.15mL','Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1696_61700e00-e257-4187-a2bf-46a51b87ffb2','0115-1696','HUMAN PRESCRIPTION DRUG','HYDROCORTISONE','','hydrocortisone','TABLET','ORAL','20070330','','ANDA','ANDA040646','Amneal Pharmaceuticals of New York LLC','HYDROCORTISONE','5','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1697_61700e00-e257-4187-a2bf-46a51b87ffb2','0115-1697','HUMAN PRESCRIPTION DRUG','HYDROCORTISONE','','hydrocortisone','TABLET','ORAL','20070330','','ANDA','ANDA040646','Amneal Pharmaceuticals of New York LLC','HYDROCORTISONE','10','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1700_61700e00-e257-4187-a2bf-46a51b87ffb2','0115-1700','HUMAN PRESCRIPTION DRUG','HYDROCORTISONE','','hydrocortisone','TABLET','ORAL','20070330','','ANDA','ANDA040646','Amneal Pharmaceuticals of New York LLC','HYDROCORTISONE','20','mg/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1701_a43644f1-f774-4be0-ba4d-73b0b1e619df','0115-1701','HUMAN PRESCRIPTION DRUG','Albendazole','','albendazole','TABLET, FILM COATED','ORAL','19960611','','NDA','NDA020666','Amneal Pharmaceuticals of New York LLC','ALBENDAZOLE','200','mg/1','Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1709_ce6dc952-c320-4f92-a7b9-7503976163ad','0115-1709','HUMAN PRESCRIPTION DRUG','Dexmethylphenidate hydrochloride','','Dexmethylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20170705','','ANDA','ANDA203614','Amneal Pharmaceuticals of New York LLC','DEXMETHYLPHENIDATE HYDROCHLORIDE','25','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1710_ce6dc952-c320-4f92-a7b9-7503976163ad','0115-1710','HUMAN PRESCRIPTION DRUG','Dexmethylphenidate hydrochloride','','Dexmethylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20170705','','ANDA','ANDA203614','Amneal Pharmaceuticals of New York LLC','DEXMETHYLPHENIDATE HYDROCHLORIDE','35','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1736_138d037f-2d87-44f9-9080-0f048a9cc403','0115-1736','HUMAN PRESCRIPTION DRUG','Methylphenidate Hydrochloride','','Methylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20160920','','ANDA','ANDA205105','Amneal Pharmaceuticals of New York LLC','METHYLPHENIDATE HYDROCHLORIDE','10','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1737_138d037f-2d87-44f9-9080-0f048a9cc403','0115-1737','HUMAN PRESCRIPTION DRUG','Methylphenidate Hydrochloride','','Methylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20160920','','ANDA','ANDA205105','Amneal Pharmaceuticals of New York LLC','METHYLPHENIDATE HYDROCHLORIDE','20','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1738_138d037f-2d87-44f9-9080-0f048a9cc403','0115-1738','HUMAN PRESCRIPTION DRUG','Methylphenidate Hydrochloride','','Methylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20160920','','ANDA','ANDA205105','Amneal Pharmaceuticals of New York LLC','METHYLPHENIDATE HYDROCHLORIDE','30','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1739_138d037f-2d87-44f9-9080-0f048a9cc403','0115-1739','HUMAN PRESCRIPTION DRUG','Methylphenidate Hydrochloride','','Methylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20160920','','ANDA','ANDA205105','Amneal Pharmaceuticals of New York LLC','METHYLPHENIDATE HYDROCHLORIDE','40','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1740_138d037f-2d87-44f9-9080-0f048a9cc403','0115-1740','HUMAN PRESCRIPTION DRUG','Methylphenidate Hydrochloride','','Methylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20160920','','ANDA','ANDA205105','Amneal Pharmaceuticals of New York LLC','METHYLPHENIDATE HYDROCHLORIDE','50','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1741_138d037f-2d87-44f9-9080-0f048a9cc403','0115-1741','HUMAN PRESCRIPTION DRUG','Methylphenidate Hydrochloride','','Methylphenidate Hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20160920','','ANDA','ANDA205105','Amneal Pharmaceuticals of New York LLC','METHYLPHENIDATE HYDROCHLORIDE','60','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1745_2043aef4-e061-4ef7-978b-768f47e347a6','0115-1745','HUMAN PRESCRIPTION DRUG','Metaxalone','','Metaxalone','TABLET','ORAL','20160526','','ANDA','ANDA040486','Amneal Pharmaceuticals of New York LLC','METAXALONE','400','mg/1','Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1750_dc809ce3-e252-421b-93df-84e294cc472f','0115-1750','HUMAN PRESCRIPTION DRUG','Acitretin','','Acitretin','CAPSULE','ORAL','20160104','','ANDA','ANDA202552','Amneal Pharmaceuticals of New York LLC','ACITRETIN','10','mg/1','Retinoid [EPC], Retinoids [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1751_dc809ce3-e252-421b-93df-84e294cc472f','0115-1751','HUMAN PRESCRIPTION DRUG','Acitretin','','Acitretin','CAPSULE','ORAL','20160104','','ANDA','ANDA202552','Amneal Pharmaceuticals of New York LLC','ACITRETIN','17.5','mg/1','Retinoid [EPC], Retinoids [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1752_dc809ce3-e252-421b-93df-84e294cc472f','0115-1752','HUMAN PRESCRIPTION DRUG','Acitretin','','Acitretin','CAPSULE','ORAL','20160104','','ANDA','ANDA202552','Amneal Pharmaceuticals of New York LLC','ACITRETIN','22.5','mg/1','Retinoid [EPC], Retinoids [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1753_dc809ce3-e252-421b-93df-84e294cc472f','0115-1753','HUMAN PRESCRIPTION DRUG','Acitretin','','Acitretin','CAPSULE','ORAL','20160104','','ANDA','ANDA202552','Amneal Pharmaceuticals of New York LLC','ACITRETIN','25','mg/1','Retinoid [EPC], Retinoids [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1757_1210fa01-a6e1-44ce-92fe-875e9a26b7fe','0115-1757','HUMAN PRESCRIPTION DRUG','Cyproheptadine Hydrochloride','','Cyproheptadine Hydrochloride','TABLET','ORAL','20150729','','ANDA','ANDA040537','Amneal Pharmaceuticals of New York LLC','CYPROHEPTADINE HYDROCHLORIDE','4','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1800_fb5aaa71-ea34-4428-b33c-e40f098f845e','0115-1800','HUMAN PRESCRIPTION DRUG','METHYLPHENIDATE HYDROCHLORIDE','','METHYLPHENIDATE HYDROCHLORIDE','TABLET','ORAL','20140407','','ANDA','ANDA091159','Amneal Pharmaceuticals of New York LLC','METHYLPHENIDATE HYDROCHLORIDE','5','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1801_fb5aaa71-ea34-4428-b33c-e40f098f845e','0115-1801','HUMAN PRESCRIPTION DRUG','METHYLPHENIDATE HYDROCHLORIDE','','METHYLPHENIDATE HYDROCHLORIDE','TABLET','ORAL','20140407','','ANDA','ANDA091159','Amneal Pharmaceuticals of New York LLC','METHYLPHENIDATE HYDROCHLORIDE','10','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1802_fb5aaa71-ea34-4428-b33c-e40f098f845e','0115-1802','HUMAN PRESCRIPTION DRUG','METHYLPHENIDATE HYDROCHLORIDE','','METHYLPHENIDATE HYDROCHLORIDE','TABLET','ORAL','20140407','','ANDA','ANDA091159','Amneal Pharmaceuticals of New York LLC','METHYLPHENIDATE HYDROCHLORIDE','20','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1803_2b8dd846-d8f4-4eae-981d-aebde4d189f1','0115-1803','HUMAN PRESCRIPTION DRUG','Hydroxyzine Pamoate','','Hydroxyzine Pamoate','CAPSULE','ORAL','19960715','','ANDA','ANDA040156','Amneal Pharmaceuticals of New York LLC','HYDROXYZINE PAMOATE','25','mg/1','Antihistamine [EPC], Histamine Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1804_2b8dd846-d8f4-4eae-981d-aebde4d189f1','0115-1804','HUMAN PRESCRIPTION DRUG','Hydroxyzine Pamoate','','Hydroxyzine Pamoate','CAPSULE','ORAL','19960615','','ANDA','ANDA040156','Amneal Pharmaceuticals of New York LLC','HYDROXYZINE PAMOATE','50','mg/1','Antihistamine [EPC], Histamine Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1864_83f79a9e-7658-4d89-a3aa-8c5ee39ac846','0115-1864','HUMAN PRESCRIPTION DRUG','Colesevelam hydrochloride','','Colesevelam hydrochloride','FOR SUSPENSION','ORAL','20230120','','ANDA','ANDA212886','Amneal Pharmaceuticals of New York LLC','COLESEVELAM HYDROCHLORIDE','3.75','g/1','Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-1911_10ac3ab8-78a4-4a5e-a4c1-b2e35fe7d865','0115-1911','HUMAN PRESCRIPTION DRUG','Rimantadine Hydrochloride','','Rimantadine Hydrochloride','TABLET, FILM COATED','ORAL','20211116','','ANDA','ANDA076132','Amneal Pharmaceuticals of New York LLC','RIMANTADINE HYDROCHLORIDE','100','mg/1','Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-2011_b32f83c1-81bd-46e2-8808-ea055c4418f9','0115-2011','HUMAN PRESCRIPTION DRUG','Orphenadrine Citrate','','ORPHENADRINE CITRATE','TABLET, EXTENDED RELEASE','ORAL','20000623','','ANDA','ANDA040368','Amneal Pharmaceuticals of New York LLC','ORPHENADRINE CITRATE','100','mg/1','Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-2134_473214e7-30ff-47aa-b0aa-827d4acd5f63','0115-2134','HUMAN PRESCRIPTION DRUG','Pyridostigmine Bromide','','PYRIDOSTIGMINE BROMIDE','TABLET','ORAL','20220808','','ANDA','ANDA040502','Amneal Pharmaceuticals of New York LLC','PYRIDOSTIGMINE BROMIDE','30','mg/1','Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-2142_64268362-73d9-44bd-b56a-00164facfe60','0115-2142','HUMAN PRESCRIPTION DRUG','COLESTIPOL HYDROCHLORIDE','','COLESTIPOL HYDROCHLORIDE','TABLET, FILM COATED','ORAL','20210817','','ANDA','ANDA077510','Amneal Pharmaceuticals of New York LLC','COLESTIPOL HYDROCHLORIDE','1','g/1','Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-2790_63a4cba1-bbae-413f-a035-f3090f1f1e93','0115-2790','HUMAN PRESCRIPTION DRUG','Chloroquine Phosphate','','CHLOROQUINE PHOSPHATE','TABLET','ORAL','20220510','','ANDA','ANDA080880','Amneal Pharmaceuticals of New York LLC','CHLOROQUINE PHOSPHATE','250','mg/1','Antimalarial [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-3511_a0089353-b8d2-41a4-81c3-1654685fbe43','0115-3511','HUMAN PRESCRIPTION DRUG','Pyridostigmine Bromide','','PYRIDOSTIGMINE BROMIDE','TABLET','ORAL','20030424','','ANDA','ANDA040502','Amneal Pharmaceuticals of New York LLC','PYRIDOSTIGMINE BROMIDE','60','mg/1','Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-4411_75ea294d-af87-4e9f-aaa8-ed99cba1ac7e','0115-4411','HUMAN PRESCRIPTION DRUG','Dantrolene Sodium','','Dantrolene Sodium','CAPSULE','ORAL','20050301','','ANDA','ANDA076856','Amneal Pharmaceuticals of New York LLC','DANTROLENE SODIUM','25','mg/1','Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-4422_75ea294d-af87-4e9f-aaa8-ed99cba1ac7e','0115-4422','HUMAN PRESCRIPTION DRUG','Dantrolene Sodium','','Dantrolene Sodium','CAPSULE','ORAL','20050301','','ANDA','ANDA076856','Amneal Pharmaceuticals of New York LLC','DANTROLENE SODIUM','50','mg/1','Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-4433_75ea294d-af87-4e9f-aaa8-ed99cba1ac7e','0115-4433','HUMAN PRESCRIPTION DRUG','Dantrolene Sodium','','Dantrolene Sodium','CAPSULE','ORAL','20050301','','ANDA','ANDA076856','Amneal Pharmaceuticals of New York LLC','DANTROLENE SODIUM','100','mg/1','Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-5211_58020682-cf49-4ba4-9ad2-a41b95b3e718','0115-5211','HUMAN PRESCRIPTION DRUG','COLESTIPOL HYDROCHLORIDE','','COLESTIPOL HYDROCHLORIDE','TABLET, FILM COATED','ORAL','20210817','','ANDA','ANDA077510','Amneal Pharmaceuticals of New York LLC','COLESTIPOL HYDROCHLORIDE','1','g/1','Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-5212_3fcfc09a-c130-4bb7-918f-6889ffa5cff4','0115-5212','HUMAN PRESCRIPTION DRUG','COLESTIPOL HYDROCHLORIDE','','COLESTIPOL HYDROCHLORIDE','SUSPENSION','ORAL','20060502','','ANDA','ANDA077277','Amneal Pharmaceuticals of New York LLC','COLESTIPOL HYDROCHLORIDE','5','g/1','Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-5213_3fcfc09a-c130-4bb7-918f-6889ffa5cff4','0115-5213','HUMAN PRESCRIPTION DRUG','COLESTIPOL HYDROCHLORIDE','','COLESTIPOL HYDROCHLORIDE','SUSPENSION','ORAL','20060502','','ANDA','ANDA077277','Amneal Pharmaceuticals of New York LLC','COLESTIPOL HYDROCHLORIDE','5','g/1','Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-5445_5fed6a81-828f-4e98-b001-a379b7551fb7','0115-5445','HUMAN PRESCRIPTION DRUG','Bupropion Hydrochloride','','BUPROPION HYDROCHLORIDE','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20041203','','ANDA','ANDA076711','Amneal Pharmaceuticals of New York LLC','BUPROPION HYDROCHLORIDE','200','mg/1','Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-5511_57d6f6cb-cd67-4942-9c12-42b415e95e1d','0115-5511','HUMAN PRESCRIPTION DRUG','FENOFIBRATE','','FENOFIBRATE','TABLET','ORAL','20100201','','ANDA','ANDA076509','Amneal Pharmaceuticals of New York LLC','FENOFIBRATE','54','mg/1','Peroxisome Proliferator Receptor alpha Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-5522_57d6f6cb-cd67-4942-9c12-42b415e95e1d','0115-5522','HUMAN PRESCRIPTION DRUG','FENOFIBRATE','','FENOFIBRATE','TABLET','ORAL','20100201','','ANDA','ANDA076509','Amneal Pharmaceuticals of New York LLC','FENOFIBRATE','160','mg/1','Peroxisome Proliferator Receptor alpha Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-6811_ebd7272f-f069-427c-9264-6a71131be596','0115-6811','HUMAN PRESCRIPTION DRUG','Bupropion Hydrochloride','','BUPROPION HYDROCHLORIDE','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20090501','','ANDA','ANDA077415','Amneal Pharmaceuticals of New York LLC','BUPROPION HYDROCHLORIDE','150','mg/1','Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-7010_423d0738-317e-41eb-8fef-d5ed14160016','0115-7010','HUMAN PRESCRIPTION DRUG','Chloroquine Phosphate','','CHLOROQUINE PHOSPHATE','TABLET','ORAL','20220510','','ANDA','ANDA040516','Amneal Pharmaceuticals of New York LLC','CHLOROQUINE PHOSPHATE','500','mg/1','Antimalarial [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-7033_dfe69736-989d-4710-89a1-6468eda394e9','0115-7033','HUMAN PRESCRIPTION DRUG','Fludrocortisone Acetate','','FLUDROCORTISONE ACETATE','TABLET','ORAL','20020318','','ANDA','ANDA040431','Amneal Pharmaceuticals of New York LLC','FLUDROCORTISONE ACETATE','0.1','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-7037_e7a7ff70-f492-409e-b9a5-472e2d9184f9','0115-7037','HUMAN PRESCRIPTION DRUG','METHITEST','','METHYLTESTOSTERONE','TABLET','ORAL','19741017','','ANDA','ANDA080767','Amneal Pharmaceuticals of New York LLC','METHYLTESTOSTERONE','10','mg/1','Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]','CIII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-9811_1d0277a5-e56b-44e2-9240-22a7f07e5abd','0115-9811','HUMAN PRESCRIPTION DRUG','Digoxin','','DIGOXIN','TABLET','ORAL','20090720','','ANDA','ANDA078556','Amneal Pharmaceuticals of New York LLC','DIGOXIN','125','ug/1','Cardiac Glycoside [EPC], Cardiac Glycosides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-9822_1d0277a5-e56b-44e2-9240-22a7f07e5abd','0115-9822','HUMAN PRESCRIPTION DRUG','Digoxin','','DIGOXIN','TABLET','ORAL','20090720','','ANDA','ANDA078556','Amneal Pharmaceuticals of New York LLC','DIGOXIN','250','ug/1','Cardiac Glycoside [EPC], Cardiac Glycosides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-9918_1a564ba0-9e42-4fd4-ac2a-40c4139ac0b9','0115-9918','HUMAN PRESCRIPTION DRUG','Dexmethylphenidate hydrochloride','','Dexmethylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20150806','','ANDA','ANDA079108','Amneal Pharmaceuticals of New York LLC','DEXMETHYLPHENIDATE HYDROCHLORIDE','5','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-9919_1a564ba0-9e42-4fd4-ac2a-40c4139ac0b9','0115-9919','HUMAN PRESCRIPTION DRUG','Dexmethylphenidate hydrochloride','','Dexmethylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20150806','','ANDA','ANDA079108','Amneal Pharmaceuticals of New York LLC','DEXMETHYLPHENIDATE HYDROCHLORIDE','10','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-9920_1a564ba0-9e42-4fd4-ac2a-40c4139ac0b9','0115-9920','HUMAN PRESCRIPTION DRUG','Dexmethylphenidate hydrochloride','','Dexmethylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20141111','','ANDA','ANDA079108','Amneal Pharmaceuticals of New York LLC','DEXMETHYLPHENIDATE HYDROCHLORIDE','15','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-9921_1a564ba0-9e42-4fd4-ac2a-40c4139ac0b9','0115-9921','HUMAN PRESCRIPTION DRUG','Dexmethylphenidate hydrochloride','','Dexmethylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20151221','','ANDA','ANDA079108','Amneal Pharmaceuticals of New York LLC','DEXMETHYLPHENIDATE HYDROCHLORIDE','20','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-9922_1a564ba0-9e42-4fd4-ac2a-40c4139ac0b9','0115-9922','HUMAN PRESCRIPTION DRUG','Dexmethylphenidate hydrochloride','','Dexmethylphenidate hydrochloride','CAPSULE, EXTENDED RELEASE','ORAL','20140224','','ANDA','ANDA079108','Amneal Pharmaceuticals of New York LLC','DEXMETHYLPHENIDATE HYDROCHLORIDE','30','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-9927_5f266881-18bf-44a9-ac0a-78f3278ec5c4','0115-9927','HUMAN PRESCRIPTION DRUG','Dextroamphetamine Sulfate','Extended-Release','Dextroamphetamine Sulfate','CAPSULE, EXTENDED RELEASE','ORAL','19760802','','NDA AUTHORIZED GENERIC','NDA017078','Amneal Pharmaceuticals of New York LLC','DEXTROAMPHETAMINE SULFATE','5','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-9928_5f266881-18bf-44a9-ac0a-78f3278ec5c4','0115-9928','HUMAN PRESCRIPTION DRUG','Dextroamphetamine Sulfate','Extended-Release','Dextroamphetamine Sulfate','CAPSULE, EXTENDED RELEASE','ORAL','19760802','','NDA AUTHORIZED GENERIC','NDA017078','Amneal Pharmaceuticals of New York LLC','DEXTROAMPHETAMINE SULFATE','10','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-9929_5f266881-18bf-44a9-ac0a-78f3278ec5c4','0115-9929','HUMAN PRESCRIPTION DRUG','Dextroamphetamine Sulfate','Extended-Release','Dextroamphetamine Sulfate','CAPSULE, EXTENDED RELEASE','ORAL','19760802','','NDA AUTHORIZED GENERIC','NDA017078','Amneal Pharmaceuticals of New York LLC','DEXTROAMPHETAMINE SULFATE','15','mg/1','Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-9930_be1c7c11-31c8-4e84-bf0a-e395f0a21485','0115-9930','HUMAN PRESCRIPTION DRUG','Levalbuterol','','Levalbuterol Hydrochloride','SOLUTION','RESPIRATORY (INHALATION)','20160322','','ANDA','ANDA203653','Amneal Pharmaceuticals of New York LLC','LEVALBUTEROL HYDROCHLORIDE','0.31','mg/3mL','Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-9931_be1c7c11-31c8-4e84-bf0a-e395f0a21485','0115-9931','HUMAN PRESCRIPTION DRUG','Levalbuterol','','Levalbuterol Hydrochloride','SOLUTION','RESPIRATORY (INHALATION)','20160322','','ANDA','ANDA203653','Amneal Pharmaceuticals of New York LLC','LEVALBUTEROL HYDROCHLORIDE','0.63','mg/3mL','Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-9932_be1c7c11-31c8-4e84-bf0a-e395f0a21485','0115-9932','HUMAN PRESCRIPTION DRUG','Levalbuterol','','Levalbuterol Hydrochloride','SOLUTION','RESPIRATORY (INHALATION)','20160322','','ANDA','ANDA203653','Amneal Pharmaceuticals of New York LLC','LEVALBUTEROL HYDROCHLORIDE','1.25','mg/3mL','Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-9935_229765ad-c63d-4aee-a2ce-bc4f5e01e282','0115-9935','HUMAN PRESCRIPTION DRUG','minocycline hydrochloride','','minocycline hydrochloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20090723','','NDA AUTHORIZED GENERIC','NDA050808','Amneal Pharmaceuticals of New York, LLC','MINOCYCLINE HYDROCHLORIDE','65','mg/1','Tetracycline-class Drug [EPC], Tetracyclines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0115-9936_229765ad-c63d-4aee-a2ce-bc4f5e01e282','0115-9936','HUMAN PRESCRIPTION DRUG','minocycline hydrochloride','','minocycline hydrochloride','TABLET, FILM COATED, EXTENDED RELEASE','ORAL','20090723','','NDA AUTHORIZED GENERIC','NDA050808','Amneal Pharmaceuticals of New York, LLC','MINOCYCLINE HYDROCHLORIDE','115','mg/1','Tetracycline-class Drug [EPC], Tetracyclines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0003_a187f677-2f93-8f95-e053-2a95a90a4c59','0116-0003','HUMAN PRESCRIPTION DRUG','Chlorhexidine Gluconate 0.12% Oral Rinse','','CHLORHEXIDINE GLUCONATE','LIQUID','BUCCAL','20140120','','ANDA','ANDA077789','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','1.2','[iU]/mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0038_edfd2be7-b14d-7bd1-e053-2a95a90aa668','0116-0038','HUMAN OTC DRUG','Bactoshield CHG','','Chlorhexidine Gluconate 2%','SOLUTION','TOPICAL','20221116','','NDA','NDA019422','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','2','mg/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0039_ee031fc6-647d-68ff-e053-2995a90a5593','0116-0039','HUMAN OTC DRUG','Bactoshield CHG','','Chlorhexidine Gluconate 4%','SOLUTION','TOPICAL','20221121','','NDA','NDA019125','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','2','mg/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0039_ee13f284-4697-06e2-e053-2a95a90a16ce','0116-0039','HUMAN OTC DRUG','Bactoshield CHG','','Chlorhexidine Gluconate 4%','SOLUTION','TOPICAL','20221122','','NDA','NDA019125','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','2','mg/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0061_bb2b6cd5-ec59-4142-e053-2a95a90a74df','0116-0061','HUMAN OTC DRUG','Cardinal Health','','CHLORHEXIDINE GLUCONATE 4%','LIQUID','TOPICAL','20150724','','NDA','NDA019125','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','4','g/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0101_a1895aa7-b2bc-dc71-e053-2995a90a2e4f','0116-0101','HUMAN PRESCRIPTION DRUG','Chlorhexidine Gluconate','','Chlorhexidine Gluconate','LIQUID','ORAL','20160122','','ANDA','ANDA077789','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','0.12','mg/mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0113_a0c0511b-f250-3c76-e053-2995a90a6b22','0116-0113','HUMAN OTC DRUG','Cardinal Health Antiseptic Skin Cleanser','','CHLORHEXIDINE GLUCONATE 2%','SOLUTION','TOPICAL','20150501','','NDA','NDA019422','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','2','g/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0115_a18a2708-24d5-1183-e053-2a95a90a24dc','0116-0115','HUMAN OTC DRUG','Antiseptic Skin Cleanser','','Chlorhexidine Gluconate 4%','LIQUID','TOPICAL','20140220','','NDA','NDA019125','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','4','mg/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0137_b14390d9-9a73-5a11-e053-2a95a90acfab','0116-0137','HUMAN OTC DRUG','Antiseptic Skin Cleanser','','Chlorhexidine Gluconate 4%','LIQUID','TOPICAL','20130401','','NDA','NDA019125','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','4','mg/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0161_b143c4c5-6666-9a9b-e053-2a95a90a7057','0116-0161','HUMAN OTC DRUG','Antiseptic Skin Cleanser','','Chlorhexidine Gluconate 4%','LIQUID','TOPICAL','20110501','','NDA','NDA019125','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','4','mg/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0162_b1448a61-1e20-dfb1-e053-2995a90a50b1','0116-0162','HUMAN OTC DRUG','Antiseptic Skin Cleanser','','Chlorhexidine Gluconate 4%','LIQUID','TOPICAL','20140101','','NDA','NDA019125','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','4','mg/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0175_b17c69eb-5b97-aab7-e053-2a95a90a5508','0116-0175','HUMAN PRESCRIPTION DRUG','Chlorhexidine Gluconate','','Chlorhexidine Gluconate','RINSE','ORAL','20090618','','ANDA','ANDA077789','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','1.2','mg/mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0200_b17c8d6c-9d57-ab28-e053-2a95a90a9453','0116-0200','HUMAN PRESCRIPTION DRUG','BETASEPT','','Antiseptic Surgical Scrub','SOLUTION','TOPICAL','19930601','','NDA','NDA019125','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','0.04','mg/mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0228_b17ca396-40c6-aae9-e053-2a95a90a36e6','0116-0228','HUMAN OTC DRUG','Antiseptic Skin Cleanser','','Chlorhexidine Gluconate 4%','LIQUID','TOPICAL','20121030','','NDA','NDA019125','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','4','mg/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0237_b17cea6b-d75a-2665-e053-2a95a90a9b78','0116-0237','HUMAN OTC DRUG','Antiseptic Skin Cleanser','','Chlorhexidine Gluconate 4%','LIQUID','TOPICAL','20140220','','NDA','NDA019125','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','4','mg/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0244_b17d2149-2713-07f7-e053-2995a90a8fba','0116-0244','HUMAN PRESCRIPTION DRUG','Denti-Care Denti-Rinse','Chlorhexidine Gluconate Oral Rinse','Chlorhexidine Gluconante','LIQUID','DENTAL','20060602','','ANDA','ANDA077789','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','1.2','mg/mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0301_b17da9aa-afcb-7a7d-e053-2995a90a7cce','0116-0301','HUMAN PRESCRIPTION DRUG','Chlorhexidine Gluconate','','Chlorhexidine Gluconate','RINSE','ORAL','20100805','','ANDA','ANDA077789','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','1.2','mg/mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0401_b17dd463-5252-20ff-e053-2995a90ac95a','0116-0401','HUMAN OTC DRUG','Antiseptic Skin Cleanser','','Chlorhexidine Gluconate 4%','LIQUID','TOPICAL','20131101','','NDA','NDA019125','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','4','mg/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0407_b17e0161-e8ea-6a45-e053-2a95a90af9e8','0116-0407','HUMAN PRESCRIPTION DRUG','ANTISEPTIC SKIN CLEANSER','','CHLORHEXIDINE GLUCONATE','SOLUTION','TOPICAL','20120101','','NDA','NDA019125','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','4','g/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0505_b17e4edc-c82c-85a7-e053-2995a90a8e36','0116-0505','HUMAN OTC DRUG','BD E-Z Scrub','','chlorhexidine gluconate','SOLUTION','TOPICAL','20060101','','NDA','NDA019127','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','40','g/1000mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0506_b17f807f-8272-5e52-e053-2995a90ac190','0116-0506','HUMAN OTC DRUG','BD E-Z Scrub','','chlorhexidine gluconate','SOLUTION','TOPICAL','20010401','','NDA','NDA019422','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','20','mg/mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0620_f0711fbf-b273-0705-e053-2a95a90a131a','0116-0620','HUMAN PRESCRIPTION DRUG','Peridex','','chlorhexidine gluconate','RINSE','ORAL','19860813','','NDA','NDA019028','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','1.2','mg/mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0722_b180c8cc-d321-96c7-e053-2a95a90a547f','0116-0722','HUMAN OTC DRUG','Scrub Care','Exidine-2 CHG','CHLORHEXIDINE GLUCONATE','SOLUTION','TOPICAL','20151201','','NDA','NDA019422','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','2','mg/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-0767_ed75d93f-fbaa-4540-e053-2a95a90aef5c','0116-0767','HUMAN OTC DRUG','Antiseptic Skin Cleanser','','CHLORHEXIDINE GLUCONATE 4%','LIQUID','TOPICAL','20110831','','NDA','NDA019125','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','4','g/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-1021_afd46c49-7a82-1bb4-e053-2a95a90a69eb','0116-1021','HUMAN OTC DRUG','DYNA-HEX','2','Chlorhexidine gluconate','LIQUID','TOPICAL','20140101','','NDA','NDA019422','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','2','g/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-1021_b18ee838-d978-6106-e053-2995a90a8ac5','0116-1021','HUMAN OTC DRUG','DYNA-HEX','2','Chlorhexidine Gluconate','LIQUID','TOPICAL','20140101','','NDA','NDA019422','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','2','g/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-1022_b18f1e18-04d5-ef27-e053-2995a90a7b09','0116-1022','HUMAN OTC DRUG','Dyna-Hex 2','','Chlorhexidine Gluconate 2%','SOLUTION','TOPICAL','20160129','','NDA','NDA019422','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','20','mg/mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-1060_b18f6442-777e-769b-e053-2a95a90a8223','0116-1060','HUMAN OTC DRUG','DYNA-HEX 4','','Chlorhexidine Gluconate','LIQUID','TOPICAL','20160101','','NDA','NDA019125','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','4','g/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-1061_6e5e678f-3833-d201-e053-2a91aa0a5ea8','0116-1061','HUMAN OTC DRUG','ANTISEPTIC SKIN CLEANSER','','Chlorhexidine Gluconate','SOLUTION','TOPICAL','20110831','','NDA','NDA019125','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','4','g/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-1061_6e62eb50-ebab-361e-e053-2991aa0aba6f','0116-1061','HUMAN OTC DRUG','ANTISEPTIC SKIN CLEANSER','','Chlorhexidine Gluconate','SOLUTION','TOPICAL','20180801','','NDA','NDA019125','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','4','g/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-1061_857ab9e4-897b-dbde-e053-2a91aa0a2c14','0116-1061','HUMAN OTC DRUG','ANTISEPTIC SKIN CLEANSER','','CHLORHEXIDINE GLUCONATE','SOLUTION','TOPICAL','20110831','','NDA','NDA019125','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','4','g/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-2001_e1e372cd-d5c1-9d53-e053-2995a90a411a','0116-2001','HUMAN PRESCRIPTION DRUG','Chlorhexidine Gluconate','','Chlorhexidine Gluconate','RINSE','ORAL','20100601','','ANDA','ANDA077789','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','1.2','mg/mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-2800_b1bc2086-5f5f-29b5-e053-2995a90ad40f','0116-2800','HUMAN OTC DRUG','Antiseptic Skin Cleanser','Exidine-2 CHG','CHLORHEXIDINE GLUCONATE','SOLUTION','TOPICAL','20160701','','NDA','NDA019422','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','2','mg/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-2992_a7bd3755-1162-97f3-e053-2995a90a1f21','0116-2992','HUMAN OTC DRUG','Scrub Care','Exidine-2 CHG','CHLORHEXIDINE GLUCONATE','SOLUTION','TOPICAL','20100501','','NDA','NDA019422','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','2','g/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-2994_a7bcc492-b3bb-6a6c-e053-2995a90a345a','0116-2994','HUMAN OTC DRUG','Scrub Care','Exidine -4 CHG','Chlorhexidine Gluconate','LIQUID','TOPICAL','20121101','','NDA','NDA019125','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','4','mg/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-2994_b2305626-fff1-610d-e053-2995a90a93bf','0116-2994','HUMAN OTC DRUG','Scrub Care','Exidine -4 CHG','Chlorhexidine gluconate','LIQUID','TOPICAL','20121101','','NDA','NDA019125','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','4','mg/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-3678_96c90b64-d0ba-2fa0-e053-2a95a90a684c','0116-3678','HUMAN OTC DRUG','Antiseptic Skin Cleanser','','Chlorhexidine Gluconate 4%','LIQUID','TOPICAL','20130101','','NDA','NDA019125','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','4','mg/100mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-4005_ee298e3d-9b6d-0ab7-e053-2995a90a74d5','0116-4005','HUMAN PRESCRIPTION DRUG','Lactulose','','Lactulose','SOLUTION','ORAL','20220701','','ANDA','ANDA075911','Xttrium Laboratories, Inc.','LACTULOSE','10','g/15mL','Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-4075_e1a5afc7-1921-4bf1-e053-2995a90a8d60','0116-4075','HUMAN PRESCRIPTION DRUG','Acclean Chlorhexidine Gluconate 0.12% Oral Rinse','','Chlorhexidine Gluconate 0.12% Oral Rinse','LIQUID','ORAL','20091001','','ANDA','ANDA077789','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','1.2','mg/mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-6000_973ca7d5-fa90-213c-e053-2a95a90a78fa','0116-6000','HUMAN PRESCRIPTION DRUG','Chlorhexidine Gluconate','','Chlorhexidine Gluconate','RINSE','ORAL','20120418','','ANDA','ANDA077789','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','1.2','mg/mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-6720_e807e9d4-9ee5-0f20-e053-2995a90a1d7c','0116-6720','HUMAN PRESCRIPTION DRUG','Acclean Chlorhexidine Gluconate 0.12% Oral Rinse','','Chlorhexidine Gluconate 0.12% Oral Rinse','LIQUID','ORAL','20130201','','ANDA','ANDA077789','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','1.2','mg/mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0116-8500_973e0c34-8585-ba4d-e053-2995a90a8fb0','0116-8500','HUMAN OTC DRUG','Provon Antimicrobial Foam Handwash','','Chlorhexidine Gluconate 2%','SOLUTION','TOPICAL','20160701','','NDA','NDA019422','Xttrium Laboratories, Inc.','CHLORHEXIDINE GLUCONATE','20','mg/mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0431_d4da9913-7711-6580-e053-2995a90a6e55','0121-0431','HUMAN OTC DRUG','Milk of Magnesia','','Magnesium Hydroxide','SUSPENSION','ORAL','19790904','','OTC MONOGRAPH FINAL','part331','Pharmaceutical Associates, Inc.','MAGNESIUM HYDROXIDE','400','mg/5mL','Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0489_e16d8ed2-bd4a-f5d4-e053-2995a90a153b','0121-0489','HUMAN PRESCRIPTION DRUG','DIPHENHYDRAMINE HYDROCHLORIDE','','DIPHENHYDRAMINE HYDROCHLORIDE','SOLUTION','ORAL','19820210','','ANDA','ANDA087513','Pharmaceutical Associates, Inc.','DIPHENHYDRAMINE HYDROCHLORIDE','12.5','mg/5mL','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0504_d62a2fb0-e51a-46b7-a413-52f659dcf611','0121-0504','HUMAN PRESCRIPTION DRUG','Acetaminophen and Codeine Phosphate','','ACETAMINOPHEN and CODEINE PHOSPHATE','SOLUTION','ORAL','19810821','','ANDA','ANDA087508','PAI Holdings, LLC','ACETAMINOPHEN; CODEINE PHOSPHATE','120; 12','mg/5mL; mg/5mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0531_d4dbd9ed-e7bc-038e-e053-2a95a90a8a27','0121-0531','HUMAN PRESCRIPTION DRUG','Phenobarbital','','Phenobarbital','SOLUTION','ORAL','20070219','','UNAPPROVED DRUG OTHER','','Pharmaceutical Associates, Inc.','PHENOBARBITAL','20','mg/5mL','','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0576_49eecb65-9859-4e18-b6cb-55b971a4cec3','0121-0576','HUMAN PRESCRIPTION DRUG','Metoclopramide','','metoclopramide hydrochloride','SOLUTION','ORAL','19910601','','ANDA','ANDA072744','PAI Holdings, LLC','METOCLOPRAMIDE HYDROCHLORIDE','5','mg/5mL','Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0577_ee162463-154d-b3e9-e053-2995a90a1528','0121-0577','HUMAN PRESCRIPTION DRUG','LACTULOSE','','LACTULOSE','SOLUTION','ORAL','19660730','','ANDA','ANDA074623','Pharmaceutical Associates, Inc,','LACTULOSE','10','g/15mL','Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0581_e17db615-a894-3771-e053-2995a90a4fdc','0121-0581','HUMAN PRESCRIPTION DRUG','Haloperidol','','Haloperidol','SOLUTION','ORAL','20091110','','ANDA','ANDA073037','Pharmaceutical Associates, Inc.','HALOPERIDOL','2','mg/mL','Typical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0595_efe0dd73-00d4-9223-e053-2a95a90a1bae','0121-0595','HUMAN PRESCRIPTION DRUG','Sodium Citrate and Citric Acid','','SODIUM CITRATE and CITRIC ACID MONOHYDRATE','SOLUTION','ORAL','19690101','','UNAPPROVED DRUG OTHER','','Pharmaceutical Associates, Inc.','ANHYDROUS CITRIC ACID; SODIUM CITRATE','334; 500','mg/5mL; mg/5mL','Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0638_e16f8554-d0c9-3799-e053-2a95a90a29d6','0121-0638','HUMAN OTC DRUG','GUAIFENESIN DM','','GUAIFENESIN and DEXTROMETHORPHAN','SYRUP','ORAL','19920701','','OTC MONOGRAPH FINAL','part341','Pharmaceutical Associates, Inc.','DEXTROMETHORPHAN; GUAIFENESIN','10; 100','mg/5mL; mg/5mL','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0646_0bb9609d-2d23-44e8-9134-03515a2f00a9','0121-0646','HUMAN PRESCRIPTION DRUG','AMANTADINE HYDROCHLORIDE','','AMANTADINE HYDROCHLORIDE','SOLUTION','ORAL','19950717','','ANDA','ANDA074509','PAI Holdings, LLC','AMANTADINE HYDROCHLORIDE','50','mg/5mL','Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0649_e16a0b54-26b1-2426-e053-2995a90ac0be','0121-0649','HUMAN PRESCRIPTION DRUG','Cimetidine','','Cimetidine Hydrochloride','SOLUTION','ORAL','20210212','','ANDA','ANDA074553','Pharmaceutical Associates, Inc.','CIMETIDINE HYDROCHLORIDE','300','mg/5mL','Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0653_d5534874-7649-31d6-e053-2995a90ad657','0121-0653','HUMAN PRESCRIPTION DRUG','Fluphenazine Hydrochloride','','Fluphenazine Hydrochloride','SOLUTION, CONCENTRATE','ORAL','20100901','','ANDA','ANDA074725','Pharmaceutical Associates, Inc.','FLUPHENAZINE HYDROCHLORIDE','5','mg/mL','Phenothiazine [EPC], Phenothiazines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0654_ea5fe599-f8e5-40ff-e053-2a95a90aaa66','0121-0654','HUMAN PRESCRIPTION DRUG','Fluphenazine Hydrochloride','','Fluphenazine Hydrochloride','ELIXIR','ORAL','20100831','','ANDA','ANDA040146','Pharmaceutical Associates, Inc.','FLUPHENAZINE HYDROCHLORIDE','0.5','mg/mL','Phenothiazine [EPC], Phenothiazines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0657_e15b8c3b-2e14-ab99-e053-2995a90ab26a','0121-0657','HUMAN OTC DRUG','Acetaminophen','','Acetaminophen','SOLUTION','ORAL','20070801','','OTC MONOGRAPH NOT FINAL','part343','Pharmaceutical Associates, Inc.','ACETAMINOPHEN','160','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0658_1ebb3dcc-88c8-4ea6-88f2-0eaf9322d875','0121-0658','HUMAN PRESCRIPTION DRUG','Trihexyphenidyl Hydrochloride','','Trihexyphenidyl Hydrochloride','SOLUTION','ORAL','19970515','','ANDA','ANDA040177','PAI Holdings, LLC','TRIHEXYPHENIDYL HYDROCHLORIDE','2','mg/5mL','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0670_0ee6fdf9-bfba-4f73-a0b8-76d7ac9ada7b','0121-0670','HUMAN PRESCRIPTION DRUG','ETHOSUXIMIDE','','ETHOSUXIMIDE','SOLUTION','ORAL','20001122','','ANDA','ANDA040253','PAI Holdings, LLC','ETHOSUXIMIDE','250','mg/5mL','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0675_4eb69580-587f-49d9-bba5-de1a57302e0f','0121-0675','HUMAN PRESCRIPTION DRUG','VALPROIC ACID','','VALPROIC ACID','SOLUTION','ORAL','20050411','','ANDA','ANDA075379','PAI Holdings, LLC','VALPROIC ACID','250','mg/5mL','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0676_16ac3c3c-e9a4-454b-9d37-3733b7af84fa','0121-0676','HUMAN PRESCRIPTION DRUG','Potassium Citrate and Citric Acid','','Potassium Citrate and Citric Acid Monohydrate','SOLUTION','ORAL','19971007','','UNAPPROVED DRUG OTHER','','PAI Holdings, LLC','CITRIC ACID MONOHYDRATE; POTASSIUM CITRATE','334; 1100','mg/5mL; mg/5mL','Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0677_d553e347-d516-19c8-e053-2995a90a2384','0121-0677','HUMAN PRESCRIPTION DRUG','TRICITRATES','','POTASSIUM CITRATE, SODIUM CITRATE, and CITRIC ACID MONOHYDRATE','SOLUTION','ORAL','20050525','','UNAPPROVED DRUG OTHER','','Pharmaceutical Associates, Inc.','CITRIC ACID MONOHYDRATE; POTASSIUM CITRATE; SODIUM CITRATE','334; 550; 500','mg/5mL; mg/5mL; mg/5mL','Acidifying Activity [MoA], Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0678_c7a2093f-0439-490b-97e5-5cec9f1826db','0121-0678','HUMAN PRESCRIPTION DRUG','Nortriptyline Hydrochloride','','Nortriptyline Hydrochloride','SOLUTION','ORAL','20000823','','ANDA','ANDA075606','PAI Holdings, LLC','NORTRIPTYLINE HYDROCHLORIDE','10','mg/5mL','Tricyclic Antidepressant [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0721_e16e3979-5182-33f4-e053-2995a90a7339','0121-0721','HUMAN PRESCRIPTION DRUG','Fluoxetine','','FLUOXETINE HYDROCHLORIDE','SOLUTION','ORAL','20020130','','ANDA','ANDA076015','Pharmaceutical Associates, Inc.','FLUOXETINE HYDROCHLORIDE','20','mg/5mL','Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0727_d56a22ea-5dab-e98a-e053-2a95a90a34c4','0121-0727','HUMAN PRESCRIPTION DRUG','Ranitidine','','RANITIDINE','SYRUP','ORAL','20101101','','ANDA','ANDA077405','Pharmaceutical Associates, Inc.','RANITIDINE','15','mg/mL','Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0744_e16ed09e-75ba-7bd1-e053-2a95a90a25e7','0121-0744','HUMAN OTC DRUG','GUAIFENESIN','','GUAIFENESIN','SOLUTION','ORAL','20020901','','OTC MONOGRAPH FINAL','part341','Pharmaceutical Associates, Inc.','GUAIFENESIN','100','mg/5mL','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0747_d554fc2f-929a-72a1-e053-2a95a90a6f20','0121-0747','HUMAN PRESCRIPTION DRUG','Sucralfate','','Sucralfate','SUSPENSION','ORAL','20091119','','NDA','NDA019183','Pharmaceutical Associates, Inc.','SUCRALFATE','1','g/10mL','Aluminum Complex [EPC], Organometallic Compounds [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0759_d069e75f-2f88-4773-b31b-058775792c02','0121-0759','HUMAN PRESCRIPTION DRUG','Prednisolone Sodium Phosphate','','Prednisolone Sodium Phosphate','SOLUTION','ORAL','20050425','','ANDA','ANDA076913','PAI Holdings, LLC','PREDNISOLONE SODIUM PHOSPHATE','15','mg/5mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0766_eeb71e98-775f-e61d-e053-2995a90a5cb3','0121-0766','HUMAN OTC DRUG','Calcium Carbonate','','Calcium Carbonate','SUSPENSION','ORAL','20041201','','OTC MONOGRAPH FINAL','part331','Pharmaceutical Associates, Inc.','CALCIUM CARBONATE','1250','mg/5mL','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0770_e5f67a93-3cca-391b-e053-2a95a90af637','0121-0770','HUMAN PRESCRIPTION DRUG','Lorazepam','','Lorazepam','LIQUID','ORAL','20101101','','ANDA','ANDA090260','Pharmaceutical Associates, Inc.','LORAZEPAM','2','mg/mL','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0772_e17e391f-c75d-1bdc-e053-2a95a90a9401','0121-0772','HUMAN PRESCRIPTION DRUG','Hydrocodone Bitartrate and Acetaminophen','','HYDROCODONE BITARTRATE and ACETAMINOPHEN','SOLUTION','ORAL','20130729','','ANDA','ANDA040838','Pharmaceutical Associates, Inc.','ACETAMINOPHEN; HYDROCODONE BITARTRATE','325; 7.5','mg/15mL; mg/15mL','Opioid Agonist [EPC], Opioid Agonists [MoA]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0773_cd3c2ec3-09c0-51d7-e053-2995a90aba82','0121-0773','HUMAN PRESCRIPTION DRUG','Prednisolone Sodium Phosphate','','Prednisolone Sodium Phosphate','SOLUTION','ORAL','20170131','','ANDA','ANDA078465','Pharmaceutical Associates, Inc.','PREDNISOLONE SODIUM PHOSPHATE','10','mg/5mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0775_e16f3d0c-f07b-3d84-e053-2a95a90a2789','0121-0775','HUMAN OTC DRUG','Guaifenesin and Codeine Phosphate','','Guaifenesin and Codeine Phosphate','SOLUTION','ORAL','20061001','','OTC MONOGRAPH FINAL','part341','Pharmaceutical Associates, Inc.','CODEINE PHOSPHATE; GUAIFENESIN','10; 100','mg/5mL; mg/5mL','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0777_d5792e8c-ee14-64a5-e053-2a95a90ad2fb','0121-0777','HUMAN PRESCRIPTION DRUG','Prednisolone Sodium Phosphate','','Prednisolone Sodium Phosphate','SOLUTION','ORAL','20170131','','ANDA','ANDA078988','Pharmaceutical Associates, Inc.','PREDNISOLONE SODIUM PHOSPHATE','20','mg/5mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0781_e9bdeba1-2908-7289-e053-2995a90a5e18','0121-0781','HUMAN OTC DRUG','Childrens Pain and Fever','','Acetaminophen','SUSPENSION','ORAL','20220928','','OTC MONOGRAPH NOT FINAL','part343','Pharmaceutical Associates, Inc.','ACETAMINOPHEN','160','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0799_f03283e8-8881-775a-e053-2a95a90a4b7a','0121-0799','HUMAN PRESCRIPTION DRUG','Levetiracetam','','LEVETIRACETAM','SOLUTION','ORAL','20150604','','ANDA','ANDA201157','Pharmaceutical Associates, Inc.','LEVETIRACETAM','100','mg/mL','Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0810_d57cde69-0eb9-180d-e053-2995a90a33aa','0121-0810','HUMAN PRESCRIPTION DRUG','Nystatin','','NYSTATIN','SUSPENSION','ORAL','20160201','','ANDA','ANDA203621','Pharmaceutical Associates, Inc.','NYSTATIN','100000','[USP''''U]/mL','Polyene Antifungal [EPC], Polyenes [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0820_b3e90b4e-1bd9-4112-b1e0-37caaca041d7','0121-0820','HUMAN PRESCRIPTION DRUG','THEOPHYLLINE','','THEOPHYLLINE','SOLUTION','ORAL','20161216','','ANDA','ANDA206344','PAI Holdings, LLC','THEOPHYLLINE','80','mg/15mL','Methylxanthine [EPC], Xanthines [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0825_fb581fb2-a860-4eb7-a222-9ee0db19e178','0121-0825','HUMAN PRESCRIPTION DRUG','Morphine Sulfate','','MORPHINE SULFATE','SOLUTION','ORAL','20161114','','ANDA','ANDA206573','PAI','MORPHINE SULFATE','100','mg/5mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0826_e8095cba-a76f-24ef-e053-2a95a90a3450','0121-0826','HUMAN PRESCRIPTION DRUG','OXYCODONE HYDROCHLORIDE','','OXYCODONE HYDROCHLORIDE','SOLUTION','ORAL','20180604','','ANDA','ANDA206822','Pharmaceutical Associates, Inc.','OXYCODONE HYDROCHLORIDE','100','mg/5mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0827_81862aa3-6834-4ba9-affd-6376b10be351','0121-0827','HUMAN PRESCRIPTION DRUG','OXYCODONE HYDROCHLORIDE','','OXYCODONE HYDROCHLORIDE','SOLUTION','ORAL','20190408','','ANDA','ANDA206914','PAI Holdings, LLC','OXYCODONE HYDROCHLORIDE','5','mg/5mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0841_cd3a937e-3347-6368-e053-2a95a90abe56','0121-0841','HUMAN PRESCRIPTION DRUG','Potassium Chloride','','POTASSIUM CHLORIDE','SOLUTION','ORAL','20190402','','ANDA','ANDA210766','Pharmaceutical Associates, Inc.','POTASSIUM CHLORIDE','40','meq/15mL','Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0853_d78243e9-f204-909e-e053-2a95a90ac4b1','0121-0853','HUMAN PRESCRIPTION DRUG','Sulfamethoxazole and Trimethoprim','','Sulfamethoxazole and Trimethoprim','SUSPENSION','ORAL','19830701','','NDA','NDA018615','Pharmaceutical Associates, Inc.','SULFAMETHOXAZOLE; TRIMETHOPRIM','200; 40','mg/5mL; mg/5mL','Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0854_c12524e1-2c97-49c2-b2d9-35366f72907c','0121-0854','HUMAN PRESCRIPTION DRUG','SULFATRIM','','Sulfamethoxazole and Trimethoprim','SUSPENSION','ORAL','19830701','','NDA','NDA018615','PAI Holdings, LLC','SULFAMETHOXAZOLE; TRIMETHOPRIM','200; 40','mg/5mL; mg/5mL','Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0862_6480cf3e-b4a0-4dfc-b505-6c74bcddcdff','0121-0862','HUMAN PRESCRIPTION DRUG','Carbamazepine','','Carbamazepine','SUSPENSION','ORAL','20020605','','ANDA','ANDA075714','PAI Holdings, LLC','CARBAMAZEPINE','100','mg/5mL','Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0865_c4e71fc9-c7e0-e4cd-e053-2995a90a4508','0121-0865','HUMAN OTC DRUG','Diphenhydramine HCl Oral Solution','','diphenhydramine hydrochloride','SOLUTION','ORAL','20200618','','OTC MONOGRAPH FINAL','part341','Pharmaceutical Associates, Inc.','DIPHENHYDRAMINE HYDROCHLORIDE','12.5','mg/5mL','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0867_10c31aed-0d69-49ba-9747-7c7119c87c5d','0121-0867','HUMAN PRESCRIPTION DRUG','VANCOMYCIN HYDROCHLORIDE','','VANCOMYCIN HYDROCHLORIDE','CAPSULE','ORAL','20190725','','ANDA','ANDA210729','PAI Holdings, LLC','VANCOMYCIN HYDROCHLORIDE','125','mg/1','Glycopeptide Antibacterial [EPC], Glycopeptides [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0867_46c61b28-1b3a-4f06-bcba-bf1fba0a6287','0121-0867','HUMAN PRESCRIPTION DRUG','VANCOMYCIN HYDROCHLORIDE','','VANCOMYCIN HYDROCHLORIDE','CAPSULE','ORAL','20190725','','ANDA','ANDA210729','PAI Holdings, LLC','VANCOMYCIN HYDROCHLORIDE','125','mg/1','Glycopeptide Antibacterial [EPC], Glycopeptides [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0868_dffe6584-ea26-48e3-bb20-ac2dab65d433','0121-0868','HUMAN PRESCRIPTION DRUG','Nystatin','','NYSTATIN','SUSPENSION','ORAL','20200717','','ANDA','ANDA203621','PAI Holdings, LLC','NYSTATIN','100000','[USP''''U]/mL','Polyene Antifungal [EPC], Polyenes [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0873_f0597d2a-6162-74d7-e053-2995a90a9894','0121-0873','HUMAN PRESCRIPTION DRUG','LACTULOSE','','Lactulose','SOLUTION','ORAL','20191203','','ANDA','ANDA074623','Pharmaceutical Associates, Inc.','LACTULOSE','10','g/15mL','Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0890_10c31aed-0d69-49ba-9747-7c7119c87c5d','0121-0890','HUMAN PRESCRIPTION DRUG','VANCOMYCIN HYDROCHLORIDE','','VANCOMYCIN HYDROCHLORIDE','CAPSULE','ORAL','20190725','','ANDA','ANDA210729','PAI Holdings, LLC','VANCOMYCIN HYDROCHLORIDE','250','mg/1','Glycopeptide Antibacterial [EPC], Glycopeptides [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0890_46c61b28-1b3a-4f06-bcba-bf1fba0a6287','0121-0890','HUMAN PRESCRIPTION DRUG','VANCOMYCIN HYDROCHLORIDE','','VANCOMYCIN HYDROCHLORIDE','CAPSULE','ORAL','20190725','','ANDA','ANDA210729','PAI Holdings, LLC','VANCOMYCIN HYDROCHLORIDE','250','mg/1','Glycopeptide Antibacterial [EPC], Glycopeptides [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0892_598abf5c-cda1-4f2b-80a6-08244044c5ee','0121-0892','HUMAN PRESCRIPTION DRUG','Phenytoin','','Phenytoin','SUSPENSION','ORAL','20040408','','ANDA','ANDA040521','PAI Holdings, LLC','PHENYTOIN','125','mg/5mL','Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0893_efe0b1c4-571c-e951-e053-2995a90a7883','0121-0893','HUMAN PRESCRIPTION DRUG','CHLORHEXIDINE GLUCONATE','','CHLORHEXIDINE GLUCONATE','RINSE','ORAL','19951215','','ANDA','ANDA074522','Pharmaceutical Associates, Inc.','CHLORHEXIDINE GLUCONATE','1.2','mg/mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0898_0d67fa4c-b36a-4d81-8e7d-a661db92df22','0121-0898','HUMAN PRESCRIPTION DRUG','Atovaquone','','Atovaquone','SUSPENSION','ORAL','20181011','','ANDA','ANDA210692','PAI Holdings, LLC','ATOVAQUONE','750','mg/5mL','Antimalarial [EPC], Antiprotozoal [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0902_c2c5fb34-8e7e-4954-e053-2a95a90ad0ad','0121-0902','HUMAN PRESCRIPTION DRUG','Prednisolone Sodium Phosphate','','Prednisolone Sodium Phosphate','SOLUTION','ORAL','20040525','','ANDA','ANDA075988','Pharmaceutical Associates, Inc.','PREDNISOLONE SODIUM PHOSPHATE','5','mg/5mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0903_d5c843b5-65cb-b0a4-e053-2995a90a29e6','0121-0903','HUMAN PRESCRIPTION DRUG','Lidocaine Viscous','','Lidocaine Hydrochloride','SOLUTION','ORAL','19850426','','ANDA','ANDA088802','Pharmaceutical Associates, Inc.','LIDOCAINE HYDROCHLORIDE','20','mg/mL','Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0904_dbfb7f28-f2db-4c13-e053-2a95a90a0872','0121-0904','HUMAN PRESCRIPTION DRUG','Morphine Sulfate','','Morphine Sulfate','SOLUTION','ORAL','20170317','','NDA','NDA022195','Pharmaceutical Associates, Inc.','MORPHINE SULFATE','10','mg/5mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0905_cc0d49f5-c681-9d48-e053-2a95a90a597b','0121-0905','HUMAN PRESCRIPTION DRUG','Diazepam','','Diazepam','SOLUTION','ORAL','19870403','','ANDA','ANDA070928','Pharmaceutical Associates, Inc.','DIAZEPAM','5','mg/5mL','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0908_e20b8c76-152c-9fee-e053-2a95a90aa52d','0121-0908','HUMAN PRESCRIPTION DRUG','Propranolol Hydrochloride','','Propranolol Hydrochloride','SOLUTION','ORAL','20210903','','ANDA','ANDA070979','Pharmaceutical Associates, Inc.','PROPRANOLOL HYDROCHLORIDE','20','mg/5mL','Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0910_dec3f97d-3508-4672-e053-2a95a90a3df0','0121-0910','HUMAN OTC DRUG','Stomach Relief','','Bismuth subsalicylate','LIQUID','ORAL','20200717','','OTC MONOGRAPH FINAL','part335','Pharmaceutical Associates, Inc.','BISMUTH SUBSALICYLATE','525','mg/30mL','Bismuth [CS], Bismuth [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0914_e78c2544-9dfe-6399-e053-2995a90ac3d0','0121-0914','HUMAN OTC DRUG','Childrens Ibuprofen Oral Suspension','','Ibuprofen','SUSPENSION','ORAL','19990430','','ANDA','ANDA074916','Pharmaceutical Associates, Inc.','IBUPROFEN','100','mg/5mL','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0917_e1e1b2a4-6261-ad42-e053-2995a90a3407','0121-0917','HUMAN OTC DRUG','Childrens Ibuprofen','','Ibuprofen','SUSPENSION','ORAL','19990430','','ANDA','ANDA074916','Pharmaceutical Associates, Inc.','IBUPROFEN','100','mg/5mL','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0918_d30c087d-a4bf-d940-e053-2995a90a1588','0121-0918','HUMAN PRESCRIPTION DRUG','Ibuprofen','','Ibuprofen','SUSPENSION','ORAL','20170623','','ANDA','ANDA209204','Pharmaceutical Associates, Inc.','IBUPROFEN','100','mg/5mL','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0925_6468c79b-ff80-4d93-ad5a-7a63f54b5c70','0121-0925','HUMAN PRESCRIPTION DRUG','Promethazine VC with Codeine Oral Solution','','Promethazine and Phenylephrine Hydrochloride and Codeine Phosphate','SOLUTION','ORAL','20210318','','ANDA','ANDA040660','PAI Holdings, LLC','CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE','10; 5; 6.25','mg/5mL; mg/5mL; mg/5mL','Adrenergic alpha1-Agonists [MoA], Full Opioid Agonists [MoA], Opioid Agonist [EPC], Phenothiazine [EPC], Phenothiazines [CS], alpha-1 Adrenergic Agonist [EPC]','CV','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0926_ece63603-a56d-428f-83dd-c8833c079261','0121-0926','HUMAN PRESCRIPTION DRUG','Promethazine VC','','Promethazine Hydrochloride and Phenylephrine Hydrochloride','SOLUTION','ORAL','20210311','','ANDA','ANDA040654','PAI Holdings, LLC','PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE','5; 6.25','mg/5mL; mg/5mL','Adrenergic alpha1-Agonists [MoA], Phenothiazine [EPC], Phenothiazines [CS], alpha-1 Adrenergic Agonist [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0927_e20b6b57-77e4-1370-e053-2a95a90ae5e1','0121-0927','HUMAN PRESCRIPTION DRUG','Promethazine Hydrochloride','','Promethazine Hydrochloride','SOLUTION','ORAL','20200918','','ANDA','ANDA040643','Pharmaceutical Associates, Inc.','PROMETHAZINE HYDROCHLORIDE','6.25','mg/5mL','Phenothiazine [EPC], Phenothiazines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0928_d5c9a447-d506-eee6-e053-2a95a90a389d','0121-0928','HUMAN PRESCRIPTION DRUG','Promethazine with Codeine','','Promethazine Hydrochloride and Codeine Phosphate','SOLUTION','ORAL','20200918','','ANDA','ANDA040650','Pharmaceutical Associates, Inc.','CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE','10; 6.25','mg/5mL; mg/5mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC], Phenothiazine [EPC], Phenothiazines [CS]','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0933_e2acfcb3-ef3b-331f-e053-2995a90a64fa','0121-0933','HUMAN PRESCRIPTION DRUG','Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide','','Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide','SOLUTION','ORAL','20220303','','ANDA','ANDA202940','Pharmaceutical Associates, Inc.','BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE','2; 10; 30','mg/5mL; mg/5mL; mg/5mL','Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0935_c9acc4ea-adee-3c73-e053-2a95a90a9702','0121-0935','HUMAN OTC DRUG','Docusate Sodium','','Docusate Sodium Liquid','LIQUID','ORAL','20210816','','OTC MONOGRAPH NOT FINAL','part334','Pharmaceutical Associates, Inc.','DOCUSATE SODIUM','50','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0939_e5d6567e-a8f6-5bb7-e053-2a95a90a0f87','0121-0939','HUMAN OTC DRUG','Childrens Acetaminophen','','Acetaminophen','SUSPENSION','ORAL','20210129','','OTC MONOGRAPH NOT FINAL','part343','Pharmaceutical Associates, Inc.','ACETAMINOPHEN','160','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0940_d7244125-1c8e-78ba-e053-2995a90ab764','0121-0940','HUMAN OTC DRUG','Milk of Magnesia Concentrate','','MAGNESIUM HYDROXIDE','SUSPENSION','ORAL','20220118','','OTC MONOGRAPH FINAL','part331','Pharmaceutical Associates, Inc.','MAGNESIUM HYDROXIDE','2400','mg/10mL','Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0941_d3945cb4-2cad-6418-e053-2995a90a138f','0121-0941','HUMAN OTC DRUG','Acetaminophen','','Acetaminophen','SUSPENSION','ORAL','20210903','','OTC MONOGRAPH NOT FINAL','part343','Pharmaceutical Associates, Inc.','ACETAMINOPHEN','160','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0942_cae1f392-4081-90f9-e053-2a95a90a8fb5','0121-0942','HUMAN PRESCRIPTION DRUG','Phenobarbital Oral Solution','','Phenobarbital Oral','SOLUTION','ORAL','20210820','','UNAPPROVED DRUG OTHER','','Pharmaceutical Associates, Inc.','PHENOBARBITAL','20','mg/5mL','','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0945_d336fb0b-58c7-4d98-e053-2995a90a6cca','0121-0945','HUMAN PRESCRIPTION DRUG','Megestrol Acetate','','Megestrol Acetate','SUSPENSION','ORAL','20010725','','ANDA','ANDA075671','Pharmaceutical Associates, Inc.','MEGESTROL ACETATE','400','mg/10mL','Progesterone Congeners [CS], Progestin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0946_dff1f086-659e-c701-e053-2995a90a4175','0121-0946','HUMAN OTC DRUG','Childrens Acetaminophen','','Childrens Acetaminophen','SUSPENSION','ORAL','20210907','','OTC MONOGRAPH NOT FINAL','part343','Pharmaceutical Associates, Inc.','ACETAMINOPHEN','160','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0947_c64c38ed-d17b-47d3-9538-23663d4c4027','0121-0947','HUMAN PRESCRIPTION DRUG','Carbamazepine','','Carbamazepine','SUSPENSION','ORAL','20211007','','ANDA','ANDA076729','PAI Holdings, LLC','CARBAMAZEPINE','100','mg/5mL','Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0966_e282c122-a715-e397-e053-2995a90a9632','0121-0966','HUMAN OTC DRUG','Childrens Acetaminophen Oral Suspension','','Acetaminophen','SUSPENSION','ORAL','20220309','','OTC MONOGRAPH NOT FINAL','part343','Pharmaceutical Associates, Inc.','ACETAMINOPHEN','160','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0973_325c94eb-443a-41bd-9368-321720d788b3','0121-0973','HUMAN OTC DRUG','Childrens Pain and Fever','','Childrens Pain and Fever','SUSPENSION','ORAL','20221121','','OTC MONOGRAPH NOT FINAL','part343','PAI Holdings, LLC','ACETAMINOPHEN','160','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0974_cac2ff1f-650b-468d-b55c-f0e105f456c3','0121-0974','HUMAN PRESCRIPTION DRUG','Sucralfate','','Sucralfate','SUSPENSION','ORAL','20220315','','ANDA','ANDA211884','PAI Holdings, LLC','SUCRALFATE','1','g/10mL','Aluminum Complex [EPC], Organometallic Compounds [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0975_cd1b0352-64f5-4bb4-95d6-e83a86d31a58','0121-0975','HUMAN OTC DRUG','Childrens Pain and Fever','','Childrens Pain and Fever','SUSPENSION','ORAL','20221121','','OTC MONOGRAPH NOT FINAL','part343','PAI Holdings, LLC','ACETAMINOPHEN','160','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0978_e16d8ed2-bd4a-f5d4-e053-2995a90a153b','0121-0978','HUMAN PRESCRIPTION DRUG','DIPHENHYDRAMINE HYDROCHLORIDE','','DIPHENHYDRAMINE HYDROCHLORIDE','SOLUTION','ORAL','19820210','','ANDA','ANDA087513','Pharmaceutical Associates, Inc.','DIPHENHYDRAMINE HYDROCHLORIDE','25','mg/10mL','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-0992_a95d174d-efee-4ba5-8734-9adaad16be27','0121-0992','HUMAN PRESCRIPTION DRUG','Lacosamide','','Lacosamide','SOLUTION','ORAL','20220531','','ANDA','ANDA209301','PAI','LACOSAMIDE','50','mg/5mL','Decreased Central Nervous System Disorganized Electrical Activity [PE]','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1154_ee162463-154d-b3e9-e053-2995a90a1528','0121-1154','HUMAN PRESCRIPTION DRUG','LACTULOSE','','LACTULOSE','SOLUTION','ORAL','19660730','','ANDA','ANDA074623','Pharmaceutical Associates, Inc,','LACTULOSE','20','g/30mL','Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1190_efe0dd73-00d4-9223-e053-2a95a90a1bae','0121-1190','HUMAN PRESCRIPTION DRUG','Sodium Citrate and Citric Acid','','SODIUM CITRATE and CITRIC ACID MONOHYDRATE','SOLUTION','ORAL','19690101','','UNAPPROVED DRUG OTHER','','Pharmaceutical Associates, Inc.','ANHYDROUS CITRIC ACID; SODIUM CITRATE','334; 500','mg/5mL; mg/5mL','Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1276_e16f8554-d0c9-3799-e053-2a95a90a29d6','0121-1276','HUMAN OTC DRUG','GUAIFENESIN DM','','GUAIFENESIN and DEXTROMETHORPHAN','SYRUP','ORAL','19920701','','OTC MONOGRAPH FINAL','part341','Pharmaceutical Associates, Inc.','DEXTROMETHORPHAN; GUAIFENESIN','20; 200','mg/10mL; mg/10mL','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1298_e16a0b54-26b1-2426-e053-2995a90ac0be','0121-1298','HUMAN PRESCRIPTION DRUG','Cimetidine','','Cimetidine Hydrochloride','SOLUTION','ORAL','20210326','','ANDA','ANDA074553','Pharmaceutical Associates, Inc.','CIMETIDINE HYDROCHLORIDE','400','mg/6.67mL','Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1314_e15b8c3b-2e14-ab99-e053-2995a90ab26a','0121-1314','HUMAN OTC DRUG','Acetaminophen','','Acetaminophen','SOLUTION','ORAL','20070801','','OTC MONOGRAPH NOT FINAL','part343','Pharmaceutical Associates, Inc.','ACETAMINOPHEN','325','mg/10.15mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1350_4eb69580-587f-49d9-bba5-de1a57302e0f','0121-1350','HUMAN PRESCRIPTION DRUG','VALPROIC ACID','','VALPROIC ACID','SOLUTION','ORAL','20050411','','ANDA','ANDA075379','PAI Holdings, LLC','VALPROIC ACID','500','mg/10mL','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1488_e16ed09e-75ba-7bd1-e053-2a95a90a25e7','0121-1488','HUMAN OTC DRUG','GUAIFENESIN','','GUAIFENESIN','SOLUTION','ORAL','20020901','','OTC MONOGRAPH FINAL','part341','Pharmaceutical Associates, Inc.','GUAIFENESIN','200','mg/10mL','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1544_e17e391f-c75d-1bdc-e053-2a95a90a9401','0121-1544','HUMAN PRESCRIPTION DRUG','Hydrocodone Bitartrate and Acetaminophen','','HYDROCODONE BITARTRATE and ACETAMINOPHEN','SOLUTION','ORAL','20130729','','ANDA','ANDA040838','Pharmaceutical Associates, Inc.','ACETAMINOPHEN; HYDROCODONE BITARTRATE','217; 5','mg/10mL; mg/10mL','Opioid Agonist [EPC], Opioid Agonists [MoA]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1550_e16f3d0c-f07b-3d84-e053-2a95a90a2789','0121-1550','HUMAN OTC DRUG','Guaifenesin and Codeine Phosphate','','Guaifenesin and Codeine Phosphate','SOLUTION','ORAL','20061001','','OTC MONOGRAPH FINAL','part341','Pharmaceutical Associates, Inc.','CODEINE PHOSPHATE; GUAIFENESIN','20; 200','mg/10mL; mg/10mL','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1576_49eecb65-9859-4e18-b6cb-55b971a4cec3','0121-1576','HUMAN PRESCRIPTION DRUG','Metoclopramide','','metoclopramide hydrochloride','SOLUTION','ORAL','19910601','','ANDA','ANDA072744','PAI Holdings, LLC','METOCLOPRAMIDE HYDROCHLORIDE','5','mg/5mL','Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1598_f03283e8-8881-775a-e053-2a95a90a4b7a','0121-1598','HUMAN PRESCRIPTION DRUG','Levetiracetam','','LEVETIRACETAM','SOLUTION','ORAL','20150604','','ANDA','ANDA201157','Pharmaceutical Associates, Inc.','LEVETIRACETAM','1000','mg/10mL','Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1680_cd3a937e-3347-6368-e053-2a95a90abe56','0121-1680','HUMAN PRESCRIPTION DRUG','Potassium Chloride','','POTASSIUM CHLORIDE','SOLUTION','ORAL','20190402','','ANDA','ANDA210766','Pharmaceutical Associates, Inc.','POTASSIUM CHLORIDE','20','meq/15mL','Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1724_6480cf3e-b4a0-4dfc-b505-6c74bcddcdff','0121-1724','HUMAN PRESCRIPTION DRUG','Carbamazepine','','Carbamazepine','SUSPENSION','ORAL','20020605','','ANDA','ANDA075714','PAI Holdings, LLC','CARBAMAZEPINE','200','mg/10mL','Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1730_c4e71fc9-c7e0-e4cd-e053-2995a90a4508','0121-1730','HUMAN OTC DRUG','Diphenhydramine HCl Oral Solution','','diphenhydramine hydrochloride','SOLUTION','ORAL','20200618','','OTC MONOGRAPH FINAL','part341','Pharmaceutical Associates, Inc.','DIPHENHYDRAMINE HYDROCHLORIDE','25','mg/10mL','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1744_e16ed09e-75ba-7bd1-e053-2a95a90a25e7','0121-1744','HUMAN OTC DRUG','GUAIFENESIN','','GUAIFENESIN','SOLUTION','ORAL','20020901','','OTC MONOGRAPH FINAL','part341','Pharmaceutical Associates, Inc.','GUAIFENESIN','100','mg/5mL','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1746_f0597d2a-6162-74d7-e053-2995a90a9894','0121-1746','HUMAN PRESCRIPTION DRUG','LACTULOSE','','LACTULOSE','SOLUTION','ORAL','20191203','','ANDA','ANDA074623','Pharmaceutical Associates, Inc.','LACTULOSE','20','g/30mL','Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1760_e499949c-ef7f-4dd3-927d-b069e0625e82','0121-1760','HUMAN OTC DRUG','Mag-AL Liquid','','Aluminum Hydroxide and Magnesium Hydroxide','SUSPENSION','ORAL','20040114','','OTC MONOGRAPH FINAL','part331','PAI Holdings, LLC','ALUMINUM HYDROXIDE; MAGNESIUM HYDROXIDE','200; 200','mg/5mL; mg/5mL','Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1761_f06e82bc-61c3-d07d-e053-2a95a90a23a1','0121-1761','HUMAN OTC DRUG','Mag-AL Plus','','Aluminum Hydroxide, Magnesium Hydroxide, and Simethicone','SUSPENSION','ORAL','20040114','','OTC MONOGRAPH FINAL','part331','Pharmaceutical Associates, Inc.','ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE','200; 20; 200','mg/5mL; mg/5mL; mg/5mL','Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1762_e5d41e85-a31b-7939-e053-2a95a90a4c54','0121-1762','HUMAN OTC DRUG','Mag-AL Plus','XS','Aluminum Hydroxide, Magnesium Hydroxide, and Dimethicone','SUSPENSION','ORAL','20040114','','OTC MONOGRAPH FINAL','part331','Pharmaceutical Associates, Inc.','ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE','400; 40; 400','mg/5mL; mg/5mL; mg/5mL','Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1775_e16f3d0c-f07b-3d84-e053-2a95a90a2789','0121-1775','HUMAN OTC DRUG','Guaifenesin and Codeine Phosphate','','Guaifenesin and Codeine Phosphate','SOLUTION','ORAL','20061001','','OTC MONOGRAPH FINAL','part341','Pharmaceutical Associates, Inc.','CODEINE PHOSPHATE; GUAIFENESIN','10; 100','mg/5mL; mg/5mL','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1781_f391dba4-5d6a-bebe-e053-2995a90ad1e3','0121-1781','HUMAN OTC DRUG','Childrens Acetaminophen','','Acetaminophen','SUSPENSION','ORAL','20070917','','OTC MONOGRAPH NOT FINAL','part343','Pharmaceutical Associates, Inc.','ACETAMINOPHEN','160','mg/5mL','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1796_0d67fa4c-b36a-4d81-8e7d-a661db92df22','0121-1796','HUMAN PRESCRIPTION DRUG','Atovaquone','','Atovaquone','SUSPENSION','ORAL','20181011','','ANDA','ANDA210692','PAI Holdings, LLC','ATOVAQUONE','1500','mg/10mL','Antimalarial [EPC], Antiprotozoal [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1814_eede0b34-5b22-b120-e053-2995a90aec0e','0121-1814','HUMAN PRESCRIPTION DRUG','Dexamethasone','','Dexamethasone','SOLUTION','ORAL','19750725','','ANDA','ANDA088306','Pharmaceutical Associates, Inc.','DEXAMETHASONE','1','mg/10mL','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1828_e78c2544-9dfe-6399-e053-2995a90ac3d0','0121-1828','HUMAN OTC DRUG','Childrens Ibuprofen Oral Suspension','','Ibuprofen','SUSPENSION','ORAL','19990430','','ANDA','ANDA074916','Pharmaceutical Associates, Inc.','IBUPROFEN','100','mg/10mL','Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1870_c9acc4ea-adee-3c73-e053-2a95a90a9702','0121-1870','HUMAN OTC DRUG','Docusate Sodium','','Docusate Sodium Liquid','LIQUID','ORAL','20210816','','OTC MONOGRAPH NOT FINAL','part334','Pharmaceutical Associates, Inc.','DOCUSATE SODIUM','100','mg/10mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1878_e5d6567e-a8f6-5bb7-e053-2a95a90a0f87','0121-1878','HUMAN OTC DRUG','Childrens Acetaminophen','','Acetaminophen','SUSPENSION','ORAL','20210129','','OTC MONOGRAPH NOT FINAL','part343','Pharmaceutical Associates, Inc.','ACETAMINOPHEN','320','mg/10mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1882_d3945cb4-2cad-6418-e053-2995a90a138f','0121-1882','HUMAN OTC DRUG','Acetaminophen','','Acetaminophen','SUSPENSION','ORAL','20210903','','OTC MONOGRAPH NOT FINAL','part343','Pharmaceutical Associates, Inc.','ACETAMINOPHEN','325','mg/10.15mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1884_cae1f392-4081-90f9-e053-2a95a90a8fb5','0121-1884','HUMAN PRESCRIPTION DRUG','Phenobarbital Oral Solution','','Phenobarbital Oral','SOLUTION','ORAL','20210820','','UNAPPROVED DRUG OTHER','','Pharmaceutical Associates, Inc.','PHENOBARBITAL','30','mg/7.5mL','','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1894_c64c38ed-d17b-47d3-9538-23663d4c4027','0121-1894','HUMAN PRESCRIPTION DRUG','Carbamazepine','','Carbamazepine','SUSPENSION','ORAL','20211007','','ANDA','ANDA076729','PAI Holdings, LLC','CARBAMAZEPINE','200','mg/10mL','Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1971_e15b8c3b-2e14-ab99-e053-2995a90ab26a','0121-1971','HUMAN OTC DRUG','Acetaminophen','','Acetaminophen','SOLUTION','ORAL','20070801','','OTC MONOGRAPH NOT FINAL','part343','Pharmaceutical Associates, Inc.','ACETAMINOPHEN','650','mg/20.3mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-1984_a95d174d-efee-4ba5-8734-9adaad16be27','0121-1984','HUMAN PRESCRIPTION DRUG','Lacosamide','','Lacosamide','SOLUTION','ORAL','20220531','','ANDA','ANDA209301','PAI','LACOSAMIDE','100','mg/10mL','Decreased Central Nervous System Disorganized Electrical Activity [PE]','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-2232_e16ed09e-75ba-7bd1-e053-2a95a90a25e7','0121-2232','HUMAN OTC DRUG','GUAIFENESIN','','GUAIFENESIN','SOLUTION','ORAL','20020901','','OTC MONOGRAPH FINAL','part341','Pharmaceutical Associates, Inc.','GUAIFENESIN','300','mg/15mL','Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-2316_e17e391f-c75d-1bdc-e053-2a95a90a9401','0121-2316','HUMAN PRESCRIPTION DRUG','Hydrocodone Bitartrate and Acetaminophen','','HYDROCODONE BITARTRATE and ACETAMINOPHEN','SOLUTION','ORAL','20130729','','ANDA','ANDA040838','Pharmaceutical Associates, Inc.','ACETAMINOPHEN; HYDROCODONE BITARTRATE','325; 7.5','mg/15mL; mg/15mL','Opioid Agonist [EPC], Opioid Agonists [MoA]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-2397_f03283e8-8881-775a-e053-2a95a90a4b7a','0121-2397','HUMAN PRESCRIPTION DRUG','Levetiracetam','','LEVETIRACETAM','SOLUTION','ORAL','20150604','','ANDA','ANDA201157','Pharmaceutical Associates, Inc.','LEVETIRACETAM','1500','mg/15mL','Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-2520_cd3a937e-3347-6368-e053-2a95a90abe56','0121-2520','HUMAN PRESCRIPTION DRUG','Potassium Chloride','','POTASSIUM CHLORIDE','SOLUTION','ORAL','20190402','','ANDA','ANDA210766','Pharmaceutical Associates, Inc.','POTASSIUM CHLORIDE','40','meq/30mL','Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-2823_d3945cb4-2cad-6418-e053-2995a90a138f','0121-2823','HUMAN OTC DRUG','Acetaminophen','','Acetaminophen','SUSPENSION','ORAL','20210903','','OTC MONOGRAPH NOT FINAL','part343','Pharmaceutical Associates, Inc.','ACETAMINOPHEN','650','mg/20.3mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-2826_cae1f392-4081-90f9-e053-2a95a90a8fb5','0121-2826','HUMAN PRESCRIPTION DRUG','Phenobarbital Oral Solution','','Phenobarbital Oral','SOLUTION','ORAL','20210820','','UNAPPROVED DRUG OTHER','','Pharmaceutical Associates, Inc.','PHENOBARBITAL','60','mg/15mL','','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-2976_a95d174d-efee-4ba5-8734-9adaad16be27','0121-2976','HUMAN PRESCRIPTION DRUG','Lacosamide','','Lacosamide','SOLUTION','ORAL','20220531','','ANDA','ANDA209301','PAI','LACOSAMIDE','150','mg/15mL','Decreased Central Nervous System Disorganized Electrical Activity [PE]','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-3968_a95d174d-efee-4ba5-8734-9adaad16be27','0121-3968','HUMAN PRESCRIPTION DRUG','Lacosamide','','Lacosamide','SOLUTION','ORAL','20220531','','ANDA','ANDA209301','PAI','LACOSAMIDE','200','mg/20mL','Decreased Central Nervous System Disorganized Electrical Activity [PE]','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-4577_ee162463-154d-b3e9-e053-2995a90a1528','0121-4577','HUMAN PRESCRIPTION DRUG','LACTULOSE','','LACTULOSE','SOLUTION','ORAL','19660730','','ANDA','ANDA074623','Pharmaceutical Associates, Inc,','LACTULOSE','10','g/15mL','Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-4675_4eb69580-587f-49d9-bba5-de1a57302e0f','0121-4675','HUMAN PRESCRIPTION DRUG','VALPROIC ACID','','VALPROIC ACID','SOLUTION','ORAL','20050411','','ANDA','ANDA075379','PAI Holdings, LLC','VALPROIC ACID','250','mg/5mL','Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-4721_e16e3979-5182-33f4-e053-2995a90a7339','0121-4721','HUMAN PRESCRIPTION DRUG','Fluoxetine','','FLUOXETINE HYDROCHLORIDE','SOLUTION','ORAL','20020201','','ANDA','ANDA076015','Pharmaceutical Associates, Inc.','FLUOXETINE HYDROCHLORIDE','20','mg/5mL','Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-4727_d56a22ea-5dab-e98a-e053-2a95a90a34c4','0121-4727','HUMAN PRESCRIPTION DRUG','Ranitidine','','RANITIDINE','SYRUP','ORAL','20101101','','ANDA','ANDA077405','Pharmaceutical Associates, Inc.','RANITIDINE','15','mg/mL','Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-4766_eeb71e98-775f-e61d-e053-2995a90a5cb3','0121-4766','HUMAN OTC DRUG','Calcium Carbonate','','Calcium Carbonate','SUSPENSION','ORAL','20041201','','OTC MONOGRAPH FINAL','part331','Pharmaceutical Associates, Inc.','CALCIUM CARBONATE','1250','mg/5mL','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-4772_e17e391f-c75d-1bdc-e053-2a95a90a9401','0121-4772','HUMAN PRESCRIPTION DRUG','Hydrocodone Bitartrate and Acetaminophen','','HYDROCODONE BITARTRATE and ACETAMINOPHEN','SOLUTION','ORAL','20130729','','ANDA','ANDA040838','Pharmaceutical Associates, Inc.','ACETAMINOPHEN; HYDROCODONE BITARTRATE','108; 2.5','mg/5mL; mg/5mL','Opioid Agonist [EPC], Opioid Agonists [MoA]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-4776_ee9c9ed1-d2a8-09d8-e053-2995a90a39c7','0121-4776','HUMAN PRESCRIPTION DRUG','Megestrol Acetate','','MEGESTROL ACETATE','SUSPENSION','ORAL','20060707','','ANDA','ANDA076721','Pharmaceutical Associates, Inc.','MEGESTROL ACETATE','40','mg/mL','Progesterone Congeners [CS], Progestin [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-4799_f03283e8-8881-775a-e053-2a95a90a4b7a','0121-4799','HUMAN PRESCRIPTION DRUG','Levetiracetam','','LEVETIRACETAM','SOLUTION','ORAL','20150604','','ANDA','ANDA201157','Pharmaceutical Associates, Inc.','LEVETIRACETAM','500','mg/5mL','Decreased Central Nervous System Disorganized Electrical Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-4810_d57cde69-0eb9-180d-e053-2995a90a33aa','0121-4810','HUMAN PRESCRIPTION DRUG','Nystatin','','NYSTATIN','SUSPENSION','ORAL','20160201','','ANDA','ANDA203621','Pharmaceutical Associates, Inc.','NYSTATIN','100000','[USP''''U]/mL','Polyene Antifungal [EPC], Polyenes [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-4811_d2bc7ada-7c23-34be-e053-2a95a90ac145','0121-4811','HUMAN PRESCRIPTION DRUG','Hydrocodone Bitartrate and Homatropine Methylbromide','','Hydrocodone Bitartrate and Homatropine Methylbromide','SYRUP','ORAL','20091228','','ANDA','ANDA088008','Pharmaceutical Associates, Inc.','HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE','1.5; 5','mg/5mL; mg/5mL','Opioid Agonist [EPC], Opioid Agonists [MoA]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-4820_b3e90b4e-1bd9-4112-b1e0-37caaca041d7','0121-4820','HUMAN PRESCRIPTION DRUG','THEOPHYLLINE','','THEOPHYLLINE','SOLUTION','ORAL','20161216','','ANDA','ANDA206344','PAI Holdings, LLC','THEOPHYLLINE','80','mg/15mL','Methylxanthine [EPC], Xanthines [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-4827_81862aa3-6834-4ba9-affd-6376b10be351','0121-4827','HUMAN PRESCRIPTION DRUG','OXYCODONE HYDROCHLORIDE','','OXYCODONE HYDROCHLORIDE','SOLUTION','ORAL','20190408','','ANDA','ANDA206914','PAI Holdings, LLC','OXYCODONE HYDROCHLORIDE','5','mg/5mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-4839_d57d9fd8-8252-3c89-e053-2995a90aa9f3','0121-4839','HUMAN PRESCRIPTION DRUG','Oxycodone Hydrochloride','','Oxycodone Hydrochloride','SOLUTION','ORAL','20160516','','ANDA','ANDA206456','Pharmaceutical Associates, Inc.','OXYCODONE HYDROCHLORIDE','5','mg/5mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0121-4967_e79e9c91-c923-6c35-e053-2a95a90aa851','0121-4967','HUMAN OTC DRUG','Senna Syrup','','sennosides','LIQUID','ORAL','20220322','','OTC MONOGRAPH NOT FINAL','part334','Pharmaceutical Associates, Inc.','SENNOSIDES','8.8','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0126-0016_f4c2f476-bdd5-49d1-80f7-361be61e47e5','0126-0016','HUMAN PRESCRIPTION DRUG','PreviDent','5000 Dry Mouth','Sodium fluoride','GEL, DENTIFRICE','DENTAL','20090706','','UNAPPROVED DRUG OTHER','','Colgate Oral Pharmaceuticals, Inc.','SODIUM FLUORIDE','6.1','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0126-0022_6b3ab11f-e5c3-460b-8519-1214876dd629','0126-0022','HUMAN PRESCRIPTION DRUG','PreviDent 5000 Enamel Protect','','SODIUM FLUORIDE and POTASSIUM NITRATE','GEL, DENTIFRICE','DENTAL','20110330','','UNAPPROVED DRUG OTHER','','Colgate Oral Pharmaceuticals, Inc.','POTASSIUM NITRATE; SODIUM FLUORIDE','57.5; 5.8','mg/mL; mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0126-0032_7adda5d7-0176-42ab-8331-ae3deeb0c935','0126-0032','HUMAN OTC DRUG','Colgate Phos-Flur Ortho Defense Alcohol Free Anticavity Mint Fluoride','','SODIUM FLUORIDE','RINSE','DENTAL','20110112','','OTC MONOGRAPH FINAL','part355','Colgate Oral Pharmaceuticals, Inc.','SODIUM FLUORIDE','2','mg/10mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0126-0033_228280d8-dad7-4a08-98f4-e9166df917e8','0126-0033','HUMAN PRESCRIPTION DRUG','PreviDent Alcohol Free','','Sodium Fluoride','MOUTHWASH','DENTAL','20160613','','UNAPPROVED DRUG OTHER','','Colgate Oral Pharmaceuticals, Inc.','SODIUM FLUORIDE','0.9','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0126-0034_48c88d15-0f72-4adf-b918-1f183b64c6d5','0126-0034','HUMAN OTC DRUG','Colgate Phos-Flur Ortho Defense Alcohol Free Anticavity Gushing Grape Fluoride','','SODIUM FLUORIDE','RINSE','DENTAL','20110215','','OTC MONOGRAPH FINAL','part355','Colgate Oral Pharmaceuticals, Inc.','SODIUM FLUORIDE','2','mg/10mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0126-0035_e4a91c69-7ce9-43e8-9061-421e111c36f4','0126-0035','HUMAN PRESCRIPTION DRUG','Periogard (Chlorhexidine Gluconate)','','Chlorhexidine Gluconate','RINSE','BUCCAL','20180125','20231130','ANDA','ANDA077789','Colgate Oral Pharmaceuticals, Inc.','CHLORHEXIDINE GLUCONATE','1.2','mg/mL','Decreased Cell Wall Integrity [PE]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0126-0070_9d1b6e76-002b-49e4-b483-be15723a03d6','0126-0070','HUMAN PRESCRIPTION DRUG','PreviDent','5000 Sensitive','Sodium fluoride and Potassium nitrate','GEL, DENTIFRICE','DENTAL','20090706','','UNAPPROVED DRUG OTHER','','Colgate Oral Pharmaceuticals, Inc.','POTASSIUM NITRATE; SODIUM FLUORIDE','57.5; 5.8','mg/mL; mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0126-0072_72ab37ae-a7f5-4b46-b688-d8fb6c2c3c15','0126-0072','HUMAN PRESCRIPTION DRUG','PreviDent 5000 Booster Plus Fruitastic','','Sodium Fluoride','PASTE, DENTIFRICE','DENTAL','20150301','','UNAPPROVED DRUG OTHER','','Colgate Oral Pharmaceuticals, Inc.','SODIUM FLUORIDE','6','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0126-0074_0225f351-5f0f-4edf-b2c9-417f05adb0b8','0126-0074','HUMAN PRESCRIPTION DRUG','PrevidDent 5000 Booster Plus Spearmint','','Sodium Fluoride','PASTE, DENTIFRICE','DENTAL','20150301','','UNAPPROVED DRUG OTHER','','Colgate Oral Pharmaceuticals, Inc.','SODIUM FLUORIDE','6','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0126-0083_56331d75-a18b-434d-a26c-0ee9cf160d55','0126-0083','HUMAN OTC DRUG','Peroxyl Mouth Sore Mild Mint','','Hydrogen Peroxide','RINSE','BUCCAL','20090101','','OTC MONOGRAPH NOT FINAL','part356','Colgate Oral Pharmaceuticals, Inc.','HYDROGEN PEROXIDE','15','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0126-0088_a6cbc0a2-eec1-4d79-ba4b-9fb4f271b849','0126-0088','HUMAN PRESCRIPTION DRUG','PreviDent Fresh Mint','','Sodium Fluoride','GEL, DENTIFRICE','DENTAL','20120829','','UNAPPROVED DRUG OTHER','','Colgate Oral Pharmaceuticals, Inc.','SODIUM FLUORIDE','5','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0126-0165_da8d4753-973b-4192-9f9a-70000bb9eaee','0126-0165','HUMAN OTC DRUG','Gel-Kam Fruit and Berry','','Stannous Fluoride','GEL, DENTIFRICE','DENTAL','19900101','','OTC MONOGRAPH FINAL','part355','Colgate Oral Pharmaceuticals, Inc.','STANNOUS FLUORIDE','1','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0126-0192_da8d4753-973b-4192-9f9a-70000bb9eaee','0126-0192','HUMAN OTC DRUG','Gel-Kam Mint','','Stannous Fluoride','GEL, DENTIFRICE','DENTAL','19900101','','OTC MONOGRAPH FINAL','part355','Colgate Oral Pharmaceuticals, Inc.','STANNOUS FLUORIDE','1','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0126-0272_95ea00bd-fed8-4cc0-84a4-f45c33d87094','0126-0272','HUMAN PRESCRIPTION DRUG','Periogard Alcohol Free','','Chlorhexidine Gluconate','RINSE','BUCCAL','20201118','','ANDA','ANDA203212','Colgate Oral Pharmaceuticals, Inc.','CHLORHEXIDINE GLUCONATE','1.2','mg/mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0126-0282_2eb30568-8cea-42ca-88f4-ca5add1c3d75','0126-0282','HUMAN PRESCRIPTION DRUG','Periogard Alcohol Free','','Chlorhexidine Gluconate','RINSE','BUCCAL','20211004','','ANDA','ANDA203212','Colgate Oral Pharmaceuticals, Inc.','CHLORHEXIDINE GLUCONATE','1.2','mg/mL','Decreased Cell Wall Integrity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0126-0286_3d5698fb-6f22-4700-bd35-77019cce7549','0126-0286','HUMAN PRESCRIPTION DRUG','PreviDent','5000 Plus Fruitastic','Sodium Fluoride','PASTE, DENTIFRICE','DENTAL','20120829','','UNAPPROVED DRUG OTHER','','Colgate Oral Pharmaceuticals, Inc.','SODIUM FLUORIDE','11','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0126-0287_3d5698fb-6f22-4700-bd35-77019cce7549','0126-0287','HUMAN PRESCRIPTION DRUG','PreviDent','5000 Plus Spearmint','Sodium Fluoride','PASTE, DENTIFRICE','DENTAL','20120829','','UNAPPROVED DRUG OTHER','','Colgate Oral Pharmaceuticals, Inc.','SODIUM FLUORIDE','11','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0126-0288_a6cbc0a2-eec1-4d79-ba4b-9fb4f271b849','0126-0288','HUMAN PRESCRIPTION DRUG','PreviDent Very Berry','','Sodium Fluoride','GEL, DENTIFRICE','DENTAL','20120829','','UNAPPROVED DRUG OTHER','','Colgate Oral Pharmaceuticals, Inc.','SODIUM FLUORIDE','5','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0126-0289_7614b377-1c90-4bce-a8d7-f439ec93ceb8','0126-0289','HUMAN PRESCRIPTION DRUG','PreviDent OrthoDefense','','SODIUM FLUORIDE','PASTE, DENTIFRICE','DENTAL','20190304','','UNAPPROVED DRUG OTHER','','Colgate Oral Pharmaceuticals, Inc.','SODIUM FLUORIDE','6','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0131-1810_4ed2e9ca-d6f5-458f-9eb6-5721bcb978ab','0131-1810','HUMAN PRESCRIPTION DRUG','Vimpat','','lacosamide','INJECTION','INTRAVENOUS','20090526','','NDA','NDA022254','UCB, Inc.','LACOSAMIDE','10','mg/mL','Decreased Central Nervous System Disorganized Electrical Activity [PE]','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0131-2477_4ed2e9ca-d6f5-458f-9eb6-5721bcb978ab','0131-2477','HUMAN PRESCRIPTION DRUG','Vimpat','','lacosamide','TABLET, FILM COATED','ORAL','20090526','','NDA','NDA022253','UCB, Inc.','LACOSAMIDE','50','mg/1','Decreased Central Nervous System Disorganized Electrical Activity [PE]','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0131-2478_4ed2e9ca-d6f5-458f-9eb6-5721bcb978ab','0131-2478','HUMAN PRESCRIPTION DRUG','Vimpat','','lacosamide','TABLET, FILM COATED','ORAL','20090526','','NDA','NDA022253','UCB, Inc.','LACOSAMIDE','100','mg/1','Decreased Central Nervous System Disorganized Electrical Activity [PE]','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0131-2479_4ed2e9ca-d6f5-458f-9eb6-5721bcb978ab','0131-2479','HUMAN PRESCRIPTION DRUG','Vimpat','','lacosamide','TABLET, FILM COATED','ORAL','20090526','','NDA','NDA022253','UCB, Inc.','LACOSAMIDE','150','mg/1','Decreased Central Nervous System Disorganized Electrical Activity [PE]','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0131-2480_4ed2e9ca-d6f5-458f-9eb6-5721bcb978ab','0131-2480','HUMAN PRESCRIPTION DRUG','Vimpat','','lacosamide','TABLET, FILM COATED','ORAL','20090526','','NDA','NDA022253','UCB, Inc.','LACOSAMIDE','200','mg/1','Decreased Central Nervous System Disorganized Electrical Activity [PE]','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0131-5410_4ed2e9ca-d6f5-458f-9eb6-5721bcb978ab','0131-5410','HUMAN PRESCRIPTION DRUG','Vimpat','','lacosamide','SOLUTION','ORAL','20100420','','NDA','NDA022255','UCB, Inc.','LACOSAMIDE','10','mg/mL','Decreased Central Nervous System Disorganized Electrical Activity [PE]','CV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0075_601a16df-55e4-4f9b-a7ff-4c8412f8efe7','0132-0075','HUMAN OTC DRUG','Fleet','','Glycerin','SUPPOSITORY','RECTAL','19841101','','OTC MONOGRAPH NOT FINAL','part334','C.B. Fleet Company, Inc.','GLYCERIN','2','g/1','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0079_49522e90-32f5-41ae-869e-634fd19bcacd','0132-0079','HUMAN OTC DRUG','Fleet','','Glycerin','SUPPOSITORY','RECTAL','19841101','20230430','OTC MONOGRAPH NOT FINAL','part334','C.B. Fleet Company, Inc.','GLYCERIN','2','g/1','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0079_976e400d-348c-4999-a913-3a3fd17fbce4','0132-0079','HUMAN OTC DRUG','Fleet','','Glycerin','SUPPOSITORY','RECTAL','19841101','20230430','OTC MONOGRAPH NOT FINAL','part334','C.B. Fleet Company, Inc.','GLYCERIN','2','g/1','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0079_bd5b99f1-cc80-4067-9398-06a26ddf9d1a','0132-0079','HUMAN OTC DRUG','Fleet','','Glycerin','SUPPOSITORY','RECTAL','19841101','20230430','OTC MONOGRAPH NOT FINAL','part334','C.B. Fleet Company, Inc.','GLYCERIN','2','g/1','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0079_e8b27564-47e3-40b3-9644-45eb34b96d7e','0132-0079','HUMAN OTC DRUG','Fleet','','Glycerin','SUPPOSITORY','RECTAL','19841101','20230430','OTC MONOGRAPH NOT FINAL','part334','C.B. Fleet Company, Inc.','GLYCERIN','2','g/1','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0081_aefc01c3-9e8b-42df-85a8-bf8ce77334e4','0132-0081','HUMAN OTC DRUG','Pedia-Lax','','Glycerin','SUPPOSITORY','RECTAL','20080301','','OTC MONOGRAPH NOT FINAL','part334','C.B. Fleet Company, Inc.','GLYCERIN','1','g/1','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0106_e8816dce-8c24-4e27-9a41-b64eecb0497a','0132-0106','HUMAN OTC DRUG','Pedia-Lax','','Docusate Sodium','LIQUID','ORAL','20080301','','OTC MONOGRAPH NOT FINAL','part334','C.B. Fleet Company, Inc.','DOCUSATE SODIUM','50','mg/15mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0119_5d796181-8d4f-4fb3-b0d2-89352cd9e282','0132-0119','HUMAN OTC DRUG','Fleet','','Enema','ENEMA','RECTAL','20110526','','OTC MONOGRAPH NOT FINAL','part334','C.B. Fleet Company, Inc.','SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC','7; 19','g/133mL; g/133mL','Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0185_d6b010f8-98e7-44d4-ab49-cfa75c8830a9','0132-0185','HUMAN OTC DRUG','Fleet','','glycerin','LIQUID','RECTAL','20020603','','OTC MONOGRAPH NOT FINAL','part334','C.B. Fleet Company, Inc.','GLYCERIN','5.4','g/1','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0190_3f2cb644-2271-42c1-a64b-6351c07e698e','0132-0190','HUMAN OTC DRUG','Pedia-Lax','','Glycerin','LIQUID','RECTAL','20080301','','OTC MONOGRAPH NOT FINAL','part334','C.B. Fleet Company, Inc.','GLYCERIN','2.8','g/1','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0194_15079401-c9d2-49d2-86e4-7cb9b7e5c07d','0132-0194','HUMAN OTC DRUG','Boudreauxs','','Zinc Oxide','PASTE','TOPICAL','20161001','','OTC MONOGRAPH FINAL','part347','C.B. Fleet Company, Inc.','ZINC OXIDE','40','g/100g','Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0195_2db5157b-2ca6-4160-bbf6-8fd37ba8bef5','0132-0195','HUMAN OTC DRUG','Pedia-Lax','','Glycerin','LIQUID','RECTAL','20190201','','OTC MONOGRAPH NOT FINAL','part334','C.B. Fleet Company, Inc.','GLYCERIN','2.8','g/4mL','Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0201_00c5b580-1fe5-49f0-bbca-25506c75cf6f','0132-0201','HUMAN OTC DRUG','Fleet','','sodium phosphate, dibasic and sodium phosphate, monobasic','ENEMA','RECTAL','19530310','','OTC MONOGRAPH NOT FINAL','part334','C.B. Fleet Company, Inc.','SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC','7; 19','g/133mL; g/133mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0201_b574e93a-5c0b-4eaa-b8ce-2e5ffc539afe','0132-0201','HUMAN OTC DRUG','Fleet','','sodium phosphate, dibasic and sodium phosphate, monobasic','ENEMA','RECTAL','20040625','','OTC MONOGRAPH NOT FINAL','part334','C.B. Fleet Company, Inc.','SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC','7; 19','g/230mL; g/230mL','Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0202_d209543b-7e07-4f13-8972-24ecd6059321','0132-0202','HUMAN OTC DRUG','Pedia-Lax','','sodium phosphate, dibasic and sodium phosphate, monobasic','ENEMA','RECTAL','20020510','','OTC MONOGRAPH NOT FINAL','part334','C.B. Fleet Company, Inc.','SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC','3.5; 9.5','g/66mL; g/66mL','Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0208_fa4012b5-0ff1-4521-b066-0cac49f1486f','0132-0208','HUMAN OTC DRUG','PHAZYME','','Simethicone','CAPSULE, GELATIN COATED','ORAL','20120201','','OTC MONOGRAPH FINAL','part332','C.B. Fleet Company, Inc.','DIMETHICONE','180','mg/1','Skin Barrier Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0211_9d80febf-4f04-4be6-92ba-024af7839d0b','0132-0211','HUMAN OTC DRUG','PHAZYME','','Simethicone','CAPSULE, GELATIN COATED','ORAL','20140401','','OTC MONOGRAPH FINAL','part332','C.B. Fleet Company, Inc.','DIMETHICONE','250','mg/1','Skin Barrier Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0217_28126b40-bb23-4f17-920e-73d4d505b87a','0132-0217','HUMAN OTC DRUG','PHAZYME ULTIMATE','','SIMETHICONE','CAPSULE, LIQUID FILLED','ORAL','20210215','','OTC MONOGRAPH FINAL','part332','C.B. Fleet Company, Inc.','DIMETHICONE','500','mg/1','Skin Barrier Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0323_506a264b-66b3-4a01-840d-f40fde15cda6','0132-0323','HUMAN OTC DRUG','Boudreauxs','','Zinc Oxide','CREAM','TOPICAL','20120201','','OTC MONOGRAPH FINAL','part347','C.B. Fleet Company, Inc.','ZINC OXIDE','40','g/113g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0324_797da4de-e86c-4406-b6e0-de5d4530ca77','0132-0324','HUMAN OTC DRUG','Boudreauxs','','Zinc Oxide','OINTMENT','TOPICAL','20191202','','OTC MONOGRAPH FINAL','part347','C.B. Fleet Company, Inc.','ZINC OXIDE','16','g/113g','Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0325_61d49cc6-c567-4546-badb-e10bc6decf25','0132-0325','HUMAN OTC DRUG','Boudreauxs Rash Kicking Kit','','Zinc oxide','KIT','TOPICAL','20180525','','OTC MONOGRAPH FINAL','part347','C.B. Fleet Company, Inc.','','','','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0326_4cc9575d-b9dc-4da0-bc07-a6618139eafc','0132-0326','HUMAN OTC DRUG','Boudreauxs Butt Barrier','','Dimethicone','OINTMENT','TOPICAL','20220301','','OTC MONOGRAPH FINAL','part347','C.B. Fleet Company, Inc.','DIMETHICONE','1','g/113g','Skin Barrier Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0333_343d2ab8-551d-482a-a4f7-0f70b5a1f8ee','0132-0333','HUMAN OTC DRUG','Boudreauxs','','Zinc Oxide','CREAM','TOPICAL','20120201','','OTC MONOGRAPH FINAL','part347','C.B. Fleet Company, Inc.','ZINC OXIDE','16','g/113g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0334_1855f24f-5645-4a73-868c-ae1098c1b99d','0132-0334','HUMAN OTC DRUG','Boudreauxs','','Zinc Oxide','CREAM','TOPICAL','20120201','','OTC MONOGRAPH FINAL','part347','C.B. Fleet Company, Inc.','ZINC OXIDE','16','g/113g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0507_428c1326-85da-4bc5-a2ae-1f7e10e31ef0','0132-0507','HUMAN OTC DRUG','PHAZYME','','Simethicone and Calcium Carbonate','TABLET, CHEWABLE','ORAL','20160301','','OTC MONOGRAPH FINAL','part332','C.B. Fleet Company, Inc.','CALCIUM CARBONATE; DIMETHICONE','750; 250','mg/241; mg/241','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Skin Barrier Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0556_f18e33d2-38cf-497c-b1c0-70257bc02ff5','0132-0556','HUMAN OTC DRUG','FLEET','','Mineral Oil','ENEMA','RECTAL','20020501','','OTC MONOGRAPH NOT FINAL','part334','C.B. Fleet Company, Inc.','MINERAL OIL','100','g/100mL','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0655_efb807d6-fe33-4e99-8b0b-8bd9e2f09f7d','0132-0655','HUMAN OTC DRUG','Pedia-Lax','','Magnesium hydroxide','TABLET, CHEWABLE','ORAL','20080301','','OTC MONOGRAPH NOT FINAL','part334','C.B. Fleet Company, Inc.','MAGNESIUM HYDROXIDE','400','mg/1','Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-0703_36be417e-8635-49a0-930e-12d1d4b86dcf','0132-0703','HUMAN OTC DRUG','Fleet','','Bisacodyl','ENEMA','RECTAL','20020510','','OTC MONOGRAPH NOT FINAL','part334','C.B. Fleet Company, Inc.','BISACODYL','10','mg/30mL','Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-8743_26c73f2b-f79c-43a5-b4b7-6300debaf90f','0132-8743','HUMAN OTC DRUG','SUMMERS EVE','','povidone-iodine','DOUCHE','VAGINAL','20020510','','OTC MONOGRAPH NOT FINAL','part333E','C.B. Fleet Company, Inc.','POVIDONE-IODINE','4','g/133mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0132-8744_f7005aae-bd72-43e2-b633-33eb2225507f','0132-8744','HUMAN OTC DRUG','Summers Eve Active Chafe','','Dimethicone','GEL','TOPICAL','20210112','','OTC MONOGRAPH FINAL','part347','C.B. Fleet Company, Inc.','DIMETHICONE','12','mg/g','Skin Barrier Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0070_2d63d3e8-3f40-4c05-949b-e38d970f94fd','0135-0070','HUMAN OTC DRUG','TUMS','','calcium carbonate','TABLET','ORAL','20100310','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','500','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0071_2d63d3e8-3f40-4c05-949b-e38d970f94fd','0135-0071','HUMAN OTC DRUG','TUMS','','calcium carbonate','TABLET','ORAL','20100310','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','500','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0074_f8e38186-22b2-454e-a24d-03f8d983e495','0135-0074','HUMAN OTC DRUG','TUMS','EX','calcium carbonate','TABLET','ORAL','20100118','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','750','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0076_f8e38186-22b2-454e-a24d-03f8d983e495','0135-0076','HUMAN OTC DRUG','TUMS','EX','calcium carbonate','TABLET','ORAL','20100118','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','750','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0089_b0e21094-8ff0-4777-acce-89a81b795243','0135-0089','HUMAN OTC DRUG','CITRUCEL','','methylcellulose','POWDER, FOR SOLUTION','ORAL','20100916','','OTC MONOGRAPH NOT FINAL','part334','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','METHYLCELLULOSE (4000 MPA.S)','2','g/19g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0090_b0e21094-8ff0-4777-acce-89a81b795243','0135-0090','HUMAN OTC DRUG','CITRUCEL','','methylcellulose','POWDER, FOR SOLUTION','ORAL','20100916','','OTC MONOGRAPH NOT FINAL','part334','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','METHYLCELLULOSE (4000 MPA.S)','2','g/10.2g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0094_38e516bd-bbb3-461c-a194-467da5d1dd37','0135-0094','HUMAN OTC DRUG','GAVISCON','','aluminum hydroxide and magnesium carbonate','LIQUID','ORAL','20110114','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE','95; 358','mg/15mL; mg/15mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0095_38e516bd-bbb3-461c-a194-467da5d1dd37','0135-0095','HUMAN OTC DRUG','GAVISCON','','aluminum hydroxide and magnesium carbonate','LIQUID','ORAL','20110114','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE','254; 237.5','mg/5mL; mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0118_3cc802ad-35d1-4f7c-8537-b542638ad603','0135-0118','HUMAN OTC DRUG','TUMS','ULTRA','calcium carbonate','TABLET, CHEWABLE','ORAL','20100212','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','1000','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0140_f8e38186-22b2-454e-a24d-03f8d983e495','0135-0140','HUMAN OTC DRUG','TUMS','EX','calcium carbonate','TABLET','ORAL','20100118','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','750','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0154_f8e38186-22b2-454e-a24d-03f8d983e495','0135-0154','HUMAN OTC DRUG','TUMS','EX','calcium carbonate','TABLET','ORAL','20100118','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','750','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0155_c01ac048-a94e-494f-adbc-95bbf7497fc0','0135-0155','HUMAN OTC DRUG','TUMS','Extra Strength Sugar-Free','calcium carbonate','TABLET, CHEWABLE','ORAL','20180318','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','750','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0157_5c6952ac-d702-453f-b1a5-3f53228a0b9b','0135-0157','HUMAN OTC DRUG','Nicorette','Original','nicotine polacrilex','GUM, CHEWING','ORAL','20090629','','NDA','NDA018612','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0158_5c6952ac-d702-453f-b1a5-3f53228a0b9b','0135-0158','HUMAN OTC DRUG','Nicorette','Original','nicotine polacrilex','GUM, CHEWING','ORAL','20090629','','NDA','NDA020066','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0178_f8e38186-22b2-454e-a24d-03f8d983e495','0135-0178','HUMAN OTC DRUG','TUMS','EX','calcium carbonate','TABLET','ORAL','20100118','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','750','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0180_3cc802ad-35d1-4f7c-8537-b542638ad603','0135-0180','HUMAN OTC DRUG','TUMS','ULTRA','calcium carbonate','TABLET, CHEWABLE','ORAL','20100212','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','1000','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0181_3cc802ad-35d1-4f7c-8537-b542638ad603','0135-0181','HUMAN OTC DRUG','TUMS','ULTRA','calcium carbonate','TABLET, CHEWABLE','ORAL','20100212','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','1000','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0183_b03b5245-b573-4817-8d66-ad1bc90dbe93','0135-0183','HUMAN OTC DRUG','Tums Chewy Bites','','calcium carbonate','TABLET, CHEWABLE','ORAL','20190301','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','1000','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0184_9043983c-7ee4-4971-8885-36f814bb570f','0135-0184','HUMAN OTC DRUG','Tums Chewy Bites','Berry Shake','calcium carbonate','TABLET, CHEWABLE','ORAL','20210305','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','750','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0194_25db1674-fc71-4a47-91fa-be0e69542fca','0135-0194','HUMAN OTC DRUG','NICODERM','CQ','nicotine','PATCH, EXTENDED RELEASE','TRANSDERMAL','20110512','','NDA','NDA020165','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','21','mg/24h','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0195_25db1674-fc71-4a47-91fa-be0e69542fca','0135-0195','HUMAN OTC DRUG','NICODERM','CQ','nicotine','PATCH, EXTENDED RELEASE','TRANSDERMAL','20110512','','NDA','NDA020165','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','14','mg/24h','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0196_25db1674-fc71-4a47-91fa-be0e69542fca','0135-0196','HUMAN OTC DRUG','NICODERM','CQ','nicotine','PATCH, EXTENDED RELEASE','TRANSDERMAL','20110512','','NDA','NDA020165','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','7','mg/24h','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0199_dd9771a7-adf9-133b-e053-2a95a90a966c','0135-0199','HUMAN OTC DRUG','CITRUCEL','','methylcellulose','TABLET','ORAL','20100201','','OTC MONOGRAPH NOT FINAL','part334','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','METHYLCELLULOSE (4000 MPA.S)','500','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0200_6fb7d5bf-0d91-4c98-9fe1-aef61e9e6e4e','0135-0200','HUMAN OTC DRUG','ABREVA','','docosanol','CREAM','TOPICAL','20100319','','NDA','NDA020941','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DOCOSANOL','100','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0225_5c6952ac-d702-453f-b1a5-3f53228a0b9b','0135-0225','HUMAN OTC DRUG','Nicorette','Fresh Mint','nicotine polacrilex','GUM, CHEWING','ORAL','20090629','','NDA','NDA018612','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0226_5c6952ac-d702-453f-b1a5-3f53228a0b9b','0135-0226','HUMAN OTC DRUG','Nicorette','Fresh Mint','nicotine polacrilex','GUM, CHEWING','ORAL','20090629','','NDA','NDA020066','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0228_3cc802ad-35d1-4f7c-8537-b542638ad603','0135-0228','HUMAN OTC DRUG','TUMS','ULTRA','calcium carbonate','TABLET, CHEWABLE','ORAL','20100212','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','1000','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0229_5c6952ac-d702-453f-b1a5-3f53228a0b9b','0135-0229','HUMAN OTC DRUG','Nicorette','Mint','nicotine polacrilex','GUM, CHEWING','ORAL','20090629','','NDA','NDA018612','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0230_5c6952ac-d702-453f-b1a5-3f53228a0b9b','0135-0230','HUMAN OTC DRUG','Nicorette','Mint','nicotine polacrilex','GUM, CHEWING','ORAL','20090629','','NDA','NDA020066','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0234_f019c187-dd76-4dc1-b5f3-b4d91ef3352b','0135-0234','HUMAN OTC DRUG','AQUAFRESH','EXTREME CLEAN WHITENING ACTION','sodium fluoride','PASTE','DENTAL','20110325','','OTC MONOGRAPH FINAL','part355','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','SODIUM FLUORIDE','1.13','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0235_693a588b-5d27-437f-90ff-db8df704f3b7','0135-0235','HUMAN OTC DRUG','TUMS','ULTRA','calcium carbonate','TABLET, CHEWABLE','ORAL','20210621','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','1000','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0241_52600828-7fdb-4741-9fc9-74e40dcda324','0135-0241','HUMAN OTC DRUG','Nicorette','Fruit Chill','nicotine polacrilex','GUM, CHEWING','ORAL','20090914','','NDA','NDA018612','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0242_52600828-7fdb-4741-9fc9-74e40dcda324','0135-0242','HUMAN OTC DRUG','Nicorette','Fruit Chill','nicotine polacrilex','GUM, CHEWING','ORAL','20090914','','NDA','NDA020066','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0243_06065f63-3c3b-43b0-ae01-18e1d7447b28','0135-0243','HUMAN OTC DRUG','TUMS','Smoothies','calcium carbonate','TABLET, CHEWABLE','ORAL','20100324','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','750','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0245_06065f63-3c3b-43b0-ae01-18e1d7447b28','0135-0245','HUMAN OTC DRUG','TUMS','Smoothies','calcium carbonate','TABLET, CHEWABLE','ORAL','20100324','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','750','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0246_06065f63-3c3b-43b0-ae01-18e1d7447b28','0135-0246','HUMAN OTC DRUG','TUMS','Smoothies','calcium carbonate','TABLET, CHEWABLE','ORAL','20100324','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','750','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0300_08951acc-d3e0-4629-b2b1-02d02a91d4af','0135-0300','HUMAN OTC DRUG','ABREVA','','docosanol','CREAM','TOPICAL','20220325','','ANDA','ANDA208754','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','DOCOSANOL','100','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0355_5c6952ac-d702-453f-b1a5-3f53228a0b9b','0135-0355','HUMAN OTC DRUG','Nicorette','Spearmint Burst','nicotine polacrilex','GUM, CHEWING','ORAL','20170913','','NDA','NDA020066','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0450_b6b53ab0-82ee-459a-be1a-14e12c2582f5','0135-0450','HUMAN OTC DRUG','SENSODYNE PRONAMEL','mineral BOOST refreshing peppermint','potassium nitrate and sodium fluoride','PASTE','ORAL','20210104','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0456_06065f63-3c3b-43b0-ae01-18e1d7447b28','0135-0456','HUMAN OTC DRUG','TUMS','Smoothies','calcium carbonate','TABLET, CHEWABLE','ORAL','20100324','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','750','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0460_d6b00a8e-c06e-432e-8836-2acf05730597','0135-0460','HUMAN OTC DRUG','SENSODYNE PRONAMEL','Daily Protection','potassium nitrate and sodium fluoride','PASTE','ORAL','20101018','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0461_8fc7b624-3e2d-462b-b056-ff2358f97ee1','0135-0461','HUMAN OTC DRUG','ALLI','','orlistat','CAPSULE','ORAL','20070207','','NDA','NDA021887','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ORLISTAT','60','mg/1','Intestinal Lipase Inhibitor [EPC], Lipase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0466_5c6952ac-d702-453f-b1a5-3f53228a0b9b','0135-0466','HUMAN OTC DRUG','Nicorette','Cinnamon Surge','nicotine polacrilex','GUM, CHEWING','ORAL','20090629','','NDA','NDA018612','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0467_5c6952ac-d702-453f-b1a5-3f53228a0b9b','0135-0467','HUMAN OTC DRUG','Nicorette','Cinnamon Surge','nicotine polacrilex','GUM, CHEWING','ORAL','20090629','','NDA','NDA020066','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0474_5c6952ac-d702-453f-b1a5-3f53228a0b9b','0135-0474','HUMAN OTC DRUG','Nicorette','White Ice Mint','nicotine polacrilex','GUM, CHEWING','ORAL','20090629','','NDA','NDA018612','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0475_5c6952ac-d702-453f-b1a5-3f53228a0b9b','0135-0475','HUMAN OTC DRUG','Nicorette','White Ice Mint','nicotine polacrilex','GUM, CHEWING','ORAL','20090629','','NDA','NDA020066','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0479_a06e2549-3c4e-4818-b53e-1dea6828219f','0135-0479','HUMAN OTC DRUG','SENSODYNE','Advanced Whitening','potassium nitrate','PASTE','ORAL','20201016','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0480_b6b53ab0-82ee-459a-be1a-14e12c2582f5','0135-0480','HUMAN OTC DRUG','SENSODYNE PRONAMEL','mineral BOOST whitening action','potassium nitrate and sodium fluoride','PASTE','ORAL','20210104','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0481_770c2c23-3f4e-4209-93c0-315691daea5b','0135-0481','HUMAN OTC DRUG','SENSODYNE PRONAMEL','Intensive Enamel Repair Whitening','potassium nitrate and sodium fluoride','PASTE','ORAL','20200106','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US)','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0484_d6b00a8e-c06e-432e-8836-2acf05730597','0135-0484','HUMAN OTC DRUG','SENSODYNE PRONAMEL','Gentle Whitening','potassium nitrate and sodium fluoride','PASTE','ORAL','20101018','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0486_770c2c23-3f4e-4209-93c0-315691daea5b','0135-0486','HUMAN OTC DRUG','SENSODYNE PRONAMEL','Intensive Enamel Repair Extra Fresh','potassium nitrate and sodium fluoride','PASTE','ORAL','20181129','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US)','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0492_770c2c23-3f4e-4209-93c0-315691daea5b','0135-0492','HUMAN OTC DRUG','SENSODYNE PRONAMEL','Intensive Enamel Repair Clean Mint','potassium nitrate and sodium fluoride','PASTE','ORAL','20181129','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US)','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0510_dd969610-fdfd-41b1-9145-e0ab51b9209c','0135-0510','HUMAN OTC DRUG','NICORETTE','','nicotine polacrilex','LOZENGE','ORAL','20101019','','NDA','NDA021330','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0511_dd969610-fdfd-41b1-9145-e0ab51b9209c','0135-0511','HUMAN OTC DRUG','NICORETTE','','nicotine polacrilex','LOZENGE','ORAL','20101019','','NDA','NDA021330','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0520_d6b00a8e-c06e-432e-8836-2acf05730597','0135-0520','HUMAN OTC DRUG','SENSODYNE PRONAMEL','Fresh Breath','potassium nitrate and sodium fluoride','PASTE','ORAL','20110414','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0521_f8e38186-22b2-454e-a24d-03f8d983e495','0135-0521','HUMAN OTC DRUG','TUMS','EX','calcium carbonate','TABLET','ORAL','20110323','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','750','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0525_38529353-3b28-4a02-b2d7-54209276fc78','0135-0525','HUMAN OTC DRUG','Sensodyne','Extra Whitening','potassium nitrate and sodium fluoride','PASTE','DENTAL','19900930','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.11','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0528_38529353-3b28-4a02-b2d7-54209276fc78','0135-0528','HUMAN OTC DRUG','Sensodyne','Fresh Impact','potassium nitrate and sodium fluoride','PASTE','DENTAL','20000701','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0529_38529353-3b28-4a02-b2d7-54209276fc78','0135-0529','HUMAN OTC DRUG','Sensodyne','Fresh Mint','potassium nitrate and sodium fluoride','PASTE','DENTAL','19900930','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0532_5c6952ac-d702-453f-b1a5-3f53228a0b9b','0135-0532','HUMAN OTC DRUG','Nicorette','Spearmint Burst','nicotine polacrilex','GUM, CHEWING','ORAL','20170913','','NDA','NDA018612','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0533_5c6952ac-d702-453f-b1a5-3f53228a0b9b','0135-0533','HUMAN OTC DRUG','Nicorette','Spearmint Burst','nicotine polacrilex','GUM, CHEWING','ORAL','20170913','','NDA','NDA020066','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0537_7bad4144-ffbc-4d33-9a1d-95b4b39cd637','0135-0537','HUMAN OTC DRUG','PANADOL','','acetaminophen','SUSPENSION','ORAL','20121015','','OTC MONOGRAPH NOT FINAL','part343','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN','160','mg/5mL','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0539_be98c798-4afe-4975-9936-b3bca28e2bd7','0135-0539','HUMAN OTC DRUG','PANADOL','','acetaminophen','SUSPENSION','ORAL','20121015','','OTC MONOGRAPH NOT FINAL','part343','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN','160','mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0540_3cc802ad-35d1-4f7c-8537-b542638ad603','0135-0540','HUMAN OTC DRUG','TUMS','ULTRA','calcium carbonate','TABLET, CHEWABLE','ORAL','20100212','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','1000','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0547_3dec0f2d-e250-4b6d-9240-b6327a1dca51','0135-0547','HUMAN OTC DRUG','SENSODYNE','Repair and Protect Extra Fresh','stannous fluoride','PASTE','ORAL','20210628','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','STANNOUS FLUORIDE','1.1','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0548_3dec0f2d-e250-4b6d-9240-b6327a1dca51','0135-0548','HUMAN OTC DRUG','SENSODYNE','Repair and Protect','stannous fluoride','PASTE','ORAL','20210628','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','STANNOUS FLUORIDE','1.1','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0550_84202ac9-7804-4e03-bf5e-1715c3b611f9','0135-0550','HUMAN OTC DRUG','Sensodyne','','potassium nitrate and sodium fluoride','PASTE','DENTAL','20040217','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.1','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0551_84202ac9-7804-4e03-bf5e-1715c3b611f9','0135-0551','HUMAN OTC DRUG','Sensodyne','','potassium nitrate and sodium fluoride','PASTE','DENTAL','20020102','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.1','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0553_c544120f-15f0-48b5-88b2-d4820f180f50','0135-0553','HUMAN OTC DRUG','Tums','Ultra','Calcium carbonate','TABLET, CHEWABLE','ORAL','20230301','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','1000','mg/1','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0557_993a3b7d-e9f7-4fd5-ada5-ca00ce7774d7','0135-0557','HUMAN OTC DRUG','BIOTENE','Fresh Mint Original','sodium fluoride','PASTE','ORAL','20130715','','OTC MONOGRAPH FINAL','part355','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','SODIUM FLUORIDE','1.5','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0558_993a3b7d-e9f7-4fd5-ada5-ca00ce7774d7','0135-0558','HUMAN OTC DRUG','BIOTENE','Gentle Mint','sodium fluoride','PASTE','ORAL','20130715','','OTC MONOGRAPH FINAL','part355','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','SODIUM FLUORIDE','1.5','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0560_c34c21a0-b4b1-4c88-8b16-81ce8bb76490','0135-0560','HUMAN OTC DRUG','Tums','Chewy Delights','calcium carbonate','BAR, CHEWABLE','ORAL','20130801','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','1177','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0561_c34c21a0-b4b1-4c88-8b16-81ce8bb76490','0135-0561','HUMAN OTC DRUG','Tums','Chewy Delights','calcium carbonate','BAR, CHEWABLE','ORAL','20130801','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','1177','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0568_d6b00a8e-c06e-432e-8836-2acf05730597','0135-0568','HUMAN OTC DRUG','SENSODYNE PRONAMEL','Multi Action','potassium nitrate and sodium fluoride','PASTE','ORAL','20131209','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0569_c34c21a0-b4b1-4c88-8b16-81ce8bb76490','0135-0569','HUMAN OTC DRUG','Tums','Chewy Delights','calcium carbonate','BAR, CHEWABLE','ORAL','20140815','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','1177','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0572_52e90a02-fe75-44d2-8102-c67e9a2a730c','0135-0572','HUMAN OTC DRUG','Sensodyne Complete Protection','Extra Fresh','stannous fluoride','PASTE','DENTAL','20140714','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','STANNOUS FLUORIDE','1.1','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0573_52e90a02-fe75-44d2-8102-c67e9a2a730c','0135-0573','HUMAN OTC DRUG','Sensodyne Complete Protection','','stannous fluoride','PASTE','DENTAL','20140714','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','STANNOUS FLUORIDE','1.1','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0574_38e516bd-bbb3-461c-a194-467da5d1dd37','0135-0574','HUMAN OTC DRUG','GAVISCON','','aluminum hydroxide and magnesium carbonate','LIQUID','ORAL','20140801','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE','254; 237.5','mg/5mL; mg/5mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0575_3dec0f2d-e250-4b6d-9240-b6327a1dca51','0135-0575','HUMAN OTC DRUG','SENSODYNE','Repair and Protect Whitening','stannous fluoride','PASTE','ORAL','20210628','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','STANNOUS FLUORIDE','1.1','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0576_d81d23b3-d161-47c6-9fa6-0c665b5a454f','0135-0576','HUMAN OTC DRUG','FLONASE','ALLERGY RELIEF','fluticasone propionate','SPRAY, METERED','NASAL','20141204','','NDA','NDA205434','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','FLUTICASONE PROPIONATE','50','ug/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0577_517f89aa-dd25-44de-ae8e-824379ca0c28','0135-0577','HUMAN OTC DRUG','biotene','','sodium monofluorophosphate','PASTE','ORAL','20160901','','OTC MONOGRAPH FINAL','part355','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','SODIUM MONOFLUOROPHOSPHATE','1.4','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0578_282c103c-3888-4a35-a5b1-d492ed6892c1','0135-0578','HUMAN OTC DRUG','FLONASE','Headache and Allergy Relief','acetaminophen, chlorpheniramine maleate, phenylephrine hcl','TABLET','ORAL','20220310','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE','325; 2; 5','mg/1; mg/1; mg/1','Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0579_40e3fe1a-6f43-40ab-a98c-dc43bc266f52','0135-0579','HUMAN OTC DRUG','Sensodyne','True white','potassium nitrate and sodium fluoride','PASTE','DENTAL','20151221','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0580_94e07979-943b-45bb-8e2b-90d686f3692e','0135-0580','HUMAN OTC DRUG','Sensodyne Pronamel','Gentle Whitening Advanced','potassium nitrate and sodium fluoride','PASTE','DENTAL','20210315','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0581_40e3fe1a-6f43-40ab-a98c-dc43bc266f52','0135-0581','HUMAN OTC DRUG','Sensodyne','True white','potassium nitrate and sodium fluoride','PASTE','DENTAL','20151221','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0582_12254acb-5dd8-449a-852b-e3bb2a71c6b6','0135-0582','HUMAN OTC DRUG','CHILDRENS FLONASE','ALLERGY RELIEF','fluticasone propionate','SPRAY, METERED','NASAL','20160229','','NDA','NDA205434','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','FLUTICASONE PROPIONATE','50','ug/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0582_7fd20bd6-cb90-4afa-8775-1743648297cd','0135-0582','HUMAN OTC DRUG','CHILDRENS FLONASE','ALLERGY RELIEF','fluticasone propionate','SPRAY, METERED','NASAL','20160229','','NDA','NDA205434','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','FLUTICASONE PROPIONATE','50','ug/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0590_406bcedb-ab48-4b75-8e0a-0fa02064deda','0135-0590','HUMAN OTC DRUG','AQUAFRESH','CAVITY PROTECTION','sodium fluoride','PASTE','DENTAL','20161001','','OTC MONOGRAPH FINAL','part355','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','SODIUM FLUORIDE','1.15','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0591_406bcedb-ab48-4b75-8e0a-0fa02064deda','0135-0591','HUMAN OTC DRUG','AQUAFRESH','EXTRA FRESH PLUS WHITENING','sodium fluoride','PASTE','DENTAL','20140509','','OTC MONOGRAPH FINAL','part355','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','SODIUM FLUORIDE','1.15','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0593_334649e8-73cb-4325-be15-6db61eace0d1','0135-0593','HUMAN OTC DRUG','sensodyne','','potassium nitrate and sodium fluoride','PASTE','DENTAL','20161219','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0598_06b968d1-077f-43d1-8c64-123c591261de','0135-0598','HUMAN OTC DRUG','parodontax','','stannous fluoride','PASTE','DENTAL','20161219','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','STANNOUS FLUORIDE','1.1','mg/g','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0599_06b968d1-077f-43d1-8c64-123c591261de','0135-0599','HUMAN OTC DRUG','parodontax','','stannous fluoride','PASTE','DENTAL','20161219','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','STANNOUS FLUORIDE','1.1','mg/g','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0601_06b968d1-077f-43d1-8c64-123c591261de','0135-0601','HUMAN OTC DRUG','parodontax','','stannous fluoride','PASTE','DENTAL','20161219','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','STANNOUS FLUORIDE','1.1','mg/g','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0602_52cc971b-ced0-403f-bac5-95a4961ca02d','0135-0602','HUMAN OTC DRUG','Sensodyne Pronamel','Strong and Bright Enamel Mint','potassium nitrate and sodium fluoride','PASTE','ORAL','20161219','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0603_52cc971b-ced0-403f-bac5-95a4961ca02d','0135-0603','HUMAN OTC DRUG','Sensodyne Pronamel','Strong and Bright Enamel Extra Fresh','potassium nitrate and sodium fluoride','PASTE','ORAL','20161219','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0604_8f0a27c8-a067-4834-b375-88dca5472d53','0135-0604','HUMAN OTC DRUG','Aquafresh','Extreme Clean Pure Breath Action','sodium fluoride','PASTE','DENTAL','20160601','','OTC MONOGRAPH FINAL','part355','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','SODIUM FLUORIDE','1.15','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0607_a26625e4-000e-4e91-b538-4b4d3df55f3b','0135-0607','HUMAN OTC DRUG','Panadol','Cold and Flu NonDrowsy','acetaminophen and phenyleprine HCl','TABLET, FILM COATED','ORAL','20170601','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE','325; 5','mg/1; mg/1','Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0608_b26b54e1-fce0-4e33-9323-6360ff62963e','0135-0608','HUMAN OTC DRUG','PANADOL','PM','acetaminophen and diphenhydramine HCl','TABLET, FILM COATED','ORAL','20161201','','OTC MONOGRAPH NOT FINAL','part343','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE','500; 25','mg/1; mg/1','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0609_120d4df8-ef28-40eb-91ed-4fc67626fc2c','0135-0609','HUMAN OTC DRUG','PANADOL','Extra Strength','acetaminophen','TABLET, FILM COATED','ORAL','20170315','','OTC MONOGRAPH NOT FINAL','part343','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN','500','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0610_23419246-72a9-4295-805d-4eb4eeab0327','0135-0610','HUMAN OTC DRUG','TUMS','ULTRA','calcium carbonate','TABLET, CHEWABLE','ORAL','20160901','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','1000','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0611_5274f4e0-ef15-4ff2-9cc1-7e3daa34b909','0135-0611','HUMAN OTC DRUG','Tums','Regular Strength','calcium carbonate','TABLET, CHEWABLE','ORAL','20160901','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','500','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0612_23419246-72a9-4295-805d-4eb4eeab0327','0135-0612','HUMAN OTC DRUG','TUMS','ULTRA','calcium carbonate','TABLET, CHEWABLE','ORAL','20160901','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','1000','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0615_750bb88d-03d6-4acd-923d-a2937d9237ac','0135-0615','HUMAN OTC DRUG','FLONASE SENSIMIST','ALLERGY RELIEF','fluticasone furoate','SPRAY, METERED','NASAL','20170201','','NDA','NDA022051','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','FLUTICASONE FUROATE','27.5','ug/1','Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0618_b5a85266-8e54-4276-93c8-3be1dc0e386b','0135-0618','HUMAN OTC DRUG','Tums Chewy Bites','','calcium carbonate','TABLET, CHEWABLE','ORAL','20170518','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','750','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0619_6c21e9f9-9df7-42fd-994d-483d16d2caa5','0135-0619','HUMAN OTC DRUG','Aquafresh','Kids Cavity Protection','sodium monofluorophosphate','PASTE','DENTAL','20170901','','OTC MONOGRAPH FINAL','part355','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','SODIUM MONOFLUOROPHOSPHATE','1.1','mg/g','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0621_0fad4fa7-3504-4cfe-8665-2bfdd91cbeee','0135-0621','HUMAN OTC DRUG','SENSODYNE','Rapid Relief','stannous fluoride','PASTE','ORAL','20180108','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','STANNOUS FLUORIDE','1.1','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0622_0fad4fa7-3504-4cfe-8665-2bfdd91cbeee','0135-0622','HUMAN OTC DRUG','SENSODYNE','Rapid Relief','stannous fluoride','PASTE','ORAL','20180108','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','STANNOUS FLUORIDE','1.1','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0624_41047eed-6d6e-4ffa-bfd6-c82c9e490755','0135-0624','HUMAN OTC DRUG','Tums Chewy Bites with Gas Relief','','calcium carbonate and simethicone','TABLET, CHEWABLE','ORAL','20180301','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE; DIMETHICONE','750; 80','mg/1; mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Skin Barrier Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0625_1dc126d5-ca50-43b7-97d7-4d4f30b7c7cd','0135-0625','HUMAN OTC DRUG','NICORETTE','','nicotine polacrilex','LOZENGE','ORAL','20190411','','NDA','NDA021330','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0626_1dc126d5-ca50-43b7-97d7-4d4f30b7c7cd','0135-0626','HUMAN OTC DRUG','NICORETTE','','nicotine polacrilex','LOZENGE','ORAL','20190411','','NDA','NDA021330','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0627_1150c2c7-e357-42f7-8d10-44e27aa258ae','0135-0627','HUMAN OTC DRUG','parodontax','Complete Protection','stannous fluoride','PASTE','DENTAL','20181101','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US)','STANNOUS FLUORIDE','1.1','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0630_b5a85266-8e54-4276-93c8-3be1dc0e386b','0135-0630','HUMAN OTC DRUG','Tums Chewy Bites','','calcium carbonate','TABLET, CHEWABLE','ORAL','20190301','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','750','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0631_b5a85266-8e54-4276-93c8-3be1dc0e386b','0135-0631','HUMAN OTC DRUG','Tums Chewy Bites','','calcium carbonate','TABLET, CHEWABLE','ORAL','20190301','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','750','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0632_0fad4fa7-3504-4cfe-8665-2bfdd91cbeee','0135-0632','HUMAN OTC DRUG','SENSODYNE','Rapid Relief','stannous fluoride','PASTE','ORAL','20190708','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','STANNOUS FLUORIDE','1.1','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0633_b5a85266-8e54-4276-93c8-3be1dc0e386b','0135-0633','HUMAN OTC DRUG','Tums Chewy Bites','','calcium carbonate','TABLET, CHEWABLE','ORAL','20190928','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','750','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0634_04f60474-b859-42d3-b4c2-43b16fb1c847','0135-0634','HUMAN OTC DRUG','parodontax','Complete Protection','stannous fluoride','PASTE','DENTAL','20200106','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US)','STANNOUS FLUORIDE','1.1','mg/g','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0637_ae24ec34-d182-409b-93bd-4795deeb3a76','0135-0637','HUMAN OTC DRUG','parodontax','Active Gum Repair','stannous fluoride','PASTE','DENTAL','20210104','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','STANNOUS FLUORIDE','1.1','mg/g','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0638_817e804c-e55e-4d77-9ab9-ff54ae794725','0135-0638','HUMAN OTC DRUG','parodontax','Active Gum Repair Whitening','stannous fluoride','PASTE','DENTAL','20220103','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','STANNOUS FLUORIDE','1.1','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0641_99c7361d-6b93-43ef-8f30-7f8fd76a9ede','0135-0641','HUMAN OTC DRUG','Tums Chewy Bites','Mixed Fruit','calcium carbonate','TABLET, CHEWABLE','ORAL','20210115','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','1000','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0642_97760d0b-c769-4bca-acfa-4680b3fba721','0135-0642','HUMAN OTC DRUG','Tums Chewy Bites','Orange and Cream ES','calcium carbonate','TABLET, CHEWABLE','ORAL','20210305','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','750','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0650_d4956ce5-d348-4d4b-92ad-c39427617d27','0135-0650','HUMAN OTC DRUG','Parodontax','Active Gum Health Clear Mint','cetylpyridinium chloride','MOUTHWASH','ORAL','20220103','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CETYLPYRIDINIUM CHLORIDE','0.7','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0651_d4956ce5-d348-4d4b-92ad-c39427617d27','0135-0651','HUMAN OTC DRUG','Parodontax','Active Gum Health Mint','cetylpyridinium chloride','MOUTHWASH','ORAL','20220103','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CETYLPYRIDINIUM CHLORIDE','70','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0700_e8684615-f544-4871-b935-0a0f93639d7d','0135-0700','HUMAN OTC DRUG','SENSODYNE PRONAMEL','Active Shield Fresh Mint','potassium nitrate and sodium fluoride','PASTE','ORAL','20230102','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US)','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0701_e8684615-f544-4871-b935-0a0f93639d7d','0135-0701','HUMAN OTC DRUG','SENSODYNE PRONAMEL','Active Shield Cool Mint','potassium nitrate and sodium fluoride','PASTE','ORAL','20230102','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US)','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0710_557eeb32-64f4-41e8-ada4-91bd39ae2920','0135-0710','HUMAN OTC DRUG','Polident','ProPartial','stannous fluoride','PASTE','DENTAL','20210104','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','STANNOUS FLUORIDE','1.5','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-0711_4c01ca1f-f991-491d-bfb8-61ad548373ea','0135-0711','HUMAN OTC DRUG','Polident','ProPartial','sodium fluoride','MOUTHWASH','ORAL','20210104','','OTC MONOGRAPH FINAL','part355','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','SODIUM FLUORIDE','0.2','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-1000_594b43cb-d7b1-4a2e-a178-fdd269386b97','0135-1000','HUMAN OTC DRUG','TUMS','','calcium carbonate','TABLET','ORAL','20211008','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','750','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-1001_594b43cb-d7b1-4a2e-a178-fdd269386b97','0135-1001','HUMAN OTC DRUG','TUMS','','calcium carbonate','TABLET','ORAL','20211008','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','750','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-1002_11078d7c-373b-4c7b-b33b-f1deba613fc1','0135-1002','HUMAN OTC DRUG','TUMS','extra strength, smoothies','calcium carbonate','TABLET, CHEWABLE','ORAL','20211129','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','750','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-1200_71b95962-2693-49f5-94d2-f2a035b5e0c8','0135-1200','HUMAN OTC DRUG','NATEAN','Clean and Whiten','sodium fluoride','PASTE','ORAL','20220103','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','SODIUM FLUORIDE','1.5','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-1250_cea6f992-8a44-4eb8-baea-97b7b181b227','0135-1250','HUMAN OTC DRUG','NATEAN','Clean plus Sensitivity Relief','potassium nitrate, sodium fluoride','PASTE','ORAL','20220103','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.5','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-1326_0ea80e99-5f1b-454e-bc98-52d46cd3bfdd','0135-1326','HUMAN OTC DRUG','Tums','Naturals','calcium carbonate','TABLET, CHEWABLE','ORAL','20201015','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','1000','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-1328_0ea80e99-5f1b-454e-bc98-52d46cd3bfdd','0135-1328','HUMAN OTC DRUG','Tums','Naturals','calcium carbonate','TABLET, CHEWABLE','ORAL','20201015','','OTC MONOGRAPH FINAL','part331','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','CALCIUM CARBONATE','1000','mg/1','Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-1329_070fb5a4-1848-41e8-90bf-57e682de1762','0135-1329','HUMAN OTC DRUG','FLONASE','Nighttime Allergy Relief','triprolidine hcl','TABLET','ORAL','20221215','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','TRIPROLIDINE HYDROCHLORIDE','2.5','mg/1','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-1500_c7f32ab1-f6bd-46f5-9852-8eb5b78a3326','0135-1500','HUMAN OTC DRUG','NICORETTE','','nicotine polacrilex','LOZENGE','ORAL','20220601','','NDA','NDA022360','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','4','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-2029_5d76e753-563d-4d55-b7bf-387580dbea4c','0135-2029','HUMAN OTC DRUG','Chapstick','12 Days of Christmas','white petrolatum','KIT','','20210930','','OTC MONOGRAPH FINAL','part347','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','','','','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-2800_c7f32ab1-f6bd-46f5-9852-8eb5b78a3326','0135-2800','HUMAN OTC DRUG','NICORETTE','','nicotine polacrilex','LOZENGE','ORAL','20220601','','NDA','NDA022360','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','NICOTINE','2','mg/1','Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-5022_648897dc-dfb6-463f-baef-6e6ee930072f','0135-5022','HUMAN OTC DRUG','SENSODYNE','Sensitivity Gum and Enamel Mint','stannous fluoride','PASTE','ORAL','20230102','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','STANNOUS FLUORIDE','1.1','mg/g','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-5023_7f1b4a6b-3b70-4688-8aa6-76887735bf86','0135-5023','HUMAN OTC DRUG','SENSODYNE','Sensitivity and Gum Mint','stannous fluoride','PASTE','ORAL','20200106','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','STANNOUS FLUORIDE','1.1','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-5024_7f1b4a6b-3b70-4688-8aa6-76887735bf86','0135-5024','HUMAN OTC DRUG','SENSODYNE','Sensitivity and Gum Whitening','stannous fluoride','PASTE','ORAL','20200106','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','STANNOUS FLUORIDE','1.1','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-5025_7f1b4a6b-3b70-4688-8aa6-76887735bf86','0135-5025','HUMAN OTC DRUG','SENSODYNE','SENSITIVITY AND GUM CLEAN AND FRESH','stannous fluoride','PASTE','ORAL','20210106','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','STANNOUS FLUORIDE','1.1','mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-5026_d02580a5-d7e1-47a5-8fca-78ed88df2bc5','0135-5026','HUMAN OTC DRUG','Sensodyne','Nourish Gently Soothing','potassium nitrate and sodium fluoride','PASTE','DENTAL','20220103','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-5027_aca38560-2fd7-47be-9e93-2abc3214e856','0135-5027','HUMAN OTC DRUG','Sensodyne','Nourish Healthy White','potassium nitrate and sodium fluoride','PASTE','DENTAL','20220103','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-5028_1418cddb-6a90-4d0f-8787-ca988fd98fce','0135-5028','HUMAN OTC DRUG','Sensodyne','Natural white','potassium nitrate and sodium fluoride','PASTE','DENTAL','20220124','','OTC MONOGRAPH NOT FINAL','part356','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','POTASSIUM NITRATE; SODIUM FLUORIDE','50; 1.15','mg/g; mg/g','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-7011_7964bb07-d1a4-46a9-8a41-657164358dc3','0135-7011','HUMAN OTC DRUG','PANADOL','Extra Strength','acetaminophen','TABLET, FILM COATED','ORAL','20210215','','OTC MONOGRAPH NOT FINAL','part343','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN','500','mg/1','','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-7021_b9015bb7-f72e-4ab6-833e-82e5603986b2','0135-7021','HUMAN OTC DRUG','PANADOL','PM','acetaminophen and diphenhydramine HCl','TABLET, FILM COATED','ORAL','20210625','','OTC MONOGRAPH NOT FINAL','part343','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE','500; 25','mg/1; mg/1','Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0135-7031_fa0ce51f-441d-4409-8617-b3402b00f187','0135-7031','HUMAN OTC DRUG','Panadol','Cold and Flu NonDrowsy','acetaminophen and phenyleprine HCl','TABLET, FILM COATED','ORAL','20221220','','OTC MONOGRAPH FINAL','part341','GlaxoSmithKline Consumer Healthcare Holdings (US) LLC','ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE','325; 5','mg/1; mg/1','Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0140-0004_5da13043-2476-406e-8658-834dfdb39530','0140-0004','HUMAN PRESCRIPTION DRUG','Valium','','diazepam','TABLET','ORAL','19631115','','NDA','NDA013263','Roche Laboratories Inc.','DIAZEPAM','2','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0140-0005_5da13043-2476-406e-8658-834dfdb39530','0140-0005','HUMAN PRESCRIPTION DRUG','Valium','','diazepam','TABLET','ORAL','19631115','','NDA','NDA013263','Roche Laboratories Inc.','DIAZEPAM','5','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0140-0006_5da13043-2476-406e-8658-834dfdb39530','0140-0006','HUMAN PRESCRIPTION DRUG','Valium','','diazepam','TABLET','ORAL','19631115','','NDA','NDA013263','Roche Laboratories Inc.','DIAZEPAM','10','mg/1','Benzodiazepine [EPC], Benzodiazepines [CS]','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-1171_f9213dbf-e8bd-4b9e-82ac-c01bc0bcab48','0143-1171','HUMAN PRESCRIPTION DRUG','Captopril','','Captopril','TABLET','ORAL','19960213','','ANDA','ANDA074505','Hikma Pharmaceuticals USA Inc.','CAPTOPRIL','12.5','mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-1172_f9213dbf-e8bd-4b9e-82ac-c01bc0bcab48','0143-1172','HUMAN PRESCRIPTION DRUG','Captopril','','Captopril','TABLET','ORAL','19960213','','ANDA','ANDA074505','Hikma Pharmaceuticals USA Inc.','CAPTOPRIL','25','mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-1173_f9213dbf-e8bd-4b9e-82ac-c01bc0bcab48','0143-1173','HUMAN PRESCRIPTION DRUG','Captopril','','Captopril','TABLET','ORAL','19960213','','ANDA','ANDA074505','Hikma Pharmaceuticals USA Inc.','CAPTOPRIL','50','mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-1174_f9213dbf-e8bd-4b9e-82ac-c01bc0bcab48','0143-1174','HUMAN PRESCRIPTION DRUG','Captopril','','Captopril','TABLET','ORAL','19960213','','ANDA','ANDA074505','Hikma Pharmaceuticals USA Inc.','CAPTOPRIL','100','mg/1','Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-1227_ab1abd30-25fd-46ed-a992-925836112c98','0143-1227','HUMAN PRESCRIPTION DRUG','Dicyclomine','','Dicyclomine hydrochloride','TABLET','ORAL','19961001','','ANDA','ANDA040161','Hikma Pharmaceuticals USA Inc.','DICYCLOMINE HYDROCHLORIDE','20','mg/1','Anticholinergic [EPC], Cholinergic Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-1240_21e3ba50-c28b-43ab-9b80-7b2e42e17c0d','0143-1240','HUMAN PRESCRIPTION DRUG','Digoxin','','Digoxin','TABLET','ORAL','20071030','','ANDA','ANDA077002','Hikma Pharmaceuticals USA Inc.','DIGOXIN','125','ug/1','Cardiac Glycoside [EPC], Cardiac Glycosides [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-1241_21e3ba50-c28b-43ab-9b80-7b2e42e17c0d','0143-1241','HUMAN PRESCRIPTION DRUG','Digoxin','','Digoxin','TABLET','ORAL','20071030','','ANDA','ANDA077002','Hikma Pharmaceuticals USA Inc.','DIGOXIN','250','ug/1','Cardiac Glycoside [EPC], Cardiac Glycosides [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-1455_8b0f0d64-752d-4827-8455-e3b3c90ff849','0143-1455','HUMAN PRESCRIPTION DRUG','Phenobarbital','','Phenobarbital','TABLET','ORAL','19990111','','UNAPPROVED DRUG OTHER','','Hikma Pharmaceuticals USA Inc.','PHENOBARBITAL','60','mg/1','','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-1458_8b0f0d64-752d-4827-8455-e3b3c90ff849','0143-1458','HUMAN PRESCRIPTION DRUG','Phenobarbital','','Phenobarbital','TABLET','ORAL','20000107','','UNAPPROVED DRUG OTHER','','Hikma Pharmaceuticals USA Inc.','PHENOBARBITAL','100','mg/1','','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-1495_8b0f0d64-752d-4827-8455-e3b3c90ff849','0143-1495','HUMAN PRESCRIPTION DRUG','Phenobarbital','','Phenobarbital','TABLET','ORAL','20200305','','UNAPPROVED DRUG OTHER','','Hikma Pharmaceuticals USA Inc.','PHENOBARBITAL','15','mg/1','','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-1500_8b0f0d64-752d-4827-8455-e3b3c90ff849','0143-1500','HUMAN PRESCRIPTION DRUG','Phenobarbital','','Phenobarbital','TABLET','ORAL','20200305','','UNAPPROVED DRUG OTHER','','Hikma Pharmaceuticals USA Inc.','PHENOBARBITAL','30','mg/1','','CIV','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-1769_a2887992-062a-49ed-aa56-fdd790d363bf','0143-1769','HUMAN PRESCRIPTION DRUG','Isosorbide Dinitrate','','Isosorbide Dinitrate','TABLET','ORAL','19781201','','ANDA','ANDA086067','Hikma Pharmaceuticals USA Inc.','ISOSORBIDE DINITRATE','5','mg/1','Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-1771_a2887992-062a-49ed-aa56-fdd790d363bf','0143-1771','HUMAN PRESCRIPTION DRUG','Isosorbide Dinitrate','','Isosorbide Dinitrate','TABLET','ORAL','19781201','','ANDA','ANDA086066','Hikma Pharmaceuticals USA Inc.','ISOSORBIDE DINITRATE','10','mg/1','Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-1772_a2887992-062a-49ed-aa56-fdd790d363bf','0143-1772','HUMAN PRESCRIPTION DRUG','Isosorbide Dinitrate','','Isosorbide Dinitrate','TABLET','ORAL','19830426','','ANDA','ANDA088088','Hikma Pharmaceuticals USA Inc.','ISOSORBIDE DINITRATE','20','mg/1','Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-2112_3dc3f962-d460-42a2-b205-12d16f05f42f','0143-2112','HUMAN PRESCRIPTION DRUG','Doxycycline','','Doxycycline hyclate','TABLET, COATED','ORAL','20030702','','ANDA','ANDA065095','Hikma Pharmaceuticals USA Inc.','DOXYCYCLINE HYCLATE','100','mg/1','Tetracycline-class Drug [EPC], Tetracyclines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-3018_25be6987-570b-4208-9887-a43a0c83b843','0143-3018','HUMAN PRESCRIPTION DRUG','Colchicine','','Colchicine','CAPSULE','ORAL','20141001','','NDA','NDA204820','Hikma Pharmaceuticals USA Inc.','COLCHICINE','0.6','mg/1','Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-3126_008f2526-f7fc-4c9b-939d-04661bcec6be','0143-3126','HUMAN PRESCRIPTION DRUG','Dicyclomine hydrochloride','','Dicyclomine hydrochloride','CAPSULE','ORAL','19970228','','ANDA','ANDA040204','Hikma Pharmaceuticals USA Inc.','DICYCLOMINE HYDROCHLORIDE','10','mg/1','Anticholinergic [EPC], Cholinergic Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-3141_b9a37a1f-be49-4077-9bda-2298525bb41e','0143-3141','HUMAN PRESCRIPTION DRUG','Doxycycline Hyclate','','Doxycycline Hyclate','CAPSULE, GELATIN COATED','ORAL','19841107','','ANDA','ANDA062396','Hikma Pharmaceuticals USA Inc.','DOXYCYCLINE HYCLATE','50','mg/1','Tetracycline-class Drug [EPC], Tetracyclines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-3142_b9a37a1f-be49-4077-9bda-2298525bb41e','0143-3142','HUMAN PRESCRIPTION DRUG','Doxycycline Hyclate','','Doxycycline Hyclate','CAPSULE, GELATIN COATED','ORAL','19840507','','ANDA','ANDA062396','Hikma Pharmaceuticals USA Inc.','DOXYCYCLINE HYCLATE','100','mg/1','Tetracycline-class Drug [EPC], Tetracyclines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9005_8534291c-eeeb-4cfa-b703-1719a47eb534','0143-9005','HUMAN PRESCRIPTION DRUG','Testosterone Cypionate','','Testosterone Cypionate','INJECTION','INTRAMUSCULAR','20211122','','ANDA','ANDA091244','Hikma Pharmaceuticals USA Inc.','TESTOSTERONE CYPIONATE','200','mg/mL','Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]','CIII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9006_6933faa5-ca70-4215-8f52-7055a688c287','0143-9006','HUMAN PRESCRIPTION DRUG','AcetaZOLAMIDE','','Acetazolamide','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','19960501','','ANDA','ANDA040089','Hikma Pharmaceuticals USA Inc.','ACETAZOLAMIDE SODIUM','500','mg/1','Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9022_aaafdc34-8bf3-4671-a93b-b074879f8f1a','0143-9022','HUMAN PRESCRIPTION DRUG','Fulvestrant','','Fulvestrant','INJECTION','INTRAMUSCULAR','20220210','','ANDA','ANDA214682','Hikma Pharmaceuticals USA Inc.','FULVESTRANT','50','mg/mL','Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9084_5fd657ff-0d18-419f-829b-550cb3521fce','0143-9084','HUMAN PRESCRIPTION DRUG','Doxorubicin Hydrochloride','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19960501','','ANDA','ANDA062975','Hikma Pharmaceuticals USA Inc.','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9085_5fd657ff-0d18-419f-829b-550cb3521fce','0143-9085','HUMAN PRESCRIPTION DRUG','Doxorubicin Hydrochloride','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19960501','','ANDA','ANDA062975','Hikma Pharmaceuticals USA Inc.','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9086_5fd657ff-0d18-419f-829b-550cb3521fce','0143-9086','HUMAN PRESCRIPTION DRUG','Doxorubicin Hydrochloride','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19960501','','ANDA','ANDA062975','Hikma Pharmaceuticals USA Inc.','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9087_5fd657ff-0d18-419f-829b-550cb3521fce','0143-9087','HUMAN PRESCRIPTION DRUG','Doxorubicin Hydrochloride','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19960501','','ANDA','ANDA064097','Hikma Pharmaceuticals USA Inc.','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9088_693136bd-63da-463d-bd80-9b4182d8b7a8','0143-9088','HUMAN PRESCRIPTION DRUG','Doxorubicin Hydrochloride','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19960501','','ANDA','ANDA062975','Hikma Pharmaceuticals USA Inc.','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9089_693136bd-63da-463d-bd80-9b4182d8b7a8','0143-9089','HUMAN PRESCRIPTION DRUG','Doxorubicin Hydrochloride','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19960501','','ANDA','ANDA062975','Hikma Pharmaceuticals USA Inc.','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9090_693136bd-63da-463d-bd80-9b4182d8b7a8','0143-9090','HUMAN PRESCRIPTION DRUG','Doxorubicin Hydrochloride','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19960501','','ANDA','ANDA062975','Hikma Pharmaceuticals USA Inc.','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9091_693136bd-63da-463d-bd80-9b4182d8b7a8','0143-9091','HUMAN PRESCRIPTION DRUG','Doxorubicin Hydrochloride','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19960501','','ANDA','ANDA064097','Hikma Pharmaceuticals USA Inc.','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9092_e29e7a67-10c1-4368-bf19-bfa344198192','0143-9092','HUMAN PRESCRIPTION DRUG','Doxorubicin Hydrochloride','','Doxorubicin Hydrochloride','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20180119','','ANDA','ANDA062921','Hikma Pharmaceuticals USA Inc.','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9093_e29e7a67-10c1-4368-bf19-bfa344198192','0143-9093','HUMAN PRESCRIPTION DRUG','Doxorubicin Hydrochloride','','Doxorubicin Hydrochloride','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20180119','','ANDA','ANDA062921','Hikma Pharmaceuticals USA Inc.','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9098_e673dbf4-9d4e-4665-ac36-81c6537044fc','0143-9098','HUMAN PRESCRIPTION DRUG','bortezomib','','bortezomib','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS; SUBCUTANEOUS','20220727','','ANDA','ANDA215011','Hikma Pharmaceuticals USA Inc.','BORTEZOMIB','3.5','mg/1','Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9128_21a56169-eed4-47ef-ae9e-ed40c31145a5','0143-9128','HUMAN PRESCRIPTION DRUG','Gentamicin','','Gentamicin','INJECTION, SOLUTION','INTRAMUSCULAR; INTRAVENOUS','20220215','','ANDA','ANDA062251','Hikma Pharmaceuticals USA Inc.','GENTAMICIN SULFATE','40','mg/mL','Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9129_21a56169-eed4-47ef-ae9e-ed40c31145a5','0143-9129','HUMAN PRESCRIPTION DRUG','Gentamicin','','Gentamicin','INJECTION, SOLUTION','INTRAMUSCULAR; INTRAVENOUS','20220215','','ANDA','ANDA062251','Hikma Pharmaceuticals USA Inc.','GENTAMICIN SULFATE','40','mg/mL','Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9135_967161c6-2423-4ce9-b386-0a4855b1cb75','0143-9135','HUMAN PRESCRIPTION DRUG','Mitomycin','','Mitomycin','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20221001','','ANDA','ANDA064117','Hikma Pharmaceuticals USA Inc.','MITOMYCIN','20','mg/1','Alkylating Activity [MoA], Alkylating Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9136_967161c6-2423-4ce9-b386-0a4855b1cb75','0143-9136','HUMAN PRESCRIPTION DRUG','Mitomycin','','Mitomycin','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20221001','','ANDA','ANDA064117','Hikma Pharmaceuticals USA Inc.','MITOMYCIN','40','mg/1','Alkylating Activity [MoA], Alkylating Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9139_7c1ee339-cbdc-447b-be59-7611ef0552ad','0143-9139','HUMAN PRESCRIPTION DRUG','Cefazolin','','Cefazolin','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20230301','','NDA','NDA216109','Hikma Pharmaceuticals USA Inc.','CEFAZOLIN SODIUM','2','g/1','Cephalosporin Antibacterial [EPC], Cephalosporins [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9140_7c1ee339-cbdc-447b-be59-7611ef0552ad','0143-9140','HUMAN PRESCRIPTION DRUG','Cefazolin','','Cefazolin','INJECTION, POWDER, FOR SOLUTION','INTRAVENOUS','20230301','','NDA','NDA216109','Hikma Pharmaceuticals USA Inc.','CEFAZOLIN SODIUM','3','g/1','Cephalosporin Antibacterial [EPC], Cephalosporins [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9161_2a51f66c-3d82-46c3-9792-5f9d68d2bb24','0143-9161','HUMAN PRESCRIPTION DRUG','VANCOMYCIN HYDROCHLORIDE','','vancomycin hydrochloride','INJECTION, POWDER, FOR SOLUTION','INTRAVENOUS; ORAL','20230202','','NDA','NDA210274','HIKMA PHARMACEUTICALS USA INC.','VANCOMYCIN HYDROCHLORIDE','513','mg/mg','Glycopeptide Antibacterial [EPC], Glycopeptides [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9162_2a51f66c-3d82-46c3-9792-5f9d68d2bb24','0143-9162','HUMAN PRESCRIPTION DRUG','VANCOMYCIN HYDROCHLORIDE','','vancomycin hydrochloride','INJECTION, POWDER, FOR SOLUTION','INTRAVENOUS; ORAL','20230202','','NDA','NDA210274','HIKMA PHARMACEUTICALS USA INC.','VANCOMYCIN HYDROCHLORIDE','1025','mg/mg','Glycopeptide Antibacterial [EPC], Glycopeptides [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9163_509c6f17-041d-4433-bf3e-5fec684c88c3','0143-9163','HUMAN PRESCRIPTION DRUG','VANCOMYCIN HYDROCHLORIDE','','vancomycin hydrochloride','INJECTION, POWDER, FOR SOLUTION','INTRAVENOUS; ORAL','20230203','','NDA','NDA210274','HIKMA PHARMACEUTICALS USA INC.','VANCOMYCIN HYDROCHLORIDE','5.13','g/g','Glycopeptide Antibacterial [EPC], Glycopeptides [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9164_509c6f17-041d-4433-bf3e-5fec684c88c3','0143-9164','HUMAN PRESCRIPTION DRUG','VANCOMYCIN HYDROCHLORIDE','','vancomycin hydrochloride','INJECTION, POWDER, FOR SOLUTION','INTRAVENOUS; ORAL','20230202','','NDA','NDA210274','HIKMA PHARMACEUTICALS USA INC.','VANCOMYCIN HYDROCHLORIDE','10.25','g/g','Glycopeptide Antibacterial [EPC], Glycopeptides [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9202_a854383a-1d91-456c-baae-2e4011faf1a5','0143-9202','HUMAN PRESCRIPTION DRUG','Epirubicin Hydrochloride','','Epirubicin Hydrochloride','INJECTION','INTRAVENOUS','20070807','','ANDA','ANDA065289','Hikma Pharmaceuticals USA Inc.','EPIRUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9203_a854383a-1d91-456c-baae-2e4011faf1a5','0143-9203','HUMAN PRESCRIPTION DRUG','Epirubicin Hydrochloride','','Epirubicin Hydrochloride','INJECTION','INTRAVENOUS','20070807','','ANDA','ANDA065289','Hikma Pharmaceuticals USA Inc.','EPIRUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9204_5d638381-b992-4287-9ef3-2b0c47a9d3b7','0143-9204','HUMAN PRESCRIPTION DRUG','Docetaxel','','Docetaxel','INJECTION, SOLUTION, CONCENTRATE','INTRAVENOUS','20210114','','ANDA','ANDA204490','Hikma Pharmaceuticals USA Inc.','DOCETAXEL','20','mg/mL','Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9205_5d638381-b992-4287-9ef3-2b0c47a9d3b7','0143-9205','HUMAN PRESCRIPTION DRUG','Docetaxel','','Docetaxel','INJECTION, SOLUTION, CONCENTRATE','INTRAVENOUS','20210114','','ANDA','ANDA204490','Hikma Pharmaceuticals USA Inc.','DOCETAXEL','20','mg/mL','Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9209_a652f290-f8c6-4483-9fe4-b1fd50dec37d','0143-9209','HUMAN PRESCRIPTION DRUG','Chloroprocaine Hydrochloride','','Chloroprocaine Hydrochloride','INJECTION, SOLUTION','EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL','19981101','','ANDA','ANDA040273','Hikma Pharmaceuticals USA Inc.','CHLOROPROCAINE HYDROCHLORIDE','20','mg/mL','Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9210_a652f290-f8c6-4483-9fe4-b1fd50dec37d','0143-9210','HUMAN PRESCRIPTION DRUG','Chloroprocaine Hydrochloride','','Chloroprocaine Hydrochloride','INJECTION, SOLUTION','EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL','19981101','','ANDA','ANDA040273','Hikma Pharmaceuticals USA Inc.','CHLOROPROCAINE HYDROCHLORIDE','30','mg/mL','Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9217_d4f406e6-f893-409d-acca-9315919232bc','0143-9217','HUMAN PRESCRIPTION DRUG','Idarubicin Hydrochloride','','Idarubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','20170130','','ANDA','ANDA065275','Hikma Pharmaceuticals USA Inc.','IDARUBICIN HYDROCHLORIDE','1','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9218_d4f406e6-f893-409d-acca-9315919232bc','0143-9218','HUMAN PRESCRIPTION DRUG','Idarubicin Hydrochloride','','Idarubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','20170130','','ANDA','ANDA065275','Hikma Pharmaceuticals USA Inc.','IDARUBICIN HYDROCHLORIDE','1','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9219_d4f406e6-f893-409d-acca-9315919232bc','0143-9219','HUMAN PRESCRIPTION DRUG','Idarubicin Hydrochloride','','Idarubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','20170130','','ANDA','ANDA065275','Hikma Pharmaceuticals USA Inc.','IDARUBICIN HYDROCHLORIDE','1','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9230_1a816eb9-6de4-4751-831b-d183254f36af','0143-9230','HUMAN PRESCRIPTION DRUG','Rifampin','','Rifampin','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20160303','','ANDA','ANDA205039','Hikma Pharmaceuticals USA Inc.','RIFAMPIN','600','mg/1','Rifamycin Antibacterial [EPC], Rifamycins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9232_cb43d4f5-2c2a-4fca-94d2-429d92282fef','0143-9232','HUMAN PRESCRIPTION DRUG','Vecuronium Bromide','','Vecuronium Bromide','INJECTION, POWDER, FOR SOLUTION','INTRAVENOUS','20190801','','ANDA','ANDA203725','Hikma Pharmaceuticals USA Inc.','VECURONIUM BROMIDE','20','mg/1','Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9233_c4eed915-e44c-4afc-9cb8-061de68bbc0a','0143-9233','HUMAN PRESCRIPTION DRUG','Benztropine Mesylate','','Benztropine Mesylate','INJECTION','INTRAMUSCULAR; INTRAVENOUS','20211014','','ANDA','ANDA209442','Hikma Pharmaceuticals USA Inc.','BENZTROPINE MESYLATE','1','mg/mL','Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9234_cb43d4f5-2c2a-4fca-94d2-429d92282fef','0143-9234','HUMAN PRESCRIPTION DRUG','Vecuronium Bromide','','Vecuronium Bromide','INJECTION, POWDER, FOR SOLUTION','INTRAVENOUS','20190801','','ANDA','ANDA203725','Hikma Pharmaceuticals USA Inc.','VECURONIUM BROMIDE','10','mg/1','Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9240_17a59fa2-9e0c-4be6-b9ef-8d1299352a0f','0143-9240','HUMAN PRESCRIPTION DRUG','Bleomycin','','Bleomycin','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS','20180109','','ANDA','ANDA065042','Hikma Pharmaceuticals USA Inc.','BLEOMYCIN SULFATE','15','[USP''''U]/1','Cytoprotective Agent [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9241_17a59fa2-9e0c-4be6-b9ef-8d1299352a0f','0143-9241','HUMAN PRESCRIPTION DRUG','Bleomycin','','Bleomycin','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS','20180109','','ANDA','ANDA065042','Hikma Pharmaceuticals USA Inc.','BLEOMYCIN SULFATE','30','[USP''''U]/1','Cytoprotective Agent [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9245_aac851c5-8ca2-4b13-87cb-f8f78b1f2cbc','0143-9245','HUMAN PRESCRIPTION DRUG','Dacarbazine','','Dacarbazine','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20010808','','ANDA','ANDA075812','Hikma Pharmaceuticals USA Inc.','DACARBAZINE','10','mg/mL','Alkylating Activity [MoA], Alkylating Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9246_0c4e9254-1f64-45fb-acfd-2114a638262d','0143-9246','HUMAN PRESCRIPTION DRUG','Buprenorphine Hydrochloride','','Buprenorphine Hydrochloride','INJECTION','INTRAMUSCULAR; INTRAVENOUS','20050525','','ANDA','ANDA076931','Hikma Pharmaceuticals USA Inc.','BUPRENORPHINE HYDROCHLORIDE','0.324','mg/mL','Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]','CIII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9247_2c71aef6-33cc-4f1d-acba-8a2c4c6bce95','0143-9247','HUMAN PRESCRIPTION DRUG','Dexrazoxane','','Dexrazoxane','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20050331','','ANDA','ANDA076068','Hikma Pharmaceuticals USA Inc.','DEXRAZOXANE HYDROCHLORIDE','10','mg/mL','Cytoprotective Agent [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9248_2c71aef6-33cc-4f1d-acba-8a2c4c6bce95','0143-9248','HUMAN PRESCRIPTION DRUG','Dexrazoxane','','Dexrazoxane','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20050331','','ANDA','ANDA076068','Hikma Pharmaceuticals USA Inc.','DEXRAZOXANE HYDROCHLORIDE','10','mg/mL','Cytoprotective Agent [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9249_e63c35be-9cf4-4f1f-b67b-42ff22f3c840','0143-9249','HUMAN PRESCRIPTION DRUG','Amoxicillin and Clavulanate Potassium','','Amoxicillin and Clavulanate Potassium','TABLET','ORAL','20160823','','ANDA','ANDA203824','Hikma Pharmaceuticals USA Inc.','AMOXICILLIN; CLAVULANATE POTASSIUM','875; 125','mg/1; mg/1','Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9250_dbb889ca-0c91-4ab7-88cf-7b147c4a4b7a','0143-9250','HUMAN PRESCRIPTION DRUG','Rocuronium Bromide','','Rocuronium Bromide','INJECTION','INTRAVENOUS','20170430','','ANDA','ANDA204679','Hikma Pharmaceuticals USA Inc.','ROCURONIUM BROMIDE','10','mg/mL','Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9251_dbb889ca-0c91-4ab7-88cf-7b147c4a4b7a','0143-9251','HUMAN PRESCRIPTION DRUG','Rocuronium Bromide','','Rocuronium Bromide','INJECTION','INTRAVENOUS','20170430','','ANDA','ANDA204679','Hikma Pharmaceuticals USA Inc.','ROCURONIUM BROMIDE','10','mg/mL','Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9252_7345e945-864d-43bb-b418-470a6843b4c4','0143-9252','HUMAN PRESCRIPTION DRUG','Dopamine Hydrochloride','','Dopamine Hydrochloride','INJECTION','INTRAVENOUS','20180411','','ANDA','ANDA207707','Hikma Pharmaceuticals USA Inc.','DOPAMINE HYDROCHLORIDE','40','mg/mL','Catecholamine [EPC], Catecholamines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9253_7345e945-864d-43bb-b418-470a6843b4c4','0143-9253','HUMAN PRESCRIPTION DRUG','Dopamine Hydrochloride','','Dopamine Hydrochloride','INJECTION','INTRAVENOUS','20180411','','ANDA','ANDA207707','Hikma Pharmaceuticals USA Inc.','DOPAMINE HYDROCHLORIDE','80','mg/mL','Catecholamine [EPC], Catecholamines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9254_7345e945-864d-43bb-b418-470a6843b4c4','0143-9254','HUMAN PRESCRIPTION DRUG','Dopamine Hydrochloride','','Dopamine Hydrochloride','INJECTION','INTRAVENOUS','20180411','','ANDA','ANDA207707','Hikma Pharmaceuticals USA Inc.','DOPAMINE HYDROCHLORIDE','40','mg/mL','Catecholamine [EPC], Catecholamines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9255_7345e945-864d-43bb-b418-470a6843b4c4','0143-9255','HUMAN PRESCRIPTION DRUG','Dopamine Hydrochloride','','Dopamine Hydrochloride','INJECTION','INTRAVENOUS','20180411','','ANDA','ANDA207707','Hikma Pharmaceuticals USA Inc.','DOPAMINE HYDROCHLORIDE','80','mg/mL','Catecholamine [EPC], Catecholamines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9261_ea333849-55d3-4257-94e5-d70ba608f8c5','0143-9261','HUMAN PRESCRIPTION DRUG','Cefazolin','','Cefazolin','INJECTION, POWDER, FOR SOLUTION','INTRAVENOUS','20041018','','ANDA','ANDA065143','West-Ward Pharmaceuticals Corp','CEFAZOLIN SODIUM','10','g/1','Cephalosporin Antibacterial [EPC], Cephalosporins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9262_ec660da2-fc70-4a4c-830b-f514938768cc','0143-9262','HUMAN PRESCRIPTION DRUG','Cefazolin','','Cefazolin','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','20010918','','ANDA','ANDA065047','Hikma Pharmaceuticals USA Inc.','CEFAZOLIN SODIUM','330','mg/mL','Cephalosporin Antibacterial [EPC], Cephalosporins [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9263_1249ed50-7d61-4a9d-9ffa-6020756df74e','0143-9263','HUMAN PRESCRIPTION DRUG','Ropivacaine Hydrochloride','','Ropivacaine Hydrochloride','INJECTION','EPIDURAL; INFILTRATION','20200720','','ANDA','ANDA214074','Hikma Pharmaceuticals USA Inc.','ROPIVACAINE HYDROCHLORIDE','2','mg/mL','Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9264_1249ed50-7d61-4a9d-9ffa-6020756df74e','0143-9264','HUMAN PRESCRIPTION DRUG','Ropivacaine Hydrochloride','','Ropivacaine Hydrochloride','INJECTION','EPIDURAL; INFILTRATION','20200720','','ANDA','ANDA214074','Hikma Pharmaceuticals USA Inc.','ROPIVACAINE HYDROCHLORIDE','5','mg/mL','Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9265_1249ed50-7d61-4a9d-9ffa-6020756df74e','0143-9265','HUMAN PRESCRIPTION DRUG','Ropivacaine Hydrochloride','','Ropivacaine Hydrochloride','INJECTION','EPIDURAL','20200720','','ANDA','ANDA214074','Hikma Pharmaceuticals USA Inc.','ROPIVACAINE HYDROCHLORIDE','7.5','mg/mL','Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9266_1249ed50-7d61-4a9d-9ffa-6020756df74e','0143-9266','HUMAN PRESCRIPTION DRUG','Ropivacaine Hydrochloride','','Ropivacaine Hydrochloride','INJECTION','EPIDURAL','20200720','','ANDA','ANDA214074','Hikma Pharmaceuticals USA Inc.','ROPIVACAINE HYDROCHLORIDE','10','mg/mL','Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9270_c53f6694-0965-4846-bbdc-28d8736d73cc','0143-9270','HUMAN PRESCRIPTION DRUG','Floxuridine','','Floxuridine','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRA-ARTERIAL','20180215','','ANDA','ANDA075387','Hikma Pharmaceuticals USA Inc.','FLOXURIDINE','100','mg/mL','Antimetabolite [EPC], Deoxyuridine [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9273_896ee223-d027-4b0e-83de-d3a4d718b791','0143-9273','HUMAN PRESCRIPTION DRUG','Dihydroergotamine Mesylate','','Dihydroergotamine Mesylate','INJECTION','INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS','20170915','','ANDA','ANDA206621','Hikma Pharmaceuticals USA Inc.','DIHYDROERGOTAMINE MESYLATE','1','mg/mL','Ergotamine Derivative [EPC], Ergotamines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9275_79560e42-fedf-48d0-b2f9-db8b1feacf0b','0143-9275','HUMAN PRESCRIPTION DRUG','Adriamycin','','Doxorubicin Hydrochloride','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20180119','','ANDA','ANDA062921','Hikma Pharmaceuticals USA Inc.','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9277_79560e42-fedf-48d0-b2f9-db8b1feacf0b','0143-9277','HUMAN PRESCRIPTION DRUG','Adriamycin','','Doxorubicin Hydrochloride','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20180119','','ANDA','ANDA062921','Hikma Pharmaceuticals USA Inc.','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9279_6bccab87-11af-47b4-bfec-2206939135c1','0143-9279','HUMAN PRESCRIPTION DRUG','Mitomycin','','Mitomycin','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','19960501','','ANDA','ANDA064117','West-Ward Pharmaceuticals Corp','MITOMYCIN','20','mg/40mL','Alkylating Activity [MoA], Alkylating Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9280_6bccab87-11af-47b4-bfec-2206939135c1','0143-9280','HUMAN PRESCRIPTION DRUG','Mitomycin','','Mitomycin','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','19990901','','ANDA','ANDA064117','West-Ward Pharmaceuticals Corp','MITOMYCIN','40','mg/80mL','Alkylating Activity [MoA], Alkylating Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9284_8aaebaec-c4dc-4177-9424-daa3d43236f6','0143-9284','HUMAN PRESCRIPTION DRUG','Pantoprazole Sodium','','Pantoprazole Sodium','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20170922','','NDA','NDA209463','Hikma Pharmaceuticals USA Inc.','PANTOPRAZOLE SODIUM','40','mg/1','Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9285_b63e7196-6c1f-4d48-b80e-19f1dc98a7b4','0143-9285','HUMAN PRESCRIPTION DRUG','Amoxicillin','','Amoxicillin','TABLET, COATED','ORAL','20060329','','ANDA','ANDA065255','Hikma Pharmaceuticals USA Inc.','AMOXICILLIN','875','mg/1','Penicillin-class Antibacterial [EPC], Penicillins [CS]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9288_5c41d7ef-a393-4b22-b2aa-dadcc21e9465','0143-9288','HUMAN PRESCRIPTION DRUG','Argatroban','','Argatroban','INJECTION','INTRAVENOUS','20120105','','NDA','NDA203049','Hikma Pharmaceuticals USA Inc.','ARGATROBAN','250','mg/2.5mL','Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9289_5402dd96-aec7-4cbf-b2a4-1a9eb86c8934','0143-9289','HUMAN PRESCRIPTION DRUG','Estradiol Valerate','','Estradiol Valerate','INJECTION','INTRAMUSCULAR','20200421','','ANDA','ANDA203723','Hikma Pharmaceuticals USA Inc.','ESTRADIOL VALERATE','10','mg/mL','Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9290_5402dd96-aec7-4cbf-b2a4-1a9eb86c8934','0143-9290','HUMAN PRESCRIPTION DRUG','Estradiol Valerate','','Estradiol Valerate','INJECTION','INTRAMUSCULAR','20200421','','ANDA','ANDA203723','Hikma Pharmaceuticals USA Inc.','ESTRADIOL VALERATE','20','mg/mL','Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9291_5402dd96-aec7-4cbf-b2a4-1a9eb86c8934','0143-9291','HUMAN PRESCRIPTION DRUG','Estradiol Valerate','','Estradiol Valerate','INJECTION','INTRAMUSCULAR','20200421','','ANDA','ANDA203723','Hikma Pharmaceuticals USA Inc.','ESTRADIOL VALERATE','40','mg/mL','Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9295_afe82a8f-f76a-401f-8b9f-977b4c2a3cd8','0143-9295','HUMAN PRESCRIPTION DRUG','Haloperidol Decanoate','','Haloperidol Decanoate','INJECTION','INTRAMUSCULAR','19981001','','ANDA','ANDA075305','Hikma Pharmaceuticals USA Inc.','HALOPERIDOL DECANOATE','100','mg/mL','Typical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9296_afe82a8f-f76a-401f-8b9f-977b4c2a3cd8','0143-9296','HUMAN PRESCRIPTION DRUG','Haloperidol Decanoate','','Haloperidol Decanoate','INJECTION','INTRAMUSCULAR','19981001','','ANDA','ANDA075305','Hikma Pharmaceuticals USA Inc.','HALOPERIDOL DECANOATE','100','mg/mL','Typical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9297_eafbaffa-64c7-4bee-9ad5-235399687f81','0143-9297','HUMAN PRESCRIPTION DRUG','Dantrolene','','Dantrolene','INJECTION, POWDER, FOR SOLUTION','INTRAVENOUS','20170619','','ANDA','ANDA204762','Hikma Pharmaceuticals USA Inc.','DANTROLENE SODIUM','20','mg/1','Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9298_0773cd05-6e92-4bff-aef7-eda5d81f6796','0143-9298','HUMAN PRESCRIPTION DRUG','Sodium Ferric Gluconate Complex in Sucrose','','Sodium Ferric Gluconate Complex in Sucrose','INJECTION','INTRAVENOUS','20110331','','ANDA','ANDA078215','Hikma Pharmaceuticals USA Inc.','SODIUM FERRIC GLUCONATE COMPLEX','12.5','mg/mL','Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9299_0fff71bc-b705-4d81-ab82-83f218f3160d','0143-9299','HUMAN PRESCRIPTION DRUG','Ganciclovir','','Ganciclovir sodium','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20210617','','ANDA','ANDA076222','Hikma Pharmaceuticals USA Inc.','GANCICLOVIR SODIUM','50','mg/mL','Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9300_28d24193-d823-4063-b1c4-7b9baffbe464','0143-9300','HUMAN PRESCRIPTION DRUG','Pantoprazole Sodium','','Pantoprazole Sodium','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20170922','','NDA','NDA209463','Hikma Pharmaceuticals USA Inc.','PANTOPRAZOLE SODIUM','40','mg/1','Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9306_c290c041-b554-4830-80a6-a4ad90d7d00d','0143-9306','HUMAN PRESCRIPTION DRUG','Idarubicin Hydrochloride','','Idarubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','20180112','','ANDA','ANDA065275','Hikma Pharmaceuticals USA Inc.','IDARUBICIN HYDROCHLORIDE','1','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9307_c290c041-b554-4830-80a6-a4ad90d7d00d','0143-9307','HUMAN PRESCRIPTION DRUG','Idarubicin Hydrochloride','','Idarubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','20180112','','ANDA','ANDA065275','Hikma Pharmaceuticals USA Inc.','IDARUBICIN HYDROCHLORIDE','1','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9308_c290c041-b554-4830-80a6-a4ad90d7d00d','0143-9308','HUMAN PRESCRIPTION DRUG','Idarubicin Hydrochloride','','Idarubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','20180112','','ANDA','ANDA065275','Hikma Pharmaceuticals USA Inc.','IDARUBICIN HYDROCHLORIDE','1','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9309_d0f63141-76d8-4a02-a31f-bc8c15a74159','0143-9309','HUMAN PRESCRIPTION DRUG','Thiotepa','','Thiotepa','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRACAVITARY; INTRAVENOUS; INTRAVESICAL','20010601','','ANDA','ANDA075547','Hikma Pharmaceuticals USA Inc.','THIOTEPA','15','mg/1.5mL','Alkylating Activity [MoA], Alkylating Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9310_75377609-4286-4a2a-93c4-a2718c01478a','0143-9310','HUMAN PRESCRIPTION DRUG','Etomidate','','Etomidate','INJECTION','INTRAVENOUS','20160225','','ANDA','ANDA202354','Hikma Pharmaceuticals USA Inc.','ETOMIDATE','2','mg/mL','General Anesthesia [PE], General Anesthetic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9311_75377609-4286-4a2a-93c4-a2718c01478a','0143-9311','HUMAN PRESCRIPTION DRUG','Etomidate','','Etomidate','INJECTION','INTRAVENOUS','20160225','','ANDA','ANDA202354','Hikma Pharmaceuticals USA Inc.','ETOMIDATE','2','mg/mL','General Anesthesia [PE], General Anesthetic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9315_05cdb9d7-2bce-400d-8565-8a76c4a1a8e3','0143-9315','HUMAN PRESCRIPTION DRUG','Levofloxacin','','Levofloxacin','INJECTION, SOLUTION','INTRAVENOUS','20110916','','ANDA','ANDA091375','Hikma Pharmaceuticals USA Inc.','LEVOFLOXACIN','250','mg/50mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9316_05cdb9d7-2bce-400d-8565-8a76c4a1a8e3','0143-9316','HUMAN PRESCRIPTION DRUG','Levofloxacin','','Levofloxacin','INJECTION, SOLUTION','INTRAVENOUS','20110916','','ANDA','ANDA091375','Hikma Pharmaceuticals USA Inc.','LEVOFLOXACIN','500','mg/100mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9317_05cdb9d7-2bce-400d-8565-8a76c4a1a8e3','0143-9317','HUMAN PRESCRIPTION DRUG','Levofloxacin','','Levofloxacin','INJECTION, SOLUTION','INTRAVENOUS','20110916','','ANDA','ANDA091375','Hikma Pharmaceuticals USA Inc.','LEVOFLOXACIN','750','mg/150mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9318_4e4bd5c7-3e4b-4e5f-9693-5d2f56d268bf','0143-9318','HUMAN PRESCRIPTION DRUG','Norepinephrine Bitartrate','','Norepinephrine Bitartrate','INJECTION','INTRAVENOUS','20180801','','ANDA','ANDA203662','Hikma Pharmaceuticals USA Inc.','NOREPINEPHRINE BITARTRATE','1','mg/mL','Catecholamine [EPC], Catecholamines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9319_b93ee0dc-a484-402b-8345-3d68ba0c689a','0143-9319','HUMAN PRESCRIPTION DRUG','Haloperidol','','Haloperidol lactate','INJECTION','INTRAMUSCULAR','20180914','','ANDA','ANDA075858','Hikma Pharmaceuticals USA Inc.','HALOPERIDOL LACTATE','5','mg/mL','Typical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9320_6b69f581-9d97-4e63-9a84-b82d1a945d1c','0143-9320','HUMAN PRESCRIPTION DRUG','Labetalol Hydrochloride','','Labetalol Hydrochloride','INJECTION','INTRAVENOUS','19991129','','ANDA','ANDA075303','West-Ward Pharmaceuticals Corp','LABETALOL HYDROCHLORIDE','5','mg/mL','Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9326_181d0496-395b-420b-ae94-99921949fc16','0143-9326','HUMAN PRESCRIPTION DRUG','Milrinone Lactate','','Milrinone Lactate','INJECTION, SOLUTION','INTRAVENOUS','20101203','','ANDA','ANDA077966','Hikma Pharmaceuticals USA Inc.','MILRINONE LACTATE','1','mg/mL','Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9328_db94d1d6-2933-4aea-a7ed-b6dd80119360','0143-9328','HUMAN PRESCRIPTION DRUG','Bupivacaine Hydrochloride','','Bupivacaine Hydrochloride','INJECTION, SOLUTION','INFILTRATION; PERINEURAL','20210211','','ANDA','ANDA205141','Hikma Pharmaceuticals USA Inc.','BUPIVACAINE HYDROCHLORIDE','2.5','mg/mL','Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9329_db94d1d6-2933-4aea-a7ed-b6dd80119360','0143-9329','HUMAN PRESCRIPTION DRUG','Bupivacaine Hydrochloride','','Bupivacaine Hydrochloride','INJECTION, SOLUTION','PERINEURAL','20210211','','ANDA','ANDA205141','Hikma Pharmaceuticals USA Inc.','BUPIVACAINE HYDROCHLORIDE','5','mg/mL','Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9330_bdb4d6f4-9e82-43e2-aed0-f6dc1f794852','0143-9330','HUMAN PRESCRIPTION DRUG','Bupivacaine Hydrochloride','','Bupivacaine Hydrochloride','INJECTION, SOLUTION','EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL','20210211','','ANDA','ANDA204842','Hikma Pharmaceuticals USA Inc.','BUPIVACAINE HYDROCHLORIDE','2.5','mg/mL','Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9331_bdb4d6f4-9e82-43e2-aed0-f6dc1f794852','0143-9331','HUMAN PRESCRIPTION DRUG','Bupivacaine Hydrochloride','','Bupivacaine Hydrochloride','INJECTION, SOLUTION','EPIDURAL; INTRACAUDAL; PERINEURAL','20210211','','ANDA','ANDA204842','Hikma Pharmaceuticals USA Inc.','BUPIVACAINE HYDROCHLORIDE','5','mg/mL','Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9332_bdb4d6f4-9e82-43e2-aed0-f6dc1f794852','0143-9332','HUMAN PRESCRIPTION DRUG','Bupivacaine Hydrochloride','','Bupivacaine Hydrochloride','INJECTION, SOLUTION','EPIDURAL; RETROBULBAR','20210211','','ANDA','ANDA204842','Hikma Pharmaceuticals USA Inc.','BUPIVACAINE HYDROCHLORIDE','7.5','mg/mL','Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9333_bdb4d6f4-9e82-43e2-aed0-f6dc1f794852','0143-9333','HUMAN PRESCRIPTION DRUG','Bupivacaine Hydrochloride','','Bupivacaine Hydrochloride','INJECTION, SOLUTION','EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL','20210211','','ANDA','ANDA204842','Hikma Pharmaceuticals USA Inc.','BUPIVACAINE HYDROCHLORIDE','2.5','mg/mL','Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9334_bdb4d6f4-9e82-43e2-aed0-f6dc1f794852','0143-9334','HUMAN PRESCRIPTION DRUG','Bupivacaine Hydrochloride','','Bupivacaine Hydrochloride','INJECTION, SOLUTION','EPIDURAL; INTRACAUDAL; PERINEURAL','20210211','','ANDA','ANDA204842','Hikma Pharmaceuticals USA Inc.','BUPIVACAINE HYDROCHLORIDE','5','mg/mL','Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9335_bdb4d6f4-9e82-43e2-aed0-f6dc1f794852','0143-9335','HUMAN PRESCRIPTION DRUG','Bupivacaine Hydrochloride','','Bupivacaine Hydrochloride','INJECTION, SOLUTION','EPIDURAL; RETROBULBAR','20210211','','ANDA','ANDA204842','Hikma Pharmaceuticals USA Inc.','BUPIVACAINE HYDROCHLORIDE','7.5','mg/mL','Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9338_1fbea511-9489-46c5-ae04-28235a9dd991','0143-9338','HUMAN PRESCRIPTION DRUG','Succinylcholine Chloride','','Succinylcholine Chloride','INJECTION, SOLUTION','INTRAMUSCULAR; INTRAVENOUS','20210426','','ANDA','ANDA213229','Hikma Pharmaceuticals USA Inc.','SUCCINYLCHOLINE CHLORIDE DIHYDRATE','20','mg/mL','Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9355_e298d434-6e7e-4a46-9744-a098386a89d6','0143-9355','HUMAN PRESCRIPTION DRUG','Vancomycin Hydrochloride','','Vancomycin Hydrochloride','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20181003','','ANDA','ANDA206616','Hikma Pharmaceuticals USA Inc.','VANCOMYCIN','750','mg/1','Glycopeptide Antibacterial [EPC], Glycopeptides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9356_431d7445-e798-40a7-a8aa-6a8b1ac5813f','0143-9356','HUMAN PRESCRIPTION DRUG','Vancomycin Hydrochloride','','Vancomycin Hydrochloride','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20200811','','ANDA','ANDA203300','Hikma Pharmaceuticals USA Inc.','VANCOMYCIN HYDROCHLORIDE','500','mg/1','Glycopeptide Antibacterial [EPC], Glycopeptides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9357_431d7445-e798-40a7-a8aa-6a8b1ac5813f','0143-9357','HUMAN PRESCRIPTION DRUG','Vancomycin Hydrochloride','','Vancomycin Hydrochloride','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20200811','','ANDA','ANDA203300','Hikma Pharmaceuticals USA Inc.','VANCOMYCIN HYDROCHLORIDE','1','g/1','Glycopeptide Antibacterial [EPC], Glycopeptides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9358_fcd91c44-1388-4e34-8078-678c1a640c9c','0143-9358','HUMAN PRESCRIPTION DRUG','Vancomycin Hydrochloride','','Vancomycin Hydrochloride','INJECTION, POWDER, FOR SOLUTION','INTRAVENOUS','20181015','','ANDA','ANDA204360','Hikma Pharmaceuticals USA Inc.','VANCOMYCIN HYDROCHLORIDE','5','g/1','Glycopeptide Antibacterial [EPC], Glycopeptides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9359_fcd91c44-1388-4e34-8078-678c1a640c9c','0143-9359','HUMAN PRESCRIPTION DRUG','Vancomycin Hydrochloride','','Vancomycin Hydrochloride','INJECTION, POWDER, FOR SOLUTION','INTRAVENOUS','20181015','','ANDA','ANDA204360','Hikma Pharmaceuticals USA Inc.','VANCOMYCIN HYDROCHLORIDE','10','g/1','Glycopeptide Antibacterial [EPC], Glycopeptides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9361_cafa9061-bee0-48bf-938f-ba688ded1140','0143-9361','HUMAN PRESCRIPTION DRUG','Micafungin','','Micafungin sodium','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20210709','','ANDA','ANDA213261','Hikma Pharmaceuticals USA Inc.','MICAFUNGIN','10','mg/mL','Echinocandin Antifungal [EPC], Lipopeptides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9362_cafa9061-bee0-48bf-938f-ba688ded1140','0143-9362','HUMAN PRESCRIPTION DRUG','Micafungin','','Micafungin sodium','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20210709','','ANDA','ANDA213261','Hikma Pharmaceuticals USA Inc.','MICAFUNGIN','20','mg/mL','Echinocandin Antifungal [EPC], Lipopeptides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9363_922f21dc-0eb6-4beb-85ce-58fe4edb1b89','0143-9363','HUMAN PRESCRIPTION DRUG','Labetalol HCl in Sodium Chloride','','LABETALOL HYDROCHLORIDE','INJECTION','INTRAVENOUS','20201109','','NDA','NDA213330','Hikma Pharmaceuticals USA Inc.','LABETALOL HYDROCHLORIDE','1','mg/mL','Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9364_922f21dc-0eb6-4beb-85ce-58fe4edb1b89','0143-9364','HUMAN PRESCRIPTION DRUG','Labetalol HCl in Sodium Chloride','','LABETALOL HYDROCHLORIDE','INJECTION','INTRAVENOUS','20201109','','NDA','NDA213330','Hikma Pharmaceuticals USA Inc.','LABETALOL HYDROCHLORIDE','1','mg/mL','Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9365_922f21dc-0eb6-4beb-85ce-58fe4edb1b89','0143-9365','HUMAN PRESCRIPTION DRUG','Labetalol HCl in Sodium Chloride','','LABETALOL HYDROCHLORIDE','INJECTION','INTRAVENOUS','20201109','','NDA','NDA213330','Hikma Pharmaceuticals USA Inc.','LABETALOL HYDROCHLORIDE','1','mg/mL','Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9366_922f21dc-0eb6-4beb-85ce-58fe4edb1b89','0143-9366','HUMAN PRESCRIPTION DRUG','Labetalol HCl in Dextrose','','Labetalol Hydrochloride','INJECTION','INTRAVENOUS','20201109','','NDA','NDA213330','Hikma Pharmaceuticals USA Inc.','LABETALOL HYDROCHLORIDE','1','mg/mL','Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9367_f8fa3869-95ff-42a2-9658-8641a30e9eec','0143-9367','HUMAN PRESCRIPTION DRUG','Methotrexate','','Methotrexate','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS','20050906','','ANDA','ANDA040632','Hikma Pharmaceuticals USA Inc.','METHOTREXATE','1','g/1','Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9368_0000f768-a8cc-46ba-95a1-88b0ebd09be7','0143-9368','HUMAN PRESCRIPTION DRUG','Leucovorin Calcium','','Leucovorin Calcium','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19950523','','ANDA','ANDA040056','Hikma Pharmaceuticals USA Inc.','LEUCOVORIN CALCIUM','200','mg/20mL','Folate Analog [EPC], Folic Acid [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9369_64517d03-d04d-40ed-8627-afcae0b156bd','0143-9369','HUMAN PRESCRIPTION DRUG','Adriamycin','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19960501','','ANDA','ANDA062975','Hikma Pharmaceuticals USA Inc.','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9370_64517d03-d04d-40ed-8627-afcae0b156bd','0143-9370','HUMAN PRESCRIPTION DRUG','Adriamycin','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19960501','','ANDA','ANDA062975','Hikma Pharmaceuticals USA Inc.','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9371_64517d03-d04d-40ed-8627-afcae0b156bd','0143-9371','HUMAN PRESCRIPTION DRUG','Adriamycin','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19960501','','ANDA','ANDA062975','Hikma Pharmaceuticals USA Inc.','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9372_64517d03-d04d-40ed-8627-afcae0b156bd','0143-9372','HUMAN PRESCRIPTION DRUG','Adriamycin','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19960501','','ANDA','ANDA064097','Hikma Pharmaceuticals USA Inc.','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9373_9a946e38-e151-4627-91dc-2ee4b978b9e0','0143-9373','HUMAN PRESCRIPTION DRUG','Milrinone Lactate','','Milrinone Lactate','INJECTION, SOLUTION','INTRAVENOUS','20101203','','ANDA','ANDA077966','Hikma Pharmaceuticals USA Inc.','MILRINONE LACTATE','1','mg/mL','Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9374_9a946e38-e151-4627-91dc-2ee4b978b9e0','0143-9374','HUMAN PRESCRIPTION DRUG','Milrinone Lactate','','Milrinone Lactate','INJECTION, SOLUTION','INTRAVENOUS','20101203','','ANDA','ANDA077966','Hikma Pharmaceuticals USA Inc.','MILRINONE LACTATE','1','mg/mL','Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9375_c46b3216-1e79-4473-b4f3-951fd506ab92','0143-9375','HUMAN PRESCRIPTION DRUG','Terbutaline Sulfate','','Terbutaline Sulfate','INJECTION','SUBCUTANEOUS','20090520','','ANDA','ANDA078630','Hikma Pharmaceuticals USA Inc.','TERBUTALINE SULFATE','1','mg/mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9376_59f81d09-9385-478e-a1d7-19588a08a239','0143-9376','HUMAN PRESCRIPTION DRUG','Etoposide','','Etoposide','INJECTION','INTRAVENOUS','19960501','','ANDA','ANDA074290','Hikma Pharmaceuticals USA Inc.','ETOPOSIDE','20','mg/mL','Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9377_b40b10c5-7a46-45e7-a665-307512a3f2b9','0143-9377','HUMAN PRESCRIPTION DRUG','Argatroban','','Argatroban','INJECTION','INTRAVENOUS','20200325','','NDA','NDA203049','Hikma Pharmaceuticals USA Inc.','ARGATROBAN','50','mg/50mL','Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9378_806f1a3f-9c54-4a7d-9749-9e7348b5409b','0143-9378','HUMAN PRESCRIPTION DRUG','Daptomycin','','Daptomycin','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20200101','','ANDA','ANDA212022','Hikma Pharmaceuticals USA Inc.','DAPTOMYCIN','500','mg/10mL','Lipopeptide Antibacterial [EPC], Lipopeptides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9381_6339f3cd-e271-4cca-b8ad-e2676747a7c2','0143-9381','HUMAN PRESCRIPTION DRUG','Doxycycline','','Doxycycline','INJECTION, POWDER, FOR SOLUTION','INTRAVENOUS','20210517','','ANDA','ANDA062992','Hikma Pharmaceuticals USA Inc.','DOXYCYCLINE HYCLATE','100','mg/1','Tetracycline-class Drug [EPC], Tetracyclines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9384_b1f3d842-7902-4887-bd41-819a54b19f64','0143-9384','HUMAN PRESCRIPTION DRUG','FOSAPREPITANT DIMEGLUMINE','','FOSAPREPITANT DIMEGLUMINE','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20200908','','ANDA','ANDA213106','Hikma Pharmaceuticals USA Inc.','FOSAPREPITANT DIMEGLUMINE','150','mg/5mL','Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9385_f03251b9-a685-4db3-9ca3-7b17ac29a0b8','0143-9385','HUMAN PRESCRIPTION DRUG','decitabine','','decitabine','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20220415','','ANDA','ANDA213472','Hikma Pharmaceuticals USA Inc.','DECITABINE','50','mg/1','Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9386_d9fee470-efb0-4a2f-accb-1c496ea508f2','0143-9386','HUMAN PRESCRIPTION DRUG','Acetaminophen','','Acetaminophen','INJECTION','INTRAVENOUS','20220603','','NDA','NDA206968','Hikma Pharmaceuticals USA Inc.','ACETAMINOPHEN','1000','mg/100mL','','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9391_76680bf5-083a-43d3-93c6-998cfbe321bb','0143-9391','HUMAN PRESCRIPTION DRUG','REMIFENTANIL HYDROCHLORIDE','','REMIFENTANIL HYDROCHLORIDE','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20210515','','ANDA','ANDA210594','Hikma Pharmaceuticals USA Inc.','REMIFENTANIL HYDROCHLORIDE','1','mg/mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9392_76680bf5-083a-43d3-93c6-998cfbe321bb','0143-9392','HUMAN PRESCRIPTION DRUG','REMIFENTANIL HYDROCHLORIDE','','REMIFENTANIL HYDROCHLORIDE','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20210515','','ANDA','ANDA210594','Hikma Pharmaceuticals USA Inc.','REMIFENTANIL HYDROCHLORIDE','2','mg/2mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9393_76680bf5-083a-43d3-93c6-998cfbe321bb','0143-9393','HUMAN PRESCRIPTION DRUG','REMIFENTANIL HYDROCHLORIDE','','REMIFENTANIL HYDROCHLORIDE','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20210515','','ANDA','ANDA210594','Hikma Pharmaceuticals USA Inc.','REMIFENTANIL HYDROCHLORIDE','5','mg/5mL','Full Opioid Agonists [MoA], Opioid Agonist [EPC]','CII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9394_37afef8b-07d8-4857-934a-ddea3296e592','0143-9394','HUMAN PRESCRIPTION DRUG','Gemcitabine','','Gemcitabine','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20210625','','ANDA','ANDA206617','Hikma Pharmaceuticals USA Inc.','GEMCITABINE','200','mg/1','Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9395_37afef8b-07d8-4857-934a-ddea3296e592','0143-9395','HUMAN PRESCRIPTION DRUG','Gemcitabine','','Gemcitabine','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20210625','','ANDA','ANDA206617','Hikma Pharmaceuticals USA Inc.','GEMCITABINE','1','g/1','Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9398_f854c51c-2c99-4168-81d4-c71769ae9c0f','0143-9398','HUMAN PRESCRIPTION DRUG','ertapenem sodium','','ertapenem sodium','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','20210802','','ANDA','ANDA208790','Hikma Pharmaceuticals USA, Inc.','ERTAPENEM SODIUM','1','g/1','Carbapenems [CS], Penem Antibacterial [EPC]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9428_8c0f31c8-d8b7-453f-9cd9-041942311040','0143-9428','HUMAN PRESCRIPTION DRUG','FOSAPREPITANT DIMEGLUMINE','','FOSAPREPITANT DIMEGLUMINE','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20210501','','ANDA','ANDA213106','Hikma Pharmaceuticals USA Inc.','FOSAPREPITANT DIMEGLUMINE','150','mg/5mL','Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9501_38dc32f5-1ed9-4f0a-beb0-bd51828dcead','0143-9501','HUMAN PRESCRIPTION DRUG','Haloperidol','','Haloperidol lactate','INJECTION','INTRAMUSCULAR','20010619','','ANDA','ANDA075858','Hikma Pharmaceuticals USA Inc.','HALOPERIDOL LACTATE','5','mg/mL','Typical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9502_38dc32f5-1ed9-4f0a-beb0-bd51828dcead','0143-9502','HUMAN PRESCRIPTION DRUG','Haloperidol','','Haloperidol Lactate','INJECTION','INTRAMUSCULAR','20010619','','ANDA','ANDA075858','Hikma Pharmaceuticals USA Inc.','HALOPERIDOL LACTATE','5','mg/mL','Typical Antipsychotic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9503_3ae6699a-f856-443c-8a20-4c58fb10811b','0143-9503','HUMAN PRESCRIPTION DRUG','AcetaZOLAMIDE','','Acetazolamide','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','19960501','','ANDA','ANDA040089','Hikma Pharmaceuticals USA Inc.','ACETAZOLAMIDE SODIUM','500','mg/1','Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9504_2c569ef0-588f-4828-8b2d-03a2120c9b4c','0143-9504','HUMAN PRESCRIPTION DRUG','CISplatin','','Cisplatin','INJECTION','INTRAVENOUS','20001107','','ANDA','ANDA075036','West-Ward Pharmaceuticals Corp','CISPLATIN','1','mg/mL','Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9505_2c569ef0-588f-4828-8b2d-03a2120c9b4c','0143-9505','HUMAN PRESCRIPTION DRUG','CISplatin','','Cisplatin','INJECTION','INTRAVENOUS','20001107','','ANDA','ANDA075036','West-Ward Pharmaceuticals Corp','CISPLATIN','1','mg/mL','Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9506_bfe7b7a7-defe-4fa6-b935-80c40560637a','0143-9506','HUMAN PRESCRIPTION DRUG','Etomidate','','Etomidate','INJECTION','INTRAVENOUS','20160225','','ANDA','ANDA202354','Hikma Pharmaceuticals USA Inc.','ETOMIDATE','2','mg/mL','General Anesthesia [PE], General Anesthetic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9507_bfe7b7a7-defe-4fa6-b935-80c40560637a','0143-9507','HUMAN PRESCRIPTION DRUG','Etomidate','','Etomidate','INJECTION','INTRAVENOUS','20160225','','ANDA','ANDA202354','Hikma Pharmaceuticals USA Inc.','ETOMIDATE','2','mg/mL','General Anesthesia [PE], General Anesthetic [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9508_3205b1e7-c233-4299-8c21-e34f7f897c97','0143-9508','HUMAN PRESCRIPTION DRUG','Ketamine Hydrochloride','','Ketamine Hydrochloride','INJECTION','INTRAMUSCULAR; INTRAVENOUS','19960701','','ANDA','ANDA074524','Hikma Pharmaceuticals USA Inc.','KETAMINE HYDROCHLORIDE','50','mg/mL','General Anesthesia [PE], General Anesthetic [EPC]','CIII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9509_3205b1e7-c233-4299-8c21-e34f7f897c97','0143-9509','HUMAN PRESCRIPTION DRUG','Ketamine Hydrochloride','','Ketamine Hydrochloride','INJECTION','INTRAMUSCULAR; INTRAVENOUS','19960701','','ANDA','ANDA074524','Hikma Pharmaceuticals USA Inc.','KETAMINE HYDROCHLORIDE','100','mg/mL','General Anesthesia [PE], General Anesthetic [EPC]','CIII','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9510_8f7f9bf4-220e-4fe1-9e6d-b75c2f3948d3','0143-9510','HUMAN PRESCRIPTION DRUG','Etoposide','','Etoposide','INJECTION','INTRAVENOUS','19960501','','ANDA','ANDA074290','Hikma Pharmaceuticals USA Inc.','ETOPOSIDE','20','mg/mL','Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9511_8f7f9bf4-220e-4fe1-9e6d-b75c2f3948d3','0143-9511','HUMAN PRESCRIPTION DRUG','Etoposide','','Etoposide','INJECTION','INTRAVENOUS','19970201','','ANDA','ANDA074290','Hikma Pharmaceuticals USA Inc.','ETOPOSIDE','20','mg/mL','Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9512_8f7f9bf4-220e-4fe1-9e6d-b75c2f3948d3','0143-9512','HUMAN PRESCRIPTION DRUG','Etoposide','','Etoposide','INJECTION','INTRAVENOUS','19970201','','ANDA','ANDA074290','Hikma Pharmaceuticals USA Inc.','ETOPOSIDE','20','mg/mL','Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9513_7dc05b1a-344a-410b-a7b3-171727713cf1','0143-9513','HUMAN PRESCRIPTION DRUG','Palonosetron Hydrochloride','','Palonosetron Hydrochloride','INJECTION','INTRAVENOUS','20170901','','NDA','NDA207963','West-Ward Pharmaceuticals Corp','PALONOSETRON HYDROCHLORIDE','0.25','mg/2mL','Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9514_a7e520ca-3213-4203-9a23-5295d82088e3','0143-9514','HUMAN PRESCRIPTION DRUG','DROPERIDOL','','DROPERIDOL','INJECTION, SOLUTION','INTRAMUSCULAR; INTRAVENOUS','20220601','','ANDA','ANDA208197','Hikma Pharmaceuticals USA Inc.','DROPERIDOL','2.5','mg/mL','Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9515_a7e520ca-3213-4203-9a23-5295d82088e3','0143-9515','HUMAN PRESCRIPTION DRUG','DROPERIDOL','','DROPERIDOL','INJECTION, SOLUTION','INTRAMUSCULAR; INTRAVENOUS','20220601','','ANDA','ANDA208197','Hikma Pharmaceuticals USA Inc.','DROPERIDOL','2.5','mg/mL','Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9516_bae2f7a9-edf9-4b30-b301-a334b1ffa3da','0143-9516','HUMAN PRESCRIPTION DRUG','Methotrexate','','Methotrexate','SOLUTION','INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS','20180105','','ANDA','ANDA089343','Hikma Pharmaceuticals USA Inc.','METHOTREXATE','25','mg/mL','Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9517_bae2f7a9-edf9-4b30-b301-a334b1ffa3da','0143-9517','HUMAN PRESCRIPTION DRUG','Methotrexate','','Methotrexate','SOLUTION','INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS','20180105','','ANDA','ANDA089342','Hikma Pharmaceuticals USA Inc.','METHOTREXATE','25','mg/mL','Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9518_bae2f7a9-edf9-4b30-b301-a334b1ffa3da','0143-9518','HUMAN PRESCRIPTION DRUG','Methotrexate','','Methotrexate','SOLUTION','INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS','20180105','','ANDA','ANDA089341','Hikma Pharmaceuticals USA Inc.','METHOTREXATE','25','mg/mL','Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9519_bae2f7a9-edf9-4b30-b301-a334b1ffa3da','0143-9519','HUMAN PRESCRIPTION DRUG','Methotrexate','','Methotrexate','SOLUTION','INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS','20171010','','ANDA','ANDA089340','Hikma Pharmaceuticals USA Inc.','METHOTREXATE','25','mg/mL','Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9525_5fc99e11-9424-4a5c-88a2-a91996a869b8','0143-9525','HUMAN PRESCRIPTION DRUG','Dexmedetomidine Hydrochloride','','Dexmedetomidine Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','20200130','','ANDA','ANDA206407','Hikma Pharmaceuticals USA Inc.','DEXMEDETOMIDINE HYDROCHLORIDE','4','ug/mL','Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9526_5fc99e11-9424-4a5c-88a2-a91996a869b8','0143-9526','HUMAN PRESCRIPTION DRUG','Dexmedetomidine Hydrochloride','','Dexmedetomidine Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','20200130','','ANDA','ANDA206407','Hikma Pharmaceuticals USA Inc.','DEXMEDETOMIDINE HYDROCHLORIDE','4','ug/mL','Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9529_b224759c-812e-4881-a641-bd823e5ca875','0143-9529','HUMAN PRESCRIPTION DRUG','Fluphenazine Decanoate','','Fluphenazine Decanoate','INJECTION','INTRAMUSCULAR; SUBCUTANEOUS','19960830','','ANDA','ANDA074531','Hikma Pharmaceuticals USA Inc.','FLUPHENAZINE DECANOATE','25','mg/mL','Phenothiazine [EPC], Phenothiazines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9530_bd51c1ba-55f5-4a33-b2db-f2643891b055','0143-9530','HUMAN PRESCRIPTION DRUG','Ifosfamide','','Ifosfamide','INJECTION','INTRAVENOUS','20170610','','ANDA','ANDA076619','Hikma Pharmaceuticals USA Inc.','IFOSFAMIDE','50','mg/mL','Alkylating Activity [MoA], Alkylating Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9531_bd51c1ba-55f5-4a33-b2db-f2643891b055','0143-9531','HUMAN PRESCRIPTION DRUG','Ifosfamide','','Ifosfamide','INJECTION','INTRAVENOUS','20170610','','ANDA','ANDA076619','Hikma Pharmaceuticals USA Inc.','IFOSFAMIDE','50','mg/mL','Alkylating Activity [MoA], Alkylating Drug [EPC]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9532_38075d5c-5eef-48f3-b08a-35b3589f6d39','0143-9532','HUMAN PRESCRIPTION DRUG','Dexmedetomidine HCl','','Dexmedetomidine HCl','INJECTION','INTRAVENOUS','20170426','','ANDA','ANDA205046','Hikma Pharmaceuticals USA Inc.','DEXMEDETOMIDINE HYDROCHLORIDE','100','ug/mL','Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]','','N','20241231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9533_5f7a1da9-2b25-46d2-8b6b-fdb44a4e1fd7','0143-9533','HUMAN PRESCRIPTION DRUG','Allopurinol sodium','','Allopurinol sodium','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20040901','','ANDA','ANDA076870','Hikma Pharmaceuticals USA Inc.','ALLOPURINOL SODIUM','500','mg/25mL','Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9534_14253ab1-76a6-4df9-8811-739fe7be9d31','0143-9534','HUMAN PRESCRIPTION DRUG','Linezolid','','Linezolid','INJECTION, SOLUTION','INTRAVENOUS','20221227','','ANDA','ANDA206454','Hikma Pharmaceuticals USA Inc.','LINEZOLID','600','mg/300mL','Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9542_b87038d9-8a91-428b-8d7f-6eef3a836742','0143-9542','HUMAN PRESCRIPTION DRUG','Nicardipine Hydrochloride','','Nicardipine Hydrochloride','INJECTION','INTRAVENOUS','20120302','','NDA','NDA022276','Hikma Pharmaceuticals USA Inc.','NICARDIPINE HYDROCHLORIDE','2.5','mg/mL','Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9546_7eb88b4b-34e3-4d47-80f4-f17bd690d3b5','0143-9546','HUMAN PRESCRIPTION DRUG','Adriamycin','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19960501','','ANDA','ANDA064097','Hikma Pharmaceuticals USA Inc.','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9547_7eb88b4b-34e3-4d47-80f4-f17bd690d3b5','0143-9547','HUMAN PRESCRIPTION DRUG','Adriamycin','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19960501','','ANDA','ANDA062975','Hikma Pharmaceuticals USA Inc.','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9548_7eb88b4b-34e3-4d47-80f4-f17bd690d3b5','0143-9548','HUMAN PRESCRIPTION DRUG','Adriamycin','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19960501','','ANDA','ANDA062975','Hikma Pharmaceuticals USA Inc.','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9549_7eb88b4b-34e3-4d47-80f4-f17bd690d3b5','0143-9549','HUMAN PRESCRIPTION DRUG','Adriamycin','','Doxorubicin Hydrochloride','INJECTION, SOLUTION','INTRAVENOUS','19960501','','ANDA','ANDA062975','Hikma Pharmaceuticals USA Inc.','DOXORUBICIN HYDROCHLORIDE','2','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9550_b43c2345-599b-42c0-bd18-9e35f62eac5e','0143-9550','HUMAN PRESCRIPTION DRUG','Daunorubicin Hydrochloride','','Daunorubicin Hydrochloride','INJECTION','INTRAVENOUS','20180102','','NDA','NDA050731','Hikma Pharmaceuticals USA Inc.','DAUNORUBICIN HYDROCHLORIDE','5','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9551_b43c2345-599b-42c0-bd18-9e35f62eac5e','0143-9551','HUMAN PRESCRIPTION DRUG','Daunorubicin Hydrochloride','','Daunorubicin Hydrochloride','INJECTION','INTRAVENOUS','20180102','','NDA','NDA050731','Hikma Pharmaceuticals USA Inc.','DAUNORUBICIN HYDROCHLORIDE','5','mg/mL','Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9552_e2d1484b-2920-45ab-9207-4caa5285fef4','0143-9552','HUMAN PRESCRIPTION DRUG','Leucovorin Calcium','','Leucovorin Calcium','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','20000420','','ANDA','ANDA040335','Hikma Pharmaceuticals USA Inc.','LEUCOVORIN CALCIUM','350','mg/17.5mL','Folate Analog [EPC], Folic Acid [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9553_e2d1484b-2920-45ab-9207-4caa5285fef4','0143-9553','HUMAN PRESCRIPTION DRUG','Leucovorin Calcium','','Leucovorin Calcium','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19950523','','ANDA','ANDA040056','Hikma Pharmaceuticals USA Inc.','LEUCOVORIN CALCIUM','200','mg/20mL','Folate Analog [EPC], Folic Acid [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9554_e2d1484b-2920-45ab-9207-4caa5285fef4','0143-9554','HUMAN PRESCRIPTION DRUG','Leucovorin Calcium','','Leucovorin Calcium','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19880328','','ANDA','ANDA089717','Hikma Pharmaceuticals USA Inc.','LEUCOVORIN CALCIUM','100','mg/10mL','Folate Analog [EPC], Folic Acid [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9555_e2d1484b-2920-45ab-9207-4caa5285fef4','0143-9555','HUMAN PRESCRIPTION DRUG','Leucovorin Calcium','','Leucovorin Calcium','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19870914','','ANDA','ANDA089384','Hikma Pharmaceuticals USA Inc.','LEUCOVORIN CALCIUM','50','mg/5mL','Folate Analog [EPC], Folic Acid [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9558_d5427bbc-8598-4e79-9aeb-b0a9317e3433','0143-9558','HUMAN PRESCRIPTION DRUG','Levoleucovorin','','Levoleucovorin','INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','INTRAVENOUS','20160707','','ANDA','ANDA206263','Hikma Pharmaceuticals USA Inc.','LEVOLEUCOVORIN CALCIUM','50','mg/5mL','Folate Analog [EPC], Folic Acid [CS]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9559_7fcb5097-ef38-4eae-80ef-871f3d842d13','0143-9559','HUMAN PRESCRIPTION DRUG','Argatroban','','Argatroban','INJECTION','INTRAVENOUS','20161101','','NDA','NDA203049','Hikma Pharmaceuticals USA Inc.','ARGATROBAN','50','mg/50mL','Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]','','N','20231231');
execute format('INSERT INTO %I.%I(PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,
ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,
PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH)VALUES (%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L,%L)',
schema_name, table_name,'0143-9564_b086317f-d4f5-40c1-bf4c-e56a3a941552','0143-9564','HUMAN PRESCRIPTION DRUG','Phentolamine Mesylate','','Phentolamine Mesylate','INJECTION, POWDER, FOR SOLUTION','INTRAMUSCULAR; INTRAVENOUS','19980515','','ANDA','ANDA040235','West-Ward Pharmaceuticals Corp','PHENTOLAMINE MESYLATE','5','mg/mL','Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]','','N','20231231');
-- Log success message
  call SP0018_log_creation(schema_name,logtbl_name, 'SP0301_insert_ndc_codes');
  EXCEPTION
  WHEN OTHERS THEN
    -- Log error message
    call SP0017_log_failed(schema_name,logtbl_name, 'SP0301_insert_ndc_codes',SQLERRM);
    RETURN;
END;
END;
$$;
call SP0301_insert_ndc_codes('SCHEMANAME','master_ndc_code','re_execution_log');
drop procedure SP0301_insert_ndc_codes;